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ABSTRACT
The asymmetric construction of quaternary stereocenters is a topic of great
interest in the organic chemistry community given their prevalence in natural products
and biologically active molecules.  Over the last decade, the Stoltz group has pursued the
synthesis of this challenging motif via a palladium-catalyzed allylic alkylation using
chiral phosphinooxazoline (PHOX) ligands.  Recent results indicate that the alkylation of
lactams and imides consistently proceeds with enantioselectivities substantially higher
than any other substrate class previously examined in this system.  This observation
prompted exploration of the characteristics that distinguish these molecules as superior
alkylation substrates, resulting in newfound insights and marked improvements in the
allylic alkylation of carbocyclic compounds.
General routes to cyclopentanoid and cycloheptanoid core structures have been
developed that incorporate the palladium-catalyzed allylic alkylation as a key
transformation.  The unique reactivity of !-quaternary vinylogous esters upon addition of
hydride or organometallic reagents enables divergent access to "-quaternary
acylcyclopentenes or cycloheptenones through respective ring contraction or carbonyl
transposition pathways.  Derivatization of the resulting molecules provides a series of
mono-, bi-, and tricyclic systems that can serve as valuable intermediates for the total
synthesis of complex natural products.
The allylic alkylation and ring contraction methodology has been employed to
prepare variably functionalized bicyclo[5.3.0]decane molecules and enables the
enantioselective total syntheses of daucene, daucenal, epoxydaucenal B, and 14-p-
anisoyloxydauc-4,8-diene.  This route overcomes the challenge of accessing #-substituted
acylcyclopentenes by employing a siloxyenone to effect the Grignard addition and ring
opening in a single step.  Subsequent ring-closing metathesis and aldol reactions form the
hydroazulene core of these targets.  Derivatization of a key enone intermediate allows
access to either the daucane sesquiterpene or sphenobolane diterpene carbon skeletons, as
well as other oxygenated scaffolds.
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CHAPTER 1
Expanding Insight into the Asymmetric Palladium-Catalyzed
Allylic Alkylation of N-Heterocyclic Molecules and Cyclic Ketones†
1.1 INTRODUCTION AND BACKGROUND
The asymmetric construction of quaternary stereocenters is a topic of great
interest in the organic chemistry community.  Among the available methods that afford
this motif,1 palladium-catalyzed decarboxylative allylic alkylation2,3 has proven
particularly effective and, over the last decade, our group has pursued this strategy
employing chiral phosphinooxazoline (PHOX) ligands.4,5  Our initial efforts in this area
led to the preparation of enantioenriched !-quaternary ketones (e.g., 2a) in good yields
and enantioselectivities using (S)-t-BuPHOX (3)5a–b as a chiral ligand (Scheme 1.1A).6
Since these early results, we have considerably expanded the scope,7 demonstrated
multiple applications,8 and performed mechanistic investigations9 of this powerful
                                                 
† This research was performed in collaboration with Douglas C. Duquette and Drs. Jimin Kim, Wen-Bo
Liu, Alexander N. Marziale, Douglas C. Behenna, Scott C. Virgil and has been published.  See: Bennett, N.
B.‡; Duquette, D. C.‡; Kim, J.; Liu, W.-B.; Marziale, A. N.; Behenna, D. C.; Virgil, S. C.; Stoltz, B. M.
Chem.—Eur. J. 2013, 19, 4414–4418. ‡N.B.B. and D.C.D contributed equally to this article.
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 2
transformation.  Recently, we discovered that the allylic alkylation of lactams (4a to 5a)
and imides (6a  to 7a) with (S) - (CF3)3-t-BuPHOX (8)
5c consistently proceeds with
enantioselectivities substantially higher than any other substrate class previously
examined in this system (Scheme 1.1B and C).10 This observation prompted us to
investigate which characteristics distinguish these molecules as superior alkylation
substrates.  The basic distinctions between these ketone and N-heterocyclic molecules are
the deviation in electronic nature of the enolate and the identity of the !'-functionality
(i.e., the group flanking the carbonyl at the site opposite of alkylation).  Thus, we have
designed several new alkylation substrates to examine the relative contribution of each
effect.  We have found that the exceptional enantioselectivities observed in the
lactam/imide series are likely not a result of a purely electronic effect, but a combination
of stereoelectronic and steric factors associated with the ! '-substituent.  To provide a
more complete perspective on allylic alkylation selectivity, this chapter also discusses
related research efforts performed by other groups.
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Scheme 1.1.  Comparison of allylic alkylation of ketones, lactams, and imides.
O
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N
O
CO2allyl
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(12.5 mol %)
toluene, 40 °C
N
O
5a
99% ee
For other substrates, 47–99% yield and 93–99% ee (average = 96% ee)
Ph2P N
O
t-Bu
(S)-t-BuPHOX
(S)-(CF3)3-t-BuPHOX
B.  Lactam !-amidoesters
(8)
(3)
C.  Cyclic !-imidoesters
Bz Bz
N
O
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Pd2(pmdba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX
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N
O
7a
94% ee
Bz Bz
O O
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85% yield
85% yield
81% yield
P N
O
t-Bu
CF3
F3C
CF3
1.1.1 Pd-Catalyzed Asymmetric Allylic Alkylation Background
Our entry into asymmetric allylic alkylation methodology began in 2004, when
we reported the preparation of !-quaternary cyclic ketones from allyl enol carbonates (9)
and silyl enol ethers (10).6a  Twenty years prior, Tsuji performed the regioselective
allylation of these and other unstabilized enolate precursors under essentially neutral
conditions with Pd(0) catalysts (Scheme 1.2).11  Inspired by Tsuji’s approach, we
screened a series of chiral P,P-, P,O-, and P,N-ligands in the allylic alkylation of allyl
enol carbonate 9a with Pd2(dba)3 as a Pd(0) source.  Gratifyingly, P,N-ligands generate
the desired enantioenriched ketone product in good yield and ee, with (S)-t-BuPHOX (3)
providing the greatest enhancement in selectivity (Scheme 1.3).  Silyl enol ethers (10)
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necessitate the addition of a fluoride source and allyl carbonate, but provide similar
results.6a  We later found that racemic "-ketoesters (1) are also excellent substrates under
the standard enol carbonate conditions.  Notably, "-ketoesters are easy to prepare, are
often more stable than the corresponding allyl enol carbonates, and avoid regioselectivity
issues in enolate formation with ! ,"-unsaturated substrates.  Following our initial
publication, Trost disclosed allylic alkylation conditions for allyl enol carbonates with
their C2-symmetric P,P-ligands (e.g., (R,R)-12, Scheme 1.3).
2a,12 These initial publications
by Stoltz and Trost represent the first examples of the regioselective and enantioselective
alkylation of ketones with multiple acidic sites.  Although not discussed in this chapter,
Hayashi,13 Ito,14 Trost,2a,15 and Hou and Dai16 have also performed asymmetric alkylation
of ketones, however, their approaches require the substrate to possess an occluded !'-
position (i.e., one deprotonation site) or a stabilizing !-group (i.e., favored deprotonation
site).
Scheme 1.2.  Various enolate precursors investigated in the Tsuji reaction.
10a
OAc
O O
O
OTMSO
O
O
Pd(0)
Bu3SnOMe
Pd(0)
–CO2
Pd(0)
–CO2
1a
9a
11a
O
+ PdIILn
, Pd(0), F—RO
O
O
O
2a
allylation
OR
O
O
–CO2
–CO2
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Scheme 1.3.  Pd-catalyzed asymmetric allylic alkylations performed by Stoltz and Trost.
O O
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(S)
O
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O O
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H
N
H
N
O
O
PPh2
Ph2P
(R,R)-12
Ph2P N
O
t-Bu
(S)-t-BuPHOX
3
Stoltz
Trost
As part of our efforts to expand the reaction scope, we explored nitrogen-
containing substrates including lactams.10  Early efforts indicated the N-substituent plays
a significant role in conversion and enantioselectivity.  Notably, electron-rich lactams (N-
group = Me or Bn) exhibit little to no conversion to the desired products and, as such, are
poor alkylation substrates.  We consequently prepared a variety of lactams with electron-
withdrawing functionality (4a–h) and screened these molecules against two electronically
differentiated chiral ligands, (S)-3 and (S)-8, and four solvents of varying polarity:
tetrahydrofuran (THF), tert-butyl methyl ether (TBME), toluene, and 2:1 hexane–toluene
(Table 1.1).  In general, higher enantioselectivities are observed in less polar solvents
with (S)-8 as a ligand.  Among the N-substituent, benzoyl is optimal and provides nearly
perfect selectivity.  The transformation is also tolerant of various !-groups and ring sizes
and additionally provides high ee for cyclic imides.  By comparison, !-quaternary
ketones are formed with approximately 10% lower ee, prompting us to question what
characteristics distinguish lactams and imides as better substrates.
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Table 1.1.  Lactam allylic alkylation screen.a
Ph2P N
O
t-Bu
(4-CF3C6H4)2P N
O
t-Bu
CF3
! (S)-t-BuPHOX ! (S)-(CF3)3-t-BuPHOX
3 8
N
O
O
O
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
solvent (0.033 M), 40 oC
N
O
4 5
R R
THF TBME Toluene 2:1 Hex–Tol
5d
5f
5h
5g
42
95
86
99
83
99
96
99
57
70
75
72
74
73
77
71
36
80
75
84
75
87
72
83
4
35
26
57
7
37
31
44
46
79
65
85
38
87
45
85
Enantiomeric Excess (% ee)b
5a
52
96
88
99
86
99
96
99
product 5
5c
60
97
91
98
87
99
97
99
5e
5b
20
75
64
91
62
90
83
91
ligand
3
8
3
8
3
8
3
8
3
8
3
8
3
8
3
8
entry
7
8
9
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12
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13
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3
4
5
6
1
2
4d
4f
4h
4g
4a
substrate 4
4c
4e
4b
Cbz
Tsc
Fmoc
Bz
R
4-MeO-Bz
Bocc
Ac
a Conditions: lactam 4 (1.0 equiv), Pd2(dba)3 (5 mol %), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-BuPHOX
(8) (12.5 mol %) in solvent (0.033 M) at 40 °C. b!Determined by GC, HPLC, or SFC analysis. Red = with 
(S)-(3) as ligand and blue = with (S)-(8) as ligand. c Reaction performed with Pd2(pmdba)3 at 50 °C.
d
Reaction performed at 60 °C.
4-F-Bz
d d d
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1.2 RESULTS AND DISCUSSION
1.2.1 Electronically Variable Substrates
Initially, we hypothesized that the divergence in enolate electronics between the
substrate classes depicted in Scheme 1.1 could be the major determining factor of the
observed enantioselectivities.  Insight from our previous work9,10 suggested that
selectivity in the alkylation of electron-poor and -rich molecules could be considerably
different.  To investigate the electronic effect of the nitrogen atom on alkylation
selectivity without the influence of !'-functionality, we examined variably functionalized
enaminones (16, i.e., vinylogous amides)17 as electronic analogues of lactams (4, Figure
1.1).  We were particularly drawn to this new class of compounds as our past experience
with vinylogous esters (14)18 and thioesters (15)18b,19 would provide a foundation and
comparison point.20
Figure 1.1. Ketone and lactam enantioselectivity divergence as inspiration for investigation of enolate
electronics using vinylogous systems.
O
O
O
N
R
Bn
enaminones (16)
O
O
O
ketones (1)
N
O
O
O
lactams (4)
role of nitrogen in 
enolate electronics
R
O
O
O
enones (13, R = H)
vinylogous esters (14, R = OR')
and thioesters (15, R = SR')
R
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To this end, we prepared a number of racemic enaminone alkylation precursors
from vinylogous ester 14a (Scheme 1.4A).  Treatment of vinylogous ester 14a with
hydrochloric acid in THF selectively removes the vinylogous group without hydrolyzing
the carboxylic ester, as reported by Desmaële.21  The resulting dione (17) can be
condensed with an amine under dehydrative conditions to generate enaminones 16a–c,
which bear electron-donating groups.22,23,24  To prepare substrates with electron-
withdrawing functionality, we explored derivatization of enaminone 16c to acetyl (16d),
benzoyl (16e), tosyl (16g), and Boc (16f) accessorized products (Scheme 1.4B).  The
acylation of secondary enaminones using an amine base has previously been
reported;23a,25 however, exposure of intermediate 16c to diisopropylethylamine (i-Pr2NEt)
and benzoyl chloride surprisingly produces diene 18 in 90% yield.  We also examined
other amine bases (e.g., pyridine and Et3N), reagent equivalents, and the order of reagent
addition, but in each case isolated a mixture of over acylated product and desired
enaminone 16e.26  Similar results were obtained with acetyl chloride.  The use of sodium
hydride27 eliminates over acylation, but provides enaminone 16e with insufficient purity.
Nevertheless, these conditions are amenable to the synthesis of tosyl enaminone 16g,
albeit in low yield.28  The acylated and benzoylated enaminones (16d and e) can
ultimately be obtained from iodoenone 1929 through a Buchwald coupling30 and
alkylation sequence (Scheme 1.4C).  Boc functionalized enaminone 16f is prepared
without complication following the precedent of Hiemstra (Scheme 1.4B).31
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Scheme 1.4.  Preparation of enaminone alkylation precursors.
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70% yield16a (R = Me)
31% yield16b (R = Ph)
92% yield16c (R = H)
EDG
substrates
O
O O
O
O
O
O
N
O
O
Bn
H
O
N
Bn
O
O
Ts
45% yield
i. NaH
   THF, 23 °C
ii. TsCl
16c
16g
O
N
Bn
O
O
Boc
90% yield
Boc2O, DMAP
CH2Cl2
0!23 °C
16f
BzO
N
Bn
Bz
90% yield
i. i-Pr2NEt
   CH2Cl2, 0 °C
ii. BzCl
    0!23 °C
18
O
O
O
N
Bn
Bz
O
O
EWG
substrates
16c
(R = H)
A.
B.
I I
O O
1. LDA, THF
    –78 °C; then
18% yield
2 steps
19 20
CuI (10 mol %)
RNH2, Cs2CO3
H
N
N
H
O
N
H
86% yield16h (R = Ac)
70% yield16i (R = Bz)
NaH
DMF, 0 °C
then BnBr
0!23 °C
O
N
Bn
R
71% yield16d (R = Ac)
60% yield16e (R = Bz)
(20 mol%)
H2O/THF, 60 °C
O
O
O
O
O
O
C.
16e not isolated
NC O
O
2. NaH, MeI
    THF, 23 °C
With a number of enaminones in hand, we screened a series of palladium-
catalyzed decarboxylative allylic alkylation conditions (Table 1.2).  Enaminone
substrates that possess a hydrogen on the nitrogen (e.g., 16c and i) generate a number of
alkylation products with a Pd(PHOX) system and were consequently excluded from this
study.  The enaminone screen was performed in a manner similar to the previous
investigation of lactams,10,32 employing the ligands (S)-3 and (S)-8 and the same four
solvents: tetrahydrofuran (THF), tert-butyl methyl ether (TBME), toluene, and 2:1
hexane–toluene.
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Table 1.2.  Enaminone allylic alkylation screen.a
Ph2P N
O
t-Bu
(4-CF3C6H4)2P N
O
t-Bu
CF3
! (S)-t-BuPHOX ! (S)-(CF3)3-t-BuPHOX
3 8
O
O
O
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
solvent (0.033 M), 40 oC
R
O
R
13, 14, or 16 21, 22, or 23
THF TBME Toluene 2:1 Hex–Tol
23b
23e
23g
23f
81
76
87
74
85
82
83
83
89
83
90
85
88
88
88
86
86
80
87
83
88
82
87
83
84
82
83
83
83
83
82
83
87
84
86
84
87
81
82
83
Enantiomeric Excess (% ee)b
22a
85
86
85
86
86
86
87
88
product
23a
61
79
60
78
55
84
52
83
23d
21a
87
85
88
86
87
88
87
85
ligand
3
8
3
8
3
8
3
8
3
8
3
8
3
8
3
8
entry
7
8
9
10
11
12
15
16
13
14
3
4
5
6
1
2
16b
16e
16g
16f
14a
substrate
16a
16d
13a
NPh(Bn)
NBz(Bn)
NTs(Bn)
NBoc(Bn)
Oi-Bu
R
NMe(Bn)
NAc(Bn)
H
a Conditions: enone 13a, vinylogous ester 14a, or enaminone 16a, b, d–g (1.0 equiv), Pd2(dba)3 (5 mol
%), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-BuPHOX (8) (12.5 mol %) in solvent (0.033 M) at 40 °C.
b
!Determined by GC, HPLC, or SFC analysis. Red = with (S)-(3) as ligand and blue = with (S)-(8) as ligand.
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We made several observations upon analysis of the ligand, solvent, and substrate
trends that distinguished this substrate class considerably from the previously examined
lactams.  First, enaminones are obtained in modestly better selectivity with (S)-3 as a
ligand in most solvents (entries 7–16), with the exception of methyl enaminone 23a,
which significantly favors (S)-8 (entries 5–6).  Second, no significant solvent trend is
observed for enaminones overall.  Third, electron-rich enaminones (i.e., 16a and b)
display decreased enantioselectivities and also require extended reaction times for
completion,33 while enaminones bearing electron-withdrawing substituents (23d–g) are
all generated in 80–90% ee.  By comparison, lactam substrates perform with much higher
enantioselectivity with ligand (S)-8 in non-polar solvents.10,34  Furthermore, the modest
distinction in enantioselectivity for the electron-withdrawing enaminones sharply
contrasts with the corresponding lactam series, where the N-substituent plays a
considerable role, producing significant variation in selectivity.10,35  These differences
suggest that the N-functional group does not contribute to enantioselectivity solely
through a perturbation of enolate electronics.
Beyond these considerations, the most striking feature of the screen is that
enantioselectivities observed for enaminones 23d–g are approximately equivalent to
results obtained for enone 21a,36 vinylogous ester 22a, previously investigated
vinylogous molecules (Table 1.3),18b,19 and even more general ketone substrates.  Of all
the enaminones screened, acetyl variant 23d provides the highest selectivity at 90% ee in
TBME, which is only marginally better than the optimal values for the related vinylogous
systems.  The modest differences between these vinylogous molecules (i.e., 21–23)
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further suggest that the electronic nature of the enolate is not likely the predominant
factor in providing high enantioselectivity for lactams and imides.
Table 1.3.  Alkylation of other vinylogous esters and thioesters.a
R1
O
R2
O
O
n
R1
O
R2 n
yield (%) ee (%)bn
1 86 75
solvent
toluene
entry R1
Me
product
22b
R2
Oi-Bu
substrate
14b1
a Conditions: vinylogous ester 14/24 or vinylogous thioester 15/25, Pd2(pmdba)3 (2.5 mol %), and (S)-t-BuPHOX (3) 
(6.25 mol %) in solvent at temp. b!Determined by HPLC or SFC analysis. c !-Ketoester 15a recovered in 26% yield.
1 85 92tolueneMe 26aSPh15a2
Pd2(pmdba)3 (2.5 mol %)
(S)-t-BuPHOX (3)
(6.25 mol %)
solvent, temp
14/24 and 15/25 22/27 and 26/28
temp (°C)
80
50
1 61c 92benzeneMe 26aSPh15a3 50
1 88 92Me 26aSPh15a4 50THF
1 88 92Me 26aSPh15a5 501,4-dioxane
2 93 8627aOi-Bu24a6
2 86 8928aSPh25a7
30
30
Et2O
Et2O
H
H
ref.
19a
19a
19a
19a
19a
18b
18b
While pursuing enaminones, we also briefly examined the related 2,3-
dihydropyridin-4-ones, which possess the nitrogen within the ring (Table 1.4).  Acylation
and alkylation (or vice versa) of known dihydropyridinones37,38,39 allows preparation of
the reaction precursors 29a–d.  Under our standard palladium-catalyzed conditions, N-
carboxybenzyl substituted product 30a is formed with enantioselectivities similar to
electronically related enaminones.  Electron-rich 2,3-dihydropyridin-4-ones 30b and c are
curiously also generated in the same range.  Even 2,3-dihydropyridin-4-one 30d is
produced in excellent enantioselectivity, despite the highly electron-rich nature of the
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enolate.  These results again allude to other factors beyond enolate electronics that direct
alkylation selectivity.
Table 1.4.  Allylic alkylation of 2,3-dihydropyridin-4-ones.a
N
O
R1
R2
30
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
toluene, 40 °CN
O
R1
R2
N
O
CO2allyl
MeO
MeO
O
O
29
R3 R3
yield (%) ee (%)bR1
Me
80
98
86
84
ligand
3
8
entry R2
Cbz
product 30
30a
Me
82
94
88
86
3
8Bn 30b
i-Bu
85
81
84
88
3
8Bn 30c
81 9187 30d
R3
H
H
H
substrate 29
29a
29b
29c
29d
1
2
3
4
5
6
a Conditions: 2,3-dihydropyridin-4-ones 29, Pd2(dba)3 (5 mol %), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-
BuPHOX (8) (12.5 mol %) in toluene (0.033 M) at 40 °C. b!Determined by HPLC or SFC analysis. Red
= with (S)-3 as ligand and blue = with (S)-8 as ligand.
1.2.1.1 Other Reports of Allylic Alkylation on Vinylogous Molecules
Trost has also reported the palladium-catalyzed allylic alkylation of vinylogous
esters and thioesters employing their C2-symmetric P,P-ligands.  In particular, their 2006
study prepares a range of related !-quaternary vinylogous products using (R,R)-12.20a
This effort first focused on the transformation of vinylogous esters into allyl enol
carbonate alkylation precursors.  However, enolate regioselectivity (!  vs. #
deprotonation) is poor for a number of vinylogous alkoxy groups except benzyl (32b),
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although this carbonate product is formed in low yield (Scheme 1.5A).  Several "-
ketoesters were alternatively examined, but lower conversions were observed with these
substrates than with enol carbonate 32b (Scheme 1.5B).  The best results were obtained
with phenyl and Boc substituted "-ketoesters (14e and f), which have decreased electron-
donating contribution from the vinylogous oxygen.  Trost consequently investigated the
analogous thioesters, reasoning that sulfur would have less orbital overlap.  Vinylogous
thioester 14b performs with good yield and perfect enantioselectivity (Scheme 1.6), and a
variety of other thioesters are also produced with good to excellent ee.  Trost has also
examined exocyclic vinylogous esters and carried the enantioenriched products onto the
natural products hamigeran B20b,c and allocyathin B2.
20d
Scheme 1.5.  Asymmetric allylic alkylation of vinylogous esters performed by Trost.
Pd2(dba)3•CHCl3
(2.5 mol %)
(R,R)-12 (6 mol %)
THF or 1,4-dioxane
23 °C
yield (%)b ee (%)cR1
Et 26 94
entry product 14
14c
Bn 51 9114b
t-Bu 29 9714d
substrate 31
31c
31b
31d
2
1
3
a Conditions: vinylogous ester 16, Pd2(dba)3 (5 mol %), and (R,R)-12 (6 mol %) in solvent (0.1 M) at 23 
°C. b!Isolated yield. c Determined by HPLC analysis. d 1,4-dioxane as solvent. e THF as solvent.
yield (%)b
85
87
85
product 22
22c
22b
22d
Ph 70 9614e31e4 91 22e
Boc 66 9414f31f5 32 22f
d
e
d
d
e
14
RO
O
RO
O
O
O
31
LDA 
THF, –78 °C
then allyl 
chloroformate RO
O
22
Pd2(dba)3•CHCl3
(2.5 mol %)
(R,R)-12 (6 mol %)
THF or 1,4-dioxane
23 °C
32b
BnO
O
BnO
O
31b
LDA, TMEDA
THF, –78 °C
then allyl 
chloroformate
BnO
O
22b
O
O
87% yield, 85% ee
A.
B.
!
"
31% yield
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Scheme 1.6.  Asymmetric allylic alkylation of vinylogous thioesters performed by Trost.
Pd2(dba)3•CHCl3
(2.5 mol %)
(R,R)-12 (6 mol %)
1,4-dioxane, 23 °C
14b
PhS
O
PhS
O
O
O
33
LDA, toluene
–78 °C
then allyl 
chloroformate
–78!23 °C
PhS
O
22b
14 other examples
75% yield, 100% ee
Concurrent with our efforts on enaminones, Lupton40 and Shao41 independently
published sequential reports on the Pd-catalyzed allylic alkylation of two other
vinylogous amide classes, carbazolones (33) and indolones (34) (Scheme 1.7).  The
reaction parameters between the two papers are almost identical (Lupton: 5 mol% ligand,
50 °C; Shao: 6.25 mol % ligand, 70 °C)42 and many of the substrates are also related.  In
these efforts, Lupton selects a Boc N-protecting group, while Shao employs a benzyl
substituent.  The enantioselectivities of the methyl/allyl !-quaternary carbazolones (35a
and b) and indolones (36a) are comparable to our results with enaminones that possess
electron-withdrawing functionality.  Even the N-benzyl carbazolones are produced in
good to excellent ee, unlike the enaminones that bear electron-rich groups (23a and b).
In addition to screening several alkylation precursors, both laboratories advance their
enriched cyanide alkylation products (35g and h) onto (+)-kopsihainanine A (37) through
total and formal synthetic routes, and Shao also completes the alkaloid (–)-
aspidospermidine (38, Scheme 1.8).
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Scheme 1.7.  Alkylation of carbazolone (Lupton, R1 = Boc; Shao, R1 = Bn) and indolone (Lupton)
substrates reported in 2013.
N
R1
O
R2
O
O
carbazolones (33)
and indolones (34)
Pd2(dba)3 (2.5 mol %)
(S)-t-BuPHOX (3) (5–6.25 mol %)
toluene, temp N
R1
O
R2
carbazolones (35)
and indolones (36)
N
R1
O
CN
N
R1
O
CO2Et
N
R1
O
N
R1
O
35a (R1 = Boc)
72% yield, 83% ee
35b (R1 = Bn)
82% yield, 88% ee
CO2Et
N
Boc
O
CN
36f
98% yield, 86% ee
N
Boc
O
CO2Et
36e
73% yield, 85% ee
N
Boc
O
36d
97% yield, 83% ee
N
Boc
O
R2
36a–c
R2 = Me
R2 = Et
R2 = Bn
73% yield, 80% ee
69% yield, 87% ee
79% yield, 82% ee
CO2Et
R1 = Boc: 5 mol % (S)-3, 50 °C
R1 = Bn: 6.25 mol % (S)-3, 70 °C
35c (R1 = Boc)
80% yield, 87% ee
35d (R1 = Bn)
83% yield, 92% ee
35g (R1 = Boc)
90% yield, 94% ee
35h (R1 = Bn)
93% yield, 92% ee
35e (R1 = Boc)
87% yield, 91% ee
35f (R1 = Bn)
80% yield, 85% ee
Scheme 1.8.  Derivatization of cyanides 35g and h to alkaloid natural products.
N
R1
O
CN
35g (R1 = Boc)
35h (R1 = Bn)
N
H
N
H
(–)-aspidospermidine (38)
Shao (R1 = Bn)
10 steps
Lupton (R1 = Boc)
3 steps to 
formal synthesis
Shao (R1 = Bn)
7 steps
N
H
N
(+)-kopsihainanine A (37)
HO
O
H
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1.2.2 !'-Functionalized Substrates
Having investigated the impact of enolate electronics, we diverted our efforts to
study the influence of ! '-functionality on alkylation selectivity (Scheme 1.9).  Our
previous lactam screen identified the benzoyl moiety as the optimal protecting group,10
providing high to nearly perfect enantioselectivities for a variety of lactams (e.g., 5a).
Interestingly, both electron-rich and electron-poor benzoyl lactams (5b–d) as well as
naphthoyl lactams (5e and f) display excellent ee, whereas acetyl lactams (e.g., 5g and h)
provide lower selectivity.  This prompted us to question whether these results are due to a
hybridization or steric effect.  Consequently, we synthesized the bulky sp3 hybridized
cyclohexoyl lactam 4i  and pivaloyl lactam 4j , which proceed in improved
enantioselectivities compared to analogous acetyl lactam 4g, supporting a steric effect.43
Scheme 1.9.  Impact of various sp3 and sp2 acyl groups on allylic alkylation enantioselectivity for
lactams.
N
O
N
OO
5a (R = H)
85% yield
99% ee
5f (2-naphthyl)
82% yield
97% ee
N
O O
O
Pd2(pmdba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
toluene, 40 °C
N
O
N
OO
5i
63% yield
95% ee
N
O
5j
46% yield
96% ee
N
O
R
5g (R = Me)
47% yield
91% ee
4 5
O O
5e (1-naphthyl)
86% yield
99% ee
A.  sp2 hybridized
B.  sp3 hybridized
R
O
R
5c (R = F)
89% yield
99% ee
5b (R = OMe)
93% yield
99% ee
5d (R = Ph)
85% yield
99% ee
O O
5h (R = Bn)
90% yield
88% ee
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In conjunction with our investigation of the asymmetric allylic alkylation of
lactams, we found that N-benzoyl cyclic imides 7a and b are furnished in excellent ee
(Scheme 1.10).  However, we observed that formation of N-methyl imide 7c proceeds
with moderate enantioselectivity and is hampered by low reactivity.43  As this substrate
also generates an intermediate imido enolate (as do lactams 5a–j, Scheme 1.9), this result
further supports our conclusion that enolate electronics do not play a major role in the
enhanced enantioselectivities observed for N-benzoyl lactams.  As such, we examined the
influence of alternate N-substituents in the context of the allylic alkylation with imides.
Scheme 1.10.  Allylic alkylation of cyclic imides.
N
O
O
Me
N
O
O
Bz
N
O
O
BnO
7c
32% yield
76% ee
7a
81% yield
94% ee
7d
99% yield
96% ee
N
O
Et
O
Bz
7b
86% yield
96% ee
N
O
Et
O
BnO
7e
80% yield
98% ee
N
R1
O
R2
O
O N
R1
O
R2
O O
Pd2(pmdba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
toluene, 40 °C
6 7
Gratifyingly, we identified N-benzyloxy imides as excellent substrates for this
methodology, generating imides 7d and e in yields and enantioselectivities comparable to
their N-benzoyl counterparts.  In conjunction with the results obtained for substituted N-
acyl lactams 5g–j, we reason that the nature of the !'-substituent leads to the observed
enhancements in enantioselectivity, though enolate electronics have been shown to
dramatically affect the reaction rate.
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We sought to further probe the ! '-group contribution without the influence of
nitrogen and consequently focused on a series of !'-functionalized enones, including
benzoyl enone 13b  (Scheme 1.11).  Previous research suggested enolization
regioselectivity issues may arise in acylating/alkylating enone 39 (! vs. #, path A),6b
prompting us to pursue approaches to enone 13b through retrosynthetic disconnection of
the benzoyl substituent (path B).  Unfortunately, attempts to acylate and oxidize "-
ketoester 1 a  proved unsuccessful.  Both lithium halogen exchange and
Nozaki–Hiyama–Kishi coupling on iodoenone 41 also failed to install the benzoyl group.
The synthesis of enone 13b is ultimately possible via a Baylis–Hillman44 reaction and
oxidation sequence (Scheme 1.11B).  A number of oxidants were examined in the latter
transformation, but only Dess–Martin periodinane (DMP) proved successful.  Benzoyl
enone 13b is very sensitive to alkene isomerization, and thus the addition of potassium
carbonate as a buffer and the use of triethylamine deactivated silica gel for purification
are necessary.  Although we were able to prepare enone 13b, stability issues make this
molecule a poor alkylation substrate and prohibit the isolation of the desired methyl/allyl
!-quaternary enone under our standard palladium-catalyzed conditions.
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Scheme 1.11.  Retrosynthetic approaches and successful route to benzoyl enone 13b.
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I I
OO
Ph O
O OO
Ph O
O
[O]
O
O
O
acylation
OO
Phacylation/
alkylation
13b 40 1a
!
"
potential
regioselectivity
issues
lithium halogen 
exchange or Nozaki–
Hiyama–Kishi
42
O
O
O O
acylation/
alkylation
41
a
dis
co
nn
ec
tio
n a
b
disconnection b
disconnection b
OO
Ph O
O
13b
very unstable
O
O
O
13a
OOH
Ph O
O
44
1:1 d.r.
TMPDA (43)
benzaldehyde
THF/H2O, 23 °C
N N
32% yield
63% recovered 13a
69% yield
DMP, K2CO3
CH2Cl2, 23 °C
Baylis-Hillman
B.
A.
Despite the complications with benzoyl enone 13b, we were able to synthesize
enones 13c and d and diosphenol ethers 45a and b under standard acylation/alkylation
conditions.  To examine the relative merit of the steric and stereoelectronic effects
associated with the ! '-substituent, we subjected these substrates to the palladium-
catalyzed alkylation parameters employed with lactams and imides (Scheme 1.12).  In
this transformation, enones 21c and d are formed in low enantioselectivity.  By contrast,
benzyl diosphenol ether 46a, which differs from 21d only in the substitution of oxygen
for a methylene group, is generated in 92% yield and 94% ee.  This suggests that purely
steric or $-stacking interactions are not the sole contributing factors to enantioselectivity.
Rather, electronic effects of the ! '-substituent exert an important influence on the
stereoselectivity of the reaction.  However, a certain amount of steric bulk appears critical
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in obtaining high enantioselectivity as methyl diosphenol ether 46b is produced in 85%
ee.  In comparison, analogous enone 21a, which bears no !'-functionality, proceeds under
the same conditions to afford enone 21a in 88% ee,36 with vinylogous amides and esters
also in the ~80–90% ee range (vide supra).  Overall, our studies on the role of the !'-
substituent have culminated in the discovery of substrate 45a, which proceeds with the
greatest enantioselectivity observed in a Pd(PHOX) catalyst system for a carbocyclic
substrate bearing an !-methyl and unsubstituted allyl moiety.
Scheme1.12.  Allylic alkylation of !'-functionalized enones and diosphenol ethers.
O
21a
78% yield
88% ee
O O
O
O
Pd2(dba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
toluene, 40 °C
enones (13)
diosphenol ethers (45)
enones (21)
diosphenol ethers (46)
O
RO
46a (R = Bn)
92% yield
94% ee
O
Ph
n
46b (R = Me)
80% yield
85% ee
21c (n = 1)
77% yield
53% ee
21d (n = 2)
50% yield
65% ee
1.3 CONCLUDING REMARKS
In summary, we have designed and evaluated a number of novel substrates to
probe the influence of enolate electronics and the role of !'-functionality on selectivity in
the palladium-catalyzed decarboxylative allylic alkylation.  Based on these results, we
reason that the high enantioselectivities observed with lactams and imides are a
consequence of both electronic and steric effects associated with !'-substituents, and that
enolate electronics alone contribute relatively little to the stereochemical outcome of the
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reaction.  Both experimental and theoretical investigations are currently underway in our
group to determine the nature and origin of the effect of ! '-substitution on this
transformation and to use this insight to improve and expand our methods.
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1.4 EXPERIMENTAL SECTION
1.1.1 MATERIALS AND METHODS
Unless otherwise stated, reactions were performed in flame-dried glassware under
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried
by passage through an activated alumina column under argon.45  Acetone was used
directly from a Sigma-Aldrich ACS reagent grade bottle.  Brine solutions are saturated
aqueous solutions of sodium chloride.  Reagents were purchased from Sigma-Aldrich,
Acros Organics, Strem, or Alfa Aesar and used as received unless otherwise stated.  (S)-t-
BuPHOX (3),
5ab
 (S)-(CF3)3-t-BuPHOX (8),
5c
 and allyl cyanoformate
46
 were prepared by
known methods.
  Reaction temperatures were controlled by an IKAmag temperature
modulator.  Reaction progress was monitored by thin-layer chromatography (TLC).  TLC
was performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and
visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  ICN
silica gel (particle size 0.032-0.0653 mm) was used for flash column chromatography.
Preparative HPLC purification was performed on an Agilent 1200 Series HPLC using an
Agilent Prep-SIL column (5 µm, 30 x 250 mm) at ambient temperature with a flow rate
of 50 mL/min.  Separation was monitored by UV (% = 254 nm) and fractions were
collected at the valleys between peaks.  1H NMR spectra were recorded on a Varian
Mercury 300 MHz or Varian Inova 500 MHz spectrometer and are reported relative to
residual CHCl3 (& 7.26 ppm) or benzene-d6 (& 7.16 ppm).  
13C NMR spectra are recorded
on a Varian Mercury 300 MHz or Varian Inova 500 MHz spectrometer (75 or 125 MHz
respectively) and are reported relative to CDCl3 (&  77.16 ppm) or benzene-d6 (&  128.06
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ppm).  Variable temperature NMR experiments were performed on a Varian Inova 500
MHz spectrometer and are reported relative to residual DMSO (& 2.50 ppm).  Data for 1H
NMR are reported as follows: chemical shift (&  ppm) (multiplicity, coupling constant
(Hz), integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t =
triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, dm = doublet of multiplets,
br s = broad singlet, br d = broad doublet, app = apparent. Data for 13C are reported in
terms of chemical shifts (& ppm).  IR spectra were obtained by use of a Perkin Elmer
Spectrum BXII spectrometer using thin films deposited on NaCl plates and reported in
frequency of absorption (cm-1).  Optical rotations were measured with a Jasco P-2000
polarimeter operating on the sodium D-line (589 nm), using a 100 mm path-length cell
and are reported as: [!]D
T (concentration in g/100 mL, solvent, ee).  Analytical chiral
HPLC was performed with an Agilent 1100 Series HPLC utilizing a Chiralpak (AD, AD-
H, or AS) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from
Daicel Chemical Industries, Ltd.  Analytical chiral SFC was performed with a JASCO
2000 series instrument or a Thar SFC utilizing Chiralpak (AD-H or AS-H) or Chiralcel
(OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm), or a Chiralpak IC column (4.6 mm
x 10 cm) obtained from Daicel Chemical Industries, Ltd.  High resolution mass spectra
(HRMS) were obtained from the Caltech Mass Spectral Facility (GC-EI+, EI+, or FAB+)
or Agilent 6200 Series TOF with an Agilent G1978A Multimode source in electrospray
ionization (ESI+), atmospheric pressure chemical ionization (APCI+), or mixed
ionization mode (MM: ESI-APCI+).
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1.4.2 PREPARTIVE PROCEDURES
1.4.2.2 Preparation of Compounds Related to Enaminone Screen
1.4.2.2.1 Enaminone Allylic Alkylation Precursors
O
i-BuO
O
O O
O
O
O
HCl (1 M)
THF, 23 °C
78% yield14a 17
Dione 17.  Procedure adapted from report by Desmaële.21  A 100 mL round-bottom flask
equipped with a magnetic stir bar was charged with vinylogous ester 14a18c (3.08 g, 11.58
mmol, 1.00 equiv), THF (30 mL, 0.39 M), and aq HCl (1 M in H2O, 14.00 mL, 14.00
mmol, 1.21 equiv).  The reaction mixture was initially a suspension that developed into a
solution over time.  After 7 h of vigorous stirring at ambient temperature, the reaction
was diluted with EtOAc (30 mL) and transferred to a separatory funnel where the
aqueous layer was extracted seven times with EtOAc.  The combined organics (400 mL)
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil
was purified by flash column chromatography (SiO2, 31 x 5 cm, 100%
hexanes'20%'50% EtOAc in hexanes) to afford dione 17 (1.89 g, 11.58 mmol, 78%
yield) as a pale yellow oil; Rf = 0.17 (30% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) and 
13C NMR (125 MHz, CDCl3) mixture of keto-enol tautomers, see spectra
section; IR (Neat Film NaCl) 3500–2500 (broad stretch), 3088, 2983, 2939, 2657, 2591,
1734, 1595, 1457, 1413, 1383, 1358, 1343, 1309, 1272, 1249, 1190, 1114, 986, 932, 853
cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C11H15O4 [M+H]
+: 211.0965, found
211.0966.
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O
O
O
O O
N
O
O
Bn
Me
BnHNMe, p-TsOH•H2O
toluene, reflux, Dean–Stark
70% yield17 16a
Enaminone 16a.  A 50 mL round-bottom flask containing a magnetic stir bar was
charged with dione 17 (465.4 mg, 2.21 mmol, 1.00 equiv), toluene (24 mL, 0.09 M),
benzylmethylamine (320 µL, 2.48 mmol, 1.12 equiv), and p-toluenesulfonic acid
monohydrate (42.3 mg, 0.22 mmol, 10 mol %).  The flask was equipped with a Dean-
–Stark trap and water condenser and was lowered into a preheated oil bath (135 °C).
After 2 h of refluxing, the solution was removed from the oil bath and allowed to cool to
room temperature.  The solution was quenched with a sat. Na2CO3 solution (20 mL) and
transferred to a separatory funnel where the aqueous layer was extracted four times with
CH2Cl2.  The combined organics (200 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash column
chromatography (SiO2, 27 x 3 cm, 100% hexanes'20%'50%'60%'70% EtOAc in
hexanes) to afford enaminone 16a (484.8 mg, 1.55 mmol, 70% yield) as a yellow/orange
oil; Rf = 0.24 (50% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.37–7.33 (m, 2H),
7.32–7.27 (m, 1H), 7.09 (d, J = 7.4 Hz, 2H), 5.93–5.83 (m, 1H), 5.29 (dq, J = 17.3, 1.5
Hz, 1H), 5.26 (s, 1H), 5.18 (dq, J = 10.5, 1.4 Hz, 1H), 4.66–4.56 (m, 2H), 4.51 (s, 2H),
2.96 (s, 3H), 2.74–2.63 (m, 1H), 2.56–2.45 (m, 2H), 1.95–1.84 (m, 1H), 1.43 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 193.9, 173.7, 164.3, 132.2, 129.1, 127.8, 126.7, 118.0, 98.1,
65.6, 55.2, 51.1, 38.5, 32.6, 24.4, 21.0; IR (Neat Film NaCl) 3063, 3028, 2933, 2873,
1733, 1615, 1585, 1563, 1557, 1495, 1455, 1415, 1377, 1352, 1332, 1295, 1258, 1222,
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1203, 1174, 1113, 1028, 989, 929, 821, 735 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d
for C19H24NO3 [M+H]
+: 314.1751, found 314.1754.
O
O
O
O O
N
O
O
Bn
Ph
BnHNPh, p-TsOH•H2O
toluene, reflux, Dean–Stark
31% yield17 16b
Enaminone 16b. A 50 mL round-bottom flask containing a magnetic stir bar was
charged with dione 17 (500.3 mg, 2.38 mmol, 1.00 equiv), toluene (24 mL, 0.10 M),
benzylphenylamine (480.0 mg, 2.62 mmol, 1.10 equiv), and p-toluenesulfonic acid
monohydrate (45.6 mg, 0.24 mmol, 10 mol %).  The flask was equipped with a Dean-
–Stark trap and water condenser and was lowered into a preheated oil bath (135 °C).
After 8 h of refluxing, the solution was removed from the oil bath and allowed to cool to
room temperature.  The solution was quenched with a sat. Na2CO3 solution (20 mL) and
transferred to a separatory funnel where the aqueous layer was extracted four times with
CH2Cl2.  The combined organics (200 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified twice by flash column
chromatography (SiO2, 26 x 3 cm, 100% hexanes'10%'15%'20%'30%'40%
EtOAc in hexanes then  SiO2, 26.5 x 3 cm, 100% hexanes' 5%'10%'15%
'20%'30%'  50% EtOAc in hexanes) to afford enaminone 16b (276.6 mg, 0.74
mmol, 31% yield) as a yellow oil; Rf = 0.50 (50% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.38–7.33 (m, 2H), 7.33–7.24 (m, 4H), 7.21–7.18 (m, 2H), 7.13–7.10 (m,
2H), 5.90 (dddd, J = 17.2, 10.7, 5.4, 5.4 Hz, 1H), 5.39 (s, 1H), 5.31 (dq, J = 17.2, 1.6 Hz,
1H), 5.21 (dq, J = 10.5, 1.4 Hz, 1H), 4.83 (s, 2H), 4.68–4.63 (m, 1H), 4.62–4.57 (m, 1H),
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2.55–2.47 (m, 1H), 2.42 (ddd, J = 13.3, 6.1, 4.9 Hz, 1H), 2.33–2.27 (m, 1H), 1.84 (ddd, J
= 13.5, 8.7, 4.9 Hz, 1H), 1.42 (s, 3H); 13C NMR (125 MHz, CDCl3) & 194.6, 173.3, 163.9,
144.3, 136.4, 132.2, 129.9, 128.9, 128.0, 127.9, 127.7, 127.1, 118.0, 100.4, 65.6, 56.8,
51.6, 32.9, 25.9, 21.0; IR (Neat Film NaCl) 3061, 3031, 2975, 2933, 2872, 1734, 1623,
1560, 1494, 1453, 1426, 1408, 1377, 1346, 1327, 1293, 1255, 1210, 1174, 1112, 1080,
1061, 1022, 989, 929, 885, 825, 779, 733, 702 cm-1; HRMS (MM: ESI-APCI+) m/z
calc’d for C24H26NO3 [M+H]
+: 376.1907, found 376.1903.
O
O
O
O O
N
O
O
Bn
H
H2NBn, p-TsOH•H2O
toluene, reflux, Dean–Stark
92% yield17 16c
Enaminone 16c.  A 250 mL round-bottom flask containing a magnetic stir bar was
charged with dione 17 (1.89 g, 8.98 mmol, 1.00 equiv), toluene (90 mL, 0.10 M),
benzylamine (1.1 mL, 10.04 mmol, 1.12 equiv), and p-toluenesulfonic acid monohydrate
(169.0 mg, 0.89 mmol, 10 mol %).  The flask was equipped with a Dean–Stark trap and
water condenser and was lowered into a preheated oil bath (135 °C).  After 5.5 h of
refluxing, the solution was removed from the oil bath and allowed to cool to room
temperature.  The solution was quenched with a sat. Na2CO3 solution (50 mL) and
transferred to a separatory funnel where the aqueous layer was extracted once with Et2O
and three times with dichloromethane.  The combined organics were dried over MgSO4,
filtered, and concentrated under reduced pressure.  The crude oil was purified by flash
column chromatography (SiO2, 31 x 5 cm, 100% hexanes'20%'50% EtOAc in
hexanes) to afford enaminone 16c (2.48 g, 8.28 mmol, 92% yield) as a yellow solid; Rf =
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0.27 (30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.40–7.30 (m, 3H), 7.29 (s,
2H), 5.95–5.82 (m, 1H), 5.30 (dq, J = 17.2, 1.6 Hz, 1H), 5.22 (s, 1H), 5.20 (dq, J = 10.5,
1.4 Hz, 1H), 4.62 (tt, J = 5.6, 1.5 Hz, 2H), 4.56 (br s, 1H), 4.24 (d, J = 5.0 Hz, 2H), 2.59
(ddd, J = 16.5, 8.8, 4.9 Hz, 1H), 2.50 (ddd, J = 13.3, 6.2, 4.9 Hz, 1H), 2.33 (dt, J = 16.6,
5.3 Hz, 1H), 1.91 (ddd, J = 13.6, 8.8, 5.0 Hz, 1H), 1.44 (s, 3H); 13C NMR (125 MHz,
CDCl3) & 194.4, 173.4, 162.6, 136.7, 132.2, 129.1, 128.2, 128.0, 118.0, 96.7, 65.6, 52.1,
47.5, 32.4, 26.7, 21.1; IR (Neat Film NaCl) 3260, 3064, 2978, 2933, 2868, 1730, 1576,
1545, 1452, 1427, 1375, 1359, 1297, 1253, 1218, 1199, 1172, 1107, 1028, 987, 929, 822,
735 cm-1; HRMS (GC-EI+) m/z calc’d for C18H21NO3 [M+•]
+: 299.1521, found 299.1522.
O
N
O
O
Bn
H
BzO
N
O
O
Bn
Bz
90% yield
i. i-Pr2NEt
   CH2Cl2, 0 °C
ii. BzCl
    0!23 °C
16c 18
Diene 18.  A 1 dram (4 mL) vial equipped with a stir bar and Teflon septa was charged
with enaminone 16c (49.9 mg, 0.167 mmol, 1.00 equiv) and lowered into a 0 °C bath
(ice/water).  Dichloromethane (1.7 mL, 0.10 M), i-Pr2NEt (150 µL, 0.861 mmol, 5.17
equiv), and benzoyl chloride (40 µL, 0.345 mmol, 2.07 equiv) were added and the
reaction was allowed to warm to room temperature over time.  After 13 h, TLC analysis
indicated consumption of starting material.  The reaction was subsequently quenched
with water (5 mL) and the aqueous layer was extracted four times with dichloromethane.
The combined organics (50 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure.  The resulting crude oil was purified by flash chromatography (SiO2, 26
x 1 cm, 5%'10%'15% EtOAc in hexanes) to afford diene 18 (75.8 mg, 0.149 mmol,
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90% yield) as a yellow oil; Rf = 0.77 (50% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) & 8.07–8.02 (m, 2H), 7.65–7.59 (m, 1H), 7.56–7.51 (m, 2H), 7.50–7.45 (m, 2H),
7.39 (s, 2H), 7.37–7.32 (m, 3H), 7.32–7.30 (m, 2H), 7.28–7.24 (m, 1H), 6.20 (s, 1H),
5.81–5.72 (m, 1H), 5.22 (dt, J = 17.2, 1.4 Hz, 1H), 5.13 (dt, J = 10.3, 1.3 Hz, 1H),
4.97–4.79 (m, 3H), 4.56–4.43 (m, 2H), 2.75 (dd, J = 17.4, 4.6 Hz, 1H), 2.03 (dd, J = 17.4,
4.7 Hz, 1H), 1.21 (s, 3H); 13C NMR (125 MHz, CDCl3) & 173.6, 170.7, 164.0, 150.5,
137.2, 136.2, 136.1, 133.9, 131.7, 130.2, 130.0, 129.4, 129.0, 128.8, 128.5, 128.3, 128.1,
127.5, 120.2, 118.6, 113.4, 66.1, 50.6, 46.4, 35.1, 20.4; IR (Neat Film NaCl) 3062, 3030,
2981, 2934, 1740, 1646, 1600, 1577, 1495, 1451, 1400, 1349, 1326, 1244, 1176, 1145,
1112, 1077, 1050, 1023, 1001, 980, 935, 824, 797, 755 cm-1; HRMS (MM: ESI-APCI+)
calc’d for C32H30O5N [M+H]
+: 508.2118, found 508.2122.
O
N
O
O
Bn
H
O
N
O
O
Bn
Boc
90% yield
Boc2O, DMAP
CH2Cl2, 0!23 °C
16c 16f
Enaminone 16f.  A flame-dried 25 mL round-bottom flask containing a magnetic stir bar
was loaded with enaminone 16c  (300.1 mg, 1.00 mmol, 1.00 equiv) and 4-
dimethylaminopyridine (9.5 mg, 0.078 mmol, 7.8 mol %).  The flask was charged with
dichloromethane (10 mL, 0.10 M) and lowered into a 0 °C bath (ice/water).  Di-tert-butyl
dicarbonate (252.7 mg, 1.16 mmol, 1.15 equiv) was added, and the solution transitioned
from yellow to clear.  The ice bath was allowed to expire as the reaction was stirred
overnight.  After 22 h, the stir bar was removed from the flask, the reaction contents were
concentrated under reduced pressure, and the resulting crude oil was purified by flash
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column chromatography (SiO2, 26.5 x 3 cm, 100% hexanes'5%'10%'15%'20%
EtOAc in hexanes) to afford enaminone 16f (360.0 mg, 0.90 mmol, 90% yield) as a pale
yellow oil; Rf = 0.79 (50% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.34–7.28
(m, 2H), 7.26–7.21 (m, 1H), 7.16–7.12 (m, 2H), 5.85 (dddd, J = 17.2, 10.5, 5.5, 5.5 Hz,
1H), 5.73 (t, J = 0.9 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dq, J = 10.5, 1.3 Hz,
1H), 4.80 (s, 2H), 4.58 (dddd, J = 5.6, 2.8, 1.5, 1.5 Hz, 2H), 2.92–2.77 (m, 2H), 2.45 (dt,
J = 13.5, 5.3 Hz, 1H), 1.86 (ddd, J = 13.5, 7.7, 5.7 Hz, 1H), 1.42 (s, 9H), 1.38 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 196.8, 172.6, 162.2, 152.9, 137.2, 131.9, 128.8, 127.5, 126.3,
118.3, 114.8, 83.0, 65.8, 53.0, 52.5, 33.6, 28.1, 27.5, 20.4; IR (Neat Film NaCl) 3090,
3064, 3034, 2978, 2935, 2873, 1718, 1662, 1654, 1595, 1497, 1453, 1425, 1369, 1344,
1317, 1300, 1248, 1210, 1150, 1113, 1029, 989, 937, 856, 815, 769, 737 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C23H30NO5 [M+H]
+: 400.2118, found 400.2127.
O
N
O
O
Bn
H
O
N
O
O
Bn
Ts
45% yield
i. NaH, THF, 23 °C
ii. TsCl
16c 16g
Enaminone 16g.  A flame-dried 25 mL round-bottom flask containing a magnetic stir bar
was cycled into a glove box and loaded with sodium hydride (95% by weight, 32.6 mg,
1.29 mmol, 1.29 equiv).  The flask was removed from the glove box, reconnected to an
Ar-filled manifold, and charged with THF (6 mL).  Enaminone 16c (300.3 mg, 1.00
mmol, 1.00 equiv) was added in one portion and the grey suspension bubbled and became
a yellow solution over time.  The flask was rinsed with additional THF (4 mL, 10 mL
total, 0.10 M).  The reaction was stirred vigorously for 70 min before p-toluenesulfonyl
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chloride (287.6 mg, 1.51 mmol, 1.50 equiv) was added in one portion.  After 6 h, the
flask was lowered into a 0 °C bath (ice/water) and quenched with water (reaction mixture
bubbled).  The mixture was transferred to a separatory funnel where the aqueous layer
was extracted four times with CH2Cl2.  The combined organics (100 mL) were dried over
MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was purified by
flash column chromatography (SiO2, 27 x 3 cm, 100% hexanes'5%'10%'15%'
50% EtOAc in hexanes) to afford enaminone 16g (203.8 mg, 0.45 mmol, 45% yield) as a
yellow oil; Rf = 0.68 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.69 (d, J =
8.3 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.33–7.25 (m, 3H), 7.23 (d, J = 6.6 Hz, 2H), 5.75
(dddd, J = 17.3, 10.8, 5.6, 5.6 Hz, 1H), 5.68 (t, J = 1.1 Hz, 1H), 5.24–5.15 (m, 2H),
4.81–4.69 (m, 2H), 4.48 (dddd, J = 13.5, 5.6, 1.4, 1.4 Hz, 1H), 4.40 (dddd, J = 13.2, 5.6,
1.4, 1.4 Hz, 1H), 2.67–2.55 (m, 2H), 2.46 (s, 3H), 2.32 (dt, J = 13.9, 5.2 Hz, 1H), 1.69
(ddd, J = 13.8, 8.0, 5.9 Hz, 1H), 1.22 (s, 3H); 13C NMR (125 MHz, CDCl3) & 196.0,
171.9, 158.4, 144.8, 135.6, 135.3, 131.7, 130.2, 128.9, 128.1, 127.6, 127.5, 119.5, 118.5,
65.9, 53.0, 52.2, 32.4, 27.9, 21.8, 20.0; IR (Neat Film NaCl) 3064, 3032, 2981, 2935,
2873, 1735, 1669, 1596, 1496, 1454, 1424, 1359, 1321, 1292, 1255, 1164, 1115, 1089,
1058, 1028, 984, 910, 883, 816, 773, 743 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for
C25H28NSO5 [M+H]
+: 454.1683, found 454.1691.
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I I
O O
O
O1. LDA, THF, –78 °C
    then allyl cyanoformate
2. NaH, MeI, THF, 23 °C
18% yield, 2 steps
19 20
"-Iodoenone 20.  A 200 mL round-bottom flask equipped with a magnetic stir bar was
charged with diisopropyl amine (1.52 mL, 10.85 mmol, 1.19 equiv) and THF (36 mL).
The flask was lowered into a 0 °C bath (ice/water) and n-BuLi (4.5 mL, 2.3 M in
hexanes, 10.35 mmol, 1.14 equiv) was added dropwise over several minutes.  The
reaction was stirred for 15 min before the ice bath was removed and replaced with a –78
°C bath (dry ice/acetone).  "-Iodoenone 1929 (2.00 g, 9.09 mmol, 1.00 equiv) was
transferred via cannula to the flask using several THF rinses (1 x 14 mL and 2 x 5 mL
rinses, total added = 60 mL, 0.15 M), producing a yellow solution that transitioned to red
over time.  The reaction was stirred for 1 h before allyl cyanoformate (1.12 mL, 10.38
mmol, 1.14 equiv) was added dropwise.  After 2.25 h, the reaction was quenched with
sat. NH4Cl solution and allowed to warm to room temperature.  The reaction contents
were transferred to a separatory funnel where the aqueous phase was extracted four times
with Et2O.  The combined organics were dried over MgSO4, filtered, and concentrated
under reduced pressure.  The resulting crude oil was filtered through a short silica gel
plug to afford an orange oil.
A 50 mL round-bottom flask equipped with a magnetic stir bar was cycled into a
glove box and loaded with sodium hydride (161.0 mg, 95% by weight, 6.37 mmol, 1.21
equiv).  The flask was removed from the glove box, reconnected to an Ar-filled manifold,
and charged with THF (6 mL).  The crude orange oil from the previous step (1.61 g, 5.27
mmol, 1.00 equiv) was transferred via cannula to the flask using several THF rinses (1 x
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5 mL + 3 x 2 mL, total added = 21.0 mL, 0.25 M).  The grey suspension bubbled and
became a yellow solution that transitioned to red over time.  The reaction was stirred for
30 min before methyl iodide (400 µL, 6.43 mmol, 1.22 equiv) was added dropwise.
After 3.5 h, the reaction was quenched with water and extracted four times with
dichloromethane.  The combined organics were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The resulting crude oil was purified by flash
column chromatography (SiO2, 28.5 x 4 cm, 100% hexanes'5% EtOAc in hexanes) to
afford "-Iodoenone 20 (536.3 mg, 1.68 mmol, 18% yield over two steps) as a yellow oil;
Rf = 0.72 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 6.81 (dd, J = 2.2, 1.2
Hz, 1H), 5.94–5.79 (m, 1H), 5.32–5.26 (m, 1H), 5.24 (dt, J = 10.5, 1.1 Hz, 1H),
4.67–4.56 (m, 2H), 3.05–2.96 (m, 1H), 2.93–2.85 (m, 1H), 2.43 (dt, J = 13.8, 4.9 Hz,
1H), 1.95 (ddd, J = 14.0, 9.0, 5.3 Hz, 1H), 1.39 (s, 3H); 13C NMR (125 MHz, CDCl3) &
192.6, 171.7, 139.6, 131.6, 125.5, 118.8, 66.1, 52.7, 38.6, 35.0, 20.3; IR (Neat Film
NaCl) 3084, 2982, 2936, 2868, 1732, 1682, 1597, 1455, 1424, 1378, 1333, 1295, 1246,
1169, 1098, 1033, 986, 926, 852, 770, 737 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for
C11H14O3I [M+H]
+: 320.9982, found 320.9981.
O O
O
CuI (10 mol %)
AcNH2, Cs2CO3, H2O
THF, 60 °C
86% yield20
I
H
N
N
H
(20 mol %) O O
O
N
H
16h
Ac
Enaminone 16h.  Adapted from procedure by Buchwald.30  CuI (24 mg, 0.13 mmol, 0.10
equiv), Cs2CO3 (624 mg, 1.92  mmol, 1.50 equiv)  and acetamide (91 mg, 1.5  mmol, 1.2
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equiv) were added to a 25 mL Schlenck bomb equipped with a stir bar under argon
atmosphere. The Schlenck bomb was evacuated and backfilled with argon three times.  A
solution of vinyl iodide 2 0  (409 mg, 1.28 mmol, 1.00 equiv), N , N ' -
dimethylethylenediamine (23 mg, 0.26 mmol, 0.20 equiv) and nanopure water (23 mg,
1.3 mmol, 1.0 equiv) in THF (2.6 mL, 0.5 M) was added via syringe.  The reaction flask
was lowered into a 60 °C oil bath.  After 12 h of stirring, TLC analysis indicated
complete conversion of starting material.  The reaction was subsequently diluted with 15
mL CH2Cl2, transferred to a separatory funnel and washed twice with 5% aqueous
NH4OH (10 mL).  The combined aqueous layers were extracted twice with CH2Cl2 (15
mL).  The combined organics were washed with brine (20 mL), dried over Na2SO4,
filtered, and concentrated under reduced pressure.  The resulting crude oil was purified
by flash chromatography (SiO2, 12 x 3 cm, 20'33'50'67% EtOAc in hexanes) to
afford enaminone 16h (276 mg, 1.10 mmol, 86% yield) as a pale yellow oil; Rf = 0.10
(50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 8.30 (s, 1H), 6.60 (s, 1H),
5.90–5.77 (m, 1H), 5.27 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (dq, J = 10.5, 1.2 Hz, 1H), 4.58
(dq, J = 5.6, 1.3 Hz, 2H), 2.78 – 2.64 (m, 1H), 2.62–2.43 (m, 1H), 2.54–2.45 (m, 1H),
2.11 (s, 3H), 2.02–1.83 (m, 1H), 1.39 (s, 3H); 
13
C NMR (125 MHz, CDCl3) & 197.8,
172.5, 169.9, 155.9, 131.7, 118.5, 110.1, 65.9, 52.3, 31.9, 25.7, 25.0, 20.6; IR (Neat Film
NaCl) 3299, 3135, 2937, 1728, 1626, 1520, 1456, 1426, 1370, 1259, 1220, 1184, 1114,
999, 939, 877 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C13H18NO4 [M+H]
+:
252.1230, found 252.1219.
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NaH, DMF, 0 °C
then BnBr, 0!23 °C
71% yield
O O
O
N
Ac
O O
O
N
H
16h
Ac
Bn
16d
Enaminone 16d.  In a 5 mL round bottom flask equipped with a stir bar under nitrogen
atmosphere, enaminone 16h (63 mg, 0.25 mmol, 1.0 equiv) was taken up in dry DMF
(2.8 mL, 0.089 M) and cooled to 0 °C with an ice/water bath.  Sodium hydride (60%
suspension in mineral oil, 12 mg, 0.30 mmol, 1.2 equiv) was added to the mixture,
accompanied by the formation of bubbles.  The reaction was stirred for 1 h before the
dropwise addition of benzyl bromide (36 µL, 0.30 mmol, 1.2 equiv) by syringe.  The
reaction temperature was maintained at 0 °C for 5 h before allowing the ice bath to
gradually expire.  After an additional 6 h at 23 °C, TLC analysis indicated complete
conversion of starting material.  The reaction was subsequently diluted with EtOAc (10
mL) and sat. NH4Cl sol. (10 mL) and transferred to a separatory funnel.  The organic
layer was separated from the aqueous layer, and the aqueous layer was extracted twice
with EtOAc (2 x 10 mL).  The combined organics were washed with brine (15 mL), dried
over MgSO4, filtered, and concentrated under reduced pressure.  The resulting crude oil
was purified by flash chromatography (SiO2, 15 x 3 cm, 20% acetone in hexanes) to
afford enaminone 16d (61 mg, 0.18 mmol, 71% yield) as a yellow oil; 1H NMR (500
MHz, CDCl3) & 7.34–7.29 (m, 2H), 7.29–7.24 (m, 1H), 7.19–7.16 (m, 2H), 5.87–5.79 (m,
1H), 5.78 (s, 1H), 5.27 (dt, J = 17.2, 1.4 Hz, 1H), 5.21 (dt, J = 10.5, 1.3 Hz, 1H),
4.89–4.84 (m, 1H), 4.78–4.72 (m, 1H), 4.56 (dt, J = 5.7, 1.3 Hz, 2H), 2.58 (ddd, J = 9.3,
4.9, 1.6 Hz, 1H), 2.56–2.48 (m, 1H), 2.44 (dtd, J = 13.8, 4.8, 1.2 Hz, 1H), 2.16 (s, 3H),
1.87–1.78 (m, 1H), 1.36 (s, 3H); 13C NMR (125 MHz, CDCl3) & 196.2, 172.0, 170.0,
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160.8, 136.5, 131.6, 129.0, 127.9, 127.5, 123.8, 1190, 66.1, 52.6, 50.8, 32.8, 27.3, 23.2,
20.2; IR (Neat Film NaCl) 3063, 3030, 2981, 2937, 2873, 1731, 1667, 1624, 1496, 1454,
1424, 1387, 1375, 1344, 1312, 1250, 1190, 1113, 1029, 986, 948, 882, 738 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C20H24O4N [M+H]
+: 342.1700, found 342.1705.
O O
O
CuI (10 mol %)
BzNH2, Cs2CO3, H2O
THF, 60 °C
70% yield20
I
H
N
N
H
(20 mol %) O O
O
N
H
Bz
16i
Enaminone 16i.  Adapted from procedure by Buchwald.30  Prepared from 20 in an
analogous manner to 16h.  Purified by flash chromatography (SiO2, 12 x 3 cm,
20'33'50% EtOAc in hexanes) to afford enaminone 16i (220 mg, 0.702 mmol, 70%
yield) as a pale yellow oil that solidified to a pale yellow amorphous solid upon standing
at –20 °C; Rf = 0.10 (50% EtOAc in hexanes); 
1
H NMR (500 MHz, CDCl3) & 8.31 (s,
1H), 7.83 – 7.74 (m, 2H), 7.56–7.47 (m, 1H), 7.47–7.40 (m, 2H), 6.70 (s, 1H), 5.88–5.75
(m, 1H), 5.25 (dq, J = 17.2, 1.6 Hz, 1H), 5.17 (dq, J = 10.5, 1.4 Hz, 1H), 4.55 (dq, J =
5.5, 1.5 Hz, 2H), 2.92–2.82 (m, 1H), 2.79–2.69 (m, 1H), 2.53 (dt, J = 13.7, 5.4 Hz, 1H),
1.99–1.87 (m, 1H), 1.38 (s, 3H); 13C NMR (125 MHz, CDCl3) & 197.2, 172.5, 166.5,
155.6, 133.8, 132.7, 131.7, 128.9, 127.5, 118.4, 111.1, 65.8, 52.3, 32.0, 25.9, 20.5; IR
(Neat Film NaCl) 3334, 2936, 1732, 1694, 1621, 1514, 1492, 1376, 1258, 1185, 1115,
1071, 1023, 931, 710 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C18H20NO4 [M+H]
+:
314.1387, found 314.1381.
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NaH, DMF, 0 °C
then BnBr, 0!23 °C
60% yield
O O
O
N
Bz
O O
O
N
H
16i
Bz
Bn
16e
Enaminone 16e.  Prepared from 16i in an analogous manner to 16d.  Purified by flash
chromatography (SiO2, 15 x 3 cm, 20% acetone in hexanes) to afford enaminone 16e
(134 mg, 0.332 mmol, 60% yield) as a yellow oil; Rf = 0.63 (50% EtOAc in hexanes); 
1
H
NMR (500 MHz, CDCl3) & 7.65–7.55 (m, 2H), 7.52–7.43 (m, 1H), 7.43–7.37 (m, 2H),
7.36–7.26 (m, 5H), 5.84 (s, 1H), 5.83–5.71 (m, 1H), 5.28–5.15 (m, 2H), 5.10–4.98 (m,
2H), 4.58–4.38 (m, 2H), 2.38–2.26 (m, 1H), 2.26–2.13 (m, 2H), 1.56 (s, 6H), 1.24 (s,
3H); 13C NMR (125 MHz, CDCl3) & 195.9, 171.8, 161.8, 136.8, 136.0, 131.8, 131.6,
128.9, 128.8, 128.2, 127.9, 127.7, 127.7, 121.4, 118.5, 65.9, 52.8, 52.4, 32.6, 28.8, 20.2;
IR (Neat Film NaCl) 2936, 1733, 1661, 1601, 1496, 1447, 1377, 1344, 1300, 1253, 1174,
1111, 974, 794, 724 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C25H26NO4 [M+H]
+:
404.1856, found 404.1850.
O
O
O
O O
H2N
O
O
85% yield
NH4OAc
MeOH/CH3CN, 45 °C
17 16j
Enaminone 16j.  A flame-dried 50 mL round-bottom flask containing a stir bar was
cycled into a glove box and loaded with ammonium acetate (185.3 mg, 2.40 mmol, 1.16
equiv).  The flask was removed from the glove box, reconnected to an Ar-filled manifold,
and charged with MeOH (1.5 mL).  Dione 17 (437.5 mg, 2.08 mmol, 1.00 equiv) was
transferred to the flask via cannula using MeOH (5 mL, total added = 6.5 mL, 0.32 M)
and CH3CN (6.5 mL, 0.32 M) rinses.  The flask was lowered into a preheated oil bath (45
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°C) and the reaction was heated for five days before TLC analysis indicated consumption
of starting material.  The reaction was cooled to room temperature and the contents were
concentrated under reduced pressure.  The resulting crude material was recrystallized
twice with toluene to produce enaminone 16j (369.0 mg, 1.76 mmol, 85% yield) as a
white crystal; Rf = 0.18 (EtOAc); 
1H NMR (500 MHz, CDCl3) & 5.88 (dddd, J = 17.2,
10.4, 5.5, 5.5 Hz, 1H), 5.29 (dq, J = 17.2, 1.6 Hz, 1H), 5.25 (d, J = 0.8 Hz, 1H), 5.20 (dq,
J = 10.5, 1.4 Hz, 1H), 4.61 (dddd, J = 5.4, 3.9, 1.5, 1.5 Hz, 2H), 4.53 (broad s, 2H),
2.60–2.52 (m, 1H), 2.49 (ddd, J = 13.3, 5.8, 5.0 Hz, 1H), 2.35–2.28 (m, 1H), 1.93–1.86
(m, 1H), 1.42 (s, 3H); 13C NMR (125 MHz, CDCl3) & 194.7, 173.3, 163.7, 132.1, 118.1,
99.9, 65.7, 51.6, 32.3, 26.0, 21.0; IR (Neat Film NaCl) 3338, 3189, 3064, 2983, 2934,
2873, 1735, 1654, 1551, 1437, 1383, 1358, 1291, 1253, 1216, 1194, 1175, 1103, 989,
930, 841, 824 cm-1; HRMS (MM: ESI-APCI+) calc’d for C11H16O3N [M+H]
+: 210.1125,
found 210.1119.
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1.4.2.2.2 General Procedure for Screening Reactions
THF TBME Toluene 2:1 Hex–Tol
23b
23e
23g
23f
81
76
87
74
85
82
83
83
89
83
90
85
88
88
88
86
86
80
87
83
88
82
87
83
84
82
83
83
83
83
82
83
87
84
86
84
87
81
82
83
Enantiomeric Excess (% ee)b
22a
85
86
85
86
86
86
87
88
product
23a
61
79
60
78
55
84
52
83
23d
21a
87
85
88
86
87
88
87
85
ligand
3
8
3
8
3
8
3
8
3
8
3
8
3
8
3
8
entry
7
8
9
10
11
12
15
16
13
14
3
4
5
6
1
2
16b
16e
16g
16f
14a
substrate
16a
16d
13a
NPh(Bn)
NBz(Bn)
NTs(Bn)
NBoc(Bn)
Oi-Bu
R
NMe(Bn)
NAc(Bn)
H
a Conditions: enone 13a, vinylogous ester 14a, or enaminone 16a, b, d–g (1.0 equiv), Pd2(dba)3 (5 mol
%), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-BuPHOX (8) (12.5 mol %) in solvent (0.033 M) at 40 °C.
b
!Determined by GC, HPLC, or SFC analysis. Red = with (S)-(3) as ligand and blue = with (S)-(8) as ligand.
Ph2P N
O
t-Bu
(4-CF3C6H4)2P N
O
t-Bu
CF3
! (S)-t-BuPHOX ! (S)-(CF3)3-t-BuPHOX
3 8
O
O
O
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
solvent (0.033 M), 40 oC
R
O
R
13, 14, or 16 21, 22, or 23
Enone 13a Screen Procedure.  Pd2(dba)3 (2.4 mg, 0.00262 mmol, 0.05 equiv) and the
appropriate PHOX ligand ((S)-t-BuPHOX (3): 2.5 mg, 0.00645 mmol, 0.125 equiv or
(S)-(CF3)3-t-BuPHOX (8): 3.8 mg, 0.00643 mmol, 0.125 equiv) were added to an oven-
dried 1 dram vial equipped with a magnetic stir bar.  A separate oven-dried 1 dram vial
was charged with enone 13a6 (10.0 mg, 0.0515 mmol, 1.00 equiv) and both vials were
cycled into a nitrogen-filled glove box.  The palladium/ligand vial was charged with
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solvent (THF, TBME, toluene: 360 µL or 2:1 hexanes/toluene: 120 µL toluene and 340
µL hexanes) and stirred at ambient glove box temperature.  After 30 min, enone 9a was
transferred to the reaction vial with several solvent rinses (THF, TBME, toluene: 3 x 400
µL, 1.56 mL total, 0.033 M or 2:1 hexanes/toluene: 400 µL toluene and 400 µL + 300 µL
hexanes, 1.56 mL solvent total, 0.033 M).  The vials were tightly sealed with a teflon
lined cap and electrical tape, removed from the glove box, and lowered into a heating
block set to 40 °C.  After 2 days, the reaction were either loaded directly onto a column
(toluene and 2:1 hexanes/toluene) or filtered through a celite plug and concentrated prior
to chromatography (THF and TBME).  All reactions were purified by flash column
chromatography (SiO2, ~22 x 1 cm, 2%'3% Et2O in pentane), resuspended in Et2O for
analysis, and analyzed for enantiomeric excess with chiral GC.  Characterization data for
enone 21a matches that previously reported.6  As part of the screen, the yield was
determined for enone 21a with (S)-8 in toluene (6.0 mg, 0.040 mmol, 78% yield).
Vinylogous Ester 14a and Enaminone Symyx Core Module Screen Procedure.  All
reagents were dispensed as solutions using a Symyx Core Module within a nitrogen-filled
glovebox.  Oven-dried half-dram vials were charged with a solution of the palladium
source (Pd2(dba)3, 1.65 µmol, 0.05 equiv) in THF (400 µL).  The palladium solutions
were evaporated to dryness under reduced pressure using a Genevac centrifugal
evaporator within the glovebox, and stirbars were added to the vials.  The reaction vials
were then charged with a solution of the PHOX ligand (4.13 µmol, 0.125 equiv) in the
reaction solvent (300 µL) and stirred at 20 °C.  After 30 min, a solution of vinylogous
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ester 14a or the enaminone substrate (16, 33.0 µmol, 1.0 equiv) in the reaction solvent
(700 µL) were added.  The reaction vials were tightly capped and heated to the desired
temperature (40 °C).  The consumption of the starting material was observed by
colorimetric change (from light yellow/green to red/orange) and after 5 days, the
reactions were removed from the glovebox, filtered through a short silica gel plug
(rinsing with EtOAc), concentrated under reduced pressure, resuspended in an
appropriate solvent for analysis (HPLC: hexanes or SFC: MeOH), and analyzed for
enantiomeric excess (see Methods for the Determination of Enantiomeric Excess).
Characterization data for vinylogous ester 22a matches that previously reported.18c
Experimental procedures and characterization data for enaminones 23a, b, d–g follows.
1.4.2.2.3 Enaminone Allylic Alkylation Products
O
N
O
O O
N
Bn
Me
(S)-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40!60 °C
68% yield
16a 23a
81% ee
Me
Bn
Ph2P N
O
t-Bu3
Enaminone 23a.  Pd2(dba)3 (14.6 mg, 0.0159 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
15.5 mg, 0.0400 mmol, 12.5 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (2 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16a (1 M in toluene, 320 µL, 0.320 mmol, 1.00 equiv) and
additional toluene (7.35 mL, total added = 9.67 mL, 0.033 M) were added, producing a
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green solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 5 days, the temperature was raised
to 60 °C and heated for an additional day before the reaction mixture transitioned back to
a red/orange solution.  The reaction was filtered through a silica gel plug, rinsed with
EtOAc, and concentrated under reduced pressure.  The crude oil was purified twice by
flash column chromatography (SiO2, 27.5 x 2 cm, 100% hexanes'20%'30%'50%
EtOAc in hexanes' 100% EtOAc then  SiO2, 26.5 x 1.5 cm, 100%
hexanes'20%'30%'40% EtOAc in hexanes) to afford enaminone 23a (58.9 mg,
0.219 mmol, 68% yield) as a pale yellow oil; Rf = 0.12 (50% EtOAc in hexanes); 
1H
NMR (500 MHz, CDCl3) & 7.38–7.33 (m, 2H), 7.31–7.26 (m, 1H), 7.10 (d, J = 7.2 Hz,
2H), 5.84–5.74 (m, 1H), 5.17 (s, 1H), 5.07–5.00 (m, 2H), 4.51 (s, 2H), 2.95 (s, 3H),
2.58–2.44 (m, 2H), 2.38 (dddd, J = 13.7, 7.1, 1.2, 1.2 Hz, 1H), 2.23–2.18 (m, 1H), 1.93
(ddd, J = 13.2, 7.5, 5.5 Hz, 1H), 1.71 (ddd, J = 13.7, 6.9, 5.4 Hz, 1H), 1.09 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 201.2, 163.7, 136.9, 135.2, 129.1, 127.7, 126.3, 117.5, 98.1,
55.0, 42.1, 41.8, 38.5, 32.8, 24.0, 22.6; IR (Neat Film NaCl) 3066, 3029, 2958, 2926,
2867, 1728, 1615, 1557, 1495, 1451, 1412, 1373, 1354, 1333, 1315, 1297, 1276, 1253,
1204, 1156, 1103, 1077, 1029, 1001, 924, 823, 792, 733 cm-1; HRMS (EI+) m/z calc’d for
C18H23ON [M+•]
+: 269.1780, found 269.1782; [!]D
25.0 –24.18 (c 1.04, CHCl3, 81% ee);
JASCO SFC conditions: 5% MeOH in CO2, 5 mL/min, Chiralcel OD-H column, % = 210
nm, tR (min): major = 10.45, minor = 9.60.
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O
N
O
O O
N
Bn
Ph
(S)-t-BuPHOX (12.9 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
78% yield
16b 23b
83% ee
Ph
Bn
Ph2P N
O
t-Bu3
Enaminone 23b.  Pd2(dba)3 (3.5 mg, 0.00382 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
3.8 mg, 0.00981 mmol, 12.9 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (0.5 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16b (28.6 mg, 0.0762 mmol, 1.00 equiv) was transferred to the
flask with several toluene rinses (1 x 0.81 mL + 2 x 0.5 mL, total added = 2.31 mL, 0.033
M), producing a green solution.  The vial was sealed with a Teflon-lined cap, removed
from the glove box, and lowered into a heating block (40 °C).  After 4 days, the reaction
mixture transitioned back to an orange solution.  Subsequently, the reaction was filtered
through a silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.
The crude oil was purified twice by flash column chromatography (SiO2, 19.5 x 1.5 cm,
100% hexanes'50% EtOAc in hexanes'100% EtOAc then SiO2, 23.5 x 1 cm, 100%
hexanes'10%'20%'30%'40% EtOAc in hexanes) to afford enaminone 23b (19.7
mg, 0.0594 mmol, 78% yield) as a frosty colorless oil; Rf = 0.63 (50% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) & 7.37–7.33 (m, 2H), 7.33–7.29 (m, 2H),
7.29–7.22 (m, 2H), 7.22–7.18 (m, 2H), 7.15–7.11 (m, 2H), 5.76 (dddd, J = 15.8, 11.3,
7.8, 7.0 Hz, 1H), 5.29 (s, 1H), 5.05–5.00 (m, 2H), 4.83 (s, 2H), 2.38 (dddd, J = 13.8, 7.1,
1.3, 1.3 Hz, 1H), 2.35–2.31 (m, 2H), 2.19 (dddd, J = 13.7, 7.8, 1.1, 1.1 Hz, 1H),
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1.90–1.83 (m, 1H), 1.65 (ddd, J = 13.5, 6.5, 5.6 Hz, 1H), 1.08 (s, 3H); 13C NMR (125
MHz, CDCl3) & 201.8, 163.3, 144.6, 136.7, 135.0, 129.8, 128.8, 128.0, 127.6, 127.5,
127.0, 117.6, 100.5, 56.7, 42.2, 42.0, 33.0, 25.5, 22.6; IR (Neat Film NaCl) 3063, 3031,
2959, 2926, 2863, 1622, 1563, 1494, 1453, 1426, 1404, 1374, 1351, 1329, 1275, 1204,
1156, 1078, 1060, 1028, 1002, 911, 830, 730 cm-1; HRMS (EI+) m/z calc’d for C23H26ON
[M+H]
+: 332.2009, found 332.1999; [!]D
25.0 –29.79 (c 1.91, CHCl3, 83% ee); JASCO
SFC conditions: 5% MeOH in CO2, 5 mL/min, Chiralpak AS-H column, % = 254 nm, tR
(min): major = 8.60, minor = 6.48.
O
N
O
O O
N
Bn
Ac
(S)-t-BuPHOX (12.3 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
71% yield
16d 23d
86% ee
Ac
Bn
Ph2P N
O
t-Bu3
Enaminone 23d.  Pd2(dba)3 (2.6 mg, 0.00284 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
2.7 mg, 0.00697 mmol, 12.3 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (0.51 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16d (19.3 mg, 0.0565 mmol, 1.00 equiv) was transferred to the
flask with several toluene rinses (4 x 0.3 mL, total added = 1.71 mL, 0.033 M), producing
a yellow solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 2 days, the reaction mixture
transitioned back to an orange solution.  Subsequently, the reaction was filtered through a
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silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.  The crude
oil was purified by flash column chromatography (SiO2, 19.5 x 1.5 cm,
5%'10%'20%'30% EtOAc in hexanes) to afford enaminone 23d (12.0 mg, 0.0404
mmol, 71% yield) as a yellow oil; Rf = 0.46 (50% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.32 (ddt, J = 8.1, 6.7, 1.2 Hz, 2H), 7.30–7.23 (m, 1H), 7.19 (ddt, J = 7.3,
1.4, 0.7 Hz, 2H), 5.68 (t, J = 1.3 Hz, 1H), 5.66 (ddt, J = 16.9, 10.1, 7.3 Hz, 1H), 5.05 (ddt,
J = 10.1, 1.9, 0.9 Hz, 1H), 4.99 (ddt, J = 17.0, 2.1, 1.4 Hz, 1H), 4.81 (s, 2H), 2.50–2.39
(m, 2H), 2.21 (ddt, J = 13.8, 7.3, 1.2 Hz, 1H), 2.17 (s, 3H), 2.10 (ddt, J = 13.8, 7.5, 1.1
Hz, 1H), 1.87 (dt, J = 13.8, 5.9 Hz, 1H), 1.69 (ddd, J = 13.8, 6.6, 5.7 Hz, 1H), 1.01 (s,
3H); 13C NMR (125 MHz, CDCl3) & 203.1, 169.7, 160.1, 136.6, 133.6, 128.9, 127.9,
127.7, 123.8, 118.6, 50.9, 43.6, 40.8, 32.6, 27.1, 23.2, 21.5; IR (Neat Film NaCl) 3066,
2926, 2854, 1663, 1624, 1496, 1453, 1387, 1371, 1189, 991, 916 cm-1; HRMS (FAB+)
m/z calc’d for C19H24NO2 [M+H]
+: 298.1807, found 298.1794; [!]D
25.0 –14.12 (c 1.20,
CHCl3, 86% ee); Thar SFC conditions: 5% MeOH in CO2, 3 mL/min, Chiralpak AD-H
column, % = 254 nm, tR (min): major = 8.45, minor = 10.35.
O
N
O
O O
N
Bn
Bz
(S)-t-BuPHOX (12.4 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
71% yield
16e 23e
84% ee
Bz
Bn
Ph2P N
O
t-Bu3
Enaminone 23e.  Pd2(dba)3 (4.6 mg, 0.00502 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
4.8 mg, 0.0124 mmol, 12.4 mol %) were added to an oven-dried scintillation vial
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equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (0.93 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16e (1 M in toluene, 100 µL, 0.100 mmol, 1.00 equiv) was
transferred to the flask with more toluene (1 mL, total added including enaminone
solution = 3.03 mL, 0.033 M), producing a yellow/orange solution.  The vial was sealed
with a Teflon-lined cap, removed from the glove box, and lowered into a heating block
(40 °C).  After 2 days, the reaction mixture transitioned back to an orange solution.
Subsequently, the reaction was filtered through a silica gel plug, rinsed with EtOAc, and
concentrated under reduced pressure.  The crude oil was purified by flash column
chromatography (SiO2, 19.5 x 1.5 cm, 5%'10%'15% EtOAc in hexanes) to afford
enaminone 23e (26.3 mg, 0.0713 mmol, 71% yield, 95% purity) as a yellow oil; Rf = 0.57
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.63–7.59 (m, 2H), 7.50–7.43
(m, 1H), 7.39 (ddt, J = 8.2, 6.6, 1.1 Hz, 2H), 7.35–7.29 (m, 4H), 7.29–7.25 (m, 1H), 5.74
(t, J = 1.1 Hz, 1H), 5.54 (ddt, J = 17.3, 10.1, 7.4 Hz, 1H), 5.09 (d, J = 15.3 Hz, 1H), 5.00
(d, J = 15.3 Hz, 1H), 4.98 (dm, J = 9.9 Hz, 1H), 4.86 (dm, J = 17.0 Hz, 1H), 2.11–2.08
(m, 2H), 2.03 (dd, J = 14.2, 7.9 Hz, 1H), 1.95 (ddt, J = 13.8, 7.3, 1.2 Hz, 1H), 1.59 (ddd, J
= 13.7, 6.5, 5.4 Hz, 1H), 1.41 (ddd, J = 13.4, 6.8, 5.3 Hz, 1H), 0.88 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 202.7, 170.8, 160.9, 136.8, 136.2, 133.6, 131.6, 128.9, 128.7, 128.1,
128.0, 127.9, 122.3, 118.4, 52.5, 43.3, 40.6, 32.4, 28.4, 21.3; IR (Neat Film NaCl) 3063,
3030, 2961, 2928, 2855, 1655, 1610, 1496, 1447, 1384, 1374, 1347, 1324, 1273, 1189,
1140, 1076, 1028, 1001, 974, 919, 792 cm-1; HRMS (FAB+) m/z calc’d for C24H26NO2
[M+H]
+: 360.1964, found 360.1956; [!]D
25.0 –26.61 (c 1.87, CHCl3, 84% ee); Thar SFC
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conditions: 7% MeOH in CO2, 2.5 mL/min, Chiralpak AD-H column, % = 254 nm, tR
(min): major = 18.14, minor = 20.28.
O
N
O
O O
N
Bn
Boc
(S)-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
82% yield
16f 23f
82% ee
Boc
Bn
Ph2P N
O
t-Bu3
Enaminone 16f.  Pd2(dba)3 (11.5 mg, 0.0126 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
12.1 mg, 0.0312 mmol, 12.5 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (2 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16f (1 M in toluene, 250 µL, 0.250 mmol, 1.00 equiv) and
additional toluene (6.34 mL, total added = 7.59 mL, 0.033 M) were added, producing a
green solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 2 days, the reaction mixture
transitioned back to an orange solution.  Subsequently, the reaction was filtered through a
silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.  The crude
oil was purified by flash column chromatography (SiO2, 28 x 3 cm, 100%
hexanes'5%'10% EtOAc in hexanes) to afford enaminone 23f (72.6 mg, 0.204 mmol,
82% yield) as a pale yellow oil; Rf = 0.65 (30% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) & 7.33–7.29 (m, 2H), 7.26–7.22 (m, 1H), 7.17–7.14 (m, 2H), 5.69 (dddd, J = 16.8,
10.2, 7.4, 7.4 Hz, 1H), 5.63 (t, J = 0.9 Hz, 1H), 5.07–4.99 (m, 2H), 4.78 (s, 2H), 2.75 (tm,
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J = 6.1 Hz, 2H), 2.29 (dddd, J = 13.7, 7.3, 1.2, 1.2 Hz, 1H), 2.13 (dddd, J = 13.7, 7.5, 1.2,
1.2 Hz, 1H), 1.90–1.84 (m, 1H), 1.71–1.65 (m, 1H), 1.43 (s, 9H), 1.04 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 203.6, 161.6, 153.0, 137.4, 134.1, 128.8, 127.4, 126.4, 118.2, 115.4,
82.6, 52.9, 43.2, 41.2, 33.5, 28.2, 27.2, 21.9; IR (Neat Film NaCl) 3066, 3031, 3004,
2976, 2931, 2868, 1716, 1656, 1598, 1497, 1455, 1428, 1382, 1368, 1350, 1326, 1302,
1243, 1209, 1192, 1153, 1076, 1030, 998, 946, 916, 858, 779, 767, 734 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C22H30O3N [M+H]
+: 356.2229, found 356.2220; [!]D
25.0
–23.61 (c 0.92, CHCl3, 82% ee); JASCO SFC conditions: 7% MeOH in CO2, 5 mL/min,
Chiralpak AD-H column, % = 210 nm, tR (min): major = 4.04, minor = 2.20.
O
N
O
O O
N
Bn
Ts
(S)-t-BuPHOX (12.7 mol %)
Pd2(dba)3 (5.1 mol %)
toluene, 40 °C
71% yield
16g 23g
84% ee
Ts
Bn
Ph2P N
O
t-Bu3
Enaminone 23g.  Pd2(dba)3 (10.2 mg, 0.0111 mmol, 5.1 mol %) and (S)-t-BuPHOX (3,
10.8 mg, 0.0279 mmol, 12.7 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (2 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16g (1 M in toluene, 220 µL, 0.220 mmol, 1.00 equiv) and
additional toluene (5.46 mL, total added = 6.68 mL, 0.033 M) were added, producing a
green solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 2 days, the reaction 
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transitioned back to an orange solution.  Subsequently, the reaction was filtered through a
silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.  The crude
oil was purified by flash column chromatography (SiO2, 27 x 2 cm, 100%
hexanes'5%'10%'15% EtOAc in hexanes) to afford enaminone 23g (64.1 mg, 0.157
mmol, 71% yield) as a pale yellow oil; Rf = 0.55 (30% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.70 (dm, J = 8.3 Hz, 2H), 7.35 (dm, J = 8.6 Hz, 2H), 7.33–7.26 (m, 3H),
7.25–7.22 (m, 2H), 5.60–5.50 (m, 2H), 4.98 (dm, J = 10.2 Hz, 1H), 4.86 (dm, J = 17.0
Hz, 1H), 4.74 (d, J = 15.0 Hz, 1H), 4.66 (d, J = 15.0 Hz, 1H), 2.56–2.44 (m, 2H), 2.46 (s,
3H), 1.99–1.86 (m, 2H), 1.70 (ddd, J = 13.9, 6.6, 5.3 Hz, 1H), 1.55 (ddd, J = 13.9, 7.2,
5.5 Hz, 1H), 0.85 (s, 3H); 13C NMR (125 MHz, CDCl3) & 202.9, 157.74, 144.7, 135.4,
135.3, 133.7, 130.1, 128.9, 128.1, 127.9, 127.5, 120.7, 118.3, 53.1, 43.2, 40.6, 32.2, 27.9,
21.8, 21.3; IR (Neat Film NaCl) 3066, 3027, 2963, 2928, 2868, 1663, 1654, 1597, 1496,
1453, 1424, 1355, 1306, 1164, 1089, 1055, 1028, 1001, 912, 859, 814, 745 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C24H28O3NS [M+H]
+: 410.1784, found 410.1792;
[!]D
25.0 –33.05 (c 0.37, CHCl3, 84% ee); JASCO SFC conditions: 10% MeOH, 5 mL/min,
AD-H column, % = 210 nm, tR (min): major = 5.60, minor = 4.73.
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1.4.2.3 Preparation of 2,3-Dihydropyridin-4-ones
1.1.1.1.4 2,3-Dihydropyridin-4-one Allylic Alkylation Precursors
N
Cbz
O
1. LDA, THF, –78 °C
   then allyl cyanoformate
2. K2CO3, MeI
    acetone, 50 °C
43% yield, 2 steps
N
Cbz
O
O
O
47a 29a
2,3-Dihydropyridin-4-one 29a.  A 100 mL round-bottom flask equipped with a
magnetic stir bar was charged with diisopropyl amine (442 µL, 3.01 mmol, 1.20 equiv)
and THF (28 mL).  The flask was cooled to –78 °C bath (dry ice/IPA) and n-BuLi (1.30
mL, 3.01 mmol, 2.32 M in hexanes, 1.20 equiv) was added.  The reaction was allowed to
warm to 0 °C over 1 h.  The solution was cooled back to –78 °C and added dropwise to a
solution of 2,3-dihydropyridin-4-one 47a37 (580 mg, 2.51 mmol, 1.0 equiv) in THF (40
mL) at –78 °C using positive pressure cannulation.  The reaction was stirred for 1 h at
this temperature before allyl cyanoformate (300 µL, 2.88 mmol, 1.15 equiv) was added
dropwise.  The flask was removed from the bath, allowed to warm to room temperature
slowly, and stirred overnight.  The reaction was quenched with water and sat. NH4Cl
solution.  The phases were separated and the aqueous phase was extracted three times
with EtOAc.  The combined organic layers were dried over MgSO4, filtered, and
concentrated under reduce pressure.  The resulting yellow oil was purified by flash-
chromatography (2:1 Et2O/hexanes).
The yellow oil was transferred to an argon filled 25 mL Schlenk tube equipped
with a magnetic stir bar using several acetone rinses (3 x 2 mL).  K2CO3 (252 mg, 1.83
mmol, 2.0 equiv) and methyl iodide (115 µL, 1.84 mmol, 2.02 equiv) were added to the
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reaction.  The resulting suspension was heated to 50 °C and vigorously stirred for 14 h.
Upon completion, the reaction was allowed to cool to room temperature and filtered
through a plug of celite.  The resulting yellow solution was concentrated under reduced
pressure and purified by flash-chromatography (1:1 Et2O/hexanes) to afford 2,3-
Dihydropyridin-4-one 29a (210 mg, 0.64 mmol, 43% yield over two steps) as a yellow
oil; Rf = 0.38 (1:1 Et2O/hexanes); 
1H NMR (500 MHz, CDCl3) & 7.83 (br s, J = 22.5 Hz,
1H), 7.45–7.31 (m, 5H), 5.82 (ddt, J = 17.2, 10.4, 5.6 Hz, 1H), 5.37 (br s, 1H), 5.27 (s,
2H), 5.26 (dq, J = 17.1, 1.5 Hz, 1H), 5.20 (dq, J = 10.5, 1.3 Hz, 1H), 4.64 (dd, J = 13.5,
0.9 Hz, 1H), 4.59 (dt, J = 5.6, 1.5 Hz, 2H), 3.63 (d, J = 13.5 Hz, 1H), 1.40 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 190.9, 170.1, 152.5, 142.7, 134.8, 131.3, 128.8, 128.7, 128.4,
118.6, 106.2, 69.2, 66.1, 51.6, 50.5, 17.9; IR (Neat Film, NaCl) 3076, 3034, 2965, 2929,
2360, 2922, 1729, 1668, 1605, 1498, 1456, 1418, 1393, 1344, 1302, 1205, 1157, 1101,
1029, 966, 917, 814, 763 cm-1; HRMS (MM: ESI/APCI+) m/z calc’d for C18H20NO5
[M+H]+: 330.1335, found 330.1335.
N
O
Bn
LDA, THF, –78 °C
then allyl cyanoformate
–78 ! 23 °C
N
O
O
O
Bn
47b 48b44% yield
2,3-Dihydropyridin-4-one 48b.  To a flame-dried 50 mL Schlenk round-bottom flask
equipped with a magnetic stir bar was added 2,3-dihydropyridin-4-one 47b38 (162.0 mg,
0.87 mmol) and THF (10 mL).  The solution was cooled to –78 °C and LDA (0.1 M in
THF, 9.10 mL, 0.91 mmol, 1.05 equiv) was added dropwise by syringe.  After 1 h at –78
°C, allyl cyanoformate (105.2 mg, 0.96 mmol, 1.10 equiv) was added, and the reaction
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was stirred for another 3 h and then quenched with a sat. NH4Cl sol.  The reaction was
transferred to a separatory funnel where the aqueous layer was extracted with CH2Cl2 (4 x
30 mL). The combined organics were washed with brine, dried over MgSO4, fitered, and
concentrated under reduced pressure.  The resulting crude mixture was purified by flash
chromatography (SiO2, 10 x 2.5 cm, 30% EtOAc ' 50% EtOAc in hexanes) to afford
2,3-dihydropyridin-4-one 48b (104.8 mg, 0.38 mmol, 44% yield) as a yellow oil; Rf =
0.30 (50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.45–7.31 (m, 3H),
7.28–7.23 (m, 2H), 7.17 (d, J = 7.5 Hz, 1H), 5.87 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.32
(dq, J = 17.2, 1.5 Hz, 1H), 5.22 (dq, J = 10.4, 1.3 Hz, 1H), 5.06 (d, J = 7.5 Hz, 1H),
4.69–4.55 (m, 2H), 4.40 (d, J = 2.5 Hz, 2H), 3.76 (dd, J = 13.3, 8.7 Hz, 1H), 3.51 (dd, J =
13.3, 5.9 Hz, 1H), 3.40 (dd, J = 8.7, 5.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) & 185.2,
168.8, 153.6, 135.1, 131.6, 129.1, 128.5, 127.8, 118.6, 97.7, 66.0, 60.0, 50.5, 48.4; IR
(Neat Film NaCl) 3029, 2935, 2853, 1732, 1641, 1588, 1494, 1455, 1393, 1361, 1321,
1204, 1154, 1078, 1028, 991, 967, 935, 78, 731 cm-1; HRMS (MM: ESI-APCI+) m/z
calc’d for C16H18NO3 [M+H]
+: 272.1287, found 272.1314.
N
O
O
O
Bn
48b
N
O
O
O
Bn
NaH, MeI
THF, 0 °C
29b
86% yield
2,3-Dihydropyridin-4-one 29b.   To a flame-dried 25 mL round-bottom flask equipped
with a magnetic stir bar was cycled into a glove box and loaded with sodium hydride (9.3
mg, 0.39 mmol, 1.00 equiv).  The flask was removed from the glove box, reconnected to
an Ar-filled manifold, charged with THF (3 mL), and cooled to 0 °C.  A solution of 2,3-
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dihydropyridin-4-one 48b (104.2 mg, 0.39 mmol, 1.00 equiv) was added by syringe and
the mixture was stirred at 0 °C for 30 min.  The reaction was quenched with water,
transferred to a separatory funnel, and extracted four times with CH2Cl2.  The combined
organics were washed with brine, dried over MgSO4, filtered, and concentrated under
reduced pressure.  The crude oil was purified by flash chromatography (SiO2, 10 x 2.5
cm, 30% EtOAc in hexanes) to afford 2,3-dihydropyridin-4-one 29b (95.9 mg, 0.34
mmol, 86% yield) as a colorless oil; Rf = 0.40 (50% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.43–7.30 (m, 3H), 7.25–7.20 (m, 2H), 7.13 (d, J = 7.4 Hz, 1H), 5.83
(ddt, J = 17.1, 10.8, 5.5 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.19 (dq, J = 10.5, 1.3
Hz, 1H), 5.01 (d, J = 7.4 Hz, 1H), 4.56 (qdt, J = 13.4, 5.5, 1.5 Hz, 2H), 4.46–4.30 (m,
2H), 3.78 (d, J = 13.2 Hz, 1H), 3.15 (d, J = 13.3 Hz, 1H), 1.30 (s, 3H); 13C NMR (125
MHz, CDCl3) & 189.1, 171.7, 152.8, 135.2, 131.8, 129.1, 128.5, 128.1, 118.2, 97.1, 65.9,
60.1, 55.1, 51.4, 18.6; IR (Neat Film NaCl) 3029, 2979, 2934, 2871, 1732, 1642, 1592,
1494, 1455, 1393, 1372, 1359, 1343,  1295, 1223, 1166, 1115, 1028, 975, 937, 792, 732
cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C17H20NO3 [M+H]
+: 286.1443, found
286.1480.
N
O
Bn
N
O
Bn
47b 48c
LDA, THF, –78 °C
I
7% yield
–78!23 °C
then
2,3-Dihydropyridin-4-one 48c.  To a flame-dried 100 mL Schlenk round-bottom flask
equipped with a magnetic stir bar was added 2,3-dihydropyridin-4-one 47b38 (0.68 g, 3.63
mmol) and THF (30 mL).  The solution was cooled to –78 °C and LDA (19.0 mL, 3.80
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mmol, 1.05 equiv, 0.2 M in THF) was added dropwise by syringe.  After 1 h at –78 °C,
1-iodo-2-methylpropane (0.87 g, 4.73 mmol, 1.30 equiv) was added, and the reaction was
stirred for another 1 h at –78 °C, brought to room temperature, and stirred overnight.  The
reaction was quenched with a sat. NH4Cl sol., transferred to a separatory funnel, and
extracted with CH2Cl2 (50 mL x 3). The combined organics were washed with brine,
dried over MgSO4, fitered, and concentrated. The crude mixture was purified by flash
chromatography (SiO2, 10 x 3 cm, 30% EtOAc in hexanes) to afford 2,3-dihydropyridin-
4-one 48c (58.2 mg, 0.24 mmol, 7% yield) as a yellow oil; Rf = 0.50 (50% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) & 7.46–7.32 (m, 3H), 7.29–7.25 (m, 2H), 7.12 (d,
J = 7.4 Hz, 1H), 4.96 (d, J = 7.4 Hz, 1H), 4.43–4.28 (m, 2H), 3.38 (dd, J = 13.0, 5.4 Hz,
1H), 3.08 (dd, J = 13.0, 7.7 Hz, 1H), 2.29 (ddt, J = 10.1, 7.6, 5.2 Hz, 1H), 1.56 (ddd, J =
14.0, 9.3, 5.0 Hz, 1H), 1.37 (dpd, J = 9.3, 6.6, 5.2, 1H), 1.18 (ddd, J = 13.7, 9.6, 5.3 Hz,
1H), 0.82 (d, J = 6.5 Hz, 3H), 0.78 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) &
195.0, 152.8, 135.8, 128.9, 128.3, 127.8, 97.7, 60.0, 50.4, 42.0, 37.5, 25.0, 23.3, 21.4; IR
(Neat Film NaCl) 3029, 2954, 2868, 1633, 1593, 1494, 1463, 1455, 1385, 1361, 1302,
1210, 1161, 1077, 778, 730 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H22NO
[M+H]+: 244.1701, found 244.1707.
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N
O
Bn
48c
N
O
Bn
29c
CO2allylLDA, THF, –78 °C
then allyl cyanoformate
–78!23 °C
30% yield
2,3-Dihydropyridin-4-one 29c.  To a flame-dried 25 mL Schlenk tube equipped with a
magnetic stir bar was added 2,3-dihydropyridin-4-one 48c (50.5 mg, 0.21 mmol) and
THF (5 mL).  After the solution was cooled to -78 °C, LDA (2.2 mL, 0.22 mmol, 1.06
equiv, 0.1 M in THF) was added dropwise by syringe.  The mixture was stirred for 1 h at
-78 °C and allyl cyanoformate (26.4 mg, 0.24 mmol, 1.20 equiv) was added.  The
reaction was stirred for another 3 h and quenched with saturated NH4Cl aqueous.  The
aqueous layer was extracted with CH2Cl2 (30 mL x 4) and the combined organics were
washed with brine, dried over MgSO4, and concentrated.  The crude mixture was purified
by flash chromatography (SiO2, 10 x 1 cm, 30% EtOAc in hexanes) to afford 29c (19.8
mg, 0.06 mmol, 30% yield) as a yellow oil; Rf = 0.30 (30% EtOAc in hexanes); 
1H NMR
(500 MHz, CDCl3) & 7.45–7.31 (m, 3H), 7.29–7.19 (m, 2H), 7.07 (d, J = 7.4 Hz, 1H),
5.86 (ddt, J = 17.2, 10.4, 5.6 Hz, 1H), 5.32 (dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dq, J = 10.5,
1.3 Hz, 1H), 4.96 (d, J = 7.3 Hz, 1H), 4.67–4.51 (m, 2H), 4.43 (s, 2H), 3.82 (d, J = 13.4
Hz, 1H), 3.27 (d, J = 13.4 Hz, 1H), 2.03 (dd, J = 14.2, 7.1 Hz, 1H), 1.64–1.45 (m, 2H),
0.85 (d, J = 6.5 Hz, 3H), 0.80 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) & 187.7,
170.9, 152.2, 135.1, 131.7, 129.0, 128.1, 118.4, 96.7, 65.8, 60.1, 54.4, 52.6, 40.4, 24.6,
24.3, 23.2; IR (Neat Film NaCl) 3029, 2957, 2870, 1729, 1644, 1593, 1455, 1360, 1267,
1215, 1159, 1132, 1077, 1029, 971, 778, 735 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d
for C20H26NO3 [M+H]
+: 328.1913, found 328.1947.
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N
O
MeO
MeO
47c
N
O
MeO
MeO
48d
LDA, THF, –78 °C
I
21 % yield
39% recovered 47c
then
2,3-Dihydropyridin-4-one 48d.  To a cooled (–78 °C) solution of 47c39 (0.67 g, 2.6
mmol, 1 equiv) in THF (25 mL) was added LDA (30 mL, 0.1 M, in THF, 30 mmol, 1.15
equiv) dropwise over 10 min.  The reaction was stirred for 1 h before 1-iodo-2-
methylpropane (0.57 g, 3.1 mmol, 1.20 equiv) was added dropwise.  After 2 h, the
reaction was brought to room temperature and stirred overnight.  The reaction was
quenched with sat. NH4Cl sol. and transferred to a separatory funnel where the aqueous
phase was extracted four times with CH2Cl2.  The combined organics were washed with
brine, dried over MgSO4, filtered, and concentrated under reduced pressure.  The
resulting crude mixture purified by flash column chromatography (SiO2, 15 x 3 cm, 50%
EtOAc in hexanes'100% EtOAc) to afford recovered 47c (0.26 g, 1.01 mmol, 39%
recovered) and also 48d (0.17 g, 0.54 mmol, 21% yield) as a yellow solid; Rf = 0.20
(50% EtOAc in hexanes).  Spectral data matches that reported previously.47  NMR data is
included to assist the reader.  1H NMR (300 MHz, CDCl3) & 7.14 (s, 1H), 6.65 (s, 1H),
5.62 (s, 1H), 3.90 (s, 3H), 3.86 (s, 3H), 3.64 (dd, J = 12.5, 5.3 Hz, 1H), 3.45–3.24 (m,
3H), 2.94 (td, J = 6.3, 3.5 Hz, 2H), 2.51–2.35 (m, 1H), 1.80–1.59 (m, 2H), 1.36–1.19 (m,
1H), 0.96 (d, J = 6.2 Hz, 3H), 0.91 (d, J = 6.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) &
195.5, 156.6, 151.5, 148.1, 129.0, 120.9, 110.5, 108.4, 94.4, 56.1, 55.9, 49.2, 42.1, 37.6,
28.6, 25.6, 23.6, 21.9.
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N
O
MeO
MeO
48d
62% yield
N
O
MeO
MeO
CO2allyl
29d
LDA, THF, –78 °C
then allyl cyanoformate
2,3-Dihydropyridin-4-one 29d.  A solution of 48d (149.1 mg, 0.47 mmol in 15 mol of
THF) was cooled to –78 °C and LDA (5.2 mL, 0.1 M in THF, 0.52 mmol, 1.10 equiv)
was added dropwise.  The reaction was stirred for 1 h before allyl cyanoformate (60.2
mg, 0.54 mmol, 1.15 equiv) was added dropwise.  After 12 h, the reaction was quenched
with sat. NH4Cl sol. and allowed to warm to room temperature.  The reaction contents
were transferred to a separatory funnel where the aqueous phase was extracted four times
with CH2Cl2.  The combined organics were washed with brine, dried over MgSO4,
filtered, and concentrated under reduced pressure.  The resulting crude mixture was
purified by flash column chromatography (SiO2, 15 x 3 cm, 50% EtOAc in hexanes) to
afford 2,3-dihydropyridin-4-one 29d (116.0 mg, 0.29 mmol, 62% yield) as a yellow
solid; Rf = 0.40 (50% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.13 (s, 1H),
6.66 (s, 1H), 5.87 (ddt, J = 17.2, 10.3, 5.6 Hz, 1H), 5.59 (s, 1H), 5.30 (dq, J = 17.2, 1.6
Hz, 1H), 5.17 (dq, J = 10.4, 1.3 Hz, 1H), 4.61 (ddt, J = 5.6, 2.7, 1.4 Hz, 2H), 4.05 (d, J =
13.0 Hz, 1H), 3.91 (s, 3H), 3.87 (s, 3H), 3.62 (d, J = 13.1 Hz, 1H), 3.55 (ddd, J = 12.1,
8.1, 5.7 Hz, 1H), 3.43 (ddd, J = 12.2, 6.9, 5.4 Hz, 1H), 3.00–2.77 (m, 2H), 2.23–2.06 (m,
1H), 1.79–1.60 (m, 2H), 0.96 (d, J = 6.2 Hz, 3H), 0.90 (d, J = 6.2 Hz, 3H);  13C NMR
(125 MHz, CDCl3) & 188.1, 171.0, 155.7, 151.6, 148.0, 131.8, 129.0, 120.5, 118.3, 110.3,
108.4, 92.8, 65.7, 56.5, 56.0, 56.0, 54.5, 48.6, 40.4, 28.3, 25.0, 24.4, 23.5;   IR (Neat Film
NaCl) 2955, 1720, 1625, 1583, 1544, 1495, 1343, 1237, 1211, 1167, 11523, 1120, 1016
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cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C23H30NO5 [M+H]
+: 400.2124, found
400.2110.
1.4.2.3.5 2,3-Dihydropyridin-4-one Allylic Alkylation Products
N
Cbz
O
O
O
29a
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
98% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
30a
84% ee
N
Cbz
O
2,3-Dihydropyridin-4-one 30a.  2,3-Dihydropyridin-4-one 29a (27.6 mg, 0.084 mmol,
1.0 equiv) was preloaded in a 1 dram vial and cycled into a glove box.  A separate 1 dram
vial was loaded with (S)-(CF3)3-t-Bu-PHOX (8, 4.1 mg, 10.5 µmol, 0.125 equiv),
Pd2(dba)3 (3.9 mg, 4.20 µmol, 0.05 equiv), and a magnetic stir-bar.  Toluene (1.6 mL)
was added and the black suspension was stirred at 30 °C in a heating block for 30 min.
2,3-Dihydropyridin-4-one 29a was dissolved in 1 mL of toluene and added to the orange
catalyst solution, causing an immediate color change to olive green.  The vial was capped
with a Teflon screw cap and the reaction was stirred for 14 h at 40 °C in the glove box.
Upon completion of the reaction, the vial was allowed to cool to room temperature and
removed from the glove box.  The reaction was concentrated under reduced pressure and
the resulting brown oil was purified by flash-chromatography (1:1 Et2O/hexanes) to
afford 2,3-dihydropyridin-4-one 30a (23.7 mg, 0.083 mmol, 98%) as a colorless oil; Rf =
0.73 (1:1 Et2O/hexanes); 
1H NMR (500 MHz, CDCl3) & 7.78 (s, 1H), 7.42–7.36 (m, 5H),
5.69 (td, J = 17.3, 7.5 Hz, 1H), 5.27 (d, J = 2.7 Hz, 3H), 5.05 (dd, J = 29.7, 13.4 Hz, 2H),
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3.91 (d, J = 13.4 Hz, 1H), 3.58 (d, J = 11.8 Hz, 1H), 2.22 (ddd, J = 46.4, 13.8, 7.5 Hz,
2H), 1.07 (s, 3H); 13C NMR (125 MHz, CDCl3) & 198.3, 152.7, 141.7, 135.0, 132.6, 128.8,
128.7, 128.4, 119.2, 106.4, 69.1, 51.4, 43.4, 39.4, 19.5; IR (Neat Film, NaCl) 2922, 1728,
1673, 1602, 1498, 1453, 1416, 1381, 1342, 1305, 1232, 1200, 1144, 1119, 1088, 956,
913, 813, 761 c m-1; HRMS (MM: ESI/APCI+) m/z calc’d for C17H20NO3 [M+H]
+:
286.1443, found 286.1438; [!]D
25.0 +9.88 (c 1.15, CHCl3, 84% ee); Thar SFC conditions:
10% MeOH in CO2, 3 mL/min, Chiralpak AD-H column, % = 254 nm, tR (min): major =
2.80, minor = 3.13.
30b
86% ee
29b
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
94% yield
N
O
O
O
Bn
N
O
Bn
2,3-Dihydropyridin-4-one 30b.  In a glove box, Pd2(dba)3 (2.3 mg, 0.0025 mmol, 5.0
mol %) and (S)-(CF3)3-t-BuPHOX (8, 3.7 mg, 0.00625 mmol, 12.5 mol %) were added to
a scintillation vial equipped with a stir bar.  The vial was charged with toluene (0.5 mL)
and heated at 40 °C for 30 min.  2,3-Dihydropyridin-4-one 29b (14.3 mg, 0.050 mmol,
1.00 equiv) and additional toluene (1.0 mL, total added = 1.5 mL, 0.033 M) were added,
producing a green solution.  The vial was sealed and stirred at 40 °C until the starting
material was fully converted, determined by LCMS.  The reaction was filtered through a
celite pad, rinsed with EtOAc, and concentrated under reduced pressure.  The crude oil
was purified by flash chromatography (SiO2, 5 x 1 cm, 30% EtOAc in hexanes) to afford
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2,3-dihydropyridin-4-one 30b (11.3 mg, 0.047 mmol, 94% yield) as a yellow oil; Rf =
0.30 (30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.38–7.25 (m, 3H),
7.24–7.14 (m, 2H), 7.03 (d, J = 7.4 Hz, 1H), 5.54 (ddt, J = 17.4, 10.1, 7.4 Hz, 1H), 4.94
(ddt, J = 9.9, 1.9, 0.9 Hz, 1H), 4.91–4.81 (m, 2H), 4.27 (d, J = 3.1 Hz, 2H), 3.07 (d, J =
13.0 Hz, 1H), 2.90 (d, J = 13.0 Hz, 1H), 2.22–1.97 (m, 2H), 0.90 (s, 3H); 13C NMR (125
MHz, CDCl3) & 196.5, 152.3, 135.6, 133.6, 129.0, 129.0, 129.0, 128.3, 128.0, 118.3, 96.9,
60.1, 55.9, 42.7, 39.7, 20.1, 20.0; IR (Neat Film NaCl) 3067, 3029, 2962, 2926, 1634,
1593, 1455, 1359, 1321, 1204, 1172, 1076, 1001, 916, 795 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C18H20NO [M+H]
+: 242.1545, found 242.1553; [!]D
25.0 +86.46 (c
1.16, CHCl3, 86% ee); HPLC conditions: 10% IPA in hexanes, 1 mL/min, Chiralcel OJ
column, % = 210 nm, tR (min): major = 18.77, minor = 21.21.
30c
88% ee
29c
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
81% yield
N
O
O
O
Bn
N
O
Bn
2,3-Dihydropyridin-4-one 30c.  In a glove box, Pd2(dba)3 (1.4 mg, 0.0015 mmol, 5.0
mol %) and (S)-(CF3)3-t-BuPHOX (8, 2.2 mg, 0.00375 mmol, 12.5 mol %) were added to
a scintillation vial equipped with a stir bar.  The vial was charged with toluene (0.5 mL)
and heated at 40 °C for 30 min.  2,3-Dihydropyridin-4-one 29c (9.8 mg, 0.030 mmol,
1.00 equiv) and additional toluene (0.5 mL, total added = 1.0 mL, 0.030 M) were added,
producing a green solution.  The vial was sealed and stirred at 40 °C until the starting
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 62
material was fully converted, determined by TLC.  The reaction was filtered through a
celite pad, rinsed with EtOAc, and concentrated under reduced pressure.  The crude oil
was purified by flash chromatography (SiO2, 5 x 1 cm, 30% EtOAc in hexanes) to afford
2,3-dihydropyridin-4-one 30c (6.9 mg, 0.024 mmol, 81% yield) as a yellow oil; Rf = 0.40
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.45–7.32 (m, 3H), 7.29–7.22
(m, 2H), 7.05 (d, J = 7.4 Hz, 1H), 5.62 (dddd, J = 17.1, 10.1, 7.8, 7.0 Hz, 1H), 5.00 (ddt,
J = 10.1, 2.1, 1.0 Hz, 1H), 4.97–4.91 (m, 2H), 4.33 (s, 2H), 3.13 (d, J = 3.2 Hz, 2H),
2.34–2.24 (m, 1H), 2.16 (ddt, J = 14.1, 7.8, 1.1 Hz, 1H), 1.61 (qd, J = 6.7, 5.6 Hz, 1H),
1.47 (dd, J = 14.2, 6.3 Hz, 1H), 1.33 (dd, J = 14.2, 5.5 Hz, 1H), 0.84 (d, J = 6.6 Hz, 3H),
0.82 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) & 196.7, 152.4, 135.7, 133.7,
129.1, 128.5, 128.1, 118.4, 97.1, 60.2, 56.0, 42.8, 39.8, 20.2.; IR (Neat Film NaCl) 3072,
3029, 2954, 2867, 1633, 1593, 1494, 1455, 1385, 1361, 1296, 1205, 1173, 1105, 1076,
1028, 998, 793, 736 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C19H26NO [M+H]
+:
284.2014, found 284.2023; [!]D
25.0 +50.23 (c 0.65, CHCl3, 88% ee); HPLC conditions:
7% IPA in hexanes, 1 mL/min, Chiralcel OJ column, % = 210 nm, tR (min): major =
11.44, minor = 14.80.
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N
O
MeO
MeO
30d
90% ee
N
O
CO2allyl
MeO
MeO
29d
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
81% yield
2,3-Dihydropyridin-4-one 30d.  Pd2(dba)3 (1.4 mg, 0.0015 mmol, 5.0 mol %) and (S)-
(CF3)3-t-BuPHOX (8, 2.2 mg, 0.00375 mmol, 12.5 mol %) were added to an oven-dried
Schlenk tube equipped with a magnetic stir bar, and the tube was backfilled with argon 3
times.  The tube was charged with toluene (1 mL) and heated at 40 °C for 30 min,
generating a red/orange solution.  2,3-Dihydropyridin-4-one 29d (11.9 mg, 0.03 mmol,
1.00 equiv) were added and the tube was lowered into a heating block (40 °C).  After 3 h,
TLC analysis indicated the reaction was complete.  Consequently, the reaction was
filtered through a silica gel plug, rinsed with EtOAc, and concentrated under reduced
pressure.  The crude mixture was purified by flash column chromatography (SiO2, 10 x 2
cm, 50% EtOAc in hexanes) to afford dihydropyridine-4-one 30d (8.6 mg, 0.0242 mmol,
81% yield) as yellow oil; Rf = 0.50 (50% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) & 7.16 (s, 1H), 6.66 (s, 1H), 5.82 (ddt, J = 17.4, 10.2, 7.4 Hz, 1H), 5.62 (s, 1H),
5.10–5.03 (m, 2H), 3.91 (s, 3H), 3.87 (s, 3H), 3.39 (s, 2H), 3.37 (td, J = 6.5, 1.5 Hz, 2H),
2.99–2.89 (m, 2H), 2.43 (ddt, J = 13.9, 7.2, 1.3 Hz, 1H), 2.25 (ddt, J = 14.0, 7.7, 1.1 Hz,
1H), 1.74 (hd, J = 6.6, 5.0 Hz, 1H), 1.66 (dd, J = 14.1, 6.5 Hz, 1H), 1.44 (dd, J = 14.1, 5.1
Hz, 1H), 0.94 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3)
& 196.3, 155.6, 151.4, 148.0, 134.7, 128.7, 120.8, 117.9, 110.4, 108.3, 94.3, 58.9, 56.0,
48.9, 46.1, 41.7, 39.2, 28.4, 25.1, 24.5, 24.1; IR (Neat Film NaCl) 2953, 1622, 1586,
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1549, 1495, 1464, 1342, 1212, 1173, 1110, 1016, 913, 794 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C22H30NO3 [M+H]
+: 356.2147, found 356.2221; [!]D
25.0 +32.49 (c
0.71, CHCl3, 90% ee); HPLC conditions: 30% IPA in hexanes, 1 mL/min, Chiralpak AD
column, % = 254 nm, tR (min): major = 21.87, minor = 18.59.
1.4.2.4 Preparation of Lactams
1.4.2.4.6 Lactam Allylic Alkylation Precursors
HN
O
O
O
Et3N, DMAP
THF, 0!23 °C
Cl
O
N
O
O
OO
49 4i89% yield
Lactam 4i.  Lactam 4910 (117.8 mg, 0.597 mmol, 1.00 equiv) was transferred to a flame-
dried 15 mL round-bottom flask using THF (4 x 0.5 mL + 1 x 0.4 mL rinses, total = 2.4
mL, 0.25 M).  Et3N (250 µL, 1.79 mmol, 3.00 equiv) and DMAP (9.3 mg, 0.0761 mmol,
13 mol%) were added and the flask was lowered into a 0 °C bath (ice/water).
Cyclohexanecarbonyl chloride (160 µL, 1.20 mmol, 2.00 equiv) was added dropwise, and
the reaction mixture transitioned from a solution to a white slurry.  The ice bath expired
gradually as the reaction was stirred overnight.  After 15 h of stirring, no starting material
remained by TLC analysis.  The reaction was subsequently quenched with brine (15 mL)
and transferred to a separatory funnel where the aqueous layer was extracted four times
with EtOAc.  The combined organics (100 mL) were rinsed twice with brine (20 mL),
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash column chromatography (SiO2, 27.5 x 2 cm, 100%
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hexanes'10% EtOAc in hexanes) to afford lactam 4i (163.5 mg, 0.532 mmol, 89%
yield) as a yellow oil; Rf = 0.60 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) &
5.88 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.32 (dq, J = 17.2, 1.5 Hz, 1H), 5.25 (dq, J =
10.4, 1.2 Hz, 1H), 4.64 (ddt, J = 5.8, 2.5, 1.3 Hz, 2H), 3.77 (ddd, J = 13.1, 7.7, 5.1 Hz,
1H), 3.58 (dddd, J = 13.4, 7.0, 5.0, 1.1 Hz, 1H), 3.27 (tt, J = 11.4, 3.2 Hz, 1H), 2.42
(dddd, J = 13.4, 6.0, 4.9, 0.9 Hz, 1H), 1.95 (dtd, J = 10.5, 3.5, 1.8 Hz, 1H), 1.92–1.80 (m,
3H), 1.79–1.70 (m, 3H), 1.67 (dtt, J = 10.8, 3.2, 1.5 Hz, 1H), 1.52 (s, 3H), 1.47–1.34 (m,
2H), 1.34–1.16 (m, 3H); 13C NMR (125 MHz, CDCl3) & 181.3, 173.5, 172.7, 131.4,
119.2, 66.4, 53.5, 45.7, 44.6, 33.1, 30.1, 29.6, 26.1, 25.9, 25.8, 23.0, 20.3; IR (Neat Film
NaCl) 3086, 2931, 2855, 1738, 1694, 1652, 1479, 1451, 1378, 1330, 1301, 1249, 1218,
1196, 1159, 1134, 1073, 1053, 1032, 981, 957, 939, 896, 887, 842, 796, 773 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C17H26O4N [M+H]
+: 308.1856, found 308.1871.
HN
O
O
O
Et3N, DMAP, PivCl
THF, 0!23 °C
N
O
O
OO
49 4j89% yield
Lactam 4j.  Lactam 499 (480 mg, 2.4 mmol, 1.0 equiv) in a 25 mL round-bottom flask
equipped with a magnetic stir bar was taken up in THF (9.6 mL, 0.25 M).  Et3N (1.0 mL,
7.2  mmol, 3.0 equiv) and DMAP (29 mg, 0.24 mmol, 0.10 equiv) were added and the
flask was lowered into a 0 °C bath (ice/water).  Pivaloyl chloride (0.59 mL, 4.8 mmol,
2.0 equiv) was added dropwise and the reaction mixture transitioned from a solution to a
white slurry.  The ice bath expired gradually as the reaction was stirred overnight.  After
24 h of stirring, TLC analysis indicated that conversion had ceased at approximately
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90%.  The reaction was subsequently diluted with 20 mL EtOAc, quenched with brine
(20 mL), and transferred to a separatory funnel where the aqueous layer was extracted
three times with EtOAc (20 mL).  The combined organics were washed twice with brine
(20 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure.  The
resulting crude oil was purified by flash column chromatography (SiO2, 11 x 3 cm, 20%
EtOAc in hexanes) to afford lactam 4j (612 mg, 2.18 mmol, 89% yield) as a pale yellow
oil; Rf = 0.37 (20% EtOAc in hexanes); 
1
H NMR (500 MHz, CDCl3) & 5.90 (ddt, J =
17.2, 10.4, 5.9 Hz, 1H), 5.33 (dq, J = 17.2, 1.5 Hz, 1H), 5.25 (dq, J = 10.4, 1.3 Hz, 1H),
4.70–4.59 (m, 2H), 3.62 (ddd, J = 12.8, 8.2, 4.9 Hz, 1H), 3.45 (dddd, J = 12.4, 6.2, 4.9,
1.0 Hz, 1H), 2.40 (dddd, J = 13.6, 7.1, 4.0, 1.0 Hz, 1H), 2.01–1.83 (m, 2H), 1.74 (ddd, J
= 13.7, 9.5, 4.1 Hz, 1H), 1.52 (s, 3H), 1.29 (s, 9H); 
13
C NMR (125 MHz, CDCl3) & 190.8,
172.5, 131.7, 119.2, 66.4, 52.5, 47.9, 44.5, 33.6, 28.0, 22.8, 20.3; IR (Neat Film NaCl)
3434, 2090, 1650, 1257, 1125 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C15H24NO4
[M+H]+: 282.1700, found 282.1705.
1.4.2.4.7 Lactam Allylic Alkylation Products
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
63% yield
N
OO
5i
95% ee
N
O
O
OO
4i
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
Lactam 5i.  Pd2(dba)3 (16.4 mg, 0.0150 mmol, 5.0 mol %) and (S)-(CF3)3-t-BuPHOX (8,
22.1 mg, 0.0374 mmol, 12.5 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
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charged with toluene (2.06 mL) and stirred at ambient temperature for 30 min, generating
a red/orange solution. Lactam 4i (91.9 mg, 0.299 mmol, 1.00 equiv) was transferred to
the scintillation vial with toluene (3 x 2 mL + 1 x 1 mL rinses, total = 9.06 mL, 0.033 M)
producing a green solution.  The vial was sealed with a Teflon-lined cap, removed from
the glove box, and lowered into a heating block (40 °C).  After 7 days, the reaction was
filtered through a silica gel plug, rinsed with EtOAc, and concentrated under reduced
pressure.  The crude oil was purified by flash column chromatography (SiO2, 27.5 x 2
cm, 100% hexanes'5%'10% EtOAc in hexanes) to afford recovered lactam 4i (17.2
mg, 0.0560 mmol, 19% recovered) and lactam 5i (49.8 mg, 0.189 mmol, 63% yield, 78%
yield based on recovered lactam 4i) as a yellow oil; Rf = 0.73 (30% EtOAc in hexanes);
1H NMR (500 MHz, CDCl3) & 5.74 (dddd, J = 16.6, 10.4, 7.8, 6.9 Hz, 1H), 5.13–5.06 (m,
2H), 3.76–3.67 (m, 1H), 3.57–3.49 (m, 1H), 3.18 (tt, J = 11.4, 3.3 Hz, 1H), 2.51 (ddt, J =
13.6, 6.9, 1.2 Hz, 1H), 2.27 (ddt, J = 13.6, 7.8, 1.1 Hz, 1H), 1.90 (dddd, J = 12.7, 5.5, 2.9,
1.4 Hz, 1H), 1.87–1.72 (m, 7H), 1.67 (dtt, J = 10.8, 3.5, 1.5 Hz, 1H), 1.62–1.56 (m, 1H),
1.42 (dtdd, J = 12.9, 12.0, 11.2, 3.2 Hz, 2H), 1.35–1.19 (m, 2H), 1.26 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 181.9, 179.5, 133.5, 118.9, 46.1, 45.8, 45.0, 44.5, 33.3, 30.0, 30.0,
26.1, 25.9, 25.9, 25.8, 19.8; IR (Neat Film NaCl)  3076, 2930, 2854, 1690, 1478, 1451,
1375, 1329, 1313, 1286, 1246, 1198, 1158, 1136, 1089, 1072, 1031, 996, 975, 919, 759
cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H26O2N [M+H]
+: 264.1958, found
264.1945; [!]D
25.0 –96.13 (c 1.06, CHCl3, 95% ee); JASCO SFC conditions: 1% IPA in
CO2, 5 mL/min, Chiralcel OJ-H column, % = 222 nm, tR (min): major = 2.53, minor =
2.13.
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(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
46% yield
N
OO
5j
96% ee
N
O
O
OO
4j
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
Lactam 5j.  Pd2(pmdba)3 (27 mg, 25 µmol, 5.0 mol %) and (S)-(CF3)3-t-BuPHOX (8, 37
mg, 63 µmol, 12.5 mol %) were added to an oven-dried 20 mL scintillation vial equipped
with a magnetic stir bar in a glove box.  The vial was charged with toluene (12 mL) and
stirred at ambient temperature (28 °C) for 30 min, resulting in a deep orange solution.
Lactam 4j (140  mg, 0.50 mmol, 1.0 equiv) was transferred to the scintillation vial with
toluene (2 mL, total = 15 mL, 0.033 M), producing a light green solution.  The vial was
sealed with a Teflon-lined cap and lowered into a heating block (40 °C).  After 16 days,
TLC analysis indicated that conversion had ceased at approximately 50% and the vial
was removed from the glove box and the reaction was filtered through a silica gel plug,
rinsed with Et2O, and concentrated under reduced pressure.  The crude oil was purified
by flash column chromatography (SiO2, 15 x 2.5 cm, 5% EtOAc in hexanes) to afford
lactam 5j (54 mg, 0.23 mmol, 46% yield) as a colorless oil; Rf = 0.58 (20% EtOAc in
hexanes); 
1
H NMR (500 MHz, CDCl3) & 5.77 (dddd, J = 17.1, 10.2, 7.8, 7.0 Hz, 1H),
5.16–5.05 (m, 2H), 3.53–3.38 (m, 2H), 2.51 (ddt, J = 13.7, 7.0, 1.3 Hz, 1H), 2.28 (ddt, J
= 13.7, 7.7, 1.1 Hz, 1H), 1.92–1.80 (m, 3H), 1.61–1.58 (m, 1H), 1.27 (s, 9H), 1.25 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 191.5, 179.0, 133.7, 118.9, 48.5, 44.2, 43.4, 43.3,
33.4, 28.1, 25.0, 19.8; IR (Neat Film NaCl) 2963, 1684, 1482, 1457, 1391, 1282, 1259,
1156, 917 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C14H24NO2 [M+H]
+
: 238.1802,
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found 238.1809; [!]D
25.0
 –7.13 (c 2.45, CHCl3, 96% ee); HPLC conditions: 5% IPA in
hexanes, 1 mL/min, Chiralcel OD-H column, % = 210 nm, tR (min): major = 7.95, minor
= 6.52.
1.4.2.5 Preparation of Imides
1.4.2.5.8 Imide Allylic Alkylation Precursors
N
O
O
N
O
O
O
O
50 6c
1. LiHMDS, THF, –78 °C ! – 30 °C
    then allyl cyanoformate, –78 °C
2.  NaH, THF, 0 °C ! 23  °C
     then MeI, 0 °C ! 23  °C
50% yield, 2 steps
N-Methyl imide 6c. A flame-dried 200 mL round-bottom flask containing a magnetic
stir bar was cycled into a glove box and loaded with LiHMDS (5.69 g, 34.0 mmol, 1.7
equiv).  The flask was removed from the glove box, reconnected to a manifold, and
charged with THF (100 mL, 0.2 M) and lowered into a –78 °C bath.  Imide 5048 (2.54 g,
20.0 mmol, 1.0 equiv) was added neat.  After 1 h at –78 °C, the solution was warmed to
30 °C and stirred for 30 min before cooling back to –78 °C.  Allyl cyanoformate (2.67 g,
24.0 mmol, 1.2 equiv) was added neat and the reaction was stirred for 1.5 h before TLC
analysis indicated consumption of starting material.  The reaction was subsequently
quenched with brine and transferred to a separatory funnel where the aqueous layer was
extracted with EtOAc (4 x 50 mL).  The combined organics were rinsed twice with brine,
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash column chromatography (SiO2, 5 cm x 7 inches,
25%'30%'40% EtOAc in hexanes) to afford an intermediate oil (2.63 g, 0.45 mmol,
62% yield) that was moved on to the next step.
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A flame-dried 200 mL flask equipped with a magnetic stir bar was charged with
sodium hydride (60% in mineral oil, 312.5 mg, 7.81 mmol, 1.1 equiv) and THF (71 mL,
0.1 M) and cooled to 0 °C.  A portion of the oil from the previous step (1.5 g, 7.10 mmol,
1.0 equiv) was added neat.  After 1.5 h at 0 °C, the reaction was warmed to room
temperature and stirred for 1 h before cooling back to 0 °C.  Methyl iodide (886 µL,
14.20 mmol, 2.0 equiv) was added and the reaction was stirred for 2 h before warming to
room temperature.  After 15 h, the reaction was poured over a mixture of water and brine
and transferred to a separatory funnel where the aqueous layer was extracted with EtOAc
(4 x 50 mL).  The combined organics were rinsed twice with aq. Na2S2O3 (sat. solution
half diluted) and twice with brine, dried over Na2SO4, filtered, and concentrated under
reduced pressure.  The resulting crude oil was purified by flash column chromatography
(SiO2, 5 cm x 8 inches, 10% '20% EtOAc in hexanes) to afford imide 6c (1.28 g, 5.69
mmol, 80% yield, 50% yield over two steps); Rf = 0.32 (35% EtOAc in hexanes); 
1H
NMR (500 MHz, CDCl3) & 5.85 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.29 (dq, J = 17.2, 1.5
Hz, 1H), 5.25 (dq, J = 10.5, 1.2 Hz, 1H), 4.63 (ddt, J = 5.6, 4.1, 1.4 Hz, 2H), 3.18 (s, 3H),
2.72 (ddd, J = 18.1, 5.4, 4.4 Hz, 1H), 2.64 (ddd, J = 17.9, 11.6, 5.4 Hz, 1H), 2.35 (ddd, J
= 13.9, 5.4, 4.4 Hz, 1H), 1.89 (ddd, J = 13.9, 11.6, 5.4 Hz, 1H), 1.56 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 172.0, 171.8, 171.3, 131.2, 119.3, 66.5, 50.9, 30.0, 28.7, 27.3, 21.9;
IR (Neat Film NaCl) 2987, 2943, 1726, 1678, 1458, 1416, 1381, 1356, 1305, 1261, 1247,
1182, 1106, 1036, 993, 938 cm–1; HRMS (MM: ESI-APCI+) m/z calc’d for C11H18NO4
[M+H]
+: 226.1074, found 226.1078.
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i. BnONH2, CH2Cl2
ii. AcCl, EtOAc, reflux
63% yield
O
O
O
N
O
BnO
O
50
N-benzyloxyimide 50.  Benzyloxyamine hydrochloride (3.15 g, 19.7 mmol) in a 100 mL
round-bottom flask was taken up in dichloromethane (30 mL) and saturated aqueous
K2CO3 (30 mL) and stirred for 30 min.  The mixture was transferred to a separatory
funnel and the phases were separated.  The aqueous phase was extracted twice with
dichloromethane (30 mL), the combined organic phases were dried over Na2SO4, filtered,
and concentrated under reduced pressure.  A portion of the resulting crude colorless oil
(1.23 g, 10.0 mmol, 1.00 equiv) was diluted with dichloromethane (10 mL, 1.0 M) in a 50
mL round-bottom flask and glutaric anhydride (1.14 g, 10.0 mmol, 1.00 equiv) was
added.  An exotherm was observed, and the mixture was immediately concentrated under
reduced pressure.  The resulting residue was taken up in EtOAc (13 mL, 0.75 M) and
acetyl chloride (2.00 mL, 2.81 mmol, 2.81 equiv) was added.  A water condenser was
affixed and the reaction was heated to a gentle reflux (oil bath, 85 °C) for 18 h.  The
reaction was diluted with EtOAc (30 mL), dried over Na2SO4, filtered, and concentrated
under reduced pressure.  The crude solid was purified by flash column chromatography
(SiO2, 6 x 5 cm, 20% EtOAc in hexanes'50% Et2O in dichloromethane) to afford N-
benzyloxyimide 50 (1.37 g, 6.25 mmol, 63% yield) as a white solid; Rf = 0.64 (20% Et2O
in methylene chloride); 
1
H NMR (500 MHz, CDCl3) & 7.56–7.45 (m, 2H), 7.41–7.29 (m,
3H), 5.01 (s, 2H), 2.74–2.60 (m, 4H), 1.94–1.85 (m, 2H); 
13
C NMR (125 MHz, CDCl3) &
168.48 , 133.95 , 130.09 , 129.23 , 128.51 , 78.17 , 33.47 , 17.05; IR (Neat Film NaCl)
3033, 2957, 2902, 1689, 1457, 1381, 1350, 1331, 1251, 1175, 1134, 1087, 1056, 999,
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968, 919, 893, 838, 759 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C12H14NO3
[M+H]
+
: 220.0968, found 220.0971.
N
BnO
O
O
N
BnO
O
O
O
O
50 6d73% yield, 2 steps
1. LiHMDS, THF, –78 °C
    then allyl cyanoformate
2.  Cs2CO3, MeI
     MeCN, 50 °C
N-Benzyloxy imide 6d.  Acylation performed in manner analogous to N-methyl imide 6c
at –78 °C using N-benzyloxy imide 50 as starting material.  Alkylation performed in
manner analogous to "-ketoester 45a at 50 °C.  N-Benzyloxy imide 6d was isolated after
flash column chromatography (SiO2, 17 to 25% EtOAc in hexanes) as a colorless oil
(73% yield over two steps); Rf = 0.20 (20% EtOAc in hexanes); 1H NMR (500 MHz,
CDCl3) & 7.53 (m, 2H), 7.37 (m, 3H), 5.87 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.33 (dq, J =
17.2, 1.5 Hz, 1H), 5.28 (dq, J = 10.4, 1.2 Hz, 1H), 5.01 (s, 2H), 4.66 (ddt, J = 13.0, 5.9,
1.3 Hz, 1H), 4.65 (ddt, J = 13.0, 5.9, 1.3 Hz, 1H), 2.72 (m, 2H), 2.30 (ddd, J = 14.1, 5.2,
4.0 Hz, 1H), 1.86 (ddd, J = 14.1, 11.8, 5.5 Hz, 1H), 1.56 (s, 3H); 13C NMR (125 MHz,
CDCl3) & 170.7, 167.9, 167.4, 133.9, 130.9, 130.1, 129.2, 128.5, 119.9, 77.9, 66.9, 52.1,
30.5, 28.5, 21.6; IR (Neat Film NaCl) 2943, 1738, 1733, 1708, 1451, 1255, 1200, 1168,
976 cm–1; HRMS (MM: ESI-APCI) m/z calc'd for C17H20NO5 [M+H]
+: 318.1336, found
318.1339.
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 73
N
BnO
O
O
N
BnO
O
O
Et
O
O
50 6e54% yield, 2 steps
1. LiHMDS, THF, –78 °C
    then allyl cyanoformate
2.  Cs2CO3, EtI
     MeCN, 85 °C
N-Benzyloxy imide 6e.  Acylation performed in manner analogous to N-methyl imide 6c
at –78 °C using N-benzyloxy imide 50 as starting material.  Alkylation performed in
manner analogous to "-ketoester 45a at 85 °C using ethyl iodide.  N-Benzyloxy imide 6e
was isolated after flash column chromatography (SiO2, 14 to 20% EtOAc in hexanes) as a
colorless oil (54% yield over two steps); Rf = 0.24 (20% EtOAc in hexanes); 1H NMR
(500 MHz, CDCl3) & 7.53 (m, 2H), 7.37 (m, 3H), 5.87 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H),
5.34 (dq, J = 17.2, 1.5 Hz, 1H), 5.27 (dq, J = 10.4, 1.2 Hz, 1H), 5.0 (s, 2H), 4.66 (dt, J =
5.9, 1.3 Hz, 2H), 2.74 (m, 2H), 2.22 (ddd, J = 14.0, 5.2, 3.5 Hz, 1H), 2.05(m, 2H), 1.96
(ddd, J = 14.0, 12.3, 5.4 Hz, 1H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3)
& 170.2, 167.5, 167.1, 134.0, 131.0, 130.1, 129.3, 128.6, 120.0, 77.9, 66.8, 56.2, 30.4,
28.3, 24.8, 9.0; IR (Neat Film NaCl) 2943, 1733, 1713, 1648, 1454, 1237, 1190, 1168,
976, 752 cm–1; HRMS (MM: ESI-APCI) m/z calc'd for C18H22NO5 [M+H]
+: 332.1492,
found 332.1493.
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1.4.2.5.9 Imide Allylic Alkylation Products
N
O
O
O
O
6c
N
O
O
7c
76% ee
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C, 20 d
32% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
N-Methyl imide 7c.  Prepared in a manner analogous to lactam 5h using N-methyl imide
6c as starting material.  After 20 d, the reaction was filtered, concentrated, and N-Methyl
imide 7c was isolated following flash column chromatography (SiO2, 3 cm x 10 inches,
5%'7%'9%'10% '12% EtOAc in hexanes) as an oil (32% yield); Rf = 0.36 (20%
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 5.71 (dddd, J = 17.1, 10.2, 7.6, 7.1
Hz, 1H), 5.15–5.08 (m, 2H), 3.12 (s, 3H), 2.75–2.62 (m, 2H), 2.47 (ddt, J = 13.8, 7.1, 1.2
Hz, 1H), 2.29 (ddt, J = 13.8, 7.7, 1.1 Hz, 1H), 1.92 (ddd, J = 14.3, 8.6, 5.9 Hz, 1H), 1.66
(ddd, J = 14.0, 7.1, 5.8 Hz, 1H), 1.24 (s, 3H); 13C NMR (125 MHz, CDCl3) & 177.6,
172.5, 132.8, 119.5, 42.6, 41.7, 29.3, 27.8, 27.0, 23.4; IR (Neat Film NaCl) 2971, 2937,
2876, 1723, 1674, 1464, 1415, 1378, 1356, 1291, 1240, 1110, 1036, 998, 919 cm–1;
HRMS (MM: ESI-APCI) m/z calc'd for C10H16NO2 [M+H]
+: 182.1176, found 182.1178;
[!]D
25.0
 –54.19 (c 1.64, CHCl3, 76% ee); HPLC conditions: 3% IPA in hexanes, 1
mL/min, Chiralpak AD column, % = 210 nm, tR (min): major = 11.94, minor = 17.86.
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N
BnO
O
O
O
O
6d
N
BnO
O
O
7d
96% ee
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
99% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
N-Benzyloxy imide 7d.  Prepared in a manner analogous to lactam 5h using N-
benzyloxy imide 6d as starting material.  N-Benzyloxy imide 7d was isolated after flash
column chromatography (SiO2, 20% EtOAc in hexanes) as a colorless oil (99% yield); Rf
= 0.29 (20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.51 (m, 2H), 7.36 (m,
3H), 5.64 (dddd, J = 17.2, 10.2, 7.7, 7.1 Hz, 1H), 5.09–5.15 (m, 2H), 5.0 (s, 2H),
2.66–2.77 (m, 2H), 2.43 (ddt, J = 13.9, 7.1, 1.2 Hz, 1H), 2.26 (ddt, J = 13.9, 7.7, 1.2 Hz,
1H), 1.87 (ddd, J = 14.3, 8.5, 5.9 Hz, 1H), 1.60 (ddd, J = 14.3, 7.0, 5.7 Hz, 1H), 1.21 (s,
3H); 13C NMR (125 MHz, CDCl3) &  173.4, 168.1, 133.9, 132.3, 130.3, 129.2, 128.5,
119.9, 78.0, 43.1, 42.3, 29.7, 27.6, 23.1; IR (Neat Film NaCl) 3067, 2974, 2935, 1740,
1703, 1700, 1456, 1172, 978, 748 cm–1; HRMS (MM: ESI-APCI) m/z  calc'd for
C16H20NO3 [M+H]
+: 274.1438, found 274.1437; [!]D
25.0
 –58.59 (c 1.26, CHCl3, 96% ee);
Thar SFC conditions: 5% MeOH in CO2, 3 mL/min, Chiralcel OJ-H column, % = 210 nm,
tR (min): major = 4.03, minor = 3.64.
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N
BnO
O
O
Et
O
O
6e
N
BnO
O
O
Et
7e
98% ee
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
80% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
N-Benzyloxy imide 7e.  Prepared in a manner analogous to lactam 5h using N-benzyloxy
imide 6e as starting material.  N-Benzyloxy imide 7e was isolated after flash column
chromatography (SiO2, 20% EtOAc in hexanes) as a colorless oil (80% yield); Rf = 0.20
(20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.51 (m, 2H), 7.36 (m, 3H),
5.63 (dddd, J = 17.3, 10.3, 7.7, 6.9 Hz, 1H), 5.08–5.10 (m, 2H), 4.99 (s, 2H), 2.67–2.76
(m, 2H), 2.46 (ddt, J = 14.0, 6.9, 1.3 Hz, 1H), 2.27 (ddt, J = 14.0, 7.7, 1.1 Hz, 1H), 1.80
(ddd, J = 14.2, 7.9, 6.4 Hz, 1H), 1.76–1.71 (m, 1H), 1.70 (dq, J = 14.2, 7.5 Hz, 1H), 1.62
(dq, J = 14.2, 7.5 Hz, 1H), 0.86 (t, J = 7.5 Hz, 3 H); 13C NMR (125 MHz, CDCl3) &
172.6, 168.0, 134.0, 132.6, 130.2, 129.2, 128.5, 119.6, 78.0, 46.5, 40.0, 29.5, 28.6, 24.7,
8.2; IR (Neat Film NaCl) 3033, 2972, 1739, 1702, 1699, 1455, 1169, 977, 751 cm–1;
HRMS (MM: ESI-APCI) m/z calc'd for C17H22NO3 [M+H]
+
: 288.1594, found 288.1591;
[!]D
25.0
 –35.98 (c 1.98, CHCl3, 98% ee); Thar SFC conditions: 1% MeOH in CO2, 2.5
mL/min, Chiralcel OB-H column, % = 210 nm, tR (min): major = 14.34, minor = 13.39.
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1.4.2.6 Preparation of Enones and Diosphenol Ethers
1.4.2.6.10 Enone and Diosphenol Ether Allylic Alkylation Precursors
O
O
OTMPDA (43)
benzaldehyde
THF/H2O, 23 °C
13a 44
1:1 d.r.
OH
N N
O
O
O
32% yield
63% recovered 13a
Alcohol 44.  Procedure adapted from the literature precedent of Kim.44  A 15 mL round-
bottom flask equipped with a stir bar was charged with enone 13a (852.1 mg, 4.39 mmol,
1.94 equiv), THF (1.4 mL, 1.6 M), benzaldehyde (230 µL, 2.26 mmol, 1.00 equiv), H2O
(1.4 mL, 1.6 M), and TMPDA (43, 380 µL, 2.27 mmol, 1.00 equiv).  The reaction
mixture was a yellow suspension that transitioned to orange over time.  After 6 days, the
reaction was diluted with H2O (10 mL) and transferred to a separatory funnel where the
aqueous phase was extracted four times with CH2Cl2.  The combined organics were dried
over MgSO4, filtered, and concentrated under reduced pressure.  The resulting crude oil
was purified by flash chromatography (SiO2, 25.5 x 3 cm, 100%
hexanes'5%'10%'15%'20% EtOAc in hexanes) to afford recovered enone 13a
(536.0 mg, 2.76 mmol, 63% recovered) pale yellow oil and alcohol 44 (217.7 mg, 0.725
mmol, 32% yield, 45% yield based on recovered enone 13a) as a yellow oil; Rf = 0.28
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) ~1:1 mixture of diastereomers,
see Figure 1.42.1; IR (Neat Film NaCl) 3503 (broad), 3061, 3030, 2980 2934, 1735,
1672, 1492, 1452, 1424, 1379, 1291, 1246, 1187, 1165, 1111, 1018, 982, 936, 760 cm-1;
HRMS (EI+) calc’d for C18H20O4 [M+•]
+: 300.1362, found 300.1376.
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O
O
O
K2CO3, DMP
CH2Cl2, 23 °C
69% yield 13b
OO
O
O
44
1:1 d.r.
OH
Enone 13b.  A scintillation vial containing alcohol 44 (44.5 mg, 0.148 mmol, 1.00 equiv)
was equipped with a stir bar, connected to a manifold, backfilled with Ar, and charged
with CH2Cl2 (1 mL, 0.15 M).  K2CO3 (62.5 mg, 0.452 mmol, 3.05 equiv) and DMP (96.3
mg, 0.227 mmol, 1.53 equiv) were added simultaneously to the vial.  After 2 h of stirring,
no starting material was detected by TLC analysis.  Consequently, the reaction was
diluted with CH2Cl2 (1 mL), filtered through a short celite plug rinsing with CH2Cl2, and
concentrated under reduced pressure.  The resulting crude oil was purified by flash
chromatography (SiO2, 27 x 1 cm, 0.1% Et3N in hexanes'0.1% Et3N and 10% EtOAc in
hexanes) to afford enone 13b (30.4 mg, 0.102 mmol, 69% yield) as a yellow oil; Rf =
0.43 (30% EtOAc in hexanes); 1H NMR (500 MHz, C6D6) & 8.11–8.07 (m, 2H),
7.15–7.08 (m, 3H), 6.62 (ddd, J = 5.0, 2.9, 1.2 Hz, 1H), 5.61 (ddt, J = 17.1, 10.3, 5.7 Hz,
1H), 5.05 (dq, J = 17.2, 1.5 Hz, 1H), 4.92 (dq, J = 10.4, 1.3 Hz, 1H), 4.37 (dt, J = 5.7, 1.4
Hz, 2H), 2.11 (dddd, J = 13.5, 4.8, 3.4, 1.2 Hz, 1H), 2.04 (dddd, J = 20.1, 9.6, 5.1, 2.9 Hz,
1H), 1.59 (dtdd, J = 20.1, 5.1, 3.4, 1.4 Hz, 1H), 1.36–1.27 (m, 1H), 1.32 (s, 3H); 13C
NMR (125 MHz, C6D6) & 194.0, 193.6, 172.1, 150.9, 141.4, 137.6, 133.1, 132.0, 129.9,
128.5, 118.5, 65.9, 53.8, 33.5, 23.6, 20.6; IR (Neat Film NaCl) 3063, 3027, 2981, 2935,
2873, 2855, 2280, 1732, 1668, 1621, 1598, 1581, 1449, 1423, 1378, 1358, 1293, 1265,
1244, 1178, 1157, 1111, 988, 940, 814, 769, 712; HRMS (FAB+) cal’d for C18H18O4
[M+•]
+: 298.1205, found 298.1219.
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O
I
O
I
O
O1. LDA, THF, –78 °C
    then allyl cyanoformate
2. K2CO3, MeI
    acetone, 50 °C
31% yield, 2 steps
42 41
!-Iodoenone 41.  A 50 mL round-bottom flask equipped with a stir bar was charged with
diisopropyl amine (450 µL, 3.21 mmol, 1.10 equiv) and THF (7 mL).  The flask was
lowered into a 0 °C bath (water/ice) and n-BuLi (1.26 mL, 2.43 M in hexanes, 3.06
mmol, 1.05 equiv) was added dropwise over several minutes.  The reaction was stirred
for 15 min before the ice bath was removed and replaced with a –78 °C bath (acetone/dry
ice).  !-Iodoenone 42 (641.3 mg, 2.91 mmol, 1.00 equiv) was transferred via cannula to
the flask using several THF rinses (1 x 6 mL and 2 x 1 mL rinses, total added = 15 mL,
0.19 M), producing a yellow solution.  The reaction was stirred for 1 h before allyl
cyanoformate (330 µL, 3.06 mmol, 1.05 equiv) was added dropwise.  After 2.5 h, no
starting material was observed by 1H NMR analysis and the reaction was subsequently
quenched after an additional hour with sat. NH4Cl solution (10 mL) and allowed to warm
to room temperature.  The reaction contents were transferred to a separatory funnel where
the aqueous phase was extracted four times with Et2O.  The combined organics (100 mL)
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash chromatography (SiO2, 27.5 x 3 cm, 100%
hexanes'5%'10% EtOAc in hexanes) to afford a yellow oil (Rf = 0.52, 30% EtOAc in
hexanes) that was moved on to the next step.
The resulting yellow oil was transferred to an argon filled 25 mL Schlenk bomb
(14/20 joint off of an 8 mm Kontes valve) equipped with a magnetic stir bar using several
acetone rinses (ACS reagent grade, 5 x 2 mL).  Additional acetone (3.2 mL, total added =
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13.2 mL, 0.10 M), K2CO3 (367.6 mg, 2.66 mmol, 2.01 equiv), and MeI (170 µL, 2.73
mmol, 2.06 equiv) were added to the bomb.  The Kontes valve was sealed, the bomb was
lowered into a preheated oil bath (50 °C), and the reaction was stirred vigorously.  After
18 h, 1H NMR analysis indicated residual starting material, and consequently more MeI
(90 µL, total added = 260 µL, 4.18 mmol, 3.15 equiv) was added.  After an additional 21
h, no starting material remained by 1H NMR analysis.  Subsequently, the bomb was
removed from the oil bath and allowed to cool to room temperature.  The reaction
contents were filtered through a celite plug rinsing with EtOAc and concentrated under
reduced pressure.  The resulting crude oil was purified by flash chromatography (SiO2, 28
x 2 cm, 100% hexanes'5% EtOAc in hexanes) to afford !-iodoenone 41 (277.8 mg,
0.868 mmol, 31% yield over two steps) as a pale yellow oil; Rf = 0.63 (30% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) & 7.64 (ddd, J = 4.7, 3.3, 1.0 Hz, 1H), 5.85 (dddd,
J = 17.2, 10.8, 5.5, 5.5 Hz, 1H), 5.28 (dq, J = 17.2, 1.5 Hz, 1H), 5.22 (dm, J = 10.5 Hz,
1H), 4.64 (dddd, J = 11.5, 6.3, 4.8, 1.5 Hz, 1H), 4.57 (dddd, J = 11.4, 6.2, 4.7, 1.5 Hz,
1H), 2.60–2.51 (m, 2H), 2.42–2.33 (m, 1H), 2.02–1.95 (m, 1H), 1.45 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 190.4, 171.6, 158.1, 131.4, 118.7, 102.0, 66.1, 53.5, 33.3, 27.9,
21.3; IR (Neat Film NaCl) 3085, 2982, 2936, 2874, 2826, 1735, 1696, 1648, 1595, 1457,
1422, 1378, 1323, 1293, 1244, 1178, 1142, 1110, 1089, 1051, 966, 956, 930, 890, 864,
833, 782, 730 cm-1; HRMS (FAB+) calc’d for C11H14O3I [M+H]
+: 320.9988, found
320.9993.
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 81
O
O
OO 1. LHMDS, THF, –78 °C
    then diallyl carbonate
2. K2CO3, MeI
    acetone, 50 °C
57% yield, 2 steps51a 13c
Enone 13c.  A 25 mL round-bottom flask equipped with a magnetic stir bar was cycled
into a glove box, loaded with LHMDS (527.6 mg, 3.15 mmol, 2.10 equiv), removed from
the glove box, and connected to an Ar-filled manifold.  The flask was charged with THF
(1 mL) and lowered into a 0 °C bath (ice/water).  Enone 51a
49
 (279.0 mg, 1.50 mmol,
1.00 equiv) was cannula transferred slowly from a scintillation vial to the flask using
several THF rinses (1 x 4 mL + 2 x 0.5 mL, total added = 6 mL, 0.25 M), generating a
bright red/pink solution.  After the addition was complete, the 0 °C bath was removed
and the reaction was allowed to warm to room temperature.  After 30 min, the flask was
lowered back into the 0 °C bath and diallyl carbonate (230 µL, 1.60 mmol, 1.07 equiv)
was added dropwise, generating an orange solution.  The bath was allowed to expire
overnight.  After 18 h, the reaction was quenched with sat. NH4Cl sol. (10 mL) and
transferred to a separatory funnel where the aqueous layer was extracted five times with
Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The resulting crude oil was purified by flash
column chromatography (SiO2, 21 x 2 cm, 100% hexanes' 5%'10% EtOAc in
hexanes) to afford a yellow oil.
The resulting yellow oil (285.8 mg, 1.06 mmol, 1.00 equiv) was transferred to an
Ar-filled 25 mL Schlenk bomb (14/20 joint off of an 8 mm Kontes valve) equipped with
a magnetic stir bar using several acetone rinses (1 x 1.5 mL + 3 x 0.5 mL, total added = 3
mL, 0.35 M).  K2CO3 (292.7 mg, 2.12 mmol, 2.00 equiv) and methyl iodide (180 µL,
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2.89 mmol, 2.73 equiv) were added to the bomb.  The Kontes valve was sealed, the bomb
was lowered into a preheated oil bath (50 °C), and the reaction was stirred vigorously.
After 11 h, 1H NMR analysis indicated residual starting material, and consequently more
methyl iodide (130 µL, total added = 310 µL, 4.98 mmol, 4.71 equiv) was added.  After
an additional 8.5 h, no starting material remained by 1H NMR analysis.  Subsequently,
the bomb was removed from the oil bath and allowed to cool to room temperature.  The
reaction contents were filtered through a celite plug rinsing with CH2Cl2 and concentrated
under reduced pressure.  The resulting crude oil was purified by flash column
chromatography (SiO2, 26.5 x 1.5 cm, 100% hexanes'5% EtOAc in hexanes) to afford
enone 13c (271.2 mg, 0.954 mmol, 64% yield over two steps, 90% purity) as a yellow oil.
This yellow oil was diluted in EtOAc (50 mg/mL) and purified further by preparative
HPLC (10% EtOAc in hexanes) to afford analytically pure enone 13c (242.8 mg, 0.851
mmol, 57% yield over two steps) as a pale yellow oil; Rf = 0.59 (30% EtOAc in hexanes);
1
H NMR (500 MHz, CDCl3) & 7.29–7.25 (m, 2H), 7.21–7.14 (m, 3H), 6.50–6.45 (m, 1H),
5.78 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.24 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (dq, J = 10.5,
1.1 Hz, 1H), 4.53 (dm, J = 5.6 Hz, 2H), 3.58 (dq, J = 15.7, 1.7 Hz, 1H), 3.51 (dq, J =
15.6, 1.7 Hz, 1H), 2.52–2.40 (m, 2H), 2.34–2.24 (m, 1H), 1.94–1.86 (m, 1H), 1.40 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 196.6, 172.6, 145.1, 139.5, 138.8, 131.8, 129.3,
128.5, 126.2, 118.4, 65.8, 53.6, 36.0, 33.7, 23.6, 20.6; IR (Neat Film NaCl) 3084, 3061,
3027, 2980, 2934, 1734, 1685, 1603, 1496, 1453, 1430, 1375, 1292, 1246, 1166, 1111,
1077, 1029, 984, 747 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C18H21O3 [M+H]
+
:
285.1485, found 285.1482.
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O
O
OO 1. LHMDS, THF, –78 °C
    then diallyl carbonate
2. K2CO3, MeI
    acetone, 50 °C
30% yield, 2 steps51b 13d
Enone 13d.  A 25 mL round-bottom flask equipped with a magnetic stir bar was cycled
into a glove box, loaded with LHMDS (215.6 mg, 1.29 mmol, 2.12 equiv), removed from
the glove box, and connected to an Ar-filled manifold.  The flask was charged with THF
(0.5 mL) and lowered into a 0 °C bath (ice/water).  Enone 51b
49
 (122.0 mg, 0.609 mmol,
1.00 equiv) was cannula transferred slowly from a scintillation vial to the flask using
several THF rinses (1 x 1 mL + 2 x 0.5 mL, total added = 2.5 mL, 0.24 M), generating a
bright pink solution.  After the addition was complete, the 0 °C bath was removed and the
reaction was allowed to warm to room temperature.  After 30 min, the flask was lowered
back into the 0 °C bath and diallyl carbonate (100 µL, 0.697 mmol, 1.14 equiv) was
added dropwise.  The bath was allowed to expire overnight.  After 18 h, the reaction was
quenched with sat. NH4Cl sol. (5 mL) and transferred to a separatory funnel where the
aqueous layer was extracted five times with Et2O.  The combined organics (70 mL) were
dried over MgSO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash column chromatography (SiO2, 27 x 1.5 cm, 100%
hexanes'5% EtOAc in hexanes) to afford a yellow oil.
The resulting yellow oil (84.6 mg, 0.298 mmol, 1.00 equiv) was transferred to an
Ar-filled 25 mL Schlenk bomb (14/20 joint off of an 8 mm Kontes valve) equipped with
a magnetic stir bar using several acetone rinses (4 x 0.5 mL, total added = 2 mL, 0.15 M).
K2CO3 (87.0 mg, 0.630 mmol, 2.12 equiv) and methyl iodide (100 µL, 1.61 mmol, 5.40
equiv) were added to the bomb.  The Kontes valve was sealed, the bomb was lowered
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into a preheated oil bath (50 °C), and the reaction was stirred vigorously.  After 16 h, 1H
NMR analysis indicated residual starting material, and consequently more methyl iodide
(130 µL, total added = 310 µL, 4.98 mmol, 4.71 equiv) was added.  After an additional
8.5 h, no starting material remained by 1H NMR analysis.  Subsequently, the bomb was
removed from the oil bath and allowed to cool to room temperature.  The reaction
contents were filtered through a celite plug rinsing with CH2Cl2 and concentrated under
reduced pressure.  The resulting crude oil was purified by flash column chromatography
(SiO2, 28 x 1.5 cm, 100% hexanes'2% EtOAc in hexanes) to afford enone 13d (75.6
mg, 0.253 mmol, 42% yield over two steps, 80% purity) as a yellow oil.  This yellow oil
was diluted with EtOAc (50 mg/mL) and purified further by preparative HPLC (10%
EtOAc in hexanes, 50 mL/min) to afford analytically pure enone 13d (54.1 mg, 0.181
mmol, 30% yield over two steps) as a pale yellow oil; Rf = 0.67 (30% EtOAc in hexanes);
1
H NMR (500 MHz, CDCl3) & 7.29–7.24 (m, 2H), 7.20–7.15 (m, 3H), 6.53 (ddq, J = 4.6,
3.3, 1.0 Hz, 1H), 5.87 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.29 (dq, J = 17.2, 1.5 Hz, 1H),
5.22 (dq, J = 10.5, 1.3 Hz, 1H), 4.65–4.57 (m, 2H), 2.74 (ddd, J = 13.4, 9.7, 6.1 Hz, 1H),
2.67 (ddd, J = 13.4, 9.3, 6.1 Hz, 1H), 2.57 (dddq, J = 13.8, 9.2, 6.4, 1.5 Hz, 1H),
2.52–2.37 (m, 2H), 2.29 (qt, J = 4.9, 1.3 Hz, 1H), 2.25 (ddt, J = 9.9, 4.8, 1.3 Hz, 1H), 1.88
(ddd, J = 13.4, 8.4, 5.3 Hz, 1H), 1.41 (s, 3H); 
13
C NMR (125 MHz, CDCl3) & 196.9,
172.7, 144.5, 142.0, 138.2, 131.8, 128.7, 128.4, 126.0, 118.5, 65.8, 53.6, 34.9, 33.6, 32.5,
23.5, 20.6; IR (Neat Film NaCl) 3026, 2930, 1733, 1683, 1603, 1495, 1456, 1377, 1244,
1167, 1109, 985, 931, 748 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C19H23O3
[M+H]
+
: 299.1642, found 299.1638.
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O
O
O
41% yield, 2 steps
1.  LDA, THF, —78 °C;
     allyl chloroformate
2.  Cs2CO3, MeI
     MeCN, 80 °C
52a
BnO
45a
O
BnO
"-ketoester 45a.  Diisopropylamine (390 µL, 2.78 mmol, 4.46 equiv) in a 10 mL round-
bottom flask equipped with a magnetic stir bar was taken up in 2.0 mL THF and lowered
into a 0 °C bath (ice/water).  To the stirring solution was added n-butyl lithium (4.7 M
solution in hexanes, 0.583 mL, 2.74 mmol, 4.40 equiv).  This solution was stirred for 30
min before transferring the flask to a –78 °C bath (dry ice/acetone) and stirring the
mixture for another 15 min.  Benzyl diosphenol ether 52a
50
 (126 mg, 0.623 mmol, 1.00
equiv) in 1.1 mL THF (total = 3.1 mL, 0.2 M) was added dropwise by syringe, and the
solution was stirred for 2 h.  Allyl cyanoformate (270 µL, 2.49 mmol, 4.00 equiv) was
added dropwise by syringe, and the reaction was stirred for 8 h until analysis by TLC
showed complete consumption of starting material.  The reaction was diluted with 2 mL
EtOAc and quenched with 1.5 mL each saturated aqueous NH4Cl and water.  The –78 °C
bath was removed and the biphasic mixture was warmed to room temperature.  The
mixture was transferred to a separatory funnel and the phases were separated.  The
aqueous phase was extracted twice with EtOAc (5 mL).  The combined organic phases
were dried over MgSO4, filtered and concentrated under reduced pressure.  The resulting
crude yellow oil was taken up in acetonitrile (2.0 mL, 0.3 M) in a flame-dried 2-dram vial
equipped with a magnetic stir bar.  Cs2CO3 (264 mg, 0.810 mmol, 1.30 equiv) and methyl
iodide (116 µL, 1,86 mmol, 3.00 equiv) were added, and the reaction was blanketed
under argon and sealed with a Teflon-lined cap.  The vial was placed in a heating block
(80 °C) and stirred for 8 h until analysis by TLC showed complete consumption of
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starting material.  The reaction was diluted with 5 mL EtOAc, filtered and concentrated
under reduced pressure.  The resulting crude oil was purified by flash column
chromatography (SiO2, 12 x 1.5 cm, 20% Et2O in hexanes) to afford "-ketoester 45a (77
mg, 0.26 mmol, 41% yield over two steps) as a colorless oil; Rf = 0.34 (40% Et2O in
hexanes);
 1
H NMR (500 MHz, CDCl3) & 7.41–7.29 (m, 5H), 5.93–5.79 (m, 2H), 5.30 (dq,
J = 17.2, 1.6 Hz, 1H), 5.23 (dq, J = 10.5, 1.3 Hz, 1H), 4.95–4.83 (m, 2H), 4.67–4.52 (m,
2H), 2.50–2.41 (m, 2H), 2.39–2.27 (m, 1H), 1.96–1.83 (m, 1H), 1.46 (s, 3H); 
13
C NMR
(125 MHz, CDCl3) & 192.0, 172.3, 149.7, 136.7, 131.7, 128.6, 128.0, 127.3, 118.8, 118.5,
70.1, 65.9, 54.3, 33.7, 21.7, 20.6; IR (Neat Film NaCl) 3394, 2916, 2167, 1996, 1692,
1627, 1455, 1251, 1153, 1110, 1056 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for
C18H21O4 [M+H]
+
: 301.1434, found 301.1422.
O
O
O
27% yield, 2 steps
1.  LDA, THF, —78 °C;
     allyl chloroformate
2.  Cs2CO3, MeI
     MeCN, 80 °C
52b
MeO
45b
O
MeO
Diosphenol ether 45b.  Prepared from 52b
51
 in an analogous manner to 45a.  Purified by
flash chromatography (SiO2, 15 x 3 cm, 20'40% Et2O in hexanes) to afford diosphenol
ether 45b (57 mg, 0.25 mmol, 27% yield over two steps) as a colorless oil; Rf = 0.54
(50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 5.96–5.80 (m, 1H), 5.78 (d, J =
4.5 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dq, J = 10.5, 1.3 Hz, 1H), 4.67–4.55
(m, 2H), 3.60 (s, 3H), 2.56–2.43 (m, 2H), 2.42–2.32 (m, 1H), 1.95–1.85 (m, 1H), 1.43 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 192.0, 172.2, 150.7, 131.7, 118.4, 115.2, 65.9, 55.2,
54.3, 33.9, 21.5, 20.6; IR (Neat Film NaCl) 2936, 2839, 1734, 1696, 1631, 1455, 1378,
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1365, 1252, 1231, 1174, 1110, 1081, 1064, 979, 935, 824 cm
–1
; HRMS (MM: ESI-
APCI+) m/z calc'd for C12H17O4 [M+H]
+
: 225.1121, found 225.1122.
1.4.2.6.11 Diosphenol Ether and Enone Allylic Alkylation Products
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
77% yield
OO
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
13c 21c
52% ee
Enone 21c.  Prepared from 13c in an analogous manner to 46a.  Purified by flash column
chromatography (SiO2, 12 x 2 cm, 10'20% Et2O in hexanes) to afford enone 21c (68
mg, 0.28 mmol, 77% yield) as a colorless oil and recovered enone 13c (19 mg, 18%
recovered); Rf = 0.70 (40% Et2O in hexanes); 
1
H NMR (500 MHz, CDCl3) & 7.31–7.20
(m, 2H), 7.23 – 7.10 (m, 3H), 6.46 (d, J = 4.0 Hz, 1H), 5.75 – 5.60 (m, 1H), 5.08 – 4.93
(m, 2H), 3.50 (dq, J = 3.3, 1.6 Hz, 2H), 2.41 – 2.23 (m, 3H), 2.16 (ddt, J = 13.7, 7.6, 1.2
Hz, 1H), 1.89 (ddd, J = 13.7, 6.4, 5.5 Hz, 1H), 1.74 (ddd, J = 13.6, 6.9, 5.5 Hz, 1H), 1.06
(s, 3H); 
13
C NMR (125 MHz, CDCl3) & 203.06 , 144.55 , 140.04 , 137.98 , 134.25 ,
129.19 , 128.45 , 126.11 , 118.09 , 44.49 , 41.21 , 36.03 , 33.41 , 23.03 , 21.90; IR (Neat
Film NaCl) 3063, 3027, 2964, 2924, 1668, 1640, 1495, 1453, 1430, 1376, 1174, 1077,
996, 915, 749 cm
–1
; [!]D
25.0
 –200.23 (c 3.86, CHCl3, 52% ee); HRMS (MM: ESI-APCI+)
m/z calc'd for C17H21O [M+H]
+
: 241.1587, found 241.1575; JASCO SFC conditions: 3%
MeOH in CO2, 5 mL/min, Chiralcel OJ-H column, % = 210 nm, tR (min): major = 2.40,
minor = 2.11.
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(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
50% yield
OO
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
13d 21d
68% ee
Enone 21d.  Prepared from 13d in an analogous manner to 46a.  Purified by flash
column chromatography (SiO2, 12 x 2 cm, 10'20% Et2O in hexanes) to afford enone
13c (17 mg, 67 !mol, 50% yield) as a colorless oil and recovered enone 13d (8 mg, 20%
recovered); Rf = 0.73 (40% Et2O in hexanes); 
1
H NMR (500 MHz, CDCl3) & 7.32–7.21
(m, 2H), 7.22–7.13 (m, 3H), 6.50 (t, J = 4.1 Hz, 1H), 5.74 (ddt, J = 16.8, 10.3, 7.4 Hz,
1H), 5.12–5.00 (m, 2H), 2.76–2.62 (m, 2H), 2.59–2.41 (m, 2H), 2.40–2.12 (m, 4H), 1.89
(ddd, J = 13.6, 6.7, 5.5 Hz, 1H), 1.72 (ddd, J = 13.6, 6.7, 5.5 Hz, 1H), 1.07 (s, 3H); 
13
C
NMR (125 MHz, CDCl3) & 203.4, 144.2, 142.1, 137.4, 134.4, 128.7, 128.3, 125.9, 118.1,
44.4, 41.3, 35.2, 33.4, 32.4, 23.0, 22.0; IR (Neat Film NaCl) 3062, 3026, 2962, 2924,
2855, 1669, 1639, 1496, 1453, 1430, 1377, 1175, 1078, 995, 914, 747 cm
–1
; [!]D
25.0
–32.55 (c 1.24, CHCl3, 68% ee); HRMS (MM: ESI-APCI+) m/z calc'd for C18H23O
[M+H]
+
: 255.1743, found 255.1730; JASCO SFC conditions: 3% MeOH in CO2, 5
mL/min, Chiralcel OJ-H column, % = 210 nm, tR (min): major = 2.41, minor = 2.17.
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(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
92% yield
O
BnO
O
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
BnO
45a 46a
94% ee
Diosphenol ether 46a.  Pd2(pmdba)3 (4.2 mg, 3.8 µmol, 5.0 mol %) and (S)-(CF3)3-t-
BuPHOX (8, 5.7 mg, 9.6 µmol, 12.5 mol %) were added to an oven-dried 2-dram vial
equipped with a magnetic stir bar in a glove box.  The vial was charged with toluene (1.8
mL) and stirred at ambient temperature (28 °C) for 30 min, resulting in a deep orange
solution.  "-ketoester 45a (23 mg, 77 µmol, 1.0 equiv) was transferred to the scintillation
vial with toluene (0.5 mL, total = 2.3 mL, 0.033 M), producing a light green solution.
The vial was sealed with a Teflon-lined cap and lowered into a heating block (40 °C).
After 6 days, the reaction was complete by TLC and colorimetric analysis (the reaction
mixture had reverted to an orange color) and was removed from the glove box.  The
reaction was filtered through a silica gel plug, rinsed with Et2O, and concentrated under
reduced pressure.  The crude oil was purified by flash column chromatography (SiO2, 15
x 1.5 cm, 5%'10% Et2O in hexanes) to afford diosphenol ether 46a (18 mg, 70 µmol,
92% yield) as a colorless oil; Rf = 0.56 (40% Et2O in hexanes); 
1
H NMR (500 MHz,
CDCl3) & 7.39–7.26 (m, 5H), 5.83 (t, J = 4.5 Hz, 1H), 5.74 (ddt, J = 16.7, 10.3, 7.4 Hz,
1H), 5.12–5.03 (m, 2H), 4.85 (s, 2H), 2.42–2.33 (m, 3H), 2.21 (ddt, J = 13.8, 7.6, 1.2 Hz,
1H), 1.89 (ddd, J = 13.7, 6.7, 5.6 Hz, 1H), 1.71 (ddd, J = 13.7, 6.6, 5.4 Hz, 1H), 1.11 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 198.5, 149.0, 136.8, 134.1, 128.6, 127.9, 127.4,
118.4, 118.0, 70.0, 45.4, 41.2, 33.1, 21.9, 20.9; IR (Neat Film NaCl) 2918, 2360, 1684,
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1628, 1457, 1220, 1204, 1094, 1050, 914, 736 cm
–1
; [!]D
25.0
 –12.01 (c 0.50, CHCl3, 94%
ee); HRMS (MM: ESI-APCI) m/z calc'd for C17H21O2 [M+H]
+
: 257.1536, found
257.1529; HPLC conditions: 7% IPA in hexanes, 1 mL/min, Chiralcel OD-H column, % =
254 nm, tR (min): major = 7.24, minor = 8.27.
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
99% yield
O
MeO
O
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
MeO
45b 46b
85% ee
Diosphenol ether 46b.  Prepared from 45b in an analogous manner to 46a.  Purified by
flash column chromatography (SiO2, 10 x 3 cm, 5'10% Et2O in hexanes) to afford
diosphenol ether 45b (111 mg, 0.616 mmol, 99% yield) as a colorless oil; Rf = 0.23 (40%
Et2O in hexanes); 
1
H NMR (500 MHz, CDCl3) & 5.79–5.65 (m, 2H), 5.12–5.01 (m, 2H),
3.58 (s, 3H), 2.47–2.34 (m, 3H), 2.20 (ddt, J = 13.7, 7.6, 1.1 Hz, 1H), 1.91 (ddd, J = 13.7,
6.8, 5.5 Hz, 1H), 1.72 (ddd, J = 13.7, 6.5, 5.4 Hz, 1H), 1.11 (s, 3H); 13C NMR (125 MHz,
CDCl3) & 198.6, 150.0, 134.0, 118.4, 114.5, 55.1, 45.4, 41.2, 33.2, 21.9, 20.8; IR (Neat
Film NaCl) 2929, 1687, 1631, 1455, 1375, 1225, 1095, 1056, 913 cm
–1
; [!]D
25.0
 –27.47 (c
6.00, CHCl3, 85% ee); HRMS (MM: ESI-APCI+) m/z calc'd for C11H17O2 [M+H]
+
:
181.1223, found 181.1222; HPLC conditions: 2% IPA in hexanes, 1 mL/min, Chiralcel
OD-H column, % = 254 nm, tR (min): major = 13.41, minor = 12.23.
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1.4.2.7 Determination of Enantiomeric Excess
Table 1.5.  Methods for the determination of enantiomeric excess (chiral HPLC and SFC).
entry product
retention time
of major
isomer (min)
% ee
1 81
retention time
of minor
isomer (min)
assay
conditions
10.45 9.60
5 824.04 2.20
2 838.60 6.48
3 868.45 10.35
4 878.04 8.97
6 845.60 4.73
842.80 3.137
SFC
Chiralpak AD-H
10% MeOH in CO2
isocratic, 3.0 mL/min
254 nm
SFC
Chiralcel OD-H
5% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
SFC
Chiralpak AS-H
5% MeOH in CO2
isocratic, 5.0 mL/min
254 nm
SFC
Chiralpak AD-H
5% MeOH in CO2
isocratic, 3.0 mL/min
254 nm
SFC
Chiralpak AD-H
7% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
SFC
Chiralpak AD-H
7% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
SFC
Chiralpak AD-H
10% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
O
N
Bn
Me
23a
O
N
Bn
Ph
23b
O
N
Bn
Ac
23d
O
N
Bn
Bz
23e
O
N
Bn
Boc
23f
O
N
Bn
Ts
23g
Cbz
N
O
30a
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8 8618.77 21.21
HPLC
Chiralcel OJ
10% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
Bn
N
O
30b
entry product
retention time
of major
isomer (min)
% ee
12 96
retention time
of minor
isomer (min)
assay
conditions
7.95 6.52
13 7611.94 17.86
14 964.03 3.64
15 9814.34 13.39
HPLC
Chiralcel OD-H
5% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
HPLC
Chiralpak AD
3% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
SFC
Chiralcel OJ-H
1% MeOH in CO2
isocratic, 3.0 mL/min
210 nm
SFC
Chiralcel OB-H
1% MeOH in CO2
isocratic, 2.5 mL/min
210 nm
N
OO
5i
N
O
O 7c
N
BnO
O
O 7d
N
BnO
O
O
Et
7e
9021.87 18.5910
11 952.53 2.13
HPLC
Chiralpak AD
30% IPA in hexanes
isocratic, 1.0 mL/min
254 nm
SFC
Chiralcel OJ-H
1% IPA in CO2
isocratic, 5.0 mL/min
222 nm
N
O
MeO
MeO
30d
N
OO
5h
9 8811.44 14.80
HPLC
Chiralcel OJ
7% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
Bn
N
O
30c
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16 522.40 2.11
SFC
Chiralcel OJ-H
3% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
O
21c
entry product
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
assay
conditions
19 8513.41 12.23
HPLC
Chiralcel OD-H
2% IPA in hexanes
isocratic, 1.0 mL/min
254 nm
MeO
O
46b
18 947.24 8.27
HPLC
Chiralcel OD-H
7% IPA in hexanes
isocratic, 1.0 mL/min
254 nm
BnO
O
46a
17 682.41 2.17
SFC
Chiralcel OJ-H
3% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
O
21d
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Figure A1.1.2.  Infrared spectrum (thin film/NaCl) of compound 17. 
Figure A1.1.3.  13C NMR (125 MHz, CDCl3) of compound 17. 
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Figure A1.2.2.  Infrared spectrum (thin film/NaCl) of compound 16a. 
Figure A1.2.3.  13C NMR (125 MHz, CDCl3) of compound 16a. 
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Figure A1.3.2.  Infrared spectrum (thin film/NaCl) of compound 16b. 
Figure A1.3.3.  13C NMR (125 MHz, CDCl3) of compound 16b. 
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Figure A1.4.2.  Infrared spectrum (thin film/NaCl) of compound 16c. 
Figure A1.4.3.  13C NMR (125 MHz, CDCl3) of compound 16c. 
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Figure A1.5.2.  Infrared spectrum (thin film/NaCl) of compound 18. 
Figure A1.5.3.  13C NMR (125 MHz, CDCl3) of compound 18. 
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Figure A1.6.2.  Infrared spectrum (thin film/NaCl) of compound 16f. 
Figure A1.6.3.  13C NMR (125 MHz, CDCl3) of compound 16f. 
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Figure A1.7.2.  Infrared spectrum (thin film/NaCl) of compound 16g. 
Figure A1.7.3.  13C NMR (125 MHz, CDCl3) of compound 16g. 
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Figure A1.8.2.  Infrared spectrum (thin film/NaCl) of compound 20. 
Figure A1.8.3.  13C NMR (125 MHz, CDCl3) of compound 20. 
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Figure A1.9.2.  Infrared spectrum (thin film/NaCl) of compound 16h. 
Figure A1.9.3.  13C NMR (125 MHz, CDCl3) of compound 16h. 
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Figure A1.10.2.  Infrared spectrum (thin film/NaCl) of compound 16d. 
Figure A1.10.3.  13C NMR (125 MHz, CDCl3) of compound 16d. 
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Figure A1.11.2.  Infrared spectrum (thin film/NaCl) of compound 16i. 
Figure A1.11.3.  13C NMR (125 MHz, CDCl3) of compound 16i. 
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Figure A1.12.2.  Infrared spectrum (thin film/NaCl) of compound 16e. 
Figure A1.12.3.  13C NMR (125 MHz, CDCl3) of compound 16e. 
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Figure A1.13.2.  Infrared spectrum (thin film/NaCl) of compound 16j. 
Figure A1.13.3.  13C NMR (125 MHz, CDCl3) of compound 16j. 
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Figure A1.14.2.  Infrared spectrum (thin film/NaCl) of compound 23a. 
Figure A1.14.3.  13C NMR (125 MHz, CDCl3) of compound 23a. 
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Figure A1.15.2.  Infrared spectrum (thin film/NaCl) of compound 23b. 
Figure A1.15.3.  13C NMR (125 MHz, CDCl3) of compound 23b. 
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Figure A1.16.2.  Infrared spectrum (thin film/NaCl) of compound 23d. 
Figure A1.16.3.  13C NMR (125 MHz, CDCl3) of compound 23d. 
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Figure A1.17.2.  Infrared spectrum (thin film/NaCl) of compound 23e. 
Figure A1.17.3.  13C NMR (125 MHz, CDCl3) of compound 23e. 
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Figure A1.18.2.  Infrared spectrum (thin film/NaCl) of compound 23f. 
Figure A1.18.3.  13C NMR (125 MHz, CDCl3) of compound 23f. 
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Figure A1.19.2.  Infrared spectrum (thin film/NaCl) of compound 23g. 
Figure A1.19.3.  13C NMR (125 MHz, CDCl3) of compound 23g. 
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Figure A1.20.2.  Infrared spectrum (thin film/NaCl) of compound 29a. 
Figure A1.20.3.  
13
C NMR (125 MHz, CDCl3) of compound 29a. 
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Figure A1.21.2.  Infrared spectrum (thin film/NaCl) of compound 48b. 
Figure A1.21.3.  13C NMR (125 MHz, CDCl3) of compound 48b. 
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Figure A1.22.2.  Infrared spectrum (thin film/NaCl) of compound 29b. 
Figure A1.22.3.  13C NMR (125 MHz, CDCl3) of compound 29b. 
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Figure A1.23.2.  Infrared spectrum (thin film/NaCl) of compound 48c. 
Figure A1.23.3.  13C NMR (125 MHz, CDCl3) of compound 48c. 
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Figure A1.24.2.  Infrared spectrum (thin film/NaCl) of compound 29c. 
Figure A1.24.3.  13C NMR (125 MHz, CDCl3) of compound 29c. 
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Figure A1.25.2.  13C NMR (125 MHz, CDCl3) of compound 48d. 
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Figure A1.26.2.  Infrared spectrum (thin film/NaCl) of compound 29d. 
Figure A1.26.3.  13C NMR (125 MHz, CDCl3) of compound 29d. 
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Figure A1.27.2.  Infrared spectrum (thin film/NaCl) of compound 30a. 
Figure A1.27.3.  13C NMR (125 MHz, CDCl3) of compound 30a. 
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Figure A1.28.2.  Infrared spectrum (thin film/NaCl) of compound 30b. 
Figure A1.28.3.  13C NMR (125 MHz, CDCl3) of compound 30b. 
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Figure A1.29.2.  Infrared spectrum (thin film/NaCl) of compound 30c. 
Figure A1.29.3.  13C NMR (125 MHz, CDCl3) of compound 30c. 
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Figure A1.30.2.  Infrared spectrum (thin film/NaCl) of compound 30d. 
Figure A1.30.3.  13C NMR (125 MHz, CDCl3) of compound 30d. 
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Figure A1.31.2.  Infrared spectrum (thin film/NaCl) of compound 4i. 
Figure A1.31.3.  13C NMR (125 MHz, CDCl3) of compound 4i. 
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Figure A1.32.2.  Infrared spectrum (thin film/NaCl) of compound 4j. 
Figure A1.32.3.  13C NMR (125 MHz, CDCl3) of compound 4j. 
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Figure A1.33.2.  Infrared spectrum (thin film/NaCl) of compound 5i. 
Figure A1.33.3.  13C NMR (125 MHz, CDCl3) of compound 5i. 
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Figure A1.34.2.  Infrared spectrum (thin film/NaCl) of compound 5j. 
Figure A1.34.3.  13C NMR (125 MHz, CDCl3) of compound 5j. 
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Figure A1.35.2.  Infrared spectrum (thin film/NaCl) of compound 6c. 
Figure A1.35.3.  13C NMR (125 MHz, CDCl3) of compound 6c. 
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Figure A1.36.2.  Infrared spectrum (thin film/NaCl) of compound 50. 
Figure A1.36.3.  13C NMR (125 MHz, CDCl3) of compound 50. 
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Figure A1.37.2.  Infrared spectrum (thin film/NaCl) of compound 6d. 
Figure A1.37.3.  13C NMR (125 MHz, CDCl3) of compound 6d. 
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Figure A1.38.2.  Infrared spectrum (thin film/NaCl) of compound 6e. 
Figure A1.38.3.  13C NMR (125 MHz, CDCl3) of compound 6e. 
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Figure A1.39.2.  Infrared spectrum (thin film/NaCl) of compound 7c. 
Figure A1.39.3.  13C NMR (125 MHz, CDCl3) of compound 7c. 
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Figure A1.40.2.  Infrared spectrum (thin film/NaCl) of compound 7d. 
Figure A1.40.3.  13C NMR (125 MHz, CDCl3) of compound 7d. 
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Figure A1.41.2.  Infrared spectrum (thin film/NaCl) of compound 7e. 
Figure A1.41.3.  13C NMR (125 MHz, CDCl3) of compound 7e. 
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Figure A1.42.2.  Infrared spectrum (thin film/NaCl) of compound 44. 
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Figure A1.43.2.  Infrared spectrum (thin film/NaCl) of compound 13b. 
Figure A1.43.3.  13C NMR (125 MHz, C6D6) of compound 13b. 
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Figure A1.44.2.  Infrared spectrum (thin film/NaCl) of compound 41. 
Figure A1.44.3.  13C NMR (125 MHz, CDCl3) of compound 41. 
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Figure A1.45.2.  Infrared spectrum (thin film/NaCl) of compound 13c. 
Figure A1.45.3.  13C NMR (125 MHz, CDCl3) of compound 13c. 
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Figure A1.46.2.  Infrared spectrum (thin film/NaCl) of compound 13d. 
Figure A1.46.3.  13C NMR (125 MHz, CDCl3) of compound 13d. 
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Figure A1.47.2.  Infrared spectrum (thin film/NaCl) of compound 45a. 
Figure A1.47.3.  13C NMR (125 MHz, CDCl3) of compound 45a. 
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Figure A1.48.2.  Infrared spectrum (thin film/NaCl) of compound 45b. 
Figure A1.48.3.  13C NMR (125 MHz, CDCl3) of compound 45b. 
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Figure A1.49.2.  Infrared spectrum (thin film/NaCl) of compound 21c. 
Figure A1.49.3.  13C NMR (125 MHz, CDCl3) of compound 21c. 
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Figure A1.50.2.  Infrared spectrum (thin film/NaCl) of compound 21d. 
Figure A1.50.3.  13C NMR (125 MHz, CDCl3) of compound 21d. 
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Figure A1.51.2.  Infrared spectrum (thin film/NaCl) of compound 46a. 
Figure A1.51.3.  13C NMR (125 MHz, CDCl3) of compound 46a. 
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Figure A1.52.2.  Infrared spectrum (thin film/NaCl) of compound 46b. 
Figure A1.52.3.  13C NMR (125 MHz, CDCl3) of compound 46b. 
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CHAPTER 2
Palladium-Catalyzed Asymmetric Alkylation in the Synthesis of
Cyclopentanoid and Cycloheptanoid Core Structures†
2.1 INTRODUCTION AND BACKGROUND
The stereoselective total synthesis of polycyclic natural products depends greatly
on the available tools for the efficient preparation of small and medium sized rings in
enantioenriched form.1  Facile means to elaborate these monocyclic intermediates to
fused, bridged, and spirocyclic architectures found within natural ring systems would
significantly contribute to modern synthetic methods.  While many strategies have been
developed for the preparation of six-membered rings and their corresponding polycyclic
derivatives, approaches toward the synthesis of five- and seven-membered rings would
benefit from further development.
                                                 
† This research was performed in collaboration with Drs. Allen Y. Hong, Michael R. Krout, Thomas
Jensen, and Andrew M. Harned and has been published.  This chapter was primarily derived from a
published full paper (Ref. c).  See:  (a) Hong, A. Y.; Krout, M. R.; Jensen, T.; Bennett, N. B.; Harned, A.
M.; Stoltz, B. M. Angew. Chem. Int. Ed. 2011, 50, 2756–2760.  (b) Bennett, N. B.; Hong, A. Y.; Harned, A.
M.; Stoltz, B. M. Org. Biomol. Chem. 2012, 10, 56–59. (c) Hong, A. Y.; Bennett, N. B.; Krout, M. R.;
Jensen, T.; Harned, A. M.; Stoltz, B. M. Tetrahedron 2011, 67, 10234–10248.
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Guided by our continuing interest in the synthesis of polycyclic systems bearing
all-carbon quaternary stereocenters using Pd-catalyzed asymmetric alkylation
chemistry,2,3,4,5,6 we sought to prepare various chiral cyclic ketone building blocks for
total synthesis (Figure 2.1).  Our investigation of six-membered ring substrates has
previously enabeled the enantioselective total syntheses of a number of complex natural
products (e.g., liphigal, 61).7  Given our earlier success, we aimed to generalize our
approach to gain access to natural products containing chiral cyclopentanoid and
cycloheptanoid ring systems as a part of a broader synthetic strategy.
Figure 2.1.  Application of cyclopentanoid, cyclohexanoid, and cycloheptanoid cores toward
stereoselective natural product synthesis.
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Our efforts have led to the development of general strategies for the preparation
of !-quaternary vinylogous esters and their conversion to "-quaternary cycloheptenones
using Stork–Danheiser transformations (Figure 2.2).8  During the course of this work, we
observed unusual reactivity with #-hydroxycycloheptanones and exploited a two-carbon
ring contraction to provide a general synthesis of "-quaternary acylcyclopentenes.9  With
access to the isomeric five- and seven-membered enones, we have prepared diverse
synthetic derivatives and polycyclic systems that can potentially provide different entry
points for synthetic routes toward complex natural products.
Figure 2.2.  General access to enantioenriched cyclopentanoid and cyclohexanoid cores.
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2.1 #-KETOESTER SYNTHESIS AND Pd-CATALYZED ASYMMETRIC
ALKYLATION REACTIONS
Much of our past research on the asymmetric alkylation of cyclic
ketones2,3,7a,c,g–i,10d and vinylogous esters7b,d–f,10a–c,e focused on six-membered rings, while
transformations of larger rings were less thoroughly investigated.  We hoped to expand
our work by exploring asymmetric alkylations of seven-membered vinylogous esters.
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The feasibility of various types of substrates for our asymmetric alkylation chemistry
suggested that vinylogous ester 66 could be transformed into silyl enol ether, enol
carbonate, or #-ketoester substrates, but we chose to prepare #-ketoesters due to their
relative stability and ease of further functionalization.  To access a variety of racemic !-
quaternary #-ketoester substrates for Pd-catalyzed asymmetric alkylation reactions, we
required multi-gram quantities of 1,3-cycloheptanedione (65).  Dione 65 is commercially
available,11 but we typically prepare it from cyclopentanone by the route of Ragan and
co-workers to facilitate large scale synthesis.12  Treatment of 65 with i-BuOH and
catalytic PPTS under Dean–Stark conditions produces vinylogous ester 66 (Scheme
2.1).11  Acylation of 66 with allyl cyanoformate following deprotonation with LDA
enables facile installation of the requisite allyl ester functionality.  Subsequent enolate
trapping with a variety of electrophiles under basic conditions provides substrates
containing alkyl, alkyne, alkene, 1,3-diene, vinyl chloride, nitrile, heteroarene, aldehyde,
fluoride, silyl ether, and ester functionalities in 61–88% yield over two to four steps
(24a–n).  With these quaternary #-ketoesters in hand, we evaluated the scope of Pd-
catalyzed asymmetric alkylation reactions on seven-membered ring vinylogous ester
substrates, focusing on methyl/allyl substituted 24a for our initial optimization efforts.
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Scheme 2.1.  Synthesis of parent vinylogous ester 66 and #-ketoester substrates 24.
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Optimal parameters for the asymmetric alkylation were identified with methyl-
substituted #-ketoester 24a by surveying several electronically differentiated PHOX
ligands combined with Pd2(pmdba)3
13,14 in a number of solvents (Table 2.1).  Our initial
conditions employing (S)-t-BuPHOX2,15 (3, 6.25 mol %) and Pd2(pmdba)3 (2.5 mol %) in
THF give vinylogous ester 27a in 94% yield and 84% ee (entry 1).16  Application of the
same catalyst system in other ethereal solvents, such as p-dioxane, 2-methyl THF,
TBME, and Et2O leads to only slight improvements in the enantioselectivity of the
reaction to give the desired product in up to 86% ee (entries 2–5).  Switching to aromatic
solvents provides modest increases in asymmetric induction, furnishing 27a in 91% yield
and 88% ee in the case of toluene (entries 6 and 7).
We next examined the impact of other PHOX ligands (8 and 67) in this medium.
Electron-deficient ligand 87b,f,17 improves enantioselectivity at the cost of higher catalyst
loading and lower yield (entry 8).  Structural modification of the aryl phosphine
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backbone was evaluated with ligand 67, but this proved less effective, giving reduced
yield and ee (entry 9).  Of the three ligands, 3 furnishes the best overall results.
Table 2.1.  Solvent and ligand effects on enantioselective decarboxylative allylation.a
entry solvent yield (%)b ee (%)c
1 94 84THFe
4 88 85
5 93 86
6 84 86
7 91 88
TBMEe
Et2O
benzene
toluene
2 86 84p-dioxane
3 75 852-methyl THFe
8d 57 90toluene
9 77 72toluene
ligand
13
13
13
13
13
13
13
14
150
a Conditions: !-ketoester 24a (1.0 equiv), Pd2(pmdba)3 (2.5 mol %), ligand
(6.25 mol %) in solvent (0.1 M) at 30 °C; pmdba = 4,4!-
methoxydibenzylideneacetone. b Isolated yield. c Determined by chiral
HPLC.  d Increased catalyst loadings were required to achieve full conversion: 
Pd2(pmdba)3 (5 mol %), 8 (12.5 mol %).
e THF = tetrahydrofuran, 2-methyl
THF = 2-methyl tetrahydrofuran, TBME = tert-butyl methyl ether.
O
i-BuO
27a
ligand (6.25 mol %)
Pd2(pmdba)3  (2.5 mol %)
solvent, 30 °C
O
i-BuO
24a
O
O
Ph2P N
O
P N
O
CF3
F3C
Ph2P N
O
(S)-t-BuPHOX (3)
CF3
(S)-(CF3)3-t-BuPHOX
(8)
67
With optimal ligand and solvent conditions in hand, we explored asymmetric
alkylation of a variety of ! -substituted #-ketoesters (Table 2.2).  Simple alkyl
substitution perform well under our standard conditions (entries 1 and 2), as did a variety
of aromatic and heteroaromatic groups (entries 3, 9–10).  Additionally, unsaturated
functionality such as alkynes, alkenes, and 1,3-dienes do not suffer from competitive
reaction pathways (entries 4–6).  In the case of vinyl chloride 24g, no products derived
from oxidative addition into the C–Cl bond are observed (entry 7).  Gratifyingly, N-basic
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functionality such as nitriles and pyridines can be carried through the reaction without
noticeable catalyst poisoning (entries 8 and 9).  Perhaps the most intriguing result is the
observation that substrate 24k with an unprotected aldehyde can be converted to the
enantioenriched product 27k in 90% yield and 80% ee, highlighting the essentially
neutral character of the reaction conditions (entry 11).  Tertiary fluoride products can also
be obtained efficiently in 94% yield and 91% ee (entry 12).  Although most #-ketoesters
undergo smooth asymmetric alkylation, several products such as silyl ether 27m18 and
benzoate ester 27n19 are not formed as efficiently due to unproductive side reactions
(entries 13–14).
Table 2.2.  Scope of the Pd-catalyzed enantioselective alkylation of cyclic vinylogous esters.a
entry yield 
(%)b
ee 
(%)c
1 91 88–CH3
4 88 89
5 95 87
6 90 90
7 99 86
–CH2C
–CH2CH2CH
2 89 92–CH2CH3
3 98 86–CH2Ph
96 87–CH2CH2CN
substrate
24
24a
24d
24e
24f
24g
24b
24c
24h
a Conditions: !-ketoester 24 (1.0 equiv), Pd2(pmdba)3 (2.5 mol %), (S)-t-BuPHOX (3) (6.25 mol %) in toluene (0.1 M) at 30 °C;  
pmdba = 4,4!-methoxydibenzylideneacetone. b Isolated yield. c Determined by chiral HPLC or SFC. d Ts = 4-toluenesulfonyl,
TBDPS = tert-butyldiphenylsilyl.
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2.1 UNUSUAL REACTIVITY OF #-HYDROXYCYCLOHEPTANONES
With an assortment of asymmetric alkylation products in hand, we next sought to
perform a carbonyl transposition using methods developed by Stork and Danheiser.20
Hydride reduction of six-membered vinylogous ester 22a with subsequent acid treatment
gives enone 68 as expected (Scheme 2.2A).  To our surprise, application of identical
reaction conditions to the seven-membered analog (27a) provides poor yield of
cycloheptenone 55a (Scheme 2.2B).  Only minor quantities of elimination product are
observed even after prolonged stirring with 10% aqueous HCl.  Closer inspection of the
reaction mixture revealed #-hydroxyketone 70a as the major product, suggesting that
these seven-membered ring compounds display unique and unusual reactivity compared
to their cyclohexyl counterparts.21,22,23
Scheme 2.2.  Observation of the unusual reactivity of #-hydroxycycloheptanone 70a.
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Without initial success using acidic conditions, we reasoned that #-hydroxyketone
70a24 could potentially provide cycloheptenone 55a under basic conditions through a #-
elimination pathway (Scheme 2.2B).  However, attempts in this regard did not produce
enone 55a, but instead generated isomeric enone 53a that appeared to be formed through
an unexpected ring contraction pathway.  Notably, this transformation serves as a rare
example of a two-carbon ring contraction.22,25,26
Upon consideration of the reaction mechanism, we believe this process occurs
through an initial deprotonation of the hydroxy moiety, followed by retro-aldol ring
fragmentation to a ketoaldehyde enolate (Scheme 2.3).  Subsequent isomerization to the
more substituted enolate and aldol cyclization could lead to the observed two-carbon ring
contraction product 53a.  Attempts to isolate the intermediate ketoaldehyde 72a were
unsuccessful, but aldehyde peaks could be observed by 1H NMR in reactions that did not
proceed to full conversion.  Subsequent experiments on more substituted #-
hydroxyketones enabled isolation of linear uncyclized intermediates and provided
additional support for this reaction mechanism (Scheme 2.6).
Scheme 2.3.  Proposed ring contraction mechanism.
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To explore the general stability and reactivity of #-hydroxycycloheptanones, we
briefly examined simplified analogs that do not possess the !-quaternary stereocenter
(Scheme 2.4).  Following hydride reduction, elimination to cyclohexenone 74 is observed
for the six-membered vinylogous ester 73, while #-hydroxycycloheptanone 77 and
volatile cycloheptenone 76 are observed for cycloheptyl analog 66.  In the seven-
membered ring case, a higher proportion of elimination product is observed when
compared to the substituted analog 27a.  A milder aqueous acid work-up may suffice to
hydrolyze the isobutyl enol ether and enable isolation of the #-hydroxyketone in higher
yield in this case.  Ring contraction of #-hydroxycycloheptanone 77 under basic
conditions proceeds smoothly to give volatile acylcyclopentene 78.  These observations
suggest that the unusual two-carbon ring contraction appears to be a reactivity trend
associated with seven-membered rings and motivated the development of the ring
contraction methodology as a general approach to chiral acylcyclopentenes.
Scheme 2.4.  Attempted Stork–Danheiser manipulations on unsubstituted rings.
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2.1 RING CONTRACTION STRATEGY FOR PREPARING " -
QUATERNARY ACYLCYCLOPENTENES
Intrigued by our findings, we sought to develop a robust route to "-quaternary
acylcyclopentenes with many substitution patterns.  Exploration of a number of bases,
additives, solvents, and temperatures for the ring contraction of #-hydroxyketone 70a
provided optimal parameters for the transformation (Table 2.3).  Given our early result
using LiOt-Bu, we examined a number of other aldol cyclization conditions with a
variety of non-nucleophilic bases.  We observed that several tert-butoxides in t-BuOH
and THF provide conversion to the desired product (53a) in good yields (entries 1–4), but
noted that the rate of product formation is comparatively slower with LiOt-Bu than with
NaOt-Bu or KOt-Bu.  The use of various hydroxides reveals a similar trend, where NaOH
and KOH generate acylcyclopentene 53a in 4 hours with improved yields over the
respective tert-butoxides (entries 5 and 6).  The relatively sluggish reactivity of LiOH
may be due to the lower solubility of this base in THF, providing 53a in low yield with
the formation of various intermediates (entry 7).
To improve the yield of the reaction with LiOH as base, we investigated alcohol
additives that facilitate the production of mild, organic-soluble bases under the reaction
conditions.  The combination of t-BuOH and LiOH in THF increases the yield of 53a to a
similar level as that observed with LiOt-Bu, although the reaction still proceeds slowly
(entry 8).  More acidic, non-nucleophilic alcohols such as hexafluoroisopropanol (HFIP)
and 2,2,2-trifluoroethanol (TFE) demonstrate exceptional reactivity in combination with
LiOH and efficiently afford 53a in high yields (entries 9 and 10).27  In particular, TFE
enables the production of 53a in 96% yield.  Comparable results with preformed
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 219
LiOCH2CF3
28 suggest this alkoxide could be the active base under the LiOH/TFE ring
contraction conditions (entry 11).
Table 2.3.  Ring contraction optimization.a
HO
O
conditions
70a 53a
O
entry base additive solvent T (°C) yield (%)b
–– 40 60
–– 40 81
–– 40 85
–– 60 89
–– 60 87
KOt-Bu THF
–– 60 19d
60 78
60 87
LiOH THF
TFEc 60 96
–– 60 90e
LiOt-Bu
NaOt-Bu
NaOH
KOH
LiOH
LiOH
LiOH
LiOCH2CF3
t-BuOH
HFIPc
THF
THF
THF
THF
THF
THF
THF
THF
8
9
10
2
11
7
3
4
5
6
time (h)
8
5
5
4
4
24
24
12.5
12.5
10
–– 40 71LiOt-Bu t-BuOH1 9
conversion (%)
100
100
100
100
100
78
98
99
99
––
100
40 52
40 57
40 77
NaOt-Bu THF
TFEc 40 73
HFIPc 40 81
KOt-Bu
LiOH
LiOH
LiOH
t-BuOH
t-BuOH
THF
THF
THF
THF
17
18
19
20
16 8
8
24
24
24
100
100
87
73
84
t-BuOH
–– 60 10CsF CH3CN21 2486
a Conditions: !-hydroxyketone 70a (1.0 equiv), additive (1.5 equiv), base (1.5 equiv), solvent (0.1 M) at indicated 
temperature for 9–24 h. b GC yield using an internal standard at ! 98% conversion unless otherwise stated. c
HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol; TFE = 2,2,2-trifluoroethanol. d Several reaction intermediates
observed by TLC and GC analysis; proceeded to 78% conversion. e Isolated yield. f Reaction did not reach
completion at 24 h; proceeded to 67% conversion.
60 48
60 61f
TFEc 60 86
TFEc 60 100
CsOH•H2O
Cs2CO3
Cs2CO3
Cs2CO3
––
––
THF
THF
THF
CH3CN
12
13
14
15
4
24
12.5
12.5
100
67
100
100
O
not observed
55a
+
Concurrent investigation of cesium bases reinforced the importance of alcohol
additives for the in situ formation of organic-soluble bases in the ring contraction
transformation.  With CsOH·H2O and Cs2CO3, product formation is inefficient due to low
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yield or sluggish reaction progress (entries 12 and 13).  However, the addition of TFE
affords acylcyclopentene 53a in yields comparable to those of the LiOH/TFE conditions
(entry 14).  Notably, ring contraction with Cs2CO3/TFE can also be performed in
acetonitrile as an alternative, non-ethereal solvent with high efficiency (entry 15).
Additional combinations of bases, additives, solvents, and temperatures were evaluated,
but these conditions were generally less effective (entries 16–21).29
While a number of bases are effective for the production of 53a in excellent
yields, we selected the combination of LiOH/TFE as our standard conditions for reaction
scope investigation due to the lower cost and greater availability of base.  The data from
our study further recognize the unique properties of these mild bases and suggest their
application may be examined in a broader context.30,31  Importantly, none of the
conditions surveyed for the ring contraction studies generated the #-elimination product,
cycloheptenone 55a.
With optimal base-promoted conditions in hand, we investigated the scope of the
ring contraction chemistry with a variety of substitution patterns23 (Table 2.4).  Simple
alkyl, aromatic, and heteroaromatic functionalized substrates perform well under our
standard parameters (Method A) in 84–95% yield (entries 1–6, 10).  Additionally, vinyl
chlorides, nitriles, and indoles can be incorporated into the target acylcyclopentenes in
85–92% yield (entries 7 and 8).  Further studies revealed that DIBAL can alternatively be
employed to generate the #-hydroxyketone by enabling more precise control of hydride
stoichiometry.  The use of these modified conditions followed by oxalic acid work-up in
methanol (Method B) facilitates the preparation of pyridine-containing acylcyclopentene
53i in higher yield compared to Method A (entry 9).
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Table 2.4.  Ring contraction substrate scope.a–e
reduction
conditions
A, B, C, or D
HO
O
R1
27 70
R2
O
i-BuO
R1
R2
LiOH, TFE
THF, 60 °C
53
R2
R1
O
entry product 53e yield (%)f
1 84
4 95
5 87
6 91
7 92
2 90
3 86
85
9 80
substrate 27
27a
27d
27e
27f
27g
27b
27c
27h
27i
a Reduction Conditions A: vinylogous ester 27 (1.0 equiv), LiAlH4 (0.55 equiv) in Et2O (0.2 M) at 0 °C, then 10% aqueous HCl
quench. b Reduction Conditions B: (1) vinylogous ester 27 (1.0 equiv), DIBAL (1.2 equiv) in PhCH3 (0.03 M) at –78 °C; (2) oxalic
acid·2H2O in MeOH (0.02 M).
c Reduction Conditions C: vinylogous ester 27 (1.0 equiv), CeCl3·7H2O (1.0 equiv), NaBH4 (3.0
equiv) in MeOH (0.02 M) at 0 °C, then 10% aqueous HCl in Et2O at 0 °C.
d Reduction Conditions D: (1) vinylogous ester 27 (1.0
equiv), DIBAL (3.3 equiv) in PhCH3 (0.03 M) at –78 °C; (2) 10% aqueous HCl in Et2O at 0 °C.  
e Ring Contraction Conditions E: !-
hydroxyketone 70 (1.0 equiv), TFE (1.5 equiv), LiOH (1.5 equiv) in THF (0.1 M) at 60 °C. f Isolated yield over 2–3 steps.
g Prepared from 27k. See Experimental Section. h Prepared from 27a. See Experimental Section. i Ts = 4-toluenesulfonyl,
TBDPS = tert-butyldiphenylsilyl, DIBAL = diisobutylaluminum hydride.
reduction conditions
10 8727j
11 9127m
12 8527og
13 8127ph
14 8727qg
8
Cl
N
N
Ts
R1
–CH2Ph
–CH2CH3
–CH3
–CH2CH2CN
–(CH2)3OTBDPS
i
A
A
A
A
A
A
A
A
B
A
C
C
A
A
15 2527n D
16 027l A
–OH
–F
–CH2OTBDPS
i
–CH2CH
R2
CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2C
–CH2CH2CH
CH
CH2
53a
53d
53e
53f
53g
53b
53c
53h
53i
53j
53m
53o
53p
53q
53n
53l
O
O
O
i-BuO
O
i-BuO
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While various compounds undergo the ring contraction sequence with high
efficiency, other substrates with more sensitive functionality require modification of the
reaction conditions.  To this end, we investigated the use of milder reduction conditions
developed by Luche32 to further increase the reaction scope.  Silyl ether substrate 27m33
can be converted to the corresponding acylcyclopentene 53m in 86% yield using the
LiAlH4 protocol (Method A), but application of Luche reaction conditions using (Method
C) enables improvement to 91% yield (entry 11).  The same conditions provide the
related silyl ether-containing acylcyclopentene 53o with a longer carbon chain in 85%
yield (entry 12).
Our success in performing the ring contraction with a variety of substituents at the
quaternary stereocenter encouraged studies aimed at determining whether additional
substitution patterns could be introduced into the acylcyclopentene products.  While most
substrates involve a variable group and an allyl fragment positioned on the quaternary
center, we were intrigued by the possibility of performing the ring contraction with other
groups.  Investigation of trans-propenyl substituted vinylogous ester 27p using the
standard LiOH/TFE conditions showed that the chemistry is unaffected by modification
of the allyl fragment, generating product in 81% yield (entry 13).  Additionally, the
reaction of spirocycle 27q also proceeds without complication and affords the desired
acylcyclopentene in 87% yield (entry 14).
Although many compounds perform well in the ring contraction sequence, certain
substrates pose significant challenges.  DIBAL reduction with a 10% aqueous HCl work-
up (Method D) and ensuing ring contraction of !-benzoate ester 27n provides tertiary
hydroxyl acylcyclopentene 53n, but the yield is relatively low compared to other
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substrates (entry 15).  Attempts to prepare the corresponding tertiary fluoride 27l were
unsuccessful as no desired product was observed (entry 16).  Under the reaction
conditions, both vinylogous esters lead to more complex product mixtures from
unproductive side reactions in contrast to the typically high yielding transformations
observed for other substrates.
To obtain more functionalized acylcyclopentene products and extend our
methodology, we sought access to #-substituted acylcyclopentenes by replacing the
hydride reduction step with the addition of an organometallic reagent and applying the
ring contraction chemistry on the resulting tertiary #-hydroxyketones.  We selected a
simple system for our initial investigations and evaluated the reaction of n-butyl
nucleophiles with vinylogous ester 27a.  Unfortunately, the addition of n-BuMgCl or n-
BuLi affords a complex mixture of products and proceeds slowly without reaching
completion, consequently converting unreacted starting material to dione 79 upon work-
up with strong acid (Scheme 2.5A).34  This low reactivity can be understood from the
electron-rich and sterically-crowded nature of the carbonyl electrophile.  Gratifyingly,
excellent reactivity is achieved by introducing CeCl3 to the reaction with the Grignard
reagent,35 although a fair amount of the corresponding enone is produced in the
transformation (Scheme 2.5B).36  Nevertheless, the CeCl3-supplemented addition
furnishes a significantly improved overall yield of addition products with good selectivity
for #-hydroxyketone 70r.
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Scheme 2.5.  Organometallic addition to vinylogous ester 27a.
i-BuO
O
n-BuMgCl, THF, 23 °C
then 10% aq HCl
27a
n-BuLi, THF, 23 °C
then 10% aq HCl
conditions
O
OHn-Bu
O
n-Bu
i-BuO
O CeCl3, n-BuMgCl
THF, 23 °C
then 10% aq HCl
+
27a
65% yield28% yield
55r 70r
mixture of n-Bu 
addition products
O
O
79
+
B. CeCl3 activated reaction
A. Organometallic addition product distribution
We next examined the ring contraction sequence with #-hydroxyketone 70r
(Scheme 2.6).  Treatment of alcohol 70r with the optimized ring contraction conditions
using LiOH/TFE yields linear dione 7 2 r  without any of the "-substituted
acylcyclopentene.  Even though the conditions do not afford the desired product, the
isolation of stable uncyclized intermediate 72r supports our proposed retro-aldol
fragmentation/aldol cyclization mechanism (Scheme 2.3).  By employing a stronger base
such as KOt-Bu, both steps of the rearrangement can be achieved to give
acylcyclopentene 53r.  Furthermore, significantly higher yields and reduced reaction
times are obtained with microwave irradiation.
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Scheme 2.6.  Ring contraction screen on #-hydroxyketone 70r.
n-Bu
O
O
n-Bu
O
O
OHn-Bu
70r 72r 53r
+
71% yield not observed
not observed 65% yield
not observed 73% yield
LiOH, TFE, THF, 60 °C, 3 h
KOt-Bu, THF, 60 °C, 22 h
KOt-Bu, THF, 85 °C, µwaves, 5 min
conditions
With a route to form a variety of acylcyclopentenes that possess different
substitution patterns, we were interested in increasing the enantiopurity of these
potentially useful intermediates.  Formation of the corresponding semicarbazone 80
enables us to obtain material in 98% ee after two recrystallizations (Scheme 2.7A).  A
high yielding hydrolysis affords enantioenriched acylcyclopentene 53a.  Further
functionalization of semicarbazone 80 with 4-iodobenzylamine provided crystals that
allowed verification of absolute stereochemistry by X-ray crystallography.37  To
demonstrate the viability of our method for large-scale enantioselective synthesis, we
performed the asymmetric alkylation and ring contraction transformations on multi-gram
scale (Scheme 2.7B).  Gratifyingly, our route proved to be robust and reliable.  Using 50
mmol of substrate (15 g), we are able to achieve a 94% yield and 88% ee of our desired
asymmetric alkylation product.  Notably, the increased reaction scale permits reduced
catalyst loadings (1.25 mol % Pd2(pmdba)3 and 3.12 mol % (S)-t-BuPHOX, 3) and higher
substrate concentrations (0.2 M).  #-Ketoester 24a undergoes the asymmetric alkylation
and ring contraction protocol to furnish the desired acylcyclopentene in 69% overall yield
over the three step sequence.
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Scheme 2.7.  Confirmation of absolute stereochemistry and multi-gram scale reactions.
semicarbazide•HCl
NaOAc, H2O, 60 °C
recrystallize twice
63% yield
N
H
N NH2
O
98% ee
80
81
6 M aq HCl
THF, H2O, 23 °C
93% yield
98% ee
m-xylene, 150 °C
89% yield
(S)-t-BuPHOX (3) (3.12 mol %)
Pd2(pmdba)3 (1.25 mol %)
toluene, 30 °C
94% yield, 88% ee
reduced catalyst loading
higher concentration (0.2 M)
O
i-BuO
27a
LiAlH4
Et2O, 0 °C
then 
10% aq HCl
81% yield
HO
O
LiOH, TFE
THF, 60 °C
91% yield
O
70a 53a
O
i-BuO
24a
I
NH2
O
88% ee
53a
O
O
15 g, 53.5 mmol scale
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3 steps
B. Ring contraction sequence on multi-gram scale
A. Enrichment of ee and X-ray structure determination
2.2 SYNTHESIS OF ACYLCYCLOPENTENE DERIVATIVES USING SITE-
SELECTIVE TRANSFORMATIONS
With the ultimate goal of applying our methodology toward the total synthesis of
complex natural products, we set out to probe the synthetic utility of various
acylcyclopentenes prepared using our ring contraction strategy.  While these
acylcyclopentenes (53) are chiral fragments with low molecular weights, they possess an
array of useful functionality that can be exploited for synthetic applications through site-
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selective manipulations (Figure 2.3).  Acylcyclopentene 53 contains hard and soft
electrophilic sites, a nucleophilic site, a functional group handle in the form of an allyl
group, and a variable group that is installed through asymmetric alkylation.  Additionally,
all of the acylcyclopentenes we have prepared bear an all-carbon quaternary stereocenter
or a fully substituted tertiary center.
We aimed to perform site-selective functionalizations to demonstrate that a
variety of derivatives could be prepared by recognizing the rich functionality present in
acylcyclopentene 53  (Figure 2.3).  Selective derivatization of site A enables access to
tertiary alcohols, oximes, and hydrazones in 74–92% yield (82–84).  Manipulation of site
B through olefin methathesis with methyl vinyl ketone or crotonaldehyde provides
intermediate bis-enone or enone-enal compounds in 90–95% yield as trans olefin
isomers.  Chemoselective hydrogenation with Wilkinson’s catalyst reduces the less
substituted and less sterically hindered olefin in these systems to form mono-enones 85
and 86 in 90–93% yield.  Using the insights gathered from these manipulations, we
performed chemoselective Heck and hydrogenation reactions to provide
acylcyclopentene 87 bearing a pendant phenol in 86% yield over two steps.  Through
modification of site C, access to Weinreb amides and divinyl ketones can be achieved
(88–89).  Additionally, manipulation of site D gives rise to epoxide 90.  Functionalization
of this site was also demonstrated with #-substituted acylcyclopentene 53r (Scheme 2.6).
Lastly, variations at site E are accomplished by installing the appropriate groups at an
early stage during the asymmetric alkylation step (Scheme 2.1 and Table 2.2).
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Figure 2.3.  Selective functionalizations on sites A–E of acylcyclopentenes (53).
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To further increase the potential of these chiral building blocks, we performed
manipulations on a combination of reactive sites to arrive at more advanced synthetic
intermediates (Scheme 2.8).  Hydroxydiene 92 is obtained in 55% yield over two steps
from acylcyclopentene 53a by performing a carbonyl epoxidation followed by
fragmentation (Scheme 2.8A).  Spirocyclic systems such as enones 93 and 95 are
obtained by performing an intramolecular Diels–Alder using 53f or a ring-closing
metathesis of 53g using Grubbs–Hoveyda 3rd generation catalyst (Scheme 2.8B and
Scheme 2.8C).  Additionally, phenolic indane 97 is generated in 57% yield over four
steps by exploiting an intermolecular Diels–Alder reaction with DMAD (Scheme 2.8D).
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To arrive at intermediates that bear a stronger resemblance to natural products, we
formed the triflate of Heck product 87 using Comins’ reagent38 and subjected the
compound to a subsequent intramolecular Heck reaction using the Herrmann–Beller
palladacycle 10139 to obtain tricycle 102 with the cis-ring fusion (Scheme 2.8E).  This
key tricycle contains all of the carbocyclic core of hamigerans C and D with the correct
stereochemistry at the ring fusions.
Overall, our general strategy enables the synthesis of valuable chiral building blocks
by taking advantage of the rich functional group content embedded in acylcyclopentenes
(53).  Site-selective manipulations at regions A–E produce monocyclic and polycyclic
compounds with a large degree of structural variation.  Our studies provide valuable
insight into the nature of these compounds, and we aim to apply our knowledge of these
promising intermediates in the total synthesis of complex natural products.
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 230
Scheme 2.8.  Functionalization of multiple acylcyclopentene reactive sites.
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2.1.1 Application of Ring Contraction Toward (–)-9-epi-Presilphiperfolan-
1-ol and (–)-Presilphiperfolan-1-ol40
In 2012, our group employed the ring contraction strategy toward the total
synthesis of the reported structures of (–)-9-epi-presilphiperfolan-1-ol (103) and (–)-
presilphiperfolan-1-ol (104).41  In this route, vinylogous ester 66 is acylated and alkylated
in a single step to afford vinylogous ester 24s (Scheme 2.9A).  Asymmetric allylic
alkylation of this molecule under our standard Pd-catalyzed conditions affords !-
quaternary vinylogous ester 27s in excellent yield and 95% ee.  Notably, no side products
arising from a Heck or Diels–Alder pathway are observed in this transformation.  The
ring contraction process also proceeds well with this substrate, generating
acylcyclopentene 53s in 84% yield over two steps.  A four step protection, hydroboration,
phosphorylation, and SN2' displacement sequence installs the geminal methyls at C(6) to
furnish acylcyclopentene 107 (Scheme 2.9A and B).  The tricyclic core of the natural
product is assembled via a Diels–Alder cycloaddition, although a mixture of C(7)
diastereomers is produced.  Ensuing Rubottom oxidation selectivity forms the hydroxy
group on the convex face of both diastereomeric tricycles to ultimately afford !-
hydroxyketones 108a and b (Scheme 2.9B).  The desired ketone (108b) is olefinated with
the standard Wittig ylide to give allylic alcohol 109.  Subsequent hydrogenation
completes the synthesis by installing the C(9) methyl group selectively through either a
steric (three step) or directing group (Crabtree’s catalyst) approach.  Analysis of the
reported and synthetic structures of 9-epi-presilphiperfolan-1-ol (103 ) and
presilphiperfolan-1-ol (104) suggest that the latter is not actually a natural product as the
structure was originally misassigned.  The spectral data of isolated 103 and 104 match
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closely, and upon consideration of the biosynthetic pathway, we determined that isolated
presilphiperfolan-1-ol (104) is actually 9-epi-presilphiperfolan-1-ol (103).  To avoid
future confusion, we propose that the name 9#-presilphiperfolan-1!-ol be used instead to
describe this molecule.
Scheme 2.9.  Route to (–)-9-epi-presilphiperfolan-1-ol (103) and (–)-presilphiperfolan-1-ol (104).
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2.3 CARBONYL TRANSPOSITION APPROACH TO "-QUATERNARY
CYCLOHEPTENONES
While pleased to discover the unusual reactivity of vinylogous esters 27 that led
to the synthesis of various acylcyclopentenes, we maintained our original interest in
preparing enantioenriched "-quaternary cycloheptenones (55) and began reexamining
reaction parameters to this end.  Initially, we identified conditions to obtain
cycloheptenone 55a in two steps by activation and elimination of the hydroxy group at
elevated temperatures, but ultimately desired a more direct route from vinylogous ester
27a (Scheme 2.10A).  After considerable experimentation, we fortuitously discovered
that reduction and elimination using Luche conditions effectively furnished enone 55a
with minimal #-hydroxyketone 70a (Scheme 2.10B).  A number of factors may
contribute to the reversed product distribution, with methanol as solvent likely playing a
large role.42  With an effective route to enone 55a, we also sought to prepare #-substituted
cycloheptenones through the 1,2-addition of organometallic reagents.
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Scheme 2.10.  Stepwise and one-pot formation of cycloheptenone 55a.
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We again investigated the addition of n-BuMgCl to vinylogous ester 27a with
CeCl3 additive, focusing on the impact of various quenching parameters.  While our
previous studies showed that the formation of #-hydroxyketone 70r is favored over
cycloheptenone 55r (Scheme 2.11, and Scheme 2.12, path a vs path b), we reasoned that
elevated temperatures would promote dehydration of #-hydroxyketone 70 to form
cycloheptenone 55 as the major product and simplify the product mixture (Scheme 2.12,
path c).  Subsequent heating of the reaction to 60 °C after acid quench leads to complete
consumption of #-hydroxyketone (Scheme 2.11).  However, the desired cycloheptenone
55r is isolated as a minor product along with the non-conjugated enone 110 in 76% yield
as a single olefin isomer.  The prevalence of non-conjugated enone 110 again emphasizes
the unusual reactivity of these seven-membered ring systems.  To revise our approach,
we extensively screened mild acidic work-up conditions to minimize the formation of
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side products such as isomer 110.  We ultimately discovered that a sodium phosphate
buffer quench followed by treatment of the crude enol ether43 with dilute HCl in
acetonitrile exclusively affords desired cycloheptenone 55r (Scheme 2.11).  Gratifyingly,
a number of sp3-hybridized carbon nucleophiles can be employed under these conditions,
permitting the preparation of allyl,44 homoallyl, and pentenyl substituted cycloheptenones
(Table 2.5, entries 1–6, Method F).
Scheme 2.11.  Synthesis of #-substituted cycloheptenones.
i-BuO
O
+
27a
O
+
55r 110
conditions
O
n-Bu
n-Pr
CeCl3, n-BuMgCl, THF, 23 °C
then 10% aq HCl
28% yield not observed
CeCl3, n-BuMgCl, THF, 23 °C
then 10% aq HCl, 23!60 °C
4% yield 76% yield
CeCl3, n-BuMgCl, THF, 23 °C
then sodium phosphate buffer (pH 6.5)
then aq HCl (6 mM), CH3CN
84% yield not observed
O
OHn-Bu
70r
65% yield
not observed
not observed
Scheme 2.12.  General reaction mechanism for carbonyl transposition.
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Table 2.5.  Scope of organometallic addition/elimination.a
i-BuO
O CeCl3, R–M
THF, 23 °C
then work-up
conditions
O
R
27a 55
entry product 55 yield (%)c
1 84
4 90
5 82
6 92
7d G 84
2 73
3 93
97
9e 66
a Conditions: vinylogous ester 27a (1.0 equiv), CeCl3 (2.5 equiv), RMgX or RLi (3.0 equiv) in
THF, 23 °C then work-up by Method F, G, or H. b Method F: (1) pH 6.5 sodium phosphate
buffer; (2) 6 mM HCl, CH3CN; Method G: 10% w/w aqueous HCl, 60 °C; Method H: 2 M
H2SO4, 60 °C.  
c Yield of isolated product.  d Performed without CeCl3 additive.  
e Product was 
a 1.9:1 mixture of atropisomers.
M
55r
55v
55w
55x
55y
55t
55u
55z
55aa
work-up conditionsb
10 G 7255ab
11 G 8455ac
8
R
–MgCl
–MgBr
–MgBr
–MgBr
–Li
–MgBr
–MgBr
–MgBr
–MgBr
–Li
–MgCl
Ph
O
S
F
F
F
F
F
F
H
H
We then turned our attention to sp- and sp2-hybridized carbon nucleophiles as part
of our goal to prepare variably substituted cycloheptenones (55).  Attempts to apply the
buffer and dilute acid quenching parameters provided poor selectivity and often led to
complex mixtures of products.  A thorough evaluation of work-up conditions revealed
that the desired unsaturated #-substituted cycloheptenones could be obtained by
quenching the reactions with concentrated strong acid followed by stirring at elevated
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temperatures.  Although investigated unsuccessfully for sp3-hybridized carbon
nucleophiles, the strong acid work-up conditions are more suitable for these reactions
because the only possible elimination pathway leads to conjugated enone 55.  In this
manner, the initial mixture of enone and #-hydroxyketone is funneled to the desired
product (Scheme 2.12, paths b and c).  By employing a HCl (Method G) or H2SO4
(Method H) quench, the synthesis of vinyl,45 alkynyl,46 aryl, and heteroaryl substituted
enones was achieved in moderate to excellent yield (Table 2.5, entries 7–11).
Particularly noteworthy is entry 9, where addition of an ortho-substituted Grignard
reagent produces sterically congested cycloheptenone 55aa.47
These results demonstrate that application of the appropriate quenching
parameters based on the type of carbon nucleophile is required for successful carbonyl
transposition to the cycloheptenone (Scheme 2.13).  For sp3-hybridized carbon
nucleophiles, reaction work-up with buffer and dilute acid maximizes enone yield and
minimizes formation of non-conjugated enone isomers.  In contrast, reactions using sp-
and sp2-hybridized carbon nucleophiles require strong acidic work-up with heating for
best results.  Careful application of these general protocols (Methods F–H) provides
access to diverse #-substituted "-quaternary cycloheptenones (55).
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Scheme 2.13.  Different work-up conditions for carbonyl transposition employing sp3 versus sp/sp2
carbon nucleophiles.
O
RCeCl3, RMgX or RLi
THF, 23 °C
then sodium phosphate 
buffer (pH 6.5)
then aq HCl (6 mM), CH3CN
R = alkyl
O
i-BuO
CeCl3, RMgX or RLi
THF, 23 °C
then HCl or H2SO4
23!60 °C
O
i-BuO
R
O
27a 55
27a 55R = alkenyl, alkynyl, aryl
B. Strong Acid Conditions: sp and sp2 carbon nucleophiles
A. Buffer and Dilute Acid Parameters: sp3 carbon nucleophiles
2.4 SYNTHESIS OF CYCLOHEPTENONE DERIVATIVES USING
TRANSITION METAL-CATALYZED CYCLIZATIONS
Having produced a variety of cycloheptenones, we next turned our attention to the
preparation of a series of bi- and tricyclic structures that would be valuable for total
synthesis applications.  The incorporation of alkene functionality at the #-position allows
rapid access to a series of [7–n] fused ring systems through ring-closing metathesis with
the "-allyl fragment (Table 2.6).  This transformation enables the formation of
disubstituted bicycles (111y, 111t, 111v, and 111x) from terminal alkenes in excellent
yields (entries 1, 3, 5, and 8).  Trisubstituted bicycles (111z, 111u, and 111w) are also
accessible through enyne ring-forming metathesis (entry 2) and ring-closing metathesis
with 1,1-disubstituted alkene #-substituents (entries 4 and 6).  Additionally, both
atropisomers of cycloheptenone 55aa converge to the [7–7–6] tricyclic enone (111aa)
under the reaction conditions (entry 7).
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Table 2.6.  Formation of bi- and tricyclic systems through ring-closing metathesis.a
entry product 111 yield (%)b
1c 93
4d 90
5 90
6 98
7e 96
2 99
3d 91
99
a Conditions: cycloheptenone 55 (1.0 equiv) and Grubbs–Hoveyda 2nd generation catalyst (112, 5.0 
mol %) in benzene, 50 °C. b Yield of isolated product. c Conditions: cycloheptenone 55 (1.0 equiv)
and Grubbs 2nd generation catalyst (113, 0.2 mol %) in CH2Cl2, reflux.
d 1,4-benzoquinone (10 mol
%) added.  e Performed in PhCH3.
R1
111y
111u
111v
111w
111aa
111z
111t
111x8
Ru
O
Cl
Cl
NN
111
(n = 0–3)
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
55
n
R1
O O
R2
substrate 55
55u
55v
55w
55aa
55z
55t
55x
55y
R2 = CH3
R2 = H
R2 = CH3
–––
R2 =
R2 = H
–––
R2
R2 = HPh
O
R2
O
R2
O
R2
O
O
With two [7–6] bicyclic structures in hand, we next investigated the preparation
of other such bicycles with variable olefin positions.  Addition of 3-butenylmagnesium
bromide to trans-propenyl vinylogous ester 27p followed by ring-closing metathesis
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furnishes bicycle 114 with the alkene adjacent to the quaternary stereocenter (Scheme
2.14A).  Following the precedent of Fuchs,48 we envisioned accessing bicycle 116
through a base-mediated migration from enone 111t.  However, treatment of skipped
diene 111t with an amine base at ambient temperature unexpectedly affords diene 115
instead (Scheme 2.14B).  In the end, the alkene can be migrated in the desired direction
to generate diene 116 by performing the reaction under microwave irradiation.  Overall,
these methods allow the preparation of a number of [7–6] bicycles with variable olefin
substitution.
Scheme 2.14.  Synthesis of additional [7–6] bicycles and [7–5–5] tricycles.
1.                         , CeCl3, THF, 23 °C
    then sodium phosphate buffer (pH 6.5)
    then HCl (6 mM), CH3CN
2. Grubbs–Hoveyda 2nd generation 
    (112) (5 mol %)
    benzene, 50 °C
MgBr
73% yield
27p 114
111t 115 116
+
O O O
i-BuO
O
O
DBU, CH3CN, 23 °C
DBU, CH3CN, 180 °C, µwaves
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16% yield 59% yield
conditions
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+
90% yield
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O
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O
O
H
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Recognition of the proximal enyne functionality of cycloheptenone 55z prompted
an investigation of a Pauson–Khand reaction to form more complex ring systems.
Treatment of enone 55z with dicobalt octacarbonyl in the presence of dimethylsulfoxide49
generates the [7–5–5] tricycles 117a to 117b in a 3:1 diastereomeric ratio (Scheme
2.14C).  Overall, our organometallic addition and elimination strategy combined with the
appropriate work-up conditions facilitates the preparation of numerous bi- and tricyclic
systems with a wide array of substitution patterns that may prove useful in the context of
natural product synthesis.
2.5 UNIFIED STRATEGY FOR THE SYNTHESIS OF COMPLEX
POLYCYCLIC NATURAL PRODUCTS
Our divergent approaches to the synthesis of acylcyclopentenes (53) and
cycloheptenones (55) from enantioenriched vinylogous esters (27) have provided the
foundation for the preparation of complex polycyclic molecules based on cyclopentanoid
and cycloheptanoid core structures (Figure 2.4).  Both [5–6] and [5–6–7] fused polycyclic
molecules can be obtained from acylcyclopentenes.  Synthetic elaboration of
cycloheptenones provides access to [7–5], [7–6], [7–7], [7–8], [7–7–6], and [7–5–5]
fused motifs.  Additionally, [5–5], [5–6], and [7–6] spirocyclic structures can be prepared
using our synthetic routes.  These examples significantly add to the collection of
polycyclic architectures accessible by elaboration of chiral six-membered ring
carbocycles or heterocycles (54).2,3  We have applied previously developed methodology
toward a number of polycyclic cyclohexanoid natural products7 (Figure 2.5) and similarly
plan to exploit the ring contraction and ketone transposition methodology in future efforts
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 242
toward cyclopentanoid and cycloheptanoid natural products.  The work presented in this
chapter provides the foundation for future efforts and enables a broader synthetic
approach to complex natural product targets.
Figure 2.4.  Chiral fused and spirocyclic structures prepared by asymmetric allylic alkylation.
7
O
7
O
7
O
7
O
O O
O
6
O
6
Fused Polycyclic
Structures
O
O
H
O 7
7
O
H 5
O
i-BuO
7
O
O
O
66
Spiropolycyclic Structures
O
Cl
O
5
5
5
OH
CO2Me
CO2Me
5
Common Polycyclic Systems in Natural Products
76 5555 5 5
76 7 766 65
O
6
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 243
Figure 2.5.  Pd-catalyzed asymmetric allylic alkylation in the total synthesis of cyclohexanoid natural
products.
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2.6 CONCLUDING REMARKS
We have successfully developed general, enantioselective synthetic routes toward
"-quaternary acylcyclopentenes (53) and cycloheptenones (55).  The key stereoselective
component unifying this chemistry is the Pd-catalyzed asymmetric alkylation of seven-
membered vinylogous ester substrates to form !-quaternary vinylogous esters, for which
we have demonstrated a broad substrate scope with a variety of all-carbon and
heteroatom-containing functionality.  These enantioenriched products were transformed
in a divergent manner to either facilitate a two-carbon ring contraction to
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acylcyclopentenes or a carbonyl transposition to cycloheptenones.  Further synthetic
elaboration of these products has enabled access to five- and seven-membered ring
systems that are poised for further functionalization to bi- and tricyclic ring systems.
Overall, the described strategies provide broader access to polycyclic ring systems and
thus complement our previous work with six-membered ring building blocks.  Efforts to
expand the scope of these reactions, understand the key reaction mechanisms, and apply
the chiral products to the total synthesis of natural products are the subject of future
studies.
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2.7 EXPERIMENTAL SECTION
2.7.1 MATERIALS AND METHODS
Unless otherwise stated, reactions were performed in flame-dried glassware under an
argon or nitrogen atmosphere using dry, deoxygenated solvents.  THF was distilled over
sodium/fluorenone or dried by passage through an activated alumina column under
argon50 prior to use.  p-Dioxane was distilled over sodium or dried by passage through an
activated alumina column under argon prior to use.  Methanol was distilled over
Mg(OMe)2 prior to use.  Other solvents were dried by passage through an activated
alumina column under argon.  Diisopropylamine and triethylamine were distilled over
CaH2 prior to use.  Iodomethane, iodoethane, acrylonitrile, methyl vinyl ketone, and
acrolein were distilled prior to use.  Furan was distilled over KOH and hydroquinone
prior to use.  Purified water was obtained using a Barnstead NANOpure Infinity UV/UF
system.  Brine solutions are saturated aqueous solutions of sodium chloride.  MePh3PBr
was purchased from Sigma-Aldrich and stored in a glove box prior to use.  NaH (60% wt.
dispersion in mineral oil) was purchased from Sigma-Aldrich and purified by trituration
with hexanes under a N2 atmosphere and removal of residual solvent under vacuum.
Grignard and organolithium reagents were purchased from Sigma-Aldrich unless
otherwise stated and titrated according to the method of Love.51  LiOCH2CF3 was
prepared according to the method of Shreeve.52  Allyl cyanoformate was prepared
according to the method of Mander53a or Rattigan.51b  Gramine methiodide was prepared
according to the method of Armen.54  The procedure of Maruyama and Naruta was used
to prepare 1-chloro-2,4-pentadiene (92:8 E:Z).55  Phosphinooxazoline (PHOX) ligands
(S)-t-BuPHOX (3)56 and (S)-(CF3)3-t-BuPHOX (8)
57  were prepared by methods described
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in our previous work.  Tris(4,4’-methoxydibenzylideneacetone)dipalladium(0)
(Pd2(pmdba)3) was prepared according to the method of Ibers
58 or Fairlamb.56b
Herrmann–Beller’s catalyst (101) was prepared according to a literature procedure.59  All
other reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa
Aesar and used as received unless otherwise stated.  Reaction temperatures were
controlled by an IKAmag temperature modulator.  Microwave-assisted reactions were
performed in a Biotage Initiator 2.5 microwave reactor.  Glove box manipulations were
performed under a N2 atmosphere. Reaction progress was monitored by thin-layer
chromatography (TLC).  TLC was performed using E. Merck silica gel 60 F254
precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, p-
anisaldehyde, or KMnO4 staining.  SiliaFlash P60 Academic Silica gel (particle size
0.040–0.063 mm) or ICN silica gel (particle size 0.032–0.0653 mm) was used for flash
column chromatography.  Automated flash column chromatography was performed on a
Teledyne Isco CombiFlash Rf system.  
1H NMR spectra were recorded on a Varian
Mercury 300 MHz, a Varian 400 MR 400 MHz, or a Varian Inova 500 MHz
spectrometer and are reported relative to residual CHCl3 ($ 7.26 ppm) or C6H6 ($ 7.16
ppm).  Variable temperature 1H NMR experiments were performed on a Varian Inova
500 MHz spectrometer and are reported relative to residual DMSO ($ 2.50 ppm).  13C
NMR spectra were recorded on a Varian Mercury 300 MHz, a Varian 400 MR 400 MHz,
or a Varian Inova 500 MHz spectrometer (at 75 MHz, 100 MHz, and 125 MHz
respectively) and are reported relative to CHCl3 ($ 77.16 ppm) or C6H6 ($ 128.06 ppm).
19F spectra were recorded on a Varian Mercury 300 MHz or a Varian Inova 500 MHz
spectrometer (at 282 MHz and 470 MHz respectively) and are reported without the use of
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a reference peak.  Data for 1H NMR are reported as follows:  chemical shift ($ ppm)
(multiplicity, coupling constant (Hz), integration.  Multiplicities are reported as follows:
s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet,
dm = doublet of multiplets, br s = broad singlet, br d = broad doublet, app = apparent.
Data for 13C and 19F NMR are reported in terms of chemical shifts ($ ppm).  IR spectra
were obtained using a Perkin Elmer Paragon 1000 or Perkin Elmer Spectrum BXII
spectrometer using thin films deposited on NaCl plates and reported in frequency of
absorption (cm–1).  Optical rotations were measured with a Jasco P-1010 or Jasco P-2000
polarimeter operating on the sodium D-line (589 nm) using a 100 mm path-length cell
and are reported as follows:  [!]D
T (concentration in g/100 mL, solvent, ee).  Melting
points were measured using a Thomas-Hoover capillary melting point apparatus and the
reported values are uncorrected.  Analytical chiral HPLC was performed with an Agilent
1100 Series HPLC utilizing a Chiralcel AD or OD-H column (4.6 mm x 25 cm) obtained
from Daicel Chemical Industries Ltd. with visualization at 254 nm.  Analytical chiral
SFC was performed with a Mettler Toledo SFC supercritical CO2 analytical
chromatography system with a Chiralcel AD-H column (4.6 mm x 25 cm) with
visualization at 254 nm/210 nm.  Analytical chiral GC was performed with an Agilent
6850 GC utilizing a G-TA (30 m x 0.25 mm) column (1.0 mL/min carrier gas flow).
High-resolution mass spectra (HRMS) were obtained from the Caltech Mass Spectral
Facility (EI+ or FAB+) or on an Agilent 6200 Series TOF with an Agilent G1978A
Multimode source in electrospray ionization (ESI+), atmospheric pressure chemical
ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+).
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2.7.2 PREPARATIVE PROCEDURES
2.7.2.1 PREPARATION OF PARENT VINYLOGOUS ESTER 66
O
i-BuO
66
O 1. TMSCl, Et3N, NaI
    CH3CN, 23 °C
2. Cl2CHCOCl, Et3N
    hexanes, 23 °C H
TMSO
Cl
Cl
O
3. Zn, AcOH, H2O
    i-PrOH, –10!23 °C
4. PPTS (1.5 mol %)
    i-BuOH, PhCH3
    reflux, Dean–Stark
    66% yield, 4 steps
127
Vinylogous ester 66.  NaI (157 g, 1.05 mol, 1.25 equiv) was placed in a 3 L 3-neck
round-bottom flask, dried under high vacuum at 90 °C for 12 h, and allowed to cool to
ambient temperature under N2.  CH3CN (1.3 L) was added to dissolve the NaI.  To the
solution was added cyclopentanone (74.3 mL, 0.84 mol, 1.00 equiv), followed by Et3N
(146 mL, 1.05 mol, 1.25 equiv).  The flask was fitted with an addition funnel, and the
funnel was charged with TMSCl (122 mL, 0.96 mmol, 1.14 equiv), which was added
dropwise over 30 min.  The resulting suspension was stirred for an additional 1 h at
ambient temperature.  Pentane (1.0 L) was added, and the biphasic system was stirred
vigorously for 10 min.  The phases were separated and the CH3CN layer was extracted
with pentane (3 x 400 mL).  The combined pentane phases were washed with H2O (2 x
500 mL) and brine (500 mL), dried over Na2SO4, filtered, and concentrated under
reduced pressure to afford the desired product (131 g, quantitative) as a colorless oil.
A portion of the above trimethylsilyl ether (89.7 g, 0.57 mol, 1.00 equiv) was
placed in a 3 L 3-neck round-bottom flask fitted with a stopper, an addition funnel, and
an overhead stirrer.  Hexanes (900 mL) was added, followed by Et3N (111 mL, 0.80 mol,
1.39 equiv).  Dichloroacetyl chloride (66.4 mL, 0.69 mol, 1.21 equiv) was dissolved in
hexanes (400 mL) and added dropwise over 9.5 h.  After 18 h of stirring at ambient
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temperature, the brown suspension was filtered, rinsing with EtOAc (3 x 500 mL).  The
clear brown solution was concentrated under reduced pressure and then filtered through a
pad of Al2O3 (7 x 18 cm, neutral) using EtOAc as eluent.  The solution was concentrated
under reduced pressure to afford the desired product (125 g, 0.47 mol, 82% yield) as a
brown oil that crystallized in the freezer (–20 °C).
A portion of the above dichlorocyclobutanone (53.4 g, 0.20 mol, 1.00 equiv) was
placed in a 3 L 3-neck round-bottom flask fitted with a thermometer, an addition funnel,
and an overhead stirrer.  Isopropyl alcohol and purified water (170 mL each) were added
and the suspension was cooled to –10 °C (internal temperature) using a MeOH/ice bath.
Zn dust (58.8 g, 0.90 mol, 4.50 equiv) was added in four portions (5 min between each)
and AcOH (63 mL, 1.10 mol, 5.50 equiv) dissolved in H2O (130 mL) was added
dropwise while keeping the internal temperature below 0 °C  (usually added over 1.5 h).
The reaction was stirred for an additional 30 min at –10 °C (internal temperature) before
the cooling bath was removed, and the reaction was allowed to warm to ambient
temperature.  After 8.5 h, the reaction was filtered, rinsing with isopropyl alcohol (100
mL).  The mixture was cooled to 0 °C and neutralized by portionwise addition of K2CO3
(74.6 g, 0.54 mol, 5.50 equiv).  The viscous suspension was filtered, rinsing with H2O
(100 mL) and EtOAc (300 mL).  The biphasic system was concentrated under reduced
pressure to ca. 200 mL and extracted with CH2Cl2.  The combined organics were dried
over MgSO4, filtered, and concentrated under reduced pressure to afford the desired
product (24.2 g, 0.19 mol, 96% yield) as a pale orange oil.
To a solution of 1,3-cycloheptanedione (35.8 g, 0.28 mol, 1.00 equiv) in toluene
(280 mL) in a 1 L flask fitted with a reflux condenser and Dean–Stark trap was added
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isobutanol (208 mL, 2.27 mol, 8.11 equiv) and pyridinium p-toluenesulfonate (1.07 g,
4.26 mmol, 1.50 mol %).  The solution was immersed in an oil bath at 130 °C and
monitored by TLC.  When the starting material was consumed (typically within 4–6 h),
the reaction was allowed to cool to ambient temperature.  The resulting dark orange
solution was washed with sat. aqueous NaHCO3 (200 mL).  The aqueous phase was
extracted with EtOAc (3 x 150 mL) and the combined organics were washed with brine,
dried over MgSO4, filtered, and concentrated under reduced pressure to afford a thick
dark orange oil.  The crude oil was flushed through a silica gel plug (SiO2, 7 x 9 cm,
1:4%3:7%1:1 Et2O-hexanes) to afford vinylogous ester 66 (43.5 g, 0.24 mol, 84% yield,
66% yield over 4 steps) as a pale orange oil;  Rf  = 0.22 (2:1 hexanes:EtOAc);  
1H NMR
(500 MHz, CDCl3) $ 5.37 (s, 1H), 3.49 (d, J = 6.6 Hz, 2H), 2.60–2.56 (m, 4H), 2.00 (sept,
J = 6.6 Hz, 1H), 1.88–1.77 (m, 4H), 0.96 (d, J = 6.8 Hz, 6H);  13C NMR (125 MHz,
CDCl3) $ 202.5, 176.6, 106.0, 75.0, 41.9, 33.1, 27.9, 23.7, 21.5, 19.3;  IR (Neat Film
NaCl) 2958, 2872, 1646, 1607, 1469, 1237, 1190, 1174 cm–1;  HRMS (EI+) m/z calc'd for
C11H18O2 [M]
+•: 182.1307; found 182.1310.
2.7.2.2 PREPARATION OF #-KETOESTERS 24
O
i-BuO
24a
O
O
O
i-BuO
66
1. LDA, THF, –78 °C 
     then
NC
O
O
2. CH3I, Cs2CO3
    CH3CN, 80 °C
    79% yield, 2 steps
#-Ketoester 24a.  To a solution of diisopropylamine (6.46 mL, 46.1 mmol, 1.20 equiv) in
THF (180 mL) in a 500 mL round-bottom flask at 0 °C was added n-BuLi (17.2 mL, 44.2
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mmol, 2.57 M in hexanes, 1.15 equiv) dropwise over 15 min using a syringe pump.  After
15 min of stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s)
bath.  A solution of vinylogous ester 66 (7.01 g, 38.4 mmol, 1.00 equiv) in THF (20 mL)
was added dropwise over 20 min using a syringe pump.  After an additional 1 h of
stirring at –78 °C, allyl cyanoformate (4.60 mL, 42.2 mmol, 1.10 equiv) was added
dropwise over 10 min.  The mixture was stirred at  –78 °C for 2.5 h, quenched by
addition of sat. aqueous NH4Cl and H2O (30 mL each), and allowed to warm to ambient
temperature.  The reaction was diluted with Et2O (100 mL) and the phases were
separated.  The aqueous phase was extracted with Et2O (2 x 100 mL).  The combined
organic phases were dried over MgSO4, filtered, and concentrated under reduced pressure
to afford a pale orange oil.
The crude oil was dissolved in CH3CN (130 mL) in a 500 mL round-bottom flask
and treated with CH3I (7.2 mL, 115 mmol, 3.00 equiv) and Cs2CO3 (16.76 g, 49.9 mmol,
1.30 equiv).  The flask was fitted with a condenser, immersed in an oil bath, and heated
to 80 °C with vigorous stirring.  After 12 h of stirring at 80 °C, the reaction was allowed
to cool to ambient temperature, diluted with EtOAc (100 mL), dried over MgSO4,
filtered, and concentrated under reduced pressure to afford an orange oil.  The crude
product was purified by flash column chromatography (SiO2, 5 x 15 cm, 19:1%9:1
hexanes:EtOAc, dry-loaded using Celite) to afford #-ketoester 24a (8.51 g, 30.4 mmol,
79% yield over 2 steps) as a pale yellow oil;  Rf = 0.43 (4:1 hexanes:EtOAc);  
1H NMR
(500 MHz, CDCl3) $ 5.86 (dddd, J = 17.1, 10.7, 5.6, 5.6 Hz, 1H), 5.39 (s, 1H), 5.29 (app
dq, J = 17.1, 1.5 Hz, 1H), 5.20 (app dq, J = 10.5, 1.4 Hz, 1H), 4.62 (dddd, J = 13.3, 5.6,
1.2, 1.2 Hz, 1H), 4.56 (dddd, J = 13.4, 5.6, 1.2, 1.2 Hz, 1H), 3.54–3.42 (m, 2H), 2.59
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(ddd, J = 17.8, 9.8, 3.9 Hz, 1H), 2.45–2.38 (m, 2H), 2.02–1.94 (m, 2H), 1.84–1.75 (m,
1H), 1.70 (ddd, J = 14.4, 7.3, 4.4 Hz, 1H), 1.43 (s, 3H), 0.94 (d, J = 6.6 Hz, 6H);  13C
NMR (125 MHz, CDCl3) $ 199.1, 174.0, 173.5, 132.0, 118.4, 105.2, 74.8, 65.8, 59.1,
34.3, 33.9, 27.9, 24.2, 21.4, 19.3;  IR (Neat Film NaCl) 2959, 2936, 2875, 1734, 1650,
1613, 1456, 1384, 1233, 1170, 1115, 994 cm–1;  HRMS (EI+) m/z calc'd for C16H24O4
[M]+•: 280.1675; found 280.1686.
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O
#-Ketoester 24b.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv)
in THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL,
6.30 mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A
solution of vinylogous ester 66 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at
–78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat.
aqueous NH4Cl (8 mL), and allowed to warm to ambient temperature.  The reaction was
diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was
extracted with Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4,
filtered, and concentrated under reduced pressure to afford a pale orange oil.
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The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask,
cooled to 0 °C, and stirred vigorously as hexane-washed NaH (158 mg, 6.58 mmol, 1.20
equiv) was added in one portion.  Evolution of gas was observed and the reaction was
stirred at 0 °C for 30 min to give a yellow-orange solution.  CH3CH2I (1.31 mL, 16.4
mmol, 3.00 equiv) was added dropwise.  The reaction was allowed to warm to ambient
temperature and stirred for 4.5 h.  The mixture was heated to 45 °C and stirred for 1.5 h.
Additional CH3CH2I (0.65 mL, 8.22 mmol, 1.50 equiv) was added dropwise and the
mixture was stirred at 45 °C for 6 h.  A third portion of CH3CH2I (0.33 mL, 4.11 mmol,
0.75 equiv) was added dropwise and the reaction was warmed to 55 °C and stirred for 1.5
h.  The flask was cooled to ambient temperature and quenched by addition of 50% sat.
aqueous NH4Cl (10 mL).  The phases were separated and the aqueous layer was extracted
with Et2O (3 x 15 mL).  The combined organic phases were washed with brine, dried
over Na2SO4, filtered, and concentrated under reduced pressure.  The crude product was
purified by flash column chromatography (SiO2, 5 x 20 cm, 9:1%6:1%3:1%2:1
hexanes:EtOAc) to afford #-ketoester 24b (1.31 g, 4.44 mmol, 81% yield over 2 steps) as
a yellow oil;  Rf = 0.53 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 5.85 (dddd,
J = 17.5, 10.2, 5.7, 5.7 Hz, 1H), 5.35 (s, 1H), 5.29 (app dq, J = 17.2, 1.5 Hz, 1H), 5.19
(app dq, J = 10.4, 1.3 Hz, 1H), 4.62 (dddd, J = 13.2, 5.7, 1.4, 1.4 Hz, 1H), 4.54 (dddd, J =
13.2, 5.7, 1.4, 1.4 Hz, 1H), 3.57–3.34 (m, 2H), 2.60 (dddd, J = 17.9, 9.9, 3.7, 1.2 Hz, 1H),
2.49–2.26 (m, 2H), 2.12–1.85 (m, 4H), 1.85–1.57 (m, 2H), 0.93 (d, J = 6.7 Hz, 6H), 0.84
(t, J = 7.5 Hz, 3H);  13C NMR (75 MHz, CDCl3) $ 198.7, 173.7, 173.2, 132.0, 118.5,
105.5, 74.7, 65.7, 63.1, 34.1, 31.0, 30.6, 27.9, 22.0, 19.3, 9.0;  IR (Neat Film NaCl) 3085,
2960, 2937, 2876, 1731, 1663, 1613, 1471, 1461, 1453, 1424, 1383, 1369, 1328, 1304,
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1278, 1229, 1199, 1170, 1121, 1006, 988, 931, 875, 858, 813 cm–1;  HRMS (MM: ESI-
APCI+) m/z calc'd for C17H27O4 [M+H]
+: 295.1904; found 295.1918.
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#-Ketoester 24c.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) in
THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL, 6.30
mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of stirring at
0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A solution of
vinylogous ester 66 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was added dropwise
using positive pressure cannulation.  After an additional 1 h of stirring at –78 °C, allyl
cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over 10 min.  The
mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. aqueous NH4Cl
(8 mL), and allowed to warm to ambient temperature.  The reaction was diluted with
Et2O (25 mL) and the phases were separated.  The aqueous phase was extracted with
Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4, filtered, and
concentrated under reduced pressure to afford a pale orange oil.
The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask,
cooled to 0 °C, and stirred vigorously as hexane-washed NaH (197 mg, 8.22 mmol, 1.50
equiv) was added in one portion.  Evolution of gas was observed and the reaction was
stirred at 0 °C for 30 min to give a yellow-orange solution.  Benzyl bromide (1.96 mL,
16.44 mmol, 3.00 equiv) was added dropwise.  The reaction was allowed to warm to
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ambient temperature and stirred for 3 h.  The reaction was quenched by addition of 50%
sat. aqueous NH4Cl (10 mL).  The phases were separated and the aqueous layer was
extracted with Et2O (3 x 15 mL).  The combined organic phases were washed with brine,
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude product
was purified by flash column chromatography (SiO2, 3 x 23 cm, hexanes% 10:1
hexanes:EtOAc) to afford #-ketoester 24c (1.72 g, 4.83 mmol, 88% yield over 2 steps) as
a pale yellow oil;  Rf = 0.26 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $
7.30–7.15 (m, 3H), 7.15–7.06 (m, 2H), 5.85 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.36
(s, 1H), 5.30 (app dq, J = 17.2, 1.5 Hz, 1H), 5.21 (app dq, J = 10.4, 1.3 Hz, 1H), 4.63
(dddd, J = 13.2, 5.7, 1.3, 1.3 Hz, 1H), 4.52 (dddd, J = 13.2, 5.8, 1.3, 1.3 Hz, 1H), 3.42 (d,
J = 6.5 Hz, 2H), 3.30 (d, J = 13.5 Hz, 1H), 3.23 (d, J = 13.5 Hz, 1H), 2.54 (ddd, J = 12.1,
10.0, 3.5 Hz, 1H), 2.38–2.18 (m, 2H), 2.04–1.83 (m, 2H), 1.81–1.64 (m, 2H), 0.92 (d, J =
6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 198.0, 174.0, 172.7, 137.0, 131.8, 130.7,
128.1, 126.8, 118.8, 105.7, 74.8, 66.0, 64.0, 43.1, 34.0, 31.3, 27.9, 22.0, 19.2;  IR (Neat
Film NaCl) 3085, 3062, 3029, 2959, 2934, 2873, 1736, 1732, 1661, 1652, 1611, 1495,
1471, 1454, 1423, 1383, 1368, 1270, 1235, 1173, 1088, 1007, 957, 992, 930, 862, 815,
741 cm–1;  HRMS (APCI+) m/z calc'd for C22H29O4 [M+H]
+: 357.2060; found 357.2051.
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#-Ketoester 24d.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv)
in THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL,
6.30 mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A
solution of vinylogous ester 66 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at
–78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat.
aqueous NH4Cl (8 mL), and then allowed to warm to ambient temperature.  The reaction
was diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was
extracted with Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4,
filtered, and concentrated under reduced pressure to afford a pale orange oil.
The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask,
cooled to 0 °C, and stirred vigorously as hexane-washed NaH (197 mg, 8.22 mmol, 1.5
equiv) was added in one portion.  Evolution of gas was observed and the reaction was
stirred at 0 °C for 30 min to give a yellow-orange solution.  Propargyl bromide (1.22 mL,
10.96 mmol, 80% wt in toluene, 2.00 equiv) was added dropwise and the reaction was
allowed to warm to ambient temperature and stirred for 5.5 h.  The reaction was
quenched by addition of 50% sat. aqueous NH4Cl (10 mL).  The phases were separated
and the aqueous layer was extracted with Et2O (3 x 15 mL).  The combined organic
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phases were washed with brine, dried over Na2SO4, filtered, and concentrated under
reduced pressure.  The crude product was purified by flash column chromatography
(SiO2, 3 x 24 cm, hexanes%20:1%15:1%10:1 hexanes:EtOAc) to afford #-ketoester 24d
(1.38 g, 4.53 mmol, 83% yield over 2 steps) as a pale yellow oil;  Rf = 0.55 (4:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 5.85 (dddd, J = 17.2, 10.4, 5.7, 5.7 Hz,
1H), 5.38 (s, 1H), 5.29 (app dq, J = 17.2, 1.5 Hz, 1H), 5.19 (app dq, J = 10.4, 1.3 Hz,
1H), 4.63 (dddd, J = 13.2, 5.6, 1.4, 1.4 Hz, 1H), 4.56 (dddd, J = 13.2, 5.7, 1.4, 1.4 Hz,
1H), 3.56–3.38 (m, 2H), 2.79 (dd, J = 2.7, 0.6 Hz, 1H), 2.72–2.32 (m, 4H), 2.15–1.89 (m,
4H), 1.89–1.71 (m, 1H), 0.93 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 196.5,
174.8, 171.7, 131.7, 118.7, 105.0, 80.2, 74.9, 71.4, 66.1, 62.0, 34.3, 31.2, 27.9, 27.5, 21.7,
19.2;  IR (Neat Film NaCl) 3289, 3085, 2959, 2933, 2874, 2120, 1740, 1735, 1654, 1649,
1470, 1452, 1424, 1402, 1384, 1369, 1309, 1291, 1272, 1232, 1187, 1173, 1133, 1085,
1066, 1007, 968, 930, 863, 820 cm–1;  HRMS (EI+) m/z calc'd for C18H25O4 [M+H]
+:
305.1753; found 305.1746.
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#-Ketoester 24k.  To a solution of diisopropylamine (1.49 mL, 10.63 mmol, 1.20 equiv)
in THF (43 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi (4.74 mL,
10.19 mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A
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solution of vinylogous ester 66 (1.61 g, 8.86 mmol, 1.00 equiv) in THF (3 mL) was
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at
–78 °C, allyl cyanoformate (1.06 mL, 9.74 mmol, 1.10 equiv) was added dropwise over
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat.
aqueous NH4Cl (12.9 mL), and then allowed to warm to ambient temperature.  The
reaction was diluted with Et2O (50 mL) and the phases were separated.  The aqueous
phase was extracted with Et2O (3 x 100 mL).  The combined organic phases were dried
over Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange
oil.  The crude oil was purified by automated flash column chromatography using a
Teledyne Isco CombiFlash Rf (SiO2, 25 g loading cartridge, 330 g column, hold 0% [3
min]%ramp to 20% [10 min]%hold 20% [10 min]%ramp to 50% [4 min]%hold 50%
EtOAc in hexanes [5 min]) to afford the intermediate #-ketoester (2.02 g, 7.58 mmol,
86% yield).
A portion of the intermediate #-ketoester (990 mg, 3.72 mmol, 1.00 equiv) was
dissolved in CH2Cl2 (10 mL) in a 100 mL round-bottom flask, cooled to 0 °C, and treated
with Et3N (0.518 mL, 3.72 mmol, 1.00 equiv).  Acrolein (0.248 mL, 3.72 mmol, 1.00
equiv) was added dropwise and the reaction was allowed to warm to ambient
temperature.  After 51 h, the reaction was cooled to 0 °C and an additional portion of
acrolein (0.125 mL, 1.86 mmol, 0.50 equiv) was added.  After 100 h, the reaction was
concentrated under reduced pressure, dissolved in Et2O, and filtered through a cotton
plug to remove salts.  The filtrate was concentrated under reduced pressure and the crude
product was purified by flash column chromatography (SiO2, 3 x 25 cm, 10:1%6:1%4:1
hexanes:EtOAc) to afford #-ketoester 24k (1.07 g, 3.34 mmol, 90% yield, 77% yield over
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2 steps) as a clear oil;  Rf = 0.23, broad (4:1 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 9.73 (t, J = 1.3 Hz, 1H), 5.86 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.36 (s,
1H), 5.30 (app dq, J = 17.2, 1.5 Hz, 1H), 5.22 (app dq, J = 10.4, 1.2 Hz, 1H), 4.63 (dddd,
J = 13.1, 5.7, 1.3, 1.3 Hz, 1H), 4.55 (dddd, J = 13.2, 5.8, 1.3, 1.3 Hz, 1H), 3.55–3.40 (m,
2H), 2.66–2.29 (m, 5H), 2.29–2.08 (m, 2H), 2.08–1.89 (m, 2H), 1.89–1.59 (m, 2H), 0.94
(d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 201.6, 197.9, 173.9, 172.7, 131.7,
119.0, 105.3, 74.9, 66.0, 61.8, 39.7, 34.2, 32.1, 29.6, 27.9, 21.5, 19.2;  IR (Neat Film
NaCl) 3084, 2960, 2936, 2875, 2829, 2723, 1727, 1649, 1611, 1471, 1454, 1422, 1403,
1385, 1369, 1306, 1270, 1234, 1191, 1173, 1104, 1004, 990, 931, 877, 862, 822 cm–1;
HRMS (FAB+) m/z calc'd for C18H27O5 [M+H]
+: 323.1858; found 323.1860.
#-Ketoester 24e.  MePh3PBr (1.33 g, 3.72 mmol, 1.26 equiv) was suspended in toluene
(20 mL) in 100 mL round-bottom flask and cooled to 0 °C.  KOt-Bu (0.348 g, 3.10
mmol, 1.05 equiv) was added in one portion and the bright yellow mixture was stirred at
0 °C for 30 min, warmed to ambient temperature, and stirred for an additional 2 h.  The
mixture was cooled to 0 °C and a solution of aldehyde 24k (0.95 g, 2.94 mmol, 1.00
equiv) in toluene (2 mL) was added to the reaction using positive pressure cannulation.
The mixture turned brown.  The reaction was maintained at 0 °C for 1.5 h, warmed to
ambient temperature, and stirred for 4 h.  The reaction was quenched by addition of 50%
sat. aqueous NH4Cl (4 mL).  The phases were separated and the aqueous phase was
extracted with Et2O (3 x 100 mL).  The combined organic phases were dried over
Na2SO4, filtered, and concentrated under reduced pressure.  The crude product was
purified by flash column chromatography (SiO2, 3 x 25 cm, 20:1%15:1 hexanes:EtOAc)
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to afford #-ketoester 24e (747 mg, 2.33 mmol, 79% yield) as a pale yellow oil;  Rf = 0.66
(4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 5.85 (dddd, J = 17.2, 10.4, 5.7, 5.7
Hz, 1H), 5.84–5.69 (m, 1H), 5.35 (s, 1H), 5.29 (app dq, J = 17.2, 1.5 Hz, 1H), 5.20 (app
dq, J = 10.4, 1.3 Hz, 1H), 5.08–4.96 (m, 1H), 4.96–4.87 (m, 1H), 4.62 (dddd, J = 13.1,
5.7, 1.4, 1.4 Hz, 1H), 4.54 (dddd, J = 13.1, 5.7, 1.4, 1.4 Hz, 1H), 3.53–3.38 (m, 2H), 2.59
(dddd, J = 17.9, 9.8, 3.7, 1.1 Hz, 1H), 2.51–2.29 (m, 2H), 2.09–1.87 (m, 6H), 1.87–1.66
(m, 2H), 0.94 (d, J = 6.7, 3H), 0.94 (d, J = 6.7, 3H);  13C NMR (75 MHz, CDCl3) $ 198.4,
173.7, 173.0, 138.2, 131.9, 118.6, 114.9, 105.4, 74.8, 65.8, 62.6, 36.8, 34.1, 31.5, 28.8,
27.9, 22.0, 19.3;  IR (Neat Film NaCl) 3078, 2959, 2935, 2874, 1732, 1662, 1612, 1471,
1453, 1423, 1401, 1384, 1369, 1307, 1270, 1231, 1194, 1170, 1091, 993, 913, 874, 817,
766 cm–1;  HRMS (EI+) m/z calc'd for C19H28O4 [M]
+•: 320.1988; found 320.1977.
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#-Ketoester 24f.  To a solution of diisopropylamine (0.406 mL, 2.90 mmol, 1.20 equiv)
in THF (12 mL) in a 50 mL round-bottom flask at 0 °C was added n-BuLi (1.10 mL, 2.77
mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of stirring at
0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A solution of
vinylogous ester 66 (0.44 g, 2.41 mmol, 1.00 equiv) in THF (2 mL) was added dropwise
using positive pressure cannulation.  After an additional 1 h of stirring at –78 °C, allyl
cyanoformate (0.288 mL, 2.65 mmol, 1.10 equiv) was added dropwise over 10 min.  The
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mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. aqueous NH4Cl
(4 mL), and then allowed to warm to ambient temperature.  The reaction was diluted with
Et2O (15 mL) and the phases were separated.  The aqueous phase was extracted with
Et2O (3 x 15 mL).  The combined organic phases were dried over Na2SO4, filtered, and
concentrated under reduced pressure to afford a pale orange oil.  The crude oil was
purified by automated flash column chromatography using a Teledyne Isco CombiFlash
Rf (SiO2, 5 g loading cartridge, 40 g column, hold 0% [1 min]% ramp to 20% [8
min]%hold 20% [5 min]%ramp to 50% [4 min]%50% EtOAc in hexanes [6 min]) to
afford the intermediate #-ketoester (590 mg, 2.21 mmol, 92% yield).
A portion of the intermediate #-ketoester (250 mg, 0.94 mmol, 1.00 equiv) was
dissolved in THF (5 mL) in a 50 mL round-bottom flask, cooled to 0 °C, and stirred
vigorously as hexane-washed NaH (33.8 mg, 6.58 mmol, 1.50 equiv) was added in one
portion.  Evolution of gas was observed, and the reaction was stirred at 0 °C for 30 min to
give a yellow-orange solution.  1-chloro-2,4-pentadiene53 (144 mg, 1.41 mmol, 1.50
equiv) was added dropwise, and the reaction was allowed to warm to ambient
temperature and then heated to 40 °C.  After 10.5 h, an additional portion of 1-chloro-2,4-
pentadiene (144 mg, 1.41 mmol, 1.50 equiv) was added, and the reaction was heated at
50 °C for 11.5 h.  The flask was cooled to ambient temperature and the reaction was
quenched by addition of 50% sat. aqueous NH4Cl (2 mL).  The phases were separated
and the aqueous layer was extracted with Et2O (3 x 10 mL).  The combined organic
phases were washed with brine, dried over Na2SO4, filtered, and concentrated under
reduced pressure.  The crude product was purified by flash column chromatography
(SiO2, 3 x 25 cm, 20:1%15:1%10:1 hexanes:EtOAc) to afford #-ketoester 24f (286 mg,
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0.86 mmol, 91% yield, 84% yield over 2 steps) as a pale yellow oil;  Rf = 0.59 (4:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 6.25 (ddd, J = 16.7, 10.3, 10.3 Hz, 1H),
6.11–5.98 (m, 1H), 5.83 (dddd, J = 17.2, 10.4, 5.7, 5.7 Hz, 1H), 5.58 (ddd, J = 15.1, 7.7,
7.7 Hz, 1H), 5.36 (s, 1H), 5.27 (app dq, J = 17.2, 1.5 Hz, 1H), 5.18 (app dq, J = 10.4, 1.2
Hz, 1H), 5.08 (dd, J = 16.9, 1.6 Hz, 1H), 4.96 (dd, J = 16.9, 1.6 Hz, 1H), 4.60 (dddd, J =
13.2, 5.8, 1.4, 1.4 Hz, 1H), 4.52 (dddd, J = 13.2, 5.8, 1.4, 1.4 Hz, 1H), 3.57–3.35 (m, 2H),
2.65 (d, J = 7.7 Hz, 2H), 2.56 (ddd, J = 12.7, 6.8, 2.3 Hz, 1H), 2.48–2.19 (m, 2H),
2.10–1.85 (m, 2H), 1.85–1.63 (m, 2H), 0.92 (d, J = 6.7, 3H), 0.92 (d, J = 6.7, 3H);  13C
NMR (75 MHz, CDCl3) $ 197.9, 174.0, 172.7, 136.9, 134.6, 131.9, 129.7, 118.6, 116.1,
105.4, 74.8, 65.9, 62.9, 41.0, 34.1, 31.4, 27.9, 21.8, 19.2;  IR (Neat Film NaCl) 3085,
2959, 2933, 2874, 1733, 1650, 1612, 1471, 1453, 1434, 1402, 1384, 1369, 1307, 1272,
1234, 1194, 1171, 1093, 1006, 968, 955, 929, 900, 864, 822, 761 cm–1;  HRMS (FAB+)
m/z calc'd for C20H29O4 [M+H]
+: 333.2066; found 333.2052.
O
i-BuO
66
1. LDA, THF, –78 °C 
     then
NC
O
O
2. 2,3-dichloro-1-propene
    NaH, TBAI, THF, 0!40 °C
    84% yield, 2 steps
O
i-BuO
24g
O
O
Cl
#-Ketoester 24g.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) in
THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL, 6.30
mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of stirring at
0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A solution of
vinylogous ester 66 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was added dropwise
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using positive pressure cannulation.  After an additional 1 h of stirring at –78 °C, allyl
cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over 10 min.  The
mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. aqueous NH4Cl
(8 mL), and allowed to warm to ambient temperature.  The reaction was diluted with
Et2O (25 mL) and the phases were separated.  The aqueous phase was extracted with
Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4, filtered, and
concentrated under reduced pressure to afford a pale orange oil.
The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask,
cooled to 0 °C, and stirred vigorously as hexane-washed NaH (197 mg, 8.22 mmol, 1.50
equiv) was added in one portion.  Evolution of gas was observed, and the reaction was
stirred at 0 °C for 30 min to give a yellow-orange solution.  2,3-dichloro-1-propene (1.00
mL, 10.96 mmol, 2.0 equiv) was added dropwise, and the reaction was allowed to warm
to ambient temperature.  After 10 h, TBAI (202 mg, 0.548 mmol, 0.10 equiv) was added,
and the reaction was heated to 40 °C.  After 41 h, the reaction was cooled to ambient
temperature and quenched by addition of 50% sat. aqueous NH4Cl (10 mL).  The phases
were separated and the aqueous layer was extracted with Et2O (3 x 15 mL).  The
combined organic phases were washed with brine, dried over Na2SO4, filtered, and
concentrated under reduced pressure.  The crude product was purified by flash column
chromatography (SiO2, 3 x 25 cm, 20:1%15:1 hexanes:EtOAc) to afford #-ketoester 24g
(1.57 g, 4.61 mmol, 84% yield over 2 steps) as a yellow oil;  Rf = 0.60 (4:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 5.87 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz,
1H), 5.38–5.25 (m, 3H), 5.25–5.16 (m, 2H), 4.65 (dddd, J = 13.2, 5.8, 1.3, 1.3 Hz, 1H),
4.52 (dddd, J = 13.1, 5.8, 1.3, 1.3 Hz, 1H), 3.45 (ddd, J = 21.1, 9.3, 6.5 Hz, 2H), 3.04 (s,
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2H), 2.71 (dddd, J = 18.2, 10.2, 3.0, 1.3 Hz, 1H), 2.62–2.47 (m, 1H), 2.39 (ddd, J = 17.2,
6.9, 2.6 Hz, 1H), 2.10–1.90 (m, 2H), 1.89–1.65 (m, 2H), 0.94 (d, J = 6.7 Hz, 3H), 0.94 (d,
J = 6.7 Hz, 3H);  13C NMR (75 MHz, CDCl3) $ 196.6, 174.8, 172.1, 138.1, 131.7, 118.8,
117.1, 104.9, 74.8, 66.2, 62.2, 46.1, 33.9, 30.7, 27.8, 22.6, 19.2;  IR (Neat Film NaCl)
3085, 2960, 2935, 2875, 1737, 1662, 1610, 1471, 1452, 1427, 1384, 1369, 1298, 1272,
1229, 1198, 1171, 1153, 1079, 1008, 967, 930, 890, 862, 813 cm–1;  HRMS (EI+) m/z
calc'd for C18H25O4 [M–Cl]
+: 305.1753; found 305.1742.
O
i-BuO
66
1. LDA, THF, –78 °C 
     then
NC
O
O
2. acrylonitrile
    NaH (25 mol %)
    THF, 0!23 °C
    65% yield, 2 steps
O
i-BuO
24h
O
O
NC
#-Ketoester 24h.  To a solution of diisopropylamine (1.53 mL, 10.93 mmol, 1.20 equiv)
in THF (45 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi (4.17 mL,
10.47 mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A
solution of vinylogous ester 66 (1.66 g, 9.11 mmol, 1.00 equiv) in THF (2 mL) was
added dropwise over 10 min.  After an additional 1 h of stirring at –78 °C, allyl
cyanoformate (1.09 mL, 10.0 mmol, 1.10 equiv) was added dropwise over 10 min.  The
mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. aqueous NH4Cl
(13.5 mL), and then allowed to warm to ambient temperature.  The reaction was diluted
with Et2O (50 mL) and the phases were separated.  The aqueous phase was extracted with
Et2O (3 x 100 mL).  The combined organic phases were dried over Na2SO4, filtered, and
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concentrated under reduced pressure to afford a pale orange oil.  The crude oil was
purified by automated flash column chromatography using a Teledyne Isco CombiFlash
Rf (SiO2, 25 g loading cartridge, 80 g column, multi-step gradient, hold 0% [2
min]%ramp to 20% [4 min]%hold 20% [15 min]%ramp to 50% [7 min]%hold 50%
EtOAc in hexanes [5 min]) to afford the intermediate #-ketoester (2.08 g, 7.80 mmol,
86% yield).
One third of the intermediate #-ketoester (694 mg, 2.60 mmol, 1.00 equiv) was
dissolved in THF (5 mL) in a 50 mL round-bottom flask, cooled to 0 °C, and stirred
vigorously as hexane-washed NaH (15.6 mg, 0.65 mmol, 0.25 equiv) was added in one
portion.  Evolution of gas was observed, and the reaction was stirred at 0 °C for 30 min to
give a yellow-orange solution.  Acrylonitrile (0.256 mL, 3.90 mmol, 1.50 equiv) was
added dropwise, and the reaction was allowed to warm to ambient temperature.  After 40
h, the reaction was diluted with Et2O (30 mL) and washed with H2O (5 mL) and brine (5
mL).  The aqueous layer was extracted with Et2O (3 x 20 mL).  The combined organic
phases were washed with brine, dried over Na2SO4, filtered, and concentrated under
reduced pressure.  The crude product was purified by flash column chromatography
(SiO2, 3 x 25 cm, 10:1%6:1%4:1 hexanes:EtOAc) to afford #-ketoester 24h (620 mg,
1.94 mmol, 75% yield, 65% yield over 2 steps) as a clear, colorless oil;  Rf = 0.29 (4:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 5.87 (dddd, J = 16.2, 10.4, 5.8, 5.8 Hz,
1H), 5.38 (s, 1H), 5.32 (app dq, J = 17.2, 1.4 Hz, 1H), 5.25 (app dq, J = 10.4, 1.1 Hz,
1H), 4.67 (dddd, J = 13.0, 5.8, 1.2, 1.2 Hz, 1H), 4.58 (dddd, J = 13.1, 5.9, 1.2, 1.2 Hz,
1H), 3.57–3.39 (m, 2H), 2.58 (ddd, J = 13.1, 9.6, 3.9 Hz, 1H), 2.51–2.32 (m, 4H),
2.32–2.11 (m, 2H), 2.11–1.90 (m, 2H), 1.90–1.64 (m, 2H), 0.95 (d, J = 6.7 Hz, 6H);  13C
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NMR (75 MHz, CDCl3) $ 196.9, 174.4, 172.0, 131.4, 119.7, 119.3, 105.1, 75.0, 66.3,
61.5, 34.1, 33.1, 32.0, 27.9, 21.4, 19.2, 13.3;  IR (Neat Film NaCl) 3081, 2959, 2936,
2875, 2247, 1733, 1648, 1609, 1471, 1454, 1423, 1403, 1385, 1369, 1297, 1269, 1235,
1192, 1173, 1096, 996, 932, 874, 824, 764 cm–1;  HRMS (EI+) m/z calc'd for C18H25O4N
[M]+•: 319.1784; found 319.1777.
N•HBr
Br
O
i-BuO
66
1. LDA, THF, –78 °C 
     then
NC
O
O
2. NaH, THF, 0!23 °C
O
i-BuO
24i
O
O
    71% yield, 2 steps
N
#-Ketoester 24i.  To a solution of diisopropylamine (3.54 mL, 25.27 mmol, 1.20 equiv)
in THF (108 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi (10.26 mL,
24.22 mmol, 2.36 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A
solution of vinylogous ester 66 (3.84 g, 21.06 mmol, 1.00 equiv) in THF (10 mL) was
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at
–78 °C, allyl cyanoformate (2.52 mL, 9.74 mmol, 1.10 equiv) was added dropwise over
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat.
aqueous NH4Cl (30.7 mL), and then allowed to warm to ambient temperature.  The
reaction was diluted with Et2O (100 mL) and the phases were separated.  The aqueous
phase was extracted with Et2O (3 x 100 mL).  The combined organic phases were dried
over Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange
oil.  The crude oil was purified by automated flash column chromatography using a
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Teledyne Isco CombiFlash Rf (SiO2, 32 g loading cartridge, 330 g column, multi-step
gradient, hold 0% [2 min]%ramp to 20% [10 min]%hold 20% [6 min]%ramp to 50% [3
min]%hold 50% EtOAc in hexanes [11 min]) to afford the intermediate #-ketoester (4.66
g, 17.50 mmol, 83% yield) as a pale orange oil.
A portion of the intermediate #-ketoester (1.00 g, 3.75 mmol, 1.00 equiv) was
dissolved in THF (25 mL) in a 100 mL round-bottom flask, cooled to 0 °C, and stirred
vigorously as hexane-washed NaH (90 mg, 3.75 mmol, 1.00 equiv) was added in one
portion.  Evolution of gas was observed, and the reaction was stirred at 0 °C for 30 min to
give a yellow-orange solution.  Additional NaH (202 mg, 8.43 mmol, 2.25 equiv) was
added, giving a thick yellow suspension.  After 5 min, 4-(bromomethyl)pyridine
hydrogen bromide (996 mg, 3.94 mmol, 1.05 equiv) was added portionwise, and the
reaction was allowed to warm to ambient temperature.  After 14 h, the reaction was
quenched by addition of 50% sat. aqueous NH4Cl (16 mL) to give a brown biphasic
mixture.  The phases were separated and the aqueous layer was extracted with Et2O (3 x
25 mL).  The combined organic phases were dried over Na2SO4, filtered, and
concentrated under reduced pressure.  The crude product was purified by flash column
chromatography (SiO2, 3 x 25 cm, 1:1%1:4 hexanes:EtOAc%EtOAc) to afford #-
ketoester 24i (1.16 g, 3.23 mmol, 86% yield, 71% yield over 2 steps) as a yellow oil;  Rf
= 0.28, broad (1:2 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 8.44 (dd, J = 4.4, 1.6
Hz, 2H), 7.06 (dd, J = 4.4, 1.6 Hz, 2H), 5.82 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.37
(s, 1H), 5.28 (app dq, J = 17.2, 1.5 Hz, 1H), 5.21 (app dq, J = 10.4, 1.2 Hz, 1H), 4.61
(dddd, J = 13.1, 5.9, 1.3, 1.3 Hz, 1H), 4.50 (dddd, J = 13.1, 5.9, 1.3, 1.3 Hz, 1H), 3.42 (d,
J = 6.5 Hz, 2H), 3.27 (d, J = 13.3 Hz, 1H), 3.18 (d, J = 13.3 Hz, 1H), 2.54 (ddd, J = 17.2,
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9.3, 3.0 Hz, 1H), 2.38–2.21 (m, 2H), 2.03–1.86 (m, 2H), 1.83–1.59 (m, 2H), 0.91 (d, J =
6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 197.0, 174.3, 172.3, 149.6, 146.1, 131.4,
126.0, 119.2, 105.6, 74.9, 66.1, 63.5, 42.4, 33.9, 31.5, 27.8, 21.8, 19.2;  IR (Neat Film
NaCl) 3072, 3026, 2959, 2935, 2874, 1733, 1660, 1608, 1557, 1496, 1470, 1452, 1415,
1384, 1369, 1293, 1272, 1232, 1201, 1172, 1095, 1074, 1005, 994, 956, 935, 862, 823,
773 cm–1;  HRMS (EI+) m/z calc'd for C21H27O4N [M]
+•: 357.1940; found 357.1945.
O
i-BuO
O
i-BuO
NaH, TsCl, THF
0!23 °C
91% yield
O
i-BuO
24ac
66
24j
H
N N
Ts
O
O
O
O
     71% yield, 2 steps
N
H
NMe3I
1. LDA, THF, –78 °C 
     then
NC
O
O
2. NaH, THF, 0!23 °C
Indolyl #-Ketoester 24ac.  To a solution of diisopropylamine (3.54 mL, 25.27 mmol,
1.20 equiv) in THF (108 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi
(10.26 mL, 24.22 mmol, 2.36 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15
min of stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.
A solution of vinylogous ester 66 (3.84 g, 21.06 mmol, 1.00 equiv) in THF (10 mL) was
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at
–78 °C, allyl cyanoformate (2.52 mL, 9.74 mmol, 1.10 equiv) was added dropwise over
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat.
aqueous NH4Cl (30.7 mL), and then allowed to warm to ambient temperature.  The
reaction was diluted with Et2O (100 mL) and the phases were separated.  The aqueous
phase was extracted with Et2O (3 x 100 mL).  The combined organic phases were dried
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over Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange
oil.  The crude oil was purified by automated flash column chromatography using a
Teledyne Isco CombiFlash Rf (SiO2, 32 g loading cartridge, 330 g column, multi-step
gradient, hold 0% [2 min]%ramp to 20% [10 min]%hold 20% [6 min]%ramp to 50% [3
min]%hold 50% EtOAc in hexanes [11 min]) to afford the intermediate #-ketoester (4.66
g, 17.50 mmol, 83% yield) as a pale orange oil.
A portion of the intermediate #-ketoester (0.85 g, 3.19 mmol, 1.00 equiv) was
dissolved in THF (32 mL) in a 100 mL round-bottom flask, cooled to 0 °C, and stirred
vigorously as hexane-washed NaH (84 mg, 3.51 mmol, 1.10 equiv) was added in one
portion.  Evolution of gas was observed, and the reaction was stirred at 0 °C for 30 min to
give a yellow-orange solution.  Gramine methiodide52 (1.06 g, 3.35 mmol, 1.05 equiv)
was added portionwise to give a suspension.  After 11.5 h, the reaction was a brown-
orange solution.  Additional gramine methiodide (212 mg, 0.67 mmol, 0.31 equiv) was
added.  After 30 min, the reaction was quenched by addition of 50% sat. aqueous NH4Cl
(4.3 mL) to give a brown biphasic mixture.  Volatiles were removed under reduced
pressure.  The residue was extracted with EtOAc (3 x 40 mL), dried over Na2SO4,
filtered, and concentrated under reduced pressure.  The residue was dissolved in a
minimal amount of 1:1 hexanes:EtOAc and filtered through a silica gel pad (1.5 x 10 cm,
1:1 hexanes:EtOAc).  The filtrate was concentrated under reduced pressure.  The crude
product was purified by flash column chromatography (SiO2, 5 x 20 cm, 6:1%4:1%2:1
hexanes:EtOAc) to afford #-ketoester 24ac (1.09 g, 2.75 mmol, 86% yield, 71% yield
over 2 steps) as an orange-brown semi-solid;  Rf = 0.21 (4:1 hexanes:EtOAc);  
1H NMR
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(300 MHz, CDCl3) $ 8.08 (s, 1H), 7.67–7.54 (m, 1H), 7.38–7.29 (m, 1H), 7.21–7.04 (m,
2H), 7.00 (d, J = 2.4 Hz, 1H), 5.84 (dddd, J = 17.2, 10.4, 5.7, 5.7 Hz, 1H), 5.37 (s, 1H),
5.29 (app dq, J = 17.2, 1.5 Hz, 1H), 5.20 (app dq, J = 10.4, 1.3 Hz, 1H), 4.60 (dddd, J =
13.2, 5.6, 1.4, 1.4 Hz, 1H), 4.50 (dddd, J = 13.2, 5.8, 1.4, 1.4 Hz, 1H), 3.52 (dd, J = 14.3,
0.5 Hz, 1H), 3.47–3.31 (m, 3H), 2.63–2.34 (m, 2H), 2.28 (ddd, J = 17.8, 7.7, 4.0 Hz, 1H),
2.02–1.63 (m, 4H), 0.90 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 198.8, 173.7,
173.2, 135.8, 131.9, 128.8, 124.3, 121.8, 119.5, 119.2, 118.6, 111.1, 111.0, 106.0, 74.7,
65.9, 64.3, 34.0, 32.8, 31.6, 27.8, 21.7, 19.2;  IR (Neat Film NaCl) 3785, 3584, 3392,
3079, 3057, 2958, 2930, 2874, 1729, 1641, 1607, 1457, 1457, 1433, 1423, 1384, 1368,
1341, 1233, 1191, 1174, 1127, 1085, 1010, 932, 879, 863, 822, 742 cm–1;  HRMS (EI+)
m/z calc'd for C24H29O4N [M]
+•: 395.2097; found 395.2097.
Tosylindolyl #-Ketoester 24j.  To a solution of indole 24ac (250 mg, 0.63 mmol, 1.00
equiv) in THF (9 mL) in a 100 mL round-bottom flask was added TsCl (241 mg, 1.26
mmol, 2.00 equiv).  The mixture was cooled to 0 °C and stirred vigorously as hexane-
washed NaH (61 mg, 2.53 mmol, 4.00 equiv) was added in one portion.  The reaction
was maintained at 0 °C for 5 min before warming to ambient temperature.  After 24 h, the
white suspension was cooled to 0 °C and additional TsCl (241 mg, 1.26 mmol, 2.00
equiv) was added, followed by hexane-washed NaH (121 mg, 5.06 mmol, 8.00 equiv) in
one portion.  The reaction was allowed to warm to ambient temperature.  After 46 h, the
reaction was quenched by addition of 50% sat. aqueous NH4Cl (3 mL).  The phases were
separated and the aqueous phase was extracted with Et2O (3 x 15 mL).  The combined
organic phases were dried over Na2SO4, filtered, and concentrated under reduced
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pressure.  The crude product was purified by flash column chromatography (SiO2, 3 x 25
cm, 10:1%6:1%4:1 hexanes:EtOAc) to afford #-ketoester 24j (317 mg, 5.76 mmol, 91%
yield) as a yellow foam;  Rf = 0.40 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $
7.97–7.89 (m, 1H), 7.75–7.66 (m, 2H), 7.53–7.44 (m, 1H), 7.35 (s, 1H), 7.31–7.13 (m,
4H), 5.77 (dddd, J = 17.1, 10.4, 5.8 Hz, 1H), 5.39 (s, 1H), 5.25 (app dq, J = 17.2, 1.5 Hz,
1H), 5.18 (app dq, J = 10.4, 1.2 Hz, 1H), 4.52 (dddd, J = 13.1, 5.7, 1.3, 1.3 Hz, 1H), 4.42
(dddd, J = 13.2, 5.9, 1.3, 1.3 Hz, 1H), 3.48–3.32 (m, 3H), 3.26 (d, J = 14.4 Hz, 1H), 2.52
(ddd, J = 17.7, 9.2, 3.3 Hz, 1H), 2.41–2.19 (m, 5H), 2.02–1.82 (m, 2H), 1.78–1.58 (m,
2H), 0.92 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 197.8, 174.0, 172.8, 144.8,
135.4, 134.9, 132.1, 131.6, 129.9, 127.0, 125.8, 124.6, 123.2, 119.9, 118.9, 118.0, 113.7,
105.9, 74.8, 66.1, 63.6, 34.1, 32.2, 31.7, 27.9, 21.7, 21.6, 19.2;  IR (Neat Film NaCl)
3854, 3401, 2959, 2931, 2874, 1731, 1657, 1650, 1609, 1448, 1368, 1279, 1233, 1188,
1173, 1121, 1098, 1087, 1019, 1007, 992, 976, 938, 864, 813, 748 cm–1;  HRMS (FAB+)
m/z calc'd for C31H36O6N [M+H]
+: 550.2263; found 550.2250.
O
i-BuO
66
1. LDA, THF, –78 °C 
     then
NC
O
O
2. TiCl4 (9.0 mol %)
    Selectfluor, CH3CN
    41% yield, 2 steps
O
i-BuO
F
24l
O
O
#-Ketoester 24l.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) in
THF (27 mL) in a 100 mL round-bottomed flask at 0 °C in an ice/water bath was added
n-BuLi (2.56 mL, 2.46 M in hexanes, 6.30 mmol, 1.15 equiv) dropwise over 10 min.
After 15 min of stirring at 0 °C, the mixture was cooled to –78 °C using an
acetone/CO2(s) bath.  A solution of vinylogous ester 66 (1.00 g, 5.48 mmol, 1.00 equiv)
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in THF (2 mL) was added dropwise using positive pressure cannulation.  After an
additional 1 h of stirring at –78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv)
was added dropwise over 10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched
by addition of 50% sat. aqueous NH4Cl (8 mL), and then allowed to warm to ambient
temperature.  The reaction was diluted with Et2O (25 mL) and the layers were separated.
The aqueous phase was extracted with Et2O (3 x 25 mL).  The combined organic layers
were dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a
pale orange oil.
The crude oil was dissolved in CH3CN (55 mL) in a 100 mL round-bottomed
flask under N2 and TiCl4 (53.7 µL, 0.49 mmol, 9.0 mol %) was added dropwise, giving a
dark purple-brown mixture.  After 10 min, Selectfluor (2.33 g, 6.58 mmol, 1.20 equiv)
was added in one portion.  After 3.5 h, the reaction mixture was an orange suspension.
The reaction was concentrated under reduced pressure and the orange residue was
partitioned between water (25 mL) and Et2O (25 mL).  The layers were separated and the
aqueous layer was extracted with Et2O (3 x 25 mL).  The combined organic layers were
washed with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure.
The crude product was purified by automated flash column chromatography using
Teledyne Isco CombiFlash Rf (SiO2, 25 g loading cartridge, 120 g column, 10% EtOAc in
hexanes) to afford #-ketoester 24l (639 mg, 2.25 mmol, 41% yield over 2 steps) as a pale
yellow oil;  Rf = 0.44 (4:1 hexanes:EtOAc);  
1H NMR (500 MHz, CDCl3) $ 5.86 (dddd, J
= 17.1, 10.7, 5.6, 5.6 Hz, 1H), 5.39 (s, 1H), 5.29 (ddd, J = 17.1, 2.9, 1.5 Hz, 1H), 5.20
(app d, J = 10.5 Hz, 1H), 4.59 (dddd, J = 19.0, 13.2, 5.6, 1.2 Hz, 2H), 3.50 (dd, J = 9.3,
6.8 Hz, 1H), 3.47 (dd, J = 9.3, 6.6 Hz, 1H), 2.59 (ddd, J = 17.8, 9.8, 3.9 Hz, 1H),
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2.45–2.38 (m, 2H), 2.02–1.94 (m, 1H), 1.84–1.75 (m, 1H), 1.70 (ddd, J = 14.4, 7.3, 4.4
Hz, 1H), 1.43 (s, 3H), 0.94 (d, J = 6.6 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 192.1 (d,
JCF = 24.1 Hz), 178.0, 167.6 (d, JCF = 25.4 Hz), 131.3, 119.0, 102.0 (d, JCF = 1.1 Hz), 99.3
(d, JCF = 193.5 Hz), 75.3, 66.6, 34.0 (d, JCF = 2.1 Hz), 31.9 (d, JCF = 22.5 Hz), 27.8, 20.7
(d, JCF = 1.7 Hz), 19.1;  
19F NMR (282 MHz, CDCl3) $ –148.54 (dd, J = 35.4, 20.7 Hz);
IR (Neat Film NaCl) 3086, 2960, 2938, 2876, 1752, 1654, 1649, 1603, 1471, 1453, 1422,
1403, 1385, 1369, 1282, 1249, 1229, 1204, 1176, 1137, 1095, 1045, 991, 953, 927, 874,
862, 843, 829, 795, 758 cm–1;  HRMS (EI+) m/z calc'd for C15H21O4F [M]
+•: 284.1425;
found 284.1424.
O
i-BuO
O
i-BuO
imidazole
TBDPSCl
 
DMAP, DMF
97% yield
O
i-BuO
66 24ad 24m
OH OTBDPS
O
O
O
O
1. LDA, THF, –78 °C 
     then
NC
O
O
2. KHCO3, 37% aq CH2O
    THF, 0!23 °C
    83% yield, 2 steps
Hydroxy #-Ketoester 24ad.  To a solution of diisopropylamine (1.84 mL, 13.15 mmol,
1.20 equiv) in THF (54 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi
(5.12 mL, 12.60 mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15
min of stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.
A solution of vinylogous ester 66 (2.00 g, 10.96 mmol, 1.00 equiv) in THF (4 mL) was
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at
–78 °C, allyl cyanoformate (1.34 mL, 12.06 mmol, 1.10 equiv) was added dropwise over
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat.
aqueous NH4Cl (16 mL), and then allowed to warm to ambient temperature.  The reaction
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was diluted with Et2O (200 mL) and the phases were separated.  The aqueous phase was
extracted with Et2O (3 x 100 mL).  The combined organic phases were dried over
Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange oil
(2.92 g).
Half of the crude oil (1.46 g) was dissolved in THF (10 mL) in a 50 mL round-
bottom flask and cooled to 0 °C.  KHCO3 (1.65 g, 16.44 mmol, 3.00 equiv) and 37% wt.
aqueous formaldehyde (2.81 mL, 37.73 mmol, 6.9 equiv) were added.  The reaction was
allowed to warm to ambient temperature.  After 11 h, the reaction was diluted with H2O
and CH2Cl2 (25 mL each).  The phases were separated and the aqueous layer was
extracted with CH2Cl2 (4 x 12 mL).  The combined organic phases were dried over
Na2SO4, filtered, and concentrated under reduced pressure.  The crude product was
purified by flash column chromatography (SiO2, 3 x 25 cm, 4:1% 2:1%1:1
hexanes:EtOAc) to afford #-ketoester 24ad (1.35 g, 4.55 mmol, 83% yield over 2 steps)
as a pale yellow oil;  Rf = 0.21 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 5.89
(dddd, J = 17.2, 10.4, 5.7, 5.7 Hz, 1H), 5.43 (s, 1H), 5.32 (app dq, J = 17.2, 1.5 Hz, 1H),
5.23 (app dq, J = 10.4, 1.3 Hz, 1H), 4.76–4.54 (m, 2H), 3.93–3.72 (m, 2H), 3.51 (d, J =
6.5 Hz, 2H), 3.59–3.45 (m, 1H) 2.68–2.50 (m, 1H), 2.50–2.35 (m, 1H), 2.31–2.12 (m
1H), 2.10–1.91 (m, 2H), 1.91–1.71 (m, 2H), 0.96 (d, J = 6.7 Hz, 6H);  13C NMR (75
MHz, CDCl3) $ 200.2, 175.1, 171.9, 131.6, 118.9, 105.6, 75.1, 68.7, 66.1, 63.6, 33.7,
28.6, 27.9, 20.9, 19.2;  IR (Neat Film NaCl) 3448, 3083, 2959, 2937, 2875, 1733, 1646,
1608, 1471, 1457, 1420, 1404, 1385, 1369, 1298, 1235, 1195, 1171, 1099, 1044, 998,
928, 869, 825 cm–1;  HRMS (FAB+) m/z calc'd for C16H25O5 [M+H]
+: 297.1702; found
297.1715.
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Siloxy #-Ketoester 24m.  Alcohol 24ad (895 mg, 3.02 mmol, 1.00 equiv), DMAP (553
mg, 4.53 mmol, 1.50 equiv), and imidazole (308 mg, 4.53 mmol, 1.50 equiv) were
dissolved in DMF (11 mL) in a 20 mL scintillation vial with magnetic stir bar and septum
fitted screw cap.  TBDPSCl (0.942 mL, 3.62 mmol, 1.20 equiv) was added dropwise.
The stirred mixture turned into a turbid white suspension within 5 min.  After 54 h, the
reaction was poured into H2O (35 mL) and 2:1 CH2Cl2/hexanes (75 mL).  The phases
were separated and the aqueous layer was further extracted with 2:1 CH2Cl2/hexanes (4 x
35 mL).  The combined organics were dried over Na2SO4, filtered, and concentrated
under reduced pressure.  The crude product was purified by flash column
chromatography (SiO2, 5 x 25 cm, 40:1%20:1 hexanes:EtOAc) to afford siloxy #-
ketoester 24m (1.567 g, 2.93 mmol, 97% yield) as a clear, colorless oil;  Rf = 0.58 (4:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 7.70–7.61 (m, 4H), 7.47–7.32 (m, 6H),
5.86 (dddd, J = 17.1, 10.5, 5.7, 5.7 Hz, 1H), 5.39 (s, 1H), 5.29 (app dq, J = 17.2, 1.5 Hz,
1H), 5.19 (app dq, J = 10.4, 1.2 Hz, 1H), 4.65 (dddd, J = 13.2, 5.7, 1.3, 1.3 Hz, 1H), 4.52
(dddd, J = 13.3, 5.7, 1.3, 1.3 Hz, 1H), 4.15 (d, J = 9.6 Hz, 1H), 4.05 (d, J = 9.6 Hz, 1H),
3.47 (d, J = 6.5 Hz, 2H), 2.80–2.51 (m, 2H), 2.43 (ddd, J = 11.0, 7.4, 2.9 Hz, 1H),
2.17–1.89 (m, 3H), 1.89–1.68 (m, 1H), 1.04 (s, 9H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR
(75 MHz, CDCl3) $ 197.5, 174.8, 171.6, 135.8, 135.7, 133.3, 133.2, 131.89, 129.8, 129.7,
127.8, 127.7, 118.5, 105.8, 74.8, 69.0, 65.9, 65.1, 34.5, 30.0, 27.8, 26.8, 21.9, 19.4, 19.2;
IR (Neat Film NaCl) 3460, 3071, 3049, 2958, 2931, 2890, 2857, 1738, 1650, 1609, 1472,
1429, 1384, 1362, 1299, 1236, 1200, 1173, 1113, 1007, 998, 936, 864, 822, 740 cm–1;
HRMS (FAB+) m/z calc'd for C32H43O5Si [M+H]
+: 535.2880; found 535.2880.
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O
i-BuO
24n
O
O
O
O
Ph
O
i-BuO
66
1. LDA, THF, –78 °C 
     then
NC
O
O
2. benzoyl peroxide, NaH
    toluene, 0!23 °C
      87% yield, 2 steps
#-Ketoester 24n.  To a solution of diisopropylamine (1.84 mL, 13.15 mmol, 1.20 equiv)
in THF (54 mL) in a 250 mL round-bottomed flask at 0 °C in an ice/water bath was
added n-BuLi (5.12 mL, 2.51 M in hexanes, 12.60 mmol, 1.15 equiv) dropwise over 10
min.  After 15 min of stirring at 0 °C, the mixture was cooled to –78 °C using an
acetone/CO2(s) bath.  A solution of vinylogous ester 66 (2.00 g, 10.96 mmol, 1.00 equiv)
in THF (4 mL) was added dropwise using positive pressure cannulation.  After an
additional 1 h of stirring at –78 °C, allyl cyanoformate (1.34 mL, 12.06 mmol, 1.10
equiv) was added dropwise over 10 min.  The mixture was stirred at –78 °C for 2.5 h,
quenched by addition of 50% sat. aqueous NH4Cl (16 mL), and then allowed to warm to
ambient temperature.  The reaction was diluted with Et2O (20 mL) and the layers were
separated.  The aqueous phase was extracted with Et2O (3 x 10 mL).  The combined
organic layers were dried over Na2SO4, filtered, and concentrated under reduced pressure
to afford a pale orange oil (2.92 g).
Half of the crude oil (1.46 g) was dissolved in toluene (30 mL) in a 100 mL
round-bottomed flask, cooled to 0 °C, and stirred vigorously as hexane-washed NaH (197
mg, 8.22 mmol, 1.50 equiv) was added in one portion.  Evolution of gas was observed
and the reaction was stirred at 0 °C for 30 min.  Benzoyl peroxide (1.99 g, 8.22 mmol,
1.50 equiv) was added slowly portionwise, giving a thick, pasty suspension.  The reaction
was warmed to ambient temperature and diluted with toluene (20 mL) to give a more
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freely stirring turbid yellow mixture.  After 30 min, the reaction was diluted with toluene
(50 mL) and washed with H2O (2 x 5 mL) and brine (2 x 5 mL).  The aqueous layers
were combined and extracted with EtOAc (2 x 25 mL).  The combined organic layers
were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude
product was purified by flash column chromatography (SiO2, 5 x 13 cm, 10:1
hexanes:EtOAc) to afford #-ketoester 24n (1.85 g, 4.79 mmol, 87% yield over 2 steps) as
a pale yellow oil;  Rf = 0.46 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $
8.09–7.99 (m, 2H), 7.64–7.53 (m, 1H), 7.50–7.38 (m, 2H), 5.89 (dddd, J = 17.2, 10.5,
5.7, 5.7 Hz, 1H), 5.42 (s, 1H), 5.31 (app dq, J = 17.2, 1.5 Hz, 1H), 5.20 (app dq, J = 10.4,
1.3 Hz, 1H), 4.80–4.62 (m, 2H), 3.57 (d, J = 6.5 Hz, 2H), 2.87–2.46 (m, 4H), 2.12–1.85
(m, 3H), 0.96 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 192.1, 175.9, 168.0,
165.1, 133.6, 131.7, 130.0, 129.6, 128.6, 118.7, 102.2, 88.8, 75.2, 66.6, 33.8, 31.2, 27.9,
21.2, 19.2, 19.2;  IR (Neat Film NaCl) 3070, 2960, 2937, 2875, 1753, 1727, 1661, 1605,
1471, 1452, 1423, 1384, 1369, 1315, 1280, 1222, 1206, 1175, 1107, 1097, 1070, 1044,
1026, 1002, 933, 849, 792 cm–1;  HRMS (EI+) m/z calc'd for C22H26O6 [M]
+•: 386.1733;
found 386.1729.
2.7.2.3 SYNTHESIS OF PHOX LIGANDS
Ligands (S)-t-BuPHOX (3)54 and (S)-(CF3)3-t-BuPHOX (8)
55 were prepared
according to previously reported procedures.  The preparation of ligands 128 and 67 are
described below.
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Br O
Cl
1. H2N(CH2)2OH, Na2CO3
    CH2Cl2, H2O, 23 °C
2. MsCl, Et3N, CH2Cl2
    0!40 °C
    64% yield, 2 steps
Br N
O
127
2-(2-Bromo-phenyl)-4,5-dihydrooxazole 127. 1To a solution of ethanolamine (1.32 mL,
21.9 mmol, 1.20 equiv) in CH2Cl2 (60 mL) in a 250 mL round-bottom flask was added a
solution of Na2CO3 (5.80 g, 54.7 mmol, 3.00 equiv) in H2O (45 mL).  Neat 2-
bromobenzoyl chloride (4.00 g, 2.38 mL, 18.2 mmol, 1.00 equiv) was added dropwise via
syringe to the vigorously stirred biphasic system.  The reaction flask was capped with a
yellow plastic stopper and stirred for 7.5 h at 23 °C.  The layers were separated and the
aqueous phase was extracted with CH2Cl2 (2 x 25 mL).  The combined organics were
dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a white
solid.  The crude product was dissolved in CH2Cl2 (50 mL) and hexanes (10 mL) was
added.  The solution was concentrated to ca. 25 mL under reduced pressure resulting in
precipitation of the intermediate amide (4.02 g, 16.4 mmol, 90% yield) as a white solid.
The intermediate amide (2.0 g, 8.2 mmol, 1.00 equiv) was dissolved in CH2Cl2
(62 mL) in a 100 mL round-bottom flask equipped with a reflux condenser.  Et3N (3.43
mL, 24.5 mmol, 3.00 equiv) was added, and the solution was cooled to 0 °C by use of an
ice/water bath.  Methanesulfonyl chloride (952 µL, 12.3 mmol, 1.50 equiv) was added
dropwise.  The reaction was stirred at 0 °C for 30 min and heated to 40 °C in an oil bath.
After 5 h of stirring, the resulting yellow solution was allowed to cool to ambient
temperature, diluted with CH2Cl2 (25 mL), and washed with H2O (2 x 25 mL) and brine
(25 mL).  The organic layer was dried over Na2SO4, filtered, and concentrated under
reduced pressure to afford a thick, pale yellow oil.  The crude oil was purified by flash
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chromatography (SiO2, 5 x 10 cm, 6:2:2 hexanes:EtOAc:toluene) to afford 2-(2-bromo-
phenyl)-4,5-dihydrooxazole 127 (1.31 g, 5.79 mmol, 71% yield);  Rf = 0.45 (9:1
CHCl3:MeOH);  
1H NMR (500 MHz, CDCl3) $ 7.72 (dd, J = 7.8, 2.0 Hz, 1H), 7.65 (dd, J
= 8.1, 1.0 Hz, 1H), 7.35 (app dt, J = 7.6, 1.2 Hz, 1H), 7.29 (app dt, J = 7.6, 1.7 Hz, 1H),
4.46 (t, J = 9.6 Hz, 2H), 4.12 (t, J = 9.6 Hz, 2H);  13C NMR (125 MHz, CDCl3) $ 164.0,
134.1, 131.8, 131.5, 129.8, 127.2, 122.0, 67.8, 55.5;  IR (Neat Film NaCl) 3390, 3070,
2966, 2904, 2868, 1729, 1646, 1589, 1432, 1362, 1328, 1272, 1243, 1093, 1026, 938
cm–1;  HRMS (EI+) m/z calc’d for C9H8BrNO [M]
+•: 224.9789; found 224.9779.
Br Ph2P
CuI (2 mol %), Ph2PH
N,N'-dimethylethylenediamine (10 mol %)
Cs2CO3, toluene, 110 °C
86% yield
N
O
N
O
128127
PHOX Ligand 128. 2A 250 mL Schlenk flask was charged with CuI (66.7 mg, 0.35
mmol, 2 mol %), Ph2PH (3.85 mL, 22.1 mmol, 1.25 equiv), N , N ’ -
dimethylethylenediamine (191 mL, 1.77 mmol, 10 mol %), and toluene (18 mL).  The
solution was stirred at 23 °C for 20 min.  2-(2-Bromo-phenyl)-4,5-dihydrooxazole 127
(4.0 g, 17.7 mmol, 1.00 equiv) was azeotroped with toluene (2 x 5 mL) under reduced
pressure, dissolved in toluene (18 mL), and transferred quantitatively to the Schlenk flask
by use of positive pressure cannulation.  Cs2CO3 (8.65 g, 26.5 mmol, 1.50 equiv) was
added in one portion and the flask was evacuated/backfilled with Ar (three cycles).  The
teflon valve was sealed, and the yellow heterogeneous reaction mixture was stirred
vigorously, immersed in an oil bath, and heated to 110 °C.  After 20 h of stirring at 110
°C, the mixture was allowed to cool to ambient temperature and filtered through a pad of
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Celite using CH2Cl2 (2 x 50 mL).  The filtrate was concentrated under reduced pressure to
afford a clear orange oil.  The crude oil was flushed through a plug of silica gel (SiO2, 5 x
10 cm, hexanes%9:1 CH2Cl2:Et2O) to afford PHOX ligand 128 (5.03 g, 15.2 mmol, 86%
yield) as a colorless viscous oil that crystallized upon standing;  Rf = 0.50 (7:3
hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) $  7.85 (dd, J = 7.6, 3.4 Hz, 1H),
7.37–7.26 (comp. m, 12H), 6.89 (dd, J = 4.1, 7.6 Hz, 1H), 4.08 (t, J = 9.5 Hz, 2H), 3.78
(t, J = 9.5 Hz, 2H);  13C NMR (125 MHz, CDCl3) $ 164.5 (d, JCP = 2.8 Hz), 139.1 (d, JCP
= 24.9 Hz), 138.0 (d, JCP = 11.5 Hz), 134.1 (d, JCP = 20.7 Hz), 133.7 (d, JCP = 1.8 Hz),
131.9 (d, JCP = 18.9 Hz), 130.5, 129.9 (d, JCP = 2.8 Hz), 128.7, 128.5 (d, JCP = 7.4 Hz),
128.1, 67.2, 55.0;  31P NMR (121 MHz, CDCl3) $ –3.99 (s);  IR (Neat Film NaCl) 3053,
3000, 2971, 2901, 2876, 1650, 1585, 1562, 1478, 1434, 1354, 1326, 1248, 1133, 1089,
1070, 1041, 974, 942, 898, 743 cm–1;  HRMS (FAB+) m/z calc'd for C21H19NOP [M+H]
+:
332.1204; found 332.1218;  mp = 99–101 °C.
H2N
OH
1) Na2CO3
     CH2Cl2, H2O, 23 °C
2) MsCl, Et3N, CH2Cl2  
    0!40 °C
     82% yield, 2 steps
Br N
O
Br O
Cl
129
Dihydrooxazole 129.  (S)-tert-Leucinol (1.02 g, 8.66 mmol, 1.00 equiv) was placed in a
250 mL round-bottom flask and dissolved in CH2Cl2 (14 mL).  Na2CO3 (2.75 g, 26.0
mmol, 3.00 equiv) in H2O (27.0 mL) was added dropwise via syringe to the vigorously
stirred biphasic system.  To the biphasic mixture was added a solution of 1-
bromonaphthalene-2-carbonyl chloride (2.68 g, 9.96 mmol, 1.15 equiv) in CH2Cl2 (15
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mL).  The reaction was stirred vigorously at 23 °C for 9.5 h.  The phases were separated
and the aqueous phase was extracted with CH2Cl2 (4 x 50 mL).  The combined organics
were stirred with KOH (10 mL, 10 mmol, 1.0 N in MeOH) for 30 min and then
transferred to a separatory funnel.  H2O (10 mL) was added and the mixture was
neutralized with HCl (6.0 M in H2O).  The phases were separated and the aqueous phase
was extracted with CH2Cl2 (4 x 50 mL).  The combined organics were dried over MgSO4
and concentrated under reduced pressure to afford the intermediate amide (3.03 g) as a
pale yellow solid.
The intermediate amide (3.03 g) was dissolved in CH2Cl2 (43.3 mL) in a 100 mL
3-neck round-bottom flask fitted with a reflux condenser.  The solution was cooled to 0
°C by use of an ice/water bath and Et3N (2.90 mL, 20.8 mmol, 2.40 equiv) was added.
Methanesulfonyl chloride (0.77 mL, 9.96 mmol, 1.15 equiv) was added dropwise.  The
reaction mixture was stirred at 0 °C for 30 min and heated to 40 °C in a water bath.  After
21 h of stirring, the mixture was allowed to cool to ambient temperature and saturated
aqueous NaHCO3 was added.  The biphasic system was stirred vigorously for 5 min and
the layers were separated.  The aqueous phase was extracted with CH2Cl2 (2 x 50 mL).
The combined organics were washed with brine (50 mL), dried over MgSO4, and
concentrated under reduced pressure to afford a pale yellow oil.  The crude oil was
purified by flash chromatography (SiO2, 3 x 15 cm, 9:1 hexanes:EtOAc) to afford 129
(2.36 g, 7.12 mmol, 82% yield over two steps) as a pale yellow oil that solidifies when
placed in a –20 °C freezer;  Rf = 0.73 (9:1 CHCl3:MeOH);  
1H NMR (300 MHz, CDCl3) $
8.41 (dd, J = 7.7, 0.5 Hz, 1H), 7.85–7.81 (m, 2H), 7.64 (d, J = 8.5 Hz, 1H), 7.60 (app dt,
J = 8.2, 1.3 Hz, 1H), 7.56 (app dt, J = 6.9, 1.3 Hz, 1H), 4.46 (dd, J = 10.4, 8.5 Hz, 1H),
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4.33 (dd, J = 8.5, 8.0 Hz, 1H), 4.17 (dd, J = 10.4, 8.2 Hz, 1H), 1.05 (s, 9H);  13C NMR
(125 MHz, CDCl3) $ 163.8, 134.9, 132.3, 128.8, 128.3, 128.3, 128.0, 127.8, 127.7, 126.9,
123.2, 76.9, 69.2, 34.1, 26.1;  IR (Neat Film NaCl) 3065, 2956, 2899, 2863, 1667, 1620,
1594, 1556, 1499, 1476, 1463, 1393, 1372, 1362, 1339, 1321, 1300, 1238, 1264, 1210,
1161, 1104, 1024, 977, 956, 920, 817, 752 cm–1;  HRMS (EI+) m/z calc'd for C17H18ONBr
[M]+•: 331.0572; found 331.0583;  [!]D
20.0 –64.0 (c 0.92, CHCl3);  mp = 66–68 °C.
Br Ph2P
129 67
N
O
N
O
CuI (2 mol %), Ph2PH
N,N'-dimethylethylenediamine (10 mol %)
Cs2CO3, toluene, 110 °C
86% yield
PHOX Ligand 67.  Prepared by the typical method as described for 128 above by
employing 129 (830.6 mg, 2.50 mmol).  After 24 h of stirring, the reaction mixture was
filtered through a plug of Celite, eluted with CH2Cl2 (2 x 25 mL), and concentrated under
reduced pressure.  The crude oil was passed through a short plug of silica (SiO2, 2.5 x 8
cm, hexanes%9:1 CH2Cl2:Et2O) to afford a bright yellow oil.  The crude oil was purified
by flash chromatography (SiO2, 2.5 x 25 cm, 19:1 hexanes:acetone and then 2.5 x 21 cm,
9:1%6:1 hexanes:EtOAc) to afford PHOX ligand 67 (950.8 mg, 2.17 mmol, 87% yield)
as a bright yellow foam;  Rf = 0.21 (9:1 hexanes:EtOAc);  
1H NMR (500 MHz, CDCl3) $
7.97 (d, J = 8.1 Hz, 1H), 7.96 (d, J = 8.0 Hz, 2H), 7.72 (dd, J = 8.3, 2.9 Hz, 1H), 7.45
(app dt, J = 7.8, 1.7 Hz, 2H), 7.41–7.38 (m, 3H), 7.29–7.22 (m, 6H), 7.16 (ddd, J = 8.3,
6.9, 1.0 Hz, 1H), 4.17–4.15 (m, 2H), 3.91 (dd, J = 9.8, 8.8 Hz, 1H), 0.97 (s, 9H);  13C
NMR (125 MHz, CDCl3) $ 165.6 (d, JCP = 5.1 Hz), 137.5 (d, JCP = 33.1 Hz), 136.8, (d, JCP
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= 14.7 Hz), 136.5 (d, JCP = 14.7), 134.9, 134.7 (d, JCP = 33.6 Hz), 133.1 (d, JCP = 26.7 Hz),
132.2 (d, JCP = 17.5 Hz), 132.1 (d, JCP = 17.5 Hz), 131.5 (d, JCP = 0.9 Hz), 129.1 (d, JCP =
7.4 Hz), 129.0, 128.4 (d, JCP = 6.0 Hz), 127.8 (d, JCP = 8.3 Hz), 126.6 (d, JCP = 8.7 Hz),
126.4 (d, JCP = 40.5 Hz), 76.8, 69.0, 34.1, 26.3;  
31P NMR (121 MHz, CDCl3) $ –9.33 (s);
IR (Neat Film NaCl) 3054, 2954, 2867, 1665, 1584, 1478, 1434, 1364, 1244, 1094, 1026,
986, 962, 922, 824 cm–1;  HRMS (FAB+) m/z calc'd for C29H28NOP [M]
+•: 437.1908;
found 437.1908;  [!]D
26.1 –38.2 (c 1.59, n-hexane).
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2.7.2.4 ENANTIOSELECTIVE Pd-CATALYZED DECARBOXYLATIVE
ALKYLATION SCREENING PROTOCOLa
entry solvent yield (%)b ee (%)c
1 94 84THFe
4 88 85
5 93 86
6 84 86
7 91 88
TBMEe
Et2O
benzene
toluene
2 86 84p-dioxane
3 75 852-methyl THFe
8d 57 90toluene
9 77 72toluene
ligand
13
13
13
13
13
13
13
14
150
a Conditions: !-ketoester 24a (1.0 equiv), Pd2(pmdba)3 (2.5 mol %), ligand
(6.25 mol %) in solvent (0.1 M) at 30 °C; pmdba = 4,4!-
methoxydibenzylideneacetone. b Isolated yield. c Determined by chiral
HPLC.  d Increased catalyst loadings were required to achieve full conversion: 
Pd2(pmdba)3 (5 mol %), 8 (12.5 mol %).
e THF = tetrahydrofuran, 2-methyl
THF = 2-methyl tetrahydrofuran, TBME = tert-butyl methyl ether.
O
i-BuO
27a
ligand (6.25 mol %)
Pd2(pmdba)3  (2.5 mol %)
solvent, 30 °C
O
i-BuO
24a
O
O
Ph2P N
O
P N
O
CF3
F3C
Ph2P N
O
(S)-t-BuPHOX (3)
CF3
(S)-(CF3)3-t-BuPHOX
(8)
67
Enantioselective Allylation Screen to Produce Vinylogous Ester 27a (0.20 mmol
scale).  To a 25 mL flask was added Pd2(pmdba)3 (5.00 µmol, 2.5 mol %) and ligand
(12.5 µmol, 6.25 mol %).  The flask was evacuated/backfilled with N2 (3 cycles, 5 min
evacuation per cycle).  Solvent (most of total volume, 0.1 M final concentration) was
added and the black suspension was stirred for 30 min at 30 °C using an oil bath.  A
solution of #-ketoester 24a (0.20 mmol, 1.00 equiv) in solvent (remainder of total
volume) was transferred to the catalyst solution using positive pressure cannulation.
When judged complete by TLC analysis, the reaction was filtered through a small plug of
SiO2, eluted with Et2O, and concentrated under reduced pressure.  Purification by flash
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column chromatography (SiO2, 1.5 x 15 cm, 9:1%6:1 hexanes:EtOAc) or preparative
TLC (SiO2, 2:1 hexanes:EtOAc) provided vinylogous ester 27a for analysis.  HPLC
conditions: 1% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): major = 6.30,
minor = 7.26.  (For characterization data, see p. 287)
2.7.2.5 PREPARATION OF CHIRAL VINYLOGOUS ESTERS 27
Non-enantioselective reactions were performed using Pd(PPh3)4 (5 mol %) or
achiral PHOX ligand 128 (6.25 mol %) and Pd2(pmdba)3
 (2.5 mol %) in toluene at 30 °C.
For the synthesis of ligand 128, see p. 277–283.
O
i-BuO
27a
Pd2(pmdba)3
 (2.5 mol %)
(S)-t-BuPHOX (3) (6.25 mol %)
toluene, 30 °C
91% yield, 88% ee
O
i-BuO
24a
O
O
Schlenk Manifold Method: Asymmetric Allylic Alkylation
Vinylogous Ester 27a.  Pd2(pmdba)3
 (5.0 mg, 4.5 µmol, 2.5 mol %) and (S)-t-BuPHOX
(4.4 mg, 11 µ mol, 6.25 mol %) were placed in a 1 dram vial.  The flask was
evacuated/backfilled with N2 (3 cycles, 10 min evacuation per cycle).  Toluene (1.3 mL,
sparged with N2 for 1 h immediately before use) was added and the black suspension was
immersed in an oil bath preheated to 30 °C.  After 30 min of stirring, #-ketoester 24a
(50.7 mg, 0.181 mmol, 1.00 equiv) was added as a solution in toluene (0.5 mL, sparged
with N2 immediately before use) using positive pressure cannulation.  The dark orange
catalyst solution turned olive green immediately upon addition of #-ketoester 24a.  The
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 286
reaction was stirred at 30 °C for 21 h, allowed to cool to ambient temperature, filtered
through a silica gel plug (2 x 2 cm, Et2O), and concentrated under reduced pressure.  The
crude oil was purified by preparative TLC (SiO2, 4:1 hexanes:EtOAc) to afford
vinylogous ester 27a (38.8 mg, 0.164 mmol, 91% yield, 88% ee) as a pale yellow oil.
(For characterization data, see p. 287).
Pd2(pmdba)3
 (2.5 mol %)
(S)-t-BuPHOX (3) (6.25 mol %)
toluene, 30 °C
98% yield, 83% ee
O
i-BuO
N Ts
27j
O
i-BuO
24j
O
O
N
Ts
Glove Box Method: Asymmetric Allylic Alkylation
Vinylogous Ester 27j.  A 20 mL scintillation vial was loaded with #-ketoester 24j (447
mg, 0.81 mmol, 1.00 equiv).  A separate 20 mL scintillation vial was loaded with
Pd2(pmdba)3 (19.7 mg, 0.051 mmol, 6.25 mol %), (S)-t-BuPHOX (22.3 mg, 0.020 mmol,
2.5 mol %), and magnetic stir bar.  The two vials and a teflon-lined hard cap were
evacuated/backfilled with N2 in a glove box antechamber (3 cycles, 5 min evacuation per
cycle) before being trasnsferred into the glove box.  Toluene (5 mL) was added to the vial
containing Pd2(pmdba)3 and (S)-t-BuPHOX.  The vial was capped and heated to 30 °C for
30 min.  During this time, the mixture developed a dark orange color.  #-Ketoester 24j
was dissolved in toluene (3 mL) and added to the catalyst solution dropwise, causing the
solution to turn olive green.  The solution was stirred at 30 °C in a heating block.  The
capped vial was removed from the glove box after 29 h of stirring.  The crude product
was concentrated under reduced pressure and purified by flash column chromatography
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(SiO2, 5 x 25 cm, 15:1%10:1%8:1%6:1 hexanes:EtOAc) to afford vinylogous ester 27j
(403 mg, 0.796 mmol, 98% yield, 82.9% ee) as a thick, white semi-solid.  (For
characterization data, see p. 294).
O
i-BuO
27a
Vinylogous Ester 27a  (Table 2.1, entry 1). 3Prepared using Schlenk Manifold Method.
38.8 mg, 0.164 mmol, 91% yield.  Preparative TLC (SiO2, 4:1 hexanes:EtOAc).  Rf  =
0.31 (3:1 hexanes:Et2O);  
1H NMR (500 MHz, CDCl3) $ 5.72 (dddd, J = 16.6, 10.5, 7.3,
7.3 Hz, 1H), 5.31 (s, 1H), 5.05–5.00 (m, 2H), 3.50 (dd, J = 9.3, 6.6 Hz, 1H), 3.47 (dd, J =
9.3, 6.6 Hz, 1H), 2.53–2.42 (m, 2H), 2.38 (dd, J = 13.7, 7.1 Hz, 1H), 2.20 (dd, J = 13.7,
7.8 Hz, 1H), 1.98 (app sept, J = 6.6 Hz, 1H), 1.86–1.70 (m, 3H), 1.62–1.56 (m, 1H), 1.14
(s, 3H), 0.95 (d, J = 6.6 Hz, 6H);  13C NMR (125 MHz, CDCl3) $ 206.7, 171.3, 134.6,
117.9, 105.0, 74.5, 51.5, 45.4, 36.1, 35.2, 28.0, 25.2, 19.9, 19.3, 19.3;  IR (Neat Film
NaCl) 2960, 2933, 2873, 1614, 1470, 1387, 1192, 1171, 998, 912 cm–1;  HRMS (EI+) m/z
calc'd for C15H24O2 [M]
+•: 236.1776; found 236.1767;  [!]D
25.6 –69.04 (c 1.08, CHCl3,
88.0% ee);  HPLC conditions: 1% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min):
major = 6.30, minor = 7.26.
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O
i-BuO
27b
Vinylogous Ester 27b  (Table 2.1, entry 2).  Prepared using Schlenk Manifold Method.
226.3 mg, 0.90 mmol, 89% yield.  Flash column chromatography (SiO2, 3 x 24 cm,
20:1%15:1%10:1 hexanes:EtOAc).  Rf = 0.43 (10:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $ 5.82–5.62 (m, 1H), 5.29 (s, 1H), 5.06–4.98 (m, 2H), 3.48 (dd, J = 11.1,
6.6 Hz, 1H), 3.45 (dd, J = 11.2, 6.6 Hz, 1H), 2.49–2.42 (m, 2H), 2.40 (dddd, J = 13.8,
7.1, 1.2 Hz, 1H), 2.23 (dddd, J = 13.8, 7.7, 1.1, 1.1 Hz, 1H), 1.97 (app sept, J = 6.7 Hz,
1H), 1.84–1.44 (m, 6H), 0.98–0.91 (d, J = 6.7 Hz, 6H), 0.79 (t, J = 7.5 Hz, 3H);  13C
NMR (75 MHz, CDCl3) $ 206.2, 171.0, 135.1, 117.6, 105.5, 74.4, 54.8, 41.9, 36.1, 32.3,
31.3, 28.0, 20.0, 19.3, 8.6;  IR (Neat Film NaCl) 3073, 2960, 2933, 2876, 1617, 1613,
1459, 1400, 1387, 1369, 1314, 1220, 1190, 1173, 996, 969, 954, 912, 883, 873, 856, 782
cm–1;  HRMS (EI+) m/z calc'd for C16H26O2 [M]
+•: 250.1933; found 250.1909;  [!]D
25.0
+25.83 (c 1.04, CHCl3, 91.6% ee);  HPLC conditions: 0.25% IPA in hexanes, 1.0
mL/min, AD column, tR (min): minor = 16.23, major = 18.08.
O
i-BuO
27c
Ph
Vinylogous Ester 27c  (Table 2.1, entry 3).  Prepared using Schlenk Manifold Method.
172.5 mg, 0.552 mmol, 98% yield.  Flash column chromatography (SiO2, 3 x 24 cm,
20:1%15:1%10:1 hexanes:EtOAc).  Rf = 0.50 (10:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $ 7.28–7.14 (m, 3H), 7.14–7.08 (m, 2H), 5.85–5.68 (m, 1H), 5.31 (s, 1H),
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5.10–4.99 (m, 2H), 3.44 (dd, J = 14.7, 6.6 Hz, 1H), 3.41 (dd, J = 14.7, 6.6 Hz, 1H), 3.14
(d, J = 13.3 Hz, 1H), 2.71 (d, J = 13.3 Hz, 1H), 2.51 (dddd, J = 13.7, 6.8, 1.2, 1.2 Hz,
1H), 2.45–2.32 (m, 2H), 2.16 (dddd, J = 13.7, 7.9, 1.1, 1.1 Hz, 1H), 1.93 (app sept, J =
6.7 Hz, 1H), 1.83–1.56 (m, 4H), 0.92 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $
205.5, 171.4, 138.3, 134.5, 130.8, 128.0, 126.3, 118.2, 106.3, 74.5, 56.2, 44.1, 43.9, 36.3,
31.3, 27.9, 19.5, 19.3;  IR (Neat Film NaCl) 3072, 3061, 3027, 3002, 2957, 2931, 2871,
1610, 1495, 1471, 1454, 1422, 1403, 1387, 1368, 1318, 1280, 1217, 1189, 1173, 1081,
1031, 1007, 969, 957, 913, 875, 856, 831, 760, 746, 733 cm–1;  HRMS (EI+) m/z calc'd
for C21H28O2 [M]
+•: 312.2089; found 312.2083;  [!]D
25.0 +2.91 (c 0.98, CHCl3, 86.3% ee);
HPLC conditions: 0.5% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): minor =
13.96, major = 15.70.
O
i-BuO
27d
Vinylogous Ester 27d  (Table 2.1, entry 4).  Prepared using Schlenk Manifold Method.
224.7 mg, 0.86 mmol, 88% yield.  Flash column chromatography (SiO2, 3 x 25 cm,
20:1%15:1 hexanes:EtOAc).  Rf = 0.44 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 5.74–5.59 (m, 1H), 5.32 (s, 1H), 5.12–5.02 (m, 2H), 3.50 (dd, J = 14.9, 6.5 Hz,
1H), 3.47 (dd, J = 14.7, 6.6 Hz, 1H), 2.53–2.48 (m, 4H), 2.46 (dddd, J = 13.7, 7.3, 1.2,
1.2 Hz, 1H), 2.35 (dddd, J = 13.7, 7.6, 1.1, 1.1 Hz, 1H), 2.09–1.67 (m, 5H), 1.57 (s, 1H),
0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 204.0, 171.7, 133.7, 118.5, 105.0,
81.7, 74.6, 70.8, 54.2, 42.9, 36.1, 32.5, 28.0, 27.1, 20.0, 19.3;  IR (Neat Film NaCl) 3301,
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3075, 2957, 2930, 2873, 2116, 1612, 1471, 1457, 1435, 1423, 1402, 1387, 1368, 1320,
1221, 1191, 1175, 995,  969, 916, 874, 845 cm–1;  HRMS (EI+) m/z calc'd for C17H24O2
[M]+•: 260.1776; found 260.1737;  [!]D
25.0 –26.51 (c 1.03, CHCl3, 88.5% ee);  HPLC
conditions: 0.5% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): major = 12.35,
minor = 13.43.
O
i-BuO
27e
Vinylogous Ester 27e  (Table 2.1, entry 5). 4Prepared using Glove Box Method.  287.5
mg, 1.04 mmol, 95% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 20:1
hexanes:EtOAc).  Rf = 0.44 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $
5.84–5.64 (m, 2H), 5.30 (s, 1H), 5.09–4.87 (m, 4H), 3.49 (dd, J = 11.2, 6.6 Hz, 1H), 3.46
(dd, J = 11.1, 6.6 Hz, 1H), 2.54–2.37 (m, 3H), 2.27 (dddd, J = 13.8, 7.7, 1.2, 1.2 Hz, 1H),
2.07–1.89 (m, 3H), 1.86–1.45 (m, 6H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz,
CDCl3) $ 205.8, 171.1, 138.9, 134.8, 117.9, 114.5, 105.5, 74.8, 54.4, 42.3, 38.0, 36.1,
32.7, 28.6, 28.0, 19.9, 19.3;  IR (Neat Film NaCl) 3076, 2958, 2932, 2874, 1639, 1614,
1471, 1455, 1434, 1424, 1402, 1387, 1368, 1317, 1280, 1216, 1190, 1174, 1086, 996,
969, 955, 910, 878, 853, 829, 771 cm–1;  HRMS (EI+) m/z calc'd for C18H28O2 [M]
+•:
276.2089; found 276.2060;  [!]D
25.0 +15.28 (c 0.97, CHCl3, 86.9% ee);  HPLC conditions:
0.8% IPA in hexanes, 2.0 mL/min, AD column, tR (min): major = 5.03, minor = 6.06.
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O
i-BuO
27f
Vinylogous Ester 27f  (Table 2.1, entry 6).  Prepared using Schlenk Manifold Method.
232.9 mg, 0.81 mmol, 90% yield.  Flash column chromatography (SiO2, 3 x 25 cm,
20:1%15:1 hexanes:EtOAc).  Rf = 0.45 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 6.30 (dt, J = 16.9, 10.3 Hz, 1H), 6.04 (dd, J = 15.1, 10.4 Hz, 1H), 5.82–5.53 (m,
2H), 5.31 (s, 1H), 5.15–4.92 (m, 4H), 3.48 (d, J = 6.5 Hz, 2H), 2.55–2.36 (m, 4H),
2.30–2.16 (m, 2H), 1.98 (app sept, J = 6.7 Hz, 1H), 1.84–1.67 (m, 4H), 0.95 (d, J = 6.7
Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 205.3, 171.4, 137.2, 134.5, 134.1, 130.8, 118.0,
115.5, 105.5, 74.5, 55.1, 43.1, 41.6, 36.1, 32.5, 28.0, 19.9, 19.3;  IR (Neat Film NaCl)
3075, 3036, 3007, 2958, 2931, 2873, 1726, 1635, 1611, 1471, 1456, 1436, 1402, 1387,
1368, 1312, 1277, 1219, 1190, 1173, 1085, 1005, 954, 911, 874, 831 cm–1;  HRMS
(FAB+) m/z calc'd for C19H29O2 [M+H]
+: 289.2168; found 289.2172;  [!]D
25.0 –20.62 (c
1.05, CHCl3, 89.6% ee);  SFC conditions: 5.0% IPA in hexanes, 2.5 mL/min, AD-H
column, tR (min): minor = 6.31, major = 6.99.
O
i-BuO
27g
Cl
Vinylogous Ester 27g  (Table 2.1, entry 7).  Prepared using Schlenk Manifold Method.
259.5 mg, 0.87 mmol, 99% yield.  Flash column chromatography (SiO2, 3 x 25 cm,
20:1%15:1 hexanes:EtOAc).  Rf = 0.36 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz,
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CDCl3) $ 5.78–5.62 (m, 1H), 5.36 (s, 1H), 5.25 (s, 1H), 5.14 (s, 1H), 5.11–5.01 (m, 2H),
3.54–3.43 (m, 2H), 2.95 (dd, J = 14.4, 0.7 Hz, 1H), 2.54–2.41 (m, 4H), 2.25 (dddd, J =
13.9, 7.9, 1.1, 1.1 Hz, 1H), 2.07–1.89 (m, 2H), 1.88–1.70 (m, 3H), 0.95 (d, J = 6.7 Hz,
6H);  13C NMR (75 MHz, CDCl3) $ 204.3, 171.6, 139.4, 133.9, 118.7, 116.6, 105.9, 74.6,
54.7, 46.7, 43.7, 36.3, 31.5, 28.0, 19.6, 19.3;  IR (Neat Film NaCl) 3075, 2958, 2934,
2874, 1612, 1471, 1458, 1424, 1403, 1388, 1368, 1339, 1321, 1297, 1222, 1192, 1175,
1082, 1010, 995, 968, 956, 916, 875, 847, 746 cm–1;  HRMS (FAB+) m/z calc'd for
C17H26O2Cl [M+H]
+: 297.1621; found 297.1623;  [!]D
25.0 +4.20 (c 1.02, CHCl3, 85.7%
ee);  HPLC conditions: 0.1% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): minor
= 24.19, major = 27.22.
O
i-BuO
27h
CN
Vinylogous Ester 27h  (Table 2.1, entry 8).  Prepared using Schlenk Manifold Method.
292.8 mg, 1.06 mmol, 96% yield.  Flash column chromatography (SiO2, 3 x 25 cm,
20:1%10:1%8:1%6:1 hexanes:EtOAc).  Rf = 0.39 broad (4:1 hexanes:EtOAc);  
1H NMR
(300 MHz, CDCl3) $ 5.75–5.58 (m, 1H), 5.31 (s, 1H), 5.15–5.04 (m, 2H), 3.48 (d, J = 6.5
Hz, 2H), 2.51 (t, J = 6.1 Hz, 2H), 2.40 (dddd, J = 14.0, 7.0, 1.2, 1.2 Hz, 1H), 2.35–2.22
(m, 3H), 2.11–1.93 (m, 2H), 1.93–1.62 (m, 5H), 0.96 (d, J = 6.7 Hz, 6H);  13C NMR (75
MHz, CDCl3) $ 203.9, 172.1, 133.1, 120.3, 119.2, 104.9, 74.7, 53.6, 41.8, 36.1, 33.9,
32.8, 28.0, 19.8, 19.3, 12.8;  IR (Neat Film NaCl) 3076, 2958, 2933, 2874, 2246, 1635,
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1609, 1472, 1458, 1420, 1404, 1388, 1368, 1319, 1281, 1214, 1192, 1175, 1084, 1003,
917, 880, 854, 827, 766 cm–1;  HRMS (EI+) m/z calc'd for C17H25O2N [M]
+•: 275.1885;
found 275.1893;  [!]D
25.0 –20.97 (c 1.06, CHCl3, 87.4% ee);  HPLC conditions: 5.0% IPA
in hexanes, 1.0 mL/min, OD-H column, tR (min): major = 10.67, minor = 14.66.
O
i-BuO
27i
N
Vinylogous Ester 27i  (Table 2.1, entry 9).  Prepared using Glove Box Method.  339.6
mg, 1.08 mmol, 97% yield.  Flash column chromatography (SiO2, 3 x 20 cm, 1:1%1:4
hexanes:EtOAc%EtOAc).  Rf = 0.28, broad (1:2 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 8.45 (dd, J = 4.5, 1.5 Hz, 2H), 7.05 (dd, J = 4.5, 1.6 Hz, 2H), 5.84–5.66 (m,
1H), 5.31 (s, 1H), 5.15–5.02 (m, 2H), 3.44 (dd, J = 15.1, 6.3 Hz, 1H), 3.41 (dd, J = 15.0,
6.3 Hz, 1H), 3.20 (d, J = 12.9 Hz, 1H), 2.60 (d, J = 12.9 Hz, 1H), 2.48 (dddd, J = 13.8,
6.9, 1.2, 1.2 Hz, 1H), 2.43–2.29 (m, 2H), 2.23 (dddd, J = 13.8, 7.8, 1.1, 1.1 Hz, 1H), 1.94
(app sept, J = 6.7 Hz, 1H), 1.84–1.67 (m, 2H), 1.67–1.51 (m, 2H), 0.92 (d, J = 6.7 Hz,
6H);  13C NMR (75 MHz, CDCl3) $ 204.4, 171.8, 149.5, 147.6, 133.7, 126.2, 118.9,
106.0, 74.6, 55.8, 43.8, 43.5, 36.2, 31.5, 27.9, 19.4, 19.3;  IR (Neat Film NaCl) 3072,
3024, 2957, 2931, 2873, 1608, 1558, 1496, 1471, 1458, 1438, 1415, 1388, 1368, 1320,
1220, 1190, 1173, 1072, 994, 957, 916, 876, 844, 796 cm–1;  HRMS (EI+) m/z calc'd for
C20H27O2N [M]
+•: 313.2042; found 313.2045;  [!]D
25.0 +22.44 (c 1.16, CHCl3, 84.6% ee);
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HPLC conditions: 5.0% EtOH in hexanes, 1.0 mL/min, AD column, tR (min): major =
13.22, minor = 15.13.
O
i-BuO
27j
N Ts
Vinylogous Ester 27j  (Table 2.1, entry 10). 5Prepared using Glove Box Method.  403
mg, 0.796 mmol, 98% yield.  Flash column chromatography (SiO2, 5 x 25 cm,
15:1%10:1%8:1%6:1 hexanes:EtOAc).  Rf = 0.49 (4:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $ 7.96 (dm, J = 8.4 Hz, 1H), 7.70 (dm, J = 8.4 Hz, 2H), 7.48 (dm, J = 7.9
Hz, 1H), 7.31–7.13 (m, 5H), 5.86–5.68 (m, 1H), 5.32 (s, 1H), 5.13–5.00 (m, 2H), 3.42
(dd, J = 17.0, 7.7 Hz, 1H), 3.38 (dd, J = 17.0, 7.6 Hz, 1H), 3.20 (dd, J = 14.2, 0.7 Hz,
1H), 2.73 (d, J = 14.1 Hz, 1H), 2.51 (dddd, J = 13.7, 6.9, 1.3, 1.3 Hz, 1H), 2.44–2.15 (m,
6H), 1.92 (app sept, J = 6.7 Hz, 1H), 1.76–1.46 (m, 4H), 0.92 (d, J = 6.7 Hz, 6H);  13C
NMR (75 MHz, CDCl3) $ 205.2, 171.7, 144.8, 135.4, 135.0, 134.1, 132.4, 129.8, 126.9,
125.4, 124.5, 123.2, 120.1, 119.6, 118.6, 113.8, 106.4, 74.6, 55.9, 44.1, 36.3, 33.0, 31.9,
27.9, 21.7, 19.5, 19.3;  IR (Neat Film NaCl) 3584, 3401, 2068, 2958, 2930, 2873, 1609,
1494, 1470, 1448, 1422, 1402, 1368, 1306, 1279, 1215, 1188, 1174, 1120, 1097, 1020,
975, 916, 876, 813, 782, 747 cm–1;  HRMS (FAB+) m/z calc'd for C30H36O4NS [M+H]
+:
506.2365; found 506.2358;  [!]D
25.0 +9.10 (c 1.00, CHCl3, 82.9% ee);  HPLC conditions:
5.0% EtOH in hexanes, 1.0 mL/min, AD column, tR
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O
i-BuO
27k
OH
Vinylogous Ester 27k  (Table 2.1, entry 11).  Prepared using Glove Box Method.  77.3
mg, 0.278 mmol, 90% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 6:1%4:1
hexanes:EtOAc).  Rf = 0.35, broad (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $
9.73 (t, J = 1.5 Hz, 1H), 5.78–5.61 (m, 1H), 5.29 (s, 1H), 5.11–5.02 (m, 2H), 3.47 (m,
2H), 2.54–2.33 (m, 5H), 2.28 (dddd, J = 14.0, 7.6, 1.2, 1.2 Hz, 1H), 2.07–1.73 (m, 5H),
1.73–1.56 (m, 2H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 205.0, 202.3,
171.7, 134.0, 118.5, 105.2, 74.6, 53.6, 42.1, 39.4, 36.1, 33.1, 30.3, 28.0, 19.9, 19.3;  IR
(Neat Film NaCl) 3075, 2958, 2931, 2719, 1724, 1611, 1471, 1458, 1421, 1403, 1388,
1368, 1213, 1191, 1175, 998, 915, 878 cm–1;  HRMS (FAB+) m/z calc'd for C17H27O3
[M+H]+: 279.1960; found 279.1969;  [! ]D
25.0 +15.37 (c 1.03, CHCl3, 79.5% ee);
Compound 27k was derivatized using procedure below to determine ee using the
corresponding chiral HPLC assay for vinylogous ester 27e.
MePPh3Br, KOt-Bu 
THF, 0 °C
81% yield
O
i-BuO
H O
O
i-BuO
27k 27e
Vinylogous Ester 27e.  To a solution of MePh3PBr (323.2 mg, 0.905 mmol, 0.84 equiv)
in THF (14.0 mL) in a 50 mL round-bottom flask at 0 °C was added KOt-Bu (84.6 mg,
0.754 mmol, 0.699 equiv) to give a bright yellow suspension.  Aldehyde 27k (299.9 mg,
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1.078 mmol, 1.00 equiv) in THF (2 mL) was added to the suspension using positive
pressure cannulation and maintained at 0 °C.  The reaction faded to an off-white
suspension.  After 1.5 h of stirring, an additional portion of Wittig reagent was prepared
in a 20 mL scintillation vial.  MePPh3Br (323.2 mg, 0.905 mmol, 0.84 equiv) was added
to the vial.  The vial was sealed with a septum, evacuated/backfilled with N2 (3 cycles, 5
min evacuation per cycle).  Anhydrous THF (3 mL) was added and the vial was cooled to
0 °C.  KOt-Bu (84.6 mg, 0.754 mmol, 0.699 equiv) was added in one portion, giving a
bright yellow suspension that was added to the reaction flask using positive pressure
cannulation.  The tan suspension was stirred at 0 °C for 1 h.  An additional portion of
Wittig reagent using MePPh3Br (323.2 mg, 0.905 mmol, 0.84 equiv), KOt-Bu (84.6 mg,
0.754 mmol, 0.699 equiv) and THF (3 mL) was prepared at 0 °C and added using
positive pressure cannulation as previously described.  The reaction showed a persistent
yellow color.  After 30 min of stirring at 0 °C, the reaction was quenched by addition of
sat. aqueous NH4Cl (5 mL) and stirred for 30 min while the mixture was allowed to warm
to ambient temperature.  The mixture was extracted with Et2O (3 x 20 mL), dried over
Na2SO4, filtered, and concentrated under reduced pressure.  The residue was purified by
flash column chromatography (SiO2, 3 x 25 cm, 1%%2%%3%%5% EtOAc in hexanes)
to afford vinylogous ester 27e (243.7 mg, 0.882 mmol, 81% yield) as a yellow liquid;
HPLC conditions: 0.8% IPA in hexanes, 2.0 mL/min, AD column, tR (min): major = 4.39,
minor = 3.17.  (For characterization data, see p. 290).
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O
i-BuO
F
27l
Vinylogous Ester 27l  (Table 2.1, entry 12).  Prepared using Schlenk Manifold Method.
172.5 mg, 0.552 mmol, 98% yield.  Flash column chromatography (SiO2, 3 x 24 cm,
20:1%15:1%10:1 hexanes:EtOAc).  Rf = 0.59 (4:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $ 5.89–5.72 (m, 1H), 5.28 (s, 1H), 5.18–5.08 (m, 2H), 3.53 (dd, J = 10.6,
6.5 Hz, 1H), 3.50 (dd, J = 10.6, 6.6 Hz, 1H), 2.80–2.46 (m, 3H), 2.46–2.33 (m, 1H),
2.22–1.67 (m, 5H), 0.97 (d, J = 6.7 Hz, 3H), 0.96 (d, J = 6.7 Hz, 3H);  13C NMR (75
MHz, CDCl3) $ 198.2 (d, JCF = 24.9 Hz), 176.9 (d, JCF = 1.8 Hz), 131.9 (d, JCF = 4.4 Hz),
119.3, 101.7, 101.2 (d, JCF = 180.6 Hz), 75.0, 42.1 (d, JCF = 23.2 Hz), 34.4 (d, JCF = 23.2
Hz), 34.1 (d, JCF = 2.4 Hz), 27.9, 21.7 (d, JCF = 2.1 Hz), 19.3, 19.2;  
19F NMR (282 MHz,
CDCl3) $ –145.81 (m);  IR (Neat Film NaCl) 3086, 2960, 1752, 1654, 1649, 1603, 1471,
1453, 1422, 1403, 1385, 1369, 1282, 1249, 1229, 1204, 1176, 1137, 1095, 1066, 145,
991, 927, 873, 843, 795, 758 cm–1;  HRMS (EI+) m/z calc'd for C14H21O2F [M]
+•:
240.1526; found 240.1524;  [!]D
25.0 +0.61 (c 1.02, CHCl3, 91.2% ee);  HPLC conditions:
1.0% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): minor = 8.05, major = 8.80.
O
i-BuO
27m
OTBDPS
Vinylogous Ester 27m  (Table 2.1, entry 13).  Prepared using Glove Box Method.  242.0
mg, 0.493 mmol, 66% yield.  Flash column chromatography (SiO2, 3 x 25 cm,
2%%5%%10% EtOAc in hexanes).  Rf = 0.44 (10:1 hexanes:EtOAc);  
1H NMR (300
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 298
MHz, CDCl3) $ 7.67–7.61 (m, 4H), 7.46–7.33 (m, 6H), 5.78–5.60 (m, 1H), 5.32 (s, 1H),
5.08–4.96 (m, 2H), 3.78 (d, J = 9.7 Hz, 1H), 3.67 (d, J = 9.7 Hz, 1H), 3.46 (dd, J = 14.7,
6.5 Hz, 1H), 3.43 (dd, J = 14.6, 6.5 Hz, 1H), 2.49 (dddd, J = 13.7, 6.6, 1.3, 1.3 Hz, 1H),
2.48–2.41 (m, 2H), 2.33 (dddd, J = 13.8, 7.8, 1.2, 1.2 Hz, 1H), 2.09–1.88 (m, 2H),
1.82–1.65 (m, 3H), 1.04 (s, 9H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $
204.5, 171.5, 135.9, 135.8, 134.7, 133.7, 133.5, 129.7, 127.8, 127.7, 117.8, 106.1, 74.5,
69.0, 57.4, 41.0, 36.3, 30.3, 28.0, 27.0, 20.0, 19.5, 19.3;  IR (Neat Film NaCl) 3071,
3050, 2957, 2930, 2857, 1731, 1614, 1472, 1428, 1402, 1388, 1368, 1315, 1261, 1222,
1190, 1174, 1112, 1007, 998, 969, 955, 938, 914, 880, 824, 810, 740 cm–1;  HRMS
(FAB+) m/z calc'd for C31H43O3Si [M+H]
+: 491.2982; found 491.2993;  [!]D
25.0 –6.72 (c
1.09, CHCl3, 57.8% ee);  HPLC conditions: 0.2% IPA in hexanes, 1.0 mL/min, OD-H
column, tR (min): major = 21.74, minor = 25.53.
O
i-BuO
O
27n
Ph
O
Vinylogous Ester 27n  (Table 2.1, entry 14).  Prepared using Schlenk Manifold Method.
589.8 mg, 1.72 mmol, 75% yield.  Flash column chromatography (SiO2, 5 x 13 cm,
20:1%15:1%10:1%6:1 hexanes:EtOAc).  Rf = 0.57 (4:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $ 8.03–7.96 (m, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 (t, J = 7.5 Hz, 2H),
5.96–5.78 (m, 1H), 5.27 (s, 1H), 5.19–5.08 (m, 2H), 3.42 (dd, J = 9.4, 6.6 Hz, 1H), 3.39
(dd, J = 9.4, 6.5 Hz, 1H), 3.06 (dddd, J = 14.8, 6.7, 1.4, 1.4 Hz, 1H), 2.83–2.67 (m, 2H),
2.55–2.34 (m, 2H), 2.10–1.74 (m, 4H), 0.80 (dd, J = 6.6, 4.7 Hz, 6H);  13C NMR (75
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MHz, CDCl3) $ 198.1, 174.3, 165.5, 133.1, 132.5, 130.6, 129.7, 128.5, 119.2, 102.1,
88.6, 74.9, 40.8, 34.0, 27.7, 21.9, 19.1, 19.0;  IR (Neat Film NaCl) 3073, 2959, 2934,
2873, 1718, 1672, 1649, 1613, 1479, 1451, 1421, 1382, 1368, 1315, 1291, 1258, 1231,
1199, 1174, 1108, 1070, 1026, 1004, 919, 866, 820, 801, 762, 715 cm–1;  HRMS (EI+)
m/z calc'd for C21H26O4 [M]
+•: 342.1815; found 342.1831;  [!]D
25.0 +79.72 (c 1.02, CHCl3,
57.1% ee);  HPLC conditions: 1.0% IPA in hexanes, 1.0 mL/min, OD-H column, tR
(min): major = 18.28, minor = 22.01.
O
i-BuO
H O
O
i-BuO
OTBDPS
1. NaBH4, MeOH
2. imidazole 
    TBDPSCl, DMF
85% yield, 2 steps27k 27o
Vinylogous Ester 27o.  A round-bottom flask with magnetic stir bar was charged with
aldehyde 27k (40.2 mg, 0.14 mmol, 1.00 equiv) and MeOH (3.0 mL).  The flask was
cooled to 0 °C and NaBH4 (5.5 mg, 0.14 mmol, 1.00 equiv) was added slowly
portionwise.  The mixture was stirred for 1 h at 0 °C.  Sat. aqueous NaHCO3 (3 mL) was
added, followed by CH2Cl2 (10 mL).  The mixture was stirred vigorously for 5 min.  The
phases were separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL).
Combined organic phases were dried over Na2SO4, filtered, and concentrated under
reduced pressure.  The crude alcohol was used directly in the next step without further
purification.  Rf = 0.29 (2:1 hexanes:EtOAc).
To a 2 dram vial with a solution of crude alcohol and imidazole (11.8 mg, 0.17
mmol, 1.20 equiv) in DMF (0.7 mL) at 0 °C was added TBDPSCl (39.6 µL, 0.14 mmol,
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1.00 equiv) dropwise.  After 2 h of stirring, the reaction was quenched by addition of H2O
(0.3 mL) and extracted with Et2O (5 x 5 mL).  The combined organics were dried over
MgSO4, filtered, and concentrated under reduced pressure.  The residue was purified by
automated flash column chromatography using a Teledyne Isco CombiFlash Rf (SiO2, 12
g loading cartridge, 80 g column, multi-step gradient, hold 2% [2 min]%ramp to 5% [10
min]%hold 5% [10 min]%ramp to 10% [32 min]%hold 10% Et2O in hexanes [5 min]) to
afford vinylogous ester 27o (63.3 mg, 0.12 mmol, 85% yield over 2 steps) as a pale,
white oil;  Rf = 0.42 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 7.69–7.62 (m,
4H), 7.46–7.33 (m, 6H), 5.82–5.62 (m, 1H), 5.29 (s, 1H), 5.08–4.96 (m, 2H), 3.61 (t, J =
6.1 Hz, 2H), 3.48 (dd, J = 13.7, 6.6 Hz, 1H), 3.45 (dd, J = 13.7, 6.6 Hz, 1H), 2.50–2.43
(m, 2H), 2.40 (dddd, J = 13.8, 7.0, 1.2 Hz, 1H), 2.25 (dddd, J = 13.9, 7.8, 1.1 Hz, 1H),
1.98 (app sept, J = 6.7 Hz, 1H), 1.86–1.38 (m, 8H), 1.04 (s, 9H), 0.95 (d, J = 6.7 Hz, 6H);
13C NMR (75 MHz, CDCl3) $ 206.0, 171.0, 135.7, 134.9, 134.1, 129.6, 127.7, 117.7,
105.2, 74.4, 64.4, 54.2, 42.1, 36.1, 34.8, 32.8, 28.0, 27.3, 27.0, 20.0, 19.3;  IR (Neat Film
NaCl) 3071, 3051, 3013, 2998, 2956, 2930, 2858, 1614, 1471, 1428, 1401, 1387, 1368,
1311, 1214, 1188, 1174, 1111, 1028, 1007, 998, 966, 913, 872, 823, 780, 740, 725 cm–1;
HRMS (FAB+) m/z calc'd for C33H47O3Si [M+H]
+: 519.3295; found 519.3275;  [!]D
25.0
+9.06 (c 0.95, CHCl3, 78.4% ee).
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Pd(CH3CN)2Cl2 (5 mol %)
 
CH3CN, benzene, 75 °C
92% yield
O
i-BuO
O
i-BuO
27a 27p
Vinylogous Ester 27p.  Pd(CH3CN)2Cl2 (49.1 mg, 0.189 mmol, 5 mol %) was placed in a
50 mL round-bottom Schlenk flask and evacuated/backfilled with N2 (3 cycles, 5 min per
cycle).  Benzene (10 mL) was added, followed by acetonitrile (90 µL).  A solution of
vinylogous ester 27a (895 mg, 3.79 mmol, 1.00 equiv) in benzene (5.0 mL) was added
using positive pressure cannulation.  The resulting orange solution was heated to 75 °C in
an oil bath.  After 11 h of stirring, the reaction was cooled to ambient temperature,
filtered through a Celite plug (eluted with Et2O), and concentrated carefully under
reduced pressure, allowing for a film of ice to form on the outside of the flask, to afford a
pale yellow oil.  The crude oil was purified by automated flash column chromatography
using a Teledyne Isco CombiFlash Rf (SiO2, 25 g loading cartridge, 80 g column, linear
gradient, 0%10% EtOAc in hexanes [33 min]) to afford vinylogous ester 27p (823.6 mg,
3.48 mmol, 92% yield) in a 20:1 ratio to isomeric starting material 27a.  Analytically
pure samples could be obtained using the above column conditions;  Rf = 0.56 (4:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 5.56 (dq, J = 15.7, 1.4 Hz, 1H), 5.41
(dq, J = 15.7, 6.2, Hz, 1H), 5.34 (s, 1H), 3.48 (d, J = 6.5 Hz, 2H), 2.63–2.33 (m, 2H),
2.04–1.91 (m, 1H), 1.90–1.70 (m, 4H), 1.67 (dd, J = 6.2, 1.4 Hz, 3H), 1.22 (s, 3H), 0.95
(d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 205.3, 171.6, 136.5, 123.9, 105.2,
74.5, 53.9, 36.2, 33.3, 28.0, 27.2, 20.2, 19.3, 18.4;  IR (Neat Film NaCl) 3022, 2960,
2873, 1614, 1471, 1455, 1423, 1402, 1387, 1370, 1212, 1192, 1173, 1120, 967, 883, 858,
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827 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C15H25O2 [M+H]
+: 237.1849; found
237.1848;  [!]D
25.0 +4.05 (c 1.39, CHCl3, 88.0 % ee).
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
99% yield
O
i-BuO
O
i-BuO
27e 27q
Vinylogous Ester 27q.  Vinylogous ester 27e (100 mg, 0.362 mmol, 1.00 equiv) was
added to a 50 mL 2-neck flask fitted with a rubber septum and oven-dried reflux
condenser.  The flask was evacuated/backfilled with Ar (3 cycles, 5 min evacuation per
cycle).  Dry degassed benzene (36.2 mL, sparged with N2 for 1 h immediately before use)
was added.  Grubbs–Hoveyda 2nd generation catalyst (11.3 mg, 18.1 µmol, 5 mol %)
was added to the reaction, giving the solution an olive green color.  The mixture was kept
under Ar, stirred until homogeneous, and heated to 50 °C using an oil bath.  After 30 min
of stirring, the reaction was cooled to ambient temperature and several drops of ethyl
vinyl ether were added.  After 30 min, the reaction developed a deep brown color.  The
mixture was concentrated under reduced pressure and filtered through a silica gel plug (3
x 5 cm, 1:1 hexanes:Et2O).  The solvents were removed under reduced pressure and the
residue was purified by flash column chromatography (SiO2, 3 x 25 cm,
20:1%15:1%10:1 hexanes:EtOAc) to afford vinylogous ester 27q (89.2 mg, 0.359 mmol,
99% yield) as a white solid.  R f = 0.39 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 5.69–5.58 (m, 2H), 5.30 (s, 1H), 3.49 (dd, J = 14.4, 6.5 Hz, 1H), 3.46 (dd, J =
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14.3, 6.5 Hz, 1H), 2.70–2.57 (m, 1H), 2.54–2.44 (m, 2H), 2.08–1.91 (m, 3H), 1.91–1.57
(m, 7H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) $ 207.2, 171.3, 125.6,
125.4, 104.0, 74.4, 50.5, 35.9, 33.9, 32.3, 32.2, 28.0, 22.4, 20.6, 19.3;  IR (Neat Film
NaCl) 3050, 3023, 2981, 2958, 2928, 2890, 2874, 2837, 1726, 1633, 1610, 1470, 1457,
1435, 1416, 1406, 1392, 1364, 1327, 1295, 1270, 1218, 1178, 1189, 1117, 1096, 1045,
1028, 1003, 953, 935, 917, 888, 850, 837, 807, 758, 731 cm–1;  HRMS (EI+) m/z calc'd
for C16H24O2 [M]
+•: 248.1776; found 248.1774;  [!]D
25.0 –32.18 (c 0.97, CHCl3, 78.4% ee).
2.7.2.6 SYNTHETIC STUDIES ON THE REDUCTION/REARRANGEMENT
OF SIX- AND SEVEN-MEMBERED VINYLOGOUS ESTERS
1. LDA, THF, –78 °C 
     then
NC
O
O
2. Cs2CO3, CH3I
    CH3CN, 80 °C
    84% yield, 2 steps
i-BuO
O
73
i-BuO
O
O
14a
O
#-Ketoester 14a.  To a solution of diisopropylamine (0.49 mL, 3.47 mmol, 1.17 equiv) in
THF (10 mL) in a 50 mL round-bottom flask at 0 °C was added n-BuLi (1.70 mL, 3.40
mmol, 2.1 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of stirring at 0
°C, the reaction was cooled to –78 °C using an acetone/CO2(s) bath.  A solution of
vinylogous ester 7360 (0.50 g, 2.97 mmol, 1.00 equiv) in THF (5.0 mL) was added
dropwise using positive pressure cannulation.  After an additional 1 h of stirring at –78
°C, allyl cyanoformate (0.37 mL, 3.40 mmol, 1.15 equiv) was added dropwise.  The
reaction was stirred at –78 °C for 2.5 h, quenched by addition of sat. aqueous NH4Cl and
H2O (5 mL each), and then allowed to warm to ambient temperature.  The reaction was
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diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was
extracted with Et2O (2 x 25 mL) and the combined organic phases were dried over
MgSO4, filtered, and concentrated under reduced pressure to afford a pale red oil.
The crude oil was added to a 25 mL Schlenk flask and dissolved in CH3CN (10
mL). CH3I (0.56 mL, 8.90 mmol, 3.00 equiv) was added, followed by Cs2CO3 (1.26 g,
3.90 mmol, 1.30 equiv).  The flask was sealed with a teflon valve, immersed in an oil
bath, and heated to 80 °C.  After 14 h of vigorous stirring, the suspension was allowed to
cool to ambient temperature, diluted with EtOAc (25 mL), dried over MgSO4, filtered,
and concentrated under reduced pressure.  The crude product was purified by flash
column chromatography (SiO2, 3 x 20 cm, 19:1%9:1%4:1, hexanes:EtOAc) to afford #-
ketoester 14a (0.67 g, 2.52 mmol, 84% yield over 2 steps) as a pale yellow oil;  Rf = 0.36
(4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 5.81 (dddd, J = 17.2, 10.7, 5.5, 5.5
Hz, 1H), 5.30 (s, 1H), 5.22 (app dq, J = 17.2, 1.5 Hz, 1H), 5.14 (app dq, J = 10.5, 1.3 Hz,
1H), 4.65–4.46 (m, 2H), 3.55 (d, J = 6.5 Hz, 2H), 2.60–2.23 (m, 3H), 1.97 (app sept, J =
6.6 Hz, 1H), 1.89–1.70 (m, 1H), 1.35 (s, 3H), 0.91 (d, J = 6.7 Hz, 6H);  13C NMR (75
MHz, CDCl3) $ 196.4, 176.7, 172.5, 131.9, 118.0, 101.7, 74.9, 65.5, 52.3, 31.7, 27.7,
26.3, 20.6, 19.0;  IR (Neat Film NaCl) 2961, 2937, 2876, 1733, 1660, 1608, 1457, 1427,
1406, 1385, 1369, 1346, 1319, 1248, 1199, 1176, 1113, 1039, 991, 928, 837, 818, 772,
751 cm–1;  HRMS (EI+) m/z calc'd for C15H22O4 [M]
+•: 266.1518; found 266.1510.
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i-BuO
O
22a
(S)-t-BuPHOX (3) (6.25 mol %)
Pd2(pmdba)3 (2.5 mol %)
toluene, 50 °C
97% yield, 86% ee
NPh2P
O
t-Bu
i-BuO
O
O
14a
O
Vinylogous Ester 151.  #-Ketoester 14a (180 mg, 0.68 mmol, 1.00 equiv) in a 20 mL
scintillation vial and a septum-fitted screw cap were evacuated/backfilled with N2 (3
cycles, 5 min evacuation per cycle) in a glove box antechamber before being transferred
into a glove box.  A separate 20 mL scintillation vial in the glove box was loaded with
(S)-t-BuPHOX (16.4 mg, 0.042 mmol, 6.25 mol %), Pd2(pmdba)3 (18.5 mg, 0.017 mmol,
2.5 mol %), and a magnetic stir bar.  Toluene (4 mL) was added, and the black
suspension was stirred at 30 °C in a heating block for 30 min.  #-Ketoester 14a was
dissolved in toluene (2.8 mL) and added to the orange catalyst solution, causing an
immediate color change to olive green.  The vial was capped with the septum-fitted screw
cap and the edges were sealed with electrical tape.  The vial was removed from the glove
box, connected to a N2-filled Schlenk manifold, and immersed in a 50 °C oil bath.  After
22 h, the reaction was an orange-brown solution.  The mixture was concentrated under
reduced pressure and purified by flash column chromatography (SiO2, 2 x 25 cm,
20:1%10:1, hexanes:EtOAc) to afford vinylogous ester 22a (146 mg, 0.66 mmol, 97%
yield) as a clear, colorless oil;  Rf = 0.57 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 5.81–5.63 (m, 1H), 5.22 (s, 1H), 5.08–4.98 (m, 2H), 3.56 (d, J = 6.5 Hz, 2H),
2.40 (app t, J = 6.4 Hz, 2H), 2.33 (dddd, J = 13.8, 7.6, 1.0, 1.0 Hz, 1H), 2.16 (dddd, J =
13.8, 7.6, 1.0, 1.0 Hz, 1H), 2.00 (app sept, J = 6.7 Hz, 1H), 1.90 (ddd, J = 13.4, 6.6, 6.6
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 306
Hz, 1H), 1.68 (ddd, J = 13.6, 6.2, 6.2  Hz, 1H), 1.06 (s, 3H), 0.95 (d, J = 6.7 Hz, 6H);  13C
NMR (75 MHz, CDCl3) $ 203.5, 176.1, 134.4, 117.9, 101.4, 74.8, 43.3, 41.6, 31.9, 27.9,
26.0, 22.3, 19.2;  IR (Neat Film NaCl) 3074, 2962, 2932, 2875, 1655, 1611, 1470, 1464,
1429, 1404, 1384, 1368, 1327, 1307, 1299, 1240, 1195, 1178, 1123, 1080, 1032, 996,
968, 951, 913, 862, 840, 806, 786, 736 cm–1;  HRMS (EI+) m/z calc'd for C14H22O2 [M]
+•:
222.1620; found 222.1627;  [!]D
25.0 –10.67 (c 0.98, CHCl3, 86.3% ee);  HPLC conditions:
5% IPA in hexanes, OD-H column, tR (min): major = 5.80, minor = 6.53.
LiAlH4, Et2O, 0 °C
then 10% aq HCl
92% yield22a 68
O
i-BuO O
Cyclohexenone 68.  A 50 mL round-bottom flask was charged with Et2O (11.1 mL) and
cooled to 0 °C in an ice/water bath.  LiAlH4 (13.6 mg, 0.36 mmol, 0.55 equiv) was added
in one portion.  After 10 min, a solution of vinylogous ester 22a (146 mg, 0.66 mmol,
1.00 equiv) in Et2O (2.0 mL) was added dropwise using positive pressure cannulation.
After 30 min of stirring at 0 °C, an additional portion of LiAlH4 (2.5 mg, 0.066 mmol,
0.10 equiv) was added.  After 60 min of stirring, the reaction was quenched by slow
addition of aqueous HCl (1.0 mL, 10% w/w).  The resulting biphasic system was allowed
to warm to ambient temperature and stirred vigorously for 8.5 h.  The phases were
separated and the aqueous phase was extracted with Et2O (3 x 15 mL).  The combined
organic phases were dried over Na2SO4, filtered, and concentrated under reduced
pressure.  The crude product was purified using flash column chromatography (SiO2, 2 x
25 cm, 10:1%4:1%1:1%1:2 hexanes:Et2O) to afford cyclohexenone 68 (90.5 mg, 0.60
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mmol, 92% yield) as a yellow oil;  Rf = 0.51 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 6.67 (d, J = 10.2 Hz, 1H), 5.88 (d, J = 10.2 Hz, 1H), 5.79 (dddd, J = 16.8, 10.3,
7.4, 7.4 Hz, 1H), 5.20–5.01 (m, 2H), 2.54–2.36 (m, 2H), 2.29–2.10 (m, 2H), 2.05–1.89
(m, 1H), 1.85–1.69 (m, 1H), 1.14 (s, 3H);  13C NMR (75 MHz, CDCl3) $ 199.4, 158.4,
133.4, 127.6, 118.6, 45.2, 35.7, 34.1, 33.6, 24.7;  IR (Neat Film NaCl) 3077, 3005, 2960,
2917, 2868, 2849, 1682, 1639, 1616, 1459, 1419, 1390, 1373, 1332, 1250, 1223, 1193,
1115, 996, 961, 918, 871, 803, 757 cm–1;  HRMS (EI+) m/z calc'd for C10H14O [M]
+•:
150.1045; found 150.1056;  [!]D
25.0 +26.72 (c 1.02, CHCl3, 86.3% ee).
O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then aq 10% HCl
6% yield 87% yield
27a 70a55a
HO
Cycloheptenone 55a and #-Hydroxyketone 70a.  For procedure and characterization
data, see General Method A (Section 2.10.2.8, p. 154–154).
HO
O
70a
LiOH, TFE
THF, 60 °C
96% yield 53a
O
Acylcyclopentene 53a.  For procedure and characterization data, see General Method E
(Section 2.10.2.8, p. 155).
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i-BuO
O
LiAlH4
Et2O, 0 °C
then 
10% aq HCl
40% yield
O
7473
Cyclohexenone 74.  A 25 mL round-bottom flask with magnetic stir bar and LiAlH4
(22.8 mg, 0.60 mmol, 0.60 equiv) was charged with Et2O (4 mL) and cooled to 0 °C in an
ice/water bath.  After 10 min, a solution of vinylogous ester 73 (168.23 mg, 1.00 mmol,
1.00 equiv) in Et2O (1 mL) was added dropwise using positive pressure cannulation.
After 30 min of stirring at 0 °C, the reaction was quenched by slow addition of aqueous
HCl (2.60 mL, 10% w/w).  The resulting biphasic system was allowed to warm to
ambient temperature.  The phases were separated and the aqueous phase was extracted
with Et2O (3 x 10 mL).  The combined organic phases were dried over MgSO4, filtered,
and concentrated carefully under reduced pressure in an ice/water bath.  The crude
product purified using flash column chromatography (SiO2, 2 x 25 cm, 5:1%4:1
hexanes:EtOAc) to afford cyclohexenone 74 (39.4 mg, 0.41 mmol, 40% yield) as a
volatile pale yellow oil.  Spectra for the compound match data for commercially available
material.
O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% aq HCl
24% yield 46% yield
66 7776
HO
Cycloheptenone 76 and #-Hydroxyketone 77.  A 50 mL round-bottom flask with
magnetic stir bar and LiAlH4 (806 mg, 21.2 mmol, 0.60 equiv) was charged with Et2O (8
mL) and cooled to 0 °C in an ice/water bath.  After 10 min, a solution of vinylogous ester
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66 (328.2 mg, 1.80 mmol, 1.00 equiv) in Et2O (2 mL) was added dropwise using positive
pressure cannulation.  After 30 min of stirring at 0 °C, the reaction was quenched by slow
addition of aqueous HCl (4.73 mL, 10% w/w).  The resulting biphasic system was
allowed to warm to ambient temperature.  The phases were separated and the aqueous
phase was extracted with EtOAc (3 x 10 mL).  The combined organic phases were dried
over Na2SO4, filtered, and concentrated carefully under reduced pressure in an ice/water
bath.  The crude product purified using flash column chromatography (SiO2, 2 x 25 cm,
6:1%4:1%2:1%1:1%1:2%1:4 hexanes:EtOAc) to afford #-hydroxyketone 77 (107.1
mg, 0.84 mmol, 46% yield) as a pale yellow oil and cycloheptenone 76 (47.9 mg, 0.44
mmol, 24% yield) as a colorless oil.
Cycloheptenone 76:  Spectra for the compound match data for commercially available
material.
O
160
HO
#-Hydroxyketone 77:  Rf = 0.26 (1:1 hexanes:EtOAc);  
1H NMR (500 MHz, CDCl3) $
4.18–3.97 (m, 1H), 2.89–2.67 (m, 2H), 2.55–2.35 (m, 2H), 2.10 (br s, 1H), 1.95–1.69 (m,
5H), 1.65–1.49 (m, 1H);  13C NMR (125 MHz, CDCl3) $ 212.6, 67.5, 51.8, 44.4, 38.8,
24.4, 23.8;  IR (Neat Film NaCl) 3420, 2930, 2861, 1696, 1449, 1410, 1349, 1263, 1196,
1157, 1109, 1043, 1016, 929, 878, 829, 752, 710 cm–1;  HRMS (EI+) m/z calc'd for
C7H12O2 [M]
+•: 128.0837; found 128.0828.
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HO
O
77
LiOH, TFE
THF, 60 °C
31% yield 78
O
Acylcyclopentene 78.  Alcohol 77 (101.3 mg, 0.79 mmol, 1.00 equiv) was dissolved in
THF (7.9 mL) in a 20 mL scintillation vial with magnetic stir bar.  The solution was
treated with 2,2,2-trifluoroethanol (86.4 µL, 1.19 mmol, 1.50 equiv) and anhydrous LiOH
(28.4 mg, 1.19 mmol, 1.50 equiv).  The headspace of the vial was purged with N2 and the
vial was capped with a teflon-lined hard cap and stirred at 60 °C in a heating block.  After
16 h of stirring, the suspension was allowed to cool to ambient temperature, diluted with
Et2O (150 mL), dried over Na2SO4 (30 min of stirring), filtered, and concentrated
carefully under reduced pressure in an ice/water bath.  The crude product was purified
using flash column chromatography (SiO2, 2 x 20 cm, 15:1%10:1 hexanes:Et2O) to
afford acylcyclopentene 78 (27 mg, 0.25 mmol, 31% yield) as a colorless fragrant oil.
Spectra for the compound match data for commercially available material.
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2.7.2.7 RING CONTRACTION SCREENING PROTOCOLa
HO
O
conditions
70a 53a
O
entry base additive solvent T (°C) yield (%)b
–– 40 60
–– 40 81
–– 40 85
–– 60 89
–– 60 87
KOt-Bu THF
–– 60 19d
60 78
60 87
LiOH THF
TFEc 60 96
–– 60 90e
LiOt-Bu
NaOt-Bu
NaOH
KOH
LiOH
LiOH
LiOH
LiOCH2CF3
t-BuOH
HFIPc
THF
THF
THF
THF
THF
THF
THF
THF
8
9
10
2
11
7
3
4
5
6
time (h)
8
5
5
4
4
24
24
12.5
12.5
10
–– 40 71LiOt-Bu t-BuOH1 9
conversion (%)
100
100
100
100
100
78
98
99
99
––
100
40 52
40 57
40 77
NaOt-Bu THF
TFEc 40 73
HFIPc 40 81
KOt-Bu
LiOH
LiOH
LiOH
t-BuOH
t-BuOH
THF
THF
THF
THF
17
18
19
20
16 8
8
24
24
24
100
100
87
73
84
t-BuOH
–– 60 10CsF CH3CN21 2486
a Conditions: !-hydroxyketone 70a (1.0 equiv), additive (1.5 equiv), base (1.5 equiv), solvent (0.1 M) at indicated 
temperature for 9–24 h. b GC yield using an internal standard at ! 98% conversion unless otherwise stated. c
HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol; TFE = 2,2,2-trifluoroethanol. d Several reaction intermediates
observed by TLC and GC analysis; proceeded to 78% conversion. e Isolated yield. f Reaction did not reach
completion at 24 h; proceeded to 67% conversion.
60 48
60 61f
TFEc 60 86
TFEc 60 100
CsOH•H2O
Cs2CO3
Cs2CO3
Cs2CO3
––
––
THF
THF
THF
CH3CN
12
13
14
15
4
24
12.5
12.5
100
67
100
100
O
not observed
55a
+
Ring Contraction Screen to Produce Acylcyclopentene 53a (0.10 mmol scale, Table
2.3, entries 1–15).  A benzene solution of #-hydroxyketone 70a was transferred to a dry 1
dram vial and concentrated under reduced pressure to obtain a starting mass.  To this vial
was added a magnetic stir bar and 1,4-diisopropylbenzene (internal standard).  The
contents were solvated in either t-BuOH or THF (0.1 M).  After complete solvation, an
appropriate additive (t-BuOH, TFE, or HFIP; 1.50 equiv) was added, followed by base
(1.50 equiv).  The head space of the vial was purged with N2 and the vial was capped
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with a teflon-lined hard cap and stirred at the appropriate temperature (40 or 60 °C) in a
heating block.  Reaction progress was initially followed by TLC analysis, and when
necessary, aliquots were removed and flushed through a small SiO2 plug with EtOAc for
GC analysis.  GC conditions: 90 °C isothermal for 5 min, then ramp 10 °C/min to 250 °C,
DB-WAX column, tR (min): 1,4-diisopropylbenzene = 5.3, acylcyclopentene 53a = 9.3,
#-hydroxyketone 70a = 17.1 and 17.2 (two diastereomers).  (For characterization data,
see p. 319–321).
HO
O
70a
LiOCH2CF3
THF, 60 °C
90% yield 53a
O
Ring Contraction using LiOCH2CF3 (Table 2.3, entry 11).  #-Hydroxyketone 70a (30.0
mg, 0.16 mmol, 1.00 equiv) was measured into a 1 dram vial with magnetic stir bar with
a septum-fitted screw cap.  LiOCH2CF3
50 (26.0 mg, 0.25 mmol, 1.50 equiv) was measured
into a separate 1 dram vial, capped with a septum, evacuated/backfilled with N2 (3 cycles,
5 min evacuation per cycle), and dissolved in THF (0.5 mL).  The solution was
cannulated into the vial containing #-hydroxyketone along with additional THF rinses (2
x 0.5 mL).  The yellow solution was stirred at 60 °C in a heating block.  After 10 h, the
reaction was cooled to ambient temperature.  The turbid brown solution was diluted with
Et2O and stirred with Na2SO4 for 30 min.  The reaction was filtered and concentrated
under reduced pressure at 0 °C in an ice/water bath.  The residue was purified by flash
column chromatography (SiO2, 1 x 20 cm, 15:1 hexanes:Et2O) to afford acylcyclopentene
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53a (24.4 mg, 0.149 mmol, 90% yield) as a clear, colorless oil.  (For characterization
data, see p. 320).
Additional Conditions.  Additional reaction conditions are listed in Table 2.3, entries
16–21.
Unsuccessful Conditions.  No reaction was observed using the following bases, with or
without TFE additive: DBU, TMG, Na2CO3, K2CO3, BaCO3, CaH2.  DBU = 1,8-
diazabicyclo [5.4.0]undec-7-ene, TMG = 1,1,3,3-tetramethylguanidine.
2.7.2.8 P R E P A R A T I O N  O F  # -HYDROXYKETONES AND
ACYLCYCLOPENTENES
Full characterization data is reported for acylcyclopentenes 53, cycloheptenone 55a,
and #-hydroxyketone intermediate 70a (mixture of diastereomers).  For all other #-
hydroxyketone intermediates (70b–j, l–o, mixtures of diastereomers), Rf, IR, and HRMS
data are reported and 1H NMR and IR spectra are provided for reference in Figures
A2.44–A2.58.  For acylcyclopentenes 53a , the ee value was unchanged from
corresponding vinylogous ester 27a.  For all other acylcyclopentenes (53), ee values are
assumed to be unchanged from the corresponding vinylogous esters (27).  Representative
procedures for General Methods A–E are described below.
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O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% aq HCl
6% yield 87% yield
27a 70a55a
HO
General Method A:  LiAlH4 Hydride Reduction / 10% Aq HCl Hydrolysis
Cycloheptenone 55a and #-Hydroxyketone 70a.  A 500 mL round-bottom flask with
magnetic stir bar was charged with Et2O (150 mL) and cooled to 0 °C in an ice/water
bath.  LiAlH4 (806 mg, 21.2 mmol, 0.55 equiv) was added in one portion.  After 10 min,
a solution of vinylogous ester 27a (9.13 g, 38.6 mmol, 1.00 equiv) in Et2O (43 mL) was
added dropwise using positive pressure cannulation.  The grey suspension was stirred for
40 min and additional LiAlH4 (148 mg, 3.9 mmol, 0.10 equiv) was added in one portion.
After an additional 30 min of stirring at 0 °C, the reaction was quenched by slow addition
of aqueous HCl (110 mL, 10% w/w).  The resulting biphasic system was allowed to
warm to ambient temperature and stirred vigorously for 8.5 h.  The phases were separated
and the aqueous phase was extracted with Et2O (3 x 100 mL).  The combined organic
phases were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The
crude product was azeotroped with toluene (3 x 20 mL) and purified using flash column
chromatography (SiO2, 5 x 15 cm, 9:1%3:1 hexanes:EtOAc, dry-loaded using Celite) to
afford #-hydroxyketone 70a (6.09 g, 33.41 mmol, 87% yield, 1.3:1 dr) as a colorless
semi-solid and cycloheptenone 55a (387 mg, 2.36 mmol, 6% yield) as a colorless oil.
(For characterization data, see p. 319).
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HO
O
O
i-BuO
1. DIBAL, toluene, –78 °C
2. oxalic acid·2H2O, MeOH
        89% yield, 2 steps
27i 70i
N N
General Method B:  DIBAL Reduction / Oxalic Acid Hydrolysis
#-Hydroxyketone 70i.  A 25 mL pear-shaped flask was charged with vinylogous ester
27i (29.4 mg, 0.094 mmol, 1.00 equiv) and toluene (3.0 mL).  The solution was cooled to
–78 °C using an acetone/CO2(s) bath.  A 1.0 M solution of DIBAL in toluene (112.6 µL,
0.113 mmol, 1.00 equiv) was added dropwise and the solution was stirred for 10 min.
MeOH (180 µL), Na2SO4·10H2O (1.08 g), and Celite (360 mg) were added.  The reaction
was stirred vigorously and allowed to warm slowly to ambient temperature.  The mixture
was filtered through a Celite plug (3 x 3 cm, EtOAc), and concentrated under reduced
pressure.  Rf = 0.28, broad (1:2 hexanes:EtOAc).
The crude hydroxy isobutyl enol ether was added to a 25 mL round-bottom flask
and dissolved in MeOH (4.0 mL).  Oxalic acid dihydrate (354.9 mg, 2.82 mmol, 30.0
equiv) was added in one portion.  After 1 h of stirring, the reaction was neutralized to pH
7 with 1 M aqueous pH 7 NaH2PO4/Na2HPO4 buffer (6 mL).  The biphasic mixture was
stirred vigorously for 10 min and the phases were separated.  The aqueous layer was
extracted with Et2O (4 x 15 mL).  The combined organic phases were dried over Na2SO4,
filtered, and concentrated under reduced pressure.  The crude product was purified using
flash column chromatography (SiO2, 1.5 x 25 cm, 4:1%2:1%1:2 hexanes:acetone) to
afford #-hydroxyketone 70i as a mixture of diastereomers (21.6 mg, 0.083 mmol, 89%
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yield over 2 steps, 2.8:1 dr) as a clear, colorless residue which solidified upon standing.
(For characterization data, see p. 329).
HO
O
O
i-BuO
1. NaBH4, CeCl3•7H2O
    MeOH, 0 °C
2. 10% aq HCl, Et2O, 0 °C
     95% yield, 2 steps27m
OTBDPSOTBDPS
70m
General Method C:  Luche Reduction / 10% Aq HCl Hydrolysis
#-Hydroxyketone 70m.  A 100 mL round-bottom flask with magnetic stir bar was
charged with vinylogous ester 27m (65.6 mg, 0.134 mmol, 1.00 equiv) and anhydrous
MeOH (8.3 mL).  The solution was cooled to 0 °C in an ice/water bath.  CeCl3·7H2O
(78.2 mg, 0.21 mmol, 1.56 equiv) was added in one portion and the mixture was stirred
for 5 min.  Addition of NaBH4 (23.8 mg, 0.63 mmol, 4.70 equiv) led to the evolution of
gas and a turbid solution that became clear after several minutes.  The reaction was
stirred at 0 °C.  After 15 min, the reaction was diluted with CH2Cl2 (20 mL) until turbid,
filtered through a Celite plug (3 x 3 cm, CH2Cl2), and concentrated under reduced
pressure.  The residue was taken up in CH2Cl2, filtered through a Celite plug (3 x 5 cm,
CH2Cl2), and concentrated under reduced pressure a second time.  Rf = 0.33 (10:1
hexanes:EtOAc).
The crude hydroxy isobutyl enol ether was added to a 25 mL round-bottom flask
with a magnetic stir bar and dissolved in Et2O (3.8 mL).  The vigorously stirred solution
was cooled to 0 °C and aqueous HCl (384 µL, 10% w/w) was added dropwise via
syringe.  After 30 min, the reaction was allowed to warm to ambient temperature and
extracted with Et2O (3 x 5 mL).  The combined organic phases were dried over Na2SO4,
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filtered, and concentrated under reduced pressure.  The crude product was purified using
flash column chromatography (SiO2, 1.5 x 25 cm, 6:1%4:1 hexanes:EtOAc) to afford #-
hydroxyketone 70m as a mixture of diastereomers (55.6 mg, 0.13 mmol, 95% yield over
2 steps, 3.5:1 dr) as a colorless oil.  (For characterization data, see p. 332).
HO
O
OH
O
i-BuO
O
1. DIBAL, toluene, –78 °C
2. 10% HCl, Et2O, 0 °C
             38% yield
27n 70n
O
Ph
General Method D:  DIBAL Reduction / 10% Aq HCl Hydrolysis
#-Hydroxyketone 70n.  A 50 mL pear-shaped flask was charged with vinylogous ester
27n (100 mg, 0.292 mmol, 1.00 equiv) and toluene (9.5 mL).  The solution was cooled to
–78 °C using an acetone/CO2(s) bath.  A 1.0 M solution of DIBAL in toluene (963 µL,
0.963 mmol, 1.00 equiv) was added dropwise and the mixture was stirred for 15 min.
MeOH (1.0 mL), Na2SO4·10 H2O (6.0 g), and Celite (1.2 g) were added, and the mixture
was stirred vigorously and allowed to warm slowly to ambient temperature.  The mixture
was filtered through a Celite plug (3 x 3 cm, EtOAc), and concentrated under reduced
pressure.  Rf = 0.30 (2:1 hexanes:EtOAc).
The crude hydroxy isobutyl enol ether was added to a 50 mL pear-shaped flask,
dissolved in Et2O (10 mL), and cooled to 0 °C in an ice/water bath.  Aqueous HCl (0.835
mL, 10% w/w) was added dropwise and the biphasic mixture was stirred vigorously at 0
°C.  After 40 min or stirring, additional aqueous HCl (0.835 mL, 10% w/w) was added.
After 1.5 h, the layers were separated and the aqueous layer was extracted with Et2O (5 x
15 mL).  The combined organic layers were dried over Na2SO4, filtered, and concentrated
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under reduced pressure.  The crude product was purified using flash column
chromatography (SiO2, 1.5 x 25 cm, 10:1%6:1%4:1%2:1%1:1%1:2 hexanes:EtOAc) to
afford #-hydroxyketone 70n as a mixture of diastereomers (20.3 mg, 0.110 mmol, 38%
yield over 2 steps) as a clear, colorless oil.  (For characterization data, see p. 337).
HO
O
70a
LiOH, TFE
THF, 60 °C
96% yield 53a
O
General Method E:  #-Hydroxyketone Ring Contraction
Acylcyclopentene 53a.  Alcohol 70a (6.09 g, 33.4 mmol, 1.00 equiv) was dissolved in
THF (334 mL) in a 500 mL round-bottom flask.  The solution was treated with 2,2,2-
trifluoroethanol (3.67 mL, 50.1 mmol, 1.50 equiv) and anhydrous LiOH (1.20 g, 50.1
mmol, 1.50 equiv).  The flask was fitted with a condenser, purged with N2, and heated to
60 °C using an oil bath.  After 18 h of stirring, the suspension was allowed to cool to
ambient temperature, diluted with Et2O (150 mL), dried over Na2SO4 (30 min of stirring),
filtered, and concentrated carefully under reduced pressure, allowing for a film of ice to
form on the outside of the flask.  The crude product was purified using flash column
chromatography (SiO2, 5 x 15 cm, 15:1 hexanes:Et2O) to afford acylcyclopentene 53a
(5.29 g, 32.2 mmol, 96% yield) as a colorless fragrant oil.  (For characterization data, see
p. 320).
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O
55a
Cycloheptenone 55a.  6Prepared using General Method A.  387 mg, 2.36 mmol, 6%
yield.  Flash column chromatography (SiO2, 5 x 15 cm, 9:1%3:1 hexanes:EtOAc, dry-
loaded using Celite).  Rf = 0.54 (7:3 hexanes:EtOAc);  
1H NMR (500 MHz, CDCl3) $
6.04 (dd, J = 12.9, 0.7 Hz, 1H), 5.82 (d, J = 12.9 Hz, 1H), 5.75 (dddd, J = 17.1, 10.3, 7.8,
7.1 Hz, 1H), 5.10 (dddd, J = 10.3, 1.2, 1.2, 1.2 Hz, 1H), 5.08–5.03 (m, 1H), 2.65–2.52
(m, 2H), 2.19 (app dd, J = 13.7, 6.8 Hz, 1H), 2.11 (app dd, J = 13.7, 8.1 Hz, 1H),
1.84–1.76 (m, 3H), 1.68–1.63 (m, 1H), 1.10 (s, 3H);  13C NMR (75 MHz, CDCl3) $
204.7, 152.5, 133.8, 128.6, 118.6, 47.2, 45.1, 42.7, 38.2, 27.1, 18.4;  IR (Neat Film NaCl)
3076, 3011, 2962, 2934, 2870, 1659, 1454, 1402, 1373, 1349, 1335, 1278, 1208, 1172,
997, 916, 874, 822, 772 cm–1;  HRMS (EI+) m/z calc'd for C11H16O [M]
+•: 164.1201;
found 164.1209;  [!]D
21.0 –9.55 (c 1.07, CHCl3, 88.0% ee).
O
70a
HO
#-Hydroxyketone 70a  (Table 2.4, entry 1). 7Prepared using General Method A.  6.09 g,
33.41 mmol, 87% yield, 1.3:1 dr.  Flash column chromatography (SiO2, 5 x 15 cm,
9:1%3:1 hexanes:EtOAc, dry-loaded using Celite).  Rf =  0.23 (7:3 hexanes:EtOAc);  
1H
NMR (500 MHz, CDCl3) $ major epimer: 5.88 (dddd, J = 15.1, 9.0, 7.6, 7.6 Hz, 1H),
5.12–5.08 (m, 2H), 3.70 (dd, J = 4.9, 3.9 Hz, 1H), 2.86 (dd, J = 15.6, 1.7 Hz, 1H), 2.65
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(dd, J = 15.6, 7.3 Hz, 1H), 2.54–2.43 (m, 2H), 2.24 (dd, J = 13.7, 7.8 Hz, 1H), 2.07 (dd, J
= 13.4, 7.3 Hz, 1H), 1.99 (dd, J = 15.9, 4.4 Hz, 1H), 1.82–1.69 (m, 2H), 1.45–1.41 (m,
1H), 0.96 (s, 3H);  minor epimer: 5.83 (dddd, J = 14.9, 10.3, 7.6, 7.6 Hz, 1H), 5.12–5.06
(m, 2H), 3.68 (dd, J = 4.1, 2.4 Hz, 1H) 2.80 (dd, J = 15.4, 2.4 Hz, 1H), 2.74 (dd, J = 15.4,
8.1 Hz 1H), 2.46–2.38 (m, 2H), 2.18 (dd, J = 13.9, 7.3 Hz, 1H), 2.09 (dd, J = 12.9, 7.8
Hz, 1H), 1.82–1.65 (m, 3H), 1.50–1.47 (m, 1H), 1.02 (s, 3H);  13C NMR (75 MHz,
CDCl3) $  major epimer: 213.2, 135.0, 118.1, 72.9, 46.7, 44.9, 44.2, 41.0, 36.3, 21.9,
18.9;  minor epimer: 212.6, 134.2, 118.3, 73.3, 47.2, 42.8, 41.0, 35.9, 22.6, 18.7;  IR
(Neat Film NaCl) 3436, 3074, 2932, 1692, 1638, 1443, 1403, 1380, 1352, 1318, 1246,
1168, 1106, 1069, 999, 913, 840 cm–1;  HRMS (EI+) m/z calc'd for C11H18O2 [M]
+•:
182.1313; found 182.1307;  [!]D
22.8 –57.10 (c 2.56, CHCl3, 88.0% ee).
O
53a
Acylcyclopentene 53a (Table 2.4, entry 1). 8Prepared using General Method E.  5.29 g,
32.2 mmol, 96% yield.  Flash column chromatography (SiO2, 5 x 15 cm, 15:1
hexanes:Et2O).  Rf = 0.67 (8:2 hexanes:EtOAc);  
1H NMR (500 MHz, CDCl3) $ 6.45 (app
t, J = 1.7 Hz, 1H), 5.76 (dddd, J = 16.4, 10.7, 7.3, 7.3 Hz, 1H), 5.07–5.03 (m, 2H),
2.59–2.48 (m, 2H), 2.30 (s, 3H), 2.21–2.14 (m, 2H), 1.85 (ddd, J = 12.9, 8.3, 6.3 Hz, 1H),
1.64 (ddd, J = 12.9, 8.5, 6.1 Hz, 1H), 1.11 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 197.5,
151.9, 143.8, 134.9, 117.8, 50.0, 45.3, 36.0, 29.7, 26.8, 25.6;  IR (Neat Film NaCl) 3077,
2956, 2863, 1668, 1635, 1616, 1454, 1435, 1372, 1366,  1309, 1265, 1213, 1177, 993,
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914, 862 cm–1;  HRMS (EI+) m/z calc'd for C11H17O [M+H]
+•: 165.1279; found 165.1281;
[!]D
21.4 +17.30 (c 0.955, CHCl3, 88.0% ee);  GC conditions: 80 °C isothermal, GTA
column, tR (min): major = 54.7, minor = 60.2.
70b
HO
O
#-Hydroxyketone 70b  (Table 2.4, entry 2).  Prepared using General Method A.  111.5
mg, 0.57 mmol, 95% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1%3:1
hexanes:EtOAc).  Rf = 0.36 (2:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.45.1;  IR (Neat Film NaCl) 3448, 3073, 2965, 2933,
1832, 1696, 1691, 1673, 1459, 1413, 1381, 1352, 1334, 1323, 1306, 1269, 1252, 1269,
1252, 1172, 1138, 1111, 1084, 1071, 1050, 997, 955, 930, 912, 876, 825, 777, 737 cm–1;
HRMS (EI+) m/z calc'd for C12H20O2 [M]
+•: 196.1463; found 196.1480.
O
53b
Acylcyclopentene 53b  (Table 2.4, entry 2).  Prepared using General Method E.  21.8
mg, 0.12 mmol, 95% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.73 (2:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 6.44 (dd,
J = 1.8, 1.8 Hz, 1H), 5.80–5.64 (m, 1H), 5.08–5.04 (m, 1H), 5.03–5.00 (m, 1H),
2.55–2.46 (m, 2H), 2.30 (s, 3H), 2.19–2.16 (m, 2H), 1.81–1.68 (m, 2H), 1.52–1.41 (m,
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2H), 0.85 (dd, J = 7.5, 7.5 Hz, 3H);  13C NMR (75 MHz, CDCl3) $ 197.4, 150.7, 144.6,
134.8, 117.7, 54.0, 43.1, 32.9, 31.3, 30.1, 26.9, 9.1;  IR (Neat Film NaCl) 3075, 2962,
2922, 2878, 2855, 1669, 1639, 1617, 1459, 1437, 1372, 1319, 1266, 1207, 1052, 995,
913, 868, 784 cm–1;  HRMS (EI+) m/z calc'd for C12H19O [M+H]
+: 179.1436; found
179.1401; [!]D
25.0 +7.06 (c 0.98, CHCl3, 91.6% ee).
70c
HO
O
Ph
#-Hydroxyketone 70c  (Table 2.4, entry 3).  Prepared using General Method A.  109.9
mg, 0.43 mmol, 89% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1%3:1
hexanes:EtOAc).  Rf = 0.11 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.46.1;  IR (Neat Film NaCl) 3443, 3072, 3028, 3003,
2930, 2865, 1696, 1692, 1685, 1636, 1601, 1582, 1495, 1453, 1413, 1400, 1352, 1340,
1255, 1182, 1163, 1118, 1058, 1031, 995, 970, 916, 885, 848, 809, 754 cm–1;  HRMS
(EI+) m/z calc'd for C17H22O2 [M]
+•: 258.1620; found 258.1642.
O
Ph
53c
Acylcyclopentene 53c  (Table 2.4, entry 3).  Prepared using General Method E.  22.7
mg, 0.094 mmol, 97% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.54 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 7.30–7.18
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(m, 3H), 7.14–7.08 (m, 2H), 6.45 (dd, J = 1.8, 1.8 Hz, 1H), 5.78 (dddd, J = 16.3, 10.8,
7.7, 7.0 Hz, 1H), 5.13–5.10 (m, 1H), 5.07 (dddd, J = 9.1, 2.2, 1.2, 1.2 Hz, 1H), 2.79 (d, J
= 13.3 Hz, 1H), 2.73 (d, J = 13.3 Hz, 1H), 2.43 (dddd, J = 16.5, 8.6, 5.7, 1.7 Hz, 1H),
2.27–2.17 (m, 3H), 2.21 (s, 3H), 1.91–1.75 (m, 2H);  13C NMR (75 MHz, CDCl3) $
197.1, 150.1, 144.9, 138.2, 134.7, 130.4, 128.1, 126.4, 118.3, 54.6, 45.2, 43.3, 33.3, 30.0,
26.9;  IR (Neat Film NaCl) 3061 3027, 3002, 2920, 2853, 1668, 1638. 1617, 1495, 1453,
1442, 1371, 1314, 1264, 1197, 1089, 1030, 995, 914, 861, 734 cm–1;  HRMS (EI+) m/z
calc'd for C17H20O [M]
+•: 240.1514; found 240.1530;  [!]D
25.0 –20.63 (c 0.83, CHCl3,
86.3% ee).
70d
HO
O
#-Hydroxyketone 70d  (Table 2.4, entry 4).  Prepared using General Method A.  117
mg, 0.56 mmol, 98% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1%3:1
hexanes:EtOAc).  Rf = 0.35 (10:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.47.1;  IR (Neat Film NaCl) 3434, 3295, 3074, 3002,
2932, 2114, 1690, 1684, 1637, 1447, 1354, 1252, 1166, 1124, 1064, 977, 917, 886, 838
cm–1;  HRMS (EI+) m/z calc'd for C13H18O2 [M]
+•: 206.1307; found 206.1311.
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O
53d
Acylcyclopentene 53d  (Table 2.4, entry 4).  Prepared using General Method E.  22.5
mg, 0.12 mmol, 97% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.74 (2:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 6.51 (dd,
J = 1.8, 1.8 Hz, 1H), 5.73 (dddd, J = 16.9, 10.2, 7.4, 7.4 Hz, 1H), 5.13 (dm, J = 10.2 Hz,
1H), 5.10–5.07 (m, 1H), 2.66–2.46 (m, 2H), 2.34–2.33 (m, 1H), 2.33–2.32 (m, 1H), 2.32
(s, 3H), 2.32–2.30 (m, 2H), 1.99 (dd, J = 2.7, 2.7 Hz, 1H), 1.93–1.75 (m, 2H);  13C NMR
(75 MHz, CDCl3) 197.3, 148.6, 145.2, 133.9, 118.6, 81.4, 70.3, 53.2, 42.4, 33.4, 30.0,
28.5, 26.9;  IR (Neat Film NaCl) 3298, 3075, 3001, 2924, 2857, 2116, 1669, 1639, 1617,
1457, 1437, 1372, 1318, 1265, 1222, 1204, 996, 919, 867 cm–1;  HRMS (EI+) m/z calc'd
for C13H16O [M]
+•: 188.1201; found 188.1211;  [!]D
25.0 –58.65 (c 0.71, CHCl3, 88.5% ee).
70e
HO
O
#-Hydroxyketone 70e  (Table 2.4, entry 5).  Prepared using General Method A.  116.7
mg, 0.52 mmol, 97% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1%3:1
hexanes:EtOAc).  Rf = 0.15 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.48.1;  IR (Neat Film NaCl) 3447, 3075, 3001, 2975,
2931, 2866, 1827, 1693, 1639, 1456, 1415, 1352, 1336, 1250, 1169, 1116, 1073, 995,
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910, 855, 763, 714 cm–1;  HRMS (EI+) m/z calc'd for C18H28O2 [M]
+•: 276.2089; found
276.2060.
O
53e
Acylcyclopentene 53e  (Table 2.4, entry 5).  Prepared using General Method E.  19.1
mg, 0.093 mmol, 90% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.62 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 6.45 (dd,
J = 1.8, 1.8 Hz, 1H), 5.79 (dddd, J = 16.8, 10.2, 6.5, 6.5 Hz, 1H), 5.72 (dddd, J = 16.8,
9.5, 7.3, 7.3 Hz, 1H), 5.09–5.07 (m, 1H), 5.05–4.97 (m, 2H), 4.94 (dm, J = 10.2 Hz, 1H),
2.56–2.49 (m, 2H), 2.30 (s, 3H), 2.23–2.17 (m, 2H), 2.15–1.91 (m, 2H), 1.85–1.70 (m,
2H), 1.58–1.50 (m, 2H);  13C NMR (75 MHz, CDCl3) $ 197.3, 150.4, 144.6, 138.8, 134.6,
117.9, 114.6, 53.5, 43.6, 38.1, 33.3, 30.1, 29.2, 26.9;  IR (Neat Film NaCl) 3076, 3001,
2976, 2919, 2854, 1670, 1640, 1618, 1437, 1372, 1314, 1265, 1204, 995, 911, 865 cm–1;
HRMS (EI+) m/z calc'd for C14H21O [M+H]
+: 205.1592; found 205.1588;  [!]D
25.0 –30.08
(c 0.92, CHCl3, 86.9% ee).
70f
HO
O
#-Hydroxyketone 70f  (Table 2.4, entry 6).  Prepared using General Method A.  117.5
mg, 0.50 mmol, 96% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1%3:1
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hexanes:EtOAc).  Rf = 0.19 (4:1 hexanes:EtOAc); 
1H NMR (300 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.49.1;  IR (Neat Film NaCl) 3448, 3075, 3035, 3007,
2972, 2929, 2865, 1700, 1696, 1691, 1685, 1648, 1637, 1600, 1449, 1415, 1352, 1333,
1245, 1171, 1120, 1068, 1052, 1005, 969, 954, 912, 855, 838, 817, 720 cm–1;  HRMS
(FAB+) m/z calc'd for C15H23O2 [M+H]
+: 235.1698; found 235.1697.
O
53f
Acylcyclopentene 53f  (Table 2.4, entry 6).  Prepared using General Method E.  25.2
mg, 0.12 mmol, 95% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.65 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 6.45 (dd,
J = 1.8, 1.8 Hz, 1H), 6.30 (ddd, J = 16.9, 10.2, 10.2 Hz, 1H), 6.08 (dd, J = 15.0, 10.4 Hz,
1H), 5.73 (dddd, J = 16.4, 11.6, 8.9, 7.5 Hz, 1H), 5.63 (ddd, J = 15.0, 7.6, 7.6 Hz, 1H),
5.14–5.09 (m, 2H), 5.06–5.02 (m, 1H), 5.00 (dm, J = 10.1 Hz, 1H), 2.54–2.46 (m, 2H),
2.30 (s, 3H), 2.25–2.17 (m, 4H), 1.80–1.74 (m, 2H);  13C NMR (75 MHz, CDCl3) $
197.3, 150.0, 144.8, 137.0, 134.5, 134.3, 130.4, 118.1, 115.9, 54.0, 43.3, 42.0, 33.2, 30.0,
26.9;  IR (Neat Film NaCl) 3079, 3006, 2929, 2857, 1735, 1670, 1640, 1617, 1439, 1371,
1318, 1267, 1201, 1175, 1084, 1004, 952, 912 cm–1;  HRMS (FAB+) m/z calc'd for
C15H21O [M+H]
+: 217.1592; found 217.1568;  [!]D
25.0 –32.14 (c 1.26, CHCl3, 89.6% ee).
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70g
HO
O
Cl
#-Hydroxyketone 70g  (Table 2.4, entry 7).  Prepared using General Method A.  114.9
mg, 0.47 mmol, 93% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1%3:1
hexanes:EtOAc).  Rf = 0.15 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.50.1;  IR (Neat Film NaCl) 3436, 3075, 2931, 2869,
1695, 1627, 1452, 1414, 1352, 1297, 1251, 1222, 1151, 1064, 1021, 997, 974, 915, 887,
839 cm–1;  HRMS (EI+) m/z calc'd for C13H19O2Cl [M]
+•: 242.1074; found 242.1063.
O
53g
Cl
Acylcyclopentene 53g  (Table 2.4, entry 7).  Prepared using General Method E.  23.8
mg, 0.11 mmol, 99% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.55 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 6.61 (dd,
J = 1.8, 1.8 Hz, 1H), 5.73 (dddd, J = 15.9, 11.1, 7.9, 7.3 Hz, 1H), 5.29 (d, J = 1.2 Hz,
1H), 5.15–5.14 (m, 1H), 5.11–5.10 (m, 1H), 5.08–5.04 (m, 1H), 2.56–2.48 (m, 4H), 2.31
(s, 3H), 2.28–2.25 (m, 2H), 1.93 (ddd, J = 13.3, 8.4, 6.6 Hz, 1H), 1.84 (ddd, J = 13.3, 8.1,
6.4 Hz, 1H);  13C NMR (75 MHz, CDCl3) $ 197.3, 149.6, 144.4, 139.4, 134.0, 118.7,
116.4, 53.4, 48.0, 43.4, 33.3, 29.8, 26.9;  IR (Neat Film NaCl) 3076, 2946, 2857, 1669,
1629, 1434, 1372, 1320, 1266, 1230, 1206, 1167, 996, 917, 886 cm–1;  HRMS (EI+) m/z
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calc'd for C13H18OCl [M+H]
+: 225.1046; found 225.1053;  [!]D
25.0 +46.29 (c 1.06, CHCl3,
85.7% ee).
70h
HO
O
CN
#-Hydroxyketone 70h  (Table 2.4, entry 8).  Prepared using General Method A.  72.4
mg, 0.33 mmol, 90% yield.  Flash column chromatography (SiO2, 2 x 25 cm,
4:1%2:1%1:1 hexanes:EtOAc).  Rf = 0.40, broad (1:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) mixture of two diastereomers, see Figure A2.51.1;  IR (Neat Film NaCl)
3468, 3075, 2932, 2871, 2247, 1696, 1458, 1437, 1420, 1352, 1319, 1252, 1169, 1122,
1070, 999, 921, 853, 754 cm–1;  HRMS (EI+) m/z calc'd for C13H19O2N [M]
+•: 221.1416;
found 221.1411.
O
53h
CN
Acylcyclopentene 53h  (Table 2.4, entry 8).  Prepared using General Method E.  19.4
mg, 0.095 mmol, 94% yield.  Flash column chromatography (SiO2, 1 x 20 cm,
2:1%3:2%1:1 hexanes:Et2O).  Rf = 0.84, broad (1:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $ 6.42 (dd, J = 1.8, 1.8 Hz, 1H), 5.70 (dddd, J = 16.4, 10.6, 7.4, 7.4 Hz,
1H), 5.15–5.12 (m, 1H), 5.15–5.06 (m, 1H), 2.60–2.52 (m, 2H), 2.37–2.22 (m, 2H), 2.32
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(s, 3H), 2.23–2.20 (m, 2H), 1.93–1.82 (m, 3H), 1.73 (ddd, J = 13.6, 8.2, 7.0 Hz, 1H);  13C
NMR (75 MHz, CDCl3) $ 196.8, 147.2, 146.0, 133.3, 120.0, 119.0, 53.2, 43.5, 34.2, 32.7,
30.2, 27.0, 13.1;  IR (Neat Film NaCl) 3074, 2923, 2857, 2245, 1667, 1640, 1618, 1423,
1373, 1308, 1264, 1202, 1090, 996, 918, 867 cm–1;  HRMS (EI+) m/z calc'd for C13H18NO
[M+H]+: 204.1388; found 204.1385;  [!]D
25.0 –31.11 (c 0.90, CHCl3, 87.4% ee).
70i
HO
O
N
#-Hydroxyketone 70i  (Table 2.4, entry 9). 9Prepared using General Method B.  21.6
mg, 0.083 mmol, 89% yield over 2 steps.  Flash column chromatography (SiO2, 1.5 x 25
cm, 4:1%2:1%1:2 hexanes:acetone).  Rf = 0.10 (2:1 hexanes:acetone);  
1H NMR (300
MHz, CDCl3) mixture of two diastereomers, see Figure A2.52.1;  IR (Neat Film NaCl)
3391, 3201, 3073, 2929, 2865, 1699, 1636, 1603, 1557, 1497, 1456, 1418, 1352, 1332,
1297, 1258, 1222, 1187, 1161, 1113, 1069, 1005, 995, 972, 915, 886, 851, 802, 735 cm–1;
HRMS (FAB+) m/z calc'd for C16H22O2N [M+H]
+: 260.1650; found 260.1649.
O
53i
N
Acylcyclopentene 53i  (Table 2.4, entry 9).  Prepared using General Method E.  15.7 mg,
0.065 mmol, 90% yield.  Flash column chromatography (SiO2, 1.5 x 16 cm, 2:1%1:1
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hexanes:acetone).  Rf = 0.47 (2:1 hexanes:acetone);  
1H NMR (300 MHz, CDCl3) $ 8.49
(br d, J = 3.8 Hz, 2H), 7.04 (d, J = 5.7 Hz, 2H), 6.40 (dd, J = 1.7, 1.7 Hz, 1H), 5.75
(dddd, J = 17.3, 10.3, 7.3, 7.3 Hz, 1H), 5.16–5.04 (m, 2H), 2.77 (d, J = 13.0 Hz, 1H),
2.71 (d, J = 13.0 Hz, 1H), 2.52–2.39 (m, 1H), 2.33–2.35 (m, 1H), 2.28 (s, 3H), 2.24–2.20
(m, 2H), 1.85–1.80 (m, 2H);  13C NMR (75 MHz, CDCl3) $ 196.8, 149.6, 148.6, 147.3,
145.4, 134.0, 125.7, 118.8, 54.2, 44.4, 43.3, 33.3, 30.0, 27.0;  IR (Neat Film NaCl) 3401,
3071, 3025, 2922, 2856, 1668, 1640, 1618, 1600, 1557, 1495, 1441, 1415, 1373, 1318,
1277, 1265, 1220, 1194, 1071, 994, 917, 874, 844, 810, 763 cm–1;  HRMS (EI+) m/z
calc'd for C16H19ON [M]
+•: 176.1467; found 176.1458;  [!]D
25.0 –8.58 (c 0.77, CHCl3,
84.6% ee).
70j
HO
O
N Ts
#-Hydroxyketone 70j  (Table 2.4, entry 10).  Prepared using General Method A.  300.1
mg, 0.67 mmol, 94% yield.  Flash column chromatography (SiO2, 3 x 25 cm,
4:1%3:1%2:1%1:1 hexanes:EtOAc).  Rf = 0.20, 0.26 (two diastereomers) (2:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture of two diastereomers, see Figure
A2.53.1;  IR (Neat Film NaCl) 3436, 3068, 2930, 2873, 1693, 1639, 1597, 1494, 1447,
1365, 1402, 1365, 1279, 1211, 1188, 1172, 1133, 1121, 1095, 1063, 1020, 995, 975, 913,
813, 778, 747 cm–1;  HRMS (FAB+) m/z calc'd for C26H30O4NS [M+H]
+: 452.1896; found
452.1896.
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O
53j
N
Ts
Acylcyclopentene 53j  (Table 2.4, entry 10).  Prepared using General Method E.  55.7
mg, 0.10 mmol, 93% yield.  Flash column chromatography (SiO2, 2 x 25 cm,
10:1%8:1%6:1%4:1  hexanes:EtOAc).  Rf = 0.67 (2:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $ 7.98 (br d, J = 8.2 Hz, 1H), 7.63 (dm, J = 8.4 Hz, 2H), 7.40 (dd, J = 7.3,
0.8 Hz, 1H), 7.33 (br s, 1H), 7.30 (ddd, J = 8.2, 8.2, 1.3 Hz, 1H), 7.21 (ddd, J = 7.5, 7.5,
1.1 Hz, 1H), 7.17 (dm, J = 8.2 Hz, 2H), 6.35 (dd, J = 1.8, 1.8 Hz, 1H), 5.75 (dddd, J =
16.9, 10.3, 7.7, 6.9 Hz, 1H), 5.13–5.10 (m, 1H), 5.10–5.04 (m, 1H), 2.82 (s, 3H), 2.44
(dddd, J = 14.7, 8.8, 5.9, 1.7 Hz, 1H), 2.33 (br s, 2H), 2.31–2.18 (m, 3H), 2.16 (s, 3H),
1.86 (ddd, J = 14.6, 8.6, 6.1 Hz, 1H), 1.79 (ddd, J = 14.8, 7.6, 5.8 Hz, 1H);  13C NMR (75
MHz, CDCl3) $ 196.9, 149.9, 145.1, 144.9, 135.2, 135.1, 134.3, 131.9, 130.0, 126.7,
124.8, 124.7, 123.2, 119.9, 119.4, 118.5, 113.9, 54.5, 43.5, 33.8, 33.4, 30.0, 26.8, 21.7;
IR (Neat Film NaCl) 3316, 3129, 3101, 3068, 3001, 2974, 2922, 2855, 1667, 1639, 1618,
1597, 1562, 1493, 1448, 1400, 1372, 1307, 1293, 1277, 1211, 1188, 1174, 1121, 1094,
1020, 978, 916, 853, 813, 747 cm–1;  HRMS (EI+) m/z calc'd for C26H27O3NS [M]
+•:
433.1712; found 433.1694;  [!]D
25.0 +0.35 (c 1.09, CHCl3, 82.9% ee).
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70m
HO
O
OTBDPS
#-Hydroxyketone 70m  (Table 2.4, entry 11).10Prepared using General Method C.  55.6
mg, 0.13 mmol, 95% yield over 2 steps.  Flash column chromatography (SiO2, 1.5 x 25
cm, 6:1%4:1 hexanes:EtOAc).  Rf = 0.22, 0.28 (two diastereomers) (4:1 hexanes:EtOAc);
1H NMR (300 MHz, CDCl3) mixture of two diastereomers, see Figure A2.54.1;  IR (Neat
Film NaCl) 3468, 3072, 3050, 2999, 3013, 2931, 2895, 2858, 2248, 1960, 1891, 1823,
1772, 1698, 1638, 1590, 1472, 1462, 1446, 1428, 1391, 1361, 1337, 1260, 1222, 1186,
1172, 1158, 1113, 1088, 1030, 1006, 999, 976, 914, 841, 823, 810, 740 cm–1;  HRMS
(FAB+) m/z calc'd for C27H37O3Si [M+H]
+: 437.2512; found 437.2517.
O
OTBDPS
53m
Acylcyclopentene 53m  (Table 2.4, entry 11).  Prepared using General Method E.  32.6
mg, 0.078 mmol, 96% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.60 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 7.67–7.60
(m, 4H), 7.47–7.34 (m, 6H), 6.50 (dd, J = 1.8, 1.8 Hz, 1H), 5.71 (dddd, J = 17.0, 10.1,
7.8, 6.9 Hz, 1H), 5.12–5.08 (m, 1H), 5.06–5.02 (m, 1H), 3.57 (d, J = 9.8 Hz, 1H), 3.53 (d,
J = 9.8 Hz, 1H), 2.54–2.48 (m, 2H), 2.38 (ddd, J = 13.8, 6.9, 1.1 Hz, 1H), 2.31–2.25 (m,
1H), 2.29 (s, 3H), 1.81–1.72 (m, 2H), 1.07 (s, 9H);  13C NMR (75 MHz, CDCl3) $ 197.2,
148.5, 145.7, 135.8, 135.7, 134.5, 133.6, 133.6, 129.9, 129.9, 127.8, 118.0, 69.1, 56.5,
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40.4, 30.7, 30.0, 27.0, 26.8, 19.5;  IR (Neat Film NaCl) 3072, 3050, 2999, 2956, 2931,
2896, 2857, 1671, 1639, 1618, 1472, 1463, 1427, 1367, 1320, 1266, 1232, 1188, 1112,
998, 936, 915, 864, 824, 740 cm–1;  HRMS (EI+) m/z calc'd for C27H34O2Si [M]
+•:
433.1712; found 433.1694;  [!]D
25.0 –17.58 (c 0.94, CHCl3, 51.4% ee).
70o
HO
O
OTBDPS
#-Hydroxyketone 70o  (Table 2.4, entry 12).  Prepared using General Method C.  110.6
mg, 0.24 mmol, 92% yield over 2 steps.  Flash column chromatography (SiO2, 2 x 25 cm,
6:1%4:1 hexanes:EtOAc).  Rf = 0.15 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3)
mixture of two diastereomers, see Figure A2.55.1;  IR (Neat Film NaCl) 3436, 3071,
3050, 3013, 2999, 2931, 2896, 2859, 1960, 1891, 1826, 1694, 1638, 1589, 1472, 1461,
1428, 1390, 1360, 1325, 1307, 1251, 1218, 1188, 1168, 1111, 1092, 1007, 998, 973, 934,
914, 823, 798, 740 cm–1;  HRMS (FAB+) m/z calc'd for C29H41O3Si [M+H]
+: 465.2825;
found 465.2810.
OTBDPS
O
53o
Acylcyclopentene 53o  (Table 2.4, entry 12).  Prepared using General Method E.  92.2
mg, 0.21 mmol, 92% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 15:1
hexanes:Et2O).  Rf = 0.64 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 
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(m, 4H), 7.48–7.35 (m, 6H), 6.44 (dd, J = 1.7, 1.7 Hz, 1H), 5.81–5.65 (m, 1H), 5.10–5.07
(m, 1H), 5.05–5.02 (m, 1H), 3.69–3.64 (m, 2H), 2.55–2.49 (m, 2H), 2.31 (s, 3H),
2.20–2.18 (m, 2H), 1.84–1.67 (m, 2H), 1.53–1.48 (m, 4H), 1.07 (s, 9H);  13C NMR (75
MHz, CDCl3) $ 197.3, 150.7, 144.4, 135.7, 134.7, 134.0, 129.7, 127.7, 117.8, 64.3, 53.3,
43.5, 34.8, 33.3, 30.0, 28.0, 27.0, 26.8, 19.3;  IR (Neat Film NaCl) 3071, 3050, 3013,
2999, 2931, 2897, 2857, 1670, 638, 1618, 1589, 1472, 1461, 1448, 1428, 1388, 1372,
1316, 1263, 1201, 1157, 1111, 1093, 1030, 1008, 998, 937, 915, 865, 823, 803, 741, 726
cm–1;  HRMS (FAB+) m/z calc'd for C25H29O2Si [M–C4H9]
+: 389.1968; found 389.1958;
[!]D
25.0 –14.19 (c 0.92, CHCl3, 78.4% ee).
70p
HO
O
#-Hydroxyketone 70p  (Table 2.4, entry 13).  Prepared using General Method A.  429.5
mg, 2.36 mmol, 87% yield.  Flash column chromatography (SiO2, 3 x 20 cm, 9:1%3:1
hexanes:EtOAc).  Rf = 0.14 (4:1 hexanes:EtOAc);  
1H NMR (400 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.56.1;  IR (Neat Film NaCl) 3449, 3027, 2963, 2928,
2873, 1694, 1454, 1404, 1350, 1320, 1251, 1170, 1066, 969 cm–1;  HRMS (MM: ESI-
APCI+) m/z calc'd for C11H19O2 [M+H]
+: 165.1274; found 165.1278.
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O
53p
Acylcyclopentene 53p  (Table 2.4, entry 13).  Prepared using General Method E.  Due to
the volatility of acylcyclopentene 53p, the work-up solvent (Et2O) was removed using
ambient pressure distillation (50%80 °C).  323.8 mg, 1.97 mmol, 93% yield.  The crude
oil was purified by automated flash column chromatography using a Teledyne Isco
CombiFlash Rf (SiO2, 32 g loading cartridge, 80 g column, linear gradient, 0%30% Et2O
in pentane [33 min]) and solvent was removed using ambient pressure distillation (60
°C).  Rf = 0.55 (4:1 hexanes:EtOAc);  
1H NMR (400 MHz, CDCl3) $ 6.41 (dd, J = 1.7, 1.7
Hz, 1H), 5.50 (dq, J = 15.5, 1.3 Hz, 1H), 5.39 (dq, J = 15.6, 6.2 Hz, 1H), 2.58–2.52 (m,
2H), 2.31–2.28 (m, 1H), 2.30 (s, 3H), 1.91 (ddd, J = 12.8, 7.4, 7.4 Hz, 1H), 1.74 (ddd, J =
12.8, 7.2, 7.2 Hz, 1H), 1.68–1.64 (m, 2H), 1.19 (s, 3H);  13C NMR (100 MHz, CDCl3) $
197.5, 151.4, 143.8, 137.5, 122.3, 51.5, 38.1, 29.6, 26.8, 25.4, 18.2;  IR (Neat Film NaCl)
3022, 2958, 2859, 1674, 1617, 1451, 1377, 1365, 1310, 1271, 1229, 1165, 967 cm–1;
HRMS (MM: ESI-APCI+) m/z calc'd for C11H17O [M+H]
+: 165.1279; found 165.1278;
[!]D
25.0 +89.82 (c 1.04, CHCl3, 88.0 % ee).
70q
HO
O
#-Hydroxyketone 70q  (Table 2.4, entry 14).  Prepared using General Method A.  29.1
mg, 0.150 mmol, 96% yield.  Flash column chromatography (SiO2, 2 x 20 cm, 9:1%3:1
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hexanes:EtOAc).  Rf = 0.09 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) mixture
of two diastereomers, see Figure A2.57.1;  IR (Neat Film NaCl) 3436, 3021, 2922, 2873,
2842, 2697, 1692, 1656, 1436, 1402, 1353, 1318, 1256, 1202, 1184, 1172, 1152, 1093,
1071, 1050, 1000, 981, 970, 949, 932, 876, 850, 834, 798, 750 cm–1;  HRMS (EI+) m/z
calc'd for C12H18O2 [M]
+•: 194.1307; found 194.1315.
O
53q
Acylcyclopentene 53q  (Table 2.4, entry 14).  Prepared using General Method E.  21.7
mg, 0.123 mmol, 91% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1
hexanes:Et2O).  Rf = 0.65 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $ 6.58 (dd,
J = 1.8, 1.8 Hz, 1H), 5.72 (dm, J = 10.0 Hz, 1H), 5.65 (dm, J = 10.0 Hz, 1H), 2.59–2.52
(m, 2H), 2.30 (s, 3H), 2.13–2.04 (m, 2H), 2.02–1.98 (m, 2H), 1.77–1.70 (m, 2H), 1.69
(ddd, J = 12.8, 6.3, 6.3 Hz, 1H), 1.56 (ddd, J = 12.8, 6.5, 6.5 Hz, 1H);  13C NMR (75
MHz, CDCl3) $ 197.8, 151.4, 143.9, 127.0, 125.5, 48.7, 35.8, 35.8, 32.5, 28.9, 26.8, 23.1;
IR (Neat Film NaCl) 3320, 3023, 2918, 2856, 1704, 1669, 1616, 1436, 1371, 1436, 1371,
1316, 1269, 1231, 11945, 1116, 1086, 1045, 1020, 980, 962, 935, 864, 763 cm–1;  HRMS
(EI+) m/z calc'd for C12H16O [M]
+•: 176.1201; found 176.1234;  [!]D
25.0 –10.42 (c 1.08,
CHCl3, 78.4% ee).
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 337
HO
O
OH
70n
#-Hydroxyketone 70n  (Table 2.4, entry 15).11Prepared using General Method D.  20.3
mg, 0.110 mmol, 38% yield over 2 steps.  Flash column chromatography (SiO2, 1.5 x 25
cm, 10:1%6:1%4:1%2:1%1:1%1:2 hexanes:EtOAc).  Rf = 0.19 (1:1 hexanes:EtOAc);
1H NMR (300 MHz, CDCl3) mixture of two diastereomers, see Figure A2.58.1;  IR (Neat
Film NaCl) 3369, 3077, 3011, 2947, 2924, 1688, 1641, 1469, 1439, 1343, 1268, 1216,
1193, 1128, 1108, 1079, 1052, 1032, 1019, 999, 966, 909, 889, 808, 731 cm–1;  HRMS
(MM: ESI-APCI+) m/z calc'd for C10H15O2 [M–OH]
+: 167.1067; found 167.1066.
O
OH
53n
Acylcyclopentene 53n  (Table 2.4, entry 15).  Prepared using General Method E.  12.2
mg, 0.073 mmol, 67% yield.  Flash column chromatography (SiO2, 1.5 x 25 cm,
10:1%4:1%2:1%1:1 hexanes:EtOAc);  Rf = 0.44 (1:1 hexanes:EtOAc);  
1H NMR (500
MHz, CDCl3) $  6.48 (app t, J = 1.9 Hz, 1H), 5.91–5.77 (dddd, J = 16.5, 10.7, 7.4, 7.4
Hz, 1H), 5.23–5.15 (m, 2H), 2.67 (dddd, J = 17.0, 8.9, 4.1, 1.7 Hz, 1H), 2.50–2.40 (m,
3H), 2.33 (s, 3H), 2.14 (ddd, J = 13.7, 8.5, 4.1 Hz, 1H), 2.03 (br s, 1H), 1.91 (ddd, J =
13.7, 9.0, 5.8 Hz, 1H);  13C NMR (125 MHz, CDCl3) $ 197.5, 145.9, 145.5, 132.9, 119.8,
85.2, 44.9, 37.4, 29.1, 27.0;  IR (Neat Film NaCl) 3400, 3077, 3004, 2961, 2929, 2856,
1841, 1668, 1622, 1428, 1372, 1295, 1267, 1228, 1205, 1173, 1070, 1057, 1016, 998,
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966, 935, 917, 862, 831, 776 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C10H13O
[M–OH]+: 149.0961; found 149.0967;  [!]D
25.0 –22.45 (c 1.22, CHCl3, 57.1% ee).
2.7.2.9 LARGE SCALE SYNTHESIS OF ACYLCYCLOPENTENE 53a
O
i-BuO
27a
Pd2(pmdba)3
 (1.25 mol %)
(S)-t-BuPHOX (3) (3.12 mol %)
toluene, 30 °C
94% yield, 88% ee
O
i-BuO
24a
O
O
Vinylogous Ester 27a.  Pd2(pmdba)3 (733.1 mg, 0.67 mmol, 0.0125) and (S)-t-BuPHOX
(647.0 mg, 1.67 mmol, 0.0312 equiv) were placed in a 500 mL round-bottom flask.  The
flask was evacuated/backfilled with N2 (3 cycles, 10 min evacuation per cycle).  Toluene
(222 mL, sparged with N2 for 1 h immediately before use) was added and the black
suspension was immersed in an oil bath preheated to 30 °C.  After 30 min of stirring,  #-
ketoester 24a (15.0 g, 53.5 mmol, 1.0 equiv) in toluene (46 mL, sparged with N2
immediately before use) was added using positive pressure cannulation.  The dark orange
catalyst solution turned olive green immediately after the addition of #-ketoester 24a.
The solution was stirred at 30 °C for 32 h, allowed to cool to ambient temperature,
filtered through a silica gel plug (2 x 5.5 cm SiO2, Et2O), and concentrated under reduced
pressure.  The crude oil was purified by flash column chromatography (SiO2, 8 x 12 cm,
19:1 hexanes:EtOAc, dry-loaded using SiO2) to afford vinylogous ester 27a (11.83 g,
50.1 mmol, 94% yield, 88% ee) as a pale yellow oil.  (For characterization data, see p.
287).
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HO
O
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% HCl
81% yield27a 70a
#-Hydroxyketone 70a.  A 500 mL round-bottom flask with magnetic stir bar was
charged with Et2O (150 mL) and cooled to 0 °C.  LiAlH4 (1.04 g, 0.0275 mol, 0.55 equiv)
was added in one portion.  After 10 min, a solution of vinylogous ester 27a (11.83 g, 50
mmol, 1.0 equiv) in Et2O (50 and 25 mL for quantitative transfer) was added dropwise
using positive pressure cannulation.  The grey suspension was stirred for 60 min after
which LiAlH4 (190 mg, 5.0 mmol, 0.1 equiv) was added in one portion.  After an
additional 10 min of stirring at 0 °C, the reaction was quenched by slow addition of
aqueous HCl (143 mL, 10% w/w).  The resulting biphasic system was allowed to warm
to ambient temperature and stirred vigorously for 10 h.  The reaction was diluted with
Et2O, the phases were separated and the aqueous phase was extracted with Et2O (3 x 150
mL).  The combined organic phases were dried over Na2SO4, filtered, and concentrated
under reduced pressure.  The crude product was azeotroped with toluene (50 mL) and
purified using flash column chromatography (SiO2, 8 x 13 cm, 9:1%3:1 hexanes:EtOAc,
dry-loaded using Celite) to afford #-hydroxyketone 70a (7.25 g, 39.8 mmol, 81% yield)
as a colorless semi-solid.  (For characterization data, see p. 319).
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HO
O
70a
LiOH, TFE
THF, 60 °C
91% yield 53a
O
Acylcyclopentene 53a.  Alcohol 70a (7.25 g, 39.8 mmol, 1.0 equiv) was dissolved in
THF (400 mL) in a 1 L round-bottom flask.  The solution was treated with 2,2,2-
trifluoroethanol (5.99 g, 4.36 mL, 59.7 mmol, 1.5 equiv) and LiOH (1.43 g, 59.7 mmol,
1.5 equiv).  The flask was fitted with a reflux condenser, purged with N2, and heated to
60 °C using an oil bath.  After 18 h of stirring, the suspension was allowed to cool to
ambient temperature, diluted with Et2O (200 mL), stirred with Na2SO4 for 30 min,
filtered, and concentrated carefully under reduced pressure, allowing for a film of ice to
form on the outside of the flask.  The crude product was purified using flash column
chromatography (SiO2, 8 x 12 cm, 15:1%9:1 pentane:Et2O) to afford acylcyclopentene
53a (5.93 g, 36.1 mmol, 91% yield) as a colorless fragrant oil.  (For characterization data,
see p. 320).
2.7.2.10 INITIAL SYNTHETIC STUDIES ON THE ORGANOMETALLIC
ADDITION/REARRANGEMENT OF 27a
i-BuO
O
10% aq HCl
THF, 23 °C
90% yield
27a
O
O
79
Cyclic Dione 79.  A 20 mL scintillation vial equipped with a stir bar was charged with
vinylogous ester 27a (144.6 mg, 0.61 mmol, 1.00 equiv), THF (1 mL), and aqueous HCl
(1 mL, 10% w/w, 2.87 mmol, 4.69 equiv).  After 4.5 h of vigorous stirring, the solution
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was diluted with H2O (5 mL) and transferred to a separatory funnel where the aqueous
phase was extracted four times with Et2O.  The combined organics (70 mL) were dried
over MgSO4, filtered, and concentrated.  The crude oil was purified by flash
chromatography (SiO2, 27.5 x 2 cm, 100% hexanes%10% EtOAc in hexanes) to afford
cyclic dione 79 (99.4 mg, 0.55 mmol, 90% yield) as a pale yellow oil;  Rf = 0.48 (30%
EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 5.69 (d, J = 14.0 Hz, 1H), 5.12–5.04
(m, 2H), 3.72 (d, J = 14.0 Hz, 1H), 3.53 (d, J = 14.0 Hz, 1H), 2.48 (t, J = 6.6 Hz, 2H),
2.40 (dddd, J = 13.9, 7.1, 1.2, 1.2 Hz, 1H), 2.22 (dddd, J = 13.9, 7.7, 1.1, 1.1 Hz, 1H),
2.02–1.75 (m, 4H), 1.15 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 208.4, 203.7, 133.1,
119.1, 57.6, 50.9, 43.5, 42.9, 36.7, 21.9, 19.8;  IR (Neat Film NaCl) 3076, 2972, 2935,
2871, 1719, 1695, 1639, 1463, 1417, 1378, 1337, 1210, 1160, 1112, 1059, 1026, 921
cm–1;  HRMS (EI+) m/z calc’d for C11H16O2  [M]
+•: 180.1150; found 180.1165;  [!]D
25.0
–19.38 (c 1.00, CHCl3, 88.0% ee).
O
OHn-Bu
O
n-Bu
i-BuO
O CeCl3, n-BuMgCl
THF, 23 °C
then 10% aq HCl
+
27a
65% yield28% yield
55r 70r
Cycloheptenone 55r and #-Hydroxyketone 70r.  CeCl3·7H2O (419 mg, 1.13 mmol,
2.55 equiv) in a 100 mL round-bottom flask was immersed in a preheated oil bath at 150
°C and placed under vacuum for 4 h while stirring.  The flask was cooled to ambient
temperature, backfilled with N2, and charged with THF (4 mL).  After 15 h of stirring,
additional THF (4 mL) and n-butylmagnesium chloride solution (1.2 mL, 1.86 M in THF,
2.23 mmol, 5.02 equiv) were added to the flask.  The resulting slurry was stirred for 4.25
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h before vinylogous ester 27a (105 mg, 0.444 mmol, 1.00 equiv) dissolved in THF (1
mL) was added using positive pressure cannulation followed by two THF rinses (2 x 0.5
mL).  After 45 min of stirring, the reaction was quenched by addition of 10% w/w HCl
(10 mL).  The phases were separated and the aqueous layer was extracted with ethyl
acetate (3 x 15 mL).  The combined organic phases were washed with brine, dried over
Na2SO4, filtered, and concentrated under reduced pressure.  The residue was purified by
flash column chromatography using a Teledyne Isco CombiFlash Rf system (SiO2, 25 g
loading cartridge, 12 g column, multi-step gradient, hold 0% [1 min]%ramp to 10% [5
min]%hold 10% [31 min]%100% EtOAc in hexanes [10 min]) to afford cycloheptenone
55r (28 mg, 0.13 mmol, 28% yield) and #-hydroxyketone 70r (69 mg, 0.29 mmol, 65%
yield) as pale yellow oils.
Cycloheptenone 55r.12Rf = 0.68 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3)
$ 5.89 (s, 1H), 5.63 (dddd, J = 16.9, 10.3, 7.9, 6.7 Hz, 1H), 5.10–4.98 (m, 2H), 2.61–2.54
(m, 2H), 2.37 (dddd, J = 14.1, 6.7, 1.3, 1.3 Hz, 1H), 2.18–2.03 (m, 3H), 1.85–1.72 (m,
3H), 1.66–1.56 (m, 1H), 1.53–1.43 (m, 2H), 1.37 (app. septuplet, J = 7.3 Hz, 2H), 1.15 (s,
3H), 0.92 (t, J = 7.3 Hz, 3H);  13C NMR (125 MHz, CDCl3) $ 205.4, 163.0, 134.2, 128.7,
118.1, 45.7, 45.3, 44.4, 38.8, 34.0, 32.4, 25.7, 23.0, 17.6, 14.1;  IR (Neat Film NaCl)
3076, 2957, 2933, 2872, 1652, 1611, 1467, 1414, 1379, 1342, 1263, 1218, 1178, 1109,
1072, 996, 962, 914, 841, 780, 713 cm–1;  HRMS (MM: ESI-APCI+) m/z calc’d for
C15H25O [M+H]
+: 221.1900; found 221.1905;  [!]D
25.0 –33.17 (c 1.17, CHCl3, 88.0% ee).
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#-Hydroxyketone 70r.13Rf = 0.48 (30% EtOAc in hexanes);  
1H NMR (500 MHz,
CDCl3) mixture of two diastereomers, see Figure A2.76.1 (Neat Film NaCl) 3502, 3073,
2956, 2871, 1695, 1638, 1468, 1404, 1380, 1341, 1286, 1181, 1125, 1052, 1028, 998,
913, 868, 796, 732 cm–1;  HRMS (MM: ESI-APCI+) m/z calc’d for C15H27O2 [M+H]
+:
239.2006; found 239.2013.
O
n-Bu
O
O
OHn-Bu
70r 72r
LiOH, TFE
THF, 60 °C, 3 h
71% yield
Linear Dione 72r.  A 50 mL round-bottom flask equipped with a magnetic stir and fitted
with a water condenser was charged with #-hydroxyketone 70r (56.9 mg, 0.24 mmol,
1.00 equiv), THF (3 mL), TFE (60 µL, 0.83 mmol, 3.50 equiv), and LiOH (17.3 mg, 0.72
mmol, 3.03 equiv).  The flask was backfilled with argon and lowered into a preheated oil
bath (60 °C).  After 3 h, the reaction was removed from the bath, allowed to cool to room
temperature, dried over Na2SO4, filtered, and concentrated under reduced pressure.  The
crude oil was purified by flash chromatography (SiO2, 3 x 21 cm, 10%%20%%30%
EtOAc in hexanes) to afford linear dione 72r (40.1 mg, 0.17 mmol, 71% yield) as a pale
yellow oil; Rf = 0.57 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3) $ 5.68–5.57
(m, 1H), 5.06–4.98 (m, 2H), 2.43 (t, J = 7.3 Hz, 2H), 2.39 (t, J = 6.4 Hz, 2H), 2.31 (dddd,
J = 14.0, 7.3, 1.2, 1.2 Hz, 1H), 2.18 (dddd, J = 14.0, 7.7, 1.2, 1.2 Hz, 1H), 2.11 (s, 3H),
1.63–1.34 (m, 6H), 1.33–1.24 (m, 2H), 1.10 (s, 3H), 0.89 (t, J = 7.3 Hz, 3H);  13C NMR
(125 MHz, CDCl3) $ 214.9, 208.6, 133.9, 118.1, 50.9, 44.0, 42.6, 37.4, 37.4, 30.1, 25.9,
22.6, 21.1, 18.7, 14.1;  IR (Neat Film NaCl) 3076, 2958, 2933, 2873, 1718, 1701, 1639,
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1465, 1409, 1378, 1360, 1256, 1230, 1174, 1142, 1120, 1029, 994, 916, 766, 728 cm–1;
HRMS (MM: ESI-APCI+) m/z calc’d for C15H27O2 [M+H]
+: 239.2006; found 239.2005;
[!]D
25.0 +5.57 (c 1.17, CHCl3, 88.0% ee).
n-Bu
O
O
OHn-Bu
70r 53r
KOt-Bu
THF, 60 °C, 22 h
65% yield
Acylcyclopentene 53r.  A 25 mL round-bottom flask equipped with a stir bar and fitted
with a water condenser was charged with #-hydroxyketone 70r (91.5 mg, 0.38 mmol,
1.00 equiv), THF (4 mL), and KOt-Bu (66.5 mg, 0.59 mmol, 1.55 equiv).  The flask was
lowered into a preheated oil bath (60 °C) and stirred overnight.  Additional THF (4 mL)
was added after 19 h of heating.  After an additional 3 h, the reaction was removed from
the bath, allowed to cool to room temperature, dried over Na2SO4, filtered through a silica
gel plug, and concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 3 x 27 cm, 100% pentane%2%%5%%10% Et2O in pentane) to
afford acylcyclopentene 53r (55.1 mg, 0.25 mmol, 65% yield) as a pale yellow oil;  Rf =
0.81 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 5.77–5.65 (m, 1H),
5.08–5.00 (m, 2H), 2.60–2.49 (m, 2H), 2.45–2.37 (m, 1H), 2.24–2.17 (m, 4H), 2.15–2.10
(m, 2H), 1.85 (ddd, J = 12.8, 7.7, 6.2 Hz, 1H), 1.60–1.51 (m, 1H), 1.47–1.34 (m, 4H),
1.06 (s, 3H), 0.93 (t, J = 7.1 Hz, 3H);  13C NMR (125 MHz, CDCl3) $  198.8, 164.2,
135.0, 134.7, 117.6, 52.6, 43.8, 35.0, 32.1, 31.5, 30.4, 27.6, 24.7, 23.8, 14.0;  IR (Neat
film NaCl) 3075, 3002, 2957, 2930, 2870, 2859, 1677, 1653, 1639, 1602, 1456, 1432,
1373, 1355, 1311, 1275, 1258, 1188, 1141, 1089, 995, 959, 913, 848, 801, 726 cm–1;
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HRMS (MM: ESI-APCI+) m/z calc’d for C15H25O [M+H]
+: 221.1900; found 221.1900;
[!]D
25.0  –1.44 (c 1.35, CHCl3, 88.0% ee).
n-Bu
O
O
OHn-Bu
70r 53r
KOt-Bu
THF, 85 °C, 5 min
µwaves
73% yield
Acylcyclopentene 53r.  KOt-Bu (32 mg, 0.283 mmol, 1.62 equiv), THF (1.75 mL), and
#-hydroxyketone mmol, 1.00 equiv) were added to a 0.5–2.0 mL microwave vial with a
magnetic spin vane.  The pale yellow solution was subjected to microwave irradiation in
a Biotage Initiator microwave reactor (temperature: 85 °C, sensitivity: normal).  After 5
min of irradiation, the crimp cap was removed and Na2SO4 was added to the vial.  The
contents were filtered through a silica gel plug with Et2O, concentrated under reduced
pressure, and purified by flash column chromatography (5% Et2O in pentane) to yield
acylcyclopentene 53r (31 mg, 0.14 mmol, 73% yield) as a pale yellow oil.
2.7.2.11 PREPARATION OF ACYLCYCLOPENTENE DERIVATIVES
O
53a 80
98% ee
N
H
N NH2
ONaOAc
H2O, 60 °C
recrystallize twice
63% yield
H2N
H
N NH2
O
HCl
Semicarbazone 80.  A 15 mL round-bottom flask was charged with sodium acetate (150
mg, 1.83 mmol, 1.20 equiv), semicarbazide hydrochloride (204 mg, 1.83 mmol, 1.20
equiv), and a magnetic stir bar.  Purified water (1.7 mL) was added and the mixture was
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stirred until all the solids had dissolved.  Acylcyclopentene 53a (250 mg, 1.52 mmol,
1.00 equiv) was added neat and the mixture was heated to 60 °C for 4 h.  The slurry was
allowed to cool to ambient temperature while stirring and was then vacuum filtered
(water aspirator).  The white solid was dried under reduced pressure to afford
semicarbazone 15 (311 mg, 1.40 mmol, 92% yield).  The ee of the semicarbazone at this
point was found to be 91% (measured by hydrolysis to ketone 53a, GC conditions: 80 °C
isothermal for 90 min, G-TA column, tR (min): acylcyclopentene 53a = 54.98).
The semicarbazone 80 (300 mg, 1.36 mmol) was transferred to a round-bottom
flask, the solids were suspended in toluene-hexanes (50:50), and the mixture was heated
to 90 °C while stirring.  After a few minutes of stirring, the solids had dissolved
completely to afford a clear, colorless solution.  Heating was discontinued, and the
stirring mixture was allowed to cool to ambient temperature while still immersed in the
oil bath.  After 10 h had elapsed, the slurry was vacuum filtered to afford 80 (246 mg,
1.11 mmol, 82% yield, 63% overall yield after recrystallizing twice).  The ee at this point
was found to be 94.5% (measured by hydrolysis to ketone 53a ).  A second
recrystallization following the above procedure employing 80 (241 mg, 1.09 mmol)
afforded 80 (201 mg, 0.91 mmol, 83% yield).  The ee at this point was found to be 97.9%
(measured by hydrolysis to ketone 53a);  Rf = 0.30 (9:1 CHCl3-MeOH);  
1H NMR (300
MHz, CDCl3) $ 8.52 (br s, 1H), 6.06 (br s, 1H), 5.85 (app t, J = 1.6 Hz, 1H), 5.76 (dddd, J
=  16.7, 9.3, 7.4, 7.4 Hz, 1H), 5.47 (br s, 1H), 5.06–4.98 (m, 2H), 2.67–2.49 (m, 2H),
2.15–2.12 (m, 2H), 1.98 (s, 3H), 1.82 (ddd, J = 12.8, 8.2, 6.9 Hz, 1H), 1.62 (ddd, J =
12.8, 8.5, 6.4 Hz, 1H), 1.07 (s, 3H);  13C NMR (75 MHz, CDCl3) $ 158.1, 145.0, 141.7,
141.2, 135.6, 117.2, 49.2, 45.9, 36.2, 30.8, 26.3, 12.8;  IR (Neat Film NaCl) 3473, 3266,
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3189, 2946, 2858, 1698, 1579, 1478, 1437, 1377, 1349, 1321, 1130, 1109, 993, 910, 845,
768 cm–1;  HRMS (ESI+) m/z calc'd for C12H20N3O [M+H]
+: 222.1606; found 222.1610;
[!]D
22.6 +39.80 (c 0.84, CHCl3, 97.9% ee);  mp = 145–146 °C (1:1 toluene-hexanes).
O
53a80
N
H
N NH2
O 6 M aq HCl
THF, H2O, 23 °C
93% yield
Acylcyclopentene 53a.  A solution of semicarbazone 80 (191.8 mg, 0.867 mmol, 1.00
equiv) in THF (1.92 mL) was treated with aqueous HCl (3.84 mL, 6.0 M, in H2O) was
added.  The resulting biphasic mixture was stirred vigorously at ambient temperature for
30 h.  The reaction was diluted with Et2O (10 mL), the phases were separated, and the
aqueous phase was extracted with Et2O (2 x 10 mL).  The combined organics were dried
over MgSO4, filtered, and concentrated carefully under reduced pressure, allowing for a
film of ice to form on the outside of the flask.  The residue was filtered through a short
silica gel plug (1 x 10 cm SiO2, 4:1 hexanes:Et2O) to afford acylcyclopentene 53a (132.6
mg, 0.81 mmol, 93% yield);  [!]D
22.6 +39.80 (c 0.84, CHCl3, 97.9% ee).  (For
characterization data, see p. 320).
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80
N
H
N NH2
O
N
H
N
H
N
O
I
81
m-xylene, 150 °C
89% yield
NH2
I
(X-ray)
Iodoarene 81.  To a solution of semicarbazone 80 (50 mg, 0.23 mmol, 1.00 equiv) in m-
xylene (2.2 mL) was added 4-iodo-benzylamine (63 mg, 0.27 mmol, 1.17 equiv).  The
resulting pale yellow solution was immersed in an oil bath and heated to 150 °C.  After 9
h of stirring at 150 °C, the reaction was allowed to cool to ambient temperature and
concentrated under reduced pressure to afford a pale yellow solid.  The crude solid was
purified by flash column chromatography (1.0 x 15 cm SiO2, 9:1%7:3 hexanes:EtOAc) to
afford iodoarene 81 (88 mg, 0.20 mmol, 89% yield) as a white solid.  X-ray quality
crystals were obtained by slow vapor diffusion of pentane into a chloroform solution of
81;  Rf = 0.52 (9:1 CHCl3-MeOH);  
1H NMR (500 MHz, CDCl3) $ 7.88 (s, 1H), 7.66–7.64
(m, 2H), 7.08 (d, J = 8.5 Hz, 2H), 6.50 (t, J = 6.1 Hz, 1H), 5.86 (app t, J = 1.5 Hz, 1H),
5.76 (dddd, J = 16.9, 9.0, 7.6, 7.6 Hz, 1H), 5.04–5.01 (m, 2H), 4.46 (d, J = 6.3 Hz, 2H),
2.60–2.49 (m, 2H), 2.18–2.10 (m, 2H); 1.95 (s, 3H), 1.82 (ddd, J = 12.9, 8.5, 6.3 Hz, 1H),
1.62 (ddd, J = 12.9, 8.5, 6.1 Hz, 1H), 1.07 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 156.3,
144.5, 141.5, 141.4, 139.2, 137.8, 135.6, 129.4, 117.2, 92.6, 49.3, 45.9, 43.2, 36.2, 30.9,
26.3, 12.5;  IR (Neat Film NaCl) 3411, 3194, 3075, 2946, 2920, 2863, 1677, 1528, 1486,
1401, 1323, 1259, 1142, 1114, 1057, 1000, 913, 845 cm–1;  HRMS (FAB+) m/z calc'd for
C19H25N3OI [M+H]
+: 438.1043; found 438.1036;  [!]D
22.2 +31.43 (c 0.36, CHCl3, 91.0%
ee);  mp = 123–124 °C (CHCl3-n-pentane).
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CeCl3, MeLi
THF, –78!23 °C
92% yield
O
53a 82
OH
Alcohol 82.  CeCl3 (187 mg, 0.759 mmol, 2.50 equiv) was weighed out in a glove box
and placed in a 25 mL round-bottom flask.  The flask was sealed with a septum and
removed from the glove box.  THF (3 mL) was added to the flask, the suspension was
cooled to –78 °C using an acetone/CO2(s) bath, and MeLi (326 µL, 0.912 mmol, 2.80 M
in DME, 3.00 equiv) was added in a dropwise manner.  The resulting pale brown
suspension was stirred at –78 °C for 30 min.  Acylcyclopentene 53a (50.0 mg, 0.304
mmol, 1.00 equiv) was added neat to the reaction in a dropwise manner.  After 30 min of
stirring at –78 °C, the reaction was quenched by dropwise addition of sat. aqueous NH4Cl
(1.0 mL), the cooling bath was removed, and the reaction was allowed to warm to
ambient temperature.  The reaction was diluted with Et2O (10 mL) and H2O (10 mL), and
the phases were separated.  The aqueous phase was extracted with Et2O (3 x 15 mL), and
the combined organic phases were washed with brine (10 mL), dried over MgSO4,
filtered, and concentrated under reduced pressure.  The crude product was purified by
automated flash column chromatography using a Teledyne Isco CombiFlash Rf (SiO2, 5 g
loading cartridge, 12 g column, multi-step gradient, 5% [5 min]%10% Et2O in pentane)
to afford alcohol 82 (50.4 mg, 0.280 mmol, 92% yield) as a pale yellow oil;  Rf = 0.31
(4:1 hexanes:EtOAc);  1H NMR (400 MHz, CDCl3) $ 5.78 (dddd, J = 14.7, 11.8, 9.3, 7.4
Hz, 1H), 5.34 (dd, J = 1.8, 1.8 Hz, 1H), 5.04–5.00 (m, 1H), 5.00–4.97 (m, 1H), 2.45–2.29
(m, 2H), 2.18–2.00 (m, 2H), 1.81 (ddd, J = 12.7, 8.3, 6.0 Hz, 1H), 1.60 (ddd, J = 12.7,
8.5, 6.1 Hz, 1H), 1.44 (br s, 1H), 1.34 (s, 6H), 1.02 (s, 3H);  13C NMR (100 MHz, CDCl3)
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$ 149.7, 136.21, 131.6, 116.7, 70.9, 48.2, 46.2, 36.9, 30.9, 29.3, 29.3, 26.5;  IR (Neat
Film NaCl) 3370, 3077, 2973, 2943, 2859, 1637, 1454, 1412, 1367, 1328, 1254, 1212,
1162, 1137, 997, 960, 940, 910, 853, 806 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for
C12H19 [M-OH]
+: 163.1481; found 163.1482;  [!]D
25.0 +5.34 (c 1.16, CHCl3, 88.0 % ee).
O
53a 83
N
OH
H2NOH
3 M aq NaOH
MeOH
90% yield
Oxime 83.  A 1 dram vial with magnetic stir bar was charged with acylcyclopentene 53a
(40.0 mg, 0.24 mmol, 1.00 equiv), MeOH (0.24 mL), 50% wt aqueous hydroxylamine
(47 µL, 0.76 mmol, 3.13 equiv), and 3 M aqueous NaOH (125 µL, 0.376 mmol, 0.51
equiv).  After 9 d, the reaction was diluted with Et2O (10 mL) and H2O (2 mL) and stirred
vigorously for several minutes.  The layers were separated and the aqueous layer was
extracted with Et2O (5 x 10 mL).  The combined organic layers were dried over MgSO4,
filtered, and concentrated under reduced pressure.  The residue was taken up in CH2Cl2,
filtered through a cotton plug, and concentrated under reduced pressure.  The residue was
purified by flash column chromatography (SiO2, 1.5 x 20 cm, 20:1% 15:1
hexanes:EtOAc) to afford oxime 83 (39.3 mg, 0.21 mmol, 90% yield) as a clear oil;  Rf =
0.52 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 9.73 (br s, 1H), 5.90 (br t, J =
1.5 Hz, 1H), 5.85–5.66 (m, 1H), 5.02 (m, 2H), 2.70–2.45 (m, 2H), 2.14 (m, 2H), 2.05 (s,
3H), 1.85 (ddd, J = 12.9, 8.1, 6.6 Hz, 1H), 1.65 (ddd, J = 12.8, 8.3, 6.3 Hz, 1H), 1.08 (s,
3H);  13C NMR (75 MHz, CDCl3) $ 154.0, 141.8, 139.1, 135.6, 117.2, 48.9, 45.9, 36.3,
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30.6, 26.2, 11.3;  IR (Neat Film NaCl) 3272, 3233, 3075, 3003, 2952, 2925, 2864, 1639,
1455, 1437, 1414, 1379, 1322, 1280, 1103, 1010, 995, 913, 850, 828, 756, 715 cm–1;
HRMS (EI+) m/z calc'd for C8H12NO [M–C3H5]
+: 138.0919; found 138.0960;  [!]D
25.0
+21.34 (c 1.57, CHCl3, 88.0% ee).
O
53a 84
N
NHTs
CH3(CH2)15N(CH3)3Br
KOH, TsNHNH2
ClCH2CH2Cl
74% yield
Tosylhydrazone  84 .  A 25 mL flask with magnetic stir bar was charged with
acylcyclopentene 53a (40.0 mg, 0.24 mmol, 1.00 equiv), 1,2-dichloroethane (2.7 mL),
cetyltrimethylammonium bromide (26.6 mg, 0.073 mmol, 0.30 equiv), KOH (136.7 mg,
2.44 mmol, 10.0 equiv), and TsHNNH2 (271.9 mg, 1.46 mmol, 6.00 equiv), forming a
thick white suspension.  After 43 h, the reaction was quenched by the addition of sat.
aqueous NH4Cl (5 mL).  The mixture was extracted with CH2Cl2 (5 x 10 mL) and the
combined organic layers were dried over Na2SO4, filtered, and concentrated under
reduced pressure.  The residue was purified by flash column chromatography using a
Teledyne Isco CombiFlash Rf system (SiO2, 3 x 25 cm, 4:1%3:1 hexanes:EtOAc) to
afford tosylhydrazone 84 (196.7 mg, 0.94 mmol, 74% yield) as a clear oil;  Rf = 0.41 (2:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 7.86 (d, J = 8.3 Hz, 2H), 7.54 (br s, 1H),
7.31 (d, J = 8.0 Hz, 2H), 5.85 (app t, J = 1.6 Hz, 1H), 5.81–5.62 (m, 1H), 5.06–4.92 (m,
2H), 2.58–2.48 (m, 2H), 2.43 (s, 3H), 2.19–2.00 (m, 2H), 1.89 (s, 3H), 1.85–1.71 (m,
1H), 1.71–1.50 (m, 1H), 1.03 (s, 3H);  13C NMR (75 MHz, CDCl3) $ 151.5, 144.1, 142.4,
141.6, 135.5, 135.4, 129.5, 128.3, 117.2, 49.3, 45.8, 36.2, 30.7, 26.1, 21.7, 12.9;  IR (Neat
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Film NaCl) 3217, 3072, 2953, 2924, 2864, 1706, 1639, 1618, 1598, 1495, 1454, 1401,
1337, 1307, 1292, 1212, 1185, 1168, 1094, 1059, 1029, 996, 914, 870, 850, 830, 813, 706
cm–1;  HRMS (EI+) m/z calc'd for C15H19O2N2S [M–C3H5]
+: 291.1167; found 291.1181;
[_]D
25.0 +34.25 (c 1.05, CHCl3, 88.0% ee).
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
methyl vinyl ketone
O
O
O
Rh(PPh3)3Cl (10 mol %)
CH2Cl2, H2 (1 atm)
93% yield
O
O53a 130 85
Ru
O
Cl
Cl
NN
toluene, 50 °C
99% yield
Bis-enone 130.  To an oven-dried reaction tube with magnetic stir bar was added
acylcyclopentene 53a (50 mg, 0.304 mmol, 1.00 equiv).  The headspace was purged with
N2 and dry degassed toluene (2.0 mL, sparged with N2 for 1 h immediately before use)
was added, followed by methyl vinyl ketone (124 µL, 1.53 mmol, 5.03 equiv).
Grubbs–Hoveyda 2nd generation catalyst (9.5 mg, 15.2 µmol, 5 mol %) was quickly
added to the reaction, giving the solution an olive green color.  A reflux condenser was
attached and the reaction was inserted into a 50 °C heating block.  The solution quickly
developed a dark brown color.  After 2 h, the reaction was cooled to ambient temperature.
The solution was filtered through a short silica gel plug (2 x 4 cm, Et2O).  The filtrate was
concentrated under reduced pressure and the brown residue was purified by flash column
chromatography (SiO2, 2 x 25 cm, 10:1%4:1%2:1%1:1 hexanes:EtOAc) to afford bis-
enone 130 (62.3 mg, 0.30 mmol, 99% yield) as a brown liquid;  Rf = 0.31 (2:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $  6.71 (ddd, J = 15.5, 7.6, 7.6 Hz, 1H),
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6.42 (s, 1H), 6.10 (d, J = 15.8 Hz, 1H), 2.68–2.40 (m, 2H), 2.33 (dd, J = 7.6, 0.9 Hz, 2H),
2.28 (s, 3H), 2.22 (s, 3H), 1.84 (ddd, J = 14.7, 8.2, 6.6 Hz, 1H), 1.70 (ddd, J = 13.1, 8.4,
6.1 Hz, 1H), 1.14 (s, 3H);  13C NMR (75 MHz, CDCl3) $  198.1, 197.1, 150.2, 144.3,
143.8, 133.8, 50.1, 43.7, 36.2, 29.8, 27.3, 26.8, 25.7;  IR (Neat Film NaCl) 3584, 3318,
2956, 2866, 1697, 1669, 1626, 1454, 1429, 1365, 1308, 1254, 1182, 1098, 1021, 982,
937, 867 cm–1;  HRMS (EI+) m/z calc'd for C13H18O2 [M]
+•: 206.1307; found 206.1303;
[!]D
25.0 +47.61 (c 1.02, CHCl3, 88.0% ee).
Mono-enone 85.  An oven-dried 2-neck flask fitted with a magnetic stir bar, rubber
septum, and glass T-joint with 14/20 adapter was charged with bis-enone 130 (50.0 mg,
0.24 mmol, 1.00 equiv) and evacuated/backfilled with N2 in a glove box antechamber (3
cycles, 5 min evacuation per cycle) before being transferred into the glove box.  CH2Cl2
(2.5 mL) and Rh(PPh3)3Cl (22.4 mg, 0.024 mmol, 10 mol %) were added to the flask,
giving a red solution.  The flask was sealed with a septum on one neck and T-joint (set to
the closed position) on the other neck and carefully brought out of the glove box.  A H2
balloon was attached to the T-joint and the flask was gently evacuated/backfilled with H2
(3 cycles, 2 min evacuation per cycle).  After 10 h of stirring, the brown reaction mixture
was filtered through a short silica gel plug (2 x 4 cm, Et2O) and concentrated under
reduced pressure.  The residue was purified by flash column chromatography (SiO2, 2 x
25 cm, 10:1%4:1%2:1 hexanes:Et2O) to afford enone 85 (46.8 mg, 0.23 mmol, 93%
yield) as an orange liquid;  Rf = 0.40 (2:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3)
$ 6.43 (app t, J = 1.7 Hz, 1H), 2.65–2.46 (m, 2H), 2.40 (t, J = 7.1 Hz, 2H), 2.27 (s, 3H),
2.11 (s, 3H), 1.88–1.72 (m, 1H), 1.71–1.46 (m, 3H), 1.46–1.29 (m, 2H), 1.08 (s, 3H);  13C
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NMR (75 MHz, CDCl3) $ 208.8, 197.5, 152.0, 143.6, 50.0, 44.2, 40.4, 36.1, 30.1, 29.7,
26.8, 25.6, 19.4;  IR (Neat Film NaCl) 2998, 2953, 2866, 1716, 1667, 1616, 1456, 1427,
1367, 1308, 1270, 1225, 1190, 1170, 1103, 1058, 1021, 841, 871, 726 cm–1;  HRMS
(EI+) m/z calc'd for C13H20O2 [M]
+•: 208.1463; found 208.1460;  [!]D
25.0 +25.55 (c 1.46,
CHCl3, 88.0% ee).
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
crotonaldehyde
O
O H
O
Rh(PPh3)3Cl (10 mol %)
CH2Cl2, H2 (1 atm)
90% yield
O
O H53a 131 86
Ru
O
Cl
Cl
NN
benzene, 50 °C
90% yield
Bis-enone 131.  To a 2-neck round-bottomed flask with magnetic stir bar and attached
reflux condenser was added acylcyclopentene 53a (100 mg, 0.608 mmol, 1.00 equiv).
The flask was evacuated/backfilled with N2 (3 cycles, 30 s evacuation per cycle).  Dry
degassed benzene (8.0 mL, sparged with N2 for 1 h immediately before use) was added,
followed by crotonaldehyde (251 µL, 3.06 mmol, 5.03 equiv).  Grubbs–Hoveyda 2nd
generation catalyst (19.0 mg, 30.4 µmol, 5 mol %) was quickly added to the reaction,
giving the solution an olive green color.  The flask was immersed in a 50 °C oil bath.
The solution quickly developed a dark brown color.  After 2 h, the reaction was cooled to
ambient temperature.  Several drops of ethyl vinyl ether were added and the reaction
mixture was stirred for 5 min.  The mixture was concentrated under reduced pressure and
the brown residue was purified by flash column chromatography (SiO2, 2 x 25 cm,
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10:1%4:1%2:1 hexanes:EtOAc) to afford bis-enone 131 (105.4 mg, 0.55 mmol, 90%
yield) as a brown oil;  Rf = 0.38 (2:1 hexanes:EtOAc);  
1H NMR (300 MHz, CDCl3) $
9.50 (d, J = 7.8 Hz, 1H), 6.76 (app dt, J = 15.4, 7.6 Hz, 1H), 6.42 (app t, J = 1.8 Hz, 1H),
6.13 (app ddt, J = 15.5, 7.8, 1.3 Hz, 1H), 2.68–2.50 (m, 2H), 2.45 (dd, J = 7.6, 1.3 Hz,
2H), 2.28 (s, 3H), 1.85 (ddd, J = 13.1, 8.4, 6.5 Hz, 1H), 1.72 (ddd, J = 13.1, 8.5, 6.0 Hz,
1H), 1.16 (s, 3H);  13C NMR (75 MHz, CDCl3) $ 197.0, 193.5, 154.0, 149.7, 144.5, 135.6,
50.1, 43.9, 36.1, 29.8, 26.8, 25.8;  IR (Neat Film NaCl) 3359, 3317, 3041, 2957, 2928,
2867, 2820, 2743, 2708, 1691, 1668, 1636, 1618, 1456, 1431, 1378, 1369, 1341, 1308,
1269, 1203, 1162, 1149, 1109, 1093, 1036, 1013, 978, 936, 893, 868 cm–1;  HRMS
(FAB+) m/z calc'd for C12H17O2 [M+H]
+: 193.1229; found 193.1224;  [!]D
25.0 +46.07 (c
1.13, CHCl3, 88.0% ee).
Mono-enone 86.  An oven-dried 2-neck flask fitted with a magnetic stir bar, rubber
septum, and a glass T-joint with 14/20 adapter was charged with and bis-enone 131 (42.8
mg, 0.22 mmol, 1.00 equiv) and evacuated/backfilled with N2 in a glove box antechamber
(3 cycles, 5 min evacuation per cycle) before being transferred into the glove box.
CH2Cl2 (2.5 mL) and Rh(PPh3)3Cl (10.3 mg, 0.011 mmol, 5 mol %) were added to the
flask, giving a red solution.  The flask was sealed with a septum on one neck and T-joint
(set to the closed position) on the other neck and carefully brought out of the glove box.
A H2 balloon was attached to the T-joint and the flask was gently evacuated/backfilled
with H2 (five cycles, 2 min evacuation per cycle).  After 20 h of stirring, an additional
portion of Rh(PPh3)3Cl (10.3 mg, 0.011 mmol, 5 mol %) in CH2Cl2 (0.5 mL) was added
to the reaction using positive pressure cannulation.  After 1.5 h of stirring, the reaction
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was diluted with Et2O, filtered through a short silica gel plug (2 x 4 cm, Et2O), and
concentrated under reduced pressure.  The residue was purified by flash column
chromatography (SiO2, 2 x 25 cm, 10:1%4:1 hexanes:Et2O) to afford enone 86 (39.2 mg,
0.20 mmol, 90% yield) as an pale colorless oil;  Rf = 0.48 (2:1 hexanes:EtOAc);  
1H
NMR (300 MHz, CDCl3) $  9.75 (t, J = 1.5 Hz, 1H), 6.44 (app t, J = 1.7 Hz, 1H),
2.59–2.48 (m, 2H), 2.43 (td, J = 7.1, 1.4 Hz, 2H), 2.28 (s, 3H), 1.88–1.73 (m, 1H),
1.73–1.51 (m, 3H), 1.51–1.33 (m, 2H), 1.09 (s, 3H);  13C NMR (75 MHz, CDCl3) $ 202.3,
197.5, 151.7, 143.8, 50.0, 44.5, 40.4, 36.1, 29.8, 26.8, 25.6, 17.8;  IR (Neat Film NaCl)
3427, 3314, 3042, 2951, 2865, 2721, 1723, 1665, 1616, 1457, 1411, 1378, 1367, 1340,
1308, 1269, 1193, 1156, 1105, 1060, 1034, 1020, 970, 942, 867, 801 cm–1;  HRMS (EI+)
m/z calc'd for C12H18O2 [M]
+•: 194.1307; found 194.1321;  [!]D
25.0 +32.50 (c 0.69, CHCl3,
88.0% ee).
NaOH, I2, KI
H2O, p-dioxane
0!23 °C
O
OH
O
53a 132
N
O
O
88
CDI, CH2Cl2
then         
MeHNOMe•HCl
77% yield
2 steps
Carboxylic acid 132.  A 50 mL round-bottom flask with magnetic stir bar was charged
with acylcyclopentene 53a (200 mg, 1.22 mmol, 1.00 equiv) and p-dioxane (10 mL).
The solution was cooled to 0 °C and 5 M aqueous NaOH (10 mL) was added dropwise.
The white suspension was stirred for 5 min at 0 °C.  A dark brown solution of I2 (1.37 g,
5.40 mmol, 4.40 equiv) and KI (2.09 g, 12.59 mmol, 10.50 equiv) in purified H2O (10
mL) was added to the reaction dropwise, causing the reaction to become a yellow
suspension.  After 6.5 h of stirring at 0 °C, an additional portion of I2 (343 mg, 1.35
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mmol, 1.11 equiv) in p-dioxane (2 mL) was added to the reaction.  After 30 min of
stirring at 0 °C, the reaction was acidified to pH 2 using 2 M aqueous HCl.  The reaction
was extracted with Et2O (3 x 30 mL) until the organic layer was clear.  The combined
organic phases were washed with sat. aqueous K2S2O3 (2 x 10 mL), H2O (2 x 10 mL), and
brine (2 x 10 mL).  The combined organic phases were dried over Na2SO4, filtered, and
concentrated under reduced pressure to give a yellow semi-solid.  The residue was taken
up in EtOAc, filtered through a silica gel plug (3 x 3 cm, EtOAc), and concentrated to
give carboxylic acid 132 as a pale yellow oil which was used directly in the next step;  Rf
= 0.35, broad (2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 6.69 (app t, J = 1.9
Hz, 1H), 5.89–5.62 (m, 1H), 5.11–4.99 (m, 2H), 2.68–2.47 (m, 2H), 2.26–2.09 (m, 2H),
1.91 (ddd, J = 13.0, 8.2, 7.0 Hz, 1H), 1.69 (ddd, J = 13.0, 8.2, 6.2 Hz, 1H), 1.10 (s, 3H);
13C NMR (75 MHz, CDCl3) $ 170.7, 154.3, 134.8, 133.9, 117.8, 49.8, 45.2, 36.3, 30.3,
25.5;  IR (Neat Film NaCl) 3076, 3004, 2956, 2926, 2865, 2610, 1687, 1634, 1454, 1424,
1374, 1348, 1306, 1280, 1216, 1180, 1083, 995, 915, 745, 720 cm–1;  HRMS (EI+) m/z
calc'd for C7H9O2 [M–C3H5]
+: 125.0603; found 125.0629;  [!]D
25.0 +1.43 (c 0.80, CHCl3,
88.0% ee).
Amide 88.  A 50 mL flask with magnetic stir bar was charged with carboxylic acid 132
(202.7 mg, 1.22 mmol, 1.00 equiv) and anhydrous CH2Cl2 (4.0 mL).  To the vigorously
stirred reaction was added 1,1’-carbonyldiimidazole (217 mg, 1.34 mmol, 1.10 equiv) in
a portionwise manner.  After 15 min, anhydrous N,O-dimethylhydroxylamine
hydrochloride (143 mg, 1.46 mmol, 1.20 equiv) was added portionwise.  The reaction
became turbid after several min.  After 21 h, an additional portion of N ,O -
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dimethylhydroxylamine hydrochloride (14.3 mg, 0.146 mmol, 0.12 equiv) was added.  At
23.5 h, the reaction was transferred to a separatory funnel, washed with 0.25 M HCl (2 x
2 mL), sat. aqueous NaHCO3, and brine.  The combined organic phases were dried over
Na2SO4, filtered, and concentrated under reduced pressure.  The residue was purified by
flash column chromatography (SiO2, 3 x 25 cm, 4:1%3:1 hexanes:EtOAc) to afford
amide 88 as a clear oil (196.7 mg, 0.94 mmol, 77% yield over 2 steps);  Rf = 0.41 (2:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 6.26 (app t, J = 1.9 Hz, 1H), 5.87–5.68
(m, 1H), 5.09–4.97 (m, 2H), 3.63 (s, 3H), 3.23 (s, 3H), 2.77–2.55 (m, 2H), 2.21–2.11 (m,
2H), 1.83 (ddd, J = 12.8, 8.3, 6.4 Hz, 1H), 1.62 (ddd, J = 12.7, 8.4, 6.0 Hz, 1H), 1.08 (s,
3H);  13C NMR (75 MHz, CDCl3) $ 167.5, 147.0, 135.4, 135.3, 117.4, 61.2, 49.4, 45.4,
35.9, 33.3, 32.9, 25.6;  IR (Neat Film NaCl) 3584, 3401, 3078, 2954, 2930, 2864, 1641,
1609, 1454, 1441, 1414, 1378, 1329, 1198, 1177, 1152, 1105, 1043, 997, 969, 914, 812,
723 cm–1;  HRMS (EI+) m/z calc'd for C12H20NO2 [M+H]
+: 210.1494; found 210.1498;
[!]D
25.0 +1.41 (c 0.98, CHCl3, 88.0% ee).
N
O
88 89
THF, –15 °C
45% yield
O
O
MgBr
Divinylketone 89.  A 25 mL round-bottomed flask with magnetic stir bar was charged
with amide 88 (97.0 mg, 0.46 mmol, 1.00 equiv), evacuated/backfilled with N2 (3 cycles,
5 min evacuation per cycle), dissolved in THF (3.0 mL), and cooled to –15 °C using an
ethylene glycol/CO2(s) bath.  The yellow solution became cloudy.  Vinylmagnesium
bromide solution (1.38 mL, 1.0 M in THF, 1.38 mmol, 3.00 equiv) was added dropwise.
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The solution was maintained at –15 °C for 20 min before the flask was allowed to warm
to ambient temperature.  The reaction was quenched by addition into sat. aqueous NH4Cl
(2.0 mL) using positive pressure cannulation.  The mixture was extracted with Et2O (3 x
10 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure.  The
residue was purified by flash column chromatography (SiO2, 2 x 25 cm,
0%%1%%2%%3% Et2O in hexanes) to afford divinylketone 89 (36.2 mg, 0.21 mmol,
45% yield) as a pale yellow liquid;  Rf = 0.68 (4:1 hexanes:EtOAc);  
1H NMR (300 MHz,
CDCl3) $ 6.88 (dd, J = 17.1, 10.5 Hz, 1H), 6.53 (app t, J = 1.7 Hz, 1H), 6.28 (dd, J =
17.1, 1.9 Hz, 1H), 5.85–5.65 (m, 1H), 5.69 (dd, J = 10.5, 1.9 Hz, 1H), 5.11–4.99 (m, 2H),
2.76–2.50 (m, 2H), 2.29–2.09 (m, 2H), 1.87 (ddd, J = 12.9, 8.2, 6.8 Hz, 1H), 1.67 (ddd, J
= 12.9, 8.3, 6.3 Hz, 1H), 1.13 (s, 3H);  13C NMR (75 MHz, CDCl3) $ 188.9, 152.1, 143.7,
134.8, 132.6, 127.7, 117.8, 50.3, 45.3, 35.8, 30.1, 25.5;  IR (Neat Film NaCl) 3584, 3400,
3078, 2955, 2927, 2866, 1622, 1606, 1453, 1440, 1408, 1374, 1348, 1308, 1255, 1204,
1169, 1059, 981, 956, 915, 783 cm–1;  HRMS (EI+) m/z calc'd for C9H11O [M–C3H5]
+:
135.0846; found 135.0810;  [!]D
25.0 +0.84 (c 0.81, CHCl3, 88.0% ee).
LiOH, H2O2
MeOH
96% yield
1:1.1 dr
O
53a 90
O
O
Epoxide 90.  A solution of acylcyclopentene 53a (100 mg, 0.609 mmol, 1.00 equiv) in
MeOH (6.1 mL) in a 25 mL round-bottom flask was treated with LiOH (7.3 mg, 0.30
mmol, 0.50 equiv) in one portion.  Aqueous H2O2 (75.0 µL, 83.3 mg, 2.00 equiv, 50% in
H2O) was added dropwise.  After 12 h of stirring at ambient temperature additional
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aqueous H2O2 (75.0 µL, 83.3 mg, 2.00 equiv, 50% in H2O) was added.  The reaction was
stirred for an additional 8 h, diluted with CH2Cl2 (10 mL), sat. aqueous NaHCO3 (1.0
mL), and water (1.0 mL).  The phases were separated and the aqueous phase was
extracted with CH2Cl2.  The combined organic phases were dried over Mg2SO4, filtered,
and concentrated carefully under reduced pressure.  The crude product was purified by
automated flash column chromatography using a Teledyne Isco CombiFlash Rf (SiO2, 12
g loading cartridge, 25 g column, linear gradient, 5%%30% Et2O in pentane [15 min]) to
afford epoxide 90 (106 mg, 0.588 mmol, 96% yield) as a colorless fragrant oil and as a
1.1:1 mixture of diastereomers;  Rf = 0.54 (4:1 hexanes:EtOAc);  
1H NMR (400 MHz,
CDCl3) $ 5.90–5.68 (m, 2H), 5.14–5.01 (m, 4H), 3.32 (s, 1H), 3.30 (s, 1H), 2.35–2.21 (m,
4H), 2.07 (s, 3H), 2.07 (s, 3H), 2.05–1.99 (m, 2H), 1.96–1.85 (m, 2H), 1.54–1.49 (m,
1H), 1.33–1.29 (m, 2H), 1.20–1.16 (m, 1H), 1.13 (s, 3H), 0.91 (s, 3H);  13C NMR (100
MHz, CDCl3) $ 205.8, 205.6, 134.7, 133.6, 118.4, 117.8, 70.3, 70.2, 69.4, 69.3, 42.7,
42.7, 42.4, 42.3, 41.3, 31.9, 31.4, 25.0, 24.8, 24.1, 21.7, 20.5;  IR (Neat Film NaCl) 3072,
3002, 2958, 2878, 1706, 1642, 1459, 1444, 1419, 1397, 1360, 1325, 1286, 1261, 1115,
922, 856, 831 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C11H17 [M+H]
+: 181.1223;
found 181.1226;  [!]D
25.0 –6.94 (c 1.40, CHCl3, 88.0 % ee).
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Me3SI, NaH
DMSO, THF, –5 °C
O
LDA, THF
–78!23 °C
55% yield
2 steps
53a 92
O
OH
91
Allylic alcohol 92.  NaH (36.5 mg, 0.91 mmol, 3.0 equiv, 60% w/w in mineral oil) was
suspended in DMSO (1.2 mL) in a 25 mL round-bottom flask.  After 20 min of stirring at
ambient temperature, THF (3.7 mL) was added and the resulting mixture was cooled to
–5 °C using a water/NaCl/ice bath.  Me3SI (192.3 mg, 0.95 mmol, 3.1 equiv) was
dissolved in DMSO (1.2 mL) and added dropwise to the stirred reaction.  After an
additional 5 min of stirring, acylcyclopentene 53a (50 mg, 0.30 mmol, 1.0 equiv) was
added neat dropwise.  After 1.5 h of stirring at –5 °C, the reaction was diluted with Et2O
(15 mL) and quenched by pouring the reaction over 10 g of ice.  The phases were
separated and the aqueous layer was extracted with Et2O (2 x 10 mL).  The combined
organic phases were washed with brine (10 mL), dried over MgSO4, filtered, and
concentrated carefully under reduced pressure, allowing for a film of ice to form on the
outside of the flask, to give the volatile crude epoxide 91 as a colorless oil;  Rf   = 0.60
(4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) mixture of two diastereomers, see
Figure A2.92.1; 13C NMR (100 MHz, CDCl3) mixture of two diastereomers, see Figure
A2.92.3;  IR (Neat Film NaCl) 3072, 3037, 2953, 2923, 2864, 1637, 1451, 1437, 1385,
1370, 1338, 1259, 1140, 1105, 1066, 994, 910, 856, 846, 806, 730 cm–1;  HRMS (APCI+)
m/z calc’d for C12H19O [M+H]
+: 179.1435; found 179.1430.
To a solution of diisopropylamine (0.11 mL, 0.76 mmol, 2.5 equiv) in THF (2.0
mL) in a 10 mL round-bottom flask at 0 °C was added n-BuLi (370 µL, 0.76 mmol, 2.05
M in cyclohexane, 2.5 equiv) dropwise over 10 min.  After 15 min of stirring, the
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reaction was cooled to –78 °C using an acetone/CO2(s) bath and crude epoxide 91 in THF
(1.0 mL) was added dropwise using positive pressure cannulation.  The cooling bath was
allowed to warm to ambient temperature and the reaction was stirred for 18 h.  The
reaction was diluted with Et2O (10 mL) and quenched by addition of a 50:50 (v/v)
mixture of sat. aqueous NH4Cl and water (2.0 mL each).  The phases were separated and
the aqueous phase was extracted with Et2O (2 x 10 mL).  The combined organic phases
were washed with brine (10 mL), dried over MgSO4, filtered, and concentrated carefully
under reduced pressure, allowing for a film of ice to form on the outside of the flask, to
afford a pale yellow oil.  The residue was purified by flash column chromatography
(SiO2, 1 x 22 cm, 20% Et2O in pentane) to afford allylic alcohol 92 (29.9 mg, 0.17 mmol,
55% yield over 2 steps) as a colorless oil;  Rf = 0.25 (4:1 hexanes:EtOAc);  
1H NMR (500
MHz, CDCl3) $ 5.82–5.72 (m, 1H), 5.60 (dd, J = 1.7, 1.7 Hz, 1H), 5.22 (app q, J = 1.4
Hz, 1H), 5.05–5.04 (m, 1H), 5.04–5.01 (m, 1H), 5.01–4.99 (m, 1H), 4.33 (br s, 2H),
2.58–2.45 (m, 2H), 2.17–2.08 (m, 2H), 1.82 (ddd, J = 12.7, 8.8, 5.9 Hz, 1H), 1.62 (ddd, J
= 12.7, 8.8, 5.8 Hz, 1H), 1.51 (br s, 1H), 1.06 (s, 3H);  13C NMR (125 MHz, CDCl3) $
143.6, 139.1, 136.0, 135.9, 116.9, 111.9, 64.3, 49.3, 46.2, 35.9, 32.0, 26.4;  IR (Neat Film
NaCl) 3325, 3071, 3032, 2948, 2859, 1639, 1600, 1451, 1437, 1414, 1370, 1320, 1226,
1194, 1078, 1029, 994, 910, 848 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C12H17
[M–OH]+: 161.1325; found 161.1324;  [!]D
25.0 +17.59 (c 1.38, CHCl3, 88.0% ee).
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PhCl
250 °C, µwaves
90% yield
2:2:1:1 ratio of 
isomers
OO
53f 93
Cyclohexene 93.  Acylcyclopentene 53f (25.2 mg, 0.12 mmol, 1.00 equiv) was added to
a 2.0–5.0 mL microwave vial with magnetic stir bar and sealed with a septum-fitted
crimp cap.  Chlorobenzene (5 mL) was added via syringe.  The clear, colorless solution
was subjected to microwave irradiation in a Biotage Initiator microwave reactor
(temperature: 250 °C, sensitivity: low).  After 2 h of irradiation, the vial was uncapped
and the solvent was removed under reduced pressure.  The yellow residue was purified
by flash column chromatography (SiO2, 1.5 x 15 cm, 15:1 hexanes:Et2O) to afford
cyclohexene 93 as a yellow oil (22.5 mg, 0.104 mmol, 90% yield);  Rf = 0.65 (4:1
hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) mixture of four diastereomers (2:2:1:1),
see Figure A2.94.1;  13C NMR (125 MHz, CDCl3) mixture of four diastereomers, see
Figure A2.94.3;  IR (Neat Film NaCl) 3014, 2921, 2855, 1666, 1611, 1448, 1437, 1369,
1339, 1303, 1268, 1190, 1093, 1075, 1051, 1037, 1024, 935, 868, 798, 733, 703 cm–1;
HRMS (EI+) m/z calc'd for C15H20O [M]
+•: 216.1514; found 216.1518;  [!]D
25.0 –15.57 (c
1.01, CHCl3, 88.0% ee).
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O
53g 95
O
Cl
Cl
Grubbs–Hoveyda 3rd 
generation (94) (25 mol %)
Ru
O
Cl
Cl
NN
benzene, 50 °C
59% yield
Spirocycle 95.  A 2-neck flask fitted with rubber septum and reflux condenser under N2
was charged with Grubbs–Hoveyda 3rd generation catalyst (2.2 mg, 0.035 mmol, 6.1 mol
%).  Dry degassed benzene (4 mL, sparged with N2 for 1 h immediately before use) was
added to give a pale green solution.  The flask was evacuated/backfilled with N2 (3
cycles, 5 min evacuation per cycle).  Acylcyclopentene 53g (14.2 mg, 0.063 mmol, 1.0
equiv) in dry, degassed benzene (4 mL) under N2 was added to the catalyst solution using
positive pressure cannulation.  The flask was rinsed with benzene  (2 mL) and washes
were added into the catalyst solution.  The reaction was immersed in a preheated 50 °C
oil bath and stirred for 44 h.  An additional portion of Grubbs–Hoveyda 3rd generation
catalyst (4.4 mg, 0.070 mmol, 12.2 mol %) in degassed benzene (2 mL) was added into
the reaction using positive pressure cannulation.  After stirring for an additional 15 h, a
third portion of Grubbs–Hoveyda 3rd generation catalyst (2.2 mg, 0.035 mmol, 6.1 mol
%) in degassed benzene (2 mL) was added into the reaction using positive pressure
cannulation.  After 31 h, the reaction was treated with several drops of ethyl vinyl ether
and allowed to cool to ambient temperature.  The solution was diluted with Et2O (15 mL)
and filtered through a short silica gel plug (2 x 10 cm, Et2O).  The orange filtrate was
purified by flash column chromatography (SiO2, 2 x 25 cm, 1%%3%%5%%6.5% Et2O
in hexanes) to give volatile spirocycle 95 (7.3 mg, 0.0376 mmol, 59% yield);  Rf = 0.49
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(4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) $ 6.61 (app t, J = 1.7 Hz, 1H), 5.64
(app p, J = 2.2 Hz, 1H), 2.66 (ddd, J = 16.2, 4.5, 2.1 Hz, 1H), 2.62–2.53 (m, 3H), 2.51
(ddd, J = 16.2, 4.6, 2.4 Hz, 1H), 2.43 (ddd, J = 16.3, 4.6, 2.4 Hz, 1H), 2.31 (s, 3H),
2.09–1.95 (m, 2H);  13C NMR (125 MHz, CDCl3) $  197.3, 150.2, 144.2, 130.7, 125.2,
56.2, 49.7, 44.3, 39.4, 29.6, 26.8;  IR (Neat Film NaCl) 2929, 2845, 1726, 1668, 1616,
1436, 1370, 1340, 1314, 1276, 1193, 1079, 1052, 990, 966, 936, 905, 866, 822, 804 cm–1;
HRMS (EI+) m/z calc'd for C11H13OCl [M]
+•: 196.0655; found 196.0655;  [!]D
25.0 –19.80
(c 0.53, CHCl3, 88.0% ee).
1. Et3N, TBSOTf 
    CH2Cl2, 0 °C
2. DMAD, toluene
    µwaves, 160 °C
O OTBS
CO2Me
CO2Me
1. DDQ, toluene
2. TBAF, THF
53a 97
OH
CO2Me
CO2Me
96
mixture of diastereomers
57% yield
4 steps
Phenol 97.  A 15 mL flask with magnetic stir bar was charged with acylcyclopentene 53a
(50 mg, 0.274 mmol, 1.00 equiv) and anhydrous CH2Cl2 (3.0 mL).  The flask was cooled
to 0 °C and Et3N (152.8 µL, 1.096 mmol, 4.00 equiv) was added, followed by dropwise
addition of TBSOTf (125.8 µL, 0.548 mmol, 2.00 equiv).  The reaction became a pale
yellow solution.  After 1 h of stirring at 0 °C, the reaction was quenched by the addition
of sat. aqueous NaHCO3 and slowly allowed to warm to ambient temperature.  The
mixture was extracted with CH2Cl2 (3 x 10 mL) and the combined organics were dried
over Na2SO4, filtered, and concentrated under reduced pressure.  The residue was filtered
through a silica gel plug (2 x 3 cm, 5:1 H:Et2O) and concentrated under reduced pressure
to give crude silyl enol ether as a pale yellow oil.  Rf = 0.79 (10:1 hexanes:EtOAc).
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The silyl enol ether was added to a 2.0–5.0 mL microwave vial with magnetic stir
bar and sealed with a septum-fitted crimp cap.  Toluene (5 mL) was added, followed by
dimethyl acetylenedicarboxylate (101 µL, 0.822 mmol, 3.00 equiv).  The clear, colorless
solution was subjected to microwave irradiation in a Biotage Initiator microwave reactor
(temperature: 160 °C, sensitivity: low).  After 2.5 h of irradiation, the vial was uncapped
and solvent was removed under reduced pressure.  The yellow residue was purified by
flash column chromatography (SiO2, 3 x 25 cm, 15:1%10:1%4:1%2:1 hexanes:EtOAc)
to afford siloxydiene 96 as a mixture of diastereomers.  Rf = 0.31 (10:1 hexanes:EtOAc).
A 20 mL scintillation vial with magnetic stir bar was charged with siloxydiene 96 and
toluene (3.0 mL).  DDQ (63.5 mg, 0.280 mmol, 1.02 equiv) was added portionwise.
Upon complete addition, the solution became a turbid red suspension.  After 2 h, the
reaction was diluted with CH2Cl2 and filtered through a Celite plug (2 x 3 cm, CH2Cl2).
The clear yellow solution was concentrated under reduced pressure.  The residue was
purified by flash column chromatography (SiO2, 2 x 25 cm, 20:1%15:1%10:1%4:1%2:1
hexanes:EtOAc) to afford the intermediate silyl aryl ether.  Rf = 0.31 (10:1
hexanes:EtOAc).
A 20 mL scintillation vial with magnetic stir bar was charged with silyl aryl ether.
The vial was evacuated, and backfilled with N2.  Anhydrous THF (3 mL) was added and
a TBAF solution (300 µL, 1.0 M in THF) was added dropwise, giving a bright red
solution.  After 10 min, the reaction was quenched by the addition of sat. aqueous NH4Cl
(600 µL) and H2O (600 µ L).  The mixture was stirred vigorously for 20 min and
extracted with Et2O (3 x 5 mL).  The combined organics were dried over Na2SO4, filtered,
and concentrated under reduced pressure.  The residue was purified by flash column
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chromatography (SiO2, 2 x 25 cm, 5:1%4:1 hexanes:EtOAc) to afford phenol 97 as a pale
yellow oil (52.6 mg, 0.173 mmol, 57% yield over 4 steps);  Rf = 0.11 (2:1
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) $ 7.30 (s, 1H), 5.89 (br s, J = 1.9 Hz, 1H),
5.66 (dddd, J = 17.3, 10.2, 7.9, 7.9 Hz, 1H), 5.09–4.91 (m, 2H), 3.88 (s, 3H), 3.83 (s,
3H), 2.76 (t, J = 7.3 Hz, 2H), 2.47–2.26 (m, 2H), 2.24–2.08 (ddd, J = 12.0, 7.0, 7.0 Hz,
1H), 1.85–1.70 (ddd, J = 12.7, 7.6, 7.6 Hz, 1H), 1.26 (s, 3H);  13C NMR (75 MHz,
CDCl3) $ 170.4, 166.7, 152.5, 150.0, 135.8, 135.3, 128.3, 124.0, 117.7, 115.4, 52.7, 52.5,
49.4, 44.1, 38.3, 26.1, 25.6;  IR (Neat Film NaCl) 3401, 3075, 2953, 2871, 1723, 1639,
1588, 1435, 1418, 1376, 1330, 1311, 1258, 1192, 1175, 1142, 1047, 995, 964, 916, 884,
857, 794, 769, 738, 719 cm–1;  HRMS (EI+) m/z calc'd for C17H20O5 [M]
+•: 304.1311;
found 304.1317;  [!]D
25.0 –45.63 (c 0.91, CHCl3, 88.0% ee).
TBAI, Et3N, 2-iodophenol 
Pd(OAc)2 (2.5 mol %)
     
DMF, 100 °C
90% yield
O
53a
O
100
OTf
102
Herrmann–Beller 
catalyst (101) (10 mol %)
TBAA, DMA, 115 °C
77% yield
O
(E/Z)-99
HO
Rh(PPh3)3Cl (10 mol %)
PhCH3, H2 (1 atm)
95% yield
(Ar = o-CH3-C6H4)
O
87
HO
Comins' reagent
DMAP, CH2Cl2
94% yield
N N
Tf
Tf
Cl
O
H
Pd
P
Pd
P
O O
O O
ArAr
Ar Ar
tricyclic core of 
Hamigerans C and D
Phenol 87.  DMF (1.52 mL) was sparged with N2 in a 25 mL Schlenk flask for 1 h.  Et3N
(0.849 mL, 6.09 mmol, 5.0 equiv), TBAI (450 mg, 1.22 mmol, 1.0 equiv) and 2-
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iodophenol (282.2 mg, 1.28 mmol, 1.05 equiv) were added, followed by Pd(OAc)2 (6.84
mg, 0.030 mmol, 2.5 mol %).  The flask was carefully evacuated/backfilled with N2 (3
cycles, 1 min evacuation per cycle) followed by addition of acylcyclopentene 53a (200
mg, 1.22 mmol, 1.0 equiv).  The suspension was immersed in an oil bath at 100 °C.  The
reaction turned orange within 15 min of stirring.  After 5 h of stirring, the reaction was
allowed to cool to ambient temperature, diluted with EtOAc (10 mL), and poured into
aqueous HCl (10 mL, 1.0 M).  The phases were separated and the aqueous phase was
extracted with EtOAc (2 x 10 mL).  The combined organic phases were washed with
brine (10 mL), dried over MgSO4, filtered, and concentrated under reduced pressure.  The
crude oil was purified by flash column chromatography using a Teledyne Isco
CombiFlash Rf system (SiO2, 12 g loading cartridge, 40 g column, linear gradient,
5%%30% EtOAc in hexanes [25 min]) to afford styrenyl phenol 99 as a mixture of olefin
isomers (283.0 mg, 1.10 mmol, 90% yield) as a colorless oil.  Rf = 0.17 (4:1
hexanes:EtOAc).
Rh(PPh3)3Cl (22.2 mg, 0.024 mmol, 0.10 equiv) was weighed out in a glove box
and added to a long reaction tube with magnetic stir bar.  Styrenyl phenol 99 (61.5 mg,
0.240 mmol, 1.0 equiv) was dissolved in toluene (4.8 mL) and added to the reaction tube
using positive pressure cannulation.  H2 was bubbled through the suspension for 5 min
and the reaction tube was fitted with a balloon containing H2 (1 atm).  The reaction was
stirred for an additional 6 h at which point TLC analysis indicated complete conversion
of the starting material.  The resulting clear orange reaction mixture was adsorbed onto a
12 g Isco loading cartridge and purified by flash column chromatography using a
Teledyne Isco CombiFlash Rf system (SiO2, 12 g loading cartridge, 24 g column, linear
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gradient, 5%%50% Et2O in hexanes [40 min]) to afford phenol 87 (58.9 mg, 0.228
mmol, 95% yield) as a pale yellow oil;  Rf = 0.18 (4:1 hexanes:EtOAc);  
1H NMR (300
MHz, CDCl3) $  7.13–7.04 (m, 2H), 6.87 (t, J = 7.4 Hz, 1H), 6.75 (d, J = 7.9 Hz, 1H),
6.46 (app t, J = 1.7 Hz, 1H), 4.82 (bs, 1H), 2.60 (t, J = 7.3 Hz, 2H), 2.56–2.50 (m, 2H),
2.29 (s, 3H), 1.87–1.75 (m, 1H), 1.71–1.42 (m, 5H), 1.09 (s, 3H);  13C NMR (125 MHz,
CDCl3) $ 197.9, 153.6, 152.8, 143.4, 130.4, 128.4, 127.3, 120.9, 115.3, 50.1, 40.8, 36.2,
30.8, 29.7, 26.8, 25.8, 25.5;  IR (Neat Film NaCl) 3344, 3054, 3039, 2951, 2863, 1651,
1610, 1592, 1507, 1455, 1377, 1365, 1313, 1272, 1238, 1179, 1155, 1127, 1106, 1042,
907, 853, 752 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C17H23O2 [M+H]
+:
259.1693; found 259.1691;  [!]D
25.0 +28.73 (c 0.74, CHCl3, 88.0% ee).
Triflate 100.  To a solution of phenol 87 (104.2 mg, 0.40 mmol, 1.00 equiv) in CH2Cl2
(8.0 mL) in a 20 mL vial was added DMAP (97.8 mg, 0.80 mmol, 2.0 equiv) in one
portion, followed by N,N-Bis(trifluoromethylsulfonyl)-5-chloro-2-pyridylamine (172.8
mg, 0.44 mmol, 1.1 equiv).  After 15 min of stirring at ambient temperature, TLC
revealed full conversion of phenol 87.  The reaction mixture was adsorbed onto a 12 g
Isco loading cartridge and purified by flash column chromatography using a Teledyne
Isco CombiFlash Rf system (SiO2, 12 g loading cartridge, 40 g column, linear gradient,
5%20% EtOAc in hexanes [25 min]) to afford triflate 100 (146.2 mg, 0.374 mmol, 94%
yield) as a clear, colorless oil;  Rf = 0.44.  (4:1 hexanes:EtOAc);  
1H NMR (500 MHz,
CDCl3) $ 7.32–7.30 (m, 2H), 7.28 (dd, J = 8.5, 4.0 Hz, 1H), 7.24 (dm, J = 7.8 Hz, 1H),
6.44 (app t, J = 1.8 Hz, 1H), 2.69 (t, J = 7.7 Hz, 2H), 2.61–2.46 (m, 2H), 2.29 (s, 3H),
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1.80 (ddd, J = 13.0, 8.7, 6.5 Hz, 1H), 1.66 (ddd, J = 11.8, 8.0, 5.2 Hz, 1H), 1.64–1.45 (m,
3H), 1.50 (ddd, J = 11.4, 7.5, 5.1 Hz, 1H), 1.10 (s, 3H);  13C NMR (125 MHz, CDCl3) $
197.6, 152.0, 148.1, 143.7, 135.1, 131.3, 128.5, 128.0, 121.5, 118.7 (q, J = 320 Hz, 1C),
50.0, 40.7, 36.1, 30.8, 29.8, 26.8, 25.8, 25.7;  IR (Neat Film NaCl) 3032, 2958, 2868,
1671, 1617, 1486, 1454, 1420, 1365, 1303, 1251, 1217, 1140, 1100, 1073, 893, 814, 767
cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C18H22F3O4S [M+H]
+: 391.1188; found
391.1193;  [!]D
25.0 +22.00 (c 1.31, CHCl3, 88.0% ee).
O
102
Ha
Hb
Hb
Hb
NOE
Acylcyclopentene 102.  To a solution of triflate 100 (30.0 mg, 0.077 mmol, 1.0 equiv) in
dry DMA (1.54 mL) in a 4 dram vial was added TBAA (57.9 mg, 0.19 mmol, 2.5 equiv,
stored and weighed out in a glove box).  The resulting clear, colorless solution was
degassed by bubbling Ar though the solution for 1 h.  Herrmann's catalyst57 (7.2 mg, 7.7
µ mol, 0.10 equiv) was placed in a reaction tube which was subsequently
evacuated/backfilled with Ar (3 cycles, 1 min evacuation per cycle).  The solution
containing triflate 100 was added to the catalyst using positive pressure cannulation.  The
resulting pale green-yellow solution was immersed in an oil bath at ambient temperature
and heated to 115 °C.  After 2 h of stirring, the reaction was allowed to cool to ambient
temperature, diluted with EtOAc (10 mL), and poured into aqueous HCl (1.0 M, 5.0 mL).
The phases were separated and the aqueous phase was extracted with EtOAc (10 mL).
The combined organics were washed with brine (5.0 mL), dried over MgSO4, filtered,
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and concentrated under reduced pressure.  The crude product was purified by flash
column chromatography using a Teledyne Isco CombiFlash Rf system (SiO2, 2.5 g
loading cartridge, 4 g column, multi-step gradient, hold 5% [10 min]%hold 10% [4
min]%hold 20% [3 min]% hold 60% EtOAc in hexanes [3 min]) to afford
acylcyclopentene 102 (14.3 mg, 0.0595 mmol, 77% yield, 62% yield over 4 steps) as a
pale yellow solid.  The relative stereochemistry was assigned based on strong NOE
interaction between Ha and Hb;  Rf = 0.46 (4:1 hexanes:EtOAc);  
1H NMR (500 MHz,
CDCl3) $ 7.17–7.06 (m, 3H), 6.95 (app t, J = 2.4 Hz, 1H), 6.63 (bd, J = 6.2 Hz, 1H), 3.86
(s, 1H), 2.92–2.84 (m, 1H), 2.66 (app dd, J = 13.5, 7.9 Hz, 1H), 2.41 (s, 3H), 2.32–2.18
(m, 2H) 1.84 (app ddt, J = 13.5, 7.7, 5.6 Hz, 1H), 1.58–1.43 (m, 1H), 1.30 (ddd, J = 14.0,
5.1, 2.3 Hz, 1H), 1.18 (s, 3H), 0.85 (app dt, J = 13.5, 5.6 Hz, 1H);  13C NMR (125 MHz,
CDCl3) $ 196.7, 146.2, 144.6, 139.6, 139.2, 128.5, 126.7, 126.2, 125.0, 55.5, 48.4, 43.9,
34.1, 30.6, 26.9, 25.9, 21.4;  IR (Neat Film NaCl) 3062, 3012, 2933, 2893, 2859, 1659,
1617, 1476, 1456, 1446, 1370, 1278, 1266, 1244, 1199, 1123, 997, 935, 794, 757, 752,
730 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C17H21O [M+H]
+: 241.1587; found
241.1591;  [!]D
25.0 +3.88 (c 1.43, CHCl3, 88.0% ee).
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2.1.1.12 REVISED APPROACH TO THE REDUCTION/REARRANGEMENT
AND ORGANOMETALLIC ADDITION/REARRANGEMENT OF 27a
O
H
NaOAc•3H2O
Ac2O, 110 °C
80% yield
2 steps
55a
O
HHO
O
H
i-BuO
O
+
27a
LiAlH4
Et2O, 0 °C
then
10% aq HCl
55a
70a
Cycloheptenone 55a.  A round-bottom flask charged with vinylogous ester 27a (367.0
mg, 1.55 mmol, 1.00 equiv) and THF (5 mL, 0.3 M) was cooled in a 0 °C ice/water bath
and LiAlH4 (34.0 mg, 0.90 mmol, 0.58 equiv) was added.  After 25 min of stirring, the
reaction was quenched at 0 °C with the addition of aqueous HCl (10 mL, 10% w/w) and
transferred to a separatory funnel where the aqueous phase was extracted with EtOAc (3
x 10 mL).  The combined organics were dried over Na2SO4, filtered, and concentrated
under reduced pressure.  To the resulting crude oil was added Ac2O (3.8 mL) and
NaOAc·3H2O (1.28 g, 9.43 mmol, 6.08 equiv) and the mixture was lowered into a
preheated oil bath (110 °C).  After 15 h of heating, the reaction was allowed to cool to
ambient temperature and quenched with K2CO3 (5.59 g, 40.5 mmol) and water (10 mL).
After an addition 30 min of stirring, the solution was transferred to a separatory funnel
where the aqueous phase was extracted with EtOAc (4 x 10 mL).  The combined organics
were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude oil
was purified by flash chromatography (SiO2, 2 x 16 cm, 20:1 hexanes:EtOAc) to afford
cycloheptenone 55a (203.9 mg, 1.24 mmol, 80% yield) as a pale yellow oil.  (For
characterization data, see p. 319).
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+
O
HHO
O
H
i-BuO
O
27a
CeCl3•7H2O
NaBH4, MeOH, 0 °C
then 10% aq HCl
55a
82% yield
70a
1% yield
Cycloheptenone 55a and #-Hydroxyketone 70a.  A 100 mL round-bottom flask with
magnetic stir bar was charged with vinylogous ester 27a (186.8 mg, 0.79 mmol, 1.00
equiv) and anhydrous MeOH (14 mL).  The solution was cooled to 0 °C (water/ice bath).
CeCl3·7H2O (294.5 mg, 0.79 mmol, 1.56 equiv) was added in one portion and the mixture
was stirred for 5 min.  Portionwise addition of NaBH4 (89.7 mg, 2.37 mmol, 3.00 equiv)
at 0 °C led to the evolution of gas and a turbid solution that became clearer after several
minutes.  TLC analysis indicated that no starting material remained after 2 min.
Consequently, the reaction was quenched by dropwise addition of aqueous HCl (2 mL,
10% w/w) at 0 °C.  After an additional 10 min of stirring, the reaction was diluted with
CH2Cl2 (60 mL) and H2O (2 mL).  The layers were separated.  The aqueous layer was
extracted with CH2Cl2 (6 x 5 mL).  The combined organic layers were washed with sat.
aqueous NaHCO3 (2 x 5 mL) and brine (2 x 5 mL), dried over Na2SO4, filtered, and
evaporated to give a pale yellow oil.  The crude mixture was purified using flash
chromatography (SiO2, 2 x 25 cm, 20:1%15:1%3:1 hexanes:EtOAc) to afford volatile
enone 55a (106.9 mg, 0.645 mmol, 82% yield) as a pale yellow oil and #-hydroxyketone
70a as a mixture of diastereomers (1.4 mg, 0.0077 mmol, 1% yield, 3.5:1 dr) as a
colorless oil.  (For characterization data of 55a and 70a, see p. 319–320).
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CeCl3, n-BuMgCl, THF, 23 °C
then 10% aq HCl, 60 °C
O
i-BuO
n-Bu
O O
+
27a
n-Pr
4% yield
55r 110
76% yield
Cycloheptenone 55r and Cycloheptenone Isomer 110. An oven dried 15 mL round-
bottom flask equipped with a magnetic stir bar was cycled into a glove box. The flask
was loaded with anhydrous cerium chloride (130.4 mg, 0.53 mmol, 2.49 equiv), fitted
with a septum, removed from the glove box, and connected to an argon-filled Schlenk
manifold.  A portion of THF (5.5 mL) was added, rinsing the cerium chloride to the
bottom of the flask.  As the resulting thick white slurry was stirred, a solution of n-
butylmagnesium chloride (340 µL, 1.89 M in THF, 0.64 mmol, 3.03 equiv) was added
and the mixture turned pale yellow.  After 45 min of stirring, neat vinylogous ester 27a
(50.2 mg, 0.21 mmol, 1.00 equiv) was added to the flask.  The slurry maintained the
yellow color with the addition.  TLC analysis indicated that no starting material remained
after 5 min.  After an additional 10 min of stirring, the reaction was quenched with
aqueous HCl (1 mL, 10% w/w) and lowered into a preheated oil bath (60 °C).  After 17 h,
the yellow suspension was removed from the bath, cooled to ambient temperature, and
transferred to a separatory funnel where the aqueous phase was extracted four times with
Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 1 x 27 cm, 100% hexanes%2%%10% EtOAc in hexanes) to
afford moderately contaminated cycloheptenone 55r and pure alkene isomer 110 (35.4
mg, 0.16 mmol, 76% yield) as an orange oil.  Additional purification by flash
chromatography (SiO2, 1 x 27 cm, 100% hexanes% 2%%5% EtOAc in hexanes)
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furnished cycloheptenone 55r (1.7 mg at 95% purity, 0.0076 mmol, 4% yield) as a
yellow oil.  (For characterization data of 55r, see p. 342).
O
n-Pr
110
Ha
Cycloheptenone Isomer 110.  Rf = 0.76 (30% EtOAc in hexanes); The relative alkene
stereochemistry was assigned based on NOE interactions of Ha proton;  1H NMR (500
MHz, CDCl3) $ 5.66 (dddd, J = 16.9, 10.6, 7.9, 6.6 Hz, 1H), 5.43 (t, J = 7.1 Hz, 1H),
5.03–4.97 (m, 2H), 3.20 (d, J = 14.6 Hz, 1H), 3.13 (d, J = 14.6 Hz, 1H), 2.47–2.38 (m,
1H), 2.36–2.26 (m, 2H), 2.15–1.95 (m, 3H), 1.82–1.69 (m, 2H), 1.66–1.58 (m, 1H),
1.58–1.50 (m, 1H), 1.40–1.32 (m, 2H), 1.07 (s, 3H), 0.88 (t, J = 7.4 Hz, 3H);  13C NMR
(125 MHz, CDCl3) $ 210.0, 136.2, 135.1, 130.0, 117.2, 44.8, 43.3, 43.3, 41.8, 41.1, 30.2,
25.0, 22.9, 19.6, 13.9;  IR (Neat Film NaCl) 3074, 3042, 2959, 2929, 2871, 1706, 1638,
1457, 1436, 1378, 1351, 1302, 1262, 1231, 1163, 1098, 1069, 996, 953, 912, 805, 776,
729 cm–1;  HRMS (EI+) m/z calc’d for C15H24O2 [M]
+•: 220.1827; found 220.1780;
[!]D
25.0  –10.92 (c 0.76, CHCl3, 88.0% ee).
i-BuO
O
27a 55r
1. CeCl3, n-BuMgCl, THF, 23 °C
    then Na3PO4 buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN O
n-Bu
84% yield
Cycloheptenone 55r.  A 50 mL round-bottom flask equipped with a magnetic stir bar
was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride
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(260.8 mg, 1.06 mmol, 2.50 equiv), fitted with a septum, removed from the glove box,
and connected to an argon-filled Schlenk manifold.  A portion of THF (8.5 mL) was
added, rinsing the cerium chloride to the bottom of the flask. As the resulting thick white
slurry was stirred, a solution of n-butylmagnesium bromide (680 µL, 1.87 M in THF,
1.27 mmol, 3.00 equiv) was added and the mixture turned grey.  After 30 min of stirring,
vinylogous ester 27a (100.0 mg, 0.42 mmol, 1.00 equiv) was added neat from a Hamilton
syringe and the needle was rinsed with a small portion of THF (2 mL; total THF added =
10.5 mL, 0.04 M).  The color of the slurry initially transitioned to yellow with the
vinylogous ester addition before turning back to grey.  TLC analysis indicated that no
starting material remained after 15 min.  After an additional 10 min of stirring, the
reaction was quenched with pH 6.5 Na3PO4 buffer (8 mL).  A thick grey emulsion
formed.  The mixture was transferred to a separatory funnel where the aqueous phase was
extracted four times with Et2O.  The combined organics (125 mL) were dried over
MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was transferred
to a 20 mL scintillation vial and concentrated under reduced pressure.  A stir bar, CH3CN
(1.0 mL), and 6 mM aqueous HCl (1.0 mL) were added to the vial.  The resulting cloudy
solution was stirred vigorously for 5 min before being transferred to a separatory funnel
where the aqueous phase was extracted four times with Et2O.  The combined organics
(100 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.
The crude oil was purified by flash chromatography (SiO2, 3 x 30 cm, 100%
hexanes%2%%5% EtOAc in hexanes) to afford cycloheptenone 55r (82.4 mg, 0.35
mmol, 84% yield) as a pale yellow oil.  (For characterization data of 55r, see p. 342).
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2.1.1.13 GRIGNARD AND ORGANOLITHIUM REAGENTS
Table 2.7.  Sources of Grignard and organolithium reagents.a
reagent
MgBr
entry
6
MgBr1
MgBr
3
7 Ph Li
MgBr
4
MgBr5
MgCl
10
S
MgBr2
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Li
9
O
8
MgBr
molarity (M)
0.25 M in THF
n/ab
0.86 M in Et2O
0.39 M in THF
0.44 M in THF
0.41 M in THF
0.35 M in THF
obtained from
0.40 M in THF
0.44 M in THF
n/ab
Br
Br
Cl
S
O
a Titrated using method of Love (see ref. 49). b Not titrated.
Ph
Br
Br
Grignard and Organolithium Reagents.  Reagents were purchased from Sigma-Aldrich
or prepared according to procedures listed below.  Reagents were titrated according to the
method of Love.49
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 378
MgBrBr
Mg(0), DIBAL (4 mol %)
THF
0.41 M in THF
(3-Methylbut-3-enyl)magnesium bromide  (Table 2.7, entry 4).  A 250 mL Schlenk
bomb (14/20 joint off of a 12 mm Kontes valve) equipped with a magnetic stir bar, fitted
with a rubber septum, and connected to a Schlenk manifold was flame-dried three times,
backfilling with argon after each drying cycle.  Once cool, magnesium metal (2.04 g,
83.79 mmol, 2.50 equiv) was added.  After three argon backfilling cycles, the flask was
charged with THF (50 mL, 0.7 M) and neat DIBAL61 (150 µL, 1.29 mmol, 4 mol %) and
stirring was initiated.  The stirring was stopped after 10 min, and 4-bromo-2-methylbut-1-
ene62 (5.00 g, 33.57 mmol, 1.00 equiv) was added via syringe with the needle in the
solution directly above the magnesium.  The mixture was heated to reflux, sealed by
closing the Schlenk valve, and stirred vigorously.  The flask was occasionally heated
back to reflux and then allowed to cool to room temperature (23 °C).  The reaction color
became amber over time.  After 30 min, an aliquot was removed and titrated following
the procedure of Love (0.41 M in THF).49  See p. 392 for use of this reagent.
MgBrBr
Mg(0), DIBAL (4 mol %)
THF
0.35 M in THF
Pent-4-enylmagnesium bromide  (Table 2.7, entry 5).  A 250 mL Schlenk bomb (14/20
joint off of a 12 mm Kontes valve) equipped with a magnetic stir bar, fitted with a rubber
septum, and connected to a Schlenk manifold was flame-dried three times, backfilling
with argon after each drying cycle.  Once cool, magnesium metal (614.4 mg, 25.27
mmol, 2.53 equiv) was added.  After three argon backfilling cycles, the flask was charged
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with THF (20 mL, 0.5 M) and neat DIBAL59 (50 µL, 0.43 mmol, 4 mol %) and stirring
was initiated.  The stirring was stopped after 10 min and 5-bromopent-1-ene (1.18 mL,
9.98 mmol, 1.00 equiv) was added via a syringe, with the needle in the solution directly
above the magnesium.  The mixture was heated to reflux, sealed by closing the Schlenk
valve, and stirred vigorously.  The flask was occasionally heated back to reflux and then
allowed to cool to room temperature (23 °C).  The reaction color became amber over
time.  After 30 min, an aliquot was removed and titrated following the procedure of Love
(0.35 M in THF).49  See p. 381 and p. 393 for use of this reagent.
Ph
Br
Ph
Li
t-BuLi (1.7 M in pentane)
Et2O, –78 ! 23 °C
(E)-Styryllithium  (Table 2.7, entry 7).  See p. 394 for the synthesis and use of this
reagent.
Br MgBr
Mg(0), DIBAL (18 mol %)
THF
0.40 M in THF
(2-Vinylphenyl)magnesium bromide  (Table 2.7, entry 8).  A 250 mL Schlenk round-
bottom flask (14/20 joint off of a 12 mm Kontes valve) equipped with a magnetic stir bar,
fitted with a rubber septum, and connected to a Schlenk manifold was flame-dried three
times, backfilling with argon after each drying cycle.  Once cool, magnesium metal
(491.3 mg, 20.21 mmol, 2.53 equiv) was added.  After three argon backfilling cycles, the
flask was charged with THF (16 mL, 0.5 M) and neat DIBAL59 (170 µL, 1.46 mmol, 18
mol %) and stirring was initiated.  The stirring was stopped after 10 min and o-
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bromostyrene (1.00 mL, 7.98 mmol, 1.00 equiv) was added with the needle in the
solution directly above the magnesium.  The mixture was heated to reflux, sealed by
closing the Schlenk valve, and stirred vigorously.  The flask was occasionally heated
back to reflux and then allowed to cool to room temperature (23 °C).  The reaction
became amber over time.  After 2 h, a small portion of the reaction was removed and
titrated following the procedure of Love.49  See p. 396 for use of this reagent.
Li
OO
n-BuLi
Et2O, –15 ! 23 °C
Furan-2-yllithium  (Table 2.7, entry 9).  Prepared following a procedure similar to
Sauers and Hagedorn.63  See p. 398 for the synthesis and use of this reagent.
MgCl
S
Cl
S
Mg(0), DIBAL (4 mol %)
THF
0.44 M in THF
Thiophen-2-ylmagnesium chloride  (Table 2.7, entry 10).  A two-neck 50 mL round-
bottom flask equipped with a magnetic stir bar, fitted with a rubber septum on one neck
and a water condenser on the other neck, and connected to a Schlenk manifold (through
the condenser) was flame-dried three times, backfilling with argon after each drying
cycle.  Once cool, magnesium metal (635.0 mg, 26.12 mmol, 2.60 equiv) was added.
After two argon backfilling cycles, the flask was charged with THF (20 mL) and neat
DIBAL59 (50 µL, 0.43 mmol, 4 mol %) and stirring was initiated.  The stirring was
stopped after 10 min and 2-chlorothiophene (930 µL, 10.04 mmol, 1.00 equiv) was added
via a syringe, with the needle in the solution directly above the magnesium.  The mixture
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was heated to reflux.  A small piece of I2 (size of a spatula tip) dissolved in THF (1 mL)
was cannula-transferred into the mixture after 12 h and 13.5 h.  The flask was allowed to
cool to room temperature (23 °C).  After 15 h, an aliquot was removed and titrated
following the procedure of Love (0.44 M in THF).49  See p. 382 and p. 400 for use this
reagent.
2.1.1.14 CARBONYL TRANSPOSITION TO " -QUATERNARY
CYCLOHEPTENONES
Representative procedures for General Methods F–H are described below.
O
MgBr
O
i-BuO
1. CeCl3, THF, 23 °C
    then sodium phosphate
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
             92% yield27a 55x
General Method F:
Organometallic Addition / Na3PO4 Buffer Quench / Dilute HCl Workup
Cycloheptenone 55x.  A 100 mL round-bottom flask equipped with a magnetic stir bar
was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride
(616.2 mg, 2.50 mmol, 2.50 equiv), fitted with a septum, removed from the glove box,
and connected to an argon-filled Schlenk manifold.  A portion of THF (13 mL) was
added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white
slurry was stirred, a solution of pent-4-enylmagnesium bromide (8.6 mL, 0.35 M in THF,
3.01 mmol, 3.01 equiv) was added and the mixture turned grey.  After 30 min of stirring,
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vinylogous ester 27a (236.3 mg, 1.00 mmol, 1.00 equiv) was cannula-transferred to the
slurry from a flame-dried 10 mL conical flask using several THF rinses (3 x 4 mL; total
THF added = 25 mL, 0.04 M).  TLC analysis indicated that no starting material remained
after 5 min.  After an additional 10 min of stirring, the reaction was quenched with pH
6.5 Na3PO4 buffer (20 mL).  A thick grey emulsion formed. The mixture was transferred
to a separatory funnel where the aqueous phase was extracted four times with Et2O.  The
combined organic (150 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure.  The crude oil was transferred to a 20 mL scintillation vial and
concentrated under reduced pressure.  A stir bar, CH3CN (2.0 mL), and aqueous HCl (2.0
mL, 6 mM) were added to the vial.  The resulting cloudy solution was stirred vigorously
for 30 min before being transferred to a separatory funnel where the aqueous phase was
extracted four times with Et2O.  The combined organics (75 mL) were dried over MgSO4,
filtered, and concentrated under reduced pressure. The crude oil was purified by flash
chromatography (SiO2, 3 x 30 cm, 100% hexanes%1%%2%%5% EtOAc in hexanes) to
afford cycloheptenone 55x (214.2 mg, 0.92 mmol, 92% yield) as a clear colorless oil.
O
MgCl
S
S
O
i-BuO
CeCl3, THF, 23 °C
then 10% aq HCl, 60 °C
84% yield27a 55ac
General Method G:  Organometallic Addition / Aq HCl Quench
Cycloheptenone 55ab.15A 100 mL round-bottom flask equipped with a magnetic stir
bar was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride
(616.2 mg, 2.50 mmol, 2.50 equiv), fitted with a septum, removed from the glove box,
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and connected to an argon-filled Schlenk manifold.  A portion of THF (13 mL) was
added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white
slurry was stirred, a solution of thiophen-2-ylmagnesium chloride (6.8 mL, 0.44 M in
THF, 2.99 mmol, 2.99 equiv) was added and the mixture turned dark grey.  After 30 min
of stirring, vinylogous ester 27a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a flame-dried 10 mL conical flask using several THF rinses
(3 x 4 mL; total THF added = 25 mL, 0.04 M).  TLC analysis indicated that no starting
material remained after 25 min.  After an additional 5 min of stirring, the reaction was
quenched with aqueous HCl (5 mL, 10% w/w) and lowered into a preheated oil bath (60
°C).  After 20 h, additional aqueous HCl (5 mL, 10% w/w) was added.  After 26 h, the
yellow solution was removed from the bath, cooled to ambient temperature, treated with
sat. aqueous NaHCO3 solution (25 mL), and transferred to a separatory funnel where the
aqueous phase was extracted four times with Et2O.  The combined organics (150 mL)
were rinsed once with sat. aqueous NaHCO3, dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 3 x 30 cm, 100% hexanes%2%%5% EtOAc in hexanes) to afford
cycloheptenone 55ac (206.1 mg, 0.84 mmol, 84% yield) as a yellow/orange oil.
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O
MgBr
O
i-BuO
CeCl3, THF, 23 °C
then 2 M aq H2SO4, 60 °C
97% yield
27a 55z
General Method H:  Organometallic Addition / Aq H2SO4 Quench
Cycloheptenone 55z.16A 100 mL round-bottom flask equipped with a magnetic stir bar
was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride
(616.2 mg, 2.50 mmol, 2.50 equiv), fitted with a septum, removed from the glove box,
and connected to an argon-filled Schlenk manifold.  A portion of THF (13 mL) was
added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white
slurry was stirred, a solution of prop-1-ynylmagnesium bromide (12 mL, 0.25 M in THF,
3.00 mmol, 3.00 equiv) was added and the mixture turned yellow.  After 30 min of
stirring, vinylogous ester 27a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-transferred
to the slurry from a flame-dried 10 mL conical flask using several THF rinses (3 x 4 mL;
total THF added = 25 mL, 0.04 M).  The slurry maintained the yellow color with the
addition.  TLC analysis indicated that no starting material remained after 5 min.  After an
additional 10 min of stirring, the reaction was quenched with 2 M H2SO4 (5 mL) and
lowered into a preheated oil bath (60 °C).  A white precipitate formed within several
minutes.  After 12 h, the yellow suspension was removed from the bath, cooled to
ambient temperature, treated with sat. aqueous NaHCO3 solution (50 mL), and
transferred to a separatory funnel where the aqueous phase was extracted four times with
Et2O.  The combined organics (175 mL) were rinsed once with sat. aqueous NaHCO3,
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was
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purified by flash chromatography (SiO2, 3 x 30 cm, 100% hexanes%2%%5% EtOAc in
hexanes) to afford cycloheptenone 55z (195.4 mg, 0.97 mmol, 97% yield) as a yellow oil.
O
O
i-BuO
1. CeCl3, THF, 23 °C
    then sodium phosphate 
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
84% yield27a 55r
MgBr
Cycloheptenone 55r  (Table 2.5, entry 1).17Prepared using General Method F.  A 50
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum,
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon
after each drying cycle.  The hot flask was placed into a glove box antechamber, which
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride
(260.8 mg, 1.06 mmol, 2.50 equiv), refitted with the septum, removed from the glove
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (8.5 mL)
was added, rinsing the cerium chloride to the bottom of the flask. As the resulting thick
white slurry was stirred, a solution of n-butylmagnesium bromide (680 µL, 1.87 M in
THF, 1.27 mmol, 3.00 equiv) was added and the mixture turned grey.  After 30 min of
stirring, vinylogous ester 27a (100.0 mg, 0.42 mmol, 1.00 equiv) was added neat from a
Hamilton syringe and the needle was rinsed with a small portion of THF (2 mL; total
THF added = 10.5 mL, 0.04 M).  The color of the slurry initially transitioned to yellow
with the vinylogous ester addition before turning back to grey.
TLC analysis indicated that no starting material remained after 15 min.  After an
additional 10 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (8
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mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel
where the aqueous phase was extracted four times with Et2O.  The combined organics
(125 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.
The crude oil was transferred to a 20 mL scintillation vial and concentrated under
reduced pressure.  A stir bar, CH3CN (1.0 mL), and 6 mM aqueous HCl (1.0 mL) were
added to the vial.  The resulting cloudy solution was stirred vigorously for 5 min before
being transferred to a separatory funnel where the aqueous phase was extracted four
times with Et2O.  The combined organics (100 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 3 x 30 cm, 100% hexanes%2%%5% EtOAc in hexanes) to afford
cycloheptenone 55r (82.4 mg, 0.35 mmol, 84% yield) as a pale yellow oil. (For
characterization data, see p. 342).
MgBr
73% yield
O
O
i-BuO
27a 55t
1. CeCl3, THF, 23 °C
    then sodium phosphate 
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
Cycloheptenone 55t  (Table 2.5, entry 2).18Prepared using General Method F.  A 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum,
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon
after each drying cycle.  The hot flask was placed into a glove box antechamber, which
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride
(616.3 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove
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box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL)
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick
white slurry was stirred, a solution of allylmagnesium bromide (3.49 mL, 0.86 M in Et2O,
3.00 mmol, 3.00 equiv) was added and the mixture turned initially orange, then red over
time.  After 30 min of stirring, vinylogous ester 27a (236.6 mg, 1.00 mmol, 1.00 equiv)
was cannula-transferred to the slurry from a flame-dried 10 mL conical flask using
several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M).  The mixture faded
back to orange with the addition.
TLC analysis indicated that no starting material remained after 5 min.  After an
additional 10 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (20
mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel
where the aqueous phase was extracted four times with Et2O.  The combined organics
(250 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.
The crude oil was transferred to a 20 mL scintillation vial and concentrated under
reduced pressure.  A stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were
added to the vial.  The resulting cloudy solution was stirred vigorously for 30 min before
being transferred to a separatory funnel where the aqueous phase was extracted four
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 3 x 30 cm, 100% hexanes%2%%5% EtOAc in hexanes) to afford
cycloheptenone 55t (148.6 mg, 0.73 mmol, 73% yield) as a pale yellow oil;  Rf = 0.68
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 5.88 (s, 1H), 5.75 (dddd, J =
16.9, 10.1, 6.8, 6.8 Hz, 1H), 5.64 (dddd, J = 17.0, 10.3, 7.8, 6.8 Hz, 1H), 5.14–5.00 (m,
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4H), 2.96–2.84 (m, 2H), 2.62–2.54 (m, 2H), 2.38 (dddd, J = 14.2, 6.8, 1.3, 1.3 Hz, 1H),
2.10 (dddd, J = 14.2, 7.8, 1.1, 1.1 Hz, 1H), 1.84–1.76 (m, 3H), 1.67–1.57 (m, 1H), 1.17
(s, 3H);  13C NMR (125 MHz, CDCl3) $ 205.2, 160.3, 136.0, 134.0, 130.0, 118.3, 117.9,
45.5, 45.2, 44.4, 38.8, 38.5, 25.7, 17.6;  IR (Neat Film NaCl) 3077, 2976, 2939, 2872,
1654, 1612, 1458, 1412, 1380. 1342, 1290, 1250, 1217, 1177, 1106, 996, 916 cm-1;
HRMS (MM: ESI-APCI+) m/z calc’d for C14H21O [M+H]
+: 205.1587; found 205.1587;
[!]D
25.0 –34.64 (c 1.55, CHCl3, 88% ee).
1. CeCl3, THF, 23 °C
    then sodium phosphate 
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
93% yield
O
O
i-BuO
27a 55u
MgBr
Cycloheptenone 55u  (Table 2.5, entry 3).19Prepared using General Method F.  A 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum,
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon
after each drying cycle.  The hot flask was placed into a glove box antechamber, which
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL)
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick
white slurry was stirred, a solution of (2-methylallyl)magnesium bromide (7.7 mL, 0.39
M in THF, 3.00 mmol, 3.00 equiv) was added and the mixture turned initially yellow and
eventually orange with time.  After 30 min of stirring, vinylogous ester 27a (236.2 mg,
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1.00 mmol, 1.00 equiv) was cannula-transferred to the slurry from a flame-dried 10 mL
conical flask using several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M).
TLC analysis indicated that no starting material remained after 5 min.  After an
additional 15 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (20
mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel
where the aqueous phase was extracted four times with Et2O.  The combined organics
(150 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.
The crude oil was transferred to a 20 mL scintillation vial and concentrated under
reduced pressure.  A stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were
added to the vial.  The resulting cloudy solution was stirred vigorously for 30 min before
being transferred to a separatory funnel where the aqueous phase was extracted four
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 3 x 30 cm, 100% hexanes%2%%5% EtOAc in hexanes) to afford
cycloheptenone 55u (202.9 mg, 0.93 mmol, 93% yield) as a pale yellow oil;  Rf = 0.65
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 5.89 (s, 1H), 5.65 (dddd, J =
16.9, 10.3, 7.8, 6.8 Hz, 1H), 5.09–5.01 (m, 2H), 4.94–4.91 (m, 1H), 4.78 (dd, J = 1.9, 0.9
Hz, 1H), 2.85 (q, J = 16.2 Hz, 2H), 2.63–2.55 (m, 2H), 2.37 (dddd, J = 14.1, 6.8, 1.3, 1.3
Hz, 1H), 2.10 (dddd, J = 14.2, 7.8, 1.1, 1.1 Hz, 1H), 1.85–1.75 (m, 3H), 1.68 (s, 3H),
1.66–1.59 (m, 1H), 1.16 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 205.3, 159.1, 142.8,
134.0, 129.5, 118.3, 115.2, 45.4, 45.0, 44.4, 42.7, 38.8, 25.6, 22.2, 17.6;  IR (Neat Film
NaCl) 3075, 2970, 2939, 2872, 1661, 1652, 1612, 1455, 1376, 1342, 1309, 1249, 1218,
CHAPTER 2 — Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures 390
996, 914, 893 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C15H23O [M+H]
+:
219.1743; found 219.1740;  [!]D
25.0 –35.09 (c 0.95, CHCl3, 88% ee).
90% yield
O
O
i-BuO
27a 55v
MgBr
1. CeCl3, THF, 23 °C
    then sodium phosphate 
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
Cycloheptenone 55v  (Table 2.5, entry 4).  Prepared using General Method F.  A 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum,
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon
after each drying cycle.  The hot flask was placed into a glove box antechamber, which
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL)
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting white
mixture was stirred, a solution of but-3-enylmagnesium bromide (6.82 mL, 0.44 M in
THF, 3.00 mmol, 3.00 equiv) was added, generating a thick grey slurry.  After 30 min of
stirring, vinylogous ester 27a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-transferred
to the slurry from a flame-dried 10 mL conical flask using several THF rinses (3 x 4 mL;
total THF added = 25 mL, 0.04 M).
After 20 min, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 mL).  A
thick grey emulsion formed.  The mixture was transferred to a separatory funnel where
the aqueous phase was extracted four times with Et2O.  The combined organic (150 mL)
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were dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil
was transferred to a 20 mL scintillation vial and concentrated under reduced pressure.  A
stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were added to the vial.  The
resulting cloudy solution was stirred vigorously for 5 min before being transferred to a
separatory funnel where the aqueous phase was extracted four times with Et2O.  The
combined organics (80 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure.  The crude oil was purified by flash chromatography (SiO2, 3 x 30 cm,
100% hexanes%2%%5%%10% EtOAc in hexanes) to afford cycloheptenone 55v (196.6
mg, 0.90 mmol, 90% yield) as a yellow oil;  Rf = 0.67 (30% EtOAc in hexanes);  
1H
NMR (500 MHz, CDCl3) $ 5.88 (s, 1H), 5.86–5.77 (m, 1H), 5.63 (dddd, J = 16.9, 10.3,
7.8, 6.8 Hz, 1H), 5.08–4.96 (m, 4H), 2.59–2.54 (m, 2H), 2.36 (dddd, J = 14.1, 6.7, 1.3,
1.3 Hz, 1H), 2.28–2.17 (m, 4H), 2.08 (dddd, J = 14.1, 7.9, 2.1, 1.0 Hz, 1H), 1.83–1.73
(m, 3H), 1.65–1.57 (m, 1H), 1.15 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 205.2, 161.6,
137.7, 134.0, 128.9, 118.2, 115.4, 45.7, 45.2, 44.3, 38.7, 34.0, 33.4, 25.7, 17.6;  IR (Neat
Film NaCl) 3076, 2975, 2938, 2872, 1652, 1611, 1465, 1452, 1415, 1379, 1342, 1263,
1218, 1177, 1109, 1069, 996, 914, 877, 841, 764, 714 cm-1;  HRMS (MM: ESI-APCI+)
m/z calc’d for C15H23O [M+H]
+: 219.1743; found 219.1742;  [!]D
25.0 –34.11 (c 1.21,
CHCl3, 88% ee).
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1. CeCl3, THF, 23 °C
    then sodium phosphate 
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
82% yield
O
O
i-BuO
27a 55w
MgBr
Cycloheptenone 55w  (Table 2.5, entry 5).21Prepared using General Method F.  A 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum,
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon
after each drying cycle.  The hot flask was placed into a glove box antechamber, which
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL)
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick
white slurry was stirred, a solution of (3-methylbut-3-enyl)magnesium bromide (7.3 mL,
0.41 M in THF, 2.99 mmol, 2.99 equiv) was added and the mixture turned yellow.  After
30 min of stirring, vinylogous ester 27a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a flame-dried 10 mL conical flask using several THF rinses
(3 x 4 mL; total THF added = 25 mL, 0.04 M).
TLC analysis indicated that no starting material remained after 5 min.  After an
additional 10 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (20
mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel
where the aqueous phase was extracted four times with Et2O.  The combined organic
(150 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.
The crude oil was transferred to a 20 mL scintillation vial and concentrated under
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reduced pressure.  A stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were
added to the vial.  The resulting cloudy solution was stirred vigorously for 5 min before
being transferred to a separatory funnel where the aqueous phase was extracted four
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 3 x 30 cm, 100% hexanes%2%%5% EtOAc in hexanes) to afford
cycloheptenone 55w (191.1 mg, 0.82 mmol, 82% yield) as a clear colorless oil;  Rf = 0.69
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 5.89 (s, 1H), 5.64 (dddd, J =
16.9, 10.3, 7.8, 6.8 Hz, 1H), 5.09–4.99 (m, 2H), 4.77–4.73 (m, 1H), 4.72–4.69 (m, 1H),
2.59–2.56 (m, 2H), 2.38 (dddd, J = 14.1, 6.7, 1.3, 1.3 Hz, 1H), 2.31–2.14 (m, 4H), 2.10
(dddd, J = 14.1, 7.8, 1.1, 1.1 Hz, 1H), 1.83–1.75 (m, 3H), 1.75–1.74 (m, 3H), 1.66–1.57
(m, 1H), 1.17 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 205.3, 162.1, 145.1, 134.0, 129.0,
118.3, 110.6, 45.8, 45.3, 44.3, 38.8, 38.3, 32.5, 25.7, 22.7, 17.6;  IR (Neat Film NaCl)
3075, 2968, 2938, 2873, 1652, 1611, 1455, 1415, 1377, 1342, 1262, 1218, 1181, 1109,
1069, 996, 915, 887 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C16H25O [M+H]
+:
233.1900; found 233.1896;  [!]D
25.0 –32.57 (c 1.32, CHCl3, 88% ee).
92% yield
O
O
i-BuO
27a 55x
MgBr
1. CeCl3, THF, 23 °C
    then sodium phosphate 
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
Cycloheptenone 55x  (Table 2.5, entry 6).22Prepared using General Method F. See
procedure described above.  Rf = 0.65 (30% EtOAc in hexanes);  
1H NMR (500 MHz,
CDCl3) $ 5.88 (s, 1H), 5.79 (dddd, J = 16.9, 10.2, 6.7, 6.7 Hz, 1H), 5.67–5.57 (m, 1H),
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5.07–4.96 (m, 4H), 2.60–2.53 (m, 2H), 2.35 (dddd, J = 14.1, 6.7, 2.5, 1.2 Hz, 1H),
2.20–2.04 (m, 5H), 1.83–1.73 (m, 3H), 1.66–1.53 (m, 3H), 1.14 (s, 3H);  13C NMR (125
MHz, CDCl3) $ 205.3, 162.6, 138.2, 134.1, 128.8, 118.2, 115.3, 45.7, 45.2, 44.3, 38.7,
33.8, 33.5, 29.3, 25.7, 17.6;  IR (Neat Film NaCl) 3076, 2975, 2937, 2870, 1652, 1611,
1456, 1415, 1380, 1343, 1257, 1218, 1179, 1110, 1071, 994, 913 cm-1;  HRMS (MM:
ESI-APCI+) m/z calc’d for C16H25O [M+H]
+: 233.1900; found 233.1900;  [!]D
25.0 –34.96
(c 1.46, CHCl3, 88% ee).
O
Ph
Ph
Br
O
i-BuO
1. t-BuLi, Et2O
    –78!23 °C
   then 149a
2. 10% aq HCl
    THF/H2O, 50 °C
84% yield27a 55y
Cycloheptenone 55y  (Table 2.5, entry 7).23Prepared using General Method G.  A
flame-dried round-bottom flask equipped with a magnetic stir bar and fitted with a rubber
septum was connected to a Schlenk manifold.  The flask was charged with (E)-#-
bromostyrene (1.5 mL, 11.69 mmol, 1.98 equiv) and Et2O (13 mL) and lowered into a
dry ice/acetone bath (–78 °C).  After dropwise addition of t-butyllithium (13.5 mL, 1.7 M
in pentane, 22.95 mmol, 3.88 equiv), the solution was stirred for 2 h (at –78 °C), warmed
to room temperature (30 min stir at 23 °C), and placed back into the dry ice/acetone bath.
Vinylogous ester 27a (1.40 g, 5.92 mmol, 1.00 equiv) was transferred to the round-
bottom flask by two Et2O rinses (2 x 3 mL, total Et2O added = 19 mL, 0.3 M).  The flask
was stirred at –78 °C for 25 min before being transferred to an ice/water bath (0 °C).
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TLC analysis indicated that no starting material remained after 2 h.
Consequently, the reaction was quenched with 10% w/w aqueous HCl (10 mL).  After 20
min of stirring, the mixture was transferred to a separatory funnel where the aqueous
phase was extracted three times with Et2O.  The combined organics were dried over
MgSO4, filtered, and concentrated under reduced pressure.  A round-bottom flask was
charged with the crude oil, THF (20 mL), and 10% w/w aqueous HCl (0.5 mL) and
lowered into a preheated oil bath (50 °C).  After 2 h, the reaction allowed to cool to room
temperature, concentrated under reduced pressure, diluted with water (10 mL) and Et2O
(20 mL), and transferred to a separatory funnel where the aqueous layer was extracted
twice with Et2O (2 x 20 mL).  The combined organics were dried over MgSO4, filtered,
and concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 3 x 23 cm, 20:1% 15:1%10:1 hexanes:EtOAc) to afford
cycloheptenone 55y (1.33 g, 4.99 mmol, 84% yield) as a yellow oil;  Rf = 0.67 (30%
EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 7.42 (d, J = 7.3 Hz, 2H), 7.35 (d, J =
7.4 Hz, 2H), 7.28 (d, J = 7.3 Hz, 1H), 6.90 (s, 2H), 6.30 (s, 1H), 5.67 (dddd, J = 16.8,
10.3, 8.1, 6.5 Hz, 1H), 5.09–5.02 (m, 2H), 2.71–2.57 (m, 2H), 2.46 (dddd, J = 14.1, 6.5,
1.3, 1.3 Hz, 1H), 2.14 (dddd, J = 14.1, 8.1, 1.1, 1.1 Hz, 1H), 1.92–1.79 (m, 3H),
1.72–1.64 (m, 1H), 1.27 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.7, 158.5, 136.7,
133.9, 133.3, 129.2, 128.9, 128.5, 127.1, 127.1, 118.4, 46.2, 44.5, 44.4, 38.7, 26.8, 17.6;
IR (Neat Film NaCl) 3075, 3059, 3002, 2966, 2936, 2869, 1640, 1581, 1573, 1495, 1449,
1414, 1379. 1343, 1303, 12.77, 1250, 1217, 1178, 1109, 1082, 1028, 996, 963, 916, 839,
799, 752, 718 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C19H23O [M+H]
+:
267.1743; found 267.1755;  [!]D
25.0 –44.99 (c 0.81, CHCl3, 88% ee).
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O
MgBr
O
i-BuO
CeCl3, THF, 23 °C
then 2 M aq H2SO4, 60 °C
97% yield
27a 55z
Cycloheptenone 55z  (Table 2.5, entry 8).24Prepared using General Method H.  See
procedure described above.  Rf = 0.65 (30% EtoAc in hexanes);  
1H NMR (500 MHz,
CDCl3) $ 6.20 (s, 1H), 5.70 (dddd, J = 16.8, 10.5, 8.2, 6.6 Hz, 1H), 5.10–5.01 (m, 2H),
2.65–2.49 (m, 3H), 2.16 (dddd, J = 13.8, 8.2, 1.0, 1.0 Hz, 1H), 2.01 (s, 3H), 1.83–1.75
(m, 3H), 1.66–1.59 (m, 1H), 1.24 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 203.5, 145.6,
135.0, 134.3, 118.3, 92.9, 80.7, 46.5, 45.4, 44.6, 37.3, 27.0, 17.6, 4.7;  IR (Neat Film
NaCl) 3076, 2969, 2937, 2219, 1652, 1580, 1455, 1415, 1377, 1346, 1255, 1225, 1184,
1110, 998, 916, 893, 866, 813, 784, 716 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for
C14H19O [M+H]
+: 203.1430; found 203.1428;  [!]D
25.0  –49.25 (c 1.21, CHCl3, 88% ee).
O
O
i-BuO
CeCl3, THF, 23 °C
then
2 M aq H2SO4, 60 °C
66% yield27a 55aa
MgBr
Cycloheptenone 55aa  (Table 2.5, entry 9).25Prepared using General Method H.  A 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum,
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon
after each drying cycle.  The hot flask was placed into a glove box antechamber, which
was evacuated/backfilled with N2 (4 cycles, 1 min evacuation per cycle) before the flask
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride
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(616.4 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL)
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick
white slurry was stirred, a solution of (2-vinylphenyl)magnesium bromide (7.5 mL, 0.40
M in THF, 3.00 mmol, 3.00 equiv) was added and the mixture turned yellow and green
over time.  After 30 min of stirring, vinylogous ester 27a (236.3 mg, 1.00 mmol, 1.00
equiv) was cannula-transferred to the slurry from a flame-dried 10 mL conical flask using
several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M).  The reaction color
returned to yellow with addition of vinylogous ester 27a.
TLC analysis indicated that no starting material remained after 40 min.  After an
additional 30 min of stirring, the reaction was quenched with 2 M H2SO4 (5 mL) and
lowered into a preheated oil bath (60 °C).  A grey precipitate formed within several
minutes.  After 26 h, the yellow suspension was removed from the bath, cooled to room
temperature (23 °C), treated with sat. aqueous NaHCO3 solution (50 mL), and transferred
to a separatory funnel where the aqueous phase was extracted four times with Et2O.  The
combined organics (175 mL) were rinsed once with sat. aqueous NaHCO3, dried over
MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was purified
first by flash chromatography (SiO2, 3 x 30 cm, 100% hexanes%2%%5% EtOAc in
hexanes) and then by flash chromatography using a Teledyne Isco CombiFlash Rf system
(SiO2, 12 g loading cartridge, 40 g column, multi-step gradient, hold 0% [2 min]%ramp
to 85% [17 min]%hold 85% CH2Cl2 in hexanes [2.5 min]%ramp to 100% [3 min]%hold
100% CH2Cl2 [5 min]) to afford cycloheptenone 55aa (176.7 mg, 0.66 mmol, 66% yield)
as a pale yellow oil;  Rf = 0.74 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3)
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and 13C NMR (125 MHz, CDCl3) mixture of two atropisomers isomers (1.9 : 1 ratio), see
Figure A1.307 for 1H NMR (in CDCl3) and Figure A1.308 for variable temperature 
1H
NMR data (in DMSO-d6 at 25, 50, 75, and 100 °C);  IR (Neat Film NaCl) 3060, 3007,
2973, 2936, 2936, 1669, 1626, 1604, 1594, 1476, 1464, 1443, 1413, 1379, 1356, 1338,
1307, 1281, 1251, 1214, 1177, 1136, 1109, 1095, 1057, 1020, 996, 915, 864, 818, 769,
743 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C19H23O [M+H]
+: 267.1743; found
267.1751.
Li
O
CeCl3, THF, 23 °C
then 
10% aq HCl, 60 °C
72% yield
O
O
i-BuO
27a 55ab
O
Cycloheptenone 55ab  (Table 2.5, entry 10).26Prepared using General Method G.  A
100 and a 25 mL round-bottom flask each equipped with a magnetic stir bar, fitted with a
rubber septum, and connected to a Schlenk manifold were flame-dried three times,
backfilling with argon after each drying cycle.  The hot 100 mL flask was placed into a
glove box antechamber, which was evacuated/backfilled with N2 (3 cycles, 5 min
evacuation per cycle) before the flask was brought into the glove box.  The flask was
loaded with anhydrous cerium chloride (616.2 mg, 2.50 mmol, 2.50 equiv), refitted with
the septum, removed from the glove box, and reconnected to the argon-filled Schlenk
manifold.
Once cool, the 25 mL flask was charged with furan (230 µL, 3.16 mmol, 1.05
equiv) and Et2O (3 mL, 1 M) and lowered into an ethylene glycol/dry ice bath (–15 °C).
To the cooled solution was added n-BuLi (1.42 mL, 2.12 M in hexanes, 3.01 mmol, 1.00
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equiv) dropwise and the flask was warmed to room temperature (23 °C).  The reaction
became cloudy and white with time. After 1 h, a portion of THF (13 mL) was added to
the 100 mL flask before the contents of the 25 mL flask were cannula-transferred to the
100 mL flask.  After 30 min of stirring, vinylogous ester 27a (236.4 mg, 1.00 mmol, 1.00
equiv) was cannula-transferred to the 100 mL flask from a flame-dried 10 mL conical
flask using several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M).
After 35 min, the reaction was quenched with 10% w/w aqueous HCl (5 mL) and
lowered into a preheated oil bath (60 °C).  After 17 h, the solution was removed from the
bath, cooled to room temperature (23 °C), treated with sat. aqueous NaHCO3 solution (50
mL), and transferred to a separatory funnel where the aqueous phase was extracted four
times with Et2O.  The combined organics (250 mL) were rinsed once with sat. aqueous
NaHCO3, dried over MgSO4, filtered, and concentrated under reduced pressure.  The
crude oil was purified by flash chromatography (SiO2, 3 x 30 cm, 100%
hexanes%2%%5% EtOAc in hexanes) to afford cycloheptenone 55ab (164.7 mg, 0.72
mmol, 72% yield) as a yellow oil;  Rf = 0.70 (30% EtOAc in hexanes);  
1H NMR (500
MHz, CDCl3) $ 7.45 (dd, J = 1.8, 0.6 Hz, 1H), 6.56 (dd, J = 3.4, 0.7 Hz, 1H), 6.43 (s,
1H), 6.41 (dd, J = 3.4, 1.8 Hz, 1H), 5.65 (dddd, J = 16.9, 10.2, 8.1, 6.6 Hz, 1H), 5.01
(dddd, J = 10.2, 2.0, 0.9, 0.9 Hz, 1H), 4.97 (dddd, J = 16.9, 2.3, 1.4, 1.4 Hz, 1H),
2.71–2.60 (m, 3H), 2.24 (dddd, J = 14.1, 8.1, 1.1, 1.1 Hz, 1H), 1.97–1.81 (m, 3H),
1.72–1.64 (m, 1H), 1.38 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.7, 155.3, 149.2,
142.9, 134.3, 129.3, 118.1, 111.4, 111.2, 45.9, 44.7, 44.3, 39.8, 26.3, 17.4;  IR (Neat Film
NaCl) 3118, 3075, 2941, 2871, 1661, 1652, 1645, 1581, 1557, 1455, 1415, 1380, 1341,
1258, 1215, 1173, 1152, 1106, 1080, 1029, 997, 956, 917, 898, 886, 858, 812, 742 cm-1;
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HRMS (MM: ESI-APCI+) m/z calc’d for C15H19O2 [M+H]
+: 231.1380; found 231.1374;
[!]D
25.0 –26.90 (c 1.18, CHCl3, 88% ee).
O
MgCl
S
S
O
i-BuO
CeCl3, THF, 23 °C
then 10% aq HCl, 60 °C
84% yield27a 55ac
Cycloheptenone 55ac  (Table 2.5, entry 11).27Prepared using General Method G.  See
procedure described above.  Rf = 0.70 (30% EtOAc in hexanes);  
1H NMR (500 MHz,
CDCl3) $ 7.27 (dd, J = 5.0, 1.5 Hz, 1H), 7.00–6.95 (m, 2H), 6.17 (s, 1H), 5.69 (dddd, J =
16.7, 10.2, 8.1, 6.4 Hz, 1H), 5.06 (dddd, J = 10.2, 2.0, 1.0, 1.0 Hz, 1H), 5.01 (ddd, J =
16.9, 3.4, 1.5 Hz, 1H), 2.74–2.59 (m, 2H), 2.50 (dddd, J = 14.1, 6.4, 1.4, 1.4 Hz, 1H),
2.12 (dddd, J = 14.1, 8.1, 1.1, 1.1 Hz, 1H), 1.96–1.84 (m, 3H), 1.77–1.68 (m, 1H), 1.29
(s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.2, 154.6, 143.8, 134.0, 133.7, 127.0, 126.7,
125.5, 118.5, 45.6, 45.1, 44.2, 38.8, 26.4, 17.7;  IR (Neat Film NaCl) 3103, 3075, 2964,
2938, 2871, 1671, 1655, 1590, 1519, 1454, 1438, 1415, 1378, 1341, 1251, 1234, 1218,
1178, 1134, 1107, 1077, 1045, 996, 917, 849, 836, 761, 708 cm-1;  HRMS (MM: ESI-
APCI+) m/z calc’d for C15H19OS [M+H]
+: 247.1151; found 247.1152;  [!]D
25.0 –3.65 (c
1.31, CHCl3, 88% ee).
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1. CeCl3, THF, 23 °C
    then sodium phosphate 
    buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN
79% yield
O
O
i-BuO
27p 133
MgBr
Cycloheptenone 133.28Prepared using General Method F.  A 100 mL round-bottom
flask equipped with a magnetic stir bar, fitted with a rubber septum, and connected to a
Schlenk manifold was flame-dried three times, backfilling with argon after each drying
cycle.  The hot flask was placed into a glove box antechamber, which was
evacuated/backfilled with N2 (4 cycles, 1 min evacuation per cycle) before the flask was
brought into the glove box.  The flask was loaded with anhydrous cerium chloride (591.6
mg, 2.40 mmol, 2.50 equiv), refitted with the septum, removed from the glove box, and
reconnected to the argon-filled Schlenk manifold.  A portion of THF (12 mL) was added,
rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white slurry
was stirred, a solution of but-3-enylmagnesium bromide (6.55 mL, 0.44 M in THF, 2.88
mmol, 3.00 equiv) was added and the mixture turned pale yellow.  After 40 min of
stirring, vinylogous ester 27p (226.9 mg, 0.96 mmol, 1.00 equiv) was cannula-transferred
to the slurry from a 20 mL scintillation vial using several THF rinses (3 x 4 mL; total
THF added = 24 mL, 0.04 M).
TLC analysis indicated that no starting material remained after 5 min.  After an
additional 10 min, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 mL).  A
thick grey emulsion formed.  The mixture was transferred to a separatory funnel where
the aqueous phase was extracted four times with Et2O.  The combined organic (125 mL)
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil
was transferred to a 20 mL scintillation vial and concentrated under reduced pressure.  A
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stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were added to the vial.  The
resulting cloudy solution was stirred vigorously for 5 min before being transferred to a
separatory funnel where the aqueous phase was extracted four times with Et2O.  The
combined organics (75 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure. The crude oil was purified by flash chromatography (SiO2, 3 x 30.5 cm,
100% hexanes%2%%5% EtOAc in hexanes) to afford cycloheptenone 133 (165.0 mg,
0.76 mmol, 79% yield) as a pale yellow oil;  Rf = 0.74 (30% EtOAc in hexanes);  
1H
NMR (500 MHz, CDCl3) $ 5.93 (s, 1H), 5.83–5.74 (m, 1H), 5.43–5.32 (m, 2H), 5.02
(dm, J = 17.2 Hz, 1H), 4.97 (dm, J = 10.2 Hz, 1H), 2.66–2.50 (m, 2H), 2.27–2.12 (m,
4H), 1.84–1.71 (m, 4H), 1.69 (dd, J = 4.8, 0.7 Hz, 3H), 1.22 (s, 3H);  13C NMR (125
MHz, CDCl3) $ 204.8, 161.7, 137.8, 137.2, 129.3, 124.4, 115.2, 48.6, 44.1, 41.3, 34.8,
34.1, 26.0, 18.2, 18.0;  IR (Neat Film NaCl) 3077, 2962, 2937, 2874, 2856, 1650, 1614,
1451, 1414, 1378, 1342, 1273, 1251, 1224, 1198, 1126, 1069, 974, 911 cm-1;  HRMS
(MM: ESI-APCI+) m/z calc’d for C15H23O [M+H]
+: 219.1743; found 219.1741;  [!]D
20.0
+123.43 (c 1.10, CHCl3, 88% ee).
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2.1.1.15 PREPARATION OF POLYCYCLIC CYCLOHEPTENONE
DERIVATIVES BY RING-CLOSING METATHESIS
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
99% yield
O O
55x 111x
General Method I:  Ring-Closing Metathesis
Enone 111x.  A 100 mL round-bottom flask equipped with a magnetic stir bar, fitted
with a water condenser, and connected to a Schlenk manifold (through the condenser)
was flame-dried three times, backfilling with argon after each drying cycle.  Once cool,
the flask was loaded with neat cycloheptenone 55x (50.0 mg, 0.22 mmol, 1.00 equiv) and
backfilled with argon twice.  Benzene (1 h argon sparge before use, 43 mL, 0.005 M) was
added to the flask, followed by Grubbs–Hoveyda 2nd generation catalyst (6.7 mg, 0.011
mmol, 5 mol %).  The solution color turned pale green with addition of catalyst.  The
flask was lowered into a preheated oil bath (50 °C).  The reaction was removed from the
oil bath after 30 min, cooled to room temperature (23 °C), and quenched with ethyl vinyl
ether (1 mL).  The reaction was filtered through a short silica gel plug rinsing with Et2O
and concentrated under reduced pressure.  The crude oil was purified twice by flash
chromatography (SiO2, both columns 2 x 28 cm, 100% hexanes%2%%5% EtOAc in
hexanes) to afford cycloheptenone 111x (43.5 mg, 0.21 mmol, 99% yield) as a yellow oil.
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Ru
PCy3
Ph
Cl
Cl
NN
Grubbs 2nd generation 
(113) (0.2 mol %)
CH2Cl2, reflux
88% yield
O O
Ph
55y 111y
Enone 111y  (Table 2.6, entry 1).  A 100 mL round-bottom flask equipped with a
magnetic stir bar, fitted with a water condenser, and connected to a Schlenk manifold
(through the condenser) was flame-dried three times, backfilling with argon after each
drying cycle.  Once cool, the flask was loaded with neat cycloheptenone 55y (452.8 mg,
1.70 mmol, 1.00 equiv) and dichloromethane (60 mL, 0.03 M) and the resulting solution
was sparged with Ar.  After 30 min of degassing, Grubbs 2nd generation catalyst (3.4
mg, 0.0040 mmol, 0.2 mol %) was added to the flask.  The solution color turned pale red
with addition of catalyst.  The flask was lowered into a preheated oil bath (50 °C).
The flask was removed from oil bath after 1 h, cooled to room temperature (23
°C), and charged with DMSO (50 µL) and silica gel (70 mg).  The resulting mixture was
concentrated the reaction under reduced pressure and purified by flash chromatography
(SiO2, 2 x 17 cm, 15:1 hexanes:EtOAc) to afford cycloheptenone 111y (242.9 mg, 1.50
mmol, 88% yield) as a yellow oil;  Rf = 0.52 (30% EtOAc in hexanes);  
1H NMR (500
MHz, CDCl3) $ 6.35–6.32 (m, 1H), 6.14 (dddd, J = 5.6, 2.5, 1.7, 0.7 Hz, 1H), 5.87 (app s,
1H), 2.70 (dddt, J = 15.1, 6.4, 3.5, 0.9 Hz, 1H), 2.59–2.51 (m, 2H), 2.41 (ddd, J = 17.9,
2.9, 1.6 Hz, 1H), 2.11–2.02 (m, 1H), 2.00–1.82 (m, 3H), 1.23 (s, 3H);  13C NMR (125
MHz, CDCl3) $ 204.8, 169.2, 142.7, 134.4, 121.7, 51.6, 46.7, 45.1, 37.9, 29.7, 21.2;  IR
(Neat Film NaCl) 3056, 2930, 2867, 2841, 1651, 1615, 1580, 1449, 1372, 1352, 1293,
1261, 1211, 1190, 1159, 1080, 968, 951, 862, 844, 801, 811, 723 cm-1;  HRMS (MM:
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ESI–APCI+) m/z calc’d for C11H15O [M+H]
+: 163.1117; found 163.1120;  [!]D
26.0 –48.88
(c 1.83, CHCl3, 88% ee).
O O
55z 111z
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
99% yield
Enone 111z  (Table 2.6, entry 2).  Prepared using General Method I.  A two-neck 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a
water condenser, and connected to a Schlenk manifold (through the condenser) was
flame-dried three times, backfilling with argon after each drying cycle.  Once cool, the
flask was loaded with neat cycloheptenone 55z (50.0 mg, 0.25 mmol, 1.00 equiv) and
backfilled with argon.  Benzene (1 h argon sparge before use, 39 mL) was added to the
flask, followed by Grubbs–Hoveyda 2nd generation catalyst (7.8 mg, 0.012 mmol, 5 mol
%).  The solution color turned pale green with addition of catalyst.  The flask was rinsed
with more benzene (10 mL; total benzene added = 49 mL, 0.005 M) and lowered into a
preheated oil bath (50 °C).
TLC analysis indicated no starting material remained after 3 h.  Consequently, the
reaction was removed from oil bath, cooled to room temperature (23 °C), and quenched
with ethyl vinyl ether (1 mL).  The reaction was filtered through a short silica gel plug
rinsing with Et2O and concentrated under reduced pressure.  The crude oil was purified
by flash chromatography (SiO2, 2 x 28.5 cm, 100% hexanes%2%%5% EtOAc in
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hexanes) to afford cycloheptenone 111z (50 mg, 0.25 mmol, 99% yield) as a yellow oil;
Rf = 0.64 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3) $ 6.16 (t, J = 2.8 Hz,
1H), 6.02 (s, 1H), 5.13–5.11 (m, 1H), 4.97 (s, 1H), 2.76 (ddd, J = 14.7, 6.7, 4.7 Hz, 1H),
2.56 (ddd, J = 14.7, 9.8, 5.1 Hz, 1H), 2.48 (dd, J = 17.8, 2.0 Hz, 1H), 2.33 (dd, J = 17.8,
3.1 Hz, 1H), 2.09–1.99 (m, 1H), 1.94 (dd, J = 9.9, 4.0 Hz, 2H), 1.91–1.89 (m, 3H),
1.89–1.83 (m, 1H), 1.26 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.7, 167.2, 146.8,
138.4, 137.5, 122.0, 115.9, 49.5, 48.3, 45.0, 38.2, 28.4, 23.1, 20.9;  IR (Neat Film NaCl)
3084, 3052, 2918, 2868, 2845, 1652, 1607, 1450, 1374, 1352, 1311, 1290, 1259, 1210,
1190, 1164, 1117, 1082, 1004, 982, 944, 898, 881, 848, 811, 771, 746 cm-1;  HRMS
(MM: ESI–APCI+) m/z calc’d for C14H19O [M+H]
+: 203.1430; found 203.11428;  [!]D
25.0
–55.41 (c 1.61, CHCl3, 88% ee).
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
1,4-benzoquinone (10 mol %)
benzene, 50 °C
91% yield
O O
55t 111t
Enone 111t  (Table 2.6, entry 3).  Prepared using General Method I.  A 250 mL round-
bottom flask equipped with a magnetic stir bar, fitted with a water condenser, and
connected to a Schlenk manifold (through the condenser) was flame-dried three times,
backfilling with argon after each drying cycle.  Once cool, cycloheptenone 55t (174.6
mg, 0.85 mmol, 1.00 equiv) was cannula-transferred from a 20 mL scintillation vial to the
250 mL flask using several benzene rinses (1.5 h argon sparge before use, 5 x 4 mL).
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Additional benzene (141 mL) was added to the flask followed by 1,4-benzoquinone (9.2
mg, 0.085 mmol, 10 mol %) and Grubbs–Hoveyda 2nd generation catalyst (26.8 mg,
0.043 mmol, 5 mol %).  The solution color turned pale green with addition of catalyst.
The flask was rinsed with more benzene (10 mL; total benzene added = 171 mL, 0.005
M) and lowered into a preheated oil bath (50 °C).
The reaction was removed from oil bath after 2.5 h, cooled to room temperature
(23 °C), and quenched with ethyl vinyl ether (2 mL).  The reaction color turned dark
green with the ethyl vinyl ether addition.  The reaction was filtered through a short silica
gel plug rinsing with Et2O and concentrated under reduced pressure.  The crude oil was
purified by flash chromatography (SiO2, 3 x 25 cm, 100% hexanes%2%%5% EtOAc in
hexanes) to afford cycloheptenone 111t (47.7 mg, 0.27 mmol, 91% yield) as a yellow oil;
Rf = 0.58 (30% EtOAc in hexanes);  
1H NMR (500 MHz, C6D6) $ 5.95 (d, J = 2.1 Hz,
1H), 5.46–5.41 (m, 1H), 5.34 (ddddd, J = 9.9, 4.4, 2.8, 2.8, 1.0 Hz, 1H), 2.72 (dm, J =
20.2 Hz, 1H), 2.44–2.33 (m, 2H), 2.27 (dm, J = 20.2 Hz, 1H), 1.97 (dm, J = 17.6 Hz,
1H), 1.44 (ddd, J = 17.5, 5.2, 0.9 Hz, 1H), 1.33–1.19 (m, 4H), 0.86 (s, 3H);  13C NMR
(125 MHz, C6D6) $ 202.2, 156.0, 127.2, 125.1, 125.0, 44.3, 41.8, 41.4, 41.2, 36.3, 26.1,
17.6;  IR (Neat Film NaCl) 3274, 3029, 2933, 2833, 1720, 1650, 1619, 1452, 1420, 1381,
1345, 1306, 1264, 1239, 1219, 1185, 1125, 1105, 1082, 1004, 976, 952, 938, 924, 892,
884, 871, 836, 775, 733 cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C12H17O
[M+H]+: 177.1274; found 177.1277;  [!]D
25.0 –49.94 (c 0.86, CHCl3, 88% ee).
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Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
1,4-benzoquinone (10 mol %)
benzene, 50 °C
90% yield
O O
55u 111u
Enone 111u  (Table 2.6, entry 4).  Prepared using General Method I.  A three-neck 100
mL round-bottom flask equipped with a magnetic stir bar and fitted with rubber septa and
a water condenser was connected to a Schlenk manifold (through the condenser).  The
flask was flame-dried three times, backfilling with argon after each drying cycle.  Once
cool, the flask was loaded with neat cycloheptenone 55u (50.0 mg, 0.23 mmol, 1.00
equiv), benzene (1 h argon sparge before use, 46 mL, 0.005 M), 1,4-benzoquinone (2.5
mg, 0.023 mmol, 10 mol %), and Grubbs–Hoveyda 2nd generation catalyst (7.2 mg,
0.011 mmol, 5 mol %).  The solution color turned pale green with addition of catalyst.
The flask was lowered into a preheated oil bath (50 °C).
The reaction was removed from oil bath after 1 h, cooled to room temperature (23
°C), and quenched with ethyl vinyl ether (1.5 mL).  The reaction color turned dark green
with the ethyl vinyl ether addition.  The reaction was filtered through a short silica gel
plug rinsing with Et2O and concentrated under reduced pressure.  The crude oil was
purified by flash chromatography (SiO2, 2 x 28 cm, 100% hexanes%2%%5% EtOAc in
hexanes) to afford cycloheptenone 111u (39.0 mg, 0.21 mmol, 90% yield) as a yellow
oil;  Rf = 0.56 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3) $ 5.87 (d, J = 2.0
Hz, 1H), 5.38–5.34 (m, 1H), 3.06 (dm, J = 19.7 Hz, 1H), 2.63–2.49 (m, 3H), 2.28 (dm, J
= 17.2 Hz, 1H), 1.85 (dd, J = 17.2, 5.3 Hz, 1H), 1.81–1.75 (m, 2H), 1.74–1.65 (m, 2H),
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1.68 (s, 3H), 1.16 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 205.1, 159.4, 131.8, 126.3,
119.5, 44.3, 41.6, 41.5, 41.3, 41.3, 26.6, 22.5, 17.6;  IR (Neat Film NaCl) 3273, 3017,
2963, 2930, 1720, 1656, 1651, 1645, 1619, 1616, 1450, 1418, 1378, 1363, 1345, 1268,
1239, 1220, 1191, 1151, 1134, 1104, 1072, 1038, 989, 972, 962, 944, 931, 897, 877, 854,
827, 784, 732 cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C13H19O [M+H]
+:
191.1430; found 191.1436;  [!]D
25.0 +9.09 (c 0.86, CHCl3, 88% ee).
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
90% yield
O
111v
O
55v
Enone 111v  (Table 2.6, entry 5).  Prepared using General Method I.  A two-neck 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a
water condenser, and connected to a Schlenk manifold (through the condenser) was
flame-dried three times, backfilling with argon after each drying cycle.  Once cool, the
flask was loaded with neat cycloheptenone 55v (50.0 mg, 0.23 mmol, 1.00 equiv),
Grubbs–Hoveyda 2nd generation catalyst (7.2 mg, 0.011 mmol, 5 mol %), benzene (1 h
argon sparge before use, 46 mL, 0.005 M).  The solution color turned pale green with
addition of catalyst.  The flask was lowered into a preheated oil bath (50 °C).
TLC analysis indicated no starting material remained after 15 min.  Consequently,
the reaction was removed from the oil bath, cooled to room temperature (23 °C), and
quenched with ethyl vinyl ether (1 mL).  The reaction color turned amber with the ethyl
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vinyl ether addition.  The reaction was filtered through a short silica gel plug rinsing with
Et2O and concentrated under reduced pressure.  The crude oil was purified by flash
chromatography (SiO2, 2 x 27.5 cm, 100% hexanes%2%%5% EtOAc in hexanes) to
afford cycloheptenone 111v (39.4 mg, 0.21 mmol, 90% yield) as a yellow oil;  Rf = 0.58
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 5.87 (s, 1H), 5.65–5.58 (m,
1H), 5.54–5.49 (m, 1H), 2.81–2.74 (m, 1H), 2.66–2.59 (m, 2H), 2.56–2.46 (m, 2H),
2.24–2.13 (m, 2H), 2.07 (ddd, J = 14.1, 11.1, 3.1 Hz, 1H), 1.93 (ddddd, J = 14.1, 11.0,
9.3, 4.8, 2.9 Hz, 1H), 1.85–1.79 (m, 1H), 1.76 (dd, J = 14.9, 7.9 Hz, 1H), 1.66 (ddd, J =
14.0, 6.9, 2.8 Hz, 1H), 1.16 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.8, 165.3, 129.9,
129.7, 126.2, 47.8, 43.9, 40.7, 40.3, 34.5, 32.2, 27.8, 19.6;  IR (Neat Film NaCl) 3287,
3017, 2930, 2833, 1652, 1616, 1481, 1450, 1380, 1352, 1342, 1291, 1279, 1262, 1243,
1224, 1204, 1184, 1162, 1084, 1075, 1047, 1021, 984, 963, 921, 896, 877, 846, 834, 788,
755 cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C13H19O [M+H]
+: 191.1430; found
191.1430;  [!]D
25.0 –92.01 (c 0.82, CHCl3, 88% ee).
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
98% yield
O O
55w 111w
Enone 111w  (Table 2.6, entry 6).  Prepared using General Method I.  A two-neck 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a
water condenser, and connected to a Schlenk manifold (through the condenser) was
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flame-dried three times, backfilling with argon after each drying cycle.  Once cool, the
flask was loaded with neat cycloheptenone 55w (50.0 mg, 0.22 mmol, 1.00 equiv) and
backfilled with argon.  Benzene (1 h argon sparge before use, 33 mL) was added to the
flask, followed by Grubbs–Hoveyda 2nd generation catalyst (6.7 mg, 0.011 mmol, 5 mol
%).  The solution color turned pale green with addition of catalyst.  The flask was rinsed
with more benzene (10 mL; total benzene added = 43 mL, 0.005 M) and lowered into a
preheated oil bath (50 °C).
TLC analysis indicated no starting material remained after 30 min.  After an
additional 10 min of stirring, the reaction was removed from the oil bath, cooled to room
temperature (23 °C), and quenched with ethyl vinyl ether (1 mL).  The reaction color
turned dark brown with the ethyl vinyl ether addition.  The reaction was filtered through a
short silica gel plug rinsing with Et2O and concentrated under reduced pressure.  The
crude oil was purified by flash chromatography (SiO2, 2 x 28.5 cm, 100%
hexanes%2%%5% EtOAc in hexanes) to afford cycloheptenone 111w (43.2 mg, 0.21
mmol, 98% yield) as a clear colorless oil;  Rf = 0.63 (30% EtOAc in hexanes);  
1H NMR
(500 MHz, CDCl3) $ 5.87 (s, 1H), 5.41–5.34 (m, 1H), 2.79 (td, J = 12.3, 5.3 Hz, 1H),
2.66–2.55 (m, 2H), 2.54–2.42 (m, 2H), 2.19 (ddd, J = 12.5, 6.0, 3.3 Hz, 1H), 2.14–2.02
(m, 2H), 1.98–1.88 (m, 1H), 1.85–1.76 (m, 1H), 1.71–1.63 (m, 2H), 1.62 (s, 3H), 1.13 (s,
3H);  13C NMR (125 MHz, CDCl3) $ 204.9, 165.8, 136.9, 129.5, 120.7, 47.7, 43.9, 40.6,
40.2, 36.9, 34.3, 27.5, 25.3, 19.7;  IR (Neat Film NaCl) 3300, 3014, 2928, 2828, 1657,
1617, 1480, 1450, 1379, 1353, 1342, 1292, 1259, 1216, 1171, 1131, 1106, 1082, 1050,
1009, 982, 962, 916, 897, 874, 833, 814, 795, 765 cm-1;  HRMS (MM: ESI–APCI+) m/z
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calc’d for C14H21O2 [M+H]
+: 205.1587; found 205.1582;  [!]D
25.0 –73.66 (c 0.95, CHCl3,
88% ee).
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
toluene, 50 °C
99% yield
O O
111aa55aa
Enone 111aa  (Table 2.6, entry 7).  Prepared using General Method I.  A three-neck 100
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a
water condenser, and connected to a Schlenk manifold (through the condenser) was
flame-dried three times, backfilling with argon after each drying cycle.  Once cool,
cycloheptenone 55aa (65.8 mg, 0.25 mmol, 1.00 equiv) was cannula-transferred from a
20 mL scintillation vial to the 100 mL flask using several toluene rinses (1.5 h argon
sparge before use, 5 x 4 mL).  Additional toluene (20 mL) was added to the flask
followed by Grubbs–Hoveyda 2nd generation catalyst (7.7 mg, 0.012 mmol, 5 mol %).
The solution color turned pale green with addition of catalyst.  The flask was rinsed with
more toluene (9 mL; total toluene added = 49 mL, 0.005 M) and lowered into a preheated
oil bath (50 °C).
The reaction was removed from the oil bath after 6.5 h, cooled to room
temperature (23 °C), and quenched with ethyl vinyl ether (0.5 mL).  The reaction color
turned dark brown with the ethyl vinyl ether addition.  The reaction was filtered through a
short silica gel plug rinsing with EtOAc and concentrated under reduced pressure.  The
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crude oil was purified by flash chromatography (SiO2, 2 x 24.5 cm, 100%
hexanes%2%%5% EtOAc in hexanes) to afford cycloheptenone 111aa (56.7 mg, 0.23
mmol, 96% yield) as a yellow oil;  Rf = 0.64 (30% EtOAc in hexanes);  
1H NMR (500
MHz, CDCl3) $ 7.31–7.26 (m, 1H), 7.22–7.19 (m, 2H), 7.10 (d, J = 7.4 Hz, 1H), 6.53
(dm, J = 11.1 Hz, 1H), 6.03 (dt, J = 11.2, 6.0 Hz, 1H), 5.82 (s, 1H), 2.71–2.60 (m, 2H),
2.30 (ddd, J = 15.6, 5.8, 0.8 Hz, 1H), 2.21 (ddd, J = 15.6, 6.3, 1.8 Hz, 1H), 2.15 (ddd, J =
13.9, 7.5, 4.5 Hz, 1H), 2.01–1.85 (m, 3H), 1.14 (s, 3H);  13C NMR (125 MHz, CDCl3) $
204.3, 162.5, 142.5, 135.5, 132.0, 130.8, 130.0, 128.8, 128.8, 127.9, 127.3, 50.6, 44.2,
42.4, 40.1, 27.8, 19.3;  IR (Neat Film NaCl) 3057, 3017, 2933, 2870, 1718, 1665, 1601,
1481, 1445, 1417, 1383, 1354, 1340, 1286, 1258, 1228, 1180, 1125, 996, 984, 936, 890,
828, 780, 757 cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C17H19O [M+H]
+:
239.1430; found 239.1432;  [!]D
20.0 –86.75 (c 0.70, CHCl3, 88% ee).
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
99% yield
O O
55x 111x
Enone 185w  (Table 2.6, entry 8).  Prepared using General Method I.  See procedure
described above.  Rf = 0.56 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3) $
5.77–5.70 (m, 1H), 5.65 (tdt, J = 10.4, 6.4, 1.3 Hz, 1H), 2.68–2.55 (m, 2H), 2.54–2.44
(m, 1H), 2.30–2.24 (m, 2H), 2.24–2.15 (m, 1H), 2.13–2.04 (m, 1H), 1.94–1.69 (m, 7H),
1.52–1.41 (m, 1H), 1.22 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.2, 165.6, 132.2,
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131.9, 128.5, 49.0, 44.2, 39.8, 39.5, 35.5, 31.1, 27.0, 26.5, 17.8;  IR (Neat Film NaCl)
3018, 2928, 2859, 1645, 1608, 1468, 1448, 1411, 1380, 1343, 1327, 1279, 1253, 1214,
1178, 1131, 1102, 1088, 1051, 1015, 987, 965, 937, 920, 899, 880, 845, 796, 777, 747
cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C14H21O [M+H]
+: 205.1587; found
205.1587;  [!]D
25.0 –141.99 (c 1.01, CHCl3, 88% ee).
O O
133 114
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (112) (5 mol %)
benzene, 50 °C
99% yield
Enone 114.  Prepared using General Method I.  A 100 mL round-bottom flask equipped
with a magnetic stir bar, fitted with a water condenser, and connected to a Schlenk
manifold (through the condenser) was flame-dried three times, backfilling with argon
after each drying cycle.  Once cool, the flask was loaded with neat cycloheptenone 133
(50.0 mg, 0.23 mmol, 1.00 equiv) and backfilled with argon twice.  Benzene (1 h argon
sparge before use, 44 mL) was added to the flask, followed by Grubbs–Hoveyda 2nd
generation catalyst (7.2 mg, 0.011 mmol, 5 mol %).  The flask was rinsed with more
benzene (2 mL; total benzene added = 46 mL, 0.005 M) and lowered into a preheated oil
bath (50 °C).  The solution color turned pale green with addition of catalyst and amber
over time.
The reaction was removed from the oil bath after 50 min, cooled to room
temperature (23 °C), and quenched with ethyl vinyl ether (0.5 mL).  The reaction was
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filtered through a short silica gel plug rinsing with Et2O and concentrated under reduced
pressure.  The crude oil was purified twice by flash chromatography (SiO2, both columns
2 x 27.5 cm, 100% hexanes%2%%5% EtOAc in hexanes) to afford cycloheptenone 114
(35.8 mg, 0.23 mmol, 89% yield, 70% yield from vinylogous ester 27p) as a pale yellow
oil;  Rf = 0.62 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3) $ 5.87 (s, 1H),
5.72–5.67 (m, 1H), 5.28 (dd, J = 9.7, 2.4 Hz, 1H), 2.71–2.64 (m, 1H), 2.62–2.54 (m, 1H),
2.53–2.46 (m, 1H), 2.31–2.11 (m, 3H), 1.92–1.74 (m, 3H), 1.70 (ddd, J = 14.0, 6.6, 2.4
Hz, 1H), 1.27 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.5, 161.3, 137.8, 126.9, 125.3,
44.6, 43.6, 40.6, 33.8, 28.1, 27.7, 18.6;  IR (Neat Film NaCl) 3019, 2934, 2866, 2845,
1665, 1653, 1621, 1450, 1414, 1350, 1309, 1281, 1258, 1217, 1181, 1171, 1132, 1087,
1074, 1024, 1013, 973, 938, 902, 881, 865, 783, 767, 716 cm-1;  HRMS (MM:
ESI–APCI+) m/z  calc’d for C12H17O [M+H]
+: 177.1274; found 177.1274;  [!]D
20.0
–188.35 (c 0.72, CHCl3, 88% ee).
2.1.1.16 PREPARATION OF POLYCYCLIC CYCLOHEPTENONE
DERIVATIVES BY OTHER METHODS
OO
DBU
CH3CN, 23 °C
73% yield
111t 115
Diene 115.  A 20 mL scintillation vial containing enone 111t (31.5 mg, 0.18 mmol, 1.00
equiv) was equipped with a stir bar and sealed with a screw cap containing a teflon
septum.  The vial was connected to a Schlenk manifold and backfilled with argon three
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times.  Acetonitrile (1.8 mL, 0.1 M) was added to the vial followed by DBU (30 µL, 0.20
mmol, 1.12 equiv).  The solution was stirred at room temperature (23 °C) until no starting
material remained by TLC analysis (4 h).  The reaction was passed through a short silica
gel plug, rinsed with water, dried over MgSO4, filtered through another short silica gel
plug, and concentrated under reduced pressure.  The resulting crude oil was purified by
flash chromatography (SiO2, 1 x 28.5 cm, 100% hexanes%2%%5% EtOAc in hexanes)
to afford diene 115 (23.1 mg, 0.13 mmol, 73% yield) as a pale yellow oil;  Rf = 0.63
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 5.86 (ddt, J = 9.0, 5.3, 1.7 Hz,
1H), 5.79–5.73 (m, 2H), 3.27 (d, J = 16.3 Hz, 1H), 2.93 (d, J = 16.3 Hz, 1H), 2.73 (ddd, J
= 12.4, 10.0, 4.7 Hz, 1H), 2.33–2.23 (m, 2H), 2.08–2.00 (m, 1H), 1.89–1.67 (m, 3H),
1.49–1.41 (m, 1H), 0.99 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 212.0, 138.6, 125.4,
123.9, 123.6, 49.5, 42.7, 37.6, 37.5, 36.5, 24.1, 20.9;  IR (Neat Film NaCl) 3039, 2929,
2865, 2817, 1708, 1645, 1587, 1453, 1424, 1403, 1371, 1356, 1319, 1286, 1263, 1235,
1211, 1143, 1105, 1082, 1039, 987, 969, 940, 925, 851, 817, 761, 704 cm-1;  HRMS (GC-
EI+) m/z calc’d for C12H16O [M+&]
+: 176.1201; found 176.1219;  [!]D
25.0 –205.54 (c 0.71,
CHCl3, 88% ee).
OO
DBU
CH3CN, 180 °C
µwaves
111t 116
59% yield
O
115
16% yield
+
Diene 115 and Diene 116.  A 2.0–5.0 mL µwave vial fitted with a stir bar and sealed
with a screw cap containing a teflon septum was flame-dried three times, backfilling with
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argon after each drying cycle.  Once cool, diene 111t (66.7 mg, 0.38 mmol, 1.00 equiv)
was cannula-transferred to the vial with several acetonitrile rinses (4 x 1 mL, 0.09 M) and
the flask was charged with DBU (66 µL, 0.44 mmol, 1.17 equiv). The pale yellow
solution was subjected to microwave irradiation in a Biotage Initiator microwave reactor
(temperature: 180 °C, sensitivity: normal).  After 5 h of irradiation, the crimp cap was
removed and the reaction was filtered through a silica gel plug.  The resulting solution
was concentrated under reduced pressure and purified by flash chromatography (SiO2, 2 x
29 cm, 100% hexanes%10%%30%%50%%80% CH2Cl2 in hexanes) to yield diene 116
(39.5 mg, 0.22 mmol, 59% yield) as a yellow oil and diene 115 (10.4 mg, 0.059 mmol,
16% yield) as a pale yellow oil.
Diene 115:  Characterization data is identical to that described above.
Diene 116:  R f = 0.56 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3) $
6.13–6.07 (m, 1H), 6.02 (dd, J = 9.9, 2.8 Hz, 1H), 5.76 (s, 1H), 2.75 (dddt, J = 15.6, 6.6,
5.0, 0.9 Hz, 1H), 2.52 (ddd, J = 15.4, 9.5, 5.6 Hz, 1H), 2.38–2.27 (m, 1H), 2.19 (dtt, J =
19.3, 5.6, 1.3 Hz, 1H), 2.05–1.93 (m, 1H), 1.87–1.77 (m, 2H), 1.74–1.62 (m, 2H), 1.44
(ddt, J = 13.2, 5.4, 1.5 Hz, 1H), 1.13 (s, 3H);  13C NMR (125 MHz, CDCl3) $ 204.1,
156.2, 135.1, 131.4, 129.1, 44.6, 42.2, 38.9, 37.6, 23.1, 22.9, 18.8;  IR (Neat Film NaCl)
3026, 2967, 2922, 2868, 2849, 1650, 1621, 1583, 1449, 1428, 1383, 1353, 1338, 1284,
1244, 1225, 1207, 1173, 1163, 1130, 1114, 1090, 1077, 1023, 978, 954, 935, 911, 881,
866, 840, 777, 727 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C12H17O [M+H]
+:
177.1274; found 177.1278;  [!]D
25.0 –298.04 (c 1.24, CHCl3, 88% ee).
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55z
O
Co2(CO)8
THF, 23 °C
then DMSO, 60 °C
O
O
H
O
O
H
+
90% yield
3:1 dr
117a 117b
Enones 117a and 117b.  A 20 mL scintillation vial containing cycloheptenone 55z
(185.6 mg, 0.92 mmol, 1.00 equiv) was equipped with a stir bar and sealed with a screw
cap containing a teflon septum.  The vial was connected to a Schlenk manifold and
backfilled with argon three times.  The vial was charged with THF (5.0 mL, 0.2 M) and
dicobalt octacarbonyl (388.5 mg, 1.14 mmol, 1.24 equiv), generating a dark brown
solution.  After 12 h of stirring at room temperature (23 °C), DMSO (380 µL, 5.35 mmol,
5.83 equiv) was added and the vial was lowered into a preheated oil bath (60 °C).
Reaction turned dark red over time.  The vial was removed from the oil bath after 14 h
and cooled to room temperature.  The reaction mixture was concentrated under reduced
pressure and purified by flash chromatography using a Teledyne Isco CombiFlash Rf
system (SiO2, 25 g loading cartridge, 40 g column, multi-step gradient, hold 0% [5
min]%ramp to 5% [5 min]%hold 5% [50 min]%ramp to 10% [5 min]%hold 10% [15
min]%ramp to 15% [1 min]%hold 15% [7 min]%ramp to 20% [1 min]%hold 20%
EtOAc in hexanes [27 min]) to afford a 3:1 diastereomeric mixture of cycloheptenones
117a:117b (190.2 mg, 0.83 mmol, 90% yield).  Analytically pure samples of 117a and
117b could be obtained using the above column conditions.
Major diastereomer (117a): yellow oil that solidified upon cooling;  Rf = 0.32 (30%
EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $  6.38 (s, 1H), 3.21–3.12 (m, 1H),
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2.81–2.75 (m, 1H), 2.75 (dd, J = 17.8, 6.3 Hz, 1H), 2.62 (ddd, J = 14.0, 11.4, 4.6 Hz,
1H), 2.19–2.09 (m, 1H), 2.11 (dd, J = 17.8, 3.7 Hz, 1H), 2.01 (dd, J = 11.6, 6.9 Hz, 1H),
1.99–1.90 (m, 2H), 1.89 (d, J = 2.6 Hz, 3H), 1.88–1.81 (m, 1H), 1.32 (s, 3H), 1.28 (t, J =
11.8 Hz, 1H);  13C NMR (125 MHz, CDCl3) $ 209.5, 204.8, 172.4, 155.0, 135.6, 128.8,
50.9, 47.2, 45.6, 42.3, 40.5, 39.5, 26.8, 20.9, 9.0;  For NOESY correlation data, see
Figure A1.351;  IR (Neat Film NaCl) 2945, 2917, 2867, 1701, 1662, 1446, 1375, 1332,
1304, 1258, 1219, 1196, 1148, 1099, 1054, 978, 945, 895, 869, 852, 830, 802, 706 cm-1;
HRMS (GC-EI+) m/z calc’d for C15H19O2 [M+H]
+: 231.1380; found 231.1381;  [!]D
20.0
+150.77 (c 1.01, CHCl3, 88% ee).
Minor diastereomer (117b): orange oil that solidified upon cooling;  Rf = 0.25 (30%
EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) $ 6.27 (s, 1H), 3.09–2.98 (m, 1H), 2.70
(dd, J = 18.1, 6.4 Hz, 1H), 2.71–2.64 (m, 1H), 2.63–2.56 (m, 1H), 2.16 (dd, J = 12.5, 8.5
Hz, 1H), 2.11 (dd, J = 18.1, 3.3 Hz, 1H), 2.12–1.96 (m, 2H), 1.95–1.87 (m, 2H), 1.87 (d,
J = 2.5 Hz, 3H), 1.28 (dd, J = 12.4, 11.6 Hz, 1H), 1.24 (s, 3H);  13C NMR (125 MHz,
CDCl3) $ 209.7, 206.4, 173.0, 154.6, 133.7, 127.4, 48.9, 48.3, 42.4, 42.3, 41.3, 37.5, 31.9,
22.2, 8.5;  For NOESY correlation data, see Figure A1.355;  IR (Neat Film NaCl) 2928,
2867, 1703, 1668, 1453, 1410, 1377, 1305, 1285, 1236, 1208, 1157, 1094, 1054, 996,
949, 891, 874, 859, 791, 720 cm-1;  HRMS (GC-EI+) m/z calc’d for C15H19O2 [M+H]
+:
231.1380; found 231.1372;  [!]D
20.0 –407.06 (c 1.65, CHCl3, 88% ee).
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2.1.1.17 DETERMINATION OF ENANTIOMERIC EXCESS
Table 2.8.  Methods for the determination of enantiomeric excess (Chiral HPLC and SFC).
entry product
compound 
assayed
assay 
conditions
retention time 
of major 
isomer (min)
retention time 
of minor 
isomer (min)
% ee
1
HPLC
Chiralcel OD-H
5% IPA in hexane
isocratic, 1.0 mL/min
5.80 6.53 86
2
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
1% IPA in hexane
isocratic, 1.0 mL/min
6.30 7.26 88
O
i-BuO
O
i-BuO
3
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
0.25% IPA in hexane
isocratic, 1.0 mL/min
18.08 16.23 92
22a 22a
27a 27a
27b 27b
4
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.5% IPA in hexane
isocratic, 1.0 mL/min
15.70 13.96 86
Ph Ph
27c 27c
5
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.5% IPA in hexane
isocratic, 1.0 mL/min
12.35 13.43 89
27d 27d
6
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
0.8% IPA in hexane
isocratic, 2.0 mL/min
5.03 6.06 87
27e 27e
7
O
i-BuO
O
i-BuO
SFC
Chiralcel AD-H
5% IPA in hexane
isocratic, 2.5 mL/min
6.99 6.31 90
27f 27f
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N
Cl
entry product
compound 
assayed
assay 
conditions
retention time 
of major 
isomer (min)
retention time 
of minor 
isomer (min)
% ee
8
9
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.1% IPA in hexane
isocratic, 1.0 mL/min
27.22 24.19 86
27g 27g
Cl
CN
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
5% IPA in hexane
isocratic, 1.0 mL/min
10.67 14.66 87
27h 27h
CN
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
5% EtOH in hexane
isocratic, 1.0 mL/min
13.22 15.13 85
27i 27i
N N
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
5% EtOH in hexane
isocratic, 1.0 mL/min
11.11 16.64 83
27j 27j
N Ts Ts
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
0.8% IPA in hexane
isocratic, 2.0 mL/min
4.39 5.17 80
27k 27e
H O
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.2% IPA in hexane
isocratic, 1.0 mL/min
21.74 25.53 58
OTBDPS OTBDPS
27l 27l
O
i-BuO
F
O
i-BuO
F
HPLC
Chiralcel OD-H
1% IPA in hexane
isocratic, 1.0 mL/min
8.80 8.05 91
27l 27l
O
O
i-BuO
O
O
i-BuO
O HPLC
Chiralcel OD-H
1% IPA in hexane
isocratic, 1.0 mL/min
18.28 22.01 57
27n 27n
Ph
O
Ph
10
11
12
13
14
15
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Table 2.9.  Methods for the determination of enantiomeric excess (Chiral GC).
entry product
compound 
assayed
assay 
conditions
retention time 
of major 
isomer (min)
retention time 
of minor 
isomer (min)
% ee
1
2
GC
G-TA
80 °C isotherm
54.98 61.35 88
GC
G-TA
80 °C isotherm
54.74 60.24 98
53a 53a
O O
O O
53a 53a
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2.2 NOTES AND REFERENCES
(1) For a review discussing our strategy of using natural product structures to drive
the development of enantioselective catalysis, see:  Mohr, J. T.; Krout, M. R.;
Stoltz, B. M. Nature 2008, 455, 323–332.
(2) For examples of asymmetric palladium-catalyzed allylic alkylation reactions of
carbocyclic ketone enolates developed by our group, see:  (a) Behenna, D. C.;
Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 15044–15045.  (b) Mohr, J. T.;
Behenna, D. C.; Harned, A. M.; Stoltz, B. M. Angew. Chem., Int. Ed. 2005, 44,
6924–6927.  (c) Behenna, D. C.; Mohr, J. T.; Sherden, N. H.; Marinescu, S. C.;
Harned, A. M.; Tani, K.; Seto, M.; Ma, S.; Novák, Z.; Krout, M. R.; McFadden,
R. M.; Roizen, J. L.; Enquist, Jr., J. A.; White, D. E.; Levine, S. R.; Petrova, K.
V.; Iwashita, A.; Virgil, S. C.; Stoltz, B. M. Chem.—Eur. J. 2011, 17,
14199–14223.
(3) For examples of asymmetric palladium-catalyzed allylic alkylation reactions of
heterocyclic ketone enolates (such as those derived from dioxanones and lactams)
developed by our group, see:  (a) Seto, M.; Roizen, J. L.; Stoltz, B. M. Angew.
Chem., Int. Ed. 2008, 47, 6873–6876.  (b) Behenna, D. C.; Liu, Y.; Yurino, T.;
Kim, J.; White, D. E.; Virgil, S. C.; Stoltz, B. M. Nature Chem. 2012, 4, 130–133.
(4) For examples of asymmetric palladium-catalyzed protonation reactions of cyclic
ketone enolates, see:  (a) Mohr, J. T.; Nishimata, T.; Behenna, D. C.; Stoltz, B. M.
J. Am. Chem. Soc. 2006, 128, 11348–11349.  (b) Marinescu, S. C.; Nishimata, T.;
Mohr, J. T.; Stoltz, B. M. Org. Lett. 2008, 10, 1039–1042.
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(5) For an example of an asymmetric palladium-catalyzed conjugate addition/enolate
alkylation cascade reaction of cyclic ketone enolates, see:  Streuff, J.; White, D.
E.; Virgil, S. C.; Stoltz, B. M. Nature Chem. 2010, 2, 192–196.
(6) For studies on the computational and experimental studies on the mechanism of
palladium-catalyzed asymmetric alkylation using the PHOX ligand scaffold, see:
(a) Keith, J. A.; Behenna, D. C.; Mohr, J. T.; Ma, S.; Marinescu, S. C.; Oxgaard,
J.; Stoltz, B. M.; Goddard, III, W. A.  J. Am. Chem. Soc. 2007 , 129 ,
11876–11877.  (b) Sherden, N. H.; Behenna, D. C.; Virgil, S. C.; Stoltz, B. M.
Angew. Chem., Int. Ed. 2009, 48, 6840–6843.  (c) Keith, J. A.; Behenna, D. C.;
Sherden, N.; Mohr, J. T.; Ma, S.; Marinescu, S. C.; Nielsen, R. J.; Oxgaard, J.;
Stoltz, B. M.; Goddard, III, W. A. J. Am. Chem. Soc. 2012, 134, 19050–19060.
(7) For examples of the asymmetric alkylation of cyclic ketone, vinylogous ester, or
vinylogous thioester-derived enolates in the context of natural product synthesis,
see:  (a) Dichroanone:  McFadden, R. M.; Stoltz, B. M. J. Am. Chem. Soc. 2006,
128, 7738–7739.  (b) Elatol:  White, D. E.; Stewart, I. C.; Grubbs, R. H.; Stoltz,
B. M. J. Am. Chem. Soc. 2008, 130, 810–811.  (c) Cyanthiwigin F: Enquist, Jr., J.
A.; Stoltz, B. M. Nature 2008, 453, 1228–1231.  (d) Carissone:  Levine, S. R.;
Krout, M. R.; Stoltz, B. M. Org. Lett. 2009, 11, 289–292.  (e) Cassiol:  Petrova,
K. V.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2009, 11, 293–295.  (f) Elatol,
Laurencenone C, !-Chamigrene, and the Proposed Structure of Laurencenone B:
White, D. E.; Stewart, I. C.; Seashore-Ludlow, B. A.; Grubbs, R. H.; Stoltz, B. M.
Tetrahedron 2010, 66, 4668–4686.  (g) Hamigeran B:  Mukherjee, H. McDougal,
N. T.; Virgil, S. C.; Stoltz, B. M. Org. Lett. 2011, 13, 825–827.  (h) Liphagal:
Day, J. J.; McFadden, R. M.; Virgil, S. C.; Kolding, H.; Alleva, J. L.; Stoltz, B.
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M. Angew. Chem., Int. Ed. 2011, 50, 6814–6818.  (i) Cyanthiwigins B, F, and G:
Enquist, Jr., J. A.; Virgil, S. C.; Stoltz, B. M. Chem.—Eur. J. 2011, 17,
9957–9969.
(8) For our initial communication on the addition of organometallic reagents to chiral
vinylogous esters to form  "-quaternary cycloheptenones, see:  Bennett, N. B.;
Hong, A. Y.; Harned, A. M.; Stoltz, B. M. Org. Biomol. Chem. 2012, 10, 56–59.
(9) For our initial communication on the palladium catalyzed asymmetric alkylation
and ring contraction studies in the synthesis of "-quaternary acylcyclopentenes,
see:  Hong, A. Y.; Krout, M. R.; Jensen, T.; Bennett, N. B.; Harned, A. M.; Stoltz,
B. M. Angew. Chem., Int. Ed. 2011, 50, 2756–2760.
(10) Concurrent with our efforts, palladium–catalyzed asymmetric allylic alkylations
reactions of unstabilized enolates for the synthesis of enantioenriched !-
quaternary cyclic ketones, vinylogous esters, and vinylogous thioesters were
reported by Trost.  See:  (a) Trost, B. M.; Pissot-Soldermann, C.; Chen, I.;
Schroeder, G. M. J. Am. Chem. Soc. 2004, 126, 4480–4481.  (b) Trost, B. M.;
Schroeder, G. M. Chem.—Eur. J. 2005, 11, 174–184.  (c) Trost, B. M.; Pissot-
Soldermann, C.; Chen, I. Chem.—Eur. J. 2005, 11, 951–959.  (d) Trost, B. M.;
Xu, J. J. Am. Chem. Soc. 2005, 127, 2846–2847.  (e) Trost, B. M.; Bream, R. N.;
Xu, J. Angew. Chem., Int. Ed. 2006, 45, 3109–3112.
(11) 1,3-Cycloheptanedione (catalog #515981) and 3-isobutoxy-2-cyclohepten-1-one
(catalog #T271322) are commercially available from Sigma-Aldrich.  The price
of 1,3-cycloheptanedione is $40,000/mol.  Adopted from Aldrich August 28th,
2011.
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(12) (a) Ragan, J. A.; Makowski, T. W.; am Ende, D. J.; Clifford, P. J.; Young, G. R.;
Conrad, A. K.; Eisenbeis, S. A. Org. Process Res. Dev. 1998, 2, 379–381.
(b) Ragan, J. A.; Murry, J. A.; Castaldi, M. J.; Conrad, A. K.; Jones, B. P.; Li, B.;
Makowski, T. W.; McDermott, R.; Sitter, B. J.; White, T. D.; Young, G. R. Org.
Process. Res. Dev. 2001, 5, 498–507.  (c) Do, N.; McDermott, R. E.; Ragan, J. A.
Org. Synth. 2008, 85, 138–146.
(13) (a) Ukai, T.; Kawazura, H.; Ishii, Y.; Bonnet, J. J.; Ibers, J. A. J. Organomet.
Chem. 1974, 65, 253–266.  (b) Fairlamb, I. J. S.; Kapdi, A. R.; Lee, A. F. Org.
Lett. 2004, 6, 4435–4438.
(14) Pd2(pmdba)3 is preferable to Pd2(dba)3 in this reaction for ease of separation of
pmdba from the reaction products during purification.  pmdba = 4,4’-
methoxydibenzylideneacetone.
(15) Our group has made improvements to the synthetic route toward PHOX ligands
and developed procedures for large-scale synthesis.  See:  (a) Tani, K.; Behenna,
D. C.; McFadden, R. M.; Stoltz, B. M. Org. Lett. 2007, 9, 2529–2531.  (b) Krout,
M. R.; Mohr, J. T.; Stoltz, B. M. Org. Synth. 2009, 86, 181–193.
(16) Racemic products were obtained using Pd(PPh3)4 (5 mol %) or achiral PHOX
ligand 128 (6.25 mol %) and Pd2(pmdba)3 (2.5 mol %) in toluene at 30 °C.
Ph2P N
O
128
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(17) For a preparation of electron-deficient PHOX ligand 8 ((S)-(CF3)3-t-BuPHOX),
see:  (a) McDougal, N. T.; Streuff, J.; Mukherjee, H.; Virgil, S. C.; Stoltz, B. M.
Tetrahedron Lett. 2010, 51, 5550–5554.  (b) Also see ref. 7b and 7f.
(18) The reaction with silyl-protected alcohol 24m afforded alkylation product 27m
and exocyclic enone 134 in 10% yield.  A related silyl-protected alcohol substrate
did not display this type of elimination during an asymmetric decarboxylative
alkylation reaction on a six-membered ring #-ketoester substrate.  See ref. 2b.
O
i-BuO
27m
(S)-t-BuPHOX (3) (6.25 mol %)
Pd2(pmdba)3  (2.5 mol %)
toluene, 30 °C
24m
OTBDPS
66% yield
58% ee
O
i-BuO
134
10% yield
O
i-BuO
OTBDPS
O
O
+
(19) The reaction with benzoate ester 24n afforded alkylation product 27n and
endocyclic enone 135 in 14% yield.
O
i-BuO
O
27n
(S)-t-BuPHOX (3) (6.25 mol %)
Pd2(pmdba)3  (2.5 mol %)
toluene, 30 °C
O
i-BuO
O
24n
O
O
Ph
O
75% yield
57% ee
O
Ph
O
i-BuO
135
14% yield
+
(20) Stork, G.; Danheiser, R. L. J. Org. Chem. 1973, 38, 1775–1776.
(21) Differences in ring conformational preferences can also be observed in the 1H
NMR spectra of 1,3-cyclohexadione (exclusively ketoenol form) and 1,3-
cycloheptadione (exclusively diketo form).  See ref. 12c.
(22) For selected examples of the two-carbon ring contraction of seven-membered
carbocycles, see:  (a) Frankel, J. J.; Julia, S.; Richard-Neuville, C. Bull. Soc.
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Chim. Fr. 1968, 4870–4875.  (b) Jun, C.-H.; Moon, C. W.; Lim, S.-G.; Lee, H.
Org. Lett. 2002, 4, 1595–1597.
(23) Notably, 70a  and related # -hydroxyketones appear to undergo minimal
decomposition after several months of storage at room temperature by TLC and
1H NMR analysis, and immediate conversion to acylcyclopentenes 53a is not
necessary to achieve high yields.
(24) While a recent report shows a single example of a similar #-hydroxyketone, we
believe the unusual reactivity and synthetic potential of these compounds has not
been fully explored.  See:  Rinderhagen, H.; Mattay, J. Chem.—Eur. J. 2004, 10,
851–874.
(25) For an example of a photochemical two-carbon ring contraction of a macrocycle,
see:  Yang, Z.; Li, Y.; Pattenden, G. Tetrahedron 2010, 66, 6546–6549.
(26) For examples of ring contractions of medium-sized ring heterocycles, see:
(a) Nasveschuk, C. G.; Rovis, T. Angew. Chem., Int. Ed. 2005, 44, 3264–3267.
(b) Nasveschuk, C. G.; Rovis, T. J. Org. Chem. 2008, 73, 612–617.
(c) Nasveschuk, C. G.; Rovis, T. Org. Biomol. Chem. 2008, 6, 240–254.
(d) Baktharaman, S.; Afagh, N.; Vandersteen, A.; Yudin A. K. Org. Lett. 2010,
12, 240–243.  (e) Dubovyk, I.; Pichugin, D.; Yudin, A. K. Angew. Chem., Int. Ed.
2011, 50, 5924–5926.  (f) Volchkov, I.; Park, S.; Lee, D. Org. Lett. 2011, 13,
3530–3533.  (g) Dubinina, G. G.; Chain, W. J. Tetrahedron Lett. 2011, 52,
939–942.
(27) For a discussion of the properties of fluorinated alcohols and their use, see:
Begue, J.-P.; Bonnet-Delpon, D.; Crousse, B. Synlett 2004, 18–29.
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(28) A lithium alkoxide species is presumably generated in situ based on the following
pKa values:  (H2O = 15.7, TFE = 12.5, HFIP = 9.3 [water]; H2O = 31.2, TFE =
23.5, HFIP = 18.2 [DMSO]);  Bordwell, F. G. Acc. Chem. Res. 1988, 21,
456–463.
(29) No reaction was observed with the following bases (with or without TFE
additive):  DBU, TMG, Na2CO3, BaCO3, and CaH2. DBU = 1,8-
diazabicyclo[5.4.0]undec-7-ene, TMG = 1,1,3,3-tetramethylguanidine.
(30) The two-carbon ring contraction strategy can potentially be extended to  #-
hydroxyketones of other medium sized rings to provide other useful cyclic enone
products.  These possibilities are the subject of current investigations.
O
O
H
R2
R1
O R2
R1
138
HO
O
R2
R1
137
O
RO
R2
R1
136
(31) Fluorinated lithium alkoxides were recently used to promote
Horner–Wadsworth–Emmons olefinations of sensitive substrates, demonstrating
their mild reactivity.  See:  Blasdel, L. K.; Myers, A. G. Org. Lett. 2005, 7,
4281–4283.
(32) Luche, J. L. J. Am. Chem. Soc. 1978, 100, 2226–2227.
(33) Although we had success in preparing silyloxy acylcyclopentene 53p from
vinylogous ester 27p, we wondered whether it would be possible to perform a
ring contraction on aldehyde 27k .  Under our standard conditions, the
intermediate ketodiol 70k can be obtained in 89% yield, however the subsequent
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ring contraction proceeded in 62% yield to afford a complex mixture of pyran
diastereomers 139 and uncyclized acylcyclopentene 53k.
LiAlH4, Et2O, 0 °C
then 10% aq HCl
89% yield
O O
OH
O
1:1 dr
O
i-BuO
OH
27k 139 53k
OH
O
OH
70k
LiOH, TFE
THF, 60 °C
62% yield 
(5:1 ratio)
(34) Analytically pure samples of dione 79 can be obtained from vinylogous ester 27a
by treatment with acid.  See Experimental Section (Section 2.7.2.10) for details.
(35) The addition of cerium chloride to reactions with organolithium or Grignard
reagents has been shown to increase reactivity and reduce side reactions with
vinylogous ester systems, see:  Crimmins, M. T.; Dedopoulou, D. Synth.
Commun. 1992, 22, 1953–1958.
(36) The increase in enone formation with the organometallic addition relative to the
hydride reduction is likely due to the higher stability of the tertiary carbocation
(140) compared to the secondary carbocation (141) formed along the reduction
pathway.
vs.
H
i-BuO
R
i-BuO
141
2° carbocation
140
3° carbocation
(37) CCDC 686849 (81) contains the supplementary crystallographic data for this
chapter.  These data can be obtained free of charge from The Cambridge
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  The data
can also be viewed in Appendix 3.
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(38) Comins, D. L.; Dehghani, A. Tetrahedron Lett. 1992, 33, 6299–6302.
(39) Herrmann, W. A.; Brossmer, C.; Öfele, K.; Reisinger, C.-P.; Priermeier, T.;
Beller, M.; Fischer, H. Angew. Chem., Int. Ed. Engl. 1995, 34, 1845–1848.
(40) Another application of the ring contraction methodology toward daucane
sesquiterpenes is presented in Chapter 3.
(41) Hong, A. Y.; Stoltz, B. M. Angew. Chem., Int. Ed. 2012, 51, 9674–9678.
(42) Preferential #-hydroxyketone formation is observed when the acidification of the
intermediate isobutyl enol ether is performed in diethyl ether instead of methanol.
See Table 2.4.
(43) Attempts to purify the crude enol ether were challenging due to decomposition to
enone 55r and #-hydroxyketone 70r.
(44) The yield of cycloheptenone 55t is lower than many related enones due to the
formation of several side products presumed to be non-conjugated alkene isomers.
O
MgBr
O
i-BuO
then sodium phosphate
buffer (pH 6.5)
then HCl (6 mM), CH3CN
73% yield
27a 55t
+
CeCl3, THF, 23 °C mixture of 
olefin isomers
(45) Synthesis of the simple #-vinyl substituted enone proved challenging due to the
formation of a complex product mixture.
(46) Quenching the alkynyl nucleophile addition with hydrochloric acid provided a
complex mixture of products, most notably one with an equivalent of HCl added
into the molecule.  This issue was resolved by instead using sulfuric acid.
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(47) Cycloheptenone 55aa is formed as a 1.9:1 mixture of atropisomers whose
isomeric peaks coalesce in a variable temperature 1H NMR study.  See Figure
A2.108.4.
(48) Jin, Z.; Fuchs, P. L. J. Am. Chem. Soc. 1994, 116, 5995–5996.
(49) Chung, Y. K.; Lee, B. Y.; Jeong, N.; Hudecek, M.; Pauson, P. L. Organometallics
1993, 12, 220–223.
(50) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.
Organometallics 1996, 15, 1518–1520.
(51) Love, B. E.; Jones, E. G. J. Org. Chem. 1999, 64, 3755–3756.
(52) Mahmood, T.; Shreeve, J. M. Inorg. Chem. 1986, 25, 3830–3837.
(53) (a) Mander, L. N.; Sethi, S. P. Tetrahedron Lett. 1983 , 24, 5425–5428.
(b) Donelly, D. M.; Finet, J. P.; Rattigan, B. A. J. Chem. Soc., Perkin Trans. 1
1993, 1729–1735.
(54) Geissman, T. A.; Armen, A. J. Am. Chem. Soc. 1952, 74, 3916–3919.
(55) Maruyama, K.; Nagai, N.; Naruta, Y. J. Org. Chem. 1986, 51, 5083–5092.
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Figure A2.1.3.  13C NMR (125 MHz, CDCl3) of compound 66.
Figure A2.1.2.  Infrared spectrum (thin film/NaCl) of compound 66.
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Figure A2.2.3.  13C NMR (125 MHz, CDCl3) of compound 24a.
Figure A2.2.2.  Infrared spectrum (thin film/NaCl) of compound 24a.
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Figure A2.3.3.  13C NMR (75 MHz, CDCl3) of compound 24b.
Figure A2.3.2.  Infrared spectrum (thin film/NaCl) of compound 24b.
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Figure A2.4.3.  13C NMR (75 MHz, CDCl3) of compound 24c.
Figure A2.4.2.  Infrared spectrum (thin film/NaCl) of compound 24c.
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Figure A2.5.3.  13C NMR (75 MHz, CDCl3) of compound 24d.
Figure A2.5.2.  Infrared spectrum (thin film/NaCl) of compound 24d.
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Figure A2.6.3.  13C NMR (75 MHz, CDCl3) of compound 24e.
Figure A2.6.2.  Infrared spectrum (thin film/NaCl) of compound 24e.
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Figure A2.7.3.  13C NMR (75 MHz, CDCl3) of compound 24f.
Figure A2.7.2.  Infrared spectrum (thin film/NaCl) of compound 24f.
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Figure A2.8.3.  13C NMR (75 MHz, CDCl3) of compound 24g.
Figure A2.8.2.  Infrared spectrum (thin film/NaCl) of compound 24g.
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Figure A2.9.3.  13C NMR (75 MHz, CDCl3) of compound 24h.
Figure A2.9.2.  Infrared spectrum (thin film/NaCl) of compound 24h.
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Figure A2.10.2.  Infrared spectrum (thin film/NaCl) of compound 24i.
Figure A2.10.3.  13C NMR (75 MHz, CDCl3) of compound 24i.
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Figure A2.11.2.  Infrared spectrum (thin film/NaCl) of compound 24ac.
Figure A2.11.3. 13C NMR (75 MHz, CDCl3) of compound 24ac.
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Figure A2.12.3.  13C NMR (75 MHz, CDCl3) of compound 24j.
Figure A2.12.2.  Infrared spectrum (thin film/NaCl) of compound 24j.
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Figure A2.13.3.  13C NMR (75 MHz, CDCl3) of compound 24k.
Figure A2.13.2.  Infrared spectrum (thin film/NaCl) of compound 24k.
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Figure A2.14.3.  13C NMR (75 MHz, CDCl3) of compound 24l.
Figure A2.14.2.  Infrared spectrum (thin film/NaCl) of compound 24l.
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Figure A2.15.3.  13C NMR (75 MHz, CDCl3) of compound 24ad.
Figure A2.15.2.  Infrared spectrum (thin film/NaCl) of compound 24ad.
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Figure A2.16.3.  13C NMR (75 MHz, CDCl3) of compound 24m.
Figure A2.16.2.  Infrared spectrum (thin film/NaCl) of compound 24m.
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Figure A2.17.3.  13C NMR (75 MHz, CDCl3) of compound 24n.
Figure A2.17.2.  Infrared spectrum (thin film/NaCl) of compound 24n.
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Figure A2.18.3.  13C NMR (125 MHz, CDCl3) of compound 127.
Figure A2.18.2.  Infrared spectrum (thin film/NaCl) of compound 127.
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Figure A2.19.3.  13C NMR (125 MHz, CDCl3) of compound 128.
Figure A2.19.2.  Infrared spectrum (thin film/NaCl) of compound 128.
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Figure A2.20.3.  13C NMR (75 MHz, CDCl3) of compound 129.
Figure A2.20.2.  Infrared spectrum (thin film/NaCl) of compound 129.
APPENDIX 2 — Spectra Relevant to Chapter 2 475
Fi
gu
re
 A
2
.2
1
.1
. 
 
H
 N
M
R
 (
5
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 6
7
.
P
h
2
P
N
O
6
7
APPENDIX 2 — Spectra Relevant to Chapter 2 476
Figure A2.21.3.  13C NMR (125 MHz, CDCl3) of compound 67.
Figure A2.21.2.  Infrared spectrum (thin film/NaCl) of compound 67.
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Figure A2.22.3.  13C NMR (125 MHz, CDCl3) of compound 27a.
Figure A2.22.2.  Infrared spectrum (thin film/NaCl) of compound 27a.
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Figure A2.23.3.  13C NMR (75 MHz, CDCl3) of compound 27b.
Figure A2.23.2.  Infrared spectrum (thin film/NaCl) of compound 27b.
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Figure A2.24.3.  13C NMR (75 MHz, CDCl3) of compound 27c.
Figure A2.24.2.  Infrared spectrum (thin film/NaCl) of compound 27c.
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Figure A2.25.3.  13C NMR (75 MHz, CDCl3) of compound 27d.
Figure A2.25.2.  Infrared spectrum (thin film/NaCl) of compound 27d.
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Figure A2.26.3.  13C NMR (75 MHz, CDCl3) of compound 27e.
Figure A2.26.2.  Infrared spectrum (thin film/NaCl) of compound 27e.
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Figure A2.27.2.  Infrared spectrum (thin film/NaCl) of compound 27f.
Figure A2.27.3.  13C NMR (75 MHz, CDCl3) of compound 27f.
APPENDIX 2 — Spectra Relevant to Chapter 2 489
Fi
gu
re
 A
2
.2
8
.1
. 
 1
H
 N
M
R
 (
3
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 2
7
g .
O
i-
B
u
O
2
7
g
C
l
APPENDIX 2 — Spectra Relevant to Chapter 2 490
Figure A2.28.3.  13C NMR (75 MHz, CDCl3) of compound 27g.
Figure A2.28.2.  Infrared spectrum (thin film/NaCl) of compound 27g.
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Figure A2.29.2.  Infrared spectrum (thin film/NaCl) of compound 27h.
Figure A2.29.3.  13C NMR (75 MHz, CDCl3) of compound 27h.
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Figure A2.30.3.  13C NMR (75 MHz, CDCl3) of compound 27i.
Figure A2.30.2.  Infrared spectrum (thin film/NaCl) of compound 27i.
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Figure A2.31.2.  Infrared spectrum (thin film/NaCl) of compound 27j.
Figure A2.31.3.  13C NMR (75 MHz, CDCl3) of compound 27j.
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Figure A2.32.3.  13C NMR (75 MHz, CDCl3) of compound 27k.
Figure A2.32.2.  Infrared spectrum (thin film/NaCl) of compound 27k.
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Figure A2.33.2.  Infrared spectrum (thin film/NaCl) of compound 27l.
Figure A2.33.3.  13C NMR (75 MHz, CDCl3) of compound 27l.
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Figure A2.34.3.  13C NMR (75 MHz, CDCl3) of compound 27m.
Figure A2.34.2.  Infrared spectrum (thin film/NaCl) of compound 27m.
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Figure A2.35.3.  13C NMR (75 MHz, CDCl3) of compound 27n.
Figure A2.35.2.  Infrared spectrum (thin film/NaCl) of compound 27n.
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Figure A2.36.3.  13C NMR (75 MHz, CDCl3) of compound 27o.
Figure A2.36.2.  Infrared spectrum (thin film/NaCl) of compound 27o.
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Figure A2.37.3.  13C NMR (75 MHz, CDCl3) of compound 27p.
Figure A2.37.2.  Infrared spectrum (thin film/NaCl) of compound 27p.
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Figure A2.38.3.  13C NMR (75 MHz, CDCl3) of compound 27q.
Figure A2.38.2.  Infrared spectrum (thin film/NaCl) of compound 27q.
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Figure A2.39.3.  13C NMR (75 MHz, CDCl3) of compound 14a.
Figure A2.39.2.  Infrared spectrum (thin film/NaCl) of compound 14a.
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Figure A2.40.3.  13C NMR (75 MHz, CDCl3) of compound 22a.
Figure A2.40.2.  Infrared spectrum (thin film/NaCl) of compound 22a.
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Figure A2.41.3.  13C NMR (75 MHz, CDCl3) of compound 68.
Figure A2.41.2.  Infrared spectrum (thin film/NaCl) of compound 68.
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Figure A2.42.3.  13C NMR (125 MHz, CDCl3) of compound 77.
Figure A2.42.2.  Infrared spectrum (thin film/NaCl) of compound 77.
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Figure A2.43.3.  13C NMR (125 MHz, CDCl3) of compound 55a.
Figure A2.43.2.  Infrared spectrum (thin film/NaCl) of compound 55a.
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Figure A2.44.2.  Infrared spectrum (thin film/NaCl) of compound 70a.
Figure A2.44.3.  13C NMR (125 MHz, CDCl3) of compound 70a.
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Figure A2.45.2.  Infrared spectrum (thin film/NaCl) of compound 70b.
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Figure A2.46.2.  Infrared spectrum (thin film/NaCl) of compound 70c.
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Figure A2.47.2.  Infrared spectrum (thin film/NaCl) of compound 70d.
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Figure A2.48.2.  Infrared spectrum (thin film/NaCl) of compound 70e.
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Figure A2.49.2.  Infrared spectrum (thin film/NaCl) of compound 70f.
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Figure A2.50.2.  Infrared spectrum (thin film/NaCl) of compound 70g.
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Figure A2.51.2.  Infrared spectrum (thin film/NaCl) of compound 70h.
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Figure A2.52.2.  Infrared spectrum (thin film/NaCl) of compound 70i.
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Figure A2.53.2.  Infrared spectrum (thin film/NaCl) of compound 70j.
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Figure A2.54.2.  Infrared spectrum (thin film/NaCl) of compound 70m.
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Figure A2.55.2.  Infrared spectrum (thin film/NaCl) of compound 70o.
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Figure A2.56.2.  Infrared spectrum (thin film/NaCl) of compound 70p.
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Figure A2.57.2.  Infrared spectrum (thin film/NaCl) of compound 70q.
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Figure A2.58.2.  Infrared spectrum (thin film/NaCl) of compound 70n.
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Figure A2.59.3.  13C NMR (125 MHz, CDCl3) of compound 53a.
Figure A2.59.2.  Infrared spectrum (thin film/NaCl) of compound 53a.
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Figure A2.60.3.  13C NMR (75 MHz, CDCl3) of compound 53b.
Figure A2.60.2.  Infrared spectrum (thin film/NaCl) of compound 53b.
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Figure A2.61.3.  13C NMR (75 MHz, CDCl3) of compound 53c.
Figure A2.61.2.  Infrared spectrum (thin film/NaCl) of compound 53c.
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Figure A2.62.3.  13C NMR (75 MHz, CDCl3) of compound 53d.
Figure A2.62.2.  Infrared spectrum (thin film/NaCl) of compound 53d.
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Figure A2.63.3.  13C NMR (75 MHz, CDCl3) of compound 53e.
Figure A2.63.2.  Infrared spectrum (thin film/NaCl) of compound 53e.
APPENDIX 2 — Spectra Relevant to Chapter 2 561
Fi
gu
re
 A
2
.6
4
.1
. 
 
H
 N
M
R
 (
3
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 5
3
f.
O
5
3
f
APPENDIX 2 — Spectra Relevant to Chapter 2 562
Figure A2.64.3.  13C NMR (75 MHz, CDCl3) of compound 53f.
Figure A2.64.2.  Infrared spectrum (thin film/NaCl) of compound 53f.
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Figure A2.65.3.  13C NMR (75 MHz, CDCl3) of compound 53g.
Figure A2.65.2.  Infrared spectrum (thin film/NaCl) of compound 53g.
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Figure A2.66.3.  13C NMR (75 MHz, CDCl3) of compound 53h.
Figure A2.66.2.  Infrared spectrum (thin film/NaCl) of compound 53h.
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Figure A2.67.3.  13C NMR (75 MHz, CDCl3) of compound 53i.
Figure A2.67.2.  Infrared spectrum (thin film/NaCl) of compound 53i.
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Figure A2.68.3.  13C NMR (75 MHz, CDCl3) of compound 53j.
Figure A2.68.2.  Infrared spectrum (thin film/NaCl) of compound 53j.
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Figure A2.69.3.  13C NMR (75 MHz, CDCl3) of compound 53m.
Figure A2.69.2.  Infrared spectrum (thin film/NaCl) of compound 53m.
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Figure A2.70.3.  13C NMR (75 MHz, CDCl3) of compound 53o.
Figure A2.70.2.  Infrared spectrum (thin film/NaCl) of compound 53o.
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Figure A2.71.3.  13C NMR (100 MHz, CDCl3) of compound 53p.
Figure A2.71.2.  Infrared spectrum (thin film/NaCl) of compound 53p.
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Figure A2.72.3.  13C NMR (75 MHz, CDCl3) of compound 53q.
Figure A2.72.2.  Infrared spectrum (thin film/NaCl) of compound 53q.
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Figure A2.73.3.  13C NMR (125 MHz, CDCl3) of compound 53n.
Figure A2.73.2.  Infrared spectrum (thin film/NaCl) of compound 53n.
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Figure A2.74.3.  13C NMR (125 MHz, CDCl3) of compound 79.
Figure A2.74.2.  Infrared spectrum (thin film/NaCl) of compound 79.
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Figure A2.75.3.  13C NMR (125 MHz, CDCl3) of compound 55r.
Figure A2.75.2.  Infrared spectrum (thin film/NaCl) of compound 55r.
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Figure A2.76.2.  Infrared spectrum (thin film/NaCl) of compound 70r.
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Figure A2.77.3.  13C NMR (125 MHz, CDCl3) of compound 72r.
Figure A2.77.2.  Infrared spectrum (thin film/NaCl) of compound 72r.
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Figure A2.78.3.  13C NMR (125 MHz, CDCl3) of compound 53r.
Figure A2.78.2.  Infrared spectrum (thin film/NaCl) of compound 53r.
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Figure A2.79.3.  13C NMR (75 MHz, CDCl3) of compound 80.
Figure A2.79.2.  Infrared spectrum (thin film/NaCl) of compound 80.
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Figure A2.80.3.  13C NMR (125 MHz, CDCl3) of compound 81.
Figure A2.80.2.  Infrared spectrum (thin film/NaCl) of compound 81.
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Figure A2.81.3.  13C NMR (100 MHz, CDCl3) of compound 82.
Figure A2.81.2.  Infrared spectrum (thin film/NaCl) of compound 82.
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Figure A2.82.3.  13C NMR (75 MHz, CDCl3) of compound 83.
Figure A2.82.2.  Infrared spectrum (thin film/NaCl) of compound 83.
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Figure A2.83.3.  13C NMR (75 MHz, CDCl3) of compound 84.
Figure A2.83.2.  Infrared spectrum (thin film/NaCl) of compound 84.
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Figure A2.84.3.  13C NMR (75 MHz, CDCl3) of compound 130.
Figure A2.84.2.  Infrared spectrum (thin film/NaCl) of compound 130.
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Figure A2.85.3.  13C NMR (75 MHz, CDCl3) of compound 85.
Figure A2.85.2.  Infrared spectrum (thin film/NaCl) of compound 85.
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Figure A2.86.2.  Infrared spectrum (thin film/NaCl) of compound 131.
Figure A2.86.3.  13C NMR (75 MHz, CDCl3) of compound 131.
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Figure A2.87.3.  13C NMR (75 MHz, CDCl3) of compound 86.
Figure A2.87.2.  Infrared spectrum (thin film/NaCl) of compound 86.
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Figure A2.88.3.  13C NMR (75 MHz, CDCl3) of compound 132.
Figure A2.88.2.  Infrared spectrum (thin film/NaCl) of compound 132.
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Figure A2.89.3.  13C NMR (75 MHz, CDCl3) of compound 88.
Figure A2.89.2.  Infrared spectrum (thin film/NaCl) of compound 88.
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Figure A2.90.2.  Infrared spectrum (thin film/NaCl) of compound 89.
Figure A2.90.3.  13C NMR (75 MHz, CDCl3) of compound 89.
APPENDIX 2 — Spectra Relevant to Chapter 2 615
Fi
gu
re
 A
2
.9
1
.1
. 
 
H
 N
M
R
 (
4
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 9
0
.
O
9
0
O
APPENDIX 2 — Spectra Relevant to Chapter 2 616
Figure A2.91.3.  13C NMR (100 MHz, CDCl3) of compound 90.
Figure A2.91.2.  Infrared spectrum (thin film/NaCl) of compound 90.
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Figure A2.92.2.  Infrared spectrum (thin film/NaCl) of compound 91.
Figure A2.92.3.  13C NMR (125 MHz, CDCl3) of compound 91.
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Figure A2.93.3.  13C NMR (125 MHz, CDCl3) of compound 92.
Figure A2.93.2.  Infrared spectrum (thin film/NaCl) of compound 92.
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Figure A2.94.3.  13C NMR (125 MHz, CDCl3) of compound 93.
Figure A2.94.2.  Infrared spectrum (thin film/NaCl) of compound 93.
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Figure A2.95.3.  13C NMR (125 MHz, CDCl3) of compound 95.
Figure A2.95.2.  Infrared spectrum (thin film/NaCl) of compound 95.
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Figure A2.96.3.  13C NMR (75 MHz, CDCl3) of compound 97.
Figure A2.96.2.  Infrared spectrum (thin film/NaCl) of compound 97.
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Figure A2.97.3.  13C NMR (125 MHz, CDCl3) of compound 87.
Figure A2.97.2.  Infrared spectrum (thin film/NaCl) of compound 87.
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Figure A2.98.2.  Infrared spectrum (thin film/NaCl) of compound 100.
Figure A2.98.3.  13C NMR (125 MHz, CDCl3) of compound 100.
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Figure A2.99.3.  13C NMR (125 MHz, CDCl3) of compound 102.
Figure A2.99.2.  Infrared spectrum (thin film/NaCl) of compound 102.
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Figure A2.100.3.  13C NMR (125 MHz, CDCl3) of compound 110.
Figure A2.100.2.  Infrared spectrum (thin film/NaCl) of compound 110.
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Figure A2.101.2.  Infrared spectrum (thin film/NaCl) of compound 55t.
Figure A2.101.3.  13C NMR (125 MHz, CDCl3) of compound 55t.
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Figure A2.102.2.  Infrared spectrum (thin film/NaCl) of compound 55u.
Figure A2.102.3.  13C NMR (125 MHz, CDCl3) of compound 55u.
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Figure A2.103.2.  Infrared spectrum (thin film/NaCl) of compound 55v.
Figure A2.103.3.  13C NMR (125 MHz, CDCl3) of compound 55v.
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Figure A2.104.2.  Infrared spectrum (thin film/NaCl) of compound 55w.
Figure A2.104.3.  13C NMR (125 MHz, CDCl3) of compound 55w.
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Figure A2.105.2.  Infrared spectrum (thin film/NaCl) of compound 55x.
Figure A2.105.3.  13C NMR (125 MHz, CDCl3) of compound 55x.
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Figure A2.106.2.  Infrared spectrum (thin film/NaCl) of compound 55y.
Figure A2.106.3.  13C NMR (125 MHz, CDCl3) of compound 55y.
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Figure A2.107.2.  Infrared spectrum (thin film/NaCl) of compound 55z.
Figure A2.107.3.  13C NMR (125 MHz, CDCl3) of compound 55z.
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Figure A2.108.2.  Infrared spectrum (thin film/NaCl) of compound 55aa.
Figure A2.108.3.  13C NMR (125 MHz, CDCl3) of compound 55aa.
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Figure A2.109.2.  Infrared spectrum (thin film/NaCl) of compound 55ab.
Figure A2.109.3.  13C NMR (125 MHz, CDCl3) of compound 55ab.
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Figure A2.110.2.  Infrared spectrum (thin film/NaCl) of compound 55ac.
Figure A2.110.3.  13C NMR (125 MHz, CDCl3) of compound 55ac.
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Figure A2.111.2.  Infrared spectrum (thin film/NaCl) of compound 133.
Figure A2.111.3.  13C NMR (125 MHz, CDCl3) of compound 133.
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Figure A2.112.2.  Infrared spectrum (thin film/NaCl) of compound 111y.
Figure A2.112.3.  13C NMR (125 MHz, CDCl3) of compound 111y.
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Figure A2.113.2.  Infrared spectrum (thin film/NaCl) of compound 111z.
Figure A2.113.3.  13C NMR (125 MHz, CDCl3) of compound 111z.
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Figure A2.114.2.  Infrared spectrum (thin film/NaCl) of compound 111t.
Figure A2.114.3.  13C NMR (125 MHz, C6D6) of compound 111t.
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Figure A2.115.2.  Infrared spectrum (thin film/NaCl) of compound 111u.
Figure A2.115.3.  13C NMR (125 MHz, CDCl3) of compound 111u.
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Figure A2.116.2.  Infrared spectrum (thin film/NaCl) of compound 111v.
Figure A2.116.3.  13C NMR (125 MHz, CDCl3) of compound 111v.
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Figure A2.117.2.  Infrared spectrum (thin film/NaCl) of compound 111w.
Figure A2.117.3.  13C NMR (125 MHz, CDCl3) of compound 111w.
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Figure A2.118.2.  Infrared spectrum (thin film/NaCl) of compound 111aa.
Figure A2.118.3.  13C NMR (125 MHz, CDCl3) of compound 111aa.
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Figure A2.119.2.  Infrared spectrum (thin film/NaCl) of compound 111x.
Figure A2.119.3.  13C NMR (125 MHz, CDCl3) of compound 111x.
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Figure A2.120.2.  Infrared spectrum (thin film/NaCl) of compound 114.
Figure A2.120.3.  13C NMR (125 MHz, CDCl3) of compound 114.
APPENDIX 2 — Spectra Relevant to Chapter 2 676
Fi
gu
re
 A
2
.1
2
1
.1
. 
 
H
 N
M
R
 (
5
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 1
1
5
.
O
1
1
5
APPENDIX 2 — Spectra Relevant to Chapter 2 677
Figure A2.121.2.  Infrared spectrum (thin film/NaCl) of compound 115.
Figure A2.121.3.  13C NMR (125 MHz, CDCl3) of compound 115.
APPENDIX 2 — Spectra Relevant to Chapter 2 678
Fi
gu
re
 A
2
.1
2
2
.1
. 
 
H
 N
M
R
 (
5
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 1
1
6
.
O
1
1
6
APPENDIX 2 — Spectra Relevant to Chapter 2 679
Figure A2.122.2.  Infrared spectrum (thin film/NaCl) of compound 116.
Figure A2.122.3.  13C NMR (125 MHz, CDCl3) of compound 116.
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Figure A2.123.2.  Infrared spectrum (thin film/NaCl) of compound 117a.
Figure A2.123.3.  13C NMR (125 MHz, CDCl3) of compound 117a.
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Figure A2.124.2.  Infrared spectrum (thin film/NaCl) of compound 117b.
Figure A2.124.3.  13C NMR (125 MHz, CDCl3) of compound 117b.
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APPENDIX 3
X-Ray Crystallography Reports Relevant to Chapter 2:
Palladium-Catalyzed Asymmetric Alkylation in the Synthesis of
Cyclopentanoid and Cycloheptanoid Core Structures
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A3.1 CRYSTAL STRUCTURE ANALYSIS OF 81
N
H
N
H
N
O
I
Compound 81
(AYH02) (CCDC 686849)
Contents
Table A3.1.  Crystal data
Table A3.2.  Atomic coordinates
Table A3.3.  Full bond distances and angles
Table A3.4.  Anisotropic displacement parameters
Table A3.5.  Hydrogen bond distances and angles
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Figure A3.1.  Semicarbazone 81 is shown with 50% probability ellipsoids.
CCDC 686849 (81) contains the supplementary crystallographic data for this appendix.  These data
can be obtained free of charge from The Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif.
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Table A3.1.  Crystal data and structure refinement for semicarbazone 81 (CCDC 686849).
Empirical formula C19H24N3OI
Formula weight 437.31
Crystallization solvent Dichloromethane/pentane
Crystal habit Needle
Crystal size 0.28 x 0.11 x 0.07 mm3
Crystal color Colorless
Data Collection
Type of diffractometer Bruker KAPPA APEX II
Wavelength 0.71073 Å MoK!
Data collection temperature 100(2) K
" range for 9911 reflections used
    in lattice determination 2.57 to 28.78°
Unit cell dimensions a = 17.160(4) Å
b = 5.5921(14) Å # = 90.689(6)°
c = 19.984(5) Å
Volume 1917.6(8) Å3
Z 4
Crystal system Monoclinic
Space group P21
Density (calculated) 1.515 Mg/m3
F(000) 880
Data collection program Bruker APEX2 v2.1-0
" range for data collection 1.55 to 29.84°
Completeness to " = 29.84° 88.9 %
Index ranges –23 ! h ! 23, –7 ! k ! 7, –26 ! l ! 25
Data collection scan type $ scans; 16 settings
Data reduction program Bruker SAINT-Plus v7.34A
Reflections collected 8962
Independent reflections 8962 [Rint= 0.0000]
Absorption coefficient 1.680 mm–1
Absorption correction Semi-empirical from equivalents (TWNABS)
Max. and min. transmission 0.7460 and 0.5010
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Structure solution and Refinement
Structure solution program SHELXS-97 (Sheldrick, 2008)
Primary solution method Direct methods
Secondary solution method Difference Fourier map
Hydrogen placement Geometric positions
Structure refinement program SHELXL-97 (Sheldrick, 2008)
Refinement method Full matrix least-squares on F2
Data / restraints / parameters 8962 / 1 / 437
Treatment of hydrogen atoms Riding
Goodness-of-fit on F2 1.609
Final R indices [I>2%(I), 7203 reflections] R1 = 0.0409, wR2 = 0.0481
R indices (all data) R1 = 0.0619, wR2 = 0.0493
Type of weighting scheme used Sigma
Weighting scheme used w=1/%2(Fo2)
Max shift/error 0.002
Average shift/error 0.000
Absolute structure determination Anomalous differences
Absolute structure parameter 0.003(11)
Largest diff. peak and hole 0.807 and –0.967 e.Å–3
Special Refinement Details
The structure was refined as a single component, although the crystals were twins, using an HKLF4
format reflection file prepared with TWINABS (see below). The two orientations were separated using
CELL_NOW as follows.
Rotated from first domain by 178.9 degrees about reciprocal axis –0.032  1.000  0.104  and real axis
–0.001  1.000  0.007. Twin law to convert hkl from first to this domain (SHELXL TWIN matrix):
-1.000  -0.065   0.016
-0.003   0.998   0.014
-0.022   0.207  -0.999
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From Saint integration; Twin Law, Sample 1 of 1 transforms h1.1(1)->h1.2(2)
-0.99897 -0.07583  0.01646
-0.00750  0.99693  0.01538
-0.02464  0.19596 -0.99910
Twinabs;
PART 1 - Refinement of parameters to model systematic errors
18757 data ( 4443 unique ) involve domain  1 only,  mean I/sigma  13.7
18551 data ( 4364 unique ) involve domain  2 only,  mean I/sigma   7.1
10342 data ( 4106 unique ) involve   2 domains,  mean I/sigma  19.2
HKLF 4 dataset constructed from all observations involving domains 1..2
    8970 Corrected reflections written to file twin4.hkl
 Reflections merged according to point-group 2
 Minimum and maximum apparent transmission:  0.501007  0.745969
 Additional spherical absorption correction applied with mu*r =  0.2000
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under a
nitrogen stream at 100 K.
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold
expression of F2 > 2%( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F,
and R-factors based on ALL data will be even larger.
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances,
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds
involving l.s. planes.
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Figure A3.2.  Semicarbazone 81 (CCDC 686849).
Table A3.2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103)
for semicarbazone 81 (CCDC 686849).  U(eq) is defined as the trace of the orthogonalized Uij
tensor.
x y z Ueq
I(1) 9525(1) 8297(1) 6590(1) 36(1)
O(1A) 7955(1) 941(3) 3051(1) 30(1)
N(1A) 7500(2) 3872(4) 3727(1) 30(1)
N(2A) 6670(2) 1070(4) 3270(1) 28(1)
N(3A) 6059(2) 2296(4) 3562(1) 28(1)
C(1A) 8489(2) 4383(5) 4938(2) 26(1)
C(2A) 8786(2) 5006(6) 5555(2) 27(1)
C(3A) 9158(2) 7186(5) 5637(2) 24(1)
C(4A) 9240(2) 8700(6) 5094(2) 23(1)
C(5A) 8934(2) 8049(6) 4481(2) 24(1)
C(6A) 8541(2) 5886(5) 4389(2) 21(1)
C(7A) 8214(2) 5251(6) 3716(2) 29(1)
C(8A) 7411(2) 1915(5) 3335(2) 24(1)
C(9A) 5356(2) 1676(5) 3411(2) 25(1)
C(10A) 5153(2) -221(5) 2912(2) 34(1)
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Table A3.2 (cont.)
C(11A) 4738(2) 3016(6) 3736(2) 25(1)
C(12A) 4902(2) 5012(5) 4229(2) 30(1)
C(13A) 4096(2) 6199(5) 4302(2) 34(1)
C(14A) 3501(2) 4222(5) 4130(2) 33(1)
C(15A) 3985(2) 2625(5) 3693(2) 32(1)
C(16A) 3271(2) 2838(6) 4771(2) 47(1)
C(17A) 2751(2) 5160(6) 3793(2) 36(1)
C(18A) 2864(2) 6198(6) 3116(2) 39(1)
C(19A) 2612(2) 8233(8) 2900(2) 51(1)
I(2) 5760(1) 351(1) -1541(1) 52(1)
O(1B) 6661(1) 7118(3) 2275(1) 34(1)
N(1B) 7173(2) 4167(4) 1625(1) 34(1)
N(2B) 7955(2) 7040(4) 2098(1) 27(1)
N(3B) 8578(2) 5882(4) 1807(1) 26(1)
C(1B) 6496(2) 3858(5) 289(2) 33(1)
C(2B) 6341(2) 3322(8) -374(2) 35(1)
C(3B) 5958(2) 1240(6) -534(2) 29(1)
C(4B) 5742(2) -303(6) -40(2) 31(1)
C(5B) 5895(2) 235(6) 618(2) 28(1)
C(6B) 6287(2) 2329(5) 795(2) 26(1)
C(7B) 6454(2) 2863(6) 1519(2) 32(1)
C(8B) 7233(2) 6143(5) 2016(2) 25(1)
C(9B) 9266(2) 6619(5) 1925(2) 24(1)
C(10B) 9471(2) 8670(6) 2382(2) 33(1)
C(11B) 9892(2) 5325(6) 1586(2) 25(1)
C(12B) 9704(2) 3469(7) 1051(2) 34(1)
C(13B) 10499(2) 2401(6) 903(2) 54(1)
C(14B) 11131(2) 4019(5) 1204(2) 33(1)
C(15B) 10659(2) 5558(6) 1666(2) 30(1)
C(16B) 11736(3) 2543(7) 1600(2) 67(2)
C(17B) 11522(2) 5571(7) 690(2) 58(1)
C(18B) 12017(3) 4302(6) 194(2) 52(1)
C(19B) 11859(3) 3982(7) -416(2) 77(2)
APPENDIX 3 — X-Ray Crystallography Reports Relevant to Chapter 2 694
Table A3.3.  Bond lengths [Å] and angles [°] for semicarbazone 81 (CCDC 686849).
I(1)-C(3A) 2.092(3)
O(1A)-C(8A) 1.226(4)
N(1A)-C(8A) 1.354(4)
N(1A)-C(7A) 1.449(4)
N(2A)-C(8A) 1.361(4)
N(2A)-N(3A) 1.388(3)
N(3A)-C(9A) 1.289(4)
C(1A)-C(2A) 1.375(5)
C(1A)-C(6A) 1.386(4)
C(2A)-C(3A) 1.385(4)
C(3A)-C(4A) 1.384(4)
C(4A)-C(5A) 1.376(4)
C(5A)-C(6A) 1.397(5)
C(6A)-C(7A) 1.494(4)
C(9A)-C(11A) 1.457(4)
C(9A)-C(10A) 1.494(4)
C(11A)-C(15A) 1.312(4)
C(11A)-C(12A) 1.514(5)
C(12A)-C(13A) 1.542(4)
C(13A)-C(14A) 1.542(5)
C(14A)-C(15A) 1.505(4)
C(14A)-C(17A) 1.538(5)
C(14A)-C(16A) 1.552(5)
C(17A)-C(18A) 1.487(5)
C(18A)-C(19A) 1.290(5)
I(2)-C(3B) 2.096(3)
O(1B)-C(8B) 1.242(4)
N(1B)-C(8B) 1.356(4)
N(1B)-C(7B) 1.447(4)
N(2B)-C(8B) 1.346(4)
N(2B)-N(3B) 1.383(3)
N(3B)-C(9B) 1.270(4)
C(1B)-C(6B) 1.376(4)
C(1B)-C(2B) 1.380(5)
C(2B)-C(3B) 1.373(5)
C(3B)-C(4B) 1.366(4)
C(4B)-C(5B) 1.372(4)
C(5B)-C(6B) 1.394(5)
C(6B)-C(7B) 1.501(5)
C(9B)-C(11B) 1.467(4)
C(9B)-C(10B) 1.504(4)
C(11B)-C(15B) 1.330(4)
C(11B)-C(12B) 1.522(4)
C(12B)-C(13B) 1.521(5)
C(13B)-C(14B) 1.530(5)
C(14B)-C(15B) 1.505(4)
C(14B)-C(17B) 1.509(5)
C(14B)-C(16B) 1.537(6)
C(17B)-C(18B) 1.493(5)
C(18B)-C(19B) 1.260(5)
C(8A)-N(1A)-C(7A) 120.7(3)
C(8A)-N(2A)-N(3A) 119.8(3)
C(9A)-N(3A)-N(2A) 118.6(3)
C(2A)-C(1A)-C(6A) 122.1(3)
C(1A)-C(2A)-C(3A) 119.6(3)
C(2A)-C(3A)-C(4A) 119.8(3)
C(2A)-C(3A)-I(1) 120.1(2)
C(4A)-C(3A)-I(1) 119.9(2)
C(5A)-C(4A)-C(3A) 119.7(3)
C(4A)-C(5A)-C(6A) 121.7(3)
C(1A)-C(6A)-C(5A) 117.2(3)
C(1A)-C(6A)-C(7A) 122.8(3)
C(5A)-C(6A)-C(7A) 120.1(3)
N(1A)-C(7A)-C(6A) 115.0(3)
O(1A)-C(8A)-N(1A) 123.1(3)
O(1A)-C(8A)-N(2A) 121.2(3)
N(1A)-C(8A)-N(2A) 115.8(3)
N(3A)-C(9A)-C(11A) 116.2(3)
N(3A)-C(9A)-C(10A) 123.9(3)
C(11A)-C(9A)-C(10A) 119.8(3)
C(15A)-C(11A)-C(9A) 127.4(3)
C(15A)-C(11A)-C(12A) 109.9(3)
C(9A)-C(11A)-C(12A) 122.6(3)
C(11A)-C(12A)-C(13A) 102.6(3)
C(12A)-C(13A)-C(14A) 105.2(2)
C(15A)-C(14A)-C(17A) 114.4(3)
C(15A)-C(14A)-C(13A) 100.7(3)
C(17A)-C(14A)-C(13A) 113.7(3)
C(15A)-C(14A)-C(16A) 109.3(3)
C(17A)-C(14A)-C(16A) 108.2(3)
C(13A)-C(14A)-C(16A) 110.3(3)
C(11A)-C(15A)-C(14A) 114.4(3)
C(18A)-C(17A)-C(14A) 114.4(3)
C(19A)-C(18A)-C(17A) 127.0(3)
C(8B)-N(1B)-C(7B) 123.6(3)
C(8B)-N(2B)-N(3B) 119.3(3)
C(9B)-N(3B)-N(2B) 119.4(3)
C(6B)-C(1B)-C(2B) 121.4(3)
C(3B)-C(2B)-C(1B) 119.6(3)
C(4B)-C(3B)-C(2B) 120.0(3)
C(4B)-C(3B)-I(2) 120.1(3)
C(2B)-C(3B)-I(2) 119.8(2)
C(3B)-C(4B)-C(5B) 120.3(3)
C(4B)-C(5B)-C(6B) 120.9(3)
C(1B)-C(6B)-C(5B) 117.7(3)
C(1B)-C(6B)-C(7B) 122.4(3)
C(5B)-C(6B)-C(7B) 119.8(3)
N(1B)-C(7B)-C(6B) 113.3(3)
O(1B)-C(8B)-N(2B) 121.1(3)
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Table A3.3 (cont.)
O(1B)-C(8B)-N(1B) 123.0(3)
N(2B)-C(8B)-N(1B) 115.9(3)
N(3B)-C(9B)-C(11B) 116.0(3)
N(3B)-C(9B)-C(10B) 124.7(3)
C(11B)-C(9B)-C(10B) 119.3(3)
C(15B)-C(11B)-C(9B) 128.7(3)
C(15B)-C(11B)-C(12B) 110.6(3)
C(9B)-C(11B)-C(12B) 120.7(3)
C(13B)-C(12B)-C(11B) 102.9(3)
C(12B)-C(13B)-C(14B) 108.9(3)
C(15B)-C(14B)-C(17B) 109.6(3)
C(15B)-C(14B)-C(13B) 101.3(3)
C(17B)-C(14B)-C(13B) 112.9(3)
C(15B)-C(14B)-C(16B) 110.9(3)
C(17B)-C(14B)-C(16B) 110.8(3)
C(13B)-C(14B)-C(16B) 110.9(3)
C(11B)-C(15B)-C(14B) 114.2(3)
C(18B)-C(17B)-C(14B) 116.1(3)
C(19B)-C(18B)-C(17B) 126.3(5)
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Table A3.4.  Anisotropic displacement parameters (Å2 x 104) for semicarbazone 81 (CCDC
686849).  The anisotropic displacement factor exponent takes the form: –2&2[ h2a*2U11 + ... + 2 h k
a* b* U12 ].
U11 U22 U33 U23 U13 U12
I(1) 340(2) 433(1) 310(1) 1(1) -116(1) -2(1)
O(1A) 177(14) 294(13) 431(15) -131(10) -15(11) 35(10)
N(1A) 166(17) 377(19) 352(17) -168(12) 3(13) -6(12)
N(2A) 150(17) 315(15) 378(18) -133(12) -22(13) 22(12)
N(3A) 186(19) 310(15) 328(18) -35(12) -35(15) 38(13)
C(1A) 190(20) 176(16) 420(20) 13(15) -22(18) 9(13)
C(2A) 250(20) 237(18) 320(20) 88(15) -7(16) -4(16)
C(3A) 170(20) 261(17) 270(20) -18(14) -7(16) 69(14)
C(4A) 180(20) 200(20) 310(20) -23(14) -29(15) -13(14)
C(5A) 240(20) 201(19) 275(19) 26(16) 5(15) 34(16)
C(6A) 171(19) 195(18) 269(19) -26(14) -8(15) 64(14)
C(7A) 260(20) 280(18) 330(20) -40(17) -16(16) -38(18)
C(8A) 200(20) 257(18) 260(20) -33(14) -61(17) 19(16)
C(9A) 200(20) 231(17) 330(20) -9(14) -9(18) -26(15)
C(10A) 200(20) 410(20) 430(20) -69(17) 3(18) -44(17)
C(11A) 190(20) 240(20) 330(20) 21(16) -31(15) -26(17)
C(12A) 250(20) 283(18) 360(20) -23(16) -60(16) -30(16)
C(13A) 260(20) 305(19) 440(20) -99(15) -50(18) 42(16)
C(14A) 190(20) 305(19) 490(30) -7(15) 9(19) 19(15)
C(15A) 260(20) 240(20) 460(20) -48(14) -26(19) -18(15)
C(16A) 360(30) 500(30) 540(30) 114(18) 30(20) 88(19)
C(17A) 250(20) 390(20) 450(20) -34(18) 9(18) 40(20)
C(18A) 270(20) 480(20) 420(30) -75(18) -70(20) 77(18)
C(19A) 410(30) 600(20) 510(20) 40(20) -88(19) 120(30)
I(2) 431(2) 791(2) 333(2) -69(1) -57(1) -30(2)
O(1B) 227(16) 346(12) 447(16) -105(10) 2(13) 9(11)
N(1B) 220(19) 350(17) 440(20) -151(12) -38(16) 9(12)
N(2B) 230(20) 301(15) 272(17) -106(12) -29(14) 3(13)
N(3B) 208(18) 309(16) 277(16) -57(12) -23(14) 26(14)
C(1B) 340(30) 190(20) 470(30) -9(15) -50(20) -62(15)
C(2B) 310(20) 404(19) 350(20) 130(20) -22(16) 20(20)
C(3B) 190(20) 370(20) 310(20) -17(16) -51(17) 17(16)
C(4B) 200(20) 270(20) 450(30) -58(16) -50(18) -39(15)
C(5B) 270(20) 236(18) 340(20) 71(16) -20(16) -10(17)
C(6B) 170(20) 246(18) 350(20) 8(15) -46(17) -2(14)
C(7B) 300(20) 310(20) 360(20) -12(15) -23(17) -59(16)
C(8B) 200(20) 282(19) 270(20) -34(14) -76(16) -6(16)
C(9B) 250(20) 257(18) 220(20) 11(14) 2(17) 11(16)
C(10B) 260(20) 400(20) 330(20) -104(16) 37(16) -60(18)
C(11B) 250(20) 241(17) 253(19) -25(16) -45(15) -52(18)
C(12B) 340(20) 341(18) 330(20) -105(19) -60(16) 10(20)
C(13B) 450(30) 450(20) 730(30) -310(20) 70(30) -4(19)
C(14B) 250(20) 350(20) 390(20) -54(15) 20(19) 25(15)
APPENDIX 3 — X-Ray Crystallography Reports Relevant to Chapter 2 697
Table A3.4 (cont.)
C(15B) 340(20) 290(18) 266(19) -75(16) -25(16) 33(18)
C(16B) 720(40) 680(30) 610(30) -170(20) -50(30) 380(30)
C(17B) 840(30) 400(20) 510(30) -150(20) 330(20) -90(20)
C(18B) 500(30) 540(30) 520(30) -104(19) 110(30) -49(19)
C(19B) 1060(50) 830(40) 420(30) 40(20) 60(30) 500(30)
Table A3.5.  Hydrogen bonds for semicarbazone 81 (CCDC 686849) [Å and °].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
 N(2A)-H(2A)...O(1B)#1 0.88 2.13 2.972(3) 159.7
 N(2B)-H(2B)...O(1A)#2 0.88 2.04 2.895(3) 163.1
Symmetry transformations used to generate equivalent atoms:
#1 x,y-1,z
#2 x,y+1,z
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CHAPTER 3
Unified Approach to Daucane and Sphenolobane
Bicyclo[5.3.0]decane core: Enantioselective Synthesis of
Four Daucane Sesquiterpenes and Related Molecules†
3.1 INTRODUCTION AND BACKGROUND
The daucane (carotane) sesquiterpenes and sphenolobane (tormesane) diterpenes
are two structurally related families of natural products that share a hydroazulene (i.e.,
bicyclo[5.3.0]decane) core (Figure 3.1A).  These terpenoids feature varied degrees of
oxidation with diverse peripheral functionality and, as a group, exhibit a wide range of
biological activity (Figure 3.1B).1  As such, the synthetic community has reported several
studies2 and total syntheses1i,3 of a number of these natural products.  Central to our
interest in these molecules is the cyclopentane motif, which we envisioned accessing
from a !-quaternary acylcyclopentene (53) generated by a combination of the palladium-
catalyzed asymmetric enolate alkylation4,5,6 and ring contraction chemistry that is
                                                 
† The research has been submitted for publication.
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discussed in the preceding chapter (Figure 3.1A).7  As part of our ongoing efforts to apply
this methodology,8 we have developed a route to the sesquiterpene and diterpene
carbocyclic scaffolds, explored functionalization of the hydroazulene skeleton to oxidized
compounds including epoxydaucenal B (144b), and completed the first total syntheses of
14-p-anisoyloxydauc-4,8-diene (145) and daucenal (143) via the archetypal daucane
sesquiterpene, daucene (142).
Figure 3.1.  Bicyclo[5.3.0]decane skeletons linked to acylcyclopentene 53  and examples of
hydroazulene natural products.
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3.1.1 Isolation, Structural Determination, and Bioactivity of Relevant
Daucane Sesquiterpenes
Feldmann reported the earliest study on a daucane sesquiterpene in 1865,9 and
since that time, numerous molecules in this class have been identified and investigated.
The majority of the research on this family of natural products was performed in the
1950s–1970s, and an excellent review by Ghisalberti details the isolation,
characterization, bioactivity, and biosynthesis of these sesquiterpenes.10  The following
section focuses on the daucane sesquiterpenes associated with our synthetic efforts and
the reader is directed to the aforementioned review for further information.
The structurally simplest daucane we have prepared is daucene (142), which has
been isolated from several sources11 and is postulated to be the biosynthetic precursor to
more functionalized derivatives.11a,12  This natural product was originally obtained from
Daucus carotoa11a in 1961 by Pigulevskii and has also more recently been found as a
constituent of extracts from Piptoporus betulinus,11b Gleophyllum odoratum,11b
xCupressocyparis leylandii,11c Ferula hermonis,11d and Matricaria chamomilla.11e
Interestingly, both enantiomers of daucene occur naturally.  Pigulevskii first analyzed
daucene with Raman and infrared (IR) spectroscopy, which suggested a hydroazulene
structure with tri- and tetrasubstituted double bonds.  A series of hydrogenation
experiments were performed and the resulting reduced molecules were also examined.
The structure of daucene was ultimately confirmed by several total syntheses, which are
discussed in Section 3.2.
In 1991, Hashidoko et al. isolated daucenal (143) and epoxydaucenal A and B
(144a and b) from the leaves of Rosa rugosa.13  Initial analysis of daucenal by EI mass
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spectrometry and 1H/13C NMR suggested the molecule contained either a [7–5] or [4–8]
bicyclic skeleton.  The bicyclo[5.3.0]decane structure that is characteristic of the daucane
sesquiterpenes was ultimately confirmed by Correlation through Long-Range Coupling
(COLOC) NMR.14  The NMR spectra of epoxydaucenal A and B (144a and b) shared
several related signals to daucenal, and mass spectrometry indicated each molecule
contained an additional oxygen.  The structural similarity was confirmed as daucenal
(143) was oxidized with 3-chloroperbenzoic acid to provide a 70:30 mixture of the
epoxidized molecules (144a:144b) in 58% yield.  The relative stereochemistry of epoxy
and isopropyl groups was determined by NOE experiments.
14-p-anisoyloxydauc-4,8-diene (145) was first isolated by Miski et al.15 in 1986
from the roots of Ferula tingitana.  The molecular structure of this sesquiterpene was
elucidated by mass spectrometry and IR, ultraviolet (UV), and NMR spectroscopy.  Viola
and co-workers1a later isolated ester 145 from Ferula communis and found this molecule
displays antiproliferative activity against HL-60, Jurkat, K562, RS 4;11, and SEM human
tumor cells with IC50 values comparable or superior to many of the more oxygenated and
complex daucane sesquiterpenes screened.  Interestingly, the related 14-(4'-
hydroxybenzoyloxy)dauc-4,8-diene (146), which was isolated from Ferula hermonis,
displays antibacterial and antifungal activity.1b
Despite the earliest isolation occurring over twenty five years ago and this
bioactivity, to our knowledge no total syntheses have been reported for any of these
C(14) oxidized sesquiterpenes.
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3.1.2 Biosynthetic Studies
Two main experiments have been performed to explore the biogenesis of the
daucane sesquiterpene skeleton.16  In 1962, Soucek fed 14C-labeled sodium acetate (152a)
to Daucus carota (carrot plant) to determine the positions of isotope incorporation in
carotol (153, Scheme 3.1A).17  The resulting 14C-enriched carotol was oxidatively
degraded to generate acetic acid (154) from the C(8) and C(14) positions of the molecule.
The acetic acid formed through this process contained the 14C-isotope, suggesting that the
carbocyclic core arises through folding of cis,trans-farnesyl diphosphate (FPP, 155) as
depicted in intermediate 155a instead of conformation 155b. The latter arrangement
would necessitate an additional methyl shift to obtain the carbon skeleton and
consequently occlude 14C-incorporation in the degradation product.
Scheme 3.1.  14C- and 13C-labeled sodium acetate feeding experiments.
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A second isotope study was performed by Tsuda et al. in 1976.18  This publication
details the first isolation of a daucane sesquiterpene from a source outside the
Umbelliferae (Apiaceae) family.  To gain insight into the biosynthetic pathway in the
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fungus Aspergillus terreus, they simultaneously fed 14C- and 13C-labeled sodium acetate
(152b and 152c) to the organism and analyzed the resulting enriched aspterric acid (156,
Scheme 3.1B).  The mass of the enriched aspterric acid was obtained, and the extent of
isotope incorporation was determined from the 14C-isotope to be 1.32%.  Analysis of the
13C isotope by NMR revealed enrichment at multiple positions and a 13C–13C coupling
between C(6) and C(10) (see 157, Scheme 3.1C).  Given these results, Tsuda and co-
workers proposed that aspterric acid (156) also arises through a concerted cyclization of
cis,trans-FPP (155) through a conformation like that described by Soucek.
Ghisalberti argues in his 1994 review that a concerted cyclization mechanism is
plausible, but not necessarily operable, as such a pathway does not rationalize the
formation of other sesquiterpenes that are co-isolated with daucanes.10  To resolve this
issue, he proposes an alternative stepwise biosynthesis that explains the co-occurrence of
bisabolane (160)19 and acorane (163)11c,13,19 natural products (Scheme 3.2).  Initial
cyclization of nerolidyl diphosphate (NPP, 158) generates carbocation 159, which may be
funneled to the bisabolanes directly or undergo a subsequent cyclization/1,2-hydride shift
(161a) to afford the acorane sesquiterpenes.  Alternatively, ring expansion of
cyclohexane 161 and subsequent cyclization reveals daucane carbocation 166, which may
be converted to other cations through various 1,2-hydride shifts.  Ultimately these
carbocations may be neutralized through an elimination reaction or quenching with water.
Ghisalberti’s pathway is reasonable, but speculative.  The only justification for this route
beyond co-isolation is the observation of interconversion between the daucane and
acorane scaffolds in synthetic efforts20 and Naegeli and Kaiser’s 1962 synthesis of
daucene that also forms acoradiene (173) in the final acid-promoted cyclization (see
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Section 3.2).21  Further biological experiments are necessary to confirm the validity of
this biosynthetic proposal.
Scheme 3.2.  Biosynthetic route that rationalizes co-isolation of bisabolane (160), acorane (163),
and daucane sesquiterpenes.
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3.2 PREVIOUS TOTAL SYNTHESES OF DAUCENE
Of the daucane molecules we selected to target, only daucene (142) has been
synthesized previously.  Five main strategies have been employed to construct the [7–5]
bicyclic core of this natural product (Scheme 3.3).  Early efforts by Naegeli and Kaiser,21
Yamasaki,22 and Mehta12,23 focus on acid-promoted cyclizations that append the seven-
membered ring onto an existing cyclopentane scaffold.  Around the same time, Levisalles
reported a semipinacol and Wagner–Meerwein rearrangement sequence on trans-decalin
176 that expands the left half of the molecule to the cycloheptyl ring and contracts the
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right portion to the isopropyl-accessorized cyclopentene motif.24  In the 1980s, Seto25 and
Vandewalle26 independently reported syntheses of daucene that include a [2 + 2]
cycloaddition to prepare the bicyclic core.  Seto cleaves the resulting cyclobutane with a
retro-aldol fragmentation, while Vandewalle employs a thermally promoted retro-
cycloaddition that triggers a silyl transfer reaction in situ.  Most recently, Little has
disclosed an electrochemically-induced radical ring expansion on cyclohexane 179.27
Overall, these past routes can only produce daucene racemically or rely on
enantioenriched, naturally occurring starting materials to obtain the sesquiterpene
asymmetrically.  These approaches also suffer from low yields, poor enantiopurity,
and/or extended preparation times (e.g., >30 days).  Many of these syntheses also
incorporate similar steps or strategies to arrive at key intermediates.
Scheme 3.3.  Retrosynthetic analysis of previous routes to daucene.
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Naegeli and Kaiser accomplished the first total synthesis of daucene (142) in 1972
(Scheme 3.4).21  In their route, racemic dehydrolinalool (180) is cyclized to allylic
alcohol 181 and subsequently treated with acid and methyl isopropenyl ether at elevated
temperature to initiate a Claisen rearrangement that affords ketone 182.  Ketone 182 is
hydrogenated with Lindlar’s catalyst and converted to allylic alcohol 174 with
vinylmagnesium bromide.  Finally, a Lewis acid-induced cyclization with tin(IV)
chloride completes the synthesis of daucene (142) and also produces the natural product
acoradiene (173).  This approach furnishes daucene quickly (5 steps), but prepares the
racemic product, and does not indicate yields for several steps in the sequence.
Scheme 3.4.  First total synthesis by Naegeli and Kaiser in 1972.
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Yamasaki and co-worker’s synthesis also invokes an acid-promoted cyclization
on allylic alcohol 174, but affords the natural product in enantiopure form (Scheme 3.5).22
Their approach starts with (R)-(+)-limonene (184), which is oxidized with perbenzoic
acid to generate an epoxide that is opened with acid to furnish diol 185.  Diol 185 is
contracted to acylcyclopentene 186 by sequential treatment with sodium periodate and
piperidine in acetic acid.  An aldol condensation on acylcyclopentene 186 produces
CHAPTER 3 — Enantioselective Synthesis of Four Daucane Sesquiterpenes and Related Molecules 707
enone 187, which is reduced to the corresponding ketone ((S)-182) with triphenyltin
hydride.  Conversion of ketone (S)-182 to allylic alcohol 188 is accomplished through a
three-step hydrogenation, acetylene addition, and Lindlar reduction sequence.  It is
unclear why the authors selected a two-step installation of the vinyl group instead of
employing a vinyl organometallic reagent.  Nevertheless, treatment of allylic alcohol (S)-
174 with formic acid results in the formation of five compounds, of which (–)-daucene
(142) is isolated in 42% yield.  The key disadvantage of Yamasaki’s route is that several
steps perform poorly and consequently provide the natural product in diminished overall
yield.
Scheme 3.5.  Yamasaki’s 1972 route to enantioenriched allylic alcohol 182 and (–)-daucene (142).
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Mehta’s synthesis12,23  not only incorporates an acid-promoted cyclization, but also
follows the same initial ring opening sequence from (R)-(+)-limonene (184) employed by
Yamasaki.  However, Mehta opts to hydrogenate the isopropenyl group earlier in the
synthetic route, arriving at enal 190 instead of the dehydrated analog (186, Scheme 3.5).
Luche reduction of enal 190 generates an allylic alcohol that is treated with mercury(II)
acetate and ethyl vinyl ether to produce vinyl ether 191 (Scheme 3.6).  Vinyl ether 191 is
CHAPTER 3 — Enantioselective Synthesis of Four Daucane Sesquiterpenes and Related Molecules 708
heated in a sealed tube to initiate a Claisen rearrangement that affords aldehyde 192,
which is converted to enone 175 through Grignard addition and oxidation.  Acid-
catalyzed cyclization of enone 175 completes the cycloheptyl ring and furnishes ketone
193 as an inconsequential mixture of diastereomers.  To install the remaining olefin and
complete the synthesis, ketone 193 is reduced and the resulting alcohol is eliminated.
However, the elimination step suffers from low yield due to the formation of other olefin
isomers.  In summary, Mehta’s synthesis parallels Yamaski’s efforts closely and again
produces daucene in low overall yield.
Scheme 3.6.  Mehta’s 1988 acid-promoted cyclization approach to (–)-daucene (142).
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Shortly after the disclosure of Naegeli and Kaiser,21 Levisalles et al. reported a
route to daucene starting from (S)-(+)-carvone (194, Scheme 3.7).24  Unfortunately, their
report is vague and does not include yields for almost every transformation described,
making it challenging to compare this work to other efforts in the area.  The key sequence
starts from the carvone-derived ketone 176,24 which is treated with diazomethane to effect
a semipinacol rearrangement that generates a 2:1 inseparable mixture of ketone 195a and
the corresponding C(7) isomer.  Purification of these alcohols is accomplished by
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chromatographic separation of the corresponding acetates, after which hydrolysis again
affords alcohol 195a.  A phosphorus pentachloride-initiated Wagner–Meerwein 1,2-
rearrangement of alcohol 195a produces alkene 196 as well as the "11-isomer.  (+)-
Daucene (142) is subsequently obtained through isomerization of the C(4) olefin
(conditions unspecified), Grignard addition to the ketone, and elimination of the resulting
alcohol.  Interestingly, Levisalle and co-workers also convert daucene to (+)-carotol
(153) and (–)-daucol (198), although the process is extremely low yielding.  Overall, this
route is less desirable as several steps in the sequence have either poor regioselectivity or
diastereoselectivity.
Scheme 3.7.  Synthesis of (+)-daucene (142), (+)-carotol (153), and (–)-daucol (198) by Levisalles
in 1972.
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Seto and co-workers published an alternative strategy to racemic daucene in
1985.25  In their route, enamine 199 is first treated with acid chloride 200 to afford dione
201.  Dione 201 is converted to the acetoxy enone and subsequently irradiated to furnish
the [2 + 2] cycloaddition product, cyclobutane 202.  Fragmentation of cyclobutane 202 is
accomplished through a base-mediated retro-aldol process that initially generates bicycle
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203 en route to tricyclic ketone 204.  A Meerwein–Ponndorf–Verley reduction of ketone
204 forms the equatorial alcohol preferentially, although the process requires 30 days to
complete.  The resulting diol is selectively tosylated at the secondary position to afford
sulfonic ester 205.  Isopropyllithium initiates Grob fragmentation of alcohol 205 and also
diastereoselectively adds to the resulting ketone to produce a mixture of ketone 206 and
alcohol 207 (Route A).  Alternatively, a two-step sequence can be employed to obtain
alcohol 207 (Route B).  Elimination of the alcohol functionality with formic acid
generates daucene (142) in low yield in conjunction with other olefin products.  The early
steps in Seto’s synthesis proceed with good to excellent yields and install the necessary
C(8)-C(9) olefin selectively due to the Grob fragmentation.  However, the final steps in
the sequence are low yielding and result in multiple isomers.
Scheme 3.8.  Seto’s 1985 total synthesis of racemic daucene (142).
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Vandewalle’s 1987 synthesis of (+)-daucene also incorporates a [2 + 2]
cycloaddition, but arrives at the bicyclic core by fragmenting cyclobutane 178 through a
thermally promoted retro-cycloaddition that initially generates siloxyenone 210 (Scheme
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3.9).26  Siloxyenone 210 is conformationally oriented such that a silyl transfer is triggered
in situ.  The resulting silyl ether (212) is hydrolyzed during work-up to reveal dione 213.
Vandewalle protects the more accessible ketone of dione 213 with ethane-1,2-dithiol,
converts the sterically hindered ketone to the enone, and then removes the thioacetal
functionality with Raney-Ni.  Cuprate addition to enone 214 installs the C(14) methyl
group and the reaction is quenched with diethyl phosphorochloridate to furnish a vinyl
phosphate.  Lithium reduction of this phosphate provides an alkene that is isomerized to
(+)-daucene (142) and the "7-isomer with Grieco’s rhodium conditions.28  Vandewalle’s
approach is elegant and produces daucene in good overall yield, but in poor enantiopurity
due to the low natural enantioenrichment of the starting material.
Scheme 3.9.  Retro-cycloaddition/aldol approach to (+)-daucene by Vandewalle in 1987.
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Twenty years elapsed following Vandewalle’s and Mehta’s 1980s syntheses
before another approach to daucene was disclosed by Little and co-workers.  Their
publication focuses primarily on the development of an electrochemically-induced radical
rearrangement, but also includes a low yielding synthesis of racemic daucene to
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demonstrate application of the methodology.  To this end, enone 215 is transformed into
diene 216 through an alkylation, reduction, and elimination pathway.  A [4 + 2]
cycloaddition between diene 216 and azodicarboxylate 217 and ensuing reduction
produce hydrazine 218.  The ester groups of hydrazine 218 are removed to generate
diazene 219, which is irradiated to liberate nitrogen and form cyclobutane 179.  Radical
cleavage of the cyclobutane generates intermediate 220, which undergoes a ring
expansion rearrangement to ultimately afford alkene 221.  Alkene 221 is converted to a
ketone, treated with isopropyllithium, and the resulting alcohol is eliminated to arrive at
ketone 222.  Another organometallic addition and elimination sequence completes the
synthesis, producing daucene in 15 steps and 0.6% overall yield.  The middle portion of
Little’s synthesis is robust and well developed, but the early and late steps are low
yielding.  In particular, installation of the remaining functionality following the radical
rearrangement is cumbersome.  While the radical process provides an interesting and
powerful alternative to previous approaches, Little’s route needs optimization and could
potentially also be improved by incorporating more of the necessary functionality earlier
in the synthesis.
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Scheme 3.10.  Little’s 2008 synthesis of racemic daucene.
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3.3 ENANTIOSELECTIVE SYNTHESIS OF BICYCLO[5.3.0]DECANE
CARBOCYCLIC CORE AND DAUCANE SESQUITERPENES
3.3.1 Retrosynthetic Analysis
Our initial target was the biologically active sesquiterpene 14-p-anisoyloxydauc-
4,8-diene (145).  We retrosynthetically envisioned preparing this natural product via an
allylic oxidation at the C(14) position of daucene (142, Scheme 3.11A).  In contrast to
previous efforts, we sought to access daucene by implementation of enantioselective
catalysis in a manner that would avoid the formation of multiple olefin isomers.  To this
end, we planned a late-stage installation of the C(13) methyl group through olefination
and hydrogenation of enone 223.  This key intermediate possesses the [7–5] bicyclic core
and could potentially allow entry to either terpenoid series through incorporation of the
appropriate sesquiterpene or diterpene chain at the C(11) position.  We also anticipated
that enone 223 may be converted to more oxidized members of the daucane family.
Retrosynthetically, the cycloheptenyl portion of enone 223 would be formed through
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ring-closing metathesis of acylcyclopentene 53w , which could be generated by
employing our retro-aldol/aldol ring contraction sequence7 after Grignard addition to
vinylogous ester 27a.  As described in Chapter 2, we have previously prepared
vinylogous ester 27a7a enantioselectively from vinylogous ester 66 using our palladium-
catalyzed allylic alkylation methodology (Scheme 3.11B).4
Scheme 3.11.  (a) Retrosynthetic analysis and (b) synthesis of enantioenriched vinylogous ester 27a.
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3.3.2 Challenges with Initial Approach
As we pursued this approach, we encountered two challenges.  First, CeCl3
assisted addition of (3-methylbut-3-en-1-yl)magnesium bromide to vinylogous ester 27a
results in poor selectivity for the desired #-hydroxyketone (70w), favoring formation of
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cycloheptenone 55w (Scheme 3).  This product distribution contrasts with our previous
work with n-butylmagnesium chloride,7 where # -hydroxyketone 70r is generated
preferentially.  Ultimately, this result directs considerable material to a less productive
compound (vide infra), thus limiting our synthetic route.  In addition, our optimized
microwave-assisted ring contraction conditions proceed poorly to furnish
acylcyclopentene 53w also in diminished yield compared to the n-butyl analogue (53r,
Scheme 3B).  Alternatively, treatment of #-hydroxyketone 70w with lithium hydroxide
and trifluoroethanol (TFE) provides an excellent yield of acyclic dione 72w, from which
we envisioned installing the necessary cyclopentene ring in a later aldol reaction (see
below).  With an acceptable solution for the second issue, we turned our attention to
resolve the first.
Scheme 3.12.  Challenges with early steps.
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3.3.3 Efforts to Resolve Grignard Addition Selectivity and Siloxyenone
Solution
In attempting to alter the Grignard addition product ratios, we first screened a
series of work-up parameters.29  Unfortunately, all other acidic quenching conditions
investigated favor the cycloheptenone (55) or at best preferentially afford the #-
hydroxyketone (70), but in lower yield (Scheme 3.13).  We also examined several buffer
solutions comprising a range of acidic pH, but the majority of these conditions provide
similar results.  The main exception is a sodium phosphate buffer (pH 6.5) quench, which
leads to the transient formation of enol ether 71.30  A number of solvents and acids were
probed for the selective hydrolysis of enol ether 71, but the same trends were observed
with this substrate.  The propensity of elimination under a variety of acidic conditions is
likely due to the stability of the carbocations generated with hydrolysis of tertiary alcohol
71 or 70 (i.e., path a/c favored over path b, Scheme 3.14).  Although not necessarily the
desired outcome, these efforts did identify conditions that enabled the development of our
ketone transposition methodology toward !-quaternary cycloheptenones (see Chapter 2,
Section 2.6).7b,30
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Scheme 3.13.  Acidic work-up screen.
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Scheme 3.14.  Elimination pathways to undesired product, cycloheptenone 55.
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As varying the work-up parameters appeared ineffective at resolving this issue,
we decided to redesign our electrophile and began examining alternative vinylogous
systems.  As mentioned above, our previous screening had indicated that a sodium
phosphate buffer quench transiently provides enol ether 71 en route to cycloheptenone
55r (Scheme 3.15A).  We hypothesized that a related vinylogous molecule (224) with a
more labile alkoxy group could be orthogonally removed after Grignard addition to
afford #-hydroxyketone 70w preferentially.  Kuwajima has reported that the addition of
lithium and cerium nucleophiles to five- and six-membered ring siloxyenones temporarily
generates an $-hydroxy silyl enol ether (228) that eliminates to form #-substituted enones
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(229) upon exposure to silica gel  (Scheme 3.15B).31,32  The initial lack of desilylation or
Peterson olefination with these siloxyenone substrates suggests that the transformation is
fairly mild.  We consequently envisioned that the silyl enol ether analogue of
intermediate 225w (R = SiR3) could be cleaved prior to chromatography with a fluoride
source, prompting us to pursue siloxyenones as an alternative approach.
Scheme 3.15.  Siloxyenone inspiration based on (a) previous results and (b) Kuwajima’s precedence
with Grignard addition to five- and six-membered siloxyenones.
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Retrosynthetically, we planned to synthesize enantioenriched siloxyenone 230
through Pd-catalyzed asymmetric alkylation of #-ketoester 231 (Scheme 3.16A).  #-
Ketoester 231 would be derived from siloxyenone 232 through an acylation/alkylation
pathway, as Kuwajima has shown that siloxyenones may be alkylated under standard
LDA conditions.31  Siloxyenone 232 can be obtained from dione 65 by treatment with
CHAPTER 3 — Enantioselective Synthesis of Four Daucane Sesquiterpenes and Related Molecules 719
either sodium hydride33 or Et3N and a silylating agent (Scheme 3.16B), and we selected
the TIPS substituted siloxyenone as it is amenable to flash column chromatography.34
Although the silylation reaction proved effective, unfunctionalized siloxyenone 232 was
unstable to a variety of acylating conditions.  We screened several combinations of bases
(LDA and LHMDS) and acylating agents (allyl cyanoformate, allyl chloroformate, allyl
1H-imidazole-1-carboxylate), but could never isolate #-ketoester 233.  A simple TLC
experiment indicated that treatment of siloxyenone 232  with the acylating agent
counterions results in loss of the silyl group (CN— and imadazole > Cl—) and production
of dione 65 (Scheme 3.16B).
Scheme 3.16.  New retrosynthetic analysis and challenges with acylation of siloxyenone 232.
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As such, we devised another approach from vinylogous ester 27a that avoids
these issues as the quaternary stereocenter is already incorporated in the molecule.  To
this end, vinylogous ester 27a was hydrolyzed and the resulting dione (79) was treated
with sodium hydride and triisopropylsilyl triflate33 to produce siloxyenone 230a in good
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yield with 3:1 regioselectivity (Scheme 3.17).  A number of other conditions were
examined for the silylation; unfortunately, no improvements in reaction conversion or
regioselectivity were observed with an amine base, multiple equivalents of reagents,
other additives (i.e., 18-crown-6), or incremental warming of the reaction.  However,
siloxyenone 230b can be converted to the desired isomer through iterative fluoride
deprotection and silylation.
Scheme 3.17.  Synthesis and reactivity of siloxyenone 230a.
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With this new vinylogous electrophile in hand, we tested our hypothesis by
exposing siloxyenone 230a to CeCl3 promoted Grignard conditions with a buffer and
fluoride quench.  We were pleased to find that no cycloheptenone 55w is observed and
the reaction also incorporates the ring-opening step by directly producing acyclic dione
72w.  TLC analysis of the reaction after the fluoride quench indicates initial formation of
both acyclic dione 72w and #-hydroxyketone 70w.  The latter is converted to the dione
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over time and the addition of LiOH/TFE expedites this retro-aldol process.  A screen of
other fluoride sources revealed that a TBAT quench only produces #-hydroketone 70w
even over extended exposure (determined by TLC analysis), 35 while a cesium fluoride
and LiOH work-up also generates dione 72w, albeit in a lower 70% yield.  Overall, this
new approach resolves the Grignard addition selectivity issues and provides the first
example of interrupting the standard Stork-Danheiser ketone transposition process with a
siloxyenone.
3.3.4 Completion of Key Intermediate Enone 223
Having developed an improved route to acyclic dione 72w , we pursued
preparation of our key intermediate, enone 223 (Scheme 3.18).  Although this molecule
can be synthesized from dione 72w via acylcyclopentene 53w (Route A), the sequence
proceeds in higher yield when the ring-closing metathesis is performed first (Route B).
Racemic dione 235 has previously been prepared from nerolidol by Urones and co-
workers along several synthetic routes in 7–10 steps (13–33% yield), and these efforts are
discussed in detail in the following section (Section 3.3.5).36  By comparison, our route
proceeding via enantioselective catalysis affords dione 235 in 7 steps with 40% overall
yield.  Applying Urones’ potassium hydroxide aldol conditions generates enone 223 from
dione 235 as reported.
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Scheme 3.18.  Two paths to [7–5] bicyclic enone 223.
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3.3.5 Urones’ Synthetic Route to Dione 235 and Enone 223
During the 1990s, Urones and co-workers reported two papers on synthetic efforts
toward tormesol (248) that incorporate dione (±)-235 and enone (±)-223 as key
intermediates.36  Their first publication investigates selenium oxidation of several
cyclohepentyl molecules derived from nerolidol (236), including ketone 237 and ketal
238 (Scheme 3.19A).36a  These oxidations generate a range of products in low to
moderate yield that are sequentially moved on to alcohol 242.  The allylic olefin of
alcohol 242 is selectively oxidized under vanadium-promoted conditions, and the
resulting epoxide (245) is reduced to diol 246 with lithium aluminum hydride (LiAlH4,
Scheme 3.19B).  Hydrolysis of ketal 246 reveals the ketone functionality and ensuing
oxidative cleavage with Pb(OAc)4 affords dione 235.  Along these routes, dione 235 is
prepared in 7–10 steps and 13–33% overall yield.  Urones’ second report details efforts to
obtain tormesol from enone 223, which is derived from dione 235 as discussed
previously.36b  Ultimately, their approach is incapable of producing the desired diterpene
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due to epimerization issues, but allows preparation of the non-natural isomer 10-epi-
tormesol (247) from enone 223 in 4 steps.
Scheme 3.19.  Urones’ various routes to dione (±)-235 and enone (±)-223.
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3.3.6 Alternative Routes to Enone 223 from Cycloheptenone 55w
As our early research on the addition of (3-methylbut-3-en-1-yl)magnesium
bromide to vinylogous ester 27a had generated a significant quantity of cycloheptenone
55w (Scheme 3.12), we investigated means to direct this material back into our synthetic
efforts.  To this end, oxidation of cycloheptenone 55w with lithium hydroxide and
hydrogen peroxide generates epoxide 249 as an inconsequential 2.7:1 mixture of
diastereomers (Route A, Scheme 3.20).  Subsequent lithium naphthalenide reduction
affords #-hydroxyketone 70w, which may be conveyed onto enone 223 in 3 steps as
discussed previously (Section 3.3.4).  Unfortunately, the epoxidation step proceeds
moderately, prompting us to examine alternative routes.
Scheme 3.20.  Epoxidation routes to key intermediate enone 223.
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We consequently pursued two other approaches through bicyclic enone 111w
(Routes B and C), which can be formed from cycloheptenone 55w  via a nearly
quantitative ring-closing metathesis.  Gratifyingly, oxidation of enone 111w under the
same hydrogen peroxide conditions furnishes epoxide 250 in 84% yield.  Reduction of
epoxide 250 with lithium naphthalenide interestingly also promotes an in situ retro-aldol
reaction that produces dione 235, albeit in low yield (Route B).  Dione 235 may be
converted to enone 223 with Urones’ aldol conditions (vide supra).  Alternatively,
reduction of epoxide 250 under milder samarium diiodide conditions with lithium
chloride as an additive gives #-hydroxyketone 251 in 92% yield.  Samarium diiodide
reduction without lithium chloride or with HMPA as an additive also provides #-
hydroxyketone 251, but in lower yield or with additional side products.37  Use of our
standard ring contraction conditions (LiOH, TFE, THF, 65 °C) initiates both retro-aldol
fragmentation of #-hydroxyketone 251 and ensuing aldol condensation to form enone
223.  Overall, route C provides enone 223 from cycloheptenone 55w in the shortest
sequence with the greatest overall yield.
As cycloheptenone 55w may alternatively be prepared from vinylogous ester 27a
in 82% yield by a buffer quench (Chapter 2, Section 2.6), we also considered the relative
merit of pursuing our daucane targets via this cycloheptyl molecule.  Along this
approach, the key intermediate enone 223 is produced in 8 steps from vinylogous ester
37a with 29% overall yield.  By comparison, our siloxyenone route also proceeds to
enone 223  in 8 steps, but with a higher 35% overall yield.  Further large-scale
optimization of the cycloheptenone route may allow this alternative approach to become
more competitive.
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3.3.7 Derivatization of Enone 223 and Pursuit of Oxygenated Molecules
With several routes to enone 223 in hand, we converted this key intermediate to
both terpenoid scaffolds and other oxygenated daucane molecules as part of our initial
goals.  Treatment of enone 2 2 3  with methyllithium or (4-methylpent-3-en-1-
yl)magnesium bromide results in the formation of alcohols 23 and 24, which contain the
daucane and sphenolobane carbocyclic cores, respectively (Scheme 6A).  This tertiary
alcohol motif is present in natural products in both the daucane38 and sphenolobane
series, and alcohol 24 is the "6(10)-analogue of the diterpene (–)-tormesol (25).39  Enone
223 can also be selectively epoxidized with lithium hydroxide and hydrogen peroxide to
provide epoxyketone 255 in excellent yield as a single diastereomer (Scheme 3.21B).  A
few daucane sesquiterpenes incorporate an epoxide at this position, and of these, we
decided to pursue epoxydaucenal B (144b).13  Toward this target, Wittig olefination of
epoxyketone 255 furnishes a diene that is selectively hydrogenated at the terminal alkene
with Wilkinson’s catalyst.  The resulting isopropyl accessorized epoxide (256) is heated
in a sealed vessel with selenium dioxide40 to generate epoxydaucenal B (144b) in 12 steps
and 20% overall yield from vinylogous ester 13 (longest linear sequence).
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Scheme 3.21.  Derivatization of enone 223 to sesquiterpene/diterpene cores and conversion to (–)-
epoxydaucenal B (144b).
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Having completed this natural product, we turned our attention to the carotol
series, which contains a tertiary alcohol at C(5) (Scheme 3.22). We first explored
samarium diiodide reduction of ketoepoxide 255 based on the previous success with
epoxide 250 (Scheme 3.20), but surprisingly isolated enone 223 in 96% yield.  The
preference for elimination in the cyclopentyl, but not cycloheptyl system again suggests
that the conformation of seven-membered ring compounds imparts unique reactivity to
these molecules (see Chapter 2).  Alternatively, lithium naphthalenide reduction opens
ketoepoxide 255 to furnish tertiary alcohol 257 in 50% yield, favoring the desired C(4)
isomer (257a) in 4.5:1 diastereoselectivity.  Unfortunately, the reduction also produces
dione 235 likely through an in situ retro-aldol process, but this material can be recycled
through our route.
CHAPTER 3 — Enantioselective Synthesis of Four Daucane Sesquiterpenes and Related Molecules 728
Scheme 3.22.  Efforts toward "11-carotol (259).
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When considering olefination conditions for the installation of the C(13) carbon,
we were drawn to the work of Kauffmann and co-workers,41 who observed that
methylene(oxo)molybdenum(V) chloride (258)42 preferentially methylenates $- and #-
hydroxyketones.41c  Surprisingly, only the reports by Kauffmann on this molybdenum
alkylidene exist and no synthetic applications with this system have been reported.
Treatment of sterically hindered #-hydroxyketone 257a with complex 258 proceeds in
good yield to generate "11-carotol (259), the dehydro analogue of (–)-carotol (153).
3.3.8 Endgame for Total Syntheses of Daucene, Daucenal, and 14-p-
Anisoyloxydauc-4,8-diene
In addition to these transformations, we investigated conversion of enone 223 to
daucene (142) and related C(14) oxidized natural products (Scheme 3.23A).  Following
our retrosynthetic plan, we attempted to olefinate enone 223 with the standard Wittig
ylide, but unfortunately recovered starting material and observed poor conversion to
triene 260.  Alternatively, methylenation with Lombardo conditions43 generates triene
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260 in moderate yield in conjunction with a number of more polar products.  One of these
polar molecules provided crystals suitable for X-ray analysis and was subsequently
identified as diol 262 (Scheme 3.23B).  Diol 262 likely arises under the reaction
conditions from a titanium-mediated McMurry coupling.44  With triene 260 in hand, we
screened a series of hydrogenation conditions and found that Wilkinson’s catalyst again
preferentially reduces the terminal olefin to afford (–)-daucene (142) in 10 steps and 15%
overall yield.  Over hydrogenation to alkene 261 is also observed, especially with
extended exposure to H2.
Scheme 3.23.  Olefination and hydrogenation steps toward (–)-daucene (142).
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We next examined allylic oxidation of daucene to access C(14) functionalized
sesquiterpenes (Scheme 3.24).  Gratifyingly, the selenium dioxide conditions employed
previously also proved effective in the oxidation of daucene to generate (+)-daucenal
(143) in 8% overall yield over 11 steps.  As mentioned previously, Hashidoko completed
a semi-synthesis of epoxydaucenal A and B (144a and 144b) from daucenal as part of
CHAPTER 3 — Enantioselective Synthesis of Four Daucane Sesquiterpenes and Related Molecules 730
their isolation efforts to confirm the structures of these epoxidized sesquiterpenes.13  By
comparison to our previous route, this formal synthesis of epoxydaucenal B (144b) also
produces the natural product in 12 steps, albeit in much lower overall yield (1%).
Continuing toward our initial goal, Luche reduction of daucenal (143) provides allylic
alcohol 263, which can be treated with base and p-anisoyl chloride to afford (+)-14-p-
anisoyloxydauc-4,8-diene (145) in 13 steps with 4% overall yield.  Given the bioactivity
observed for esters 145 and 146 (Figure 3.1),1a,b we envision that exploration of other
unnatural ester derivatives prepared from alcohol 263 may prove promising in structure-
activity relationship studies and enable the subsequent preparation of more potent
analogues.
Scheme 3.24.  Endgame for (+)-daucenal (143) and (+)-14-p-anisoyloxydauc-4,8-diene (145) and
formal syntheses of epoxydaucenal A and B (144a and 144b).
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3.4 CONCLUDING REMARKS
In summary, we have completed the first catalytic enantioselective total syntheses
of epoxydaucenal B (144b), daucene (142), daucenal (143), and 14-p-anisoyloxydauc-
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4,8-diene (145) in 10–13 steps with 20%, 15%, 8%, and 4% overall yields, respectively.
Our route overcomes the challenge of accessing #-substituted acylcyclopentene 53w by
employing a siloxyenone to effect the Grignard addition and ring opening in a single step.
Subsequent ring-closing metathesis and aldol reactions form the bicyclo[5.3.0]decane
core.  Derivatization of the key intermediate, enone 223, allows access to either the
daucane sesquiterpene or sphenobolane diterpene carbon skeletons, as well as other
oxygenated scaffolds.  Our efforts feature several olefination methods to install the C(13)
carbon, including the underutilized molybdenum alkylidene developed by Kauffmann.
Future directions are focused on biological evaluation of the molecules reported herein
and application of the developed synthetic strategy to other daucane sesquiterpenes and
sphenolobane diterpenes.
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3.5 EXPERIMENTAL SECTION
3.5.1 MATERIALS AND METHODS
Unless otherwise stated, reactions were performed in flame-dried glassware under
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried
by passage through an activated alumina column under argon.45  Methanol (MeOH) was
distilled over Mg and I2 according to the procedure of Lund and Bjerrum.
46  Brine
solutions are saturated aqueous solutions of sodium chloride.  Vinylogous ester 27a was
prepared following the method found in our previous report.7a  Triisopropylsilyl triflate
was distilled immediately before use.  Oxotrischlorobis(tetrahydrofuran)molybdenum(V)
was prepared according to the procedure of McUliffe.42  All other reagents were
purchased from Sigma-Aldrich, Acros Organics, Strem, Alfa Aesar, or TCI America and
used as received unless otherwise stated.  Reaction temperatures were controlled by an
IKAmag temperature modulator.  Microwave-assisted reactions were performed in a
Biotage Initiator 2.5 microwave reactor.  Glove box manipulations were performed under
a N2 atmosphere.  Reaction progress was monitored by thin-layer chromatography (TLC).
TLC was performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm)
and visualized by UV fluorescence quenching, p-anisaldehyde staining, and/or KMnO4
staining.  ICN silica gel (particle size 0.032-0.0653 mm) or Silicycle SiliaFlash P60
Academic silica gel (particle size 0.040-0.063 mm) was used for flash column
chromatography.  1H NMR spectra were recorded on a Varian Inova 500 MHz
spectrometer and are reported relative to residual CHCl3 (% 7.26 ppm) or benzene-d6
(C6D6, %  7.16 ppm).  
13C NMR spectra are recorded on a Varian Inova 500 MHz
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spectrometer (125 MHz) and are reported relative to CDCl3 (% 77.16 ppm) or benzene-d6
(C6D6, % 128.06 ppm).  2D NMR experiments were performed on a Varian Inova 400
MHz or Varian Inova 500 MHz spectrometer and are reported relative to residual solvent.
Data for 1H NMR are reported as follows: chemical shift (% ppm) (multiplicity, coupling
constant (Hz), integration).  Multiplicities are reported as follows: s = singlet, d =
doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, dm = doublet
of multiplets, br = broad (e.g., br s = broad singlet), app = apparent.  Data for 13C are
reported in terms of chemical shifts (% ppm).  IR spectra were obtained by a Perkin Elmer
Spectrum BXII spectrometer using thin films deposited on NaCl plates and reported in
frequency of absorption (cm-1).  High resolution mass spectra (HRMS) were obtained
from the Caltech Mass Spectral Facility (EI+, GC-EI+, FAB+) or on an Agilent 6200
Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI+),
atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-
APCI+).  Optical rotations were measured with a Jasco P-2000 polarimeter operating on
the sodium D-line (589 nm), using a 100 mm path-length cell and are reported as: [$]D
T
(concentration in g/100 mL, solvent, ee).
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3.5.2 Preparative Procedures
3.5.2.1 Procedures Associated with Initial Approach
i. CeCl3,
   THF, 23 °C
ii. 10% aq HCl
70w
34% yield
55w
53% yield
+
27a
O
i-BuO O O
HOMgBr
Cycloheptenone 55w and #-Hydroxyketone 70w.  A flame-dried 250 mL round-bottom
flask equipped with a stir bar was cycled into a glove box where the flask was loaded
with anhydrous cerium chloride (2.66 g, 10.79 mmol, 2.54 equiv).  The flask was
removed from the glove box, connected to an Ar-filled manifold, and charged with THF
(50 mL).  After 24 h of stirring, (3-methylbut-3-en-1-yl)magnesium bromide47 (0.24 M in
THF, 52.85 mL, 12.69 mmol, 2.99 equiv) was added to the flask, causing the slurry to
initially turn yellow and orange over time.  After 3 h, the flask was charged with
additional THF (20 mL), and vinylogous ester 27a (1.00 g, 4.25 mmol, 1.00 equiv) was
transferred from a conical flask to the round-bottom flask using several THF rinses (3 x
10 mL, total added = 106 mL, 0.04 M).  TLC analysis indicated no starting material
remained after 5 min.  After 40 min, the reaction was quenched with HCl (10% w/w aq,
50 mL) and transferred to a separatory funnel where the aqueous layer was extracted five
times with EtOAc.  The combined organics were rinsed with brine, dried over Na2SO4,
filtered, and concentrated under reduced pressure.  The resulting crude oil was purified
by flash column chromatography (SiO2, 28 x 3 cm, 100% hexanes&5%&10%&20%
EtOAc in hexanes) to afford cycloheptenone 55w (473.0 mg, 2.04 mmol, 53% yield) as a
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pale yellow oil and #-hydroxyketone 70w (325.3 mg, 1.30 mmol, 34% yield) as a pale
yellow oil.
Cycloheptenone 55w.  Characterization data matches that previously reported.30
#-hydroxyketone 70w.  Rf = 0.55 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3)
mixture of two diastereomers, see Figure SI-1A; IR (Neat Film NaCl) 3464, 3072, 2965,
2936, 2866, 1694, 1647, 1638, 1452, 1375, 1342, 1299, 1229, 1186, 1110, 1073, 1029,
997, 967, 917, 884, 793 cm-1; HRMS (MM: ESI-APCI+) m/z  calc’d for C16H27O2
[M+H]
+: 251.2006, found 251.2007.
KOt-Bu
THF, 85 °C
µwaves
O
70w 53w
O
HO
49% yield
Acylcyclopentene 53w.  KOt-Bu (269.4 mg, 2.40 mmol, 1.65 equiv) and THF (10 mL,
0.10 M), were added to a flame-dried 20 mL microwave vial with a stir bar.  #-
hydroxyketone 70w (364.9 mg, 1.46 mmol, 1.00 equiv) was transferred to the vial using
benzene (200 µL) and THF (2 x 1 mL).  Another portion of THF (3 mL, total added = 15
mL, 0.10 M) was added to the vial.  The pale yellow solution was subjected to
microwave irradiation in a Biotage Initiator microwave reactor (temperature: 85 °C,
sensitivity: normal).  After 5 min of irradiation, the crimp cap was removed and Na2SO4
was added to the vial.  The reaction contents were transferred to a separatory funnel,
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quenched with HCl (10% w/w aq, 10 mL), and extracted four times with Et2O.  The
combined organics (300 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash
column chromatography (SiO2, 28.5 x 3 cm, 100% pentane&5%&10%&15%&20%
Et2O in pentane) to afford acylcyclopentene 53w (164.3 mg, 0.71 mmol, 49% yield) as a
yellow oil; Rf = 0.75 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) % 5.71 (dddd,
J = 16.8, 10.3, 7.6, 7.0 Hz, 1H), 5.08–5.01 (m, 2H), 4.74 (dq, J = 2.2, 1.1 Hz, 1H), 4.73
(td, J = 1.4, 0.7 Hz, 1H), 2.61–2.52 (m, 3H), 2.33 (tdt, J = 12.2, 5.0, 1.1 Hz, 1H), 2.21 (s,
3H), 2.20–2.04 (m, 4H), 1.88 (ddd, J = 12.9, 7.5, 6.3 Hz, 1H), 1.80 (dd, J = 1.4, 1.0 Hz,
3H), 1.61–1.53 (m, 1H), 1.08 (s, 3H); 13C NMR (125 MHz, CDCl3) % 198.7, 163.5, 146.3,
135.0, 134.9, 117.7, 109.9, 52.6, 43.7, 37.5, 35.0, 31.6, 30.4, 26.6, 24.7, 22.5; IR (Neat
Film NaCl) 3074, 2957, 2929, 2864, 1676, 1648, 1602, 1453, 1373, 1355, 1313, 1273,
1252, 1208, 1113, 995, 960, 913, 885 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for
C16H25O [M+H]
+: 233.1900, found 233.1903; [$]D
25.0 –7.12 (c 1.53, CHCl3, 88% ee).
LiOH, TFE
THF, 60 °C
87% yield
70w 72w
O
HO
O
O
Dione 72w.  #-Hydroxyketone 70w (50.6 mg, 0.20 mmol, 1.00 equiv) was transferred to
a flame-dried 15 mL round-bottom flask equipped with a stir bar and water condenser
using several THF rinses (4 x 1 mL, total = 4 mL, 0.05 M).  TFE (58 µL, 0.81 mmol,
4.00 equiv) and LiOH (14.2 mg, 0.59 mmol, 2.93 equiv) were added, generating a pale
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yellow solution.  The flask was lowered into a preheated oil bath (60 °C) and heated for 2
h.  After cooling to room temperature, the reaction was filtered through a short silica gel
plug (2 x 10 cm) rinsing with Et2O.  The combined organics were concentrated under
reduced pressure at 0 °C (ice/water) and purified by flash column chromatography (SiO2,
25 x 2 cm, 100% pentane&2%&5%&10%&15% Et2O in pentane) to afford dione 72w
(44.1 mg, 0.81 mmol, 87% yield) as a yellow oil; Rf = 0.56 (30% EtOAc in hexanes); 
1H
NMR (500 MHz, CDCl3) % 5.68–5.59 (m, 1H), 5.06–5.01 (m, 2H), 4.72 (dqt, J = 2.2, 1.5,
0.8 Hz, 1H), 4.67 (qq, J = 1.3, 0.8 Hz, 1H), 2.61–2.57 (m, 2H), 2.40 (dd, J = 7.3, 6.0 Hz,
2H), 2.33 (ddt, J = 14.0, 7.2, 1.2 Hz, 1H), 2.24 (t, J = 7.9 Hz, 2H), 2.21 (ddt, J = 14.0, 7.5,
1.2 Hz, 1H), 2.12 (s, 3H), 1.74 (dd, J = 1.4, 0.8 Hz, 3H), 1.63–1.54 (m, 1H), 1.52–1.33
(m, 3H), 1.13 (s, 3H); 13C NMR (125 MHz, CDCl3) % 214.2, 208.6, 145.2, 133.9, 118.3,
110.2, 51.1, 44.0, 42.6, 37.4, 36.1, 31.5, 30.1, 22.9, 21.1, 18.7; IR (Neat Film NaCl)
3076, 2968, 2935, 1717, 1703, 1648, 1640, 1458, 1437, 1410, 1358, 1271, 1229, 1174,
1076, 996, 917, 889, 725 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H27O2
[M+H]
+: 251.2006, found 251.2006; [$]D
25.0 6.64 (c 0.96, CHCl3, 88% ee).
3.5.2.2 Siloxyenone Efforts Toward Acyclic Dione 72w
TIPSO
O
232
O
O
65
i. NaH, THF, 23 °C
ii. TIPSOTf, –78!23 °C
57% yield
Siloxyenone 232.  A flame-dried 50 mL round-bottom flask equipped with a stir bar was
cycled into a glove box where the flask was loaded with sodium hydride (148.3 mg, 3.71
mmol, 1.06 equiv).  The flask was removed from the glove box, connected to an Ar-filled
manifold, and charged with THF (13 mL).  Dione 65 (442.4 mg, 3.51 mmol, 1.00 equiv)
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was transferred to the flask using several THF rinses (3 x 3 mL, total added = 22 mL,
0.16 M).  The addition caused the reaction mixture to bubble vigorously and develop into
an orange slurry.  After 30 min, the flask was lowered into a –78 °C bath and TIPSOTf
(990 µL, 3.68 mmol, 1.05 equiv) was added dropwise over several minutes.  TLC
analysis indicated no starting material remained after 1.5 h.  Consequently, the reaction
was transferred to a separatory funnel containing sat. aq NaHCO3 and Et2O and the
aqueous layer was extracted three times with Et2O.  The combined organics (150 mL)
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash column chromatography (SiO2, 25.5 x 5 cm, 100%
hexanes&5%&10% EtOAc in hexanes) to afford siloxyenone 232 (561.1 mg, 1.99
mmol, 57% yield) as an orange oil.  Characterization data matches that reported
previously by Corey et al.48
TIPSO
O
232
O
O
65
Et3N, TIPSCl
CH3CN, –78!0 °C
88% yield
Siloxyenone 232.  A flame-dried 50 mL round-bottom flask equipped with a stir bar and
dione 65 (1.00 g, 7.93 mmol, 1.00 equiv) was charged with CH3CN (79 mL, 0.10 M) and
Et3N (1.16 mL, 8.32 mmol, 1.05 equiv) and lowered into a –78 °C bath (dry ice/acetone).
TIPSCl (1.87 mL, 8.74 mmol, 1.10 equiv) was added dropwise over 10 min and the
reaction was moved to a 0 °C bath (ice/water).  TLC analysis indicated no starting
material remained after 2.5 h.  Consequently, the reaction was quenched with sat. aq
NaHCO3 (10 mL) and transferred to a separatory funnel where the aqueous layer was
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extracted three times with pentane.  The combined organics (250 mL) were dried over
MgSO4, filtered, and concentrated under reduced pressure.  
1H NMR analysis indicated
that the resulting crude oil was sufficiently pure, affording siloxyenone 232 (1.96 g, 6.94
mmol, 88% yield) as an orange oil.  Characterization data matches that reported
previously by Corey et al.48
O
i-BuO
O
O
10% aq HCl
THF, 23 °C
95% yield
7927a
Dione 79.  The following procedure affords a higher yield than our previous report.7b  A
flame-dried 50 mL round-bottom flask equipped with a stir bar was charged with
vinylogous ester 27a (1.83 g, 7.73 mmol, 1.00 equiv), THF (12.5 mL, 0.6 M), and
hydrochloric acid (10% w/w aq = 2.87 M, 12.5 mL, 35.9 mmol, 4.64 equiv).  The
reaction mixture was initially a cloudy suspension that became a colorless solution over
time.  TLC analysis indicated no starting material remained after 4.5 h.  Consequently,
the reaction was transferred to a separatory funnel, diluted with water, and extracted six
times with CH2Cl2.  The combined organics (150 mL) were dried over MgSO4, filtered,
and concentrated under reduced pressure.  The resulting crude oil was purified by flash
column chromatography (SiO2, 27 x 3 cm, 100% hexanes&15% EtOAc in hexanes) to
afford dione 79 (1.33 g, 7.37 mmol, 95% yield) as a yellow oil.  Characterization data
matches that previously reported.7b
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O
TIPSO
O
O
TIPSO
O
i. NaH, THF, 23 °C
ii. TIPSOTf, –78!23 °C
iii. sat. aq NaHCO3
+
79 230a
75% yield based
on recovered 79
230b
23% yield based
on recovered 79
86% yield
3:1 regioselectivity
12% recovered 79
Siloxyenones 230a and 230b.  A flame-dried 50 mL round-bottom flask equipped with a
stir bar was cycled into a glove box where the flask was loaded with NaH (80.9 mg, 3.20
mmol, 1.05 equiv).  The flask was removed from the glove box, connected to an Ar-filled
manifold, and charged with THF (9 mL).  Dione 79 (547.3 mg, 3.04 mmol, 1.00 equiv)
was transferred via cannula from a scintillation vial to the round-bottom flask using
several THF rinses (1 x 5 mL + 5 x 1 mL, total added = 19 mL, 0.16 M).  The reaction
was stirred at room temperature for 30 min before the flask was lowered into a –78 °C
bath (dry ice/acetone) and TIPSOTf (850 µL, 3.16 mmol, 1.04 equiv) was added
dropwise over 20 min.  After the addition was complete, the bath was removed and the
reaction was allowed to warm to room temperature.  After 13 h of stirring, the reaction
was poured into a separatory funnel containing Et2O (20 mL), sat. aq NaHCO3 (20 mL),
and water (10 mL).  The aqueous layer was extracted once with Et2O and four times with
CH2Cl2.  The combined organics were dried over MgSO4, filtered, and concentrated
under reduced pressure.  The resulting crude oil was purified by flash column
chromatography (SiO2, 26 x 3 cm, 100% hexanes&2%&15% EtOAc in hexanes) to
afford siloxyenone 230a (669.9 mg, 1.99 mmol, 66% yield, 75% yield based on
recovered dione 79) as a yellow oil, a mixed fraction of siloxyenone 230b with dione 79
(206.5 mg total, 50:1 = 230b:79, siloxyenone 230b: 204.3 mg, 0.6069 mmol, 20% yield,
23% yield based on recovered dione 79) as a yellow oil, and recovered dione 79 (66.0
mg, 0.366 mmol, 12% recovered) as a yellow oil.
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Siloxyenone 230a.  Rf = 0.76 (30% EtOAc in hexanes); 
1H NMR (500 MHz, C6D6) %
5.87–5.74 (m, 1H), 5.78 (s, 1H), 5.06–5.00 (m, 2H), 2.51 (ddt, J = 13.5, 7.1, 1.3 Hz, 1H),
2.25 (ddt, J = 13.5, 7.7, 1.1 Hz, 1H), 2.21–2.16 (m, 2H), 1.67–1.59 (m, 1H), 1.44–1.37
(m, 2H), 1.34–1.28 (m, 1H), 1.20 (s, 3H), 1.13–1.00 (m, 21H); 13C NMR (125 MHz,
C6D6) % 204.3, 167.5, 135.1, 117.8, 113.9, 51.8, 46.0, 38.2, 35.1, 25.4, 19.98, 18.1, 18.1,
12.9; IR (Neat Film NaCl) 3075, 2944, 2893, 2867, 1700, 1613, 1464, 1419, 1385, 1301,
1249, 1204, 1137, 1109, 1070, 1016, 996, 917, 883, 823, 782, 741 cm-1; HRMS (MM:
ESI-APCI+) m/z calc’d for C20H37O2Si [M+H]
+: 337.2557, found 337.2566; [$]D
25.0
–60.52 (c 1.01, CHCl3, 88% ee).
Siloxyenone 230b.  Rf = 0.64 (30% EtOAc in hexanes); 
1H NMR (500 MHz, C6D6) %
5.72 (s, 1H), 5.78–5.65 (m, 1H), 5.06–4.98 (m, 2H), 2.54 (ddt, J = 13.6, 6.5, 1.5 Hz, 1H),
2.49 (dm, J = 18.0 Hz, 1H), 2.42 (ddd, J = 17.9, 9.4, 5.1 Hz, 1H), 2.05 (ddt, J = 13.6, 8.1,
1.1 Hz, 1H), 1.62 (ddd, J = 14.4, 9.9, 1.4 Hz, 1H), 1.44 (dtdd, J = 14.6, 9.8, 4.7, 1.4 Hz,
1H), 1.41–1.30 (m, 1H), 1.26 (ddt, J = 14.4, 9.0, 1.2 Hz, 1H), 1.19–1.06 (m, 3H), 1.11 (s,
3H), 1.04 (d, J = 3.1 Hz, 9H), 1.02 (d, J = 3.0 Hz, 9H); 13C NMR (125 MHz, C6D6) %
199.3, 172.1, 134.6, 118.1, 113.9, 46.3, 45.3, 44.5, 37.0, 25.9, 18.3, 18.3, 17.9, 13.1; IR
(Neat Film NaCl) 2944, 2892, 2867, 1636, 1592, 1464, 1378, 1351, 1283, 1249, 1207,
1170, 1071, 1016, 996, 917, 883, 855, 782 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for
C20H37O2Si [M+H]
+: 337.2557, found 337.2559; [$]D
25.0 –46.35 (c 1.35, CHCl3, 88% ee).
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O
O
79
Et3N, TIPSCl
 
CH3CN, –42!23 °C
50% yield
1:1.5 regioselectivity
TIPSO
O
230a
20% yield
O
TIPSO
230b
30% yield
+
Siloxyenones 230a and 230b.  A flame-dried 15 mL round-bottom flask equipped with a
stir bar was charged with dione 79 (50.5 mg, 0.280 mmol, 1.00 equiv) and CH3CN (2.8
mL, 0.1 M) and lowered into a –42 °C (dry ice/CH3CN).  Et3N (40 µL, 0.287 mmol, 1.02
equiv) and TIPSCl (70 µL, 0.327 mmol, 1.17 equiv) were added dropwise to the reaction
and the bath was allowed to expire over time.  After 2 h, the reaction was quenched with
water (5 mL) and transferred to a separatory funnel where the aqueous layer was
extracted six times with hexanes.  The combined organics (100 mL) were dried over
Na2SO4, filtered, and concentrated under reduced pressure.  The resulting crude oil was
purified by flash column chromatography (SiO2, 27 x 1.5 cm, 100% hexanes&2%&15%
EtOAc in hexanes) to afford siloxyenone 230a (19.2 mg, 0.0570 mmol, 20% yield) as a
yellow oil and a mixed fraction of siloxyenone 230b with dione 79 (31.0 mg total, 5.6:1 =
230b:79, siloxyenone 230b: 28.3 mg, 0.0840 mmol, 30% yield) as a yellow oil.  (For
characterization of siloxyenones 230a and 230b, see p. 739).
O
O
O
O
TIPSO
O
TBAF (1 M in THF)
23 °C
79 79230b
+
99% yield
Dione 79.  To a scintillation vial containing a mixed fraction of siloxyenone 230b (262.6
mg, 0.780 mmol, 1.00 equiv) and dione 79 (12.0 mg, 0.0666 mmol) was added a stir bar
and TBAF (1.0 M in THF, 2 mL, 2.00 mmol, 2.56 equiv).  After 4 h, no siloxyenone
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230b was observed by TLC.  Consequently, the reaction was quenched with water (10
mL) and transferred to a separatory funnel where the aqueous layer was extracted six
times with CH2Cl2.  The combined organics (75 mL) were dried over MgSO4, filtered,
and concentrated under reduced pressure.  The resulting crude oil was purified by flash
column chromatography (SiO2, 27.5 x 5 cm, 100% hexanes&5%&15% EtOAc in
hexanes) to afford dione 79 (151.7 mg, 0.842 mmol, 99% yield) as a yellow oil.
Characterization data matches that previously reported.7b
i. CeCl3,
   THF, 23 °C
ii. sodium phosphate 
    buffer (pH 6.5)
iii. TBAF, LiOH, TFE, THF, 23 °C
230a
O
TIPSO
77% yield
72w
O
O
MgBr
Dione 72w.  A flame-dried 50 mL round-bottom flask equipped with a stir bar was
cycled into a glove box where the flask was loaded with anhydrous cerium chloride
(589.5 mg, 2.39 mmol, 2.50 equiv).  The flask was removed from the glove box,
connected to an Ar-filled manifold, placed under full vacuum, and lowered into an oil
bath set to 140 °C.  After 12.5 h, the flask was removed from the bath, allowed to cool to
room temperature, and charged with THF (12 mL).  After 3 h of stirring, (3-methylbut-3-
en-1-yl)magnesium bromide47 (0.59 M in THF, 4.86 mL, 2.87 mmol, 3.00 equiv) was
added and the slurry initially turned yellow and then orange over time.  After 40 min,
siloxyenone 230a  (321.8 mg, 0.956 mmol, 1.00 equiv) was transferred from a
scintillation vial to the round-bottom flask using several THF rinses (1 x 6 mL + 3 x 2
mL, total added = 24 mL, 0.04 M).  TLC analysis indicated no starting material remained
after 10 min.  Consequently, the reaction was quenched with sodium phosphate buffer
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(20 mM, pH 6.5, 20 mL) and transferred to a separatory funnel where the aqueous layer
was extracted four times with Et2O.  The combined organics (150 mL) were dried over
MgSO4, filtered, and concentrated under reduced pressure.  The resulting crude oil was
transferred to a scintillation vial equipped with a stir bar and backfilled with Ar.  The vial
was charged with TBAF (1.0 M in THF, 1.43 mL, 1.43 mmol, 1.50 equiv), TFE (210 µL,
2.88 mmol, 3.01 equiv), and LiOH (34.4 mg, 1.44 mmol, 1.50 equiv).  After 4 h, the
reaction was quenched with water (10 mL) and transferred to a separatory funnel where
the aqueous phase was extracted four times with Et2O.  The combined organics were
dried over MgSO4, filtered, and concentrated under reduced pressure at 0 °C (ice/water).
The resulting crude oil was purified twice by flash column chromatography (SiO2, 27.5 x
2 cm, 100% hexanes&5%&10% TBME in hexanes then SiO2, 28 x 2 cm, 100%
hexanes&2%&5%&20% TBME in hexanes) to afford dione 72w (185.0 mg, 0.739
mmol, 77% yield) as a pale yellow oil.  (For characterization data, see p. 734).
i. CeCl3,
   THF, 23 °C
ii. sodium phosphate 
    buffer (pH 6.5)
iii. CsF, LiOH, THF, 23 °C
230a
O
TIPSO
70% yield
72w
O
O
MgBr
Dione 72w.  A flame-dried 15 mL round-bottom flask equipped with a stir bar was
cycled into a glove box where the flask was loaded with anhydrous cerium chloride
(141.7 mg, 0.575 mmol, 2.50 equiv).  The flask was removed from the glove box,
connected to an Ar-filled manifold, placed under full vacuum, and lowered into an oil
bath set to 140 °C.  After 12 h, the flask was removed from the bath, allowed to cool to
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room temperature, and charged with THF (1.7 mL).  After 2 h of stirring, (3-methylbut-3-
en-1-yl)magnesium bromide47 (0.59 M in THF, 1.17 mL, 0.690 mmol, 3.01 equiv) was
added and the slurry initially turned yellow and then orange over time.  After 30 min,
siloxyenone 230a (77.3 mg, 0.230 mmol, 1.00 equiv) was transferred from a scintillation
vial to the round-bottom flask using several THF rinses (1 x 2 mL + 2 x 1 mL, total
added = 5.7 mL, 0.04 M).  TLC analysis indicated no starting material remained after 5
min.  Consequently, the reaction was quenched with sodium phosphate buffer (20 mM,
pH 6.5, 5 mL) and transferred to a separatory funnel where the aqueous layer was
extracted four times with Et2O.  The combined organics (75 mL) were dried over MgSO4,
filtered, and concentrated under reduced pressure.
A separate flame-dried 10 mL round-bottom flask equipped with a stir bar was
loaded with CsF (145.2 mg, 0.956 mmol, 4.16 equiv) and flame-dried again.  Upon
cooling, the crude oil from the previous step was transferred to the flask using several
THF rinses (3 x 1 mL, total added = 3 mL, 0.08 M).  As the reaction failed to progress by
TLC analysis after 1 h, LiOH (18.5 mg, 0.772 mmol, 3.36 equiv) was added.  TLC
analysis indicated the desired product was mainly present after an additional 13 h.
Consequently, the reaction was quenched with water (10 mL) and transferred to a
separatory funnel where the aqueous phase was extracted four times with Et2O.  The
combined organics (75 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash
column chromatography (SiO2, 28 x 1.5 cm, 100% hexanes&2%&5%&10% TBME in
hexanes) to afford dione 72w (40.4 mg, 0.161 mmol, 70% yield) as a pale yellow oil.
(For characterization data, see p. 734).
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3.5.2.3 Routes to Key Intermediate Enone 53w
KOH in EtOH (3M)
EtOH, 23 °C
41% yield
O
53w72w
O
O
Enone 53w.  A scintillation vial equipped with a stir bar and dione 72w (40.4 mg, 0.161
mmol, 1.00 equiv) was charged with EtOH (950 µL, 0.17 M) and KOH solution (3 M in
EtOH, 140 µL, 0.420 mmol, 2.60 equiv).  The resulting yellow solution was stirred
vigorously.  Over the course of the reaction, an additional portion of the KOH solution (2
d = 140 µL, 3 d = 280 µL, 4 d = 1.4 mL, 5 d = 5.0 mL, total added = 7.66 mL, 23.0
mmol, 142 equiv) was added.  After 6 days, the reaction was quenched with water (10
mL) and transferred to a separatory funnel where the aqueous layer was extracted four
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure at 0 °C (ice/water).  The resulting crude oil was
purified by flash column chromatography (SiO2, 28 x 1.5 cm, 100% hexanes&2%&5%
EtOAc in hexanes) to afford enone 53w (15.3 mg, 0.0660 mmol, 41% yield) as a yellow
oil. (For characterization data, see p. 733).
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O
53w 223
O
Grubbs–Hoveyda
2nd generation (5 mol %)
CH2Cl2, 35 °C
81% yield
Ru
O
Cl
Cl
NN
112
Enone 223.  A flame-dried 25 mL round-bottom flask equipped with a stir bar and water
condenser was charged with acylcyclopentene 53w (1.0 M in benzene, 100 µL, 0.100
mmol, 1.00 equiv), CH2Cl2 (20 mL, 0.005 M, 30 min Ar sparge before use), and
Grubbs–Hoveyda 2nd generation catalyst (112, 3.2 mg, 0.00511 mmol, 5 mol %),
generating a pale green solution.  The flask was lowered into a preheated oil bath (35 °C)
and stirred for 5 h before the reaction was cooled to room temperature and quenched with
ethyl vinyl ether.  The reaction was filtered through a short silica gel plug rinsing with
Et2O and concentrated under reduced pressure.  The resulting crude oil was purified by
flash column chromatography (SiO2, 21.5 x 1.3 cm, 100% hexanes&2% Et2O in pentane)
to afford enone 223 (16.5 mg, 0.081 mmol, 81% yield) as a yellow oil.  Spectral data for
enone 223 matches that previously reported by Urones36: Rf = 0.73 (30% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) % 5.36 (ddt, J = 7.9, 6.7, 1.4 Hz, 1H), 3.21 (dt, J =
11.1, 5.9 Hz, 1H), 2.66–2.56 (m, 1H), 2.50 (ddd, J = 15.3, 8.7, 2.8 Hz, 1H), 2.29–2.16
(m, 1H), 2.21 (s, 3H), 2.17–2.11 (m, 3H), 2.02 (ddd, J = 14.4, 6.6, 1.2 Hz, 1H), 1.75–1.69
(m, 1H), 1.69 (d, J = 1.4 Hz, 3H), 1.64 (ddd, J = 12.3, 7.7, 2.8 Hz, 1H), 0.99 (s, 3H); 13C
NMR (125 MHz, CDCl3) % 199.5, 165.0, 139.4, 133.4, 121.1, 52.7, 37.8, 37.3, 33.2, 30.8,
30.4, 26.1, 24.2, 23.7; IR (Neat Film NaCl) 2926, 2852, 1675, 1653, 1612, 1437, 1356,
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1301, 1262, 1204, 945, 825 cm-1; HRMS (EI+) m/z calc’d for C14H20O [M+•]
+: 204.1514,
found 204.1530; [$]D
25.0 –146.03 (c 0.98, CHCl3, 88% ee).
72w 235
O
O
O
O
Grubbs–Hoveyda
2nd generation (5 mol %)
CH2Cl2, 35 °C
99% yield
Ru
O
Cl
Cl
NN
21
Dione 235.  To a flame-dried 250 mL Schlenk flask equipped with a stir bar and water
condenser was added dione 72w (422.6 mg, 1.69 mmol, 1.00 equiv) via several CH2Cl2
rinses (5 x 6 mL, 30 min Ar sparge before use).  The flask was charged with additional
CH2Cl2 (130 mL) and Hoveyda–Grubbs 2
nd generation catalyst (21, 53.0 mg, 0.0846
mmol, 5.0 mol %), generating a pale green solution.  The flask was rinsed with CH2Cl2
(10 mL, total added = 170 mL, 0.01 M) and lowered into a preheated oil bath (35 °C).
After 22 h, the reaction was quenched with ethyl vinyl ether (3 mL), removed from the
oil bath, and allowed to cool to room temperature.  The reaction contents were filtered
through a short silica gel plug, rinsing with TBME, and concentrated under reduced
pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash column
chromatography (SiO2, 27.5 x 2 cm, 100% hexanes&5%&10%&15%&20%&30%
TBME in hexanes) to afford dione 235 (370.5 mg, 1.67 mmol, 99% yield) as a yellow oil.
Spectral data for dione 235 matches that previously reported by Urones36a: Rf = 0.39 (30%
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) % 5.45 (dddd, J = 7.7, 6.2, 3.0, 1.5 Hz,
1H), 2.88 (ddd, J = 11.5, 9.5, 5.7 Hz, 1H), 2.59 (ddd, J = 11.5, 6.9, 5.4 Hz, 1H), 2.43
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(dddd, J = 15.2, 6.1, 2.7, 1.3 Hz, 1H), 2.38 (t, J = 6.9 Hz, 2H), 2.34–2.20 (m, 2H), 2.11 (s,
3H), 2.08 (ddq, J = 15.4, 7.3, 1.0 Hz, 1H), 1.66 (q, J = 1.1 Hz, 3H), 1.56–1.38 (m, 4H),
1.05 (s, 3H); 13C NMR (125 MHz, CDCl3) % 217.0, 208.8, 137.0, 121.5, 53.8, 44.2, 38.0,
37.9, 34.7, 32.1, 30.1, 25.4, 22.4, 18.7; IR (Neat Film NaCl) 2963, 2931, 1714, 1705,
1436, 1360, 1314, 1215, 1173, 1123, 1071, 1011, 894, 826 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C14H23O2 [M+H]
+: 223.1693, found 223.1696; [$]D
25.0 52.49 (c
0.93, CHCl3, 88% ee).
223235
KOH/EtOH (3M)
EtOH, 23 °C
88% yield
O
O
O
Enone 223.  Procedure adapted from report by Urones.36a  A flame-dried 25 mL round-
bottom flask equipped with a stir bar was charged with dione 235 (255.6 mg, 1.15 mmol,
1.00 equiv), EtOH (6.74 mL, 0.17 M), and KOH solution (3 M in EtOH, 1.02 mL, 3.06
mmol, 2.66 equiv), generating a yellow solution that transitioned to orange over time.
After 9 h, an additional portion of KOH (3 M in EtOH, 0.90 mL, total added = 1.92 mL,
5.76 mmol, 5.01 equiv) was added.  After 22 h, no starting material remained by TLC.
Consequently, the reaction was diluted with water (15 mL) and transferred to a separatory
funnel where the aqueous phase was extracted four times with Et2O.  The combined
organics (100 mL) were rinsed with HCl (0.5 M, 15 mL) and water (15 mL), dried over
MgSO4, filtered, and concentrated under reduced pressure at 0 °C (ice/water).  The
resulting crude oil was purified by flash column chromatography (SiO2, 26 x 2 cm, 100%
hexanes&5% TBME in hexanes) to afford enone 223 (205.6 mg, 1.01 mmol, 88% yield)
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as a yellow oil.  Spectral data for enone 223 matches that previously reported by
Urones.36a  (For characterization data, see p. 745).
3.5.2.4 Routes to Reincorporate Cycloheptenone 55w into Synthetic Efforts
LiOH
H2O2 (30% aq)
MeOH, 23 °C
O O
HO
O
55w
O
249
lithium
naphthalenide
THF, –78 °C
70w
44% yield
2 steps
62% yield 71% yield
Epoxide 249.  Procedure adapted from report by Stoltz.7a  To a scintillation vial
containing a stir bar and cycloheptenone 55w (216.6 mg, 0.932 mmol, 1.00 equiv) was
added MeOH (3.6 mL), LiOH (56.1 mg, 2.34 mmol, 2.51 equiv), H2O2 (30% w/w aq, 950
µL, 9.30 mmol, 9.98 equiv), and additional MeOH (1.0 mL, total added = 4.6 mL, 0.2
M).  During the course of the reaction, additional LiOH (7 h = 56.5 mg, 22 h = 55.8 mg,
31 h = 56.0 mg, 95.5 h = 55.9 mg, 142 h = 56.2 mg, total added = 336.5 mg, 14.0 mmol,
15.0 equiv) and H2O2 (950 µL more at 7 h, 22 h, 31 h, 71.5 h, 142 h, 151 h, total added =
7.6 mL, 74.4 mmol, 80 equiv) were added to the flask.  The solvent level decreased over
time and so more MeOH (47.5 h = 3 mL, 71.5 h = 2 mL, 77.5 h = 3 mL) was added when
appropriate.  After 10 days, TLC analysis indicated minor starting material remaining.
Consequently, the reaction was diluted with CH2Cl2 (10 mL) and water (20 mL),
quenched with sat. NaHCO3 solution (10 mL), and transferred to a separatory funnel
where the aqueous layer was extracted six times with CH2Cl2.  The combined organics
(125 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.
The resulting crude oil was purified by flash column chromatography (SiO2, 28 x 2 cm,
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100% hexanes&2%&5%&10%&20% EtOAc in hexanes) to afford recovered
cycloheptenone 55w (22.1 mg, 0.0951 mmol, 10% recovered) and epoxide 249 (142.8
mg, 0.575 mmol, 62% yield, 69% yield based on recovered cycloheptenone 55w) as a
cloudy yellow oil; Rf = 0.75 (30% EtOAc in hexanes); 
1H NMR (500 MHz, C6D6)
mixture of two diastereomers, see Figure SI-2A; IR (Neat Film NaCl) 3075, 2970, 2936,
1703, 1649, 1639, 1457, 1395, 1376, 1339, 1291, 1261, 1206, 1169, 1121, 996, 919, 890,
848 cm-1; HRMS (FAB+) m/z calc’d for C16H25O2 [M+H]
+: 249.1855, found 249.1851.
#-Hydroxyketone 70w.  Procedure adapted from report by Liu.49  A flame-dried 25 mL
round-bottom flask equipped with a stir bar was loaded with epoxide 249 (50.0 mg, 0.201
mmol, 1.00 equiv) and THF (5.8 mL, 0.10 M) and lowered into a –78 °C bath (dry
ice/acetone).  A lithium naphthalenide solution50 (1.0 M in THF, 3.6 mL, 3.60 mmol, 6.26
equiv) was added dropwise to the flask, generating a dark green solution.  During the
course of the reaction, an additional portion of lithium naphthalenide (1.0 M in THF, 1 h
= 1.0 mL, 5 h = 2.0 mL, 2.5 h = 0.58 mL, total added = 6.60 mL, 6.60 mmol, 11.5 equiv)
was added.  After 9 h, the reaction was quenched with water (10 mL), diluted with
EtOAc, and stirred for 12 h.  The reaction contents were transferred to a separatory
funnel where the aqueous layer was extracted four times with CH2Cl2.  The combined
organics (125 mL) were dried over MgSO4, filtered, and concentrated under reduced
pressure.  The resulting crude oil was purified twice by flash column chromatography
(SiO2, 27.5 x 2 cm, 100% hexanes&5%&10%&20% EtOAc in hexanes then SiO2, 27.5
x 2 cm, 100% hexanes&2%&5%&10%&15% EtOAc in hexanes) to afford #-
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hydroxyketone 70w  (102.6 mg, 0.410 mmol, 71% yield) as a yellow oil.  (For
characterization data, see p. 733).
O
LiOH
H2O2 (30% aq)
MeOH, 23 °C
84% yield
O
O
111w 250
O
235
lithium
naphthalenide
THF, –78 °C
52% yield
O
Epoxide 250.  A flame-dried 25 round-bottom flask equipped with a stir bar was charged
with enone 111w (110.3 mg, 0.540 mmol, 1.00 equiv), MeOH (4.8 mL, 0.11 M), LiOH
(32.4 mg, 1.35 mmol, 2.50 equiv), and H2O2 (30% w/w aq, 550 µL, 5.38 mmol, 10.0
equiv).  After 30.5 h, no starting material remained by TLC analysis.  Consequently, the
reaction was quenched with sat. aq NaHCO3 (10 mL) and water (10 mL) and was
transferred to a separatory funnel where the aqueous layer was extracted five times with
CH2Cl2.  The combined organics were dried over MgSO4, filtered, and concentrated
under reduced pressure.  The resulting crude oil was purified by flash column
chromatography (SiO2, 28 x 1.5 cm, 100% hexanes&2%&5%&20% EtOAc in hexanes)
to afford epoxide 250 (99.5 mg, 0.452 mmol, 84% yield) as a yellow oil that solidified
upon freezing; Rf = 0.68 (30% EtOAc in hexanes); 
1H NMR (500 MHz, C6D6) % 5.20
(ddt, J = 8.6, 5.1, 1.8 Hz, 1H), 3.18 (d, J = 1.3 Hz, 1H), 2.45 (td, J = 11.5, 5.3 Hz, 1H),
2.24–2.14 (m, 1H), 2.07 (ddd, J = 13.3, 12.4, 2.9 Hz, 1H), 2.00–1.89 (m, 1H), 1.82 (ddt, J
= 14.9, 4.9, 1.8 Hz, 1H), 1.68 (ddd, J = 15.7, 5.6, 2.9 Hz, 1H), 1.67–1.58 (m, 1H), 1.56
(q, J = 1.4 Hz, 3H), 1.46 (dd, J = 14.8, 8.6 Hz, 1H), 1.29–1.20 (m, 1H), 1.13–1.04 (m,
2H), 0.97 (s, 3H), 0.78 (ddd, J = 13.3, 5.5, 3.2 Hz, 1H); 13C NMR (125 MHz, C6D6) %
207.8, 138.0, 121.7, 72.0, 67.5, 40.6, 40.6, 40.1, 36.3, 33.8, 31.2, 26.1, 25.7, 18.1; IR
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(Neat Film NaCl) 2961, 2928, 2843, 1698, 1452, 1437, 1330, 1270, 841 cm-1; HRMS
(EI+) m/z calc’d for C14H20O2 [M+•]
+: 220.1463, found 220.1496; [$]D
25.0 –78.43 (c 1.06,
CHCl3, 88% ee).
Dione 235.  To a 15 mL round-bottom flask equipped with a stir bar was loaded with
epoxide 250 (35.6 mg, 0.162 mmol, 1.00 equiv) and THF (1.6 mL, 0.10 M) and lowered
into a –78 °C bath (dry ice/acetone).  A lithium naphthalenide solution50 (1.0 M in THF,
680 µL, 0.680 mmol, 4.2 equiv) was added dropwise to the flask, generating a dark green
solution.  After 1.5 h, the reaction was quenched with water (5 mL), allowed to warm to
room temperature, and transferred to a separatory funnel where the aqueous layer was
extracted six times with CH2Cl2.  The combined organics (75 mL) were dried over
MgSO4, filtered, and concentrated under reduced pressure.  The resulting crude oil was
purified twice by flash column chromatography (SiO2, 29 x 1.5 cm, 100%
hexanes&5%&10%&15%&20%&50% EtOAc in hexanes then SiO2, 25.5 x 1.5 cm,
100% hexanes&10%&15% EtOAc in hexanes) to afford enone 235 (18.7 mg, 0.0842
mmol, 52% yield) as a yellow oil.  (For characterization data, see p. 746).
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Table 3.1.  Samarium diiodide reduction of epoxide 250.
O
O
SmI2, t-BuOH
additive
THF, –78 °C
then work-up O
HO
251
entry additive 251
yield (%)b
1 – 75c
2 HMPA 90d
3 76
O
111w
+
111w
–
8
–
a Conditions: epoxide 250 (1.0 equiv), SmI2 (1.8–2.1 equiv.), t-BuOH 
(1.1–1.4 equiv.), and additive in THF (0.1 M) at –78 °C. b Isolated 
yield. c 95% purity. d 86% purity. e Observed, but not isolated.
4 92 –e
250
work-up
sat. aq. NH4Cl
sat. aq. NH4Cl
sat. aq. NH4Cl
H2O
LiCl
LiCl
equiv.
–
5.7
7.1
8.6
Samarium Diiodide Reduction Screen on Epoxide 250.  A series of samarium diiodide
conditions were investigated in the reduction of epoxide 250.  A general procedure is
provided below and related reactions were performed analogously with appropriate
changes in additive and work-up conditions.
#-Hydroxyketone 251  (LiCl Additive and H2O quench: Table 3.1, entry 4).  A flame-
dried 10 mL round-bottom flask equipped with a stir bar was cycled into a glove box
where the flask was loaded with lithium chloride (52.6 mg, 1.24 mmol, 8.57 equiv).  The
flask was removed from the glove box and connected to an Ar-filled manifold.  Epoxide
250 (31.9 mg, 0.145 mmol, 1.00 equiv) was transferred to the flask using several THF
rinses (30 min Ar sparge before use, 3 x 0.5 mL, total added = 1.5 mL), t-BuOH (20 µL,
0.209 mmol, 1.44 equiv) was added, and the flask was lowered into a –78 °C bath (dry
ice/acetone).  A samarium diiodide solution51 (0.1 M in THF, 3.04 mL, 0.304 mmol, 2.10
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equiv) was added dropwise over 5 min down the side of the flask, generating a dark blue
solution.  TLC analysis indicated that no starting material remained after 5 min.  After an
additional 5 min, the reaction was quenched with water (2 mL), allowed to warm to room
temperature, and transferred to a separatory funnel where the aqueous layer was extracted
four times with EtOAc.  The combined organics were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The resulting crude oil was purified by flash
column chromatography (SiO2, 25 x 1.5 cm, 100% hexanes&20% EtOAc in hexanes) to
afford #-hydroxyketone 251 (29.7 mg, 0.133 mmol, 92% yield) as a yellow oil that
solidified upon freezing; Rf = 0.26 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3)
% 5.38 (tdd, J = 6.2, 2.6, 1.4 Hz, 1H), 3.10 (br s, 1H), 2.67 (br m, 1H), 2.43–2.32 (m, 2H),
2.20 (br m, 1H), 2.13 (br m, 1H), 2.04 (br m, 1H), 1.90 (dd, J = 15.4, 10.7 Hz, 1H),
1.84–1.76 (m, 2H), 1.73 (d, J = 1.3 Hz, 3H), 1.77–1.67 (m, 2H), 1.62 (br s, 1H), 1.57 (dd,
J = 14.3, 10.5 Hz, 1H), 1.47 (ddd, J = 13.8, 8.9, 1.8 Hz, 1H), 1.00 (s, 3H); 13C NMR (125
MHz, CDCl3) % 213.0, 140.0, 122.5, 77.3, 54.2, 43.1, 42.4, 40.1, 38.3, 36.4, 28.0, 25.4,
23.0, 18.2; IR (Neat Film NaCl) 3510, 2958, 2926, 2859, 1692, 1445, 1402, 1284, 1023,
903, 851, 828 cm-1; HRMS (EI+) m/z calc’d for C14H22O2 [M+•]
+: 222.1620, found
222.1629; [$]D
25.0 –39.67 (c 0.85, CHCl3, 86% ee).
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223
O
251
LiOH, TFE
THF, 60 °C
64% yield
OOH
Enone 223.  A 20 mL scintillation vial equipped with a stir bar and #-hydroxyketone 251
(13.6 mg, 0.0612 mmol, 1.00 equiv) was connected to an Ar-filled manifold and flushed
with Ar.  The vial was loaded with THF (1.5 mL, 0.04 M), TFE (10 µL, 0.137 mmol,
2.24 equiv), and LiOH (2.2 mg, 0.0919 mmol, 1.50 equiv) and lowered into a preheated
oil bath (60 °C).  After 72 h, the solvent had evaporated, and so the vial was charged with
additional THF (1.5 mL).  TLC analysis of the reaction after 75 h indicated no starting
material or dione 235.  Consequently, the reaction was removed from the oil bath,
allowed to cool to room temperature, filtered through a celite plug rinsing with Et2O, and
concentrated under reduced pressure at 0 °C (ice/water).  The resulting crude oil was
purified by flash column chromatography (SiO2, 23 x 1.5 cm, 100% hexanes
hexanes&5% TBME in hexanes) to afford enone 223 (8.0 mg, 0.0392 mmol, 64% yield)
as a yellow oil.  (For characterization data, see p. 745).
3.5.2.5 Derivatization of Enone 223 and Synthesis of (–)-Epoxydaucenal B
(144b) and "11-Carotol (259)
O
CeCl3, MeLi
THF, –78 °C
68% yield
OH
223 252
Alcohol 252.  A flame-dried 15 mL round-bottom flask equipped with a stir bar was
cycled into a glove box where the flask was loaded with anhydrous cerium chloride (76.4
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mg, 0.310 mmol, 2.53 equiv).  The flask was removed from the glove box, connected to
an Ar-filled manifold, placed under full vacuum, and lowered into an oil bath set to 140
°C.  After 13 h, the flask was removed from the bath, allowed to cool to room
temperature, and charged with THF (3 mL).  After 3 h of stirring, methyllithium (1.6 M
in pentane, 310 µL, 0.496 mmol, 4.05 equiv) was added and the flask was lowered into a
–78 °C bath (dry ice/acetone).  The resulting slurry initially turned yellow and then
orange over time.  After 10 min, enone 223 (25.0 mg, 0.122 mmol, 1.00 equiv) was
added neat.  TLC analysis indicated no starting material remained after 5 min.
Consequently, the reaction was quenched after 10 min with sat. NH4Cl solution (20 mL)
and transferred to a separatory funnel where the aqueous layer was extracted four times
with Et2O.  The combined organics were dried over MgSO4, filtered, and concentrated
under reduced pressure.  The resulting crude oil was purified by flash column
chromatography (SiO2, 27.5 x 2 cm, 100% hexanes&5% TBME in hexanes) to afford
alcohol 252 (18.3 mg, 0.0829 mmol, 68% yield) as a pale yellow oil; Rf = 0.65 (30%
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) % 5.38 (tp, J = 6.5, 1.5 Hz, 1H), 3.00
(ddd, J = 13.6, 4.9, 3.9 Hz, 1H), 2.37–2.26 (m, 1H), 2.21 (dddd, J = 15.6, 8.6, 3.4, 1.2 Hz,
1H), 2.14 (dt, J = 15.2, 4.6 Hz, 1H), 2.11–2.04 (m, 1H), 2.01 (dt, J = 7.0, 1.1 Hz, 2H),
1.99–1.94 (m, 1H), 1.71 (t, J = 1.3 Hz, 4H), 1.62–1.51 (m, 2H), 1.36 (s, 3H), 1.34 (s, 3H),
0.92 (s, 3H); 13C NMR (125 MHz, CDCl3) % 145.1, 139.3, 139.0, 122.0, 72.5, 51.3, 39.3,
37.8, 34.1, 31.2, 30.7, 30.5, 26.1, 24.1, 23.3; IR (Neat Film NaCl) 3373, 2965, 2924,
2850, 1455, 1367, 1331, 1259, 1172, 1138, 1083, 1043, 1012, 984, 945, 887, 822 cm-1;
HRMS (FAB+) m/z calc’d for C15H23O [(M+H)–H2]
+: 219.1749, found 219.1743; [$]D
25.0
–33.73 (c 1.83, CHCl3, 88% ee).
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O
CeCl3
THF, 23 °C
OH
MgBr
64% yield
223 !6(10)-tormesol (253)
1:1 d.r. at C11
11
10
6
"6(10)-tormesol (253).  A flame-dried 15 mL round-bottom flask equipped with a stir bar
was cycled into a glove box where the flask was loaded with anhydrous cerium chloride
(91.2 mg, 0.370 mmol, 2.52 equiv).  The flask was removed from the glove box,
connected to an Ar-filled manifold, placed under full vacuum, and lowered into an oil
bath set to 140 °C.  After 12 h, the flask was removed from the bath, allowed to cool to
room temperature, and charged with THF (1.6 mL).  After 3 h of stirring, (4-methylpent-
3-en-1-yl)magnesium bromide (0.39 M in THF, 1.13 mL, 0.441 mmol, 3.00 equiv) was
added and the slurry turned yellow.  After 45 min, enone 223 (30.0 mg, 0.147 mmol, 1.00
equiv) was transferred from a scintillation vial to the round-bottom flask using several
THF rinses (1 x 1.5 mL + 3 x 0.5 mL, total added = 4.6 mL, 0.03 M).  TLC analysis
indicated no starting material remained after 5 min.  Consequently, the reaction was
quenched with sat. NH4Cl solution (3 mL) at –78 °C and allowed to warm to room
temperature.  The reaction contents were transferred to a separatory funnel where the
aqueous layer was extracted four times with CH2Cl2 and three times with Et2O.  The
combined organics were dried over MgSO4, filtered, and concentrated under reduced
pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash column
chromatography (SiO2, 28 x 1.5 cm, 5% TBME in hexanes) to afford "
6(10)-tormesol (253,
27.1 mg, 0.0941 mmol, 64% yield) as a yellow oil; Rf = 0.75 (30% EtOAc in hexanes);
1H NMR (500 MHz, CDCl3) mixture of two diastereomers, see Figure SI-10A; IR (Neat
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Film NaCl) 3460, 2964, 2925, 2853, 1668, 1645, 1449, 1375, 1330, 1310, 1261, 1238,
1192, 1111, 1063, 1006, 983, 924, 825 cm-1; HRMS (EI+) m/z calc’d for C20H32O
[M+•]
+: 288.2453, found 288.2451.
O
LiOH, 30% aq H2O2
MeOH, 23 °C
94% yield
O
O
255
one diastereomer
223
Ketoepoxide 255.  Procedure adapted from report by Stoltz.7a  A flame-dried 25 mL
round-bottom flask equipped with a stir bar and enone 223 (100.4 mg, 0.491 mmol, 1.00
equiv) was backfilled with Ar and charged with MeOH (3 mL), LiOH (29.5 mg, 1.23
mmol, 2.50 equiv), and H2O2 (30% w/w aq, 500 µL, 4.90 mmol, 10.0 equiv).  Over the
course of the reaction, additional LiOH (29.5 mg at 33 h, 46 h, 73 h and 29.6 mg at 80.5
h, total added = 147.6 mg, 6.15 mmol, 12.5 equiv) and H2O2 (500 µL at 33 h, 46 h, 73 h,
80.5 h, total added = 2.5 mL, 24.5 mmol, 50 equiv) were added.  After 4 days, no starting
material remained by TLC analysis.  Consequently, CH2Cl2 (10 mL), water (10 mL), and
sat. NaHCO3 solution (10 mL) was added.  The reaction contents were transferred to a
separatory funnel where the aqueous layer was extracted four times with CH2Cl2.  The
combined organics were dried over Na2SO4, filtered, and concentrated under reduced
pressure.  The resulting crude oil was purified by flash column chromatography (SiO2,
28.5 x 1.5 cm, 100% hexanes&2%&5% TBME in hexanes) to afford ketoepoxide 255
(101.8 mg, 0.462 mmol, 94% yield) as a yellow oil; Rf = 0.70 (30% EtOAc in hexanes);
1H NMR (500 MHz, C6D6) % 5.31 (ddq, J = 8.7, 5.2, 1.7 Hz, 1H), 2.22 (ddd, J = 13.8,
11.1, 8.2 Hz, 1H), 2.07 (dddd, J = 13.6, 3.8, 1.9, 1.0 Hz, 1H), 2.03–1.93 (m, 1H), 1.97 (s,
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3H), 1.77 (tdd, J = 12.8, 2.0, 1.1 Hz, 1H), 1.73 (ddt, J = 13.8, 8.2, 0.9 Hz, 1H), 1.56 (td, J
= 1.8, 0.7 Hz, 3H), 1.52 (dddd, J = 14.4, 6.6, 2.0, 1.2 Hz, 1H), 1.47 (dd, J = 14.4, 8.6 Hz,
1H), 1.41 (dddd, J = 12.4, 6.2, 5.5, 0.7 Hz, 1H), 1.37 (ddd, J = 12.4, 11.1, 8.2 Hz, 1H),
1.00 (ddt, J = 12.4, 8.2, 0.8 Hz, 1H), 0.96 (s, 3H); 13C NMR (125 MHz, C6D6) % 204.9,
139.9, 122.8, 78.3, 74.7, 44.5, 35.9, 35.8, 29.1, 27.9, 26.8, 26.1, 25.2, 19.4; IR (Neat Film
NaCl) 2962, 2930, 2868, 1701, 1446, 1354, 1266, 1178, 1136, 1128, 1079, 1020, 994,
975, 954, 934, 882, 833 cm-1; HRMS (MM: ESI-APCI+) m/z  calc’d for C14H21O2
[M+H]
+: 221.1536, found 221.1530; [$]D
25.0 –50.64 (c 1.24, CHCl3, 88% ee).
H
H
H
H
HH
O
O
H
H
H
H
H
H
H
H
H
HH
O
O
H
CH3
H3C
H
H
H
H
O
O
NOESY Correlations for ketoepoxide 255
255
255
O
O
264
MePPh3Br
n-BuLi
THF
0 °C!reflux
80% yield
O
Diene 264.  A flame-dried 25 mL round-bottom flask equipped with a stir bar was cycled
into a glove box and loaded with methyltriphenylphosphonium bromide (121.1 mg, 0.339
mmol, 1.54 equiv).  The flask was removed from the glove box, connected to an Ar-filled
manifold, charged with THF (1.4 mL), and lowered into a 0 °C bath (ice/water).  n-BuLi
(2.5 M in hexanes, 110 µL, 0.275 mmol, 1.25 equiv) was added dropwise to the flask,
generating a bright yellow solution.  After 15 min, ketoepoxide 255 (48.5 mg, 0.220
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mmol, 1.00 equiv) was transferred via cannula to the flask using several THF rinses (3 x
1 mL, total added = 4.4 mL, 0.05 M) and the bath was allowed to warm to room
temperature over time.  After 1 h, significant starting material persisted by TLC analysis.
Consequently, an additional solution (15 min prestir at 0 °C) of
methyltriphenylphosphonium bromide (353.5 mg, 0.990 mmol, 4.50 equiv) and n-BuLi
(2.5 M in hexanes, 330 µL, 0.275 mmol, 1.25 equiv) in THF (2 mL) was prepared and
cannula transferred to the 25 mL flask.  After 17 h, starting material was still present by
TLC analysis, so a water condenser was attached to the flask and the reaction was heated
to reflux.  After 45 h, starting material was still observed by TLC analysis.
Consequently, another solution (15 min prestir at 0 °C) of methyltriphenylphosphonium
bromide (356.7 mg, 0.999 mmol, 4.53 equiv) and n-BuLi (2.5 M in hexanes, 330 µL,
0.275 mmol, 1.25 equiv) in THF (2 mL) was prepared and cannula transferred to the 25
mL flask.  The solvent level decreased over time and more THF (2 mL at 47 h and 65 h)
was added when appropriate.  After 4 days, no starting material was observed by TLC
analysis.  Consequently, the reaction was quenched with H2O (5 mL) and transferred to a
separatory funnel where the aqueous layer was extracted four times with Et2O.  The
combined organics (75 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash
column chromatography (SiO2, 26.5 x 1.5 cm, 100% hexanes&2%&10% TBME in
hexanes) to afford diene 264 (38.5 mg, 0.176 mmol, 80% yield) as a yellow oil; Rf = 0.76
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) % 5.47 (ddp, J = 8.6, 5.1, 1.6 Hz,
1H), 4.98 (q, J = 1.2 Hz, 2H), 2.14 (dddt, J = 14.2, 4.5, 1.8, 0.9 Hz, 1H), 2.06 (ddd, J =
13.7, 10.8, 8.3 Hz, 1H), 2.00 (br t, J = 13.8 Hz, 1H), 1.87 (t, J = 1.2 Hz, 3H), 1.87–1.83
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(m, 1H), 1.82 (ddt, J = 13.8, 8.3, 1.0 Hz, 1H), 1.80–1.72 (m, 1H), 1.76 (td, J = 1.8, 0.6
Hz, 3H), 1.67 (dddd, J = 14.0, 13.0, 2.1, 1.1 Hz, 1H), 1.41 (ddd, J = 12.7, 10.8, 8.3 Hz,
1H), 1.39 (dddd, J = 13.7, 6.5, 1.9, 0.6 Hz, 1H), 1.23 (dd, J = 12.4, 8.2 Hz, 1H), 0.99 (d, J
= 0.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) % 140.4, 139.9, 123.0, 112.9, 78.6, 74.1,
43.9, 36.2, 36.1, 29.9, 28.4, 25.4, 24.6, 20.8, 19.7; IR (Neat Film NaCl) 2962, 2929,
2868, 2851, 1646, 1444, 1373, 960, 903, 831 cm-1; HRMS (GC-EI+) m/z calc’d for
C15H22O [M+•]
+: 218.1671, found 218.1672; [$]D
25.0 –55.99 (c 1.11, CHCl3, 88% ee).
264
H2 (1 atm)
Rh(PPh3)3Cl
(22 mol %)
benzene
23 °C
89% yield
O
256
O
Epoxide 256.  A flame-dried 10 mL round-bottom flask equipped with a stir bar was
cycled into a glove box and loaded with Wilkinson’s catalyst (13.1 mg, 0.0142 mmol,
15.0 mol %).  The flask was removed from the glove box, connected to an Ar-filled
manifold, and charged with benzene (30 min Ar sparge before use, 0.15 mL).  Diene 264
(20.6 mg, 0.0944 mmol, 1.00 equiv) was transferred to the flask via a cannula using
several benzene rinses (3 x 1 mL, total added = 3.15 mL, 0.03 M).  The reaction was
disconnected from the manifold, connected to a hydrogen balloon, and flushed with
hydrogen, generating an orange solution.  After 4 h, no starting material was observed by
TLC, so the stir bar was removed and rinsed with CH2Cl2, and the reaction was
concentrated under reduced pressure at 0 °C (ice/water).  The resulting crude oil was
purified by flash column chromatography (SiO2, 24.5 x 1.5 cm, 100% hexanes&1%
TBME in hexanes) to afford an oil that contained both epoxide 256 and residual starting
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material (~10%).  The reaction was set up again following the above procedure
(Wilkinson’s catalyst: 6.3 mg, 0.00681 mmol, 7 mol %; benzene: 3.15 mL, 0.03 M).
After 3 h, a reaction aliquot was removed and 1H NMR analysis revealed no starting
material.  Consequently, the stir bar was removed and rinsed with CH2Cl2, and the
reaction was concentrated under reduced pressure at 0 °C (ice/water).  The resulting
crude oil was purified by flash column chromatography (SiO2, 27 x 1.5 cm, 100%
hexanes&1% TBME in hexanes) to afford epoxide 256 (18.4 mg, 0.0835 mmol, 89%
yield) as a yellow oil; Rf = 0.69 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) %
5.46 (ddq, J = 8.7, 5.3, 1.7 Hz, 1H), 2.17 (ttt, J = 13.3, 1.8, 0.8 Hz, 1H), 2.08 (dd, J =
14.7, 4.5 Hz, 1H), 1.94 (dddd, J = 14.4, 6.6, 1.9, 1.3 Hz, 1H), 1.82–1.74 (m, 1H), 1.77
(td, J = 1.8, 0.7 Hz, 3H), 1.76–1.66 (m, 4H), 1.43 (ddd, J = 14.1, 6.6, 1.9 Hz, 1H), 1.31
(ddd, J = 12.5, 10.5, 8.6 Hz, 1H), 1.15 (ddd, J = 12.3, 8.0, 1.0 Hz, 1H), 1.07 (d, J = 6.9
Hz, 6H), 0.96 (s, 3H); 13C NMR (125 MHz, CDCl3) % 139.6, 123.2, 77.5, 76.3, 44.1, 36.2,
35.4, 30.1, 28.6, 25.5, 25.4, 22.9, 19.7, 19.5, 19.0; IR (Neat Film NaCl) 2961, 2930,
2869, 1709, 1454, 1368, 1022, 964, 828 cm-1; HRMS (GC-EI+) m/z calc’d for C15H24O
[M+•]
+: 220.1827, found 220.1820; [$]D
25.0 –50.57 (c 1.25, CHCl3, 88% ee).
256
O SeO2, SiO2
THF, 80 °C
sealed
87% yield
OHC
(–)-epoxydaucenal B (144b)
12 steps, 20% yield
O
(–)-Epoxydaucenal B (144b).  Adapted from a procedure by Wood.40  A 20 mL
scintillation vial equipped with a stir bar and epoxide 256 (10.8 mg, 0.0490 mmol, 1.00
equiv) was connected to an Ar-filled manifold and flushed with Ar.  The vial was charged
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with THF (5.13 mL) and premixed selenium dioxide (10.9 mg, 0.0982 mmol, 2.00 equiv)
and silica gel (117.8 mg, 1.96 mmol, 40.0 equiv).  The vial was rinsed with THF (1 mL,
total added = 6.13 mL, 0.008 M), sealed with a teflon cap, and lowered into a preheated
sand bath (80 °C).  After 30 min, starting material persisted by TLC analysis, so the vial
was resealed and lowered back into the sand bath.  After an additional 15 min, no starting
material remained by TLC analysis.  Consequently, the reaction was filtered through a
short celite pad rinsing with Et2O and concentrated under reduced pressure at 0 °C
(ice/water).  The resulting crude oil was purified by flash column chromatography (SiO2,
26 x 1.5 cm, 100% hexanes& 2%& 5%& 10% TBME in hexanes) to afford
epoxydaucenal B (144b, 10.0 mg, 0.0427 mmol, 87% yield) as a yellow oil; Rf = 0.58
(30% EtOAc in hexanes); 1H NMR (500 MHz, C6D6) % 9.22 (s, 1H), 6.03 (dddd, J = 8.7,
5.1, 2.2, 1.2 Hz, 1H), 3.11–3.03 (m, 1H), 1.85 (ddtd, J = 14.0, 5.1, 1.5, 0.8 Hz, 1H),
1.69–1.60 (m, 1H), 1.62–1.52 (m, 3H), 1.51 (sept, J = 7.0 Hz, 1H), 1.44–1.40 (m, 1H),
1.41–1.33 (m, 2H), 1.03 (d, J = 6.8 Hz, 3H), 0.96–0.86 (m, 1H), 0.83 (s, 3H), 0.77 (d, J =
7.0 Hz, 3H); 13C NMR (125 MHz, C6D6) % 191.9, 152.5, 146.3, 75.7, 75.1, 44.3, 37.1,
35.7, 28.5, 25.4, 22.9, 20.1, 19.8, 19.6, 19.0; IR (Neat Film NaCl) 2961, 2931, 2869,
1687, 1683, 1644, 1455, 1444, 1378, 1229, 1149, 1023, 1003, 965, 876 cm-1; HRMS
(GC-EI+) m/z calc’d for C15H22O2 [M+•]
+: 234.1620, found 234.1630; [$]D
25.0 –20.52 (c
1.00, CHCl3, 88% ee).
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255
O
O
223
O
SmI2
t-BuOH, LiCl
THF, –78 °C
96% yield
Enone 223.  A flame-dried 10 mL round-bottom flask equipped with a stir bar was
cycled into a glove box where the flask was loaded with lithium chloride (77.0 mg, 1.82
mmol, 8.59 equiv).  The flask was removed from the glove box and connected to an Ar-
filled manifold.  Epoxide 255 (46.6 mg, 0.212 mmol, 1.00 equiv) was transferred to the
flask using several THF rinses (60 min Ar sparge before use, 1 x 0.6 mL + 3 x 0.5 mL,
total added = 2.1 mL, 0.1 M), t-BuOH (20 µL, 0.209 mmol, 0.99 equiv) was added, and
the flask was lowered into a –78 °C bath (dry ice/acetone).  A samarium diiodide
solution51 (0.1 M in THF, 4.5 mL, 0.450 mmol, 2.13 equiv) was added dropwise over 5
min down the side of the flask, generating a dark blue solution.  TLC analysis indicated
that no starting material remained after 8 min.  Consequently, the reaction was quenched
with sat. NH4Cl solution (2 mL), allowed to warm to room temperature, and transferred
to a separatory funnel where the aqueous layer was extracted four times with Et2O.  The
combined organics were dried over MgSO4, filtered, and concentrated under reduced
pressure.  The resulting crude oil was purified by flash column chromatography (SiO2, 26
x 1.5 cm, 100% hexanes&5%&10%&15%&30%&50% TBME in hexanes) to afford
enone 223 (41.5 mg, 0.203 mmol, 96% yield) as a yellow oil.  (For characterization data,
see p. 745).
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O lithium
naphthalenide
THF, –78 °C
255
O
257a
41% yield
O
OH
4
+
257b
9% yield
O
OH
4
+
4.5:1 d.r. at C(4)
O
235
26% yield
O
#-hydroxyketone 257a and b.  Procedure adapted from report by Liu.49  A flame-dried
15 mL round-bottom flask equipped with a glass stir bar and ketoepoxide 255 (50.2 mg,
0.228 mmol, 1.00 equiv) was charged with THF (2.3 mL, 0.1 M) and lowered into a –78
°C bath (acetone/dry ice).  A lithium naphthalenide solution50 (1.0 M, 680 µL, 0.680
mmol, 2.98 equiv) was added dropwise and the reaction mixture turned dark green.  Over
the course of the reaction, an additional portion of lithium naphthalenide was added (680
µL at 1.5 h, 3 h, 4.5 h, total added = 2.72 mL, 2.72 mmol, 11.9 equiv).  After 9 h, the
reaction was quenched with H2O and allowed to warm to room temperature.  The reaction
was transferred to a separatory funnel where the aqueous layer was extracted six times
with CH2Cl2.  The combined organics (50 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure at 0 °C (ice/water).  The resulting crude oil was
purified by flash column chromatography (SiO2, 28 x 1.5 cm, 100%
hexanes&2%&5%&10%&20%&40% TBME in hexanes) to afford dione 235 (13.1
mg, 0.0588 mmol, 26% yield), #-hydroxyketone 257a (20.7 mg, 0.0933 mmol, 41%
yield) as a yellow oil, and #-hydroxyketone 257b (4.6 mg, 0.0206 mmol, 9% yield) as a
yellow oil.  (For characterization data of dione 235, see p. 746).
#-hydroxyketone 257a.  Rf = 0.57 (30% EtOAc in hexanes); 
1H NMR (500 MHz, C6D6)
% 5.34 (ddt, J = 8.5, 4.5, 1.5 Hz, 1H), 3.95 (s, 1H), 2.77 (dd, J = 10.2, 9.1 Hz, 1H), 2.00
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(dddd, J = 12.2, 3.4, 1.7, 0.9 Hz, 1H), 1.96 (dt, J = 8.6, 1.6 Hz, 1H), 1.90 (ddd, J = 12.3,
10.1, 5.1 Hz, 1H), 1.87–1.74 (m, 3H), 1.69 (ddd, J = 14.4, 10.7, 1.9 Hz, 1H), 1.68 (s, 3H),
1.63 (t, J = 1.7 Hz, 3H), 1.53 (ddd, J = 17.5, 12.4, 5.1 Hz, 1H), 1.57–1.47 (m, 1H),
1.24–1.15 (m, 1H), 1.19 (s, 3H); 13C NMR (125 MHz, C6D6) % 212.8, 139.5, 122.6, 84.1,
56.3, 48.7, 40.4, 38.3, 34.2, 31.0, 29.4, 25.4, 25.3, 20.5; IR (Neat Film NaCl) 3479, 2959,
2925, 2853, 1694, 1446, 1394, 1362, 1307, 1260, 1243, 1175, 1105, 1077, 1051, 1010,
832 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C14H23O2 [M+H]
+: 223.1693, found
223.1692; [$]D
25.0 –193.24 (c 0.57, CHCl3, 88% ee).
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NOESY Correlations for !-hyrdoxyketone 257a
257a
#-hydroxyketone 257b.  Rf = 0.36 (30% EtOAc in hexanes); 
1H NMR (500 MHz, C6D6)
% 5.21 (dddd, J = 8.6, 6.4, 3.2, 1.6 Hz, 1H), 2.83 (t, J = 9.6 Hz, 1H), 2.24 (br t, J = 14.2
Hz, 1H), 2.18 (dddd, J = 13.7, 10.5, 9.7, 5.4 Hz, 1H), 2.04 (dd, J = 15.1, 6.4 Hz, 1H), 1.98
(s, 3H), 1.85 (dd, J = 15.0, 7.4 Hz, 1H), 1.69–1.57 (m, 4H), 1.53 (dt, J = 1.7, 0.8 Hz, 3H),
1.45 (dtd, J = 13.7, 9.4, 6.1 Hz, 1H), 1.26 (ddd, J = 14.9, 6.5, 2.6 Hz, 1H), 1.15 (ddd, J =
13.0, 9.3, 5.4 Hz, 1H), 0.87 (s, 3H); 13C NMR (125 MHz, C6D6) % 208.2, 140.4, 122.2,
84.2, 62.7, 47.5, 35.6, 34.2, 31.5, 31.1, 28.1, 25.2, 24.8, 20.6; IR (Neat Film NaCl) 3501,
2962, 2927, 2874, 1694, 1457, 1363, 1213, 1069, 1027, 833, 819 cm-1; HRMS (EI+) m/z
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calc’d for C14H22O2 [M+•]
+: 222.1620, found 222.1623; [$]D
25.0 67.43 (c 0.46, CHCl3,
88% ee).
OH
O
NOESY Correlations for !-hyrdoxyketone 257b
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11-carotol (259)
11 steps, 12% yield
OH
(Cl3(O)Mo(THF)2 + MeLi)
THF, –78"23 °C
86% yield
Cl
Mo
O
257a
O
OH
11
258
"11-carotol (259).  A flame-dried 25 mL round-bottom flask equipped with a stir bar was
cycled into a glove box, loaded with oxotrischlorobis(tetrahydrofuran)molybdenum(V)42
(139.0 mg, 0.383 mmol, 4.11 equiv), removed from the glove box, and connected to an
Ar-filled manifold.  The flask was charged with THF (2 mL) and lowered into a –78 °C
bath (dry ice/acetone).  Methyllithium (1.58 M in Et2O, 240 µL, 0.379 mmol, 4.06 equiv)
was added dropwise to the flask causing the reaction mixture to transition from a bright
green solution to a dark red/purple solution.  After 1 h, #-hydroxyketone 257a (20.7 mg,
0.0933 mmol, 1.00 equiv) was transferred to the flask via cannula using several THF
rinses (2 x 1.5 mL + 1 mL, total added = 6 mL), and the bath was allowed to expire over
time.  After 29 h, starting material persisted by TLC analysis.  Consequently, an
additional solution (1 h prestir at –78 °C) of oxotrischlorobis(tetrahydrofuran)-
CHAPTER 3 — Enantioselective Synthesis of Four Daucane Sesquiterpenes and Related Molecules 769
molybdenum(V) (138.7 mg, 0.383 mmol, 4.10 equiv) and methyllithium (1.58 M in Et2O,
240 µL, 0.275 mmol, 1.25 equiv) in THF (1 mL) was prepared and transferred via
cannula to the 25 mL flask at –78 °C.  The bath was once again allowed to expire over
time.  As starting material was still observed by TLC analysis after 40 h and 53 h, two
additional solutions (vide supra) were prepared at –78 °C and transferred via cannula to
the 25 mL flask at these times (Cl3(O)Mo(THF)2 total added = 556.1 mg, 1.52 mmol,
16.4 equiv; MeLi total added = 0.96 mL, 1.52 mmol, 16.3 equiv; THF total added = 9
mL).  After 65 h, starting material was completely consumed by TLC analysis.  The
reaction was subsequently quenched with water (5 mL) and transferred to a separatory
funnel where the aqueous layer was extracted four times with Et2O.  The combined
organics (50 mL) were dried over MgSO4, filtered, and concentrated under reduced
pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash column
chromatography (SiO2, 25.5 x 1.5 cm, 100% hexanes&2% TBME in hexanes) to afford
"11-carotol (259, 17.6 mg, 0.0799 mmol, 86% yield) as a yellow oil; Rf = 0.75 (30%
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) % 5.32 (ddp, J = 8.8, 4.5, 1.5 Hz, 1H),
5.04 (p, J = 1.5 Hz, 1H), 4.86 (dq, J = 1.7, 0.9 Hz, 1H), 2.77 (dd, J = 11.0, 7.7 Hz, 1H),
2.32 (ddd, J = 15.7, 4.3, 2.1 Hz, 1H), 2.18–2.01 (m, 2H), 1.84 (dd, J = 1.5, 0.8 Hz, 3H),
1.87–1.75 (m, 2H), 1.76–1.62 (m, 3H), 1.69 (t, J = 1.7 Hz, 3H), 1.51 (ddd, J = 14.2, 9.1,
2.5 Hz, 1H), 1.47 (br s, 1H), 1.35 (dd, J = 12.3, 8.0 Hz, 1H), 1.01 (d, J = 0.8 Hz, 3H); 13C
NMR (125 MHz, CDCl3) % 145.8, 139.0, 122.2, 113.3, 83.2, 53.4, 48.3, 40.4, 39.3, 34.6,
29.5, 26.8, 25.4, 25.2, 21.9; IR (Neat Film NaCl) 3545, 3069, 2963, 2924, 2867, 1636,
1448, 1374, 1006, 898, 825 cm-1; HRMS (EI+) m/z calc’d for C15H24O [M+•]
+: 220.1827,
found 220.1834; [$]D
25.0 17.49 (c 1.05, CHCl3, 88% ee).
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H
H3C
H
H3C
H
OH
NOESY Correlations for !-hyrdoxyketone 259
259
3.5.2.6 Synthesis of (–)-Daucene (142), (+)-Daucenal (143), and (+)-14-p-
Anisoyloxydauc-4,8-diene (145)
223
O
260
PbCl2, Zn, CH2I2, TiCl4
THF/CH2Cl2, 23 °C
60% yield
Triene 260.  A flame-dried two-neck 25 mL round-bottom flask equipped with a stir bar
and water condenser was loaded with lead(II) chloride (20.6 mg, 0.0740 mmol, 0.16
equiv) and zinc dust (437.5 mg, 6.69 mmol, 14.4 equiv) and backfilled with argon.  The
flask was charged with THF (6.5 mL) and diiodomethane (300 µL, 3.72 mmol, 8.02
equiv) and lowered into a preheated oil bath (70 °C).  After 15 min, the bath was
removed, the reaction was cooled to room temperature over 15 min and then lowered into
a 0 °C bath (ice/water).  Premixed titanium(IV) chloride (100 µL, 0.912 mmol, 1.96
equiv) and CH2Cl2 (830 µL) were added quickly, the bath was removed, and the reaction
was allowed to warm to room temperature.  After 1 h, enone 223 (94.9 mg, 0.464 mmol,
1.00 equiv) was transferred to the flask via cannula using several THF rinses (3 x 1 mL,
total added = 9.5 mL, 0.05 M).  No starting material remained after 1.5 h by TLC
analysis, so the reaction was quenched with a sat. NaHCO3 solution (10 mL) and filtered
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through a celite plug into a separatory funnel rinsing with Et2O.  The aqueous layer was
extracted four times with Et2O.  The combined organics were dried over MgSO4, filtered,
and concentrated under reduced pressure at 0 °C (ice/water).  The resulting crude oil was
purified by flash column chromatography (SiO2, 28 x 1.5 cm, 100% hexanes) to afford
triene 260 (56.5 mg, 0.279 mmol, 60% yield) as a pale yellow oil; Rf = 0.73 (0.3% Et2O
in hexanes); 1H NMR (500 MHz, CDCl3) % 5.43 (ddp, J = 7.4, 5.9, 1.5 Hz, 1H), 4.90 (dq,
J = 2.9, 1.5 Hz, 1H), 4.71 (dq, J = 2.5, 0.8 Hz, 1H), 2.65 (ddd, J = 13.8, 5.1, 3.6 Hz, 1H),
2.40 (dtd, J = 15.2, 8.3, 2.9 Hz, 1H), 2.29 (dddd, J = 15.4, 7.4, 4.7, 1.3 Hz, 1H),
2.11–2.04 (m, 3H), 2.01 (dd, J = 13.9, 7.6 Hz, 1H), 1.92 (ddddd, J = 16.7, 10.6, 4.7, 2.9,
1.4 Hz, 1H), 1.85 (dd, J = 1.5, 0.8 Hz, 3H), 1.74 (t, J = 1.5 Hz, 3H), 1.64–1.60 (m, 2H),
0.96 (s, 3H); 13C NMR (125 MHz, CDCl3) % 146.4, 142.6, 139.9, 135.2, 122.4, 112.8,
50.5, 40.1, 38.4, 33.7, 32.6, 26.1, 23.7, 23.6, 22.8; IR (Neat Film NaCl) 3078, 2962,
2924, 2846, 1627, 1443, 1368, 891, 829 cm-1; HRMS (GC-EI+) m/z calc’d for C15H22
[M+•]
+: 202.1721, found 202.1703; [$]D
25.0 –76.62 (c 0.94, CHCl3, 88% ee).
223
O
260
58% yield
PbCl2, Zn, CH2I2, TiCl4
THF/CH2Cl2, 23 °C
262
12% yield
+
OH
OH
Triene 260 and Diol 262.  A flame-dried two-neck 50 mL round-bottom flask equipped
with a stir bar and water condenser was loaded with lead(II) chloride (30.9 mg, 0.111
mmol, 0.16 equiv) and zinc dust (640.0 mg, 9.79 mmol, 14.4 equiv) and backfilled with
argon.  The flask was charged with THF (10 mL) and diiodomethane (440 µL, 5.46
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mmol, 8.04 equiv) and lowered into a preheated oil bath (80 °C).  After 20 min, the bath
was removed, the reaction was cooled to room temperature over 10 min, and then
lowered into a 0 °C bath (ice/water).  Premixed titanium(IV) chloride (150 µL, 1.37
mmol, 2.01 equiv) and dichloromethane (1.22 mL) were added quickly, the bath was
removed, and the reaction was allowed to warm to room temperature.  After 50 min,
enone 223 (138.9 mg, 0.680 mmol, 1.00 equiv) was transferred to the flask via cannula
using several THF rinses (1 x 1.6 mL + 2 x 1 mL, total added = 13.6 mL, 0.05 M).  TLC
analysis indicated no starting material remained after 1.5 h.  Consequently, the reaction
was quenched with a sat. aq NaHCO3 (13 mL) and filtered through a celite plug into a
separatory funnel rinsing with Et2O.  The aqueous layer was extracted four times with
Et2O.  The combined organics were dried over MgSO4, filtered, and concentrated under
reduced pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash
column chromatography (SiO2, 29 x 1.5 cm, 100% hexanes) to afford triene 260 (79.9
mg, 0.395 mmol, 58% yield) as a pale yellow oil, diol 262 (15.3 mg, 0.03735 mmol, 12%
yield) as a white solid, and several other polar organics.
Triene 260.  For characterization data, see p. 768.
Diol 262.  Rf = 0.57 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) % 5.42 (ddt, J
= 7.5, 4.5, 1.3 Hz, 2H), 3.30–3.20 (m, 2H), 2.36 (dddd, J = 15.6, 10.5, 7.5, 3.1 Hz, 2H),
2.17–2.00 (m, 12H), 1.98 (dd, J = 14.3, 7.5 Hz, 2H), 1.73 (t, J = 1.3 Hz, 6H), 1.52 (ddd, J
= 12.0, 7.5, 1.7 Hz, 2H), 1.46 (ddd, J = 12.1, 10.3, 8.4 Hz, 2H), 1.40 (s, 6H), 0.93 (s, 6H);
13C NMR (125 MHz, CDCl3) % 148.1, 140.4, 135.7, 122.2, 80.2, 50.1, 40.0, 38.4, 33.2,
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31.9, 25.5, 25.5, 24.1, 23.1; IR (Neat Film NaCl) 3339, 2965, 2942, 2924, 2849, 1439,
1368, 1184, 1097, 1057, 977, 914, 828 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for
C28H41O [M–OH]
+: 393.3152, found 393.3029; [$]D
25.0 –58.15 (c 1.53, CHCl3, 88% ee).
260
H2 (1 atm)
Rh(PPh3)3Cl 
(15 mol %)
benzene, 23 °C
(–)-daucene (142)
70% yield
261
17% yield
+
10 steps, 15% yield
(–)-Daucene (142).  A flame-dried 25 mL round-bottom flask equipped with a stir bar
was cycled into a glove box and loaded with Wilkinson’s catalyst (48.0 mg, 0.0519
mmol, 15.0 mol %).  The flask was removed from the glove box, connected to an Ar-
filled manifold, and charged with benzene (30 min Ar sparge before use, 3 mL).  Triene
260 (70.0 mg, 0.346 mmol, 1.00 equiv) was transferred to the flask via cannula using
several benzene rinses (1 x 2.5 mL + 3 x 2 mL, total added = 11.5 mL, 0.03 M).  The
flask was disconnected from the manifold, connected to a hydrogen balloon, and flushed
with hydrogen, generating an orange solution.  After 8 h, minimal starting material
remained by TLC, so the stir bar was removed and rinsed with CH2Cl2 and the reaction
was concentrated under reduced pressure at 0 °C (ice/water).  The resulting crude oil was
loaded onto a silica gel column52 using hexanes and minimal CH2Cl2 and purified by flash
column chromatography (SiO2, 27.5 x 2 cm, 100% hexanes) to afford alkene 261 (11.9
mg, 0.0576 mmol, 17% yield) as a clear colorless oil and daucene (142, 49.5 mg, 0.242
mmol, 70% yield) as a clear colorless oil.
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Alkene 261.  Rf = 0.92 (0.3% Et2O in hexanes); 
1H NMR (500 MHz, CDCl3) mixture of
two diastereomers, see Figure SI-19A; IR (Neat Film NaCl) 2955, 2923, 2856, 1457,
1379, 1369, 1360 cm-1; HRMS (GC-EI+) m/z calc’d for C15H26 [M+•]
+: 206.2034, found
206.2040.
(–)-Daucene (142).  Rf = 0.84 (0.3% Et2O in hexanes); 
1H NMR (500 MHz, CDCl3) %
5.42 (ddt, J = 9.2, 5.6, 1.5 Hz, 1H), 2.66 (sept, J = 6.8 Hz, 1H), 2.44–2.36 (m, 1H), 2.17
(ddt, J = 8.7, 6.7, 2.2 Hz, 2H), 2.08–2.03 (m, 1H), 2.05–1.99 (m, 2H), 1.94 (dd, J = 14.1,
7.8 Hz, 1H), 1.86–1.78 (m, 1H), 1.74 (t, J = 1.6 Hz, 3H), 1.62–1.48 (m, 2H), 0.98 (d, J =
6.9 Hz, 3H), 0.92 (d, J = 6.9 Hz, 3H), 0.91 (s, 3H); 13C NMR (125 MHz, CDCl3) % 142.0,
139.9, 138.8, 122.8, 49.7, 40.5, 38.7, 33.7, 27.3, 26.6, 26.1, 23.7, 22.7, 22.0, 21.4; IR
(Neat Film NaCl) 2959, 2932, 2845, 1444, 1366, 1330, 1303, 1202, 828 cm-1; HRMS
(GC-EI+) m/z calc’d for C15H24 [M+•]
+: 204.1878, found 204.1878; [$]D
25.0 –24.95 (c
1.37, CHCl3, 86% ee).
SeO2, SiO2
THF, 80 °C
sealed
51% yield
(+)-daucenal (143)
11 steps, 8% yield
O
H
(–)-daucene (142)
(+)-Daucenal (143).  Adapted from a procedure by Wood.40  A 20 mL scintillation vial
equipped with a stir bar and daucene (142, 9.6 mg, 0.047 mmol, 1.00 equiv) was
connected to an Ar-filled manifold and flushed with Ar.  The vial was charged with THF
(4.87 mL) and premixed selenium dioxide (10.4 mg, 0.0937 mmol, 2.00 equiv) and silica
gel (113.9 mg, 1.896 mmol, 40.4 equiv).  The vial was sealed with a teflon cap and
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lowered into a preheated sand bath (80 °C).  After 20 min, starting material persisted by
TLC analysis, so the vial was resealed and lowered back into the sand bath.  After an
additional 10 min, no starting material remained by TLC analysis.  Consequently, the
reaction was filtered through a short celite pad rinsing with Et2O and concentrated under
reduced pressure at 0 °C (ice/water).  The resulting crude oil was purified by flash
column chromatography (SiO2, 27.5 x 1.5 cm, 100% hexanes&5%&10%& 20% TBME
in hexanes) to afford daucenal (143, 5.2 mg, 0.0238 mmol, 51% yield) as a yellow oil; Rf
= 0.77 (30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) % 9.26 (d, J = 1.1 Hz, 1H),
6.10 (dddd, J = 8.4, 5.2, 2.0, 1.1 Hz, 1H), 3.05 (ddd, J = 15.2, 5.4, 2.7 Hz, 1H), 2.51 (sept,
J = 6.7 Hz, 1H), 2.33 (ddd, J = 14.1, 5.5, 3.1 Hz, 1H), 2.13 (ddd, J = 8.5, 5.1, 1.9 Hz, 2H),
2.05 (dd, J = 14.3, 5.2 Hz, 1H), 1.94 (ddd, J = 14.3, 8.2, 1.1 Hz, 1H), 1.76 (br tdd, J =
14.2, 3.4, 1.6 Hz, 1H), 1.62 (br ddt, J = 14.5, 10.1, 2.4 Hz, 1H), 1.55 (dtd, J = 12.6, 6.8,
1.2 Hz, 1H), 1.47 (dtd, J = 12.4, 7.7, 1.1 Hz, 1H), 0.90 (dd, J = 6.9, 1.1 Hz, 3H), 0.88 (dd,
J = 6.9, 1.1 Hz, 3H), 0.81 (s, 3H); 13C NMR (125 MHz, CDCl3) % 193.0, 152.8, 146.8,
141.0, 140.3, 49.8, 41.7, 39.2, 27.4, 26.7, 24.2, 24.0, 22.4, 21.9, 21.3; IR (Neat Film
NaCl) 2956, 2930, 2863, 1685, 1636, 1453, 1378, 1245, 1144, 929 cm-1; HRMS (GC-
EI+) m/z calc’d for C15H22O [M+•]
+: 218.1671, found 218.1680; [$]D
25.0 33.65 (c 0.50,
CHCl3, 86% ee).
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(+)-daucenal (143)
O
CeCl3 • 7H2O
NaBH4
MeOH, 0!23 °C
H
81% yield
based on 
recovered 143
263
HO
Allylic Alcohol 263.  A 20 mL scintillation vial equipped with a stir bar and daucenal
(143, 10.2 mg, 0.0467 mmol, 1.00 equiv) was connected to an Ar-filled manifold and
flushed with Ar.  The vial was charged with MeOH (930 µL) and cerium chloride
heptahydrate (20.9 mg, 0.0561 mmol, 1.20 equiv).  After 10 min of stirring, the cerium
chloride heptahydrate had dissolved, generating a yellow solution.  The vial was
subsequently lowered into a 0 °C bath (ice/water) and sodium borohydride (4.1 mg, 0.108
mmol, 2.32 equiv) was added.  The bath was allowed to expire over time.  Additional
sodium borohydride (35 min = 11.9 mg, 2 h 25 min = 12.3 mg, 6 h = 12.9 mg, 8 h = 50.2
mg; total added = 91.5 mg, 2.42 mmol, 51.8 equiv) and cerium chloride heptahydrate (8 h
= 22.7 mg; total added = 43.6 mg, 0.117 mmol, 2.51 equiv) were added.  After 20 h, the
reaction was quenched with a sat. NH4Cl solution (5 mL) and transferred to a separatory
funnel where the aqueous layer was extracted four times with Et2O.  The combined
organics were rinsed with 5% w/w HCl (10 mL), dried over MgSO4, filtered, and
concentrated under reduced pressure at 0 °C (ice/water).  The resulting crude oil was
purified by flash column chromatography (SiO2, 29 x 1.5 cm, 100%
hexanes&5%&10%&20% TBME in hexanes) to afford recovered daucenal (143, 3.4
mg, 0.0156 mmol, 33% recovered) and alcohol 263 (5.6 mg, 0.0253 mmol, 54% yield,
81% yield based on recovered 143) as a yellow oil; Rf = 0.42 (30% EtOAc in hexanes);
1H NMR (500 MHz, CDCl3) % 5.70 (ddtd, J = 8.0, 5.2, 2.0, 0.9 Hz, 1H), 4.03 (t, J = 1.5
Hz, 2H), 2.68 (sept, J = 6.8 Hz, 1H), 2.48 (ddd, J = 13.9, 5.7, 2.9 Hz, 1H), 2.22–2.16 (m,
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4H), 2.14 (dd, J = 14.1, 5.3 Hz, 1H), 2.04 (dd, J = 14.1, 8.0 Hz, 1H), 2.05–1.95 (m, 1H),
1.86–1.77 (m, 1H), 1.62 (dt, J = 12.3, 6.2 Hz, 1H), 1.55 (dt, J = 12.3, 8.2 Hz, 1H), 0.98
(d, J = 6.9 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H), 0.93 (s, 3H); 13C NMR (125 MHz, CDCl3) %
143.2, 141.6, 139.4, 124.7, 68.9, 49.4, 40.4, 38.8, 29.6, 27.3, 26.6, 23.8, 23.2, 22.0, 21.3;
IR (Neat Film NaCl) 3325, 2957, 2930, 2859, 1710, 1455, 1380, 1367, 1360, 1261, 1055,
997, 841, 803 cm-1; HRMS (EI+) m/z calc’d for C15H24O [M+•]
+: 220.1827, found
220.1830; [$]D
25.0 –13.28 (c 0.56, CHCl3, 86% ee).
263
(+)-14-p-anisoyloxydauc-4,8-diene (145)
13 steps, 4% yield
DMAP, Et3N
anisoyl chloride
CH2Cl2, 0!23 °C
61% yield
O
O
MeO
HO
14-p-Anisoyloxydauc-4,8-diene (145).  A scintillation vial equipped with allylic alcohol
263 (5.6 mg, 0.0253 mmol, 1.00 equiv), a stir bar, and a Teflon cap was flushed with Ar
and connected to an Ar-filled manifold.  The vial was charged with CH2Cl2 (2 mL, 0.01
M) and lowered into a 0 °C bath (ice/water).  DMAP (0.5 mg, 0.0041 mmol, 16 mol %),
Et3N (10 µL, 0.072 mmol, 2.8 equiv), and p-anisoyl chloride (10 µL, 0.074 mmol, 2.9
equiv) were added to the vial and the bath was allowed to expire over time.  TLC analysis
indicated starting material remained after 4 h, so additional Et3N (10 µL, total added = 20
µL, 0.14 mmol, 5.7 equiv) and p-anisoyl chloride (10 µL, total added = 20 µL, 0.15
mmol, 5.8 equiv) were added.  TLC analysis indicated no residual starting material after
18 h, so the reaction was loaded directly onto a column, and the crude material was
purified by flash column chromatography (SiO2, 28.5 x 2 cm, 100% hexanes&2% TBME
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in hexanes) to afford 14-p-anisoyloxydauc-4,8-diene (145, 5.5 mg, 0.0155 mmol, 61%
yield) as a yellow oil that solidified upon freezing; Rf = 0.70 (30% EtOAc in hexanes); 
1H
NMR (500 MHz, CDCl3) % 8.01 (dm, J = 8.9 Hz, 2H), 6.92 (dm, J = 8.9 Hz, 2H), 5.85
(ddp, J = 7.3, 5.0, 1.1 Hz, 1H), 4.70 (d, J = 1.1 Hz, 2H), 3.86 (s, 3H), 2.67 (sept, J = 6.9
Hz, 1H), 2.49 (ddd, J = 13.9, 5.7, 2.8 Hz, 1H), 2.25 (ddd, J = 14.6, 5.8, 2.8 Hz, 1H), 2.19
(ddd, J = 8.2, 6.0, 2.2 Hz, 2H), 2.20–2.14 (m, 1H), 2.07 (dd, J = 14.1, 8.1 Hz, 1H), 2.07
(tm, J = 13.5 Hz, 1H), 1.88 (dddd, J = 14.6, 12.3, 5.0, 2.5 Hz, 1H), 1.64 (dt, J = 12.3, 6.1
Hz, 1H), 1.56 (dt, J = 12.4, 8.3 Hz, 1H), 0.98 (d, J = 6.9 Hz, 3H), 0.95 (s, 3H), 0.93 (d, J
= 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) % 166.4, 163.4, 141.5, 139.5, 138.6, 131.8,
128.4, 123.0, 113.7, 70.3, 55.6, 49.4, 40.5, 38.8, 29.9, 27.3, 26.6, 23.8, 23.0, 22.0, 21.3;
IR (Neat Film NaCl) 2956, 2928, 2854, 1716, 1607, 1582, 1456, 1421, 1368, 1315, 1271,
1256, 1167, 1100, 1032, 846, 770 cm-1; HRMS (EI+) m/z calc’d for C23H30O3 [M+•]
+:
354.2195, found 354.2193; [$]D
25.0 2.27 (c 0.55, CHCl3, 86% ee).
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3.5.3 Comparison of Data for Synthetic and Reported Natural Products
Spectral data for synthetic (–)-epoxydaucenal B (144b), (–)-daucene (142), (+)-
daucenal (143), and (+)-14-p-anisoyloxydauc-4,8-diene (145) (1H NMR, 13C NMR,
[$]D
T
) were compared with available reported spectral data for either natural or synthetic
samples.  Tables comparing compound data are shown in Tables 3.2–3.9.
(–)-epoxydaucenal B (144b)
14
1
4
5
8
10 15
12
13
11
H
O
9
3
2
7
6 O
Table 3.2.  Comparison of 1H NMR data for synthetic and natural epoxydaucenal B (144b).a–b
Assignment Synthetic 144b
(ppm)c
Multiplicity,
J (Hz)
Natural13
144b (ppm)d
Multiplicity,
J (Hz)
C1 — — — —
C2 1.41–1.33 m
0.96–0.86 m
C3 1.69–1.60 m
1.41–1.33 m
C4 — — — —
C5 — — — —
C6 1.62–1.52 m
1.44–1.40 m
C7 3.11–3.03 m 3.068 m
1.62–1.52 m
C8 — — — —
C9 6.03 dddd, 8.7, 5.1, 2.2, 1.2 6.028 m
C10 1.85 ddtd, 14.0, 5.1, 1.5,
0.8
1.840 dd, 14.1, 5.0
1.62–1.52 m
C11 1.51 sept, 7.0 1.522 sept, 6.9
C12 1.03 d, 6.8 1.028 d, 6.9
C13 0.77 d, 7.0 0.763 d, 6.9
C14 9.22 s 9.211 s
C15 0.83 s 0.828 s
a See Figure 5.16.1 for 1H NMR spectra. b Blank spaces in table represent neglected or unreported signals. c
1H NMR spectra was obtained at 500 MHz in C6D6 and standardized to residual C6H6. 
d 1H NMR spectra
was obtained at 500 MHz in C6D6 and standardized to TMS.
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(–)-epoxydaucenal B (144b)
14
1
4
5
8
10 15
12
13
11
H
O
9
3
2
7
6 O
Table 3.3.  Comparison of 13C NMR data for synthetic and natural epoxydaucenal B (144b).a
Assignment Synthetic 144b
(ppm)b
Natural13
144b (ppm)c
C1 44.3 44.2
C2 35.7 35.7
C3 22.9 22.8d
C4 75.1 75.0
C5 75.7 75.7
C6 25.4 25.4d
C7 20.1 20.1
C8 146.3 146.3
C9 152.5 152.3
C10 37.1 37.1
C11 28.5 28.5
C12 19.0 18.9e
C13 19.6 19.5e
C14 191.9 191.8
C15 19.8 19.7
a See Figure 5.16.3 for 13C NMR spectra. b 13C NMR spectra was obtained at 125 MHz in C6D6 and
standardized to residual C6H6. 
c 13C NMR spectra was obtained at 125 MHz in C6D6 and standardized to
TMS. d C(3) and C(6) were misassigned, see HSQC spectra, Figure SI-14D. e C(12) and C(13) were
misassigned, see HSQC spectra, Figure 5.16.4.
CHAPTER 3 — Enantioselective Synthesis of Four Daucane Sesquiterpenes and Related Molecules 781
(–)-daucene (142)
14
1
45
8
10 15
12
13
11
9
3
2
7
6
Table 3.4, Part 1.  Comparison of 1H NMR Data for synthetic and reported53 daucene (142).a–b
Assignment Synthetic
142 (ppm)b
Multiplicity,
J (Hz)
Little27
142 (ppm)d
Multiplicity,
J (Hz)
Seto25 142
(ppm)e
Multiplicity,
J (Hz)
C1 — — — — — —
C2 1.59 ddd, 11.9, 6.7,
5.1
1.65–1.48f m
1.52 dt, 12.2, 8.5
C3 2.17 ddt, 8.7, 6.7, 2.2 2.21–2.12 m
C4 — — — — — —
C5 — — — — — —
C6 2.44–2.36 m 2.39 m
1.86–1.78 m 1.81 m
C7 2.05–1.99 m 2.05–1.90 m
C8 — — — — — —
C9 5.42 ddt, 9.2, 5.6, 1.5 5.42 m 5.43 br t, 6.6
C10 2.08–2.03 m 2.05–1.90 m
1.94 dd, 14.1, 7.8
C11 2.66 sept, 6.8 2.66 sept, 6.75 2.67 sept, 6.8
C12 0.98 d, 6.9 0.98 d, 6.75 0.98 d, 6.8
C13 0.92 d, 6.9 0.93 d, 6.75 0.92 d, 6.8
C14 1.74 t, 1.6 1.74 s 1.74 br s
C15 0.91 s 0.91 s 0.91 s
a See Figure 5.22.1 for 1H NMR spectra. b Blank spaces in table represent neglected or unreported signals. c
1H NMR spectra was obtained at 500 MHz in CDCl3 and standardized to residual CHCl3. 
d 1H NMR spectra
was obtained at 400 MHz in CDCl3 and standardized to residual CHCl3. 
e 1H NMR was obtained in CDCl3
at unknown MHz. f Little reports this signal as 3H, however HSQC data indicates only 2H for this range
(see Figure 5.22.4).
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(–)-daucene (142)
14
1
45
8
10 15
12
13
11
9
3
2
7
6
Table 3.4, Part 2.  Comparison of 1H NMR Data for synthetic and reported53 daucene (2).a–b
Assignment Synthetic
142 (ppm)b
Multiplicity,
J (Hz)
Yamasaki22
142 (ppm)e
Multiplicity,
J (Hz)
Naegeli21
142 (ppm)e
Multiplicity,
J (Hz)
C1 — — — — — —
C2 1.59 ddd, 11.9, 6.7,
5.1
1.52 dt, 12.2, 8.5
C3 2.17 ddt, 8.7, 6.7, 2.2
C4 — — — — — —
C5 — — — — — —
C6 2.44–2.36 m
1.86–1.78 m
C7 2.05–1.99 m
C8 — — — — — —
C9 5.42 ddt, 9.2, 5.6, 1.5 5.37 t, 5 5.44 t, 6.5
C10 2.08–2.03 m
1.94 dd, 14.1, 7.8
C11 2.66 sept, 6.8
C12 0.98 d, 6.9 0.99 d, 5 1.00 d, 6.5
C13 0.92 d, 6.9 0.92 d, 5 0.92 d, 6.5
C14 1.74 t, 1.6 1.73 s 1.75 br s
C15 0.91 s 0.94 s 0.91 s
a See Figure 5.22.1 for 1H NMR spectra. b Blank spaces in table represent neglected or unreported signals. c
1H NMR spectra was obtained at 500 MHz in CDCl3 and standardized to residual CHCl3. 
d 1H NMR spectra
was obtained at 400 MHz in CDCl3 and standardized to residual CHCl3. 
e 1H NMR was obtained in CDCl3
at unknown MHz.
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(–)-daucene (142)
14
1
45
8
10 15
12
13
11
9
3
2
7
6
Table 3.5.  Comparison of 13C NMR data for synthetic and reported daucene (142).a
Assignment Synthetic 142
(ppm)b
Little27 142
(ppm)c
Seto25 142
(ppm)d
C1 49.7 49.7 49.7
C2 38.7 38.7 38.7
C3 27.3 27.3 27.3
C4 138.8 138.9 138.8
C5 142.0 142.1 142.0
C6 22.7 22.7 22.6
C7 33.7 33.7 33.6
C8 139.9 140.0 139.7
C9 122.8 122.9 122.8
C10 40.5 40.6 40.5
C11 26.6 26.6 26.5
C12 22.0 22.1 21.9
C13 21.4 21.4 21.2
C14 26.1 26.2 25.9
C15 23.7 23.7 23.6
a See Figure 5.22.3 for 13C NMR spectra. b 13C NMR spectra was obtained at 125 MHz in CDCl3 and
standardized to residual CHCl3. 
c 13C NMR spectra was obtained at 100 MHz in CDCl3 and standardized to
residual CHCl3. 
d 13C NMR was obtained in CDCl3 at unknown MHz
(–)-daucene (142)
14
1
45
8
10 15
12
13
11
9
3
2
7
6
Table 3.6.  Comparison of optical rotation data for synthetic and reported daucene (142).a
Synthetic 142 (+)-Natural11a 142 Yamasaki22 142 Mehta23 142
[$]D
25 = –24.95
(c 1.37, CHCl3, 86% ee)
[$]D
25 = +23.32
(c unspecified)
[$]D
25 = –21.5
(c 0.8, EtOH)
[$]D
25 = –20
(c 1.00)
a Daucene has been isolated from a number of sources.11  Both (+)-11]  and (–)-daucene11b–c have been
isolated from nature, however the optical rotation has only been determined for natural (+)-daucene.
Yamasaki and Mehta, though, have reported rotations for synthetic (–)-daucene.
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(+)-daucenal (143)
14
1
45
8
10 15
12
13
11
H
O
9
3
2
7
6
Table 3.7.  Comparison of 1H NMR data for synthetic and natural daucenal (143).a
Assignment Synthetic
143 (ppm)b
Multiplicity,
J (Hz)
Natural13
143 (ppm)c
Multiplicity,
J (Hz)
C1 — — — —
C2 1.55 dtd, 12.6, 6.8, 1.2 1.550 dd, 12.4, 7.4
1.47 dtd,12.4, 7.7, 1.1 1.471 dd, 12.4, 7.4
C3 2.13 ddd, 8.5, 5.1, 1.9 2.125 br ddd, 7.7, 7.4, 2.9
C4 — — — —
C5 — — — —
C6 2.33 ddd, 14.1, 5.5, 3.1 2.330 ddd, 14.0, 5.4, 3.0
1.62 br ddt, 14.5, 10.1, 2.4 1.616 br ddd, 14.5, 14.0, 2.9
C7 3.06 ddd, 15.2, 5.4, 2.7 3.049 ddd, 14.9, 15.4, 2.9
1.76 br tdd, 14.2, 3.4, 1.6 1.763 br dddd, 14.9, 14.5,
3.0, 2.0
C8 — — — —
C9 6.10 dddd, 8.4, 5.2, 2.0,
1.1
6.101 ddd, 8.2, 5.2, 2.0
C10 2.05 dd, 14.3, 5.2 2.053 br dd, 14.3, 5.2
1.94 ddd, 14.3, 8.2, 1.1 1.935 dd, 14.3, 8.2
C11 2.51 sept, 6.7 2.512 sept, 6.9
C12 0.90 dd, 6.9, 1.1 0.897 d, 6.9
C13 0.88 dd, 6.9, 1.1 0.869 d, 6.9
C14 9.26 d, 1.1 9.263 s
C15 0.81 s 0.811 s
a See Figure 5.24.1 for 1H NMR spectra. b 1H NMR spectra was obtained at 500 MHz in C6D6 and
standardized to residual C6H6. 
c 1H NMR spectra was obtained at 500 MHz in C6D6 and standardized to
TMS.
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(+)-daucenal (143)
14
1
45
8
10 15
12
13
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H
O
9
3
2
7
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Table 3.8.  Comparison of 13C NMR data for synthetic and natural daucenal (143).a
Assignment Synthetic 143
(ppm)b
Natural13 143
(ppm)c
C1 49.8 49.8
C2 39.2 41.7d
C3 27.4 27.4
C4 140.3 141.0
C5 141.0 146.7e
C6 22.4 24.0
C7 24.0 22.4
C8 146.8 140.2e
C9 152.8 152.8
C10 41.7 39.2d
C11 26.7 26.7
C12 21.9 21.7
C13 21.3 21.2
C14 193.0 193.0
C15 24.2 24.2
a See Figure 5.24.3 for 13C NMR spectra. b 13C NMR spectra was obtained at 125 MHz in C6D6 and
standardized to residual C6H6. 
c 13C NMR spectra was obtained at 125 MHz in C6D6 and standardized to
TMS. d C2 and C10 were misassigned, see 2D NMR spectra, Figures 5.24.4–6. e C5 and C8 were
misassigned, see 2D NMR spectra, Figures 5.24.4–6.
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14
1
45
8
10 15
12
13
11
O 9
3
2
7
6
O
O
1'
2'
3'
4'
7'
6'
5'
8'
(+)-14-p-anisoyloxydauc-4,8-diene (145)
Table 3.9.  Comparison of 1H NMR data for synthetic and natural15,1a 14-p-anisoyloxydauc-4,8-diene
(145).a–b
Assignment Synthetic
145 (ppm)c
Multiplicity,
J (Hz)
Natural15
145 (ppm)d
Multiplicity, J
(Hz)
C1 — — — —
C2 1.64 dt, 12.3, 6.1
1.56 dt, 12.4, 8.3
C3 2.19 ddd, 8.2, 6.0, 2.2
C4 — — — —
C5 — — — —
C6 2.49 ddd, 13.9, 5.7, 2.8
1.88 dddd, 14.6, 12.3, 5.0, 2.5
C7 2.25 ddd, 14.6, 5.8, 2.8
2.07 tm, 13.5
C8 — — — —
C9 5.85 ddp, 7.3, 5.0, 1.1 5.86 br t, 6.5
C10 2.20–2.14 m
2.07 dd, 14.1, 8.1
C11 2.67 sept, 6.9 2.69 sept
C12 0.98 d, 6.9 0.98 d, 7.2
C13 0.93 d, 6.8 0.93 d, 7.2
C14 4.70 d, 1.1 4.70 br s
C15 0.95 s 0.95 s
C1' — — — —
C2' — — — —
C3'/ C7' 6.92 dm, 8.9 6.93 d, 9.1
C4'/C6’ 8.01 dm, 8.9 8.01 d, 9.1
C5' — — — —
C8' 3.86 s 3.86 s
a See Figure 5.26.1 for 1H NMR spectra. b Blank spaces in table represent neglected or unreported signals. c
1H NMR spectra was obtained at 500 MHz in CDCl3 and standardized to residual CDCl3. 
d 1H NMR spectra
was obtained at 200 MHz in CDCl3 and standardized to TMS.
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(51) Example procedure for the preparation of a samarium diiodide solution: A flame-
dried 50 mL Schlenk tube equipped with a stir bar was connected to an Ar-filled
manifold, loaded with samarium metal (311.3 mg, 2.07 mmol, 1.45 equiv), and
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an authentic sample provided by the Seto group (Ref. 25).  Consequently, Mehta’s
data has been neglected from the table.
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Scheme A4.1.  Route to key intermediate enone 223.
i-BuO
O
i-BuO
O
CO2allyl
i-BuO
O
N
O
Ph2P
t-Bu1. LDA, THF, –78 °C;
   allyl cyanoformate
2. MeI, Cs2CO3
    CH3CN, 80 °C
(S)-t-BuPHOX (3.12 mol %)
Pd2(pmdba)3 (1.25 mol %)
toluene, 30 °C
79% yield, 2 steps
94% yield, 88% ee
15 g scale
24a66 27a
3
10% aq HCl
 THF, 23 °C
O
O
79
95% yield
NaH, THF, 23 °C
    
then TIPSOTf
–78!23 °C
86% yield
3:1 regioselectivity
12% recovered 79
TIPSO
O
230a
75% yield based 
on recovered 79
O
TIPSO
230b
23% yield based 
on recovered 79
+
MgBri. CeCl3,
   THF, 23 °C
ii. sodium phosphate
    buffer (pH 6.5)
iii. TBAF, LiOH, TFE
     THF
O
O
112 (10 mol %)
CH2Cl2, 35 °C
99% yield
O
KOH/EtOH (3 M)
EtOH, 23 °C
88% yield
72w 235 O 223
7 steps, 40% yield
Grubbs–Hoveyda 
2nd generation catalyst
RuCl
Cl
NN
O
112
O
Scheme A4.2.  Synthesis of (–)-epoxydaucenal B (144b).
1.                    
    THF, reflux
2. Rh(PPh3)3Cl 
    (22 mol %)
    H2 (1 atm)
    benzene
PPh3H2C
71% yield
2 steps
255
one diastereomer
O
O
LiOH
30% aq H2O2
MeOH, 23 °C
94% yield
256
O SeO2, SiO2
THF, 80 °C
sealed
87% yield
OHC
(–)-epoxydaucenal B 
(144b) 12 steps, 20% yield
O
223
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Scheme A4.3.  Synthesis of (–)-daucene (142), (+)-daucenal (143), and (+)-14-p-anisoyloxydauc-
4,8-diene (145) and formal syntheses of epoxydaucenal A and B (144a and 144b).
(–)-daucene (142)
70% yield
10 steps, 15% yield
PbCl2, Zn
CH2I2, TiCl4
THF/CH2Cl2
23 °C
60% yield 260
H2 (1 atm)
Rh(PPh3)3Cl
(15 mol %)
benzene
23 °C
261
17% yield
1:1 d.r. at C(8)
+
8
223
O
SeO2, SiO2
THF, 80 °C
sealed
51% yield
OHC
(+)-daucenal (143)
11 steps, 8% yield
DMAP, Et3N
p-anisoyl chloride
CH2Cl2, 0!23 °C
(+)-14-p-anisoyloxydauc-4,8-diene 
(145) 13 steps, 4% yield
CeCl3 • 7H2O, NaBH4
MeOH, 0!23 °C
263
HO
O
O
MeO
m-CPBA
CHCl3, 23 °C
OHC
epoxydaucenal A
(144a, "-i-Pr) 12 steps, 3% yield
O
Previous
Semi-
Synthesis
58% yield
A:B = 70:30
81% yield
based on recovered 143
61% yield
epoxydaucenal B
(144b, #-i-Pr) 12 steps, 1% yield
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Figure A5.1.2.  Infrared spectrum (thin film/NaCl) of compound 70w. 
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Figure A5.2.2.  Infrared spectrum (thin film/NaCl) of compound 53w. 
Figure A5.2.3.  13C NMR (125 MHz, CDCl3) of compound 53w. 
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Figure A5.3.2.  Infrared spectrum (thin film/NaCl) of compound 72w. 
Figure A5.3.3.  13C NMR (125 MHz, CDCl3) of compound 72w. 
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Figure A5.4.2.  Infrared spectrum (thin film/NaCl) of compound 230a. 
Figure A5.4.3.  13C NMR (125 MHz, C6D6) of compound 230a. 
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Figure A5.5.2.  Infrared spectrum (thin film/NaCl) of compound 230b. 
Figure A5.5.3.  13C NMR (125 MHz, C6D6) of compound 230b. 
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Figure A5.6.2.  Infrared spectrum (thin film/NaCl) of compound 223. 
Figure A5.6.3.  13C NMR (125 MHz, CDCl3) of compound 223. 
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Figure A5.7.2.  Infrared spectrum (thin film/NaCl) of compound 235. 
Figure A5.7.3.  13C NMR (125 MHz, CDCl3) of compound 235. 
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Figure A5.8.2.  Infrared spectrum (thin film/NaCl) of compound 249. 
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Figure A5.9.2.  Infrared spectrum (thin film/NaCl) of compound 250. 
Figure A5.9.3.  13C NMR (125 MHz, C6D6) of compound 250. 
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Figure A5.10.2.  Infrared spectrum (thin film/NaCl) of compound 251. 
Figure A5.10.3.  13C NMR (125 MHz, CDCl3) of compound 251. 
APPENDIX 5 — Spectra Relevant to Chapter 3 
 
 
 820 
F
ig
u
re
 A
5
.1
1
.1
. 
 1
H
 N
M
R
 (
5
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 2
5
2
. 
O
H
2
5
2
!
"
#
$
%
&
'
(
)
*
"
!
+
+
,
APPENDIX 5 — Spectra Relevant to Chapter 3 
 
821 
 
 
 
 
 
!"!#!$!%!&!!&"!&#!&$!&%!"!!""!
''(
Figure A5.11.2.  Infrared spectrum (thin film/NaCl) of compound 252. 
Figure A5.11.3.  13C NMR (125 MHz, CDCl3) of compound 252. 
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Figure A5.12.2.  Infrared spectrum (thin film/NaCl) of compound 253. 
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Figure A5.13.2.  Infrared spectrum (thin film/NaCl) of compound 255. 
Figure A5.13.3.  13C NMR (125 MHz, C6D6) of compound 255. 
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Figure A5.14.2.  Infrared spectrum (thin film/NaCl) of compound 264. 
Figure A5.14.3.  13C NMR (125 MHz, CDCl3) of compound 264. 
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Figure A5.15.2.  Infrared spectrum (thin film/NaCl) of compound 256. 
Figure A5.15.3.  13C NMR (125 MHz, CDCl3) of compound 256. 
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Figure A5.16.2.  Infrared spectrum (thin film/NaCl) of compound 144b. 
Figure A5.16.3.  13C NMR (125 MHz, C6D6) of compound 144b. 
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Figure A5.17.2.  Infrared spectrum (thin film/NaCl) of compound 257a. 
Figure A5.17.3.  13C NMR (125 MHz, C6D6) of compound 257a. 
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Figure A5.18.2.  Infrared spectrum (thin film/NaCl) of compound 257b. 
Figure A5.18.3.  13C NMR (125 MHz, C6D6) of compound 257b. 
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Figure A5.19.2.  Infrared spectrum (thin film/NaCl) of compound 259. 
Figure A5.19.3.  13C NMR (125 MHz, CDCl3) of compound 259. 
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Figure A5.20.2.  Infrared spectrum (thin film/NaCl) of compound 260. 
Figure A5.20.3.  13C NMR (125 MHz, CDCl3) of compound 260. 
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Figure A5.21.2.  Infrared spectrum (thin film/NaCl) of compound 262. 
Figure A5.21.3.  13C NMR (125 MHz, CDCl3) of compound 262. 
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Figure A5.22.2.  Infrared spectrum (thin film/NaCl) of compound 142. 
Figure A5.22.3.  13C NMR (125 MHz, CDCl3) of compound 142. 
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Figure A5.23.2.  Infrared spectrum (thin film/NaCl) of compound 261. 
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Figure A5.24.2.  Infrared spectrum (thin film/NaCl) of compound 143. 
Figure A5.24.3.  13C NMR (125 MHz, C6D6) of compound 143. 
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Figure A5.25.2.  Infrared spectrum (thin film/NaCl) of compound 263. 
Figure A5.25.3.  13C NMR (125 MHz, CDCl3) of compound 263. 
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Figure A5.26.2.  Infrared spectrum (thin film/NaCl) of compound 145. 
Figure A5.26.3.  13C NMR (125 MHz, CDCl3) of compound 145. 
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APPENDIX 6
X-Ray Crystallography Reports Relevant to Chapter 3:
Unified Approach to Daucane and Sphenolobane
Bicyclo[5.3.0]decane core: Enantioselective Synthesis of
Four Daucane Sesquiterpenes and Related Molecules
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A6.1 CRYSTAL STRUCTURE ANALYSIS OF 262
OH
OH
Compound 262
(NBB04)
Contents
Table A6.1.  Crystal data.
Table A6.2.  Atomic coordinates.
Table A6.3.  Full bond distances and angles.
Table A6.4.  Anisotropic displacement parameters.
Table A6.5.  Hydrogen coordinates and isotropic displacement parameters.
Table A6.6.  Hydrogen bond distances and angles.
Figure A6.1.  Diol 262.
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Table A6.1.  Crystal data and structure analysis details for diol 262.
Empirical formula C28 H42 O2
Formula weight 410.61
Crystallization solvent CH2Cl2/hexanes
Crystal shape blade
Crystal color colourless
Crystal size 0.09 x 0.25 x 0.48 mm
Data Collection
Preliminary photograph(s) rotation
Type of diffractometer Bruker APEX-II CCD
Wavelength 0.71073 ! MoK
Data collection temperature 100 K
Theta range for 9010 reflections used
in lattice determination 2.71 to 27.56"
Unit cell dimensions a = 9.7419(3) ! != 90"
b = 10.9851(4) ! "= 90"
c = 23.6134(8) ! # = 90"
Volume 2527.01(15) !3
Z 4
Crystal system orthorhombic
Space group P 21 21 21   (# 19)
Density (calculated) 1.079 g/cm3
F(000) 904
Theta range for data collection 2.0 to 37.4"
Completeness to theta = 25.000" 100.0%
Index ranges -14 $ h $ 16, -17 $ k $ 17, -37 $ l $ 40
Data collection scan type and scans
Reflections collected 61255
Independent reflections 11770 [Rint= 0.0700]
Reflections > 2%(I) 8166
Average %(I)/(net I) 0.0702
Absorption coefficient 0.06 mm-1
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 1.0000 and 0.9369
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Table A6.1 (cont.)
Structure Solution and Refinement
Primary solution method dual
Secondary solution method ?
Hydrogen placement difmap
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 11770 / 0 / 439
Treatment of hydrogen atoms refall
Goodness-of-fit on F2 1.53
Final R indices [I>2%(I), 8166 reflections] R1 = 0.0571, wR2 = 0.0678
R indices (all data) R1 = 0.1007, wR2 = 0.0719
Type of weighting scheme used calc
Weighting scheme used
Max shift/error 0.000
Average shift/error 0.000
Absolute structure parameter 0.4(4)
Extinction coefficient 0
Largest diff. peak and hole 0.35 and -0.31 e#!-3
Programs Used
Cell refinement  SAINT V8.18C (Bruker-AXS, 2007)
Data collection  APEX2_2012.4-3 (Bruker-AXS, 2007)
Data reduction  SAINT V8.18C (Bruker-AXS, 2007)
Structure solution  SHELXT (Sheldrick, 2012)
Structure refinement  SHELXL-2012 (Sheldrick, 2012)
Graphics DIAMOND 3 (Crystal Impact, 1999)
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Table A6.2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103)
for diol 262.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
________________________________________________________________________________
x y z U
eq
________________________________________________________________________________  
O(1) 7807(1) 6932(1) 5090(1) 17(1)
O(2) 5443(1) 7868(1) 5280(1) 21(1)
C(1) 7808(1) 7750(1) 5565(1) 15(1)
C(2) 8110(2) 9030(1) 5338(1) 21(1)
C(3) 8843(1) 7404(1) 6018(1) 17(1)
C(4) 9476(2) 8399(1) 6383(1) 26(1)
C(5) 10151(2) 7684(2) 6859(1) 32(1)
C(6) 10488(1) 6435(1) 6606(1) 24(1)
C(7) 10388(2) 5445(2) 7068(1) 35(1)
C(8) 10753(2) 4178(2) 6892(1) 37(1)
C(9) 10009(2) 3526(2) 6538(1) 36(1)
C(10) 8761(2) 4065(2) 6255(1) 30(1)
C(11) 9140(2) 5120(1) 5853(1) 21(1)
C(12) 9400(1) 6320(1) 6138(1) 17(1)
C(13) 11929(2) 6439(2) 6345(1) 29(1)
C(14) 10366(3) 2243(2) 6373(1) 53(1)
C(15) 6276(1) 7657(1) 5776(1) 16(1)
C(16) 5932(2) 6374(1) 5986(1) 25(1)
C(17) 5928(1) 8596(1) 6225(1) 17(1)
C(18) 6114(2) 8266(1) 6844(1) 27(1)
C(19) 6028(2) 9496(2) 7140(1) 35(1)
C(20) 5128(1) 10286(1) 6756(1) 26(1)
C(21) 5581(2) 11630(2) 6799(1) 37(1)
C(22) 4725(2) 12522(2) 6476(1) 42(1)
C(23) 4670(2) 12550(1) 5919(1) 38(1)
C(24) 5474(2) 11644(1) 5572(1) 31(1)
C(25) 4939(2) 10347(1) 5641(1) 24(1)
C(26) 5380(1) 9708(1) 6175(1) 18(1)
C(27) 3610(2) 10146(2) 6918(1) 39(1)
C(28) 3765(3) 13405(2) 5594(1) 58(1)
________________________________________________________________________________
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Table A6.3.  Bond lengths [Å] and angles [°] for diol 262.
O(1)-H(1) 0.805(16)
O(1)-C(1) 1.4370(15)
O(2)-H(2) 0.785(18)
O(2)-C(15) 1.4447(16)
C(1)-C(2) 1.5345(18)
C(1)-C(3) 1.5172(18)
C(1)-C(15) 1.5763(18)
C(2)-H(2A) 0.985(16)
C(2)-H(2B) 0.971(14)
C(2)-H(2C) 0.961(15)
C(3)-C(4) 1.5230(18)
C(3)-C(12) 1.3393(17)
C(4)-H(4A) 0.989(15)
C(4)-H(4B) 1.009(16)
C(4)-C(5) 1.521(2)
C(5)-H(5A) 1.017(17)
C(5)-H(5B) 0.992(16)
C(5)-C(6) 1.532(2)
C(6)-C(7) 1.543(2)
C(6)-C(12) 1.5371(19)
C(6)-C(13) 1.534(2)
C(7)-H(7A) 1.008(15)
C(7)-H(7B) 0.975(16)
C(7)-C(8) 1.496(2)
C(8)-H(8) 0.989(16)
C(8)-C(9) 1.318(2)
C(9)-C(10) 1.508(2)
C(9)-C(14) 1.503(3)
C(10)-H(10A) 0.978(15)
C(10)-H(10B) 0.962(16)
C(10)-C(11) 1.544(2)
C(11)-H(11A) 0.969(14)
C(11)-H(11B) 0.999(13)
C(11)-C(12) 1.5015(19)
C(13)-H(13A) 0.948(16)
C(13)-H(13B) 0.955(16)
C(13)-H(13C) 0.997(17)
C(14)-H(14A) 1.013(19)
C(14)-H(14B) 0.99(2)
C(14)-H(14C) 0.96(2)
C(15)-C(16) 1.5310(19)
C(15)-C(17) 1.5181(19)
C(16)-H(16A) 1.011(16)
C(16)-H(16B) 0.986(15)
C(16)-H(16C) 0.969(15)
C(17)-C(18) 1.5160(19)
C(17)-C(26) 1.3383(17)
C(18)-H(18A) 0.987(15)
C(18)-H(18B) 0.984(16)
C(18)-C(19) 1.524(2)
C(19)-H(19A) 0.965(18)
C(19)-H(19B) 1.018(17)
C(19)-C(20) 1.532(2)
C(20)-C(21) 1.544(2)
C(20)-C(26) 1.5297(19)
C(20)-C(27) 1.536(2)
C(21)-H(21A) 0.977(16)
C(21)-H(21B) 0.985(19)
C(21)-C(22) 1.496(3)
C(22)-H(22) 0.912(16)
C(22)-C(23) 1.317(2)
C(23)-C(24) 1.508(2)
C(23)-C(28) 1.500(3)
C(24)-H(24A) 1.005(18)
C(24)-H(24B) 0.989(17)
C(24)-C(25) 1.526(2)
C(25)-H(25A) 0.956(14)
C(25)-H(25B) 1.020(16)
C(25)-C(26) 1.5056(19)
C(27)-H(27A) 1.034(18)
C(27)-H(27B) 0.963(19)
C(27)-H(27C) 0.952(18)
C(28)-H(28A) 0.96(2)
C(28)-H(28B) 0.97(2)
C(28)-H(28C) 1.03(2)
C(1)-O(1)-H(1) 106.8(11)
C(15)-O(2)-H(2) 104.6(14)
O(1)-C(1)-C(2) 107.47(11)
O(1)-C(1)-C(3) 113.13(10)
O(1)-C(1)-C(15) 101.87(10)
C(2)-C(1)-C(15) 110.59(11)
C(3)-C(1)-C(2) 110.41(11)
C(3)-C(1)-C(15) 112.98(10)
C(1)-C(2)-H(2A) 107.8(9)
C(1)-C(2)-H(2B) 111.5(8)
C(1)-C(2)-H(2C) 108.5(8)
H(2A)-C(2)-H(2B) 109.6(12)
H(2A)-C(2)-H(2C) 111.1(12)
H(2B)-C(2)-H(2C) 108.4(11)
C(1)-C(3)-C(4) 119.21(11)
C(12)-C(3)-C(1) 129.90(11)
C(12)-C(3)-C(4) 110.74(11)
C(3)-C(4)-H(4A) 111.0(9)
C(3)-C(4)-H(4B) 109.0(9)
H(4A)-C(4)-H(4B) 109.5(12)
C(5)-C(4)-C(3) 102.85(12)
C(5)-C(4)-H(4A) 112.8(9)
C(5)-C(4)-H(4B) 111.5(9)
C(4)-C(5)-H(5A) 113.1(9)
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Table A6.3 (cont.)
C(4)-C(5)-H(5B) 108.3(9)
C(4)-C(5)-C(6) 105.53(12)
H(5A)-C(5)-H(5B) 109.5(13)
C(6)-C(5)-H(5A) 112.6(9)
C(6)-C(5)-H(5B) 107.7(8)
C(5)-C(6)-C(7) 110.03(12)
C(5)-C(6)-C(12) 101.88(11)
C(5)-C(6)-C(13) 110.53(14)
C(12)-C(6)-C(7) 114.03(13)
C(13)-C(6)-C(7) 110.13(12)
C(13)-C(6)-C(12) 109.99(12)
C(6)-C(7)-H(7A) 107.2(8)
C(6)-C(7)-H(7B) 105.2(9)
H(7A)-C(7)-H(7B) 106.7(12)
C(8)-C(7)-C(6) 116.39(13)
C(8)-C(7)-H(7A) 109.7(8)
C(8)-C(7)-H(7B) 111.2(9)
C(7)-C(8)-H(8) 117.3(9)
C(9)-C(8)-C(7) 123.48(16)
C(9)-C(8)-H(8) 119.1(9)
C(8)-C(9)-C(10) 120.73(15)
C(8)-C(9)-C(14) 123.12(17)
C(14)-C(9)-C(10) 116.11(18)
C(9)-C(10)-H(10A) 110.7(8)
C(9)-C(10)-H(10B) 110.0(9)
C(9)-C(10)-C(11) 111.99(13)
H(10A)-C(10)-H(10B) 103.8(13)
C(11)-C(10)-H(10A) 109.9(9)
C(11)-C(10)-H(10B) 110.1(9)
C(10)-C(11)-H(11A) 108.6(8)
C(10)-C(11)-H(11B) 107.2(8)
H(11A)-C(11)-H(11B) 107.9(11)
C(12)-C(11)-C(10) 115.05(13)
C(12)-C(11)-H(11A) 109.8(8)
C(12)-C(11)-H(11B) 108.1(8)
C(3)-C(12)-C(6) 111.04(12)
C(3)-C(12)-C(11) 128.09(12)
C(11)-C(12)-C(6) 120.75(11)
C(6)-C(13)-H(13A) 111.1(10)
C(6)-C(13)-H(13B) 110.5(9)
C(6)-C(13)-H(13C) 111.6(9)
H(13A)-C(13)-H(13B) 109.9(13)
H(13A)-C(13)-H(13C) 105.9(12)
H(13B)-C(13)-H(13C) 107.7(12)
C(9)-C(14)-H(14A) 110.7(10)
C(9)-C(14)-H(14B) 110.9(11)
C(9)-C(14)-H(14C) 111.9(12)
H(14A)-C(14)-H(14B) 105.5(15)
H(14A)-C(14)-H(14C) 107.3(15)
H(14B)-C(14)-H(14C) 110.3(16)
O(2)-C(15)-C(1) 105.36(10)
O(2)-C(15)-C(16) 106.67(11)
O(2)-C(15)-C(17) 109.40(10)
C(16)-C(15)-C(1) 111.65(10)
C(17)-C(15)-C(1) 112.85(10)
C(17)-C(15)-C(16) 110.57(11)
C(15)-C(16)-H(16A) 107.9(8)
C(15)-C(16)-H(16B) 112.2(9)
C(15)-C(16)-H(16C) 108.1(9)
H(16A)-C(16)-H(16B) 109.2(12)
H(16A)-C(16)-H(16C) 109.2(13)
H(16B)-C(16)-H(16C) 110.2(13)
C(18)-C(17)-C(15) 118.92(11)
C(26)-C(17)-C(15) 130.37(12)
C(26)-C(17)-C(18) 110.58(12)
C(17)-C(18)-H(18A) 114.0(9)
C(17)-C(18)-H(18B) 109.2(9)
C(17)-C(18)-C(19) 102.90(12)
H(18A)-C(18)-H(18B) 105.4(12)
C(19)-C(18)-H(18A) 112.9(9)
C(19)-C(18)-H(18B) 112.6(8)
C(18)-C(19)-H(19A) 112.8(10)
C(18)-C(19)-H(19B) 107.9(10)
C(18)-C(19)-C(20) 105.16(13)
H(19A)-C(19)-H(19B) 108.5(14)
C(20)-C(19)-H(19A) 111.8(10)
C(20)-C(19)-H(19B) 110.5(10)
C(19)-C(20)-C(21) 109.76(13)
C(19)-C(20)-C(27) 110.28(14)
C(26)-C(20)-C(19) 101.77(11)
C(26)-C(20)-C(21) 114.20(12)
C(26)-C(20)-C(27) 109.69(13)
C(27)-C(20)-C(21) 110.79(13)
C(20)-C(21)-H(21A) 107.1(9)
C(20)-C(21)-H(21B) 105.3(10)
H(21A)-C(21)-H(21B) 104.7(14)
C(22)-C(21)-C(20) 115.65(14)
C(22)-C(21)-H(21A) 112.5(9)
C(22)-C(21)-H(21B) 110.7(10)
C(21)-C(22)-H(22) 118.4(11)
C(23)-C(22)-C(21) 123.13(16)
C(23)-C(22)-H(22) 118.4(11)
C(22)-C(23)-C(24) 120.46(16)
C(22)-C(23)-C(28) 123.33(18)
C(28)-C(23)-C(24) 116.10(17)
C(23)-C(24)-H(24A) 109.3(10)
C(23)-C(24)-H(24B) 109.6(10)
C(23)-C(24)-C(25) 112.35(14)
H(24A)-C(24)-H(24B) 104.7(14)
C(25)-C(24)-H(24A) 112.1(10)
C(25)-C(24)-H(24B) 108.4(9)
C(24)-C(25)-H(25A) 109.1(8)
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Table A6.3 (cont.)
C(24)-C(25)-H(25B) 107.3(8)
H(25A)-C(25)-H(25B) 105.6(13)
C(26)-C(25)-C(24) 115.28(13)
C(26)-C(25)-H(25A) 108.5(8)
C(26)-C(25)-H(25B) 110.6(9)
C(17)-C(26)-C(20) 111.30(11)
C(17)-C(26)-C(25) 127.83(12)
C(25)-C(26)-C(20) 120.72(11)
C(20)-C(27)-H(27A) 112.1(10)
C(20)-C(27)-H(27B) 109.8(11)
C(20)-C(27)-H(27C) 111.4(10)
H(27A)-C(27)-H(27B) 109.9(15)
H(27A)-C(27)-H(27C) 108.5(15)
H(27B)-C(27)-H(27C) 104.9(15)
C(23)-C(28)-H(28A) 109.4(14)
C(23)-C(28)-H(28B) 106.8(11)
C(23)-C(28)-H(28C) 109.9(10)
H(28A)-C(28)-H(28B) 111.7(16)
H(28A)-C(28)-H(28C) 110.4(17)
H(28B)-C(28)-H(28C) 108.6(16)
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Table A6.4.  Anisotropic displacement parameters (Å2 x 104) for diol 262.  The anisotropic
displacement factor exponent takes the form: –2&2[ h2a*2U11 + ... + 2 h k a* b* U12 ].
______________________________________________________________________________
U
11
U
22
 U
33
U
23
U
13
U
12
______________________________________________________________________________
O(1) 148(5) 184(5) 165(5) -13(4) 16(4) 7(4)
O(2) 170(5) 245(5) 208(5) -55(4) -40(4) 47(4)
C(1) 133(6) 143(6) 169(6) -7(5) 9(5) 4(5)
C(2) 201(8) 170(7) 251(8) 14(6) 48(7) -10(6)
C(3) 123(6) 219(7) 161(6) -31(5) 18(5) 7(5)
C(4) 186(7) 299(8) 292(8) -123(6) -23(6) 25(7)
C(5) 210(8) 520(10) 242(8) -139(7) -71(7) 72(8)
C(6) 167(7) 396(8) 164(7) -14(6) -15(6) 79(7)
C(7) 234(9) 631(12) 173(7) 81(7) -1(7) 102(8)
C(8) 284(9) 541(11) 288(9) 234(8) 46(8) 158(8)
C(9) 337(9) 365(9) 366(9) 216(8) 109(8) 137(8)
C(10) 289(9) 277(8) 330(9) 98(7) 26(8) 55(7)
C(11) 226(8) 205(7) 187(7) 34(6) -11(6) 61(6)
C(12) 130(6) 261(7) 131(6) 2(5) 21(5) 34(5)
C(13) 182(8) 415(10) 264(8) 0(8) -20(6) 79(7)
C(14) 528(13) 376(11) 696(16) 219(10) 35(12) 193(10)
C(15) 119(6) 178(6) 194(7) 26(5) -3(5) 16(5)
C(16) 157(8) 215(8) 391(9) 55(7) 63(7) -13(6)
C(17) 114(6) 236(7) 160(6) 30(5) 14(5) 3(5)
C(18) 240(8) 375(9) 186(7) 84(6) 36(6) 79(7)
C(19) 361(10) 525(11) 153(7) -13(7) -4(7) 130(9)
C(20) 235(8) 346(8) 183(7) -45(6) 24(6) 89(7)
C(21) 397(10) 425(10) 284(9) -176(8) -9(8) 63(8)
C(22) 486(11) 288(9) 487(11) -176(8) 3(10) 115(8)
C(23) 470(11) 200(8) 466(11) -64(7) -14(9) 82(7)
C(24) 408(10) 235(8) 289(9) 31(6) 16(8) 68(7)
C(25) 297(9) 216(7) 203(7) -30(6) -45(6) 100(7)
C(26) 133(6) 244(7) 159(6) -15(5) -12(5) 14(6)
C(27) 309(10) 506(12) 366(11) -18(9) 117(8) 128(9)
C(28) 779(17) 299(10) 669(16) 27(11) 5(14) 248(12)
______________________________________________________________________________
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Table A6.5.  Hydrogen coordinates (x 103) and isotropic displacement parameters (Å2 x 103) for diol
262.
________________________________________________________________________________
x y z U
iso
________________________________________________________________________________
H(1) 854(2) 700(1) 494(1) 29(5)
H(2) 584(2) 754(2) 503(1) 43(6)
H(2A) 745(2) 920(1) 503(1) 28(4)
H(2B) 802(1) 964(1) 563(1) 21(4)
H(2C) 904(2) 905(1) 520(1) 19(4)
H(4A) 877(2) 897(1) 652(1) 28(4)
H(4B) 1018(2) 886(1) 615(1) 30(4)
H(5A) 1099(2) 811(1) 702(1) 45(5)
H(5B) 946(2) 756(1) 716(1) 30(4)
H(7A) 942(2) 546(1) 722(1) 26(4)
H(7B) 1098(2) 573(1) 737(1) 34(5)
H(8) 1163(2) 384(1) 704(1) 36(4)
H(10A) 825(2) 344(1) 605(1) 25(4)
H(10B) 812(2) 434(1) 654(1) 28(4)
H(11A) 842(1) 521(1) 557(1) 18(4)
H(11B) 1000(1) 488(1) 565(1) 15(3)
H(13A) 1210(2) 570(1) 615(1) 30(4)
H(13B) 1204(2) 712(1) 610(1) 29(4)
H(13C) 1266(2) 650(1) 664(1) 36(5)
H(14A) 959(2) 167(2) 647(1) 59(6)
H(14B) 1049(2) 217(2) 596(1) 54(6)
H(14C) 1117(2) 196(2) 657(1) 61(6)
H(16A) 611(2) 579(1) 566(1) 29(4)
H(16B) 649(2) 614(1) 632(1) 25(4)
H(16C) 496(2) 635(1) 608(1) 31(4)
H(18A) 698(2) 783(1) 692(1) 29(4)
H(18B) 538(2) 771(1) 696(1) 26(4)
H(19A) 566(2) 944(1) 752(1) 45(5)
H(19B) 700(2) 984(2) 716(1) 44(5)
H(21A) 655(2) 1166(1) 669(1) 26(4)
H(21B) 557(2) 1182(2) 721(1) 49(5)
H(22) 418(2) 1304(1) 668(1) 40(5)
H(24A) 648(2) 1171(2) 567(1) 44(5)
H(24B) 542(2) 1187(1) 517(1) 40(5)
H(25A) 522(1) 987(1) 532(1) 21(4)
H(25B) 389(2) 1038(1) 562(1) 37(5)
H(27A) 332(2) 924(2) 694(1) 56(6)
H(27B) 344(2) 1055(2) 727(1) 52(6)
H(27C) 303(2) 1054(2) 665(1) 40(5)
H(28A) 328(2) 1393(2) 586(1) 79(7)
H(28B) 436(2) 1386(2) 534(1) 50(6)
H(28C) 307(2) 1292(2) 535(1) 58(6)
________________________________________________________________________________
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Table A6.6.  Hydrogen bonds for diol 262 [Å and °].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
 O(1)-H(1)...O(2)#1 0.805(16) 1.927(17) 2.7217(14) 169.1(16)
 O(2)-H(2)...O(1) 0.785(18) 2.035(17) 2.5617(14) 124.4(17)
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APPENDIX 7
Notebook Cross-Reference
The following notebook cross-reference has been included to facilitate access to
the original spectroscopic data obtained for the compounds presented in this thesis.  For
each compound, both hard copy and electronic characterization folders have been created
that contain copies of the original 1H NMR, 13C NMR, 19F NMR, 31P NMR, 2H NMR,
COSY, HSQC, HMBC, NOESY, IR spectra.  Additionally, HRMS and X-ray data can
also be found in these files.  All notebooks and spectral data are stored in the Stoltz
Group archives.
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Table A7.1.  Notebook cross-reference for compounds in Chapter 1.
compound chemical structure 1H NMR 13C NMR IR
4i N
O
O
OO
NBB-IX-63A NBB-IX-63A NBB-IX-63A
4j N
O
O
OO
DCD-IV-067 DCD-IV-067 DCD-IV-067
5i N
OO
NBB-IX-83A NBB-IX-83A NBB-IX-83A
5j N
OO
DCD-IV-103 DCD-IV-103 DCD-IV-103
6c N
O
O
O
O DCBIII_123 DCBIII_123 DCBIII_123
6d N
O
O
O
O
O JK-V-81 JK-V-81 JK-V-81
6e N
O
O
O
O
O JK-V-91 JK-V-91 JK-V-91
7c N
O
O
DCBIII_127_final DCBIII_127_final DCBIII_127
7d N
O
O
O
JK-V-83-chiral JK-V-83-chiral JK-V-83-chiral
7e N
O
O
O
JK-V-93-chiral JK-V-93-chiral JK-V-93-chiral
13b
O
O
OO
NBB-VIII-281A NBB-VIII-281A NBB-VIII-281A
13c
O
O
O
NBB-IX-301-2B NBB-IX-301-2B NBB-IX-301-2B
13d
O
O
O
NBB-X-15-2B NBB-X-15-2B NBB-X-15-2B
16a
O
N
O
O
NBB-VII-203A NBB-VII-203A NBB-VII-203A
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16b
O
N
O
O
NBB-VII-205-2C NBB-VII-205-2C NBB-VII-205-2B
16c
O
N
O
O
H
NBB-VI-289A NBB-VI-289A NBB-VI-289A
16d
O
N
O
O
O NBB-VII-
227&241 Frac
10–21
NBB-VII-
227&241 Frac
10–21
NBB-VII-
227&241 Frac
10–21
16e
O
N
O
O
O
DCD-IV-217 DCD-IV-217 DCD-IV-217
16f
O
N
O
O
O
O
NBB-VII-221A NBB-VII-221A NBB-VII-221A
16g
O
N
O
O
S
O
O
NBB-VII-189A NBB-VII-189A NBB-VII-189A
16h
O
N
O
O
H
O
DCD-IV-215 DCD-IV-215 DCD-IV-215
16i
O
N
O
O
H
O
DCD-IV-213 DCD-IV-213 DCD-IV-213
16j
O
H2N
O
O
NBB-VII-299
Crystal 1
NBB-VII-299
Crystal 1
NBB-VII-299
Crystal 1
17
O
O
O
O
NBB-VII-235A NBB-VII-235A NBB-VII-235A
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18
O
N
O
O
O
O
NBB-VII-81B NBB-VII-81B NBB-VII-81B
20
I
O
O
O
NBB-VII-289B NBB-VII-289B NBB-VII-289B
21c
O
DCD-V-057 DCD-V-057 DCD-V-057
21d
O
DCD-V-059 DCD-V-059 DCD-V-059
23a
O
N NBB-VIII-83-2A NBB-VIII-83-2A NBB-VIII-83-2A
23b
O
N NBB-VIII-85-2A NBB-VIII-85-2A NBB-VIII-85-2A
23d
O
N
O
NBB-IX-257A NBB-IX-257A NBB-IX-257A
23e
O
N
O
NBB-IX-259-3A NBB-IX-259-3A NBB-IX-259-3A
23f
O
NO
O
NBB-VIII-87A NBB-VIII-87A NBB-VIII-87A
23g
O
N
S
O
O
NBB-VIII-89A NBB-VIII-89A NBB-VIII-89A
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29a N
O
O
O
OO
ANM-I-105 ANM-I-105 ANM-I-130
29b N
O
O
O
WBL-III-083C-H WBL-III-083C-H WBL-III-083
29c
N
O
O
O
WBL-III-073-C-H WBL-III-073-C-H WBL-III-073
29d
N
O
O
O
O
O
WBL-II-253 WBL-II-253 WBL-II-253
30a N
O
OO
ANM-I-110 ANM-I-110 ANM-I-109
30b N
O
WBL-III-085-C-H WBL-III-085-C-H WBL-III-085
30c
N
O
WBL-III-077-C-H WBL-III-077-C-H WBL-III-077
30d
N
O
O
O
WBL-II-267-H_C WBL-II-267-H_C WBL-II-267
41
O
O
I
O
NBB-VIII-153A NBB-VIII-153A NBB-VIII-153A
44
O
O
OOH
NBB-VIII-247B — NBB-VIII-247B
45a
O
O
O
O char_DCD-III_251 char_DCD-III_251 char_DCD-III_251
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45b
O
O
O
O
DCD-III-253 DCD-III-253 DCD-III-253-2
46a
O
O char_DCD-IV-021 char_DCD-IV-021 char_DCD-IV-021
46b
O
O
DCD-IV-201 DCD-IV-201 DCD-IV-201
48b N
O
O
O
WBL-III-075-2 WBL-III-041H-C WBL-III-041
48c N
O
WBL-III-065-1-
C-H
WBL-III-065-1-
C-H
WBL-III-065-1
48d
N
O
O
O
WBL-II-249-2 WBL-II-249-2 —
50 N
O
O
O
DCD-III-281 DCD-III-281 DCD-III-281
Table A7.2.  Notebook cross-reference for compounds in Chapter 2.
compound chemical structure 1H NMR 13C NMR IR
14a
i-BuO
O
O
O
AYH-VIII-137A AYH-VIII-137A AYH-VIII-137A
22a
i-BuO
O
AYH-VIII-139A AYH-VIII-139A AYH-VIII-139A
24a
O
i-BuO
O
O
MRK_VI_
227B_1H
MRK_VI_
227B_13C
IBuOTsujiSub2
24b
O
i-BuO
O
O
AYH-V-285A AYH-V-285A AYH-V-285A
24c
O
i-BuO
Ph
O
O
AYH-V-293Bnew AYH-V-293B AYH-V-293B
24d
O
i-BuO
O
O
AYH-VI-71B AYH-VI-71B AYH-VI-71B
APPENDIX 7 — Notebook Cross-Reference 878
24e
O
i-BuO
O
O
AYH-VI-273A AYH-VI-273A AYH-VI-273A
24f
O
i-BuO
O
O
AYH-VI-
105Anew
AYH-VI-105A AYH-VI-105A
24g
O
i-BuO
O
O
Cl
AYH-VI-
151Anew
AYH-VI-151A AYH-VI-151A
24h
O
i-BuO
O
O
NC
AYH-VI-183Bnew AYH-VI-147D AYH-VI-147D
24i
O
i-BuO
O
O
N
AYH-VII-49B2 AYH-VII-49B2 AYH-VII-49B2
24j O
i-BuO
N
Ts
O
O
AYH-VII-127B AYH-VII-127B AYH-VII-127B
24k
O
i-BuO
O
H
O
O
AYH-VI-257Bnew AYH-VI-257B AYH-VI-257B
24l
O
i-BuO
F
O
O AYH-VI-37Ax AYH-VI-37A AYH-VI-37A
24m
O
i-BuO
OTBDPS
O
O
AYH-VI-251Bx3 AYH-VI-251Bx3 AYH-VI-237B
24n
O
i-BuO
O
O
O
O
Ph
AYH-VI-225Bnew AYH-VI-225B AYH-VI-225B
24ac
O
i-BuO
H
N
O
O
AYH-VII-117B AYH-VII-117B AYH-VII-117B
24ad
O
i-BuO
OH
O
O
AYH-VI-233Bnew AYH-VI-233B AYH-VI-233B2
27a
O
i-BuO
MRK_VII_
33B_1H
MRK_VII_
33B_13C
MRK_VII_33B
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27b
O
i-BuO
AYH-VI-29A AYH-VI-29A AYH-VI-29A
27c
O
i-BuO
Ph
AYH-VI-27A AYH-VI-27A AYH-VI-27A
27d
O
i-BuO
AYH-VI-101A AYH-VI-73A AYH-VI-73A
27e
O
i-BuO
AYH-VI-279A AYH-VI-279A AYH-VI-279A
27f
O
i-BuO
AYH-VI-125A AYH-VI-121A AYH-VI-121A
27g
O
i-BuO
Cl AYH-VI-
165Anew
AYH-VI-165A AYH-VI-165A
27h
O
i-BuO
CN
AYH-VI-155Bnew AYH-VI-157B AYH-VI-157B
27i
O
i-BuO
N
AYH-VII-57Cnew AYH-VII-53C AYH-VII-53C
27j O
i-BuO
N Ts
AYH-VII-135Bx AYH-VII-135Bx AYH-VII-135Bx
27k
O
i-BuO
OH
AYH-VI-269A AYH-VI-269A AYH-VI-269A
27l
O
i-BuO
F
AYH-VI-61Anew AYH-VI-43A AYH-VI-43A
27m
O
i-BuO
OTBDPS
AYH-VI-255A AYH-VI-255A AYH-VI-255A
27n
O
i-BuO
O
Ph
O
AYH-VI-229Bnew AYH-VI-229B AYH-VI-229B
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27o
O
i-BuO
OTBDPS
AYH-VIII-295Ax AYH-VIII-295Ax AYH-VIII-207A
27p
O
i-BuO
TJ-VII-127B TJ-VII-101 TJ-VII-101
27q
O
i-BuO
AYH-VIII-233A AYH-VIII-219B AYH-VIII-219B
53a
O
TJ_III_67_1H TJ_III_67_13C TJ_III_67
53b
O
AYH-VI-99A AYH-VI-99A AYH-VI-99A
53c
O
Ph
AYH-VI-59A AYH-VI-59A AYH-VI-59A
53d
O
AYH-VI-113Ax AYH-VI-113A AYH-VI-113A
53e
O
AYH-VI-291A AYH-VI-291A AYH-VI-291A
53f
O
AYH-VIII-293A AYH-VI-133A AYH-VI-133A
53g
O
Cl
AYH-VI-169A AYH-VI-169A AYH-VI-169A
53h
O
CN
AYH-VI-163A AYH-VI-163A AYH-VI-163A
53i
O
N
AYH-VIII-303A AYH-VIII-303A AYH-VIII-277Ax
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53j
O
N
Ts AYH-VII-141A AYH-VII-141A AYH-VII-141A
53m
O
OTBDPS
AYH-VIII-163A AYH-VIII-163A AYH-VI-289A
53n
O
OH
AYH-IX-107B AYH-IX-107B AYH-IX-107B
53o
OTBDPS
O
AYH-VIII-215A AYH-VIII-215A AYH-VIII-215A
53p
O
TJ-VII-141 TJ-VII-141 TJ-VII-141
53q
O
AYH-VIII-223A AYH-VIII-223A AYH-VIII-223A
53r
O
n-Bu
NBB-V-227A NBB-V-227A NBB-V-227A
55a
O
TJ-III-55A TJ-III-55A TJ-III-55A
55r
O
n-Bu
NBB-II-57B NBB-I-161 NBB-II-227B
55t
O
NBB-VI-51B NBB-VI-51B NBB-VI-41B
55u
O
NBB-VI-79B NBB-VI-79B NBB-VI-79B
55v
O
NBB-VI-97C NBB-VI-97C NBB-VI-97C
55w
O
NBB-V-301B NBB-V-301B NBB-V-301B
APPENDIX 7 — Notebook Cross-Reference 882
55x
O
NBB-VI-85A NBB-VI-85A NBB-VI-85A
55y
O
Ph
NBB-VI-245-2B NBB-VI-245-2B NBB-VI-245-2B
55z
O
NBB-VI-69-2A NBB-VI-69-2A NBB-VI-69-2A
55aa
O
NBB-VI-223-2B NBB-VI-223-2B NBB-VI-223-2B
55ab
O
O
NBB-VI-123-2A NBB-VI-123-2A NBB-VI-123-2A
55ac
O
S
NBB-VI-63B NBB-VI-63B NBB-VI-63B
66
i-BuO
O
MRK_VI_
201B_1H
MRK_VI_
201B_13C
MRK_VII_135B
67
Ph2P N
O
MRK-XI-133
flash again
MRK-XI-133
flash again
MRK-XI-133
flash
68
O
AYH-VIII-141A AYH-VIII-141A AYH-VIII-141A
70a
O
HO
TJ-III-55B TJ-III-55B TJ-III-55B
70b
HO
O
AYH-VI-97B AYH-VI-97B AYH-VI-97B
70c
HO
O
Ph
AYH-VI-57B AYH-VI-57B AYH-VI-57B
70d
HO
O
AYH-VI-111B AYH-VI-111B AYH-VI-111B
70e
HO
O
AYH-VI-287B AYH-VI-287B AYH-VI-287B
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70f
HO
O
AYH-VI-131B AYH-VI-131B AYH-VI-131B
70g
HO
O
Cl
AYH-VI-167B AYH-VI-167B AYH-VI-167B
70h
HO
O
CN
AYH-VI-161C AYH-VI-161C AYH-VI-161C
70i
HO
O
N
AYH-IX-53C AYH-IX-53C AYH-IX-53C
70j HO
O
N Ts
AYH-VII-137AB AYH-VII-137AB AYH-VII-137AB
70m
HO
O
OTBDPS
AYH-VI-161BC AYH-VI-161BC AYH-VI-161BC
70n
HO
O
OH
AYH-IX-105F AYH-IX-105F AYH-IX-105F
70o
HO
O
OTBDPS
AYH-VIII-213A AYH-VIII-213A AYH-VIII-213A
70p
HO
O
TJ-VII-133B TJ-VII-133B TJ-VII-103B
70q
HO
O
AYH-VIII-221B AYH-VIII-221B AYH-VIII-221B
70r
O
OHn-Bu
NBB-II-41C NBB-II-61B NBB-II-61B
72r
n-Bu
O
O
NBB-VII-39A NBB-VII-39A NBB-VII-39A
77
O
HO
AYH-X-245E AYH-X-245E2 AYH-X-245E2
79
O
O
NBB-VI-281A NBB-VI-281A NBB-VI-281A
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80
N
H
N NH2
O
TJ-III-83E TJ-III-83E TJ-III-83E
81
N
H
N
H
N
O
I
TJ-III-135B TJ-III-135B TJ-III-135B
82
OH
TJ-VIII-249 TJ-VIII-249 TJ-VIII-249
83
N
OH
AYH-VIII-157C AYH-VIII-157C AYH-VIII-157C
84
N
NHTs
AYH-VIII-151Cx AYH-VIII-151C AYH-VIII-151C
85
O
O
AYH-VIII-75A AYH-VIII-75Ax2 AYH-VIII-75A
86
O
O
H
AYH-VIII-111Bx AYH-VIII-111B AYH-VIII-111Bx2
87
O
HO TJ-VII-303A TJ-VII-303A TJ-VII-303A
88
N
O
O
AYH-VII-119A AYH-VII-119A AYH-VII-119A
89
O
AYH-VIII-79A AYH-VII-173C AYH-VII-173Cx
90
O
O TJ-VII-177 TJ-VII-177 TJ-VII-177
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91
O
TJ-VIII-225 TJ-VIII-225 TJ-VIII-225
92
OH
TJ-VIII-87 TJ-VIII-87 TJ-VIII-87
93
O
AYH-IX-59B AYH-IX-59B AYH-IX-59B
95
O
Cl
AYH-IX-93B AYH-IX-93B AYH-IX-93B
97
OH
CO2Me
CO2Me
AYH-VIII-253D AYH-VIII-253D AYH-VIII-253D
100
O
TfO TJ-VIII-101B TJ-VIII-101B TJ-VII-41
102
O
H TJ-VIII-181 TJ-VIII-181 TJ-VIII-181
110
O
n-Pr
NBB-VI-299A NBB-VI-299A NBB-VI-299A
111t
O
NBB-VI-167B NBB-VI-167B NBB-VI-167B
111u
O
NBB-VI-113A NBB-VI-113A NBB-VI-113A
111v
O
NBB-VI-101A NBB-VI-101A NBB-VI-101A
111w
O
NBB-VI-65A NBB-VI-65A NBB-VI-65A
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111x
O
NBB-VI-93-2B NBB-VI-93-2B NBB-VI-93-2B
111y
O
NBB-VI-255C NBB-VI-255C NBB-VI-255B
111z
O
NBB-VI-89A NBB-VI-89A NBB-VI-89A
111aa
O
NBB-VI-199A NBB-VI-199A NBB-VI-199A
114
O
NBB-VI-215A NBB-VI-215A NBB-VI-215A
115
O
NBB-VI-187-2A NBB-VI-187A NBB-VI-187A
116
O
NBB-VI-249B NBB-VI-243-2B NBB-VI-249B
117a
O
O
H
NBB-VI-213B NBB-VI-213B NBB-VI-213B
117b
O
O
H
NBB-VI-213F NBB-VI-213F NBB-VI-213F
127
Br N
O TJ-I-91 TJ-I-91 TJ-I-91-3
128
Ph2P N
O TJ-PHOX TJ-PHOX TJ-I-263A
129
Br N
O
TJ-III-143A TJ-III-143 TJ-III-143
130
O
O
AYH-VII-293F AYH-VII-293F AYH-VII-293F
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131
O
O
H
AYH-VIII-109C AYH-VIII-109C AYH-VIII-109C
132
OH
O
AYH-VI-191B AYH-VI-191B AYH-VI-191B
133
O
NBB-VI-207B NBB-VI-207B NBB-VI-207B
Table A7.3.  Notebook cross-reference for compounds in Chapter 3.
compound chemical structure 1H NMR 13C NMR IR
53w
O
NBB-IV-125B NBB-IV-125B NBB-IV-125B
70w
O
HO
NBB-V-67-2B — NBB-V-67-2B
72w
O
O
NBB-VIII-243-3A NBB-VIII-243-3A NBB-VIII-243-3A
142 NBB-IX-231D NBB-IX-231D NBB-IX-231D
143
O
H
NBB-IX-275A NBB-IX-261-2A NBB-IX-261-2A
144b
OHC
O
NBB-X-149B NBB-X-149B NBB-X-149B
145
O
O
O
NBB-X-29A NBB-X-29A NBB-X-29A
223
O
NBB-IX-139B NBB-VIII-257A NBB-VIII-257A
230a
O
TIPSO
NBB-V-221A NBB-V-221A NBB-V-221A
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230b
TIPSO
O
NBB-IX-65C NBB-V-221C NBB-IX-65C
235
O
O
NBB-IX-137B NBB-VIII-255B NBB-VIII-255B
249
O
O
NBB-IX-113A — NBB-IX-113A
250
O
O NBB-X-25-2A NBB-X-25-2A NBB-X-25-2A
251
O
HO NBB-X-77C NBB-X-77C NBB-X-77C
252
OH
NBB-IX-161B NBB-IX-161B NBB-IX-161B
253
OH
NBB-IX-229D — NBB-IX-229D
255
O
O
NBB-IX-177A NBB-IX-177A NBB-IX-177A
256
O
NBB-X-147A NBB-X-147A NBB-X-147A
257a
O
OH
NBB-IX-235C NBB-IX-235C NBB-IX-235C
257b
O
OH
NBB-X-63G NBB-X-63G NBB-X-63G
259
OH
NBB-X-127A NBB-X-127A NBB-X-127A
260 NBB-IX-233A NBB-IX-233A NBB-IX-233A
261 NBB-IX-231B NBB-IX-231B NBB-IX-231B
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262
OH
OH
NBB-IX-233E NBB-IX-233E NBB-IX-233E
263
HO
NBB-IX-275C_D NBB-IX-275C_D NBB-IX-275C+D
264
O
NBB-X-97A NBB-X-97A NBB-X-97A
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